Publication Type,Authors,Book Authors,Book Editors,Book Group Authors,Author Full Names,Book Author Full Names,Group Authors,Article Title,Source Title,Book Series Title,Book Series Subtitle,Language,Document Type,Conference Title,Conference Date,Conference Location,Conference Sponsor,Conference Host,Author Keywords,Keywords Plus,Abstract,Addresses,Affiliations,Reprint Addresses,Email Addresses,Researcher Ids,ORCIDs,Funding Orgs,Funding Name Preferred,Funding Text,Cited References,Cited Reference Count,"Times Cited, WoS Core","Times Cited, All Databases",180 Day Usage Count,Since 2013 Usage Count,Publisher,Publisher City,Publisher Address,ISSN,eISSN,ISBN,Journal Abbreviation,Journal ISO Abbreviation,Publication Date,Publication Year,Volume,Issue,Part Number,Supplement,Special Issue,Meeting Abstract,Start Page,End Page,Article Number,DOI,DOI Link,Book DOI,Early Access Date,Number of Pages,WoS Categories,Web of Science Index,Research Areas,IDS Number,Pubmed Id,Open Access Designations,Highly Cited Status,Hot Paper Status,Date of Export,UT (Unique WOS ID),Web of Science Record
J,"Liu, T; Cui, B; Zhong, J; Yu, K; Zhao, Z; Tao, L; Ren, X",,,,"Liu, T.; Cui, B.; Zhong, J.; Yu, K.; Zhao, Z.; Tao, L.; Ren, X.",,,SITUATION AND IMPACT OF INSULIN PEN NEEDLE REUSE FOR PATIENTS WITH DIABETES IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Liu, T.; Yu, K.; Zhao, Z.] Beijing Tiantan Hosp, Beijing, Peoples R China; [Cui, B.; Zhong, J.] Peking Univ, Beijing, Peoples R China; [Tao, L.] Beijing Med Econ Res Assoc, Beijing, Peoples R China; [Ren, X.] Becton Dickinson Med Devices Shanghai Co Ltd, Shanghai, Peoples R China",Capital Medical University; Peking University; Becton Dickinson,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD2,A857,A857,,10.1016/j.jval.2016.08.438,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303096,0
J,"Lu, W; Chuang, H; Chen, L; Hsiao, F",,,,"Lu, W.; Chuang, H.; Chen, L.; Hsiao, F.",,,DISEASE BURDEN OF HERPES ZOSTER IN TAIWAN: A FIVE-YEAR POPULATION BASED STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lu, W.; Chuang, H.; Hsiao, F.] Natl Taiwan Univ, Taipei, Taiwan; [Chen, L.] Taipei Vet Gen Hosp, Taipei, Taiwan",National Taiwan University; Taipei Veterans General Hospital,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN5,A908,A909,,10.1016/j.jval.2016.08.153,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303385,0
J,"Maciel, H; Salazar-Alvarado, BE; Paladio-Hernández, JA",,,,"Maciel, H.; Salazar-Alvarado, B. E.; Paladio-Hernandez, J. A.",,,COST MINIMIZATION ANALYSIS FOR THE TREATMENT OF PRIMARY IMMUNODEFICIENCY DISEASE (PIDD) IN THE MEXICAN SOCIAL SECURITY INSTITUTE IN 2016,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Maciel, H.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [Salazar-Alvarado, B. E.] Inst Nacl Pediat, Mexico City, DF, Mexico; [Paladio-Hernandez, J. A.] UACH, Cuautitlan, Mexico",Universidad Nacional Autonoma de Mexico,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND44,A432,A433,,10.1016/j.jval.2016.09.498,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300468,0
J,"Mahlich, JC; Sruamsiri, R",,,,"Mahlich, J. C.; Sruamsiri, R.",,,TREATMENT PATTERNS OF RHEUMATOID ARTHRITIS IN JAPANESE HOSPITALS AND PREDICTORS OF INITIATION BIOLOGIC AGENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mahlich, J. C.] Janssen KK, Tokyo, Japan; [Sruamsiri, R.] Janssen Pharmaceut KK, Tokyo, Japan",Johnson & Johnson; Janssen Pharmaceuticals,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS20,A918,A918,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606303439,0
J,"Martin, A",,,,"Martin, A.",,,PRO INSTRUMENTS FOR MUSCULOSKELETAL DISORDERS USED IN STUDIES PUBLISHED SINCE 2005: WHICH DISEASES HAVE HAD THE MOST TOOLS DEVELOPED?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Martin, A.] Crystallise Ltd, London, England",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS69,A543,A543,,10.1016/j.jval.2016.09.1137,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301252,0
J,"McKendrick, J; Zyczynski, T; Kudlac, A; Davis, C; Cella, D",,,,"McKendrick, J.; Zyczynski, T.; Kudlac, A.; Davis, C.; Cella, D.",,,PATIENT-REPORTED OUTCOMES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE OVERALL AND JAPANESE POPULATIONS FROM ELOQUENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[McKendrick, J.; Kudlac, A.] PRMA Consulting Ltd, Fleet, England; [Zyczynski, T.; Davis, C.] Bristol Myers Squibb, Princeton, NJ USA; [Cella, D.] Northwestern Univ, Chicago, IL 60611 USA",Bristol-Myers Squibb; Northwestern University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN45,A891,A892,,10.1016/j.jval.2016.08.254,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303289,0
J,"Migliore, A",,,,"Migliore, A.",,,A NETWORK METANALYSIS TO COMPARE BIOLOGIC AGENTS IN THE TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Migliore, A.] S Pietro Fatebenefratelli Hosp, Rome, Italy",,,,"Alberto, Migliore/AAX-9382-2020",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS4,A604,A604,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301581,0
J,"Mogulkoc, N; Okumus, G; Yildizeli, B; Kaymaz, C; Nalbantgil, S; Ozdemir, O; Erdal, E; Sar, C",,,,"Mogulkoc, N.; Okumus, G.; Yildizeli, B.; Kaymaz, C.; Nalbantgil, S.; Ozdemir, O.; Erdal, E.; Sar, C.",,,THE DIRECT COST-COMPONENTS IN PULMONARY ARTERIAL HYPERTENSION: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mogulkoc, N.; Nalbantgil, S.] Ege Univ, Fac Med, Izmir, Turkey; [Okumus, G.] Istanbul Univ, Fac Med, Istanbul, Turkey; [Yildizeli, B.] Marmara Univ, Fac Med, Istanbul, Turkey; [Kaymaz, C.] Kosuyolu Training & Res Hosp, Istanbul, Turkey; [Ozdemir, O.] Yorum Consulting Ltd, Istanbul, Turkey; [Erdal, E.; Sar, C.] Bayer Turk Kimya San Ltd Sti, Istanbul, Turkey",Ege University; Istanbul University; Marmara University; Istanbul Kartal Kosuyolu Yuksek Ihtisas Training & Research Hospital; Yorum Consultancy Ltd; Bayer Turkey,,,"Mogulkoc, Nesrin/ABG-2839-2020; Okumus, Gulfer/AAE-4618-2020","Mogulkoc, Nesrin/0000-0003-1870-5669;",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV57,A646,A646,,10.1016/j.jval.2016.09.1725,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301813,0
J,"Moital, I; Carrasco, J; Cardoso, I; Mesquita, D; Felix, J; Vandewalle, B",,,,"Moital, I; Carrasco, J.; Cardoso, I; Mesquita, D.; Felix, J.; Vandewalle, B.",,,ESTIMATING THE IMPACT ASSOCIATED TO THE USE OMALIZUMAB IN THE TREATMENT OF SEVERE PERSISTENT ALLERGIC ASTHMA IN PORTUGAL EVALUATING OUTCOMES AND TREATMENT COSTS USING REAL WORLD DATA FROM PORTUGUESE PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Moital, I; Carrasco, J.; Mesquita, D.] Novartis Farma Portugal, Porto Salvo, Portugal; [Cardoso, I] Novartis Farma Prod Farmaceut SA, Porto Salvo, Portugal; [Felix, J.] Exigo Consultores, Alhos Vedros, Portugal; [Vandewalle, B.] Exigo Consultores, Lisbon, Portugal",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS41,A555,A556,,10.1016/j.jval.2016.09.1209,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301320,0
J,"Murphy, J; Goodall, G",,,,"Murphy, J.; Goodall, G.",,,WHEN COST SAVING TECHNOLOGIES ARE NOT ADOPTED DESPITE EVIDENCE AND PAYER RECOMMENDATIONS - INTRAOPERATIVE FLUID MANAGEMENT (I0FM) IN THE UK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Murphy, J.] Edwards Lifesci, Newbury, Berks, England; [Goodall, G.] Edwards Lifesci, Nyon, Switzerland",Edwards Lifesciences; Edwards Lifesciences,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD108,A704,A704,,10.1016/j.jval.2016.09.2050,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302263,0
J,"Ng, DB; Sherman, S; Desroziers, K; Gooch, K",,,,"Ng, D. B.; Sherman, S.; Desroziers, K.; Gooch, K.",,,DEFINING EPISODES OF CARE FOR CHRONIC DISEASES: A TARGETED LITERATURE REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ng, D. B.; Gooch, K.] Astellas Pharma Global Dev Inc, Northbrook, IL USA; [Sherman, S.] Creativ Ceut, Chicago, IL USA; [Desroziers, K.] Creativ Ceut, Paris, France",Astellas Pharmaceuticals,,,,,,,,,0,0,0,2,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP345,A500,A501,,10.1016/j.jval.2016.09.894,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301028,0
J,"Ni, W; Jiang, Y",,,,"Ni, W.; Jiang, Y.",,,EVALUATE THE COST-EFFECTIVE THRESHOLD OF OSTEOPOROSIS TREATMENT ON ELDERLY WOMEN IN CHINA USING DISCRETE EVENT SIMULATION MODEL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ni, W.; Jiang, Y.] Univ Southern Calif, Los Angeles, CA USA",University of Southern California,,,"Ni, Weiyi/AAV-4344-2020",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS10,A916,A916,,10.1016/j.jval.2016.08.112,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303430,0
J,"Oh, S; Cho, H; Lee, H; Kang, H",,,,"Oh, S.; Cho, H.; Lee, H.; Kang, H.",,,ASSESSING THE ECONOMIC BURDEN OF HEART FAILURE IN KOREA: INCREMENTAL COST APPROACH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Oh, S.; Cho, H.; Lee, H.; Kang, H.] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea",Yonsei University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV53,A645,A645,,10.1016/j.jval.2016.09.1721,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301809,0
J,"Panasiuk, A; Homa, M; Pawlik, D; Przda-Machno, P; Kaczor, MP",,,,"Panasiuk, A.; Homa, M.; Pawlik, D.; Przda-Machno, P.; Kaczor, M. P.",,,TREATMENT SWITCHING PROBLEM IN CANCER CLINICAL TRIALS -IMPLICATIONS FOR HEALTH TECHNOLOGY APPRAISAL OUTCOMES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Panasiuk, A.; Homa, M.; Pawlik, D.] Aestimo Sc, Krakow, Poland; [Przda-Machno, P.] Pfizer Polska Sp Zoo, Warsaw, Poland; [Kaczor, M. P.] Jagiellonian Univ, Coll Med, Krakow, Poland",Pfizer; Jagiellonian University; Collegium Medicum Jagiellonian University,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN277,A758,A758,,10.1016/j.jval.2016.09.2353,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302556,0
J,"Pang, Y; Ip, M; You, J",,,,"Pang, Y.; Ip, M.; You, J.",,,COST-EFFECTIVENESS OF ACTIVE SURVEILLANCE OF BETA-D-GLUCAN IN INTENSIVE CARE UNITS IN HONG KONG,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pang, Y.; Ip, M.; You, J.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China",Chinese University of Hong Kong,,,"You, Joyce H. S./C-2984-2008; Ip, Margaret/K-1096-2013","You, Joyce H. S./0000-0002-5763-7403; Ip, Margaret/0000-0003-1291-6537",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD60,A695,A695,,10.1016/j.jval.2016.09.2001,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302216,0
J,"Parviainen, L; Belgaied, W; Sediri, Y; Haijeji, B; Rémuzat, C; Toumi, M",,,,"Parviainen, L.; Belgaied, W.; Sediri, Y.; Haijeji, B.; Remuzat, C.; Toumi, M.",,,EARLY MARKET ACCESS FOR PHARMACEUTICALS IN EU: WHAT IS THE IMPACT OF EMA'S ACCELERATED ASSESSMENT PROCEDURE?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Parviainen, L.] Creat Ceut, Rotterdam, Netherlands; [Belgaied, W.; Sediri, Y.; Haijeji, B.] Creat Ceut, Tunis, Tunisia; [Remuzat, C.] Creat Ceut, Paris, France; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP168,A469,A469,,10.1016/j.jval.2016.09.710,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300666,0
J,"Perreault, S; de Denus, S; White, M; White-Guay, B; Dorais, M; Dubé, M; Rouleau, J",,,,"Perreault, S.; de Denus, S.; White, M.; White-Guay, B.; Dorais, M.; Dube, M.; Rouleau, J.",,,"RISK OF MORTALITY AND HOSPITAL READMISSION AMONG OLDER ADULTS WITH HEART FAILURE TREATED WITH CARVEDILOL, BIS OPROLOL OR METOPROLOL TARTRATE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Perreault, S.; de Denus, S.; White-Guay, B.; Rouleau, J.] Univ Montreal, Montreal, PQ, Canada; [White, M.; Dube, M.] Montreal Heart Inst, Montreal, PQ, Canada; [Dorais, M.] StatSiences Inc, Notre Dame Llle Perrot, PQ, Canada",Universite de Montreal; Universite de Montreal,,,"Perreault, Sylvie/AAM-8009-2020; Dubé, Marie-Pierre/B-9364-2008","Perreault, Sylvie/0000-0002-0066-0127; Dubé, Marie-Pierre/0000-0001-8442-4393",,,,,0,0,5,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV8,A637,A637,,10.1016/j.jval.2016.09.1675,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301764,0
J,"Piche-Richard, V; Mathurin, K; Savoie, M; Lachaine, J",,,,"Piche-Richard, V; Mathurin, K.; Savoie, M.; Lachaine, J.",,,DEVELOPMENT OFA GLOBAL MODEL FOR THE ECONOMIC EVALUATION OF PERSONALIZED MEDICINE FOR THE TREATMENT OF PROSTATE CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Piche-Richard, V; Mathurin, K.] PeriPharm Inc, Montreal, PQ, Canada; [Savoie, M.; Lachaine, J.] Univ Montreal, Montreal, PQ, Canada",Universite de Montreal,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN176,A740,A740,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302458,0
J,"Pietzsch, JB; Weber, SA; Pietzsch, ML; Conradi, L",,,,"Pietzsch, J. B.; Weber, S. A.; Pietzsch, M. L.; Conradi, L.",,,ADOPTION OF TRANS CATHETER MITRAL VALVE REPAIR IN GERMANY: UTILIZATION PATTERNS AND CASE VOLUMES COMPARED TO MITRAL VALVE SURGERY IN THE PERIOD 2010-2014,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pietzsch, J. B.] Wing Tech Inc, Irvine, CA USA; [Weber, S. A.; Pietzsch, M. L.] Cellogic GmbH, Berlin, Germany; [Conradi, L.] Univ Heart Ctr Hamburg, Hamburg, Germany",University of Hamburg; University Medical Center Hamburg-Eppendorf,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,MD3,A356,A356,,10.1016/j.jval.2016.09.061,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300050,0
J,"Piniazhko, O; Zalis'ka, O; Zah, V",,,,"Piniazhko, O.; Zalis'ka, O.; Zah, V",,,ELICITING PAYERS PREFERENCES IN CENTRAL AND EASTERN EUROPE: RESULTS OF MCDA CASE STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Piniazhko, O.; Zalis'ka, O.] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine; [Zah, V] Hlth Economist, Belgrade, Serbia",Danylo Halytsky Lviv National Medical University,,,"Zaliska, Olha/AAN-6078-2020; Zah, Vlad/AAI-9140-2020","Zaliska, Olha/0000-0003-1845-7909; Zah, Vlad/0000-0003-1368-4491",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM59,A367,A367,,10.1016/j.jval.2016.09.124,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300110,0
J,"Plommet, N; Boissard, F",,,,"Plommet, N.; Boissard, F.",,,COST-EFFECTIVENESS ANALYSIS OF GAZYVARO IN ASSOCIATION TO CHLORAMBUCIL FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WHEN FULL-DOSE FLUDARABINE IS UNSUITABLE IN FRANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Plommet, N.; Boissard, F.] Roche SAS, Boulogne, France",,,,,,,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN172,A739,A739,,10.1016/j.jval.2016.09.2246,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302454,0
J,"Polistena, B; Spandonaro, F; Gasperini, C; Gb, Z; Santoni, L; Fantaccini, S; Capra, R",,,,"Polistena, B.; Spandonaro, F.; Gasperini, C.; Gb, Zimatore; Santoni, L.; Fantaccini, S.; Capra, R.",,,THE SOCIETAL IMPACT OF NATALIZUMAB TREATMENT IN THE ITALIAN RELAPSING-REMITTING MULTIPLE SCLEROSIS CLINICAL PRACTICE: THE TYSABRI PHARMACOECONOMICS (TYPE) STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Polistena, B.; Spandonaro, F.] Univ Roma Tor Vergata, Rome, Italy; [Gasperini, C.] S Camillo Forlanini Hosp, Dept Neurosci, Rome, Italy; [Gb, Zimatore] PO Dimiccoli, UO Neurol, Barletta, Italy; [Santoni, L.] Biogen, Milan, Italy; [Fantaccini, S.; Capra, R.] Spedali Civil Brescia, Multiple Sclerosis Ctr, Brescia, Italy",University of Rome Tor Vergata; Azienda Ospedaliera San Camillo-Forlanini; Hospital Spedali Civili Brescia,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND51,A434,A434,,10.1016/j.jval.2016.09.505,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300475,0
J,"Pomorski, MK; Matusewicz, W; Lipinska, A",,,,"Pomorski, M. K.; Matusewicz, W.; Lipinska, A.",,,TYPES OF RISK-SHARING SCHEMES PROPOSED IN REIMBURSEMENT APLICATION RECEIVED BY AOTMIT IN 2015,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pomorski, M. K.; Matusewicz, W.; Lipinska, A.] Agcy Hlth Technol Assessment & Tariff Syst, Warsaw, Poland",,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP343,A500,A500,,10.1016/j.jval.2016.09.892,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301026,0
J,"Psenkova, M; Mackovicova, S; Holocsi, L; Klapac, J; Sedlakova, K",,,,"Psenkova, M.; Mackovicova, S.; Holocsi, L.; Klapac, J.; Sedlakova, K.",,,PARALLEL EXPORT AND ITS IMPACT ON AVAILABILITY OF DRUGS IN SLOVAKIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Psenkova, M.; Mackovicova, S.; Holocsi, L.; Klapac, J.] Pharm In Ltd, Bratislava, Slovakia; [Sedlakova, K.] Comenius Univ, Fac Pharm, Bratislava, Slovakia",Comenius University Bratislava,,,"Šulcová, Kateřina/O-7182-2017",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP71,A451,A452,,10.1016/j.jval.2016.09.609,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300572,0
J,"Purba, FD; Hunfeld, J; Iskandarsyah, A; Fitriana, TS; Sadarjoen, SS; Passchier, J; van Busschbach, J",,,,"Purba, F. D.; Hunfeld, J.; Iskandarsyah, A.; Fitriana, T. S.; Sadarjoen, S. S.; Passchier, J.; van Busschbach, J.",,,THE FIRST INDONESIAN HEALTH-RELATED QUALITY OF LIFE VALUATION STUDY: AN EQ-5D-5L VALUE SET,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Purba, F. D.; Hunfeld, J.; van Busschbach, J.] Erasmus MC, Rotterdam, Netherlands; [Iskandarsyah, A.; Sadarjoen, S. S.] Padjadjaran State Univ, Jatinangor, Indonesia; [Fitriana, T. S.] YARSI Univ, Jakarta, Indonesia; [Passchier, J.] Vrije Univ Amsterdam, Amsterdam, Netherlands",Erasmus University Rotterdam; Erasmus MC; Universitas Padjadjaran; YARSI University; Vrije Universiteit Amsterdam,,,"Busschbach, Jan/P-1584-2019","Busschbach, Jan/0000-0002-8602-0381",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP35,A820,A820,,10.1016/j.jval.2016.08.618,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302669,0
J,"Rakonczai, P; Lang, Z; Balazs, T; Bacskai, M",,,,"Rakonczai, P.; Lang, Z.; Balazs, T.; Bacskai, M.",,,COMPARISON STUDY BASED ON SIMULATION OF PATIENT PATHWAYS USING MULTI-STATE MODELS IN ONCOLOGY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rakonczai, P.; Lang, Z.; Balazs, T.; Bacskai, M.] Healthware Consulting Ltd, Budapest, Hungary",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM127,A380,A380,,10.1016/j.jval.2016.09.193,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300178,0
J,"Ramos, M; Lamotte, M; Chevalier, P; Goodall, G",,,,"Ramos, M.; Lamotte, M.; Chevalier, P.; Goodall, G.",,,ASSESSING THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN INOPERABLE PATIENTS WITH SEVERE AORTIC STENOSIS IN UK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ramos, M.; Lamotte, M.; Chevalier, P.] IMS Hlth, Zaventem, Belgium; [Goodall, G.] Edwards Lifesci, Nyon, Switzerland",Edwards Lifesciences,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD70,A697,A697,,10.1016/j.jval.2016.09.2011,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302226,0
J,"Rao, N; Gibson, E; Lawson, RW; Goodall, JJ",,,,"Rao, N.; Gibson, E.; Lawson, R. W.; Goodall, J. J.",,,ZINFORO (CEFTAROLINE FOSAMIL) VERSUS OTHER EMPIRIC ANTIBIOTICS FOR MODERATE-TO-SEVERE COMMUNITY ACQUIRED PNEUMONIA (CAP) IN ADULTS: A NETWORK META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rao, N.; Gibson, E.] Wickenstones, Goring Heath, England; [Lawson, R. W.] AstraZeneca, Gaithersburg, MD USA; [Goodall, J. J.] AstraZeneca, Luton, Beds, England",AstraZeneca; AstraZeneca,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN6,A407,A408,,10.1016/j.jval.2016.09.354,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300330,0
J,"Ravasio, R; Ferrario, M; Pata, M; Thuresson, P",,,,"Ravasio, R.; Ferrario, M.; Pata, M.; Thuresson, P.",,,COST EFFECTIVENESS ANALYSIS OF PIRFENIDONE FOR THE TREATMENT OF MILD TO MODERATE IDIOPATHIC PULMONARY FIBROSIS (IPF) COMPARED TO BEST SUPPORTIVE CARE AND NINTEDANIB FROM THE ITALIAN NHS PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ravasio, R.] Hlth Publishing & Serv, Milan, Italy; [Ferrario, M.] Roche Spa, Monza, Italy; [Pata, M.] Hoffmann La Roche, Monza, Italy; [Thuresson, P.] F Hoffmann La Roche Ltd, Basel, Switzerland",Roche Holding; Roche Holding,,,"Thuresson, Per-Olof/GYU-1401-2022",,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS43,A556,A556,,10.1016/j.jval.2016.09.1211,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301322,0
J,"Rencz, F; Poór, AK; Péntek, M; Gulacsi, L; Beretzky, Z; Holló, P; Kárpáti, S; Brodszky, V",,,,"Rencz, F.; Poor, A. K.; Pentek, M.; Gulacsi, L.; Beretzky, Z.; Hollo, P.; Karpati, S.; Brodszky, V",,,MEASUREMENT PROPERTIES OF THE EQ-5D-5L COMPARED TO THE EQ-5D-3L IN PSORIASIS PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rencz, F.; Pentek, M.; Gulacsi, L.; Beretzky, Z.; Brodszky, V] Corvinus Univ Budapest, Budapest, Hungary; [Poor, A. K.; Hollo, P.; Karpati, S.] Semmelweis Univ, Budapest, Hungary",Corvinus University Budapest; Semmelweis University,,,"Holló, Peter/Q-6505-2018; Brodszky, Valentin/AFN-4112-2022; Péntek, Márta/HTQ-3097-2023; Gulacsi, Laszlo/HMD-6274-2023; Karpati, Sarolta/E-5786-2018","Brodszky, Valentin/0000-0002-6095-2295; Péntek, Márta/0000-0001-9636-6012; Gulacsi, Laszlo/0000-0002-9285-8746; Karpati, Sarolta/0000-0002-8472-0712",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS60,A572,A573,,10.1016/j.jval.2016.09.1305,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301411,0
J,"Rendas-Baum, R; White, MK; Kosinski, M; Vietri, J; Bjorner, JB",,,,"Rendas-Baum, R.; White, M. K.; Kosinski, M.; Vietri, J.; Bjorner, J. B.",,,A CROSS-NATIONAL COMPARISON OF THE EFFECT OF AGE AND GENDER ON HEALTH-RELATED QUALITY OF LIFE (HRQL),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rendas-Baum, R.; White, M. K.; Kosinski, M.; Bjorner, J. B.] Optum, Lincoln, RI USA; [Vietri, J.] Kantar Hlth, Horsham, PA USA",Optum,,,,,,,,,0,4,4,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP181,A471,A471,,10.1016/j.jval.2016.09.724,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300679,0
J,"Ripellino, C; Cataldo, N; Scarpignato, C",,,,"Ripellino, C.; Cataldo, N.; Scarpignato, C.",,,"UNSPECIFIED INTESTINAL MALABSORPTION ASSOCIATED WITH ANGIOTENSIN RECEPTOR BLOCKER THERAPY: RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY IN ITALY AND GERMANY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ripellino, C.; Cataldo, N.] IMS Hlth, Milan, Italy; [Scarpignato, C.] Univ Parma, Parma, Italy",University of Parma,,,"Scarpignato, Carmelo/ABC-1745-2021","Scarpignato, Carmelo/0000-0001-5645-857X",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PGI1,A509,A509,,10.1016/j.jval.2016.09.942,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301072,0
J,"Robson, RE; Chiroli, S; Iannazzo, S; Thornton, AC; Tolley, K",,,,"Robson, R. E.; Chiroli, S.; Iannazzo, S.; Thornton, A. C.; Tolley, K.",,,HEALTHCARE RESOURCE UTILISATION IS ASSOCIATED WITH PHASE OF CHRONIC MYELOID LEUKAEMIA (CML): RESULTS OF A CLINICAL EXPERT SURVEY IN ENGLAND AND WALES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Robson, R. E.; Tolley, K.] Tolley Hlth Econ, Buxton, England; [Chiroli, S.] Incyte Corp, Geneva, Switzerland; [Iannazzo, S.] SIHS SRL, Turin, Italy; [Thornton, A. C.] ACT Res Ltd, Swineshead Bridge, England",Incyte,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN191,A743,A743,,10.1016/j.jval.2016.09.2264,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302472,0
J,"Roibu, C; Pacheco, L",,,,"Roibu, C.; Pacheco, L.",,,THE ROLE OF BUDGET IMPACT ON HTA REJECTION OF ONCOLOGY DRUGS IN ROMANIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Roibu, C.; Pacheco, L.] GfK Market Access, London, England",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN279,A759,A759,,10.1016/j.jval.2016.09.2355,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302558,0
J,"Prada, MER; Celis, S; Quiñones, PAA; Acero, G",,,,"Romero Prada, M. E.; Celis, S.; Alfonso Quinones, P. A.; Acero, G.",,,COST MINIMIZATION ANALYSIS OF USING PAZOPANIB IN FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Romero Prada, M. E.] Fdn Salutia, Bogota, Colombia; [Celis, S.; Alfonso Quinones, P. A.; Acero, G.] Salutia Fdn, Bogota, Colombia",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN170,A739,A739,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302452,0
J,"Ruiz, MA; Egea, M; Muñoz, R; Viñolas, X; Silvestre, J; Alvarez, M; Martínez-Ferrer, JB",,,,"Ruiz, M. A.; Egea, M.; Munoz, R.; Vinolas, X.; Silvestre, J.; Alvarez, M.; Martinez-Ferrer, J. B.",,,BEHAVIOR OF VAS MEASURES OF PATIENT SATISFACTION WITH REMOTE MONITORING OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES. THE VALIOSA QUESTIONNAIRE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ruiz, M. A.] Univ Autonoma Madrid, Madrid, Spain; [Egea, M.] Medtron Iber, Madrid, Spain; [Munoz, R.] Hosp Univ Infanta Leonor, Madrid, Spain; [Vinolas, X.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Silvestre, J.] Hosp Univ La Paz, Madrid, Spain; [Alvarez, M.] Medtron Iber, Madrid, Spain; [Martinez-Ferrer, J. B.] Hosp Univ Araba, Vitoria, Spain",Autonomous University of Madrid; Hospital Universitario Infanta Leonor; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; University Hospital of Araba,,,"Ruiz, Miguel/B-9124-2011","Ruiz, Miguel/0000-0002-2734-2196",,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD89,A700,A700,,10.1016/j.jval.2016.09.2031,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302245,0
J,"Ruzsa, G; Gulacsi, L; Brodszky, V; Péntek, M; Gradvohl, E; Rencz, F",,,,"Ruzsa, G.; Gulacsi, L.; Brodszky, V; Pentek, M.; Gradvohl, E.; Rencz, F.",,,WILLINGNESS TO PAY FOR PRIMARY DYSMENORRHEA HEALTH STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ruzsa, G.] Corvinus Univ Budapest, Dept Stat, Budapest, Hungary; [Ruzsa, G.] Eotvos Lorand Univ Sci, Inst Psychol, Doctoral Sch Psychol, Budapest, Hungary; [Gulacsi, L.; Brodszky, V; Pentek, M.; Rencz, F.] Corvinus Univ Budapest, Budapest, Hungary; [Gradvohl, E.] Semmelweis Univ, Budapest, Hungary",Corvinus University Budapest; Eotvos Lorand University; Corvinus University Budapest; Semmelweis University,,,"Gulacsi, Laszlo/HMD-6274-2023; Péntek, Márta/HTQ-3097-2023; Brodszky, Valentin/AFN-4112-2022","Péntek, Márta/0000-0001-9636-6012; Brodszky, Valentin/0000-0002-6095-2295; Gulacsi, Laszlo/0000-0002-9285-8746",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIH30,A404,A405,,10.1016/j.jval.2016.09.336,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300314,0
J,"Saxena, N; Kannapiran, P; Ang, YG",,,,"Saxena, N.; Kannapiran, P.; Ang, Y. G.",,,TIME TO DIABETES RELATED COMPLICATIONS FOR NEWLY DIAGNOSED DIABETES PATIENTS IN SINGAPORE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saxena, N.; Kannapiran, P.; Ang, Y. G.] Natl Healthcare Grp, Singapore, Singapore",,,,"Gary, Ang Yee/B-6334-2017","Gary, Ang Yee/0000-0001-9338-7299",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB13,A897,A897,,10.1016/j.jval.2016.08.231,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303319,0
J,"Schmid, T; Michailov, G",,,,"Schmid, T.; Michailov, G.",,,THE APHERESIS-DATABASE (APHDA)-PROJECT: PATIENT CHARACTERISTICS & TREATMENT PATTERNS OF APHERESIS PATIENTS IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Schmid, T.; Michailov, G.] Amgen GmbH, Munich, Germany",Amgen; Amgen Research Munich GmbH,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV154,A664,A664,,10.1016/j.jval.2016.09.1825,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302046,0
J,"Schwarz, R; Freiberg, M; Sprick, J; Thiele, J",,,,"Schwarz, R.; Freiberg, M.; Sprick, J.; Thiele, J.",,,PATIENT CENTRICITY - PATIENT RELATED PROGRAMS IN THE GERMAN HEALTHCARE ENVIRONMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Schwarz, R.; Freiberg, M.; Sprick, J.; Thiele, J.] Quintiles Commercial Germany GmbH, Mannheim, Germany",IQVIA,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS99,A621,A621,,10.1016/j.jval.2016.09.1581,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301676,0
J,"Sherwin, G; Akpinar, P; Yap, B; Lu, V; Im, Y",,,,"Sherwin, G.; Akpinar, P.; Yap, B.; Lu, V; Im, Y.",,,HOW DOES PRICING AND ACCESS OF INNOVATIVE ONCOLOGY AGENTS IN CHINA COMPARE WITH OTHER ASIAN MARKETS?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sherwin, G.; Akpinar, P.; Yap, B.; Lu, V; Im, Y.] ICON Plc, London, England",ICON plc,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP12,A816,A816,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302647,0
J,"Siu, EC; Mills, F",,,,"Siu, E. C.; Mills, F.",,,THE DECLINING VALUE OF ECONOMICS IN CANADIAN CANCER REIMBURSEMENT REVIEWS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Siu, E. C.; Mills, F.] Wyatt Hlth Management, Oakville, ON, Canada",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN254,A754,A754,,10.1016/j.jval.2016.09.2330,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302534,0
J,"Sliwczynski, A; Brzozowska, M; Labenda, A; Orlewska, K; Milkowski, M; Orlewska, E",,,,"Sliwczynski, A.; Brzozowska, M.; Labenda, A.; Orlewska, K.; Milkowski, M.; Orlewska, E.",,,"REAL-WORLD COMORBIDITIES, TREATMENT PATTERN AND COST OF PATIENTS WITH ACROMEGALY IN POLAND BASED ON RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE CLAIMS DATA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sliwczynski, A.; Brzozowska, M.] Med Univ Lodz, Lodz, Poland; [Labenda, A.; Milkowski, M.] Natl Hlth Fund, Warsaw, Poland; [Orlewska, K.] Med Univ Warsaw, Warsaw, Poland; [Orlewska, E.] Jan Kochanowski Univ, Kielce, Poland",Medical University Lodz; Medical University of Warsaw; Jan Kochanowski University,,,"Śliwczyński, Andrzej Marek/ABD-1910-2022; Śliwczyński, Andrzej/AAT-5246-2021; Orlewska, Ewa/HMW-0385-2023","Śliwczyński, Andrzej Marek/0000-0002-0239-1637;",,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB99,A682,A683,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302148,0
J,"Song, X; Juneau, P; Meyer, N",,,,"Song, X.; Juneau, P.; Meyer, N.",,,A PROPOSED MODEL FOR THE STUDY OF THE LONGITUDINAL BEHAVIOR OF PREVALENCE RATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Song, X.] Truven Hlth Analyt, Shrewsbury, MA USA; [Juneau, P.] Truven Hlth Analyt, Boyds, MD USA; [Meyer, N.] Truven Hlth Analyt, Cambridge, MA USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM40,A855,A855,,10.1016/j.jval.2016.08.452,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303086,0
J,"Strens, D; Van Damme, P; Mork, A; Morel, T",,,,"Strens, D.; Van Damme, P.; Mork, A.; Morel, T.",,,COST OF ILLNESS STUDY IN PATIENTS WITH MYASTHENIA GRAVIS TREATED WITH PLASMA EXCHANGE THERAPY IN BELGIUM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Strens, D.] Realidad Bvba, Grimbergen, Belgium; [Van Damme, P.] UZ Leuven, Leuven, Belgium; [Mork, A.; Morel, T.] UCB Pharma, Brussels, Belgium",KU Leuven; UCB Pharma SA,,,"Van Damme, Philip/A-6464-2009","Van Damme, Philip/0000-0002-4010-2357",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY96,A592,A592,,10.1016/j.jval.2016.09.1411,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301514,0
J,"Su, N; Xu, T",,,,"Su, N.; Xu, T.",,,HEPARIN AND RELATED SUBSTANCES FOR TREATING DIABETIC FOOT ULCERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Su, N.; Xu, T.] Sichuan Univ, West China Hosp, Chengdu, Peoples R China",Sichuan University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB6,A896,A896,,10.1016/j.jval.2016.08.224,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303312,0
J,"Subedi, N",,,,"Subedi, N.",,,SYSTEMIC ADVERSE DRUG REACTIONS OF ANTIHYPERTENSIVE AGENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Subedi, N.] Coll Med Sci, Chitwan, Nepal",,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV1,A862,A862,,10.1016/j.jval.2016.08.400,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303126,0
J,"Topachevskyi, O; Siabro, V; Volovyk, A",,,,"Topachevskyi, O.; Siabro, V; Volovyk, A.",,,WEB-BASED BUDGET IMPACT MODEL ESTIMATING COST SAVINGS OF DIALYSIS PROGRAM IN THE UK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Topachevskyi, O.] Digital Hlth Outcomes, Brussels, Belgium; [Siabro, V; Volovyk, A.] Digital Hlth Outcomes, Kiev, Ukraine",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PUK7,A517,A517,,10.1016/j.jval.2016.09.992,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301117,0
J,"Trueman, D; Hancock, E; Jhund, P; McMurray, JJ; Petrie, M; Deschaseaux-Voinet, C; Haroun, R; Alexopoulos, ST; Gielen, V",,,,"Trueman, D.; Hancock, E.; Jhund, P.; McMurray, J. J.; Petrie, M.; Deschaseaux-Voinet, C.; Haroun, R.; Alexopoulos, S. T.; Gielen, V",,,THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ENGLAND AND SCOTLAND: APPLYING REAL-WORLD EVIDENCE TO ENHANCE GENERALISABILITY TO A UK POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Trueman, D.; Hancock, E.] DRG Abacus, Bicester, Oxon, England; [Jhund, P.; McMurray, J. J.; Petrie, M.] Univ Glasgow, Glasgow, Lanark, Scotland; [Deschaseaux-Voinet, C.; Haroun, R.] Novartis Pharma AG, Basel, Switzerland; [Alexopoulos, S. T.; Gielen, V] Novartis Pharmaceut UK Ltd, Frimley, Surrey, England",University of Glasgow; Novartis; Novartis,,,"Jhund, Pardeep/GLS-9508-2022; McMurray, John J.V./B-2467-2013","Jhund, Pardeep/0000-0003-4306-5317; McMurray, John J.V./0000-0002-6317-3975",,,,,0,0,1,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV104,A655,A655,,10.1016/j.jval.2016.09.1772,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301860,0
J,"Uda, A; Kuwabara, H; Shiozawa, A; Hiroi, S; Yamabe, K; Okamoto, S",,,,"Uda, A.; Kuwabara, H.; Shiozawa, A.; Hiroi, S.; Yamabe, K.; Okamoto, S.",,,THE CURRENT TREATMENT OF PARKINSON'S DISEASE IN JAPAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Uda, A.; Kuwabara, H.; Hiroi, S.; Yamabe, K.; Okamoto, S.] Takeda Pharmaceut Co Ltd, Tokyo, Japan; [Shiozawa, A.] Takeda Pharmaceut Int Inc, Deerfield, IL USA","Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.",,,"Shiozawa, Aki/O-2443-2014",,,,,,0,1,1,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND16,A876,A876,,10.1016/j.jval.2016.08.340,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303201,0
J,"ul Haq, N; Malik, Z; Nasim, A; Riaz, S; Mohammad, G; Azhar, S",,,,"ul Haq, N.; Malik, Z.; Nasim, A.; Riaz, S.; Mohammad, G.; Azhar, S.",,,"KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS HEPATITIS B AMONG MEDICAL COLLEGE STUDENTS OF QUETTA, PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[ul Haq, N.; Malik, Z.; Nasim, A.; Riaz, S.; Mohammad, G.] Univ Balochistan, Quetta, Pakistan; [Azhar, S.] Comsats Inst Informat Technol, Abbottabad, Pakistan",University of Balochistan; COMSATS University Islamabad (CUI),,,"Nasim, Aqeel/AAX-1823-2021","Nasim, Aqeel/0000-0003-1270-4753; Riaz, Sohail/0000-0002-4188-5162",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PGI15,A839,A839,,10.1016/j.jval.2016.08.546,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302781,0
J,"Vargas, C; Balmaceda, C; Rojas, R; Espinoza, MA",,,,"Vargas, C.; Balmaceda, C.; Rojas, R.; Espinoza, M. A.",,,COST EFFECTIVENESS OF NIVOLUMAB FOR THE TREATMENT OF METASTATIC MELANOMA IN CHILE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vargas, C.; Balmaceda, C.; Rojas, R.; Espinoza, M. A.] Pontificia Univ Catolica Chile, Santiago, Chile",Pontificia Universidad Catolica de Chile,,,"Espinoza, Manuel/AAU-5178-2020","Espinoza, Manuel/0000-0001-9564-9512",,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN174,A740,A740,,10.1016/j.jval.2016.09.2248,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302456,0
J,"Vestergaard, AS; Ehlers, LH",,,,"Vestergaard, A. S.; Ehlers, Holger L.",,,APPLICATION OF QUALITY INDICATORS TO ENABLE ECONOMIC EVALUATION OF QUALITY IMPROVEMENTS - A BAYESIAN DECISION THEORETICAL AND VALUE OF INFORMATION ANALYTICAL FRAMEWORK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vestergaard, A. S.; Ehlers, Holger L.] Aalborg Univ, Aalborg, Denmark",Aalborg University,,,"Ehlers, Lars/P-7531-2019","Ehlers, Lars Holger/0000-0001-6512-5566; , Anne Sig/0000-0001-9769-1490",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM219,A397,A397,,10.1016/j.jval.2016.09.289,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300270,0
J,"Vukicevic, D; Rochau, U; Savic, A; Jevdjevic, M; Buchberger, M; Sroczynski, G; Siebert, U",,,,"Vukicevic, D.; Rochau, U.; Savic, A.; Jevdjevic, M.; Buchberger, M.; Sroczynski, G.; Siebert, U.",,,COSTS OF MULTIPLE MYELOMA MANAGEMENT AND TREATMENT FOR ELDERLY PATIENTS WHO ARE NOT TRANSPLANT CANDIDATES IN THE SERBIAN HEALTH CARE SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vukicevic, D.; Jevdjevic, M.; Buchberger, M.; Sroczynski, G.] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Hall In Tirol, Austria; [Rochau, U.] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth Hlth Serv Res & Hlth Technol Asses, Hall In Tirol, Austria; [Rochau, U.] ONCOTYROL Ctr Personalized Canc Med, Area Hlth Technol Assessment, Innsbruck, Austria; [Savic, A.] Univ Novi Sad, Fac Med, Clin Hematol, Clin Ctr Vojvodina, Novi Sad, Serbia; [Siebert, U.] UMIT Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria; [Siebert, U.] ONCOTYROL Ctr Personalized Canc Med, Innsbruck, Austria; [Siebert, U.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Siebert, U.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA","UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; University of Novi Sad; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard Medical School",,,"Siebert, Uwe/M-5057-2019; Jevdjevic, Milica/R-6415-2017; Siebert, Uwe/HTO-0915-2023","Siebert, Uwe/0000-0001-6425-7671; Siebert, Uwe/0000-0001-6425-7671",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY44,A582,A582,,10.1016/j.jval.2016.09.1359,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301462,0
J,"Wang, VW; Kandiah, N; Lin, X; Wee, HL",,,,"Wang, V. W.; Kandiah, N.; Lin, X.; Wee, H. L.",,,COMPARISON OF CAREGIVER-RATED 3-LEVEL EUROQOL-5D (EQ-5D-3L) AND HEALTH UTILITIES INDEX MARK 3 (HUI3) IN PATIENTS WITH DEMENTIA IN SINGAPORE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, V. W.; Wee, H. L.] Natl Univ Singapore, Singapore, Singapore; [Kandiah, N.; Lin, X.] Natl Inst Neurosci, Singapore, Singapore",National University of Singapore; National Neuroscience Institute (NNI),,,"Wee, H/JXY-0919-2024; Wee, Hwee Lin/D-4126-2012","Wee, Hwee Lin/0000-0002-7150-1801",,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,RM3,A810,A810,,10.1016/j.jval.2016.08.710,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302615,0
J,"Watson, A; Bijos, P; Ludwikowski, R; Lewis, A; Blackney, M; Torvinen, S; Plich, A",,,,"Watson, A.; Bijos, P.; Ludwikowski, R.; Lewis, A.; Blackney, M.; Torvinen, S.; Plich, A.",,,THE POTENTIAL TO IMPROVE INHALATION TECHNIQUE IN PATIENTS WITH ASTHMA OR COPD BY SWITCHING FROM SYMBICORT® TURBUHALER® (BUDESONIDE plus FORMOTEROL) TO DUORESP® SPIROMAX® : ESTIMATED IMPACT ON THE NUMBER AND COST OF UNSCHEDULED HEALTHCARE EVENTS IN POLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Watson, A.; Lewis, A.; Blackney, M.] Covance Market Access, London, England; [Bijos, P.; Ludwikowski, R.] Teva Pharmaceut Polska, Warsaw, Poland; [Torvinen, S.; Plich, A.] Teva Pharmaceut Europe BV, Amsterdam, Netherlands",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD22,A688,A688,,10.1016/j.jval.2016.09.1963,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302178,0
J,"Widen, J; Hallberg, S; Bobula, J; Moffatt, M; Borgstrom, F",,,,"Widen, J.; Hallberg, S.; Bobula, J.; Moffatt, M.; Borgstrom, F.",,,THE IMPACT ON SOCIETAL BURDEN OF CHANGED UPTAKE OF HORMONAL TREATMENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Widen, J.; Hallberg, S.; Borgstrom, F.] Quantify Res, Stockholm, Sweden; [Bobula, J.] Pfizer Inc, Collegeville, PA USA; [Moffatt, M.] Pfizer Inc, New York, NY USA",Pfizer; Pfizer,,,,"Hallberg, Sara/0000-0003-2164-8060",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIH24,A403,A404,,10.1016/j.jval.2016.09.329,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300308,0
J,"Wiebe, K; Schmitter, S; Leverkus, F; Heathfield, A",,,,"Wiebe, K.; Schmitter, S.; Leverkus, F.; Heathfield, A.",,,G-BA EARLY ADVICE VS. EMA/HTA PARALLEL ADVICE FROM A GERMAN PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wiebe, K.] Pfizer Germany, Berlin, Germany; [Schmitter, S.; Leverkus, F.] Pfizer Deutschland GmbH, Berlin, Germany; [Heathfield, A.] Pfizer, Surrey, England",Pfizer; Pfizer; Pfizer,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP305,A493,A493,,10.1016/j.jval.2016.09.848,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300800,0
J,"Wijnands, T; Kreeftmeijer, J; Kooreman, PJ; Wagner, P; van Engen, A",,,,"Wijnands, T.; Kreeftmeijer, J.; Kooreman, P. J.; Wagner, P.; van Engen, A.",,,NICE COLLATERAL EFFECT: WHAT IS THE INFLUENCE OF NICE ON OTHER HTA BODIES?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wijnands, T.; Kreeftmeijer, J.; Kooreman, P. J.; van Engen, A.] Quintiles Advisory Serv, Hoofddorp, Netherlands; [Wagner, P.] Quintiles Advisory Serv, Neu Isenburg, Germany",IQVIA; IQVIA,,,,,,,,,0,3,3,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP266,A486,A486,,10.1016/j.jval.2016.09.808,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300761,0
J,"Willis, M; Asseburg, C",,,,"Willis, M.; Asseburg, C.",,,CORRECTLY CAPTURING UNCERTAINTY IN TREATMENT EFFECTS IN SIMULATION MODELING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Willis, M.; Asseburg, C.] Swedish Inst Hlth Econ IHE, Lund, Sweden",,,,"Asseburg, Christian/AAK-2903-2020","Asseburg, Christian/0000-0001-7196-3363",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM140,A382,A382,,10.1016/j.jval.2016.09.206,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300191,0
J,"Wu, C; Chen, H; Xie, J; Han, S; Horblyuk, R; Wang, PF; Liu, L; Lu, J; Song, H; Du, EX; Wu, EQ",,,,"Wu, C.; Chen, H.; Xie, J.; Han, S.; Horblyuk, R.; Wang, P. F.; Liu, L.; Lu, J.; Song, H.; Du, E. X.; Wu, E. Q.",,,CLINICAL AND ECONOMIC OUTCOMES OF VENOUS THROMBOEMBOLISM (VTE) AMONG HOSPITALIZED PATIENTS IN CHINA: AN ANALYSIS OF ELECTRONIC MEDICAL RECORD DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wu, C.] Peking Univ, Shenzhen Hosp, Shenzhen, Peoples R China; [Chen, H.] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Xie, J.] Anal Grp Inc, New York, NY USA; [Han, S.; Song, H.] Anal Grp Inc, Beijing, Peoples R China; [Horblyuk, R.] Pfizer Inc, New York, NY USA; [Wang, P. F.] Bristol Myers Squibb, Princeton, NJ USA; [Liu, L.] Merck, New York, NY USA; [Lu, J.] Pfizer Investment Co Ltd, Beijing, Peoples R China; [Du, E. X.; Wu, E. Q.] Anal Grp Inc, Boston, MA USA",Peking University; Peking University; Analysis Group Inc.; Analysis Group Inc.; Pfizer; Bristol-Myers Squibb; Merck & Company; Pfizer; Analysis Group Inc.,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV14,A864,A864,,10.1016/j.jval.2016.08.413,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303139,0
J,"Wu, H; Yi, L; Ran, X",,,,"Wu, H.; Yi, L.; Ran, X.",,,"HOW MUCH DO THE INSURED CITIZENS KNOW ABOUT THE PERSONAL ACCOUNT OF CHINA'S URBAN EMPLOYEES' BASIC MEDICAL INSURANCE AND WHAT ARE THEIR NEEDS? EVIDENCE FROM GUIZHOU, CHINA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wu, H.; Ran, X.] Guizhou Med Univ, Guiyang, Peoples R China; [Yi, L.] Dept Human Resources & Social Secur Guizhou Prov, Guiyang, Peoples R China",Guizhou Medical University,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP72,A826,A826,,10.1016/j.jval.2016.08.655,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302706,0
J,"Yan, BP; Chan, CK; Lee, V",,,,"Yan, B. P.; Chan, C. K.; Lee, V",,,DISCORDANCE BETWEEN KNOWLEDGE OF CARDIOVASCULAR RISK FACTORS AND IDEAL CARDIOVASCULAR HEALTH IN HONG KONG ADULTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yan, B. P.; Chan, C. K.; Lee, V] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China",Chinese University of Hong Kong,,,"Yan, Bryan P/P-5928-2015; Lee, Vivian WY/ABE-2416-2021","Lee, Vivian WY/0000-0001-5802-8899",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV36,A642,A642,,10.1016/j.jval.2016.09.1703,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301792,0
J,"Yuan, Y; Chang, P; Lo, P; Chang, H; Su, P; Hsueh, K; Tsai, Y; Lan, T",,,,"Yuan, Y.; Chang, P.; Lo, P.; Chang, H.; Su, P.; Hsueh, K.; Tsai, Y.; Lan, T.",,,COMPARATIVE EFFECTIVENESS ANALYSIS FOR SMOKING CESSATION MEDICATIONS ON SMOKING CESSATION AND RELAPSES AMONG ELDERLY SMOKERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yuan, Y.] Cheng Hsin Gen Hosp, Taipei, Taiwan; [Chang, P.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lo, P.; Chang, H.; Tsai, Y.] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei, Taiwan; [Su, P.] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Hsueh, K.] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [Lan, T.] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Taichung, Taiwan",Cheng Hsin General Hospital; Stanford University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Kaohsiung Veterans General Hospital; Taichung Veterans General Hospital,,,,,,,,,0,0,0,2,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,DM4,A813,A814,,10.1016/j.jval.2016.08.695,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302632,0
J,"Zhao, R; Martinsen, BJ",,,,"Zhao, R.; Martinsen, B. J.",,,A CLINICAL LITERATURE REVIEW OF CORONARY ARTERY CALCIFICATION AND CURRENT TREATMENT OUTCOMES IN JAPAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhao, R.; Martinsen, B. J.] Cardiovasc Syst Inc, St Paul, MN USA",,,,,,,,,,0,0,0,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD8,A858,A858,,10.1016/j.jval.2016.08.444,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303102,0
J,"Zhou, HJ; Zhao, YJ; Wojciech, AC; Lin, L; Caro, JJ; Moller, J; Dan, YY; Lim, BP",,,,"Zhou, H. J.; Zhao, Y. J.; Wojciech, A. C.; Lin, L.; Caro, J. J.; Moller, J.; Dan, Y. Y.; Lim, B. P.",,,"DIFFERENCES IN COST-EFFECTIVENESS ESTIMATES FOR CHRONIC HEPATITIS C TREATMENT AMONG COHORT MARKOV MODEL, MARKOV MICROSIMULATION AND DISCRETE EVENT SIMULATION",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhou, H. J.; Zhao, Y. J.; Lin, L.; Lim, B. P.] Natl Healthcare Grp, Grp Corp Dev, Pharm & Therapeut Off, Singapore, Singapore; [Wojciech, A. C.] TreeAge Software Inc, Williamstown, MA USA; [Caro, J. J.] Evidera, Lexington, MA USA; [Moller, J.] Lund Univ, Fac Med, Lund, Sweden; [Dan, Y. Y.] Natl Univ Singapore Hosp, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore",Evidera; Lund University; National University of Singapore,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM27,A853,A853,,10.1016/j.jval.2016.08.468,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303074,0
J,"Ziouani, S; Granados, D; Benjamin, L; Borget, I",,,,"Ziouani, S.; Granados, D.; Benjamin, L.; Borget, I",,,HOW TO DEFINE RELEVANT COMPARATORS IN FRANCE? AN ANALYSIS OF THE ECONOMIC EVALUATIONS SUBMITTED BY MANUFACTURERS AND REVIEWED BY THE ECONOMIC COMMITTEE (CEESP) OF THE FRENCH NATIONAL HEALTH AUTHORITY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ziouani, S.; Borget, I] Univ Paris Sud, Fac Pharm, GRADES, Chatenay Malabry, France; [Granados, D.; Benjamin, L.] Janssen, Issy Les Moulineaux, France",Universite Paris Saclay; Johnson & Johnson,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP186,A472,A472,,10.1016/j.jval.2016.09.729,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300684,0
J,"Duan, JC",,,,"Duan, Jin-Chuan",,,Local-momentum autoregression and the modeling of interest rate term structure,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,,LONG-MEMORY; EQUILIBRIUM,"A parsimonious autoregressive model that is globally mean-reverting but locally driven by momentum is proposed. The local-momentum autoregression (LM-AR) model carries one extra parameter, and depending on the sign of this extra parameter, it can be either local momentum-preserving or momentum-building. The LM-AR model is motivated by observing US interest rate movement over many decades, which over a long time span seems to mean revert but over a period of several months or years can actually exhibit a momentum-like behavior. We use the LM-AR model with a stochastic central tendency factor as the dominant global risk factor in interest rates and add a local variation component of the standard mean-reverting type to create a 3-factor risk environment. We then derive its corresponding term structure model and empirically implement the model on US interest rates of seven maturities from January 1954 to December 2013 on a weekly frequency to establish the presence of local momentum building. (C) 2016 Elsevier B.V. All rights reserved.","[Duan, Jin-Chuan] Natl Univ Singapore, Dept Finance, Risk Management Inst, Singapore, Singapore; [Duan, Jin-Chuan] Natl Univ Singapore, Dept Econ, Singapore, Singapore",National University of Singapore; National University of Singapore,"Duan, JC (通讯作者)，Risk Management Inst, 21 Heng Mui Keng Terrace,Level 4, Singapore 119613, Singapore.",bizdjc@nus.edu.sg,"Duan, Jin-Chuan/D-2408-2016",,,,,,22,1,1,0,13,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,OCT,2016,194.0,2.0,,,,,349,359,,10.1016/j.jeconom.2016.05.012,0.0,,,11,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DV0GR,,,,,2024-03-09,WOS:000382596500012,0
J,"Montgomery, S; Kusel, J; Allen, F; Adlard, N",,,,"Montgomery, Stephen; Kusel, Jeanette; Allen, Felicity; Adlard, Nicholas",,,Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Review,,,,,,,NATALIZUMAB,"Background and Objectives Budget impact analysis (BIA) has become an essential part of economic evaluation within health technology assessment. Several disease-modifying therapies (DMTs) are now available for the treatment of multiple sclerosis (MS). This study sought to identify the inputs and assumptions used in existing BIAs for DMTs in the UK, and the uncertainty and variation in these, to allow critique within the context of UK policy. Methods MEDLINE and the Economic Evaluations Database from the Cochrane Library were searched systematically on 15 December 2014 to identify BIAs of DMTs licensed for MS in the UK. In addition, the National Institute for Health and Care Excellence (NICE) and National Health Service (NHS) England websites were searched for relevant publications and grey literature searching was undertaken. Sources and assumptions from the included analyses were extracted, compared and critiqued. Results The database searches produced 115 de-duplicated results. An additional 12 results were identified from the NICE and NHS England websites. No BIAs of DMTs for MS in the UK were identified in the literature. All ten included studies were from the NICE website, comprising manufacturer submissions for each DMT and corresponding NICE costing templates. There are considerable uncertainties in the inputs and assumptions used in the BIAs, but limited sensitivity analyses were undertaken. Conclusions Data limitations were not highlighted in the results, failing to present the uncertainty in the results to users clearly. It is to be welcomed that NICE has recently consulted on a process change to allow additional critique of the costing templates.","[Montgomery, Stephen; Kusel, Jeanette] Costello Med Consulting Ltd, Cambridge, England; [Allen, Felicity; Adlard, Nicholas] Novartis Pharmaceut UK Ltd, 200 Frimley Business Pk, Camberley GU16 7SR, Surrey, England",Costello Medical Consulting; Novartis,"Adlard, N (通讯作者)，Novartis Pharmaceut UK Ltd, 200 Frimley Business Pk, Camberley GU16 7SR, Surrey, England.",nicholas.adlard@novartis.com,"; Montgomery, Stephen/B-5683-2011","Adlard, Nicholas/0000-0001-6912-1685; Montgomery, Stephen/0000-0002-8481-5850","Novartis Pharmaceuticals UK Ltd, Camberley, UK","Novartis Pharmaceuticals UK Ltd, Camberley, UK","NA and FA are paid employees of Novartis Pharmaceuticals UK Ltd, Camberley, UK. SM and JK are paid employees of Costello Medical Consulting Ltd, Cambridge, UK, which was contracted by Novartis to undertake some of the work. This study was funded by Novartis Pharmaceuticals UK Ltd, Camberley, UK. The views presented in this paper are those of the authors, and do not necessarily reflect those of the study funders.",,42,2,2,0,7,SPRINGER INT PUBL AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,OCT,2016,14.0,5.0,,,,,545,558,,10.1007/s40258-016-0244-3,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DY8GF,27130689.0,,,,2024-03-09,WOS:000385366300005,0
J,"van Dongen-Leunis, A; Redekop, WK; Uyl-de Groot, CA",,,,"van Dongen-Leunis, Annemieke; Redekop, W. Ken; Uyl-de Groot, Carin A.",,,Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30,VALUE IN HEALTH,,,English,Article,,,,,,acute leukemia; EQ-5D-5L; disease-specific preference based instrument; validity,ACUTE MYELOID-LEUKEMIA; CANCER-PATIENTS; MULTIPLE-MYELOMA; 5-LEVEL VERSION; BOLT-ON; HEALTH; RESPONSIVENESS; EUROQOL; CHEMOTHERAPY; INSTRUMENTS,"Objectives: The aim of this study was to assess the validity and interpretability of different preference-based questionnaires (generic 5-level EuroQol five-dimensional questionnaire [EQ-5D-54 cancer-specific Quality of Life Questionnaire Preference-Based Measure, and European Organization of Randomized Controlled Trials 8 Dimension [EORTC-8D]) in patients with acute leukemia. Methods: Patients who participated in Hemato-Oncologie voor Volwassenen Nederland (HOVON- the Haemato Oncology Foundation for Adults in the Netherlands) clinical trials between 1999 and 2011 at a single hospital were invited to complete the questionnaires. Interpretability was evaluated by the frequency of incomplete data and highest and lowest possible scores. Content validity was evaluated by exploring the health-related quality-of-life domains included in the questionnaires. Construct validity was assessed using correlations with other quality of-life scales (EQ-visual analogue scale score and global quality-of-life scale of the EORTC Quality of Life Questionnaire) and ability to distinguish between patients with different health statuses. Results: Questionnaires were returned by 89% (111 of 125) of the patients. Six to seven respondents did not return full questionnaires. Perfect health on the EQ-5D-5L was reported by 32 respondents and many of them (N = 17) did report health problems on other questionnaires. All questionnaires were strongly correlated (range 0.61-0.78) with other quality-of-life scales and yielded substantially different utility values for patients with different health statuses. Nevertheless, the disease specific preference-based questionnaires showed greater discriminatory power. Conclusions: Although the Quality of Life Questionnaire Preference-Based Measure and the EORTC-8D appear to have better validity, this study does not provide any strong evidence against the use of the EQ-5D-5L for measuring quality-of-life utilities in acute leukemia. However, our findings need to be confirmed in larger longitudinal studies.","[van Dongen-Leunis, Annemieke; Redekop, W. Ken; Uyl-de Groot, Carin A.] Erasmus Univ, Inst Med Technol Assessment, Inst Hlth Policy & Management, Rotterdam, Netherlands",Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC,"van Dongen-Leunis, A (通讯作者)，Erasmus Univ, Inst Med Technol Assessment, iBMG, POB 1738, NL-3000 DR Rotterdam, Netherlands.",a.vandongen@bmg.eur.nl,"Redekop, Ken/AAA-2423-2020","Redekop, Ken/0000-0001-9538-4083","Center for Translational Molecular Medicine (CTMM), project BioCHIP [03O-102]","Center for Translational Molecular Medicine (CTMM), project BioCHIP","This work was supported by a grant from the Center for Translational Molecular Medicine (CTMM), project BioCHIP (grant no. 03O-102). The article has been approved for publication by the CTMM.",,44,17,18,0,7,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,SEP-OCT,2016,19.0,6.0,,,,,834,843,,10.1016/j.jval.2016.05.008,0.0,,,10,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ5VS,27712712.0,hybrid,,,2024-03-09,WOS:000385930500021,0
J,"Ahn, T",,,,"Ahn, Taehyun",,,Reduction of Working Time: Does It Lead to a Healthy Lifestyle?,HEALTH ECONOMICS,,,English,Article,,,,,,working time; health behavior; South Korea,QUALITY-OF-LIFE; ECONOMIC-CONDITIONS; PHYSICAL-ACTIVITY; RISK; SMOKING; STRESS; POPULATION; PREVALENCE; PATTERNS,"I examine whether working hours have a causal effect on the health behaviors of workers. In assessing the causal relationship, I estimate fixed-effects instrumental variable models by using exogenous variation in adopting a reduced workweek in South Korea as an instrument for work hours. The estimation results reveal that shortening work hours induces individuals to exercise regularly and decreases the likelihood of smoking, with more pronounced effects for heavy smokers. While a work-hour reduction substantially increases the probability of drinking participation, it does not significantly affect the likelihood of frequent or daily drinking habits. In addition, the effect of a work-hour reduction on regular exercise is salient among women and older groups, and the effect on smoking behaviors is more pronounced among men and middle-aged groups. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Ahn, Taehyun] Sogang Univ, Sch Econ, 35 Baekbeom Ro, Seoul 121742, South Korea",Sogang University,"Ahn, T (通讯作者)，Sogang Univ, Sch Econ, 35 Baekbeom Ro, Seoul 121742, South Korea.",ahn83@sogang.ac.kr,,,Sogang University [201410027.01],Sogang University,This research was supported by the Sogang University Research Grant of 2014 (201410027.01).,,39,22,24,2,49,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,AUG,2016,25.0,8.0,,,,,969,983,,10.1002/hec.3198,0.0,,,15,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DR5JN,25974857.0,,,,2024-03-09,WOS:000379939400004,0
J,"Asheim, GB; Zuber, S",,,,"Asheim, Geir B.; Zuber, Stephane",,,Evaluating intergenerational risks,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Social evaluation; Population ethics; Decision-making under risk; Critical-level utilitarianism; Social discounting,INDIVIDUALISTIC ETHICS; ANTICIPATED UTILITY; VARIABLE-POPULATION; CARDINAL WELFARE; EQUITY; PREFERENCES; UTILITARIANISM; GENERATIONS; COMPETITION,"Climate policies have stochastic consequences that involve a great number of generations. This calls for evaluating social risk (what kind of societies will future people be born into) rather than individual risk (what will happen to people during their own lifetimes). We respond to this call by proposing and axiomatizing probability adjusted rank-discounted critical-level generalized utilitarianism (PARDCLU) through a key axiom ensuring that the social welfare order both is ethical and satisfies first-order stochastic dominance. PARDCLU yields a new useful perspective on intergenerational risks, is ethical in contrast to discounted utilitarianism, and avoids objections that have been raised against other ethical criteria. We show that PARDCLU handles situations with positive probability of human extinction and is linked to decision theory by yielding rank-dependent expected utilitarianism but with additional structure in a special case. (C) 2016 Elsevier B.V. All rights reserved.","[Asheim, Geir B.] Univ Oslo, Dept Econ, POB 1095, N-0317 Oslo, Norway; [Zuber, Stephane] Paris Sch Econ, CNRS, Ctr Econ Sorbonne, Paris, France",University of Oslo; Paris School of Economics; Centre National de la Recherche Scientifique (CNRS),"Asheim, GB (通讯作者)，Univ Oslo, Dept Econ, POB 1095, N-0317 Oslo, Norway.",g.b.asheim@econ.uio.no; stephane.zuber@univ-paris1.fr,"; Zuber, Stephane/D-3424-2014","Asheim, Geir B./0000-0003-0669-4632; Zuber, Stephane/0000-0002-4111-2397",Research Council of Norway through its Centres of Excellence funding scheme [179552]; l'Institut d'etudes avancees - Paris; Centre interuniversitaire de recherche en economie quantitative - Montreal; ANR project EquiRisk [ANR-12-INEG-0006-01]; Fransk-Norsk Senter for humaniora og samfunnsvitenskap / Centre franco-norvegien en sciences humaines et sociales; Franco-Swedish Program in Philosophy and Economics (FMSH - Paris & Riksbankens Jubileumsfond); Agence Nationale de la Recherche (ANR) [ANR-12-INEG-0006] Funding Source: Agence Nationale de la Recherche (ANR),Research Council of Norway through its Centres of Excellence funding scheme(Research Council of Norway); l'Institut d'etudes avancees - Paris; Centre interuniversitaire de recherche en economie quantitative - Montreal; ANR project EquiRisk(Agence Nationale de la Recherche (ANR)); Fransk-Norsk Senter for humaniora og samfunnsvitenskap / Centre franco-norvegien en sciences humaines et sociales; Franco-Swedish Program in Philosophy and Economics (FMSH - Paris & Riksbankens Jubileumsfond)(Swedish Foundation for Humanities & Social Sciences); Agence Nationale de la Recherche (ANR)(Agence Nationale de la Recherche (ANR)),"We thank Walter Bossert and Reyer Gerlagh for helpful discussions and are grateful for valuable suggestions from the editor, two referees and participants at seminars and conferences in Durham, Helsinki, Lisbon, Lund, Marseille, Oslo, Paris, Tokyo and Toulouse. This paper has been circulated under the title Probability adjusted rank-discounted utilitarianism. It is part of the research activities at the Centre for the Study of Equality, Social Organization, and Performance (ESOP) at the Department of Economics at the University of Oslo. ESOP is supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179552. Asheim's research has also been supported by l'Institut d'etudes avancees - Paris and Centre interuniversitaire de recherche en economie quantitative - Montreal. Zuber's research has been supported by the ANR project EquiRisk (Grant # ANR-12-INEG-0006-01), the Fransk-Norsk Senter for humaniora og samfunnsvitenskap / Centre franco-norvegien en sciences humaines et sociales and the Franco-Swedish Program in Philosophy and Economics (FMSH - Paris & Riksbankens Jubileumsfond).",,41,12,12,0,7,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2016,65.0,,,,,,104,117,,10.1016/j.jmateco.2016.05.005,0.0,,,14,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DT1MD,,"Green Submitted, Green Published",,,2024-03-09,WOS:000381245900010,0
J,"Bidian, F",,,,"Bidian, Florin",,,Robust bubbles with mild penalties for default,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Bubbles; Self-enforcing debt; Inside liquidity; Outside liquidity; Endogenous debt limits; Risk-sharing,ASSET PRICING BUBBLES; ENDOGENOUS GROWTH; DEBT; EQUILIBRIUM; CONSTRAINTS; LIQUIDITY; MARKETS; RISK; SHORTAGES,"Limited enforcement of debt contracts and mild penalties for default can lead to low equilibrium interest rates, to ensure debt repayment. Low interest rates, in turn, create conditions for bubbles. I show that bubbles in unsecured private debt exist when the punishment for default is a permanent or a temporary interdiction to trade. Bubbles are an inefficient source of liquidity, as they lower interest rates and reduce welfare by discouraging saving. (C) 2015 Elsevier B.V. All rights reserved.","[Bidian, Florin] Georgia State Univ, Robinson Coll Business, POB 4036, Atlanta, GA 30302 USA",University System of Georgia; Georgia State University,"Bidian, F (通讯作者)，Georgia State Univ, Robinson Coll Business, POB 4036, Atlanta, GA 30302 USA.",fbidian@gsu.edu,,"Bidian, Florin/0000-0001-7197-4417",,,,,40,0,0,0,7,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2016,65.0,,,,,,141,153,,10.1016/j.jmateco.2015.04.002,0.0,,,13,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DT1MD,,,,,2024-03-09,WOS:000381245900014,0
J,"Götz, TB; Hecq, A; Smeekes, S",,,,"Goetz, Thomas B.; Hecq, Alain; Smeekes, Stephan",,,Testing for Granger causality in large mixed-frequency VARs,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Granger causality; Mixed frequency VAR; Bayesian VAR; Reduced rank model; Bootstrap test,STOCK-MARKET VOLATILITY; LONG-RUN CAUSALITY; TIME-SERIES; TEMPORAL AGGREGATION; NUISANCE PARAMETER; MIDAS REGRESSIONS; OUTPUT GROWTH; BOOTSTRAP; MODEL; INFERENCE,"We analyze Granger causality testing in a mixed-frequency VAR, where the difference in sampling frequencies of the variables is large, implying parameter proliferation problems in case we attempt to estimate the model unrestrictedly. We propose several tests based on reduced rank restrictions, including bootstrap versions thereof to account for factor estimation uncertainty and improve the finite sample properties of the tests, and a Bayesian VAR extended to mixed frequencies. We compare these methods to a test based on an aggregated model, the max-test (Ghysels et al., 2016a) and an unrestricted VAR-based test (Ghysels et al., 2016b) using Monte Carlo simulations. An empirical application illustrates the techniques. (C) 2016 Elsevier B.V. All rights reserved.","[Goetz, Thomas B.] Deutsch Bundesbank, Macroecon Anal & Project Div, Wilhelm Epstein Str 14, D-60431 Frankfurt, Germany; [Hecq, Alain; Smeekes, Stephan] Maastricht Univ, Sch Business & Econ, Dept Quantitat Econ, POB 616, NL-6200 MD Maastricht, Netherlands",Deutsche Bank; Maastricht University,"Götz, TB (通讯作者)，Deutsch Bundesbank, Macroecon Anal & Project Div, Wilhelm Epstein Str 14, D-60431 Frankfurt, Germany.",thomas.goetz@bundesbank.de; a.hecq@maastrichtuniversity.nl; s.smeekes@maastrichtuniversity.nl,,"Smeekes, Stephan/0000-0002-0157-639X",Netherlands Organisation for Scientific Research (NWO) [451-12-006],Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)),"We want to particularly thank Eric Ghysels for many fruitful discussions, comments and suggestions on earlier versions of the paper. Moreover, we thank two anonymous referees, one of them deserving special gratitude for providing us with MATLAB code for the max-test. We also thank Daniela Osterrieder, Lenard Lieb, Jorg Breitung, Roman Liesenfeld, Jan-Oliver Menz, Klemens Hauzenberger, Martin Mandler and participants of the Workshop on Advances in Quantitative Economics in Maastricht 2013, the CEIS Seminar in Rome 2013, the 33rd ISF in Seoul 2013, the 24th (EC)2 conference in Cyprus 2013, the 22th SNDE in New York 2014, the 8th ECB Workshop on Forecasting Techniques in Frankfurt 2014, the Graduate School Research Seminar in Cologne 2014, the 68th ESEM in Toulouse 2014, the 8th CFE in Pisa 2014 and the Norges Bank Research Seminar in Oslo 2015 for useful suggestions and comments on earlier versions of the paper. The third author would like to thank the Netherlands Organisation for Scientific Research (NWO) (Grant number: 451-12-006) for financial support.",,73,20,20,1,42,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,AUG,2016,193.0,2.0,,,,,418,432,,10.1016/j.jeconom.2016.04.015,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DR7LL,,Green Submitted,,,2024-03-09,WOS:000380081100009,0
J,"Garfield, S; Polisena, J; Spinner, DS; Postulka, A; Lu, CY; Tiwana, SK; Faulkner, E; Poulios, N; Zah, V; Longacre, M",,,,"Garfield, Susan; Polisena, Julie; Spinner, Daryl S.; Postulka, Anne; Lu, Christine Y.; Tiwana, Simrandeep K.; Faulkner, Eric; Poulios, Nick; Zah, Vladimir; Longacre, Michael",,,"Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group",VALUE IN HEALTH,,,English,Article,,,,,,diagnostics; health technology assessment,CANCER,"Background: Health technology assessments (HTAs) are increasingly used to inform coverage, access, and utilization of medical technologies including molecular diagnostics (MDx). Although MDx are used to screen patients and inform disease management and treatment decisions, there is no uniform approach to their evaluation by HTA organizations. Objectives: The International Society for Pharmacoeconomics and Outcomes Research Devices and Diagnostics Special Interest Group reviewed diagnostic-specific HTA programs and identified elements representing common and best practices. Methods: MDx-specific HTA programs in Europe, Australia, and North America were characterized by methodology, evaluation framework, and impact. Published MDx HTAs were reviewed, and five representative case studies of test evaluations were developed: United Kingdom (National Institute for Health and Care Excellence's Diagnostics Assessment Programme, epidermal growth factor receptor tyrosine kinase mutation), United States (Palmetto's Molecular Diagnostic Services Program, OncotypeDx prostate cancer test), Germany (Institute for Quality and Efficiency in Healthcare, human papillomavirus testing), Australia (Medical Services Advisory Committee, anaplastic lymphoma kinase testing for non-small cell lung cancer), and Canada (Canadian Agency for Drugs and Technologies in Health, Rapid Response: Non-invasive Prenatal Testing). Results: Overall, the few HTA programs that have MDx-specific methods do not provide clear parameters of acceptability related to clinical and analytic performance, clinical utility, and economic impact. The case studies highlight similarities and differences in evaluation approaches across HTAs in the performance metrics used (analytic and clinical validity, clinical utility), evidence requirements, and how value is measured. Not all HTAs are directly linked to reimbursement outcomes. Conclusions: To improve MDx HTAs, organizations should provide greater transparency, better communication and collaboration between industry and HTA stakeholders, clearer links between HTA and funding decisions, explicit recognition of and rationale for differential approaches to laboratory-developed versus regulatory-approved test, and clear evidence requirements.","[Garfield, Susan] EY Boston, Boston, MA USA; [Polisena, Julie] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada; [Spinner, Daryl S.] Courtagen Life Sci Inc, Woburn, MA USA; [Postulka, Anne] Cepheid Europe, Med & Econ Value, Maurens Scopont, France; [Lu, Christine Y.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Tiwana, Simrandeep K.] Alberta Hlth Serv, Alberta Canc Prevent Legacy Fund, Edmonton, AB, Canada; [Tiwana, Simrandeep K.; Faulkner, Eric] Evidera, Bethesda, MD USA; [Faulkner, Eric] Univ N Carolina, Ctr Pharmacogen & Individualized Therapy, Chapel Hill, NC USA; [Faulkner, Eric] NAMCP, Genom Biotech & Emerging Technol Inst, Glen Allen, VA USA; [Poulios, Nick] Roche Mol Syst Inc, Pleasanton, CA USA; [Zah, Vladimir] ISPOR Serbia, Belgrade, Serbia; [Longacre, Michael] Danaher Corp, Diagnost Platform, Washington, DC USA",Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Alberta Health Services (AHS); Evidera; University of North Carolina; University of North Carolina Chapel Hill; Roche Holding; Danaher Corporation,"Garfield, S (通讯作者)，24 Sherman Bridge Rd, Wayland, MA 01778 USA.",susansgarfield@gmail.com,"Zah, Vlad/AAI-9140-2020","Zah, Vlad/0000-0003-1368-4491; Lu, Christine Y./0000-0002-7550-6837",International Society for Pharmacoeconomics and Outcomes Research (ISPOR); ISPOR Medical Devices and Diagnostics Special Interest Group,International Society for Pharmacoeconomics and Outcomes Research (ISPOR); ISPOR Medical Devices and Diagnostics Special Interest Group,This research was supported by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the ISPOR Medical Devices and Diagnostics Special Interest Group. The views expressed in this article are those of the authors and do not necessarily represent the views of the individual institutions provided in the author affiliations.,,25,26,26,0,26,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUL-AUG,2016,19.0,5.0,,,,,577,587,,10.1016/j.jval.2016.02.012,0.0,,,11,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DU5MA,27565275.0,"hybrid, Green Published",,,2024-03-09,WOS:000382254600012,0
J,"Jacobi, L; Wagner, H; Frühwirth-Schnatter, S",,,,"Jacobi, Liana; Wagner, Helga; Fruehwirth-Schnatter, Sylvia",,,Bayesian treatment effects models with variable selection for panel outcomes with an application to earnings effects of maternity leave,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Switching regression model; Shared factor model; Factor analysis; Spike and slab priors; Markov chain Monte Carlo method,MOTHERHOOD WAGE PENALTY; TREATMENT RESPONSE DATA; INSTRUMENTAL VARIABLES; PARENTAL LEAVE; FAMILY GAP; EQUATIONS; WOMEN,"We propose two alternative Bayesian treatment effect modeling and inferential frameworks for panel outcomes to estimate dynamic earnings effects of a long maternity leave on mothers' subsequent earnings. Modeling of the endogeneity of the treatment and the panel structure of the earnings are based on the modeling tradition of the Roy switching regression model and the shared factor approach, respectively. We implement stochastic variable selection to test, for example, for the presence of different dynamics under the treatment. Exploiting a change in maternity leave policy and Austrian registry data we identify substantial negative but steadily decreasing earnings effects over a 5 years period. (C) 2016 Elsevier B.V. All rights reserved.","[Jacobi, Liana] Univ Melbourne, Dept Econ, FBE Bldg,Level 4,111 Barry St, Melbourne, Vic 3010, Australia; [Wagner, Helga] Johannes Kepler Univ Linz, Dept Appl Stat, Altenberger Str 69, A-4040 Linz, Austria; [Fruehwirth-Schnatter, Sylvia] Vienna Univ Econ & Business, Dept Finance Accounting & Stat, Gebaude D4,4 Stock,Welthandelspl 1, A-1020 Vienna, Austria",University of Melbourne; Johannes Kepler University Linz; Vienna University of Economics & Business,"Frühwirth-Schnatter, S (通讯作者)，Vienna Univ Econ & Business, Dept Finance Accounting & Stat, Gebaude D4,4 Stock,Welthandelspl 1, A-1020 Vienna, Austria.",ljacobi@unimelb.edu.au; Helga.Wagner@jku.at; Sylvia.Fruehwirth-Schnatter@wu.ac.at,"Frühwirth-Schnatter, Sylvia/U-5865-2019; Fruhwirth-Schnatter, Sylvia/G-3034-2018; Jacobi, Liana/A-9285-2016","Fruhwirth-Schnatter, Sylvia/0000-0003-0516-5552; Jacobi, Liana/0000-0001-7210-0500",Austrian Science Fund (FWF) [S10309-G16]; University of Melbourne [FRG11FH10],Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Melbourne(University of Melbourne),"We thank the editor and three anonymous referees for very helpful comments. We are grateful to J.J. Heckman, Remi Piatek, Siddharta Chib and seminar participants at the University of Melbourne, Monash University, University of Innsbruck, University of Linz, as well as at the 2012 ISBA Meeting, the ESOBE 2012 meeting, the 5th Rimini Bayesian Workshop, the Melbourne Bayesian Econometrics Workshop 2013 and the IAAE 2014 Annual Conference for helpful comments and suggestions. We gratefully acknowledge funding from the Austrian Science Fund (FWF): S10309-G16 and University of Melbourne: FRG11FH10.",,37,11,12,0,16,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUL,2016,193.0,1.0,,,,,234,250,,10.1016/j.jeconom.2016.01.005,0.0,,,17,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DN8DT,,Green Submitted,,,2024-03-09,WOS:000377310100014,0
J,"Kitagawa, T; Muris, C",,,,"Kitagawa, Toru; Muris, Chris",,,Model averaging in semiparametric estimation of treatment effects,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Treatment effects; Propensity score; Model averaging; Limit experiment,FOCUSED INFORMATION CRITERION; PROPENSITY SCORE; MATCHING ESTIMATORS; TRAINING-PROGRAMS; SAMPLE PROPERTIES; CAUSAL INFERENCE; SELECTION; EFFICIENCY; SHRINKAGE,"Choosing the covariates and functional form of the propensity score is an important choice for estimating treatment effects. This paper proposes a data-driven way of averaging the estimators over candidate specifications to resolve the specification uncertainty in the propensity score weighting estimation of the ATT. The proposed procedures minimize the estimated MSE of the ATT estimator in a local asymptotic framework. We formulate model averaging as a statistical decision problem in a limit experiment, and derive an averaging scheme that is Bayes optimal with respect to a given prior. The averaging estimator outperforms selection estimators and the estimators in any of the candidate models in terms of Bayes asymptotic MSE. Our Monte Carlo studies illustrate the size of the MSE gains. We apply the averaging procedure to evaluate the effect of a labor market program. (C) 2016 Elsevier B.V. All rights reserved.","[Kitagawa, Toru] Univ London Univ Coll, Dept Econ, Gower St, London WC1E 6BT, England; [Muris, Chris] Simon Fraser Univ, Dept Econ, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada",University of London; University College London; Simon Fraser University,"Kitagawa, T (通讯作者)，Univ London Univ Coll, Dept Econ, Gower St, London WC1E 6BT, England.",t.kitagawa@ucl.ac.uk; cmuris@sfu.ca,"Kitagawa, Toru/N-6589-2015","Kitagawa, Toru/0000-0001-5550-1281; Muris, Chris/0000-0003-2781-3514","ESRC through the ESRC Centre for Microdata Methods and Practice (CeMMAP) [RES-589-28-0001]; Economic and Social Research Council [ES/I034021/1, ES/M010147/1] Funding Source: researchfish; ESRC [ES/M010147/1, ES/I034021/1] Funding Source: UKRI",ESRC through the ESRC Centre for Microdata Methods and Practice (CeMMAP); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"We thank Debopam Bhattacharya, Irene Botosaru, Xiaohong Chen, Christian Hansen, Yuichi Kitamura, Frank Kleibergen, Michael Lechner, Simon Lee, Richard Smith, and Frank Windmeijer for valuable comments and discussions. We thank an associate editor and three referees for their thorough reading and constructive comments on an earlier draft. We also thank the seminar participants at AMES 2013, University of Bristol, University of British Columbia, Brown University, the Cemmap/PEPA workshop on Program Evaluation, Georgia State University, University of Groningen, Maastricht University, University of Sankt Gallen, Tilburg University, Toulouse School of Economics, University of Washington, and Yale Econometrics Lunch for their helpful comments. All remaining errors are ours. Financial support from the ESRC through the ESRC Centre for Microdata Methods and Practice (CeMMAP) (grant number RES-589-28-0001) is gratefully acknowledged.",,49,14,15,3,16,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUL,2016,193.0,1.0,,,,,271,289,,10.1016/j.jeconom.2016.03.002,0.0,,,19,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DN8DT,,Green Submitted,,,2024-03-09,WOS:000377310100016,0
J,"Carriero, A; Kapetanios, G; Marcellino, M",,,,"Carriero, Andrea; Kapetanios, George; Marcellino, Massimiliano",,,Structural analysis with Multivariate Autoregressive Index models,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Large datasets; Multivariate Autoregressive Index models; Reduced rank regressions; Bayesian VARs; Factor models; Forecasting; Structural analysis,REDUCED RANK REGRESSION; VECTOR AUTOREGRESSIONS; MONETARY-POLICY; TESTS; INFERENCE; SHOCKS,"We address the issue of parameter dimensionality reduction in Vector Autoregressive models (VARs) for many variables by imposing specific reduced rank restrictions on the coefficient matrices that simplify the VARs into Multivariate Autoregressive Index (MAI) models. We derive the Wold representation implied by the MAIs and show that it is closely related to that associated with dynamic factor models. Then, the theoretical analysis is extended to the case of general rank restrictions on the VAR coefficients. Next, we describe classical and Bayesian estimation of large MAIs, and discuss methods for rank determination. Finally, the performance of the MAIs is compared with that of large Bayesian VARs in the context of Monte Carlo simulations and two empirical applications, on the transmission mechanism of monetary policy and on the propagation of demand and supply shocks. (C) 2016 Elsevier B.V. All rights reserved.","[Carriero, Andrea] Univ London, Queen Mary, London WC1E 7HU, England; [Marcellino, Massimiliano] Bocconi Univ, IGIER, Milan, Italy; [Marcellino, Massimiliano] Bocconi Univ, CEPR, Milan, Italy; [Kapetanios, George] Kings Coll London, London WC2R 2LS, England",University of London; Bocconi University; Bocconi University; University of London; King's College London,"Marcellino, M (通讯作者)，Bocconi Univ, IGIER, Milan, Italy.;Marcellino, M (通讯作者)，Bocconi Univ, CEPR, Milan, Italy.",a.carriero@qmul.ac.uk; George.kapetanios@kcl.ac.uk; massimiliano.marcellino@unibocconi.it,,"Marcellino, Massimiliano/0000-0002-8737-2768; Kapetanios, george/0000-0001-8557-4289; CARRIERO, ANDREA/0000-0002-4409-2870",Economic and Social Research Council [ES/K010611/1]; Economic and Social Research Council [ES/K010611/1] Funding Source: researchfish; ESRC [ES/K010611/1] Funding Source: UKRI,Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"We are grateful to the Editor Joerg Breitung, three anonymous Referees, Luc Bauwens, Siddartha Chib, Todd Clark, Herman van Dijk, Domenico Giannone, Simon Potter, Frank Schorfheide, and participants at the NBER-NSF time series conference in Vienna, seminars at University of Pennsylvania, Erasmus University Rotterdam, DIW-Berlin and the Federal Reserve Bank of St. Louis and of Cleveland, for helpful comments and suggestions. Carriero gratefully acknowledges support for this work from the Economic and Social Research Council [ES/K010611/1].",,56,8,8,0,6,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUN,2016,192.0,2.0,,,,,332,348,,10.1016/j.jeconom.2016.02.002,0.0,,,17,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DL6HG,,,,,2024-03-09,WOS:000375739700002,0
J,"Permsuwan, U; Chaiyakunapruk, N; Dilokthornsakul, P; Thavorn, K; Saokaew, S",,,,"Permsuwan, Unchalee; Chaiyakunapruk, Nathorn; Dilokthornsakul, Piyameth; Thavorn, Kednapa; Saokaew, Surasak",,,Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,REIMBURSEMENT DECISION-MAKING; HEALTH ECONOMIC-EVALUATION; NPH INSULIN; MELLITUS; RISK; COMPLICATIONS; PREVALENCE; MANAGEMENT; GLUCOSE; PROGRESSION,"Background Even though Insulin glargine (IGlar) has been available and used in other countries for more than a decade, it has not been adopted into Thai national formulary. This study aimed to evaluate the long-term cost effectiveness of IGlar versus neutral protamine Hagedorn (NPH) insulin in type 2 diabetes from the perspective of Thai Health Care System. Methods A validated computer simulation model (the IMS CORE Diabetes Model) was used to estimate the long-term projection of costs and clinical outcomes. The model was populated with published characteristics of Thai patients with type 2 diabetes. Baseline risk factors were obtained from Thai cohort studies, while relative risk reduction was derived from a meta-analysis study conducted by the Canadian Agency for Drugs and Technology in Health. Only direct costs were taken into account. Costs of diabetes management and complications were obtained from hospital databases in Thailand. Both costs and outcomes were discounted at 3 % per annum and presented in US dollars in terms of 2014 dollar value. Incremental cost-effectiveness ratio (ICER) was calculated. One-way and probabilistic sensitivity analyses were also performed. Results IGlar is associated with a slight gain in quality-adjusted life years (0.488 QALYs), an additional life expectancy (0.677 life years), and an incremental cost of THB119,543 (US$3522.19) compared with NPH insulin. The ICERs were THB244,915/QALY (US$7216.12/QALY) and THB176,525/life-year gained (LYG) (US$5201.09/LYG). The ICER was sensitive to discount rates and IGlar cost. At the acceptable willingness to pay of THB160,000/QALY (US$4714.20/QALY), the probability that IGlar was cost effective was less than 20 %. Conclusions Compared to treatment with NPH insulin, treatment with IGlar in type 2 diabetes patients who had uncontrolled blood glucose with oral anti-diabetic drugs did not represent good value for money at the acceptable threshold in Thailand.","[Permsuwan, Unchalee] Chiang Mai Univ, Fac Pharm, Suthep Rd, Chiang Mai 50200, Thailand; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia; [Chaiyakunapruk, Nathorn; Dilokthornsakul, Piyameth; Saokaew, Surasak] Naresuan Univ, Fac Pharmaceut Sci, CPOR, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Thavorn, Kednapa] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Thavorn, Kednapa] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Thavorn, Kednapa] Inst Clin & Evaluat Sci, Toronto, ON, Canada; [Saokaew, Surasak] Univ Phayao, Sch Pharmaceut Sci, Ctr Hlth Outcomes Res & Therapeut Safety COHORTS, Phayao, Thailand",Chiang Mai University; Monash University; Monash University Sunway; Naresuan University; University of Queensland; University of Wisconsin System; University of Wisconsin Madison; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Phayao,"Permsuwan, U (通讯作者)，Chiang Mai Univ, Fac Pharm, Suthep Rd, Chiang Mai 50200, Thailand.",unchalee.permsuwan@gmail.com,"Saokaew, Surasak/AAI-9804-2021; Dilokthornsakul, Piyameth/AFR-0151-2022","Saokaew, Surasak/0000-0002-1382-0660; Dilokthornsakul, Piyameth/0000-0002-6981-1771; Thavorn, Kednapa/0000-0003-4738-8447",,,,,56,9,9,0,10,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,JUN,2016,14.0,3.0,,,,,281,292,,10.1007/s40258-016-0228-3,0.0,,,12,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DM1SM,26961276.0,,,,2024-03-09,WOS:000376126500004,0
J,"Poskitt, DS",,,,"Poskitt, D. S.",,,Vector autoregressive moving average identification for macroeconomic modeling: A new methodology,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Canonical correlations; Cointegration; Echelon form; Instrumental variables; Kronecker invariants; Spectral factorization,TIME-SERIES; CANONICAL-FORMS; ARMA MODELS; SPECIFICATION; NONSTATIONARY,"This paper develops a new methodology for identifying the structure of VARMA time series models. The analysis proceeds by examining the echelon form and presents a fully automatic, strongly consistent, data driven approach to model specification. A novel feature of the inferential procedures developed here is that they work in terms of a canonical representation based on the Kronecker invariants in which the variables are expressed in the form of scalar dynamic structural equations derived from the VARMA system. This feature facilitates the construction of procedures which, from the perspective of macroeconomic modeling, can be efficacious in that they do not rely on VAR approximations. Techniques that are applicable to both asymptotically stationary and unit-root, partially nonstationary (cointegrated) time series models are presented. The inferential potential of the techniques is illustrated via simulation experiments that use data generating mechanisms based on real world examples drawn from the time series literature. Aspects of the Kronecker invariants that impinge on practical application and that have not hitherto been discussed in the literature are explored. (C) 2016 Elsevier B.V. All rights reserved.","[Poskitt, D. S.] Monash Univ, Dept Econometr & Business Stat, Clayton, Vic 3800, Australia",Monash University,"Poskitt, DS (通讯作者)，Monash Univ, Dept Econometr & Business Stat, Clayton, Vic 3800, Australia.",Donlad.Poskitt@monash.edu.au,,,Australian Research Council [DP-0984399],Australian Research Council(Australian Research Council),"A preliminary version of this paper was presented at the Conference on New Developments in Time Series Econometrics, European University Institute, Florence, 2011, which marked the end of Helmut Lutkepohl's decade as head of department at the institute. I am grateful to participants at the conference as well as George Athanasopoulos and Farshid Vahid for helpful comments. I am also indebted to three referees for correcting errors and for insightful and constructive suggestions on the content and presentation of the current paper. Financial support by the Australian Research Council under grant DP-0984399 is gratefully acknowledged.",,48,5,5,0,13,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUN,2016,192.0,2.0,,,,,468,484,,10.1016/j.jeconom.2016.02.011,0.0,,,17,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DL6HG,,,,,2024-03-09,WOS:000375739700011,0
J,"Adamson, BJ; Jain, R; Garrison, LP; Lutz, BR",,,,"Adamson, B. J.; Jain, R.; Garrison, L. P.; Lutz, B. R.",,,SMARTPHONE-ENHANCED RAPID INFLUENZA TESTS: A COST-EFFECTIVENESS ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Adamson, B. J.; Jain, R.; Garrison, L. P.; Lutz, B. R.] Univ Washington, Seattle, WA 98195 USA",University of Washington; University of Washington Seattle,,,"Adamson, Blythe/KBA-4034-2024; Lutz, Barry R/A-2101-2011; Adamson, Blythe/K-2285-2019","Adamson, Blythe/0000-0003-4251-2912",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD31,A302,A302,,10.1016/j.jval.2016.03.708,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600516,0
J,"Aderounmu, A; Rouse, MJ; Burke, S; Tembo, RT; Yaquian, EM; Sarma, S; Zaric, GS",,,,"Aderounmu, A.; Rouse, M. J.; Burke, S.; Tembo, R. T.; Yaquian, E. M.; Sarma, S.; Zaric, G. S.",,,HOW EFECTIVE IS A WORKPLACE WELNES PROGRAM IN REDUCING PRESCRIPTION DRUG EXPENDITURES IN CANADA ?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aderounmu, A.; Rouse, M. J.; Burke, S.; Tembo, R. T.; Yaquian, E. M.; Sarma, S.; Zaric, G. S.] Western Univ, London, ON, Canada",Western University (University of Western Ontario),,,"Sarma, Sisira/GQP-8686-2022",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP67,A269,A269,,10.1016/j.jval.2016.03.864,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600332,0
J,"Alghamdi, A; Seoane-Vazquez, E; Rodriguez-Monguio, R; Eguale, T; Szeinbach, S",,,,"Alghamdi, A.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.; Eguale, T.; Szeinbach, S.",,,PRICE ANALYSIS OF BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS MARKETED IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alghamdi, A.; Seoane-Vazquez, E.; Eguale, T.] Massachusetts Coll Pharm & Hlth Sci Univ, Boston, MA USA; [Rodriguez-Monguio, R.] Univ Massachusetts, Amherst, MA 01003 USA; [Szeinbach, S.] Ohio State Univ, Columbus, OH 43210 USA",University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS28,A229,A229,,10.1016/j.jval.2016.03.1128,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600110,0
J,"Alnahar, SA; Smith, MD; Elliott, RA",,,,"Alnahar, S. A.; Smith, M. D.; Elliott, R. A.",,,THE UPTAKE OF BIOSIMILAR INFLIXIMAB BY ENGLISH ACUTE TRUSTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alnahar, S. A.; Smith, M. D.; Elliott, R. A.] Univ Nottingham, Nottingham, England",University of Nottingham,,,"Elliott, Rachel/P-5894-2018","Elliott, Rachel/0000-0002-3650-0168",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP40,A265,A265,,10.1016/j.jval.2016.03.818,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600307,0
J,"Alqahtani, M; Seoane-Vazquez, E; Rodriguez-Monguio, R; Szeinbach, S; Heath, N; Eguale, T",,,,"Alqahtani, M.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.; Szeinbach, S.; Heath, N.; Eguale, T.",,,"A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, UNITED STATES, AND UNITED KINGDOM BETWEEN 1958-2015",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alqahtani, M.; Seoane-Vazquez, E.; Eguale, T.] Massachusetts Coll Pharm & Hlth Sci Univ, Boston, MA USA; [Rodriguez-Monguio, R.] Univ Massachusetts, Amherst, MA 01003 USA; [Szeinbach, S.] Ohio State Univ, Columbus, OH 43210 USA; [Heath, N.] Takeda Pharmaceut Int Co, Cambridge, MA USA","University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.",,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB71,A209,A209,,10.1016/j.jval.2016.03.1271,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000590,0
J,"Arnaud, A",,,,"Arnaud, A.",,,COSTS AND OUTCOMES COMPARISON OF TISSUE AND BLOOD BASED BIOPSIES FOR THE PURPOSE OF BIOMARKER TESTING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Arnaud, A.] Biodesix, Boulder, CO USA",,,,,,,,,,0,7,7,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN57,A143,A144,,10.1016/j.jval.2016.03.1556,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000231,0
J,"Ben-Yashar, R; Danziger, L",,,,"Ben-Yashar, Ruth; Danziger, Leif",,,The unanimity rule and extremely asymmetric committees,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Unanimity rule; Extremely asymmetric committees; Optimal composition of committees,ORGANIZATIONAL DECISION-MAKING; CONDORCETS JURY THEOREM; JUDGMENT AGGREGATION; VOTING RULES; POLYARCHIES; HIERARCHIES,"This paper analyzes how to allocate experts into committees that use the unanimity rule to make decisions. We show that an optimal allocation of experts is extremely asymmetric. To reach the optimal allocation, therefore, one needs only to rank the experts in terms of their abilities and then allocate adjacent experts such that an expert's ability tends to vary inversely with the size of his committee. In the special case of three-member committees, we show that the optimal allocation maximizes the sum of the products of the experts' skills in each committee. (C) 2016 Elsevier B.V. All rights reserved.","[Ben-Yashar, Ruth] Bar Ilan Univ, Dept Econ, IL-52900 Ramat Gan, Israel; [Danziger, Leif] Ben Gurion Univ Negev, Dept Econ, IL-84105 Beer Sheva, Israel; [Danziger, Leif] Aarhus Univ, Dept Econ & Business, DK-8210 Aarhus, Denmark; [Danziger, Leif] CESifo, Poschingerstr 5, D-81679 Munich, Germany; [Danziger, Leif] IZA, Schaumburg Lippe Str 7-9, D-53113 Bonn, Germany",Bar Ilan University; Ben Gurion University; Aarhus University; Ifo Institut; IZA Institute Labor Economics,"Danziger, L (通讯作者)，Ben Gurion Univ Negev, Dept Econ, IL-84105 Beer Sheva, Israel.",danziger@bgu.ac.il,,,,,,,22,5,5,0,4,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAY,2016,64.0,,,,,,107,112,,10.1016/j.jmateco.2016.03.008,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DN8HB,,Green Submitted,,,2024-03-09,WOS:000377318700010,0
J,"Borse, RH; McCann, E; McGill, O; Black, CM; Kachroo, S; Insinga, RP",,,,"Borse, R. H.; McCann, E.; McGill, O.; Black, C. M.; Kachroo, S.; Insinga, R. P.",,,THE COST EFFECTIVENESS OF GOLIMUMAB AS AN ADD-ON TO CONVENTIONAL CARE COMPARED TO CC FOR THE TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN SCOTLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Borse, R. H.; Insinga, R. P.] Merck & Co Inc, N Wales, PA USA; [McCann, E.] MSD, Hoddesdon, England; [McGill, O.] Merck Sharp & Dohme Ltd, Hoddesdon, England; [Black, C. M.; Kachroo, S.] Merck & Co Inc, Rahway, NJ 07065 USA",Merck & Company; Merck & Company; Merck & Company; Merck & Company,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS53,A234,A234,,10.1016/j.jval.2016.03.1153,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600135,0
J,"Boya, C; Gudala, K; Bansal, D",,,,"Boya, C.; Gudala, K.; Bansal, D.",,,ASSESSMENT OF RISK OF DIABETES USING INDIAN DIABETES RISK SCORE IN HEALTHY POSTGRADUATE STUDENTS OF INDIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Boya, C.; Gudala, K.; Bansal, D.] Natl Inst Pharmaceut Educ & Res, Mohali, India","National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)",,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD6,A297,A298,,10.1016/j.jval.2016.03.734,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600492,0
J,"Brantmüller, E; Szoke, K; Karacsony, I; Gyuró, M; Oláh, A; Boncz, I; Stromájer-Rácz, T; Pakai, A",,,,"Brantmuller, E.; Szoke, K.; Karacsony, I; Gyuro, M.; Olah, A.; Boncz, I; Stromajer-Racz, T.; Pakai, A.",,,PREMATURE BIRTH AND THE HEALTH VISITOR,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Brantmuller, E.; Szoke, K.] Univ Pecs, Kaposvar, Hungary; [Karacsony, I] Univ Pecs, Szombathely, Hungary; [Gyuro, M.; Olah, A.; Boncz, I; Stromajer-Racz, T.] Univ Pecs, Pecs, Hungary; [Pakai, A.] Univ Pecs, Zalaegerszeg, Hungary",University of Pecs; University of Pecs; University of Pecs; University of Pecs,,,"Pakai, Annamaria/AAS-2610-2020; Boncz, Imre/A-8940-2013","Pakai, Annamaria/0000-0002-2849-1310; Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIH46,A179,A180,,10.1016/j.jval.2016.03.1418,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000429,0
J,"Candrilli, SD; Tam, IM; Moss, JR",,,,"Candrilli, S. D.; Tam, I. M.; Moss, J. R.",,,DIRECT MEDICAL COSTS FOLLOWING PEDIATRIC TYMPANOSTOMY TUBE PLACEMENT IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Candrilli, S. D.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Tam, I. M.] Otonomy Inc, San Diego, CA USA; [Moss, J. R.] Charlotte Eye Ear Nose & Throat Associates, Matthews, NC USA",Research Triangle Institute,,,,"Candrilli, Sean/0000-0002-2062-1192",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSS10,A123,A123,,10.1016/j.jval.2016.03.500,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000123,0
J,"Cárdenas-Cárdenas, L; Castillo-Rodríguez, L; Alvis-Zakzuk, N; Castaneda-Orjuela, CA; Cotes-Cantillo, K; Restrepo, DF",,,,"Cardenas-Cardenas, L.; Castillo-Rodriguez, L.; Alvis-Zakzuk, N.; Castaneda-Orjuela, C. A.; Cotes-Cantillo, K.; De la Hoz Restrepo, F.",,,MALNUTRITION MORTALITY IN COLOMBIAN CHILDREN: AN INEQUALITIES ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cardenas-Cardenas, L.; Castillo-Rodriguez, L.; Alvis-Zakzuk, N.; Castaneda-Orjuela, C. A.; Cotes-Cantillo, K.] Inst Nacl Salud, Bogota, Colombia; [De la Hoz Restrepo, F.] Colombian Natl Univ, Bogota, Colombia",Instituto Nacional de Salud (Colombia); Universidad Nacional de Colombia,,,"Alvis-Zakzuk, Nelson J./HSH-0822-2023; Castaneda-Orjuela, Carlos/N-2601-2017","Castaneda-Orjuela, Carlos/0000-0002-8735-6223; CASTILLO RODRIGUEZ, LILIANA/0000-0001-9251-6423",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP60,A268,A268,,10.1016/j.jval.2016.03.784,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600326,0
J,"Endrei, D; Zemplényi, A; Csákvári, T; Molics, B; Elmer, D; Horváth, ZC; Vajda, R; Sebestyen, A; Pónusz, R; Boncz, I",,,,"Endrei, D.; Zemplenyi, A.; Csakvari, T.; Molics, B.; Elmer, D.; Horvath, Cs Z.; Vajda, R.; Sebestyen, A.; Ponusz, R.; Boncz, I",,,"CHANGES IN THE MARKET SHARE OF PRIVATE, FOR-PROFIT HEALTH CARE PROVIDERS FROM THE HUNGARIAN HEALTH INSURANCE BUDGET BETWEEN 2010-2014",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Endrei, D.; Zemplenyi, A.; Elmer, D.; Vajda, R.; Ponusz, R.; Boncz, I] Univ Pecs, Pecs, Hungary; [Csakvari, T.] Univ Pecs, Zalaegerszeg, Hungary; [Molics, B.] Univ Pecs, Pecs, Hungary; [Horvath, Cs Z.] Govt Off Baranya Cty, Pecs, Hungary; [Sebestyen, A.] Natl Hlth Insurance Fund Adm, Pecs, Hungary",University of Pecs; University of Pecs; University of Pecs,,,"Csakvari, Timea/AAE-2141-2019; Boncz, Imre/A-8940-2013","Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP88,A273,A273,,10.1016/j.jval.2016.03.885,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600352,0
J,"Foos, V; Lamotte, M; McEwan, P",,,,"Foos, V; Lamotte, M.; McEwan, P.",,,ASSESSING THE IMPACT OF SIMULATED TIME HORIZON ON PREDICTED INCREMENTAL QUALITY ADJUSTED LIFE YEARS IN TYPE 2 DIABETES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Foos, V] IMS Hlth, Basel, Switzerland; [Lamotte, M.] IMS Hlth, Vilvoorde, Belgium; [McEwan, P.] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales",Health Economics & Outcomes Research Ltd,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM91,A87,A87,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000479,0
J,"Ghosh, S; Kamal, KM; Covvey, JR; Candrilli, SD; Giannetti, V",,,,"Ghosh, S.; Kamal, K. M.; Covvey, J. R.; Candrilli, S. D.; Giannetti, V",,,EXPLORING THE ASSOCIATION BETWEEN STATINS AND COPD: AN ANALYSIS OF THE 2009-2010 NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ghosh, S.; Kamal, K. M.; Covvey, J. R.; Giannetti, V] Duquesne Univ, Mylan Sch Pharm, Pittsburgh, PA 15219 USA; [Candrilli, S. D.] RTI Hlth Solut, Res Triangle Pk, NC USA",Duquesne University; Research Triangle Institute,,,"Covvey, Jordan R/I-3407-2019","Covvey, Jordan R/0000-0003-2913-2042; Candrilli, Sean/0000-0002-2062-1192",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS8,A111,A111,,10.1016/j.jval.2016.03.428,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000054,0
J,"Grant, L; Marshall, C; Burrows, K; Khammo, N; Albrecht, H; Arbuckle, R; Shea, T",,,,"Grant, L.; Marshall, C.; Burrows, K.; Khammo, N.; Albrecht, H.; Arbuckle, R.; Shea, T.",,,EXPLORING THE QUALITATIVE EXPERIENCE OF CHEST CONGESTION WITH CHILDREN AND ADULTS TO DEVELOP PATIENT-REPORTED OUTCOME ITEMS TO SELF-ASSESS SYMPTOMS OF THE COMMON COLD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Grant, L.; Marshall, C.; Burrows, K.; Arbuckle, R.] Adelphi Values Ltd, Bollington, England; [Khammo, N.] RB, Kingston Upon Hull, N Humberside, England; [Albrecht, H.] Florida Int Univ, Miami, FL 33199 USA; [Shea, T.] RB, Parsippany, NJ USA",Adelphi Group Ltd; State University System of Florida; Florida International University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS43,A117,A117,,10.1016/j.jval.2016.03.464,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000089,0
J,"Guzauskas, GF; Serbin, M; Veenstra, DL",,,,"Guzauskas, G. F.; Serbin, M.; Veenstra, D. L.",,,COMPARING THE VALUE OF EVIDENCE OVER TIME FOR CLOPIDOGREL PHARMACOGENOMICS VERSUS DRUG-DRUG INTERACTIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Guzauskas, G. F.; Serbin, M.; Veenstra, D. L.] Univ Washington, Seattle, WA 98195 USA",University of Washington; University of Washington Seattle,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV85,A54,A54,,10.1016/j.jval.2016.03.136,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000299,0
J,"Hoang, B; Nguyen, T",,,,"Hoang, B.; Nguyen, T.",,,COST EFFECTIVENESS OF ERLOTINIB VERSUS GEMCITABINE/CARBOPLATIN IN FIRST-LINE THERAPY OF ADVANCED EGFR-MUTATIONS POSITIVE NON-SMALL-CELL LUNG CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hoang, B.] Univ Med & Pharm HCMC, Ho Chi Minh City, Vietnam; [Nguyen, T.] Ho Chi Minh City Univ Med & Pharm, Ho Chi Minh City, Vietnam",Hochiminh City University of Medicine & Pharmacy; Hochiminh City University of Medicine & Pharmacy,,,,,,,,,0,0,0,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN104,A152,A152,,10.1016/j.jval.2016.03.1603,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000277,0
J,"Hu, G; Koganov, M",,,,"Hu, G.; Koganov, M.",,,A ROLE FOR PRO-BASED PATIENT TREATMENT SIMULATORS IN OBSERVING PHYSICIAN TREATMENT OF PAIN AND DISCOMFORT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hu, G.; Koganov, M.] KMK Consulting Inc, Morristown, NJ USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM197,A106,A106,,10.1016/j.jval.2016.03.1686,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000025,0
J,"Hu, J; Aprikian, A; Cury, F; Vanhuyse, M; Zakaria, AS; Dragomir, A",,,,"Hu, J.; Aprikian, A.; Cury, F.; Vanhuyse, M.; Zakaria, A. S.; Dragomir, A.",,,IMPACT OF INITIAL LOCAL PRIMARY TREATMENT ON LATE REGIONAL COMPLICATIONS IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN QUEBEC,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hu, J.; Aprikian, A.; Cury, F.; Vanhuyse, M.; Zakaria, A. S.; Dragomir, A.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada",McGill University,,,"Cury, Fabio L./AAW-5633-2020","Cury, Fabio L./0000-0003-1293-0822",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN32,A139,A139,,10.1016/j.jval.2016.03.1654,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000206,0
J,"Iqbal, MS; Iqbal, MZ; Bahari, MB",,,,"Iqbal, M. S.; Iqbal, M. Z.; Bahari, M. B.",,,"EMERGENCY CONTRACEPTIVE PILLS KNOWLEDGE, ATTITUDES, AND PRACTICES OF COMMUNITY PHARMACISTS IN PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Iqbal, M. S.] BZU, Fac Pharm, Multan, Pakistan; [Iqbal, M. S.] MAHSA Univ, Fac Pharm, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Iqbal, M. Z.; Bahari, M. B.] AIMST Univ, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kedah, Malaysia",Bahauddin Zakariya University; Mahsa University; AIMST University,,,"Iqbal, Muhammad/HJH-2369-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP124,A279,A279,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600387,0
J,"Khan, N; Weinstock-Guttman, B; Medin, J; Christoffersen, P; Price, J; Bonzani, I; Zivadinov, R",,,,"Khan, N.; Weinstock-Guttman, B.; Medin, J.; Christoffersen, P.; Price, J.; Bonzani, I; Zivadinov, R.",,,DEVELOPMENT OF AN INNOVATIVE OBSERVATIONAL STUDY TO ASSESS MULTIPLE SCLEROSIS DISEASE PROGRESSION IN REAL WORLD CLINICAL PRACTICE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Khan, N.; Christoffersen, P.; Price, J.; Bonzani, I] IMS Hlth, Basel, Switzerland; [Weinstock-Guttman, B.] SUNY Buffalo, Buffalo, NY USA; [Medin, J.] Novartis Pharma AG, Basel, Switzerland",State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Novartis,,,"Zivadinov, Robert/Q-2054-2019","Zivadinov, Robert/0000-0002-7799-1485",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM190,A104,A105,,10.1016/j.jval.2016.03.1679,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000018,0
J,"Langley, PC; Schommer, J; Rhee, TG",,,,"Langley, P. C.; Schommer, J.; Rhee, T. G.",,,IMAGINARY WORLDS: THE STATUS OF MODELED CLAIMS PUBLISHED IN VALUE IN HEALTH JANUARY 2015 TO DECEMBER 2015,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Langley, P. C.; Schommer, J.] Univ Minnesota, Tucson, AZ USA; [Rhee, T. G.] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA",University of Minnesota System; University of Minnesota System; University of Minnesota Twin Cities,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM90,A87,A87,,10.1016/j.jval.2016.03.1802,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000478,0
J,"Law, EH; Pickard, A; Kaczynski, A; Pickard, AS",,,,"Law, E. H.; Pickard, A.; Kaczynski, A.; Pickard, A. S.",,,VALIDITY OF HEALTH PREFERENCES ELICITED FROM CHILDREN: COMPARING CHOICE BLINDNESS AND STATED PREFERENCES BETWEEN CHILDREN AND ADULTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Law, E. H.; Pickard, A. S.] Univ Illinois, Chicago, IL USA; [Pickard, A.] Second City Outcomes Res LLC, Oak Pk, IL USA; [Kaczynski, A.] Univ Appl Sci Neubrandenburg, Neubrandenburg, Germany",University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PP3,A9,A9,,10.1016/j.jval.2016.03.064,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000047,0
J,"Lee, KM; Coyle, D; Coyle, K; Loncar, M",,,,"Lee, K. M.; Coyle, D.; Coyle, K.; Loncar, M.",,,REIMBURSEMENT-BASED ECONOMIC EVALUATION OF DRUGS FOR THE TREATMENT OF OVERACTIVE BLADER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, K. M.; Loncar, M.] CADTH, Ottawa, ON, Canada; [Coyle, D.] Univ Ottawa, Ottawa, ON, Canada; [Coyle, K.] Brunel Univ, Uxbridge, Middx, England",University of Ottawa; Brunel University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PUK24,A133,A133,,10.1016/j.jval.2016.03.541,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000172,0
J,"Lefebvre, P; Chow, W; Pilon, D; Emond, B; Lafeuille, M; Pfeifer, M; Rupnow, MF; Duh, MS",,,,"Lefebvre, P.; Chow, W.; Pilon, D.; Emond, B.; Lafeuille, M.; Pfeifer, M.; Rupnow, M. F.; Duh, M. S.",,,REAL-WORLD EVALUATION OF WEIGHT LOSS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH CANAGLIFLOZIN - AN ELECTRONIC HEALTH RECORD-BASED STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lefebvre, P.; Pilon, D.; Emond, B.; Lafeuille, M.] Grp Anal Ltee, Montreal, PQ, Canada; [Chow, W.; Pfeifer, M.; Rupnow, M. F.] Janssen Sci Affairs LLC, Raritan, NJ USA; [Duh, M. S.] Anal Grp Inc, Boston, MA USA",Johnson & Johnson; Janssen Pharmaceuticals; Analysis Group Inc.,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB7,A198,A198,,10.1016/j.jval.2016.03.1314,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000528,0
J,"Maturi, B; Marino, J",,,,"Maturi, B.; Marino, J.",,,SUBCUTANEOUS TOCILIZUMAB: A COST-MINIMIZATION ANALYSIS BASED ON THE POPULATION OF QUEBEC,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Maturi, B.; Marino, J.] Hoffmann La Roche Ltd, Mississauga, ON, Canada",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS55,A234,A234,,10.1016/j.jval.2016.03.1155,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600137,0
J,"McRae, J; Calusi, G; Liu, M; Scognamiglio, V; Messina, E; Polenzani, L; Maio, V",,,,"McRae, J.; Calusi, G.; Liu, M.; Scognamiglio, V; Messina, E.; Polenzani, L.; Maio, V",,,EROSION OF EMPATHY IN PRIMARY CARE TRAINEES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[McRae, J.; Liu, M.; Maio, V] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Calusi, G.; Scognamiglio, V; Messina, E.; Polenzani, L.] AUSL 4 Prato, Prato, Italy",Jefferson University,,,,,,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS154,A36,A36,,10.1016/j.jval.2016.03.389,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,"Green Submitted, hybrid",,,2024-03-09,WOS:000376886000200,0
J,"Meyers, J; Chaudhari, P; Madhwani, S; Candrilli, SD",,,,"Meyers, J.; Chaudhari, P.; Madhwani, S.; Candrilli, S. D.",,,CLINICAL AND ECONOMIC BURDEN OF PERIPHERAL ARTERY DISEASE AMONG PATIENTS RECEIVING ENDOVASCULAR INTERVENTIONS: A RETROSPECTIVE COHORT STUDY OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Meyers, J.; Madhwani, S.; Candrilli, S. D.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Chaudhari, P.] Takeda Pharmaceut, Deerfield, IL USA",Research Triangle Institute,,,,"Meyers, Juliana/0000-0003-2938-2957; Candrilli, Sean/0000-0002-2062-1192",,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV36,A45,A45,,10.1016/j.jval.2016.03.101,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000250,0
J,"O'Brien, E; Li, S; Thomas, L; Wang, TY; Rowe, MT; Peterson, ED",,,,"O'Brien, E.; Li, S.; Thomas, L.; Wang, T. Y.; Rowe, M. T.; Peterson, E. D.",,,RISK-ADJUSTED HOSPITAL RATES OF READMISSION AND MORTALITY USING COMORBIDITY DATA FROM A CLINICAL REGISTRY VERSUS ADMINISTRATIVE CLAIMS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[O'Brien, E.; Li, S.; Thomas, L.; Wang, T. Y.; Rowe, M. T.; Peterson, E. D.] Duke Clin Res Inst, Durham, NC USA",Duke University,,,"Peterson, Eric David/ABF-5033-2021",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM177,A102,A102,,10.1016/j.jval.2016.03.1666,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000005,0
J,"Orozco, JJ; Valencia, J; Lopez, P",,,,"Orozco, J. J.; Valencia, J.; Lopez, P.",,,COST EFFECTIVENESS OF CRYOABLATION VERSUS CONVENTIONAL RADIOFRECUENCY PULMONARY VEIN ISOLATION FOR THE TREATMENT OF PATIENTS WITH PAROXISMAL ATRIAL FIBRILATION IN COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Orozco, J. J.] Medtronic PLC, Medellin, Colombia; [Valencia, J.] Medtronic, Miami, FL USA; [Lopez, P.] Medtronic PLC, Bogota, Colombia",Medtronic; Medtronic; Medtronic,,,"Valencia, Juan/GXN-0206-2022",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD35,A303,A303,,10.1016/j.jval.2016.03.712,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600520,0
J,"Pobre, MA; Riley, R; Predmore, Z; Horvitz-Lennon, M; Mattke, S",,,,"Pobre, M. A.; Riley, R.; Predmore, Z.; Horvitz-Lennon, M.; Mattke, S.",,,POTENTIAL COST SAVINGS OF HAVING ACCESS TO ANTIPSYCHOTIC PLASMA LEVELS AT THE POINT OF CARE FOR PATIENTS WITH SCHIZOPHRENIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pobre, M. A.; Riley, R.] Janssen Diagnost, Titusville, NJ USA; [Predmore, Z.; Horvitz-Lennon, M.; Mattke, S.] RAND Hlth, Boston, MA USA",RAND Corporation,,,"horvitz-lennon, marcela/HPG-0121-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH38,A188,A188,,10.1016/j.jval.2016.03.1378,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000477,0
J,"Raisch, DW; Bennett, CL; Rafi, JA; Chen, C",,,,"Raisch, D. W.; Bennett, C. L.; Rafi, J. A.; Chen, C.",,,PROGRESIVE MULTIFOCAL LEUKOENCEPHALOPATHY WITH NEW BIOLOGICALS AND TARGETED CANCER THERAPIES: SUMMARY OF REPORTS TO THE FOOD AND DRUG ADMINISTRATION'S ADVERSE EVENT REPORTING SYSTEM (FAERS),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Raisch, D. W.; Bennett, C. L.; Rafi, J. A.; Chen, C.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA",University of New Mexico,,,,"Chen, Cheng/0000-0001-5240-8284",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN1,A133,A133,,10.1016/j.jval.2016.03.1623,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000175,0
J,"Saji, K; Belaiche, A; Cherrah, Y; Ahid, S",,,,"Saji, K.; Belaiche, A.; Cherrah, Y.; Ahid, S.",,,ANALYSIS OF PRICE DECLINE OF DRUGS IN MOROCCO IN 2014,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saji, K.; Belaiche, A.; Cherrah, Y.; Ahid, S.] Mohammed V Univ, Rabat, Morocco",Mohammed V University in Rabat,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP15,A261,A261,,10.1016/j.jval.2016.03.793,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600282,0
J,"Shewale, AR; Bhandari, NR; Kathe, N; Hammond, D; Painter, JT",,,,"Shewale, A. R.; Bhandari, N. R.; Kathe, N.; Hammond, D.; Painter, J. T.",,,GEOGRAPHIC VARIATION IN ON-LABEL AND OFF-LABEL TESTOSTERONE USE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shewale, A. R.; Bhandari, N. R.; Kathe, N.; Hammond, D.; Painter, J. T.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA",University of Arkansas System; University of Arkansas Medical Sciences,,,"KATHE, NIRANJAN/AAI-5014-2020; Bhandari, Naleen Raj/W-3669-2018","KATHE, NIRANJAN/0000-0003-4932-6426; Bhandari, Naleen Raj/0000-0002-4452-8021",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP20,A261,A262,,10.1016/j.jval.2016.03.798,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600287,0
J,"Siu, EC; Wyatt, G",,,,"Siu, E. C.; Wyatt, G.",,,"CANADIAN PUBLIC REIMBURSEMENT OF BIOSIMILARS (REFERRED TO AS SUBSEQUENT ENTRY BIOLOGICS -SEBS - IN CANADA), AN UPDATE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Siu, E. C.; Wyatt, G.] Wyatt Hlth Management, Oakville, ON, Canada",,,,,,,,,,0,0,0,1,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP138,A281,A281,,10.1016/j.jval.2016.03.1999,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600398,0
J,"Tenkeu, S; Okeh, A; Onukwugha, E",,,,"Tenkeu, S.; Okeh, A.; Onukwugha, E.",,,COST OF MENTAL ILLNESS STUDIES: A DESCRIPTIVE ANALYSIS OF DESIGN CHARACTERISTICS AND COSTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tenkeu, S.; Okeh, A.] Univ Maryland, Baltimore, MD 21201 USA; [Onukwugha, E.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA",University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH32,A187,A187,,10.1016/j.jval.2016.03.1372,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000471,0
J,"Tran, TT; Nguyen, T",,,,"Tran, T. T.; Nguyen, T.",,,BUDGET IMPACT ANALYSIS OF ERLOTIB AS THE FIRST-LINE THERAPY OF ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER IN VIETNAM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tran, T. T.; Nguyen, T.] Ho Chi Minh City Univ Med & Pharm, Ho Chi Minh City, Vietnam",Hochiminh City University of Medicine & Pharmacy,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN51,A142,A143,,10.1016/j.jval.2016.03.1550,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000225,0
J,"Vitezic, D; Mance, D; Mance, D; Vitezic, M; Pelcic, JM",,,,"Vitezic, D.; Mance, D.; Mance, D.; Vitezic, M.; Pelcic, Mrsic J.",,,TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 INFECTION: COMPARISON OF HEALTH-ECONOMIC OUTCOMES FOR NAIVE PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vitezic, D.; Vitezic, M.; Pelcic, Mrsic J.] Univ Rijeka, Sch Med, Rijeka, Croatia; [Vitezic, D.] Univ Hosp Ctr Rijeka, Rijeka, Croatia; [Mance, D.] Univ Rijeka, Rijeka, Croatia; [Mance, D.] Univ Rijeka, Fac Econ, Rijeka, Croatia; [Vitezic, M.] Univ Orthopaed Clin Lovran, Lovran, Croatia",University of Rijeka; University of Rijeka; University of Rijeka; University of Rijeka,,,"Mance, Diana/S-9764-2018; Mance, Davor/S-3882-2018; Vitezic, Dinko/T-1541-2018; Vitezic, Dinko/N-8865-2019","Mance, Diana/0000-0001-6746-8693; Mance, Davor/0000-0002-6206-2464; Vitezic, Dinko/0000-0002-6295-6580",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PGI14,A314,A314,,10.1016/j.jval.2016.03.982,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600584,0
J,"Waye, A; Jacobs, P; Ospina, M; Stickland, M; Mayers, I",,,,"Waye, A.; Jacobs, P.; Ospina, M.; Stickland, M.; Mayers, I",,,"ECONOMIC SURVEILLANCE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ALBERTA, CANADA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Waye, A.; Jacobs, P.] Inst Hlth Econ, Edmonton, AB, Canada; [Ospina, M.; Stickland, M.] Strateg Clin Network, Edmonton, AB, Canada; [Mayers, I] Univ Alberta, Edmonton, AB, Canada; [Mayers, I] AHS, Edmonton, AB, Canada",University of Alberta,,,,,,,,,0,0,0,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS29,A14,A15,,10.1016/j.jval.2016.03.279,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000077,0
J,"Xia, Y; Fang, P; Reid, M; Holtz, J; Doth, A",,,,"Xia, Y.; Fang, P.; Reid, M.; Holtz, J.; Doth, A.",,,THE INFECTION RATE AND RISK FACTORS FOR PATIENTS EXPERIENCING AN INFECTION FOLOWING DEEP BRAIN STIMULATION IMPLANTATION : EVIDENCE FROM A LARGE US PAYER DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Xia, Y.; Fang, P.; Reid, M.; Holtz, J.; Doth, A.] Medtronic Inc, Minneapolis, MN USA",Medtronic,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD12,A299,A299,,10.1016/j.jval.2016.03.740,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600498,0
J,"Xu, Y; Hay, JW; Barzi, A",,,,"Xu, Y.; Hay, J. W.; Barzi, A.",,,COMPARATIVE EFFECTIVENESS OF PANITUMUMAB VERSUS CETUXIMAB IN PATIENTS WITH CHEMO-REFRACTORY WILD-TYPE KRAS METASTATIC COLORECTAL CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Xu, Y.; Hay, J. W.; Barzi, A.] Univ Southern Calif, Los Angeles, CA USA",University of Southern California,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,CO3,A2,A2,,10.1016/j.jval.2016.03.032,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000007,0
J,"Younossi, Z; Stepanova, M; Omata, M; Mizokami, M; Nader, F; Hunt, S",,,,"Younossi, Z.; Stepanova, M.; Omata, M.; Mizokami, M.; Nader, F.; Hunt, S.",,,FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Younossi, Z.] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA USA; [Stepanova, M.; Nader, F.; Hunt, S.] Ctr Outcomes Res Liver Dis, Washington, DC USA; [Omata, M.] Yamanashi Prefectural Hosp Org, Yamanashi, Japan; [Mizokami, M.] Kohnodai Hosp, Chiba, Japan",Inova Fairfax Hospital,,,"Younossi, Zobair M./JRY-9916-2023; Stepanova, Maria/V-5513-2019","Stepanova, Maria/0000-0003-0444-8155",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PGI25,A316,A317,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600595,0
J,"Zhang, D; Prabhu, V; Burrell, E; Marcella, S",,,,"Zhang, D.; Prabhu, V; Burrell, E.; Marcella, S.",,,ATTRIBUTABLE HEALTH CARE RESOURCE UTILIZATION AND COSTS FOR PATIENTS WITH PRIMARY AND RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhang, D.; Prabhu, V; Burrell, E.; Marcella, S.] Merck & Co Inc, Kenilworth, NJ USA",Merck & Company,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIN25,A216,A216,,10.1016/j.jval.2016.03.1213,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,"Green Published, hybrid",,,2024-03-09,WOS:000394931600036,0
J,"Zhang, S; Thomas, J",,,,"Zhang, S.; Thomas, J., III",,,ASSESSMENT OF ASSOCIATION BETWEEN HEALTH INSURANCE COVERAGE AND DIABETES CARE QUALITY USING DIFFERENCE-IN-DIFFERENCES ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhang, S.; Thomas, J., III] Purdue Univ, W Lafayette, IN 47907 USA",Purdue University System; Purdue University West Lafayette Campus; Purdue University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS90,A25,A25,,10.1016/j.jval.2016.03.325,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000136,0
J,"Zhao, Y; Wu, JJ; Tran, M; Liu, JS; Herrera, V",,,,"Zhao, Y.; Wu, J. J.; Tran, M.; Liu, J. S.; Herrera, V",,,REAL-WORLD USE OF SECUKINUMAB AMONG PATIENTS WITH PSORIASIS: PATIENT CHARAC TERISTICS AND DOSING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhao, Y.; Herrera, V] Novartis Pharmaceut, E Hanover, NJ USA; [Wu, J. J.] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; [Tran, M.] Scott & White Hlth Plan, Temple, TX USA; [Liu, J. S.] Havard Univ, Cambridge, MA USA",Novartis; Kaiser Permanente,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSS33,A128,A128,,10.1016/j.jval.2016.03.1827,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000145,0
J,"Drapeau, S; Jamneshan, A",,,,"Drapeau, Samuel; Jamneshan, Asgar",,,Conditional preference orders and their numerical representations,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Conditional preferences; Utility theory; Gap Lemma; von Neumann and Morgenstern,STATE-DEPENDENT PREFERENCES; EXPECTED UTILITY-THEORY; SUBJECTIVE PROBABILITIES; COMPLETENESS AXIOM; RISK MEASURES; AGGREGATION; UNCERTAINTY,"We provide an axiomatic system modeling conditional preference orders which is based on conditional set theory. Conditional numerical representations are introduced, and a conditional version of the theorems of Debreu on the existence of numerical representations is proved. The conditionally continuous representations follow from a conditional version of Debreu's Gap Lemma the proof of which relies on a conditional version of the axiom of choice, free of any measurable selection argument. We give a conditional version of the von Neumann and Morgenstern representation as well as automatic conditional continuity results, and illustrate them by examples. (C) 2016 Elsevier B.V. All rights reserved.","[Drapeau, Samuel] Shanghai Jiao Tong Univ, SAIF CAFR, 211 Huaihai Rd, Shanghai 200030, Peoples R China; [Drapeau, Samuel] Shanghai Jiao Tong Univ, Dept Math, 211 Huaihai Rd, Shanghai 200030, Peoples R China; [Jamneshan, Asgar] Univ Konstanz, Univ Str 10, D-78464 Constance, Germany",Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Konstanz,"Drapeau, S (通讯作者)，Shanghai Jiao Tong Univ, SAIF CAFR, 211 Huaihai Rd, Shanghai 200030, Peoples R China.;Drapeau, S (通讯作者)，Shanghai Jiao Tong Univ, Dept Math, 211 Huaihai Rd, Shanghai 200030, Peoples R China.",sdrapeau@saif.sjtu.edu.cn; asgar.jamneshan@uni-konstanz.de,"Jamneshan, Asgar/ABA-4764-2021","Jamneshan, Asgar/0000-0002-1450-6569",,,,,42,6,6,0,5,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAR,2016,63.0,,,,,,106,118,,10.1016/j.jmateco.2015.12.004,0.0,,,13,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DI7DF,,Green Submitted,,,2024-03-09,WOS:000373658600013,0
J,"Ewerhart, C",,,,"Ewerhart, Christian",,,An envelope approach to tournament design,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Rank-order tournaments; First-order approach; Envelope theorem,1ST-ORDER APPROACH; INCENTIVES; CONTESTS; COMPENSATION,"Optimal rank-order tournaments have traditionally been studied using a first-order approach. The present analysis relies instead on the construction of an upper envelope' over all incentive compatibility conditions. It turns out that the first-order approach is not innocuous. For example, in contrast to the traditional understanding, tournaments may be dominated by piece rates even if workers are risk-neutral. The paper also offers a strikingly simple characterization of the optimal tournament for quadratic costs and CARA utility, as well as an extension to large tournaments. (C) 2015 The Author. Published by Elsevier B.V.","[Ewerhart, Christian] Univ Zurich, Dept Econ, Schonberggasse 1, CH-8001 Zurich, Switzerland",University of Zurich,"Ewerhart, C (通讯作者)，Univ Zurich, Dept Econ, Schonberggasse 1, CH-8001 Zurich, Switzerland.",christian.ewerhart@econ.uzh.ch,,,,,,,43,2,2,0,2,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAR,2016,63.0,,,,,,1,9,,10.1016/j.jmateco.2015.11.004,0.0,,,9,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DI7DF,,"Green Submitted, Green Published, hybrid",,,2024-03-09,WOS:000373658600001,0
J,"Adarkwah, CC; Sadoghi, A; Gandjour, A",,,,"Adarkwah, Charles Christian; Sadoghi, Amirhossein; Gandjour, Afschin",,,Should Cost-Effectiveness Analysis Include the Cost of Consumption Activities? AN Empirical Investigation,HEALTH ECONOMICS,,,English,Article,,,,,,consumption; Crohn's disease; leisure time; quality-adjusted life year; time trade-off; ulcerative colitis; validation study,INFLAMMATORY-BOWEL-DISEASE; HEALTH-STATE VALUATIONS; QUALITY-OF-LIFE; POPULATION PREFERENCES; CALCULATING QALYS; FUTURE COSTS; SILENCE; PATIENT; LEISURE; INCOME,"There has been a debate on whether cost-effectiveness analysis should consider the cost of consumption and leisure time activities when using the quality-adjusted life year as a measure of health outcome under a societal perspective. The purpose of this study was to investigate whether the effects of ill health on consumptive activities are spontaneously considered in a health state valuation exercise and how much this matters. The survey enrolled patients with inflammatory bowel disease in Germany (n=104). Patients were randomized to explicit and no explicit instruction for the consideration of consumption and leisure effects in a time trade-off (TTO) exercise. Explicit instruction to consider non-health-related utility in TTO exercises did not influence TTO scores. However, spontaneous consideration of non-health-related utility in patients without explicit instruction (60% of respondents) led to significantly lower TTO scores. Results suggest an inclusion of consumption costs in the numerator of the cost-effectiveness ratio, at least for those respondents who spontaneously consider non-health-related utility from treatment. Results also suggest that exercises eliciting health valuations from the general public may include a description of the impact of disease on consumptive activities. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Adarkwah, Charles Christian] Univ Marburg, Dept Gen Practice Family Med, Marburg, Germany; [Adarkwah, Charles Christian] Maastricht Univ, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands; [Sadoghi, Amirhossein; Gandjour, Afschin] Frankfurt Sch Finance & Management, Dept Management, Frankfurt, Germany",Philipps University Marburg; Maastricht University; Frankfurt School Finance & Management,"Gandjour, A (通讯作者)，Frankfurt Sch Finance & Management, Dept Management, Frankfurt, Germany.",a.gandjour@fs.de,"Gandjour, Afschin/I-8963-2019","Adarkwah, Charles Christian/0000-0002-1073-5866",,,,,29,1,1,0,3,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,2.0,,,,,249,256,,10.1002/hec.3162,0.0,,,8,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DA9ZC,25684073.0,,,,2024-03-09,WOS:000368167300009,0
J,"Cunnama, L; Sinanovic, E; Ramma, L; Foster, N; Berrie, L; Stevens, W; Molapo, S; Marokane, P; McCarthy, K; Churchyard, G; Vassall, A",,,,"Cunnama, Lucy; Sinanovic, Edina; Ramma, Lebogang; Foster, Nicola; Berrie, Leigh; Stevens, Wendy; Molapo, Sebaka; Marokane, Puleng; McCarthy, Kerrigan; Churchyard, Gavin; Vassall, Anna",,,Using Top-down and Bottom-up Costing Approaches in LMICs: The Case for Using Both to Assess the Incremental Costs of New Technologies at Scale,HEALTH ECONOMICS,,,English,Article,,,,,,LMICs; tuberculosis; cost analysis; economies of scale; diagnostics; scale-up,,"PurposeEstimating the incremental costs of scaling-up novel technologies in low-income and middle-income countries is a methodologically challenging and substantial empirical undertaking, in the absence of routine cost data collection. We demonstrate a best practice pragmatic approach to estimate the incremental costs of new technologies in low-income and middle-income countries, using the example of costing the scale-up of Xpert Mycobacterium tuberculosis (MTB)/resistance to riframpicin (RIF) in South Africa. Materials and methodsWe estimate costs, by applying two distinct approaches of bottom-up and top-down costing, together with an assessment of processes and capacity. ResultsThe unit costs measured using the different methods of bottom-up and top-down costing, respectively, are $US16.9 and $US33.5 for Xpert MTB/RIF, and $US6.3 and $US8.5 for microscopy. The incremental cost of Xpert MTB/RIF is estimated to be between $US14.7 and $US17.7. While the average cost of Xpert MTB/RIF was higher than previous studies using standard methods, the incremental cost of Xpert MTB/RIF was found to be lower. ConclusionCosts estimates are highly dependent on the method used, so an approach, which clearly identifies resource-use data collected from a bottom-up or top-down perspective, together with capacity measurement, is recommended as a pragmatic approach to capture true incremental cost where routine cost data are scarce.","[Cunnama, Lucy; Sinanovic, Edina; Ramma, Lebogang; Foster, Nicola] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, ZA-7925 Cape Town, South Africa; [Berrie, Leigh; Stevens, Wendy; Molapo, Sebaka; Marokane, Puleng] Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa; [McCarthy, Kerrigan; Churchyard, Gavin; Vassall, Anna] Aurum Inst Hlth Res, Johannesburg, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin] London Sch Hyg & Trop Med, London WC1, England",University of Cape Town; National Health Laboratory Service; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine,"Cunnama, L (通讯作者)，Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Hlth Econ Unit, Anzio Rd, ZA-7925 Observatory, South Africa.",lucy.cunnama@uct.ac.za,"Sinanovic, Edina/AAR-2590-2020; Cunnama, Lucy/AAK-3159-2021; Ramma, Lebogang/AAT-1732-2021; Foster, Nicola/AAA-9040-2020; Cunnama, Lucy/AAQ-6468-2021","Cunnama, Lucy/0000-0003-2134-4905; Ramma, Lebogang/0000-0001-9109-9103; Foster, Nicola/0000-0003-4630-6243; Churchyard, Gavin/0000-0002-4269-3699; McCarthy, Kerrigan/0000-0001-8958-9795; Vassall, Anna/0000-0002-2911-1375; Stevens, Wendy Susan/0000-0002-1684-908X",Medical Research Council [MC_PC_16021] Funding Source: researchfish,Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),,,32,65,66,1,6,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,,,1.0,,,53,66,,10.1002/hec.3295,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DB9TF,26763594.0,"Green Published, hybrid, Green Accepted",,,2024-03-09,WOS:000368859100006,0
J,"Hamman, MK; Kapinos, KA",,,,"Hamman, Mary K.; Kapinos, Kandice A.",,,Colorectal Cancer Screening and State Health Insurance Mandates,HEALTH ECONOMICS,,,English,Article,,,,,,cancer screening; health insurance mandates,PATIENT PREFERENCES; PARITY LEGISLATION; COST-EFFECTIVENESS; PREDICTORS; SERVICES; COVERAGE; COLONOSCOPY; POPULATION; PATTERNS; ADULTS,"Colorectal cancer (CRC) is the third most deadly cancer in the USA. CRC screening is the most effective way to prevent CRC death, but compliance with recommended screenings is very low. In this study, we investigate whether CRC screening behavior changed under state mandated private insurance coverage of CRC screening in a sample of insured adults from the 1997 to 2008 Behavioral Risk Factor Surveillance Survey (BRFSS). We present difference-in-difference-in-differences (DDD) estimates that compare insured individuals age 51 to 64 to Medicare age-eligible individuals (ages 66 to 75) in mandate and non-mandate states over time. Our DDD estimates suggest endoscopic screening among men increased by 2 to 3 percentage points under mandated coverage among 51 to 64year olds relative to their Medicare age-eligible counterparts. We find no clear evidence of changes in screening behavior among women. DD estimates suggest no evidence of a mandate effect on either type of CRC screening for men or women. Copyright (c) 2014 John Wiley & Sons, Ltd.","[Hamman, Mary K.] Univ Wisconsin, Dept Econ, La Crosse, WI 54601 USA; [Kapinos, Kandice A.] RAND Corp, Arlington, VA 22202 USA",University of Wisconsin System; RAND Corporation,"Kapinos, KA (通讯作者)，RAND Corp, 1200 South Hayes St, Arlington, VA 22202 USA.",kkapinos@rand.org,,"Kapinos, Kandice/0000-0003-1577-4917","United States Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service [LIP-42-126]","United States Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service(US Department of Veterans Affairs)","The authors are grateful to Katie Carman, Ezra Golberstein, Helen Levy, Kosali Simon, and anonymous referees for their feedback on earlier drafts. The authors also wish to thank participants at AcademyHealth, the American Society of Health Economists, the Census Bureau, the Minneapolis Veterans Affairs Medical Center, the Minnesota Population Center at the University of Minnesota, the RAND Corporation, and the University of Wisconsin La Crosse for their comments. This work was supported in part by the United States Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Service (grant # LIP-42-126 to HSG). Disclaimers: The views expressed in this article are those of the authors and do not necessarily represent the position or policy of the Department of Veterans Affairs.",,46,12,12,0,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,2.0,,,,,178,191,,10.1002/hec.3132,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DA9ZC,25521438.0,,,,2024-03-09,WOS:000368167300004,0
J,"Bianchi, F",,,,"Bianchi, Francesco",,,Methods for measuring expectations and uncertainty in Markov-switching models,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Markov-switching VAR; DSGE; Moments; Expectations; Uncertainty; Impulse responses,MONETARY-POLICY; MACROECONOMIC FLUCTUATIONS; REGIME SWITCHES; BUSINESS-CYCLE; TIME-SERIES; SHIFTS; VOLATILITY; MOMENTS; SHOCKS,"I develop methods to analyze multivariate Markov-switching models. Formulas for the evolution of first and second moments are derived and then used to characterize expectations, uncertainty, impulse responses, sources of uncertainty, and welfare implications of regime changes in general equilibrium models. The methods can be used to capture the link between uncertainty and the state of the economy. Campbell's present value decomposition is generalized to allow for parameter instability. Taking into account regime changes is shown to be important for expectations, welfare, and uncertainty. All results are derived analytically and are therefore suitable for structural estimation. (C) 2015 Elsevier B.V. All rights reserved.","[Bianchi, Francesco] Cornell Univ, Ithaca, NY 14853 USA; [Bianchi, Francesco] Duke Univ, Durham, NC 27706 USA; [Bianchi, Francesco] CEPR, Washington, DC USA; [Bianchi, Francesco] NBER, Cambridge, MA 02138 USA",Cornell University; Duke University; Center for Economic & Policy Research (CEPR); National Bureau of Economic Research,"Bianchi, F (通讯作者)，Cornell Univ, Dept Econ, 464 Uris Hall, Ithaca, NY 14853 USA.",francesco.bianchi@cornell.edu,"Bianchi, Francesco/AAA-1310-2020",,,,,,47,18,20,0,16,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JAN,2016,190.0,1.0,,,,,79,99,,10.1016/j.jeconom.2015.08.004,0.0,,,21,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CY6QX,,,,,2024-03-09,WOS:000366535000005,0
J,"Bosi, G; Herden, G",,,,"Bosi, Gianni; Herden, Gerhard",,,On continuous multi-utility representations of semi-closed and closed preorders,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,,"On the basis of the classical continuous multi-utility representation theorem of Levin on locally compact and sigma-compact Hausdorff spaces, we present necessary and sufficient conditions on a topological space (X, t) under which every semi-closed and closed preorder respectively admits a continuous multi-utility representation. This discussion provides the fundaments of a mainly topological theory that systematically combines topological and order theoretic aspects of the continuous multi-utility representation problem. (C) 2015 Elsevier B.V. All rights reserved.","[Bosi, Gianni] Univ Trieste, DEAMS, Piazzale Europa 1, I-34127 Trieste, Italy; [Herden, Gerhard] Univ Duisburg Essen, Fak Math, Math Carree, Campus Essen,Thea Leymann Str 9, D-45127 Essen, Germany",University of Trieste; University of Duisburg Essen,"Herden, G (通讯作者)，Univ Duisburg Essen, Fak Math, Math Carree, Campus Essen,Thea Leymann Str 9, D-45127 Essen, Germany.",gerhard.herden@uni-due.de,,,,,,,18,15,15,0,1,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,JAN,2016,79.0,,,,,,20,29,,10.1016/j.mathsocsci.2015.10.006,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DC4QH,,Green Submitted,,,2024-03-09,WOS:000369204900004,0
J,"Carrasco, V; Orenstein, P; Salgado, P",,,,"Carrasco, Vinicius; Orenstein, Paulo; Salgado, Pablo",,,When (and how) to favor incumbents in optimal dynamic procurement auctions,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Dynamic procurement; Auctions; Time-varying private information; Selection procedure; Dynamic mechanism design,COMPETITION; MECHANISM; DESIGN,"We consider the problem faced by a benevolent government agency that procures in each of T > 1 periods an indivisible good from one of N > 1 firms. The procurement process is complicated by the superior information possessed by firms about their time-varying production costs and efficiency enhancing efforts. We fullycharacterize the optimal dynamic procurement. To reduce firms' informational rents, the government introduces distortions along two dimensions: when selecting from which firm to procure the good and when providing incentives toward efforts in cost reduction. Both distortions interact in a non-trivial way. Firms that draw lower cost parameters in the first period are favored in the selection process in all later periods, which allows for the provision-of more powerful incentives. (C) 2015 Published by Elsevier B.V.","[Carrasco, Vinicius; Salgado, Pablo] Pontificia Univ Catolica Rio de Janeiro, Dept Econ, Rio de Janeiro, Brazil; [Orenstein, Paulo] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Salgado, Pablo] Tese Gestao Investimentos, Rio De Janeiro, Brazil",Pontificia Universidade Catolica do Rio de Janeiro; Stanford University,"Carrasco, V (通讯作者)，Pontificia Univ Catolica Rio de Janeiro, Dept Econ, Rio de Janeiro, Brazil.",vncarrasco@gmail.com; paulo.oren@gmail.com; pablossalgado@gmail.com,,,,,,,22,0,0,0,2,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,JAN,2016,62.0,,,,,,52,61,,10.1016/j.jmateco.2015.10.008,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DD8XP,,,,,2024-03-09,WOS:000370210500006,0
C,"de Oliveira, DM; Colchete, AF",,"Aurand, JM",,"de Oliveira, Douglimar Meireles; Colchete Filho, Antonio Ferreira",,,"City, architecture and wine: Wine tourism in the contemporary society",39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,English,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"In the last decades, the growth of activities related to wine tourism is a potent driver of transformations in territories and societies. Wine landscapes of ancestral regions such as La Rioja in Spain, Bordeaux in France or also in the so-called New World, such as the Napa Valley in the United States, Mendoza in Argentina and many others around the world, demonstrate a new age where the wine tourism is essential for affecting their economies and leaving a mark in the contemporary society, in which architecture plays a major role to achieve these goals. In Brazil, an emerging country in wine production, the Valley of the Vineyards is one of the most traditional areas of production and it has been through major changes over the past decades. The countless vineyards, wine cellars, tourist establishments and the growing urbanization are redefining the landscape of the region. Using bibliographic revision to explore different perspectives on the theme, this article aims at highlighting the social, cultural and technical implications related to this kind of tourism. Moreover, both positive and negative effects reflect the identity and the characteristics of each area, along with cultural and architectural elements that are disposed in each wine cellar, time and place.","[de Oliveira, Douglimar Meireles; Colchete Filho, Antonio Ferreira] Univ Fed Juiz de Fora, FAU UFJF, BR-36036330 Juiz De Fora, MG, Brazil",Universidade Federal de Juiz de Fora,"de Oliveira, DM (通讯作者)，Univ Fed Juiz de Fora, FAU UFJF, BR-36036330 Juiz De Fora, MG, Brazil.",,,,,,,,26,0,1,1,20,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,3026.0,10.1051/bioconf/20160703026,0.0,,,7,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"Green Submitted, gold",,,2024-03-09,WOS:000390791700104,0
C,"Milella, RA; Pisani, R; Mastrofranceseo, L; Alba, V; Giannandrea, MA; Gasparro, M; Caputo, AR",,"Aurand, JM",,"Milella, Rosa Anna; Pisani, Rosa; Mastrofranceseo, Lisa; Alba, Vittorio; Giannandrea, Maria Angela; Gasparro, Marica; Caputo, Angelo Raffaele",,,Phenolic characterization and antioxidant capacity of ten autochthonous vines grown in southern Italy,39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,Italian,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"In plant foods are naturally present some bioactive compounds, that are compounds having or not nutritional value and with biological activity that is expressed in reducing the risk of developing many chronic diseases, therefore leading a key protective effect on our health. Within this group of compounds the antioxidants are included. The importance of antioxidants contained in food is associated with their ability to exert in vivo, in the human body, beneficial effects against chronical-degenerative diseases induced by oxidative stress and age. It has been attributed a positive role to grape polyphenols in terms of increase in endogenous antioxidant defenses, thanks to regulation of genes coding for key enzymes of antioxidant system. For the polyphenols it has also been recognized a specific action of tumor growth inhibition, linked to the modulation of enzymes involved in carcinogenesis or to the inhibition of growth factors and cell proliferation activation. After carbohydrates and acids, the phenolic compounds represent the largest group among grape constituents. The synthesis of these secondary metabolites takes place in two distinct phases of vine growth cycle: fruit set and maturation. The polyphenolic composition contributes to grapes and wine sensory properties, such as color, flavor, astringency, and determines the antioxidant capacity of the extract. These metabolites are mainly related to the variety and their content is influenced by climatic and environmental factors. Among the polyphenols, anthocyanins, hydroxicinnamiltartaric acids, flavonols, flavans, stilbene and resveratrol are of particular interest. Despite numerous studies in the vine-wine industry on polyphenols quantification and qualification, we don't know much about the environmental conditions that affect their synthesis in grapes and how they are extracted from it in wine production. Therefore, the aim of this work has been the study of antioxidant property and phenolic profile of ten autochthonous vines grown in two different areas of South Italy. By spectrophotometric analysis it has been possible to analyze qualiquantitive characteristics of such substances, while by ORAC method (Oxygen Radical Absorbance Capacity) we have measured, in vitro, the antioxidant action. The oenological potential has been evaluated, in relation to polyphenols content, of ten Vitis Vinifera varieties belonging to autochthonous vines of Basilicata, grown in espalier and tent in two areas: in the vineyard of Val d'Agri (PZ), in Basilicata, and in South-East Bari area, in Rutigliano (Ba), in Puglia. The ten varieties belonging to Southern Italy autochthonous vines include four black grapes and six white grapes. Data obtained on total polyphenols content, view of the considerable variability encountered, allow us to affirm that the polyphenolic ripening of wine grapes, thus the reaching of the maximum level, is very influenced by the terroir, defined as the cultivation area or environment, by season trend, by cultivation techniques and by the different vines nutritional conditions. The same holds true for the antioxidant activity of the 10 wine grapes varieties of this study, since it is closely related to the polyphenol content.","[Milella, Rosa Anna; Mastrofranceseo, Lisa; Alba, Vittorio; Giannandrea, Maria Angela; Gasparro, Marica; Caputo, Angelo Raffaele] CREA UTV Consiglio Ric Agr & Anal Econ Agr, Unita Ric Uva Tavola & Vitivinicoltura Ambiente M, Via Casa Massitna 148, I-70010 Turi, Ba, Italy; [Pisani, Rosa] Univ Ferrara, Fac Farm, I-44121 Ferrara, Italy",Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Ferrara,"Milella, RA (通讯作者)，CREA UTV Consiglio Ric Agr & Anal Econ Agr, Unita Ric Uva Tavola & Vitivinicoltura Ambiente M, Via Casa Massitna 148, I-70010 Turi, Ba, Italy.",,"Gasparro, Marica/AAP-9506-2021; Alba, Vittorio/AAC-5455-2021","Alba, Vittorio/0000-0001-5317-0589",,,,,13,1,1,0,6,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,1019.0,10.1051/bioconf/20160701019,0.0,,,5,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"gold, Green Submitted, Green Published",,,2024-03-09,WOS:000390791700019,0
J,"Cseh, A; Koford, BC; Phelps, RT",,,,"Cseh, Attila; Koford, Brandon C.; Phelps, Ryan T.",,,Hospital Utilization and Universal Health Insurance Coverage: Evidence from the Massachusetts Health Care Reform Act,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,,"Objective The Affordable Care Act is currently in the roll-out phase. To gauge the likely implications of the national policy we analyze how the Massachusetts Health Care Reform Act impacted various hospitalization outcomes in each of the 25 major diagnostic categories (MDC). Methods We utilize a difference-in-difference approach to identify the impact of the Massachusetts reform on insurance coverage and patient outcomes. This identification is achieved using six years of data from the Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project. We report MDC-specific estimates of the impact of the reform on insurance coverage and type as well as length of stay, number of diagnoses, and number of procedures. Results The requirement of universal insurance coverage increased the probability of being covered by insurance. This increase was in part a result of an increase in the probability of being covered by Medicaid. The percentage of admissions covered by private insurance fell. The number of diagnoses rose as a result of the law in the vast majority of diagnostic categories. Our results related to length of stay suggest that looking at aggregate results hides a wealth of information. The most disparate outcomes were pregnancy related. The length of stay for newborn babies and neonates rose dramatically. In aggregate, this increase serves to mute decreases across other diagnoses. Also, the number of procedures fell within the MDCs for pregnancy and child birth and that for new-born babies and neonates. Conclusions The Massachusetts Health Care Reform appears to have been effective at increasing insurance take-up rates. These increases may have come at the cost of lower private insurance coverage. The number of diagnoses per admission was increased by the policy across nearly all MDCs. Understanding the changes in length of stay as a result of the Massachusetts reform, and perhaps the Affordable Care Act, requires MDC-specific analysis. It appears that the most important distinction to make is to differentiate care related to new-born babies and neonates from that related to other diagnostic categories.","[Cseh, Attila] Valdosta State Univ, Dept Econ & Finance, Valdosta, GA 31698 USA; [Koford, Brandon C.] Weber State Univ, Dept Econ, Ogden, UT 84408 USA; [Phelps, Ryan T.] Stephen F Austin State Univ, Dept Econ & Finance, Nacogdoches, TX 75962 USA",University System of Georgia; Valdosta State University; Utah System of Higher Education; Weber State University,"Koford, BC (通讯作者)，Weber State Univ, Dept Econ, Ogden, UT 84408 USA.",brandonkoford@weber.edu,,,,,,,12,5,7,0,8,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,DEC,2015,13.0,6.0,,,,,627,635,,10.1007/s40258-015-0178-1,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DC2XV,26037893.0,,,,2024-03-09,WOS:000369083000006,0
J,"Haeussler, K; Marcellusi, A; Mennini, FS; Favato, G; Picardo, M; Garganese, G; Bononi, M; Costa, S; Scambia, G; Zweifel, P; Capone, A; Baio, G",,,,"Haeussler, Katrin; Marcellusi, Andrea; Mennini, Francesco Saverio; Favato, Giampiero; Picardo, Mauro; Garganese, Giorgia; Bononi, Marco; Costa, Silvano; Scambia, Giovanni; Zweifel, Peter; Capone, Alessandro; Baio, Gianluca",,,Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study,VALUE IN HEALTH,,,English,Article,,,,,,dynamic Bayesian model; cost-effectiveness analysis; herd immunity; HPV; vaccination programs,PREVENT CERVICAL-CANCER; HPV-ASSOCIATED CANCER; ECONOMIC-EVALUATION; RISK-FACTORS; INTRAEPITHELIAL NEOPLASIA; HEALTH UTILITIES; PARTICLE VACCINE; INDUCED DISEASES; NATURAL-HISTORY; GENITAL WARTS,"Background: Human papillomavirus (HPV) plays a role in the development of benign and malign neoplasms in both sexes. The Italian recommendations for HPV vaccines consider only females. The BEST II study (Bayesian modelling to assess the Effectiveness of a vaccination Strategy to prevent HPV-related diseases) evaluates 1) the cost-effectiveness of immunization strategies targeting universal vaccination compared with cervical cancer screening and female-only vaccination and 2) the economic impact of immunization on various HPV-induced diseases. Objective: The objective of this study was to evaluate whether female-only vaccination or universal vaccination is the most cost-effective intervention against HPV. Methods: We present a dynamic Bayesian Markov model to investigate transmission dynamics in cohorts of females and males in a follow-up period of 55 years. We assumed that quadrivalent vaccination (against HPV 16, 18, 6, and 11) is available for 12-year-old individuals. The model accounts for the progression of subjects across HPV-induced health states (cervical, vaginal, vulvar, anal, penile, and head/neck cancer as well as anogenital warts). The sexual mixing is modeled on the basis of age-, sex-, and sexual behavioral-specific matrices to obtain the dynamic force of infection. Results: In comparison to cervical cancer screening, universal vaccination results in an incremental cost-effectiveness ratio of 1,500. When universal immunization is compared with female-only vaccination, it is cost-effective with an incremental cost-effectiveness ratio of (sic)11,600. Probabilistic sensitivity analysis shows a relatively large amount of parameter uncertainty, which interestingly has, however, no substantial impact on the decision-making process. The intervention being assessed seems to be associated with an attractive cost-effectiveness profile. Conclusions: Universal HPV vaccination is found to be a cost-effective choice when compared with either cervical cancer screening or female-only vaccination within the Italian context.","[Haeussler, Katrin; Baio, Gianluca] UCL, Dept Stat Sci, Gower St, London WC1E 6BT, England; [Marcellusi, Andrea; Mennini, Francesco Saverio] Univ Roma Tor Vergata, Fac Econ, Econ Evaluat & HTA, Rome, Italy; [Marcellusi, Andrea] Univ Roma La Sapienza, Dept Demog, I-00185 Rome, Italy; [Mennini, Francesco Saverio; Favato, Giampiero; Capone, Alessandro] Kingston Univ London, Inst Leadership & Management Hlth, London, England; [Picardo, Mauro] San Gallicano Dermatol Inst IRCCS, Lab Cutaneous Pathophysiol, Rome, Italy; [Garganese, Giorgia; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy; [Bononi, Marco] Univ Roma La Sapienza, Dept Surg Pietro Valdoni, I-00185 Rome, Italy; [Costa, Silvano] Univ Bologna, S Orsola Malpighi Hosp, Dept Gynecol & Obstet, Bologna, Italy; [Zweifel, Peter] Univ Zurich, Socioecon Inst, Zurich, Switzerland",University of London; University College London; University of Rome Tor Vergata; Sapienza University Rome; Kingston University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Zurich,"Haeussler, K (通讯作者)，UCL, Dept Stat Sci, Gower St, London WC1E 6BT, England.",k.haeussler@ucl.ac.uk,"Marcellusi, Andrea/AAL-6573-2020; Garganese, Giorgia/AAC-3397-2020; FAVATO, Giampiero/HKF-1477-2023; Baio, Gianluca/A-2947-2012; Picardo, Mauro/JOK-5462-2023; Scambia, Giovanni/K-7539-2016","FAVATO, Giampiero/0000-0003-3499-2979; Picardo, Mauro/0000-0003-4899-6639; Scambia, Giovanni/0000-0002-9503-9041; Marcellusi, Andrea/0000-0002-3974-3798; Baio, Gianluca/0000-0003-4314-2570",,,,,127,26,28,0,12,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2015,18.0,8.0,,,,,956,968,,10.1016/j.jval.2015.08.010,0.0,,,13,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DF3GG,26686779.0,"Green Published, Green Submitted, Bronze",,,2024-03-09,WOS:000371231500003,0
J,"O'Mahony, JF; Normand, C",,,,"O'Mahony, James F.; Normand, Charles",,,"HIQA's CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not",VALUE IN HEALTH,,,English,Editorial Material,,,,,,,COST-EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATIONS; CLINICIAN GUIDE; DECISION-MAKING; HEALTH; RULES,"The Health Information and Quality Authority (HIQA) is Ireland's statutory cost-effectiveness analysis (CEA) agency. It recently published a CEA of screening strategies for women at elevated risk of breast cancer. Although the strategies recommended by HIQA exceed Ireland's cost-effectiveness threshold, they can reasonably be welcomed as a pragmatic response to constraints on disinvestment and are expected to improve screening cost-effectiveness. What is not welcome, however, is HIQA's reporting of average cost-effectiveness ratios (ACERs) as incremental cost-effectiveness ratios (ICERs). The distinction between ACERs and ICERs is well understood in CEA, as is the fact that ICERs not ACERs are the appropriate metric to determine cost-effectiveness. This article critiques HIQA's reporting, considering the implications for the particular case of breast cancer screening and the broader context of consistency of and confidence in CEA as a guide to resource allocation in Ireland. The reporting of ACERs as ICERs is unlikely to be of any great significance in the particular case of screening women at elevated risk of breast cancer, given likely constraints on disinvestment. Despite this, ICERs still need to be reported correctly. If thresholds are exceeded in certain cases, then it is important that decision makers appreciate by how much. More generally, using ACERs in some cases and ICERs in others raises concerns that methods are being applied inconsistently, which risks compromising confidence in CEA in Ireland. As Ireland's statutory CEA authority, HIQA has a special onus of responsibility to ensure established methods are applied correctly. Keywords: cost-effectiveness analysis, average cost effectiveness ratio, incremental cost effectiveness ratio, consistency. Copyright (C) 2015, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","[O'Mahony, James F.; Normand, Charles] Trinity Coll Dublin, Sch Med, Ctr Hlth Policy & Management, Dublin 2, Ireland",Trinity College Dublin,"O'Mahony, JF (通讯作者)，Trinity Coll Dublin, Dept Hlth Policy & Management, 2-4 Foster Pl, Dublin 2, Ireland.",jfomahon@tcd.ie,,"Normand, Charles/0000-0002-0885-5754; O'Mahony, James/0000-0003-3414-7388",CERVIVA II grant by the Health Research Board,CERVIVA II grant by the Health Research Board(Health Research Board - Ireland),This work was funded under the CERVIVA II grant provided by the Health Research Board (to J. O'M.) as part of the Interdisciplinary Capacity Enhancement scheme.,,34,6,6,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2015,18.0,8.0,,,,,941,945,,10.1016/j.jval.2015.08.009,0.0,,,5,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DF3GG,26686777.0,hybrid,,,2024-03-09,WOS:000371231500001,0
J,"Schmid, C",,,,"Schmid, Christian",,,Consumer Health Information and the Demand for Physician Visits,HEALTH ECONOMICS,,,English,Article,,,,,,consumer health information; health care demand; physician visits; Poisson hurdle model; JELI11; I18; C24,SUPPLIER-INDUCED DEMAND; MEDICAL-CARE; PATIENT RELATIONSHIP; PREVENTIVE CARE; SERVICES; COMPETITION; INSURANCE; MODELS; MARKET,"The present study empirically investigates the effect of consumer health information on the demand for physician visits. Using a direct information measure based on questions from the Swiss Health Survey, we estimate a Poisson hurdle model for office visits. We find that information has a negative effect on health care utilization, contradicting previous findings in the literature. We consider differences in the used information measures to be the most likely explanation for the different findings. However, our results suggest that increasing consumer health information has the potential to reduce health care expenditures. Copyright (c) 2014 John Wiley & Sons, Ltd.","Univ Bern, Dept Econ, CH-3001 Bern, Switzerland",University of Bern,"Schmid, C (通讯作者)，Univ Bern, Dept Econ, Schanzeneckstr 1, CH-3001 Bern, Switzerland.",christian.schmid@vwi.unibe.ch,,"Schmid, Christian/0000-0002-6020-385X",,,,,43,13,16,1,22,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,DEC,2015,24.0,12.0,,,,,1619,1631,,10.1002/hec.3117,0.0,,,13,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CW0WT,25339623.0,,,,2024-03-09,WOS:000364711400007,0
J,"Wright, SJ; Jones, C; Payne, K; Dharni, N; Ulph, F",,,,"Wright, Stuart J.; Jones, Cheryl; Payne, Katherine; Dharni, Nimarta; Ulph, Fiona",,,The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Review,,,,,,,TANDEM MASS-SPECTROMETRY; COA DEHYDROGENASE-DEFICIENCY; COST-EFFECTIVENESS; CYSTIC-FIBROSIS; SICKLE-CELL; CONGENITAL HYPOTHYROIDISM; DECISION-MAKING; UNIVERSAL; PARENTS; COMMUNICATION,"Background The extent to which economic evaluations have included the healthcare resource and outcome-related implications of information provision in national newborn bloodspot screening programmes (NBSPs) is not currently known. Objectives To identify if, and how, information provision has been incorporated into published economic evaluations of NBSPs. Methods A systematic review of economic evaluations of NBSPs (up to November 2014) was conducted. Three electronic databases were searched (Ovid: Medline, Embase, CINAHL) using an electronic search strategy combining a published economic search filter with terms related to national NBSPs and screening-related technologies. These electronic searches were supplemented by searching the NHS Economic Evaluations Database (NHS EED) and hand-searching identified study reference lists. The results were tabulated and summarised as part of a narrative synthesis. Results A total of 27 economic evaluations [screening-related technologies (n = 11) and NBSPs (n = 16)] were identified. The majority of economic evaluations did not quantify the impact of information provision in terms of healthcare costs or outcomes. Five studies did include an estimate of the time cost associated with information provision. Four studies included a value to reflect the disutility associated with parental anxiety caused by false-positive results, which was used as a proxy for the impact of imperfect information. Conclusion A limited evidence base currently quantifies the impact of information provision on the healthcare costs and impact on the users of NBSPs; the parents of newborns. We suggest that economic evaluations of expanded NBSPs need to take account of information provision otherwise the impact on healthcare costs and the outcomes for newborns and their parents may be underestimated.","[Wright, Stuart J.; Jones, Cheryl; Payne, Katherine] Univ Manchester, Manchester Ctr Hlth Econ, Inst Populat Hlth, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England; [Dharni, Nimarta; Ulph, Fiona] Univ Manchester, Manchester Ctr Hlth Psychol, Sch Psychol Sci, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England",University of Manchester; University of Manchester,"Payne, K (通讯作者)，Univ Manchester, Manchester Ctr Hlth Econ, Inst Populat Hlth, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.",katherine.payne@manchester.ac.uk,"Ulph, Fiona/AAD-5905-2022; Payne, Katherine/AAJ-3728-2020","Payne, Katherine/0000-0002-3938-4350; Ulph, Fiona/0000-0003-3590-6542; Jones, Cheryl/0000-0002-3024-225X; Wright, Stuart/0000-0002-4064-7998",National Institute for Health Research [11/62/02] Funding Source: researchfish; Department of Health [11/62/02] Funding Source: Medline,National Institute for Health Research(National Institutes of Health Research (NIHR)); Department of Health,,,78,8,8,1,15,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,DEC,2015,13.0,6.0,,,,,615,626,,10.1007/s40258-015-0177-2,0.0,,,12,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DC2XV,25995075.0,"Green Published, Bronze",,,2024-03-09,WOS:000369083000005,0
J,"AlAujan, S; Elliott, R; Knaggs, R",,,,"AlAujan, S.; Elliott, R.; Knaggs, R.",,,SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS IN MULTIDISCIPLINARY PAIN MANAGEMENT SERVICES FOR MANAGING PEOPLE WITH FIBROMYALGIA OR CHRONIC WIDESPREAD PAIN,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[AlAujan, S.; Elliott, R.; Knaggs, R.] Univ Nottingham, Nottingham, England",University of Nottingham,,,"Alaujan, Shiekha S/AAM-5388-2021; Elliott, Rachel/P-5894-2018","Elliott, Rachel/0000-0002-3650-0168; Knaggs, Roger/0000-0003-1646-8321; Alaujan, Shiekha/0000-0003-1973-6870",,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY8,A660,A660,,10.1016/j.jval.2015.09.2392,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300858,0
J,"Alvis-Zakzuk, N; Carrasquilla-Sotomayor, M; Alvis-Guzmán, N; Paternina-Caicedo, A; Herrera-Arrieta, J; Coronel-Rodríguez, W; Castillo-Saavedra, D",,,,"Alvis-Zakzuk, N.; Carrasquilla-Sotomayor, M.; Alvis-Guzman, N.; Paternina-Caicedo, A.; Herrera-Arrieta, J.; Coronel-Rodriguez, W.; Castillo-Saavedra, D.",,,ECONOMIC COSTS OF BACTERIAL MENINGITIS: A SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alvis-Zakzuk, N.] Inst Nacl Salud, Bogota, Colombia; [Carrasquilla-Sotomayor, M.; Alvis-Guzman, N.; Paternina-Caicedo, A.; Coronel-Rodriguez, W.] Univ Cartagena, Ctr Invest & Docencia, Hosp Infantil Napoleon Franco Pareja, Cartagena De Indias, Colombia; [Herrera-Arrieta, J.] Univ Sina, Cartagena, Colombia; [Castillo-Saavedra, D.] Funinderma, Grp Invest Econ Salud, Bogota, Colombia",Instituto Nacional de Salud (Colombia); Universidad de Cartagena,,,"Alvis-Guzman, Nelson/D-4913-2013; Alvis-Zakzuk, Nelson J./HSH-0822-2023","Alvis-Guzman, Nelson/0000-0001-9458-864X;",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,IN4,A807,A807,,10.1016/j.jval.2015.09.084,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400499,0
J,"Baser, O; Lewis-Beck, C; Fritschel, E; Baser, E; Wang, L",,,,"Baser, O.; Lewis-Beck, C.; Fritschel, E.; Baser, E.; Wang, L.",,,APPLIED COMPARISON OF META-ANALYSIS TECHNIQUES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Baser, O.] Columbia Univ, STATinMED Res, New York, NY USA; [Lewis-Beck, C.] Iowa State Univ, Des Moines, IA USA; [Fritschel, E.] Texas Dept State Hlth Serv, Austin, TX USA; [Baser, E.] STATinMED Res, Ankara, Turkey; [Baser, E.] Gazi Univ, Ankara, Turkey; [Wang, L.] STATinMED Res, Plano, TX USA",Columbia University; Iowa State University; Texas Department of State Health Services; Gazi University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM15,A814,A814,,10.1016/j.jval.2015.09.224,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400540,0
J,"Bishai, D",,,,"Bishai, David",,,Generalized Nutrient Taxes Can Increase Consumer Welfare,HEALTH ECONOMICS,,,English,Article,,,,,,obesity; fat tax; food,SOFT DRINK TAXES; FAT; OBESITY,"Certain nutrients can stimulate appetite making them fattening in a way that is not fully conveyed by the calorie content on the label. For rational eaters, this information gap could be corrected by more labeling. As an alternative, this paper proposes a set of positive and negative taxes on the fattening and slimming nutrients in food rather than on the food itself. There are conditions under which this tax plus subsidy system could increase welfare by stopping unwanted weight gain while leaving the final retail price of food unchanged. A nutrient tax system could improve welfare if fattening nutrients, net of their effect on weight, are inferior goods and the fiscal cost of administering the tax is sufficiently low. More data on the price elasticity of demand for nutrients as well as data on how specific nutrients affect satiety and how total calorie intake would be necessary before one could be sure a nutrient tax would work in practice. Copyright (c) 2014 John Wiley & Sons, Ltd.","Johns Hopkins Bloomberg Sch Publ Hlth, Populat Family & Reprod Hlth, Baltimore, MD 21205 USA",Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health,"Bishai, D (通讯作者)，Johns Hopkins Bloomberg Sch Publ Hlth, Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.",dbishai1@jhu.edu,", DaviD/JNS-4036-2023; , David Bishai/GRO-4211-2022",,,,,,19,5,5,1,11,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2015,24.0,11.0,,,,,1517,1522,,10.1002/hec.3101,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CT0PG,25241653.0,,,,2024-03-09,WOS:000362498000009,0
J,"Brook, RA; Smeeding, JE; Sax, MJ",,,,"Brook, R. A.; Smeeding, J. E.; Sax, M. J.",,,THE CURRENT LANDSCAPE AND EXPECTED CHANGES IN FORMULARY MANAGEMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Brook, R. A.; Smeeding, J. E.] TPG NPRT, Glastonbury, CT USA; [Sax, M. J.] Pharm Grp TPG, Glastonbury, CT USA",,,,"Brook, Richard A/A-8010-2009",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP82,A528,A528,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300124,0
J,"Buigues-Pastor, L; SAnchez-Chorro, JL; MÉndez-Valera, P; MuNoz-FernAndez, JI",,,,"Buigues-Pastor, L.; SAnchez-Chorro, J. L.; MEndez-Valera, P.; MuNoz-FernAndez, J., I",,,PRESCRIPTION ALGORITHMS: IMPACT ON STATINS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Buigues-Pastor, L.; MEndez-Valera, P.] Valencian Reg Govt Spain, Valencia, Spain; [SAnchez-Chorro, J. L.; MuNoz-FernAndez, J., I] Extremaduras Reg Govt Spain, Merida, Spain",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV65,A384,A385,,10.1016/j.jval.2015.09.834,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400276,0
J,"Capri, S; Barbieri, M; Oskar, B",,,,"Capri, S.; Barbieri, M.; Oskar, B.",,,COST-UTILITY ANALYSIS OF APREMILAST FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE ITALIAN SETTING,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Capri, S.] Cattaneo LIUC Univ, Sch Econ & Management, Castellanza, Italy; [Barbieri, M.] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Oskar, B.] Celgene Corp, Milan, Italy",Universita Carlo Cattaneo - Liuc; University of York - UK,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS70,A646,A646,,10.1016/j.jval.2015.09.2314,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300783,0
J,"Castillo, WC; Hendricks, J; dosReis, S",,,,"Castillo, Camelo W.; Hendricks, J.; dosReis, S.",,,ENGAGING HISPANIC CAREGIVERS IN RESEARCH: A FRAMEWORK TO DESIGN CULTURALLY SENSITIVE APPROACHES FOR ENGAGEMENT IN PATIENT-CENTERED OUTCOMES RESEARCH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Castillo, Camelo W.; dosReis, S.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Hendricks, J.] Maryland Coalit Families Childrens Mental Hlth, Hagerstown, MD USA",University System of Maryland; University of Maryland Baltimore,,,,,,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM18,A815,A815,,10.1016/j.jval.2015.09.227,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400543,0
J,"Ceyhan, M; Ozsurekci, Y; Aykac, K",,,,"Ceyhan, M.; Ozsurekci, Y.; Aykac, K.",,,ECONOMIC BURDEN OF PNEUMOCOCCAL INFECTIONS IN CHILDREN UNDER FIVE YEARS OLD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ceyhan, M.; Ozsurekci, Y.; Aykac, K.] Hacettepe Univ, Fac Med, Dept Pediat Infect Dis, Ankara, Turkey",Hacettepe University,,,"Aykac, Kubra/ABA-1959-2020; Ozsurekci, Yasemin/D-5918-2014","Aykac, Kubra/0000-0002-0974-4765; Ozsurekci, Yasemin/0000-0001-8662-6909",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS15,A417,A417,,10.1016/j.jval.2015.09.539,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400456,0
J,"Chaparro-Narváez, PE; Castañeda-Orjuela, C; Leon-Quevedo, W; De la Hoz-Restrepo, FP",,,,"Chaparro-Narvaez, P. E.; Castaneda-Orjuela, C.; Leon-Quevedo, W.; De la Hoz-Restrepo, F. P.",,,"MORTALITY DUE TO CARDIOVASCULAR DISEASE IN COLOMBIA, 1998-2011",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chaparro-Narvaez, P. E.; Leon-Quevedo, W.] Inst Nacl Salud, Bogota, Colombia; [Castaneda-Orjuela, C.; De la Hoz-Restrepo, F. P.] Inst Nacl Salud, Bogota, Colombia",Instituto Nacional de Salud (Colombia); Instituto Nacional de Salud (Colombia),,,"Castañeda-Orjuela, Carlos/N-2601-2017","Castañeda-Orjuela, Carlos/0000-0002-8735-6223",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV27,A832,A832,,10.1016/j.jval.2015.09.322,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400638,0
J,"Chen, XH; Liao, ZP",,,,"Chen, Xiaohong; Liao, Zhipeng",,,Sieve semiparametric two-step GMM under weak dependence,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Sieve two-step GMM; Weakly dependent data; Auto-correlation robust inference; Semiparametric over-identification test; Numerical equivalence; Random perturbation derivative estimator,CONSISTENT COVARIANCE-MATRIX; HETEROGENEOUS PROCESSES; MODELS; HETEROSKEDASTICITY; ESTIMATORS; VOLATILITY; MOMENTS; RESTRICTIONS,"This paper considers semiparametric two-step GMM estimation and inference with weakly dependent data, where unknown nuisance functions are estimated via sieve extremum estimation in the first step. We show that although the asymptotic variance of the second-step GMM estimator may not have a closed form expression, it can be well approximated by sieve variances that have simple closed form expressions. We present consistent or robust variance estimation, Wald tests and Hansen's (1982) over-identification tests for the second step GMM that properly reflect the first-step estimated functions and the weak dependence of the data. Our sieve semiparametric two-step GMM inference procedures are shown to be numerically equivalent to the ones computed as if the first step were parametric. A new consistent random-perturbation estimator of the derivative of the expectation of the non-smooth moment function is also provided. (C) 2015 Elsevier B.V. All rights reserved.","[Chen, Xiaohong] Yale Univ, Cowles Fdn Res Econ, New Haven, CT 06520 USA; [Liao, Zhipeng] Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90095 USA",Yale University; University of California System; University of California Los Angeles,"Chen, XH (通讯作者)，Yale Univ, Cowles Fdn Res Econ, Box 208281, New Haven, CT 06520 USA.",xiaohong.chen@yale.edu; zhipeng.liao@econ.ucla.edu,,,,,,,39,18,23,0,14,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,NOV,2015,189.0,1.0,,,,,163,186,,10.1016/j.jeconom.2015.07.001,0.0,,,24,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CS9BH,,Green Submitted,,,2024-03-09,WOS:000362383600011,0
J,"Claudepierre, P; Breban, M; De, CT; Joubert, J; Laurendeau, C; Gourmelen, J; Fagnani, F",,,,"Claudepierre, P.; Breban, M.; de, Chalus T.; Joubert, J.; Laurendeau, C.; Gourmelen, J.; Fagnani, F.",,,"PREVALENCE, COMORBIDITIES AND BURDEN OF SEVERE SPONDYLOARTHRITIS IN FRANCE: ANALYSIS OF A NATIONAL PUBLIC HEALTH INSURANCE DATABASE IN 2012 IN FRANCE",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Claudepierre, P.] CHU Henri Mondor, Creteil, France; [Breban, M.] CHU Amboise Pare, Boulogne, France; [de, Chalus T.; Joubert, J.] UCB Pharma, Colombes, France; [Laurendeau, C.; Fagnani, F.] Cemka Eval, Bourg La Reine, France; [Gourmelen, J.] UVSQ, INSERM, UMS 011, Villejuif, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UCB Pharma SA; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Universite Paris Cite,,,"Maxime, Breban/F-4772-2019","Maxime, Breban/0000-0002-6932-9395",,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS22,A637,A637,,10.1016/j.jval.2015.09.2267,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300736,0
J,"Constenal, DO; Garcia, C; Silver, D; Qi, A; Yang, HK",,,,"Constenal, D. O.; Garcia, C.; Silver, D.; Qi, A.; Yang, H. K.",,,EXPLORING VARIATION IN COST-EFFECTIVENESS ESTIMATES IN STUDIES THAT EVALUATE ADULT PNEUMOCOCCAL VACCINATION IN LATIN AMERICA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Constenal, D. O.; Garcia, C.; Silver, D.; Qi, A.] Johns Hopkins Univ, Baltimore, MD USA; [Yang, H. K.] Merck & Co Inc, West Point, PA USA",Johns Hopkins University; Merck & Company,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM5,A812,A813,,10.1016/j.jval.2015.09.214,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400530,0
J,"Cristino, J; Diel, I; Finek, J; Encinas, MP; Maniadakis, N; Ikenberg, R; Tapias, IC; Jandova, P; Zahn, DP; Moser, C; Bolognese, L; Tritaki, G; Gatta, F; Hechmati, G",,,,"Cristino, J.; Diel, I; Finek, J.; Perez Encinas, M.; Maniadakis, N.; Ikenberg, R.; Campos Tapias, I; Jandova, P.; Zahn, D. P.; Moser, C.; Bolognese, L.; Tritaki, G.; Gatta, F.; Hechmati, G.",,,"THE CLINICAL AND ECONOMIC BURDEN OF SKELETAL RELATED EVENTS IN AUSTRIA, CZECH REPUBLIC, GERMANY, GREECE, ITALY, SPAIN AND SWITZERLAND: A COMPARISON BETWEEN THE USE OF DENOSUMAB AND ZOLEDRONIC ACID IN PATIENTS WITH BREAST CANCER AND BONE METASTASES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cristino, J.; Gatta, F.; Hechmati, G.] Amgen Europe GmbH, Zug, Switzerland; [Diel, I] Praxisklin Rosengarten, Mannheim, Germany; [Finek, J.] Clin Oncol & Radiotherapy FN PLZN, Plzen, Czech Republic; [Perez Encinas, M.] Hosp Univ Fdn Alcorcon, Madrid, Spain; [Maniadakis, N.] Natl Sch Publ Hlth, Dept Hlth Serv Org, Athens, Greece; [Ikenberg, R.] Amgen GmbH, Munich, Germany; [Campos Tapias, I] Amgen SA, Barcelona, Spain; [Jandova, P.] Amgen Sro, Prague, Czech Republic; [Zahn, D. P.] Amgen Switzerland AG, Zug, Switzerland; [Moser, C.] Amgen GmbH, Vienna, Austria; [Bolognese, L.] Amgen Srl, Milan, Italy; [Tritaki, G.] AMGEN Hellas Ltd, Athens, Greece",Amgen; AMGEN Europe; Alcorcon Foundation University Hospital; National & Kapodistrian University of Athens; Amgen; Amgen Research Munich GmbH,,,"Maniadakis, Nikos/AAZ-6794-2021",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN299,A483,A483,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400815,0
J,"Defourny, N; Perrier, L; Dunscombe, P; Grau, C; Lievens, Y",,,,"Defourny, N.; Perrier, L.; Dunscombe, P.; Grau, C.; Lievens, Y.",,,THE COST OF RADIOTHERAPY: WHAT DO WE KNOW? A SYSTEMATIC SEARCH OF THE LITERATURE BETWEEN 1981 AND 2015,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Defourny, N.] Univ Ghent, Woluwe St Lambert, Belgium; [Perrier, L.] Canc Ctr Leon Berard, Lyon 08, France; [Dunscombe, P.] Univ Calgary, Calgary, AB, Canada; [Grau, C.] Aarhus Univ, Aarhus, Denmark; [Lievens, Y.] Univ Ghent, Ghent, Belgium; [Defourny, N.] Univ Ghent, Woluwe St Lambert, Belgium; [Perrier, L.] Canc Ctr Leon Berard, Lyon 08, France; [Dunscombe, P.] Univ Calgary, Calgary, AB, Canada; [Grau, C.] Aarhus Univ, Aarhus, Denmark; [Lievens, Y.] Univ Ghent, Ghent, Belgium",Ghent University; UNICANCER; Institut de cancerologie de Lorraine (ICL); University of Calgary; Aarhus University; Ghent University; Ghent University; UNICANCER; Institut de cancerologie de Lorraine (ICL); University of Calgary; Aarhus University; Ghent University,,,"Grau, Cai/I-8161-2014; Perrier, Lionel/AAC-8048-2021; Defourny, Noemie/AAA-3126-2021","Grau, Cai/0000-0003-3548-3527; Perrier, Lionel/0000-0003-4487-8723; Defourny, Noemie/0000-0002-4847-7866",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN90,A445,A445,,10.1016/j.jval.2015.09.1106,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400607,0
J,"Deger, C; Telli, F; Gunaldi, M; Keskin, S; Saglam, S; Ozdemir, O; Sar, C; Parali, E; Erdal, E; Sumer, F; Ozel, O; Asan, S",,,,"Deger, C.; Telli, F.; Gunaldi, M.; Keskin, S.; Saglam, S.; Ozdemir, O.; Sar, C.; Parali, E.; Erdal, E.; Sumer, F.; Ozel, O.; Asan, S.",,,THE LIFE TIME COST-OF-DISEASE (COD) OF METASTATIC COLORECTAL CANCER (MCRC) IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Deger, C.; Sar, C.; Parali, E.; Erdal, E.; Sumer, F.; Ozel, O.; Asan, S.] Bayer Turk Kimya San Ltd Sti, Istanbul, Turkey; [Telli, F.] Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey; [Gunaldi, M.] Bakirkoy Dr Sadi Konuk Training & Res Hosp, Istanbul, Turkey; [Keskin, S.] Mem Sisli Hosp, Istanbul, Turkey; [Saglam, S.] Istanbul Bilim Univ, Istanbul, Turkey; [Ozdemir, O.] Yorum Consulting Ltd, Istanbul, Turkey",Bayer Turkey; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Bakirkoy Dr. Sadi Konuk Research & Training Hospital; Memorial Healthcare Group; Demiroglu Bilim University; Yorum Consultancy Ltd,,,"Gunaldi, Meral/Z-1463-2018; Saglam, Sezer/AAJ-7231-2020","Saglam, Sezer/0000-0001-8954-5792",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN108,A448,A448,,10.1016/j.jval.2015.09.1124,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400625,0
J,"Dilla, T; Rentero, ML; Comellas, M; Lizan, L; Sacristán, JA",,,,"Dilla, T.; Rentero, M. L.; Comellas, M.; Lizan, L.; Sacristan, J. A.",,,PATIENTS' PREFERENCES FOR RHEUMATOID ARTHRITIS TREATMENTS AND THEIR PARTICIPATION IN THE TREATMENT DECISION-MAKING PROCESS. A SYSTEMATIC REVIEW OF THE LITERATURE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Dilla, T.; Rentero, M. L.; Sacristan, J. A.] Lilly, Alcobendas, Madrid, Spain; [Comellas, M.; Lizan, L.] Outcomes 10, Castellon de La Plana, Spain",,,,"Sacristán, José Antonio/ABG-7160-2020; lizan, luis/AAF-1953-2020",,,,,,0,8,8,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS103,A652,A652,,10.1016/j.jval.2015.09.2348,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300816,0
J,"Dunlop, W; Witt, EA; Kenworthy, JJ; Ishetwood, G",,,,"Dunlop, W.; Witt, E. A.; Kenworthy, J. J.; Ishetwood, G.",,,ASSOCATIONS BETWEEN PAIN SEVERITY AND QUALITY OF LIFE DOMAINS AMONG THOSE DIAGNOSED WITH VARIOUS PAIN TYPES IN EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Dunlop, W.; Kenworthy, J. J.] Mundipharma Int Ltd, Cambridge, England; [Witt, E. A.] Kantar Hlth, Princeton, NJ USA; [Ishetwood, G.] Kantar Hlth, Epsom, Surrey, England",,,,,"Dunlop, William/0000-0002-9794-8978",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY89,A674,A674,,10.1016/j.jval.2015.09.1989,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300939,0
J,"Edwards, SJ; Wakefield, V; Karner, C",,,,"Edwards, S. J.; Wakefield, V; Karner, C.",,,A MIXED TREATMENT COMPARISON (MTC) TO COMPARE THE EFFICACY OF ANTI-THROMBOTIC AGENTS IN THE ACUTE TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ACTIVE CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Edwards, S. J.; Wakefield, V; Karner, C.] BMJ, London, England",,,,"Edwards, Steve/E-6667-2017","Edwards, Steve/0000-0002-9049-3421",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV19,A376,A377,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400231,0
J,"Endrodi, J; Gyuró, M; Vajda, R; Boncz, I; Kívés, ZH",,,,"Endrodi, J.; Gyuro, M.; Vajda, R.; Boncz, I; Kives, Horvathne Z.",,,WORK CAPACITY AND HEALTH STATUS TEST OF POLICE OFFICERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Endrodi, J.; Gyuro, M.; Vajda, R.; Boncz, I; Kives, Horvathne Z.] Univ Pecs, Pecs, Hungary",University of Pecs,,,"Boncz, Imre/A-8940-2013","Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP285,A563,A563,,10.1016/j.jval.2015.09.1841,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300325,0
J,"Evripidou, I; Evripidou, A; Latsou, D; Toska, A; Koliou, M; Geitona, M",,,,"Evripidou, I; Evripidou, A.; Latsou, D.; Toska, A.; Koliou, M.; Geitona, M.",,,ANTIBIOTIC PRESCRIPTION PRACTICES OF PEDIATRICIANS IN HOSPITAL CARE IN CYPRUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Evripidou, I; Evripidou, A.] Univ Neapolis, Pafos, Cyprus; [Latsou, D.; Toska, A.; Geitona, M.] Univ Peloponnese, Athens, Greece; [Koliou, M.] Nicosia Hosp, Nicosia, Cyprus",University of Peloponnese,,,"Latsou, Dimitra/JBJ-6909-2023; Geitona, Mary/AAZ-2346-2020; Latsou, Dimitra/AAS-4659-2021; koliou, Maria/JRX-1589-2023","koliou, Maria/0000-0003-0647-9967",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP291,A564,A565,,10.1016/j.jval.2015.09.1847,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300331,0
J,"Faivre, P; Laplante, S; Kreuwel, H",,,,"Faivre, P.; Laplante, S.; Kreuwel, H.",,,MULTI EUROPEAN COUNTRY COST CONSEQUENCE COMPARISON OF FLOSEAL MATRIX AND SURGIFLO THROMBIN IN MAJOR AND SEVERE SPINE SURGERIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Faivre, P.] Baxter Healthcare SA, Zurich, Switzerland; [Laplante, S.] Baxter Healthcare Corp, Deerfield, IL USA; [Kreuwel, H.] Baxter Healthcare Inc, Westlake Village, CA USA",Baxter International Inc,,,,,,,,,0,3,4,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD146,A370,A370,,10.1016/j.jval.2015.09.748,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400194,0
J,"Favaro, A; Saraf, S",,,,"Favaro, A.; Saraf, S.",,,TIERED PRICING IN ONCOLOGY - DRIVERS FOR IMPROVED PATIENT ACCESS AND COMMERCIAL SUCCESS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Favaro, A.; Saraf, S.] ICON P&MA, London, England",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN290,A481,A481,,10.1016/j.jval.2015.09.1309,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400806,0
J,"Fortier, K; Kiss, N",,,,"Fortier, K.; Kiss, N.",,,SYSTEMATIC REVIEW AND MIXED TREATMENT COMPARISON OF THERAPIES FOR DIABETIC MACULAR EDEMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fortier, K.] Compass Strateg Consulting Inc, New Haven, CT USA; [Kiss, N.] Med Univ Vienna, Vienna, Austria",Medical University of Vienna,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS8,A416,A416,,10.1016/j.jval.2015.09.1010,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400449,0
J,"Figueira, SF; Cachoeira, CV; Souza, FH; Kano, BY; Hasegawa, ACP; Duarte, GBC",,,,"Franco Figueira, S.; Cachoeira, C., V; Souza, F. H.; Kano, B. Y.; Petry Hasegawa, A. C.; da Conceicao Duarte, Bertozzi G.",,,ECONOMIC BENEFITS ASSOCIATED WITH NT-PROBNP TEST IN BRAZIL AND MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Franco Figueira, S.; Cachoeira, C., V; Souza, F. H.; Kano, B. Y.] Roche Diagnost LATAM, Sao Paulo, Brazil; [Petry Hasegawa, A. C.] Roche Diagnost Brazil, Sao Paulo, Brazil; [da Conceicao Duarte, Bertozzi G.] Roche Diagnost Mexico, Santa Fe, Mexico",,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD7,A858,A858,,10.1016/j.jval.2015.09.477,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400789,0
J,"Gaglayan, B; Firidin, A; Yildirim, N; Tatar, M; Essiz, M",,,,"Gaglayan, B.; Firidin, A.; Yildirim, N.; Tatar, M.; Essiz, M.",,,COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN TURKEY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Gaglayan, B.; Firidin, A.; Yildirim, N.] UCB Pharma, Istanbul, Turkey; [Tatar, M.] Polar Hlth Econ & Policy Consulting, Ankara, Turkey",UCB Pharma SA; Polar Health Economics & Policy,,,"Yıldırım, Nurtaç/AAD-9462-2020",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS65,A645,A645,,10.1016/j.jval.2015.09.2309,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300778,0
J,"Gallagher, J; O'Sullivan, D; Mc Carthy, S; Gillespie, P; Woods, N; O'Mahony, D; Byrne, S",,,,"Gallagher, J.; O'Sullivan, D.; Mc Carthy, S.; Gillespie, P.; Woods, N.; O'Mahony, D.; Byrne, S.",,,A COST-EFFECTIVENESS ANALYSIS OF HOSPITAL PHARMACIST REVIEW IN OLDER PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gallagher, J.; O'Sullivan, D.; Mc Carthy, S.; Woods, N.; Byrne, S.] Univ Coll Cork, Cork, Ireland; [Gillespie, P.] Natl Univ Ireland Galway, Galway, Ireland; [O'Mahony, D.] Cork Univ Hosp, Cork, Ireland",University College Cork; Ollscoil na Gaillimhe-University of Galway; University College Cork,,,"Gillespie, Paddy/C-6642-2015",,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH1,A732,A733,,10.1016/j.jval.2015.09.2801,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400300,0
J,"Gillies, H",,,,"Gillies, H.",,,A COMPARISON OF DISCRETE EVENT SIMULATION (DES) VERSUS MARKOV MODELS WITH A PRACTICAL APPLICATION TO HUMAN-IMMUNODEFICIENCY VIRUS (HIV),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gillies, H.] Abacus Int, Bicester, Oxon, England",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM92,A699,A699,,10.1016/j.jval.2015.09.2609,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400112,0
J,"Green, W; Hahn-Pedersen, J; Andreasen, N; Taylor, M",,,,"Green, W.; Hahn-Pedersen, J.; Andreasen, Norgaard J.; Taylor, M.",,,SQ® HDM SLIT-TABLETS IN ADDITION TO PHARMACOTHERAPY ARE COST-EFFECTIVE COMPARED TO PHARMACOTHERAPY ONLY IN TREATING PATIENTS WITH ALLERGIC ASTHMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Green, W.; Taylor, M.] York Hlth Econ Consortium, York, N Yorkshire, England; [Hahn-Pedersen, J.; Andreasen, Norgaard J.] ALK, Horsholm, Denmark",University of York - UK,,,"Green, William/HGB-7114-2022",,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS53,A502,A503,,10.1016/j.jval.2015.09.1427,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400922,0
J,"Greene, N; Greene, M",,,,"Greene, N.; Greene, M.",,,DESCRIPTIVE EVALUATION OF PATIENT CHARACTERISTICS AND HEALTH CARE RESOURCE UTILIZATION OF PATIENTS DIAGONSED WITH OVARIAN CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Greene, N.] MCPHS Univ, Medford, MA USA; [Greene, M.] Georgia State Univ, Medford, MA USA",University System of Georgia; Georgia State University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN286,A480,A481,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400802,0
J,"Greene, N; Greene, M",,,,"Greene, N.; Greene, M.",,,PATIENT CHARACTERISTICS AND HEALTH CARE RESOURCE UTILIZATION OF PATIENTS DIAGONSED WITH PROSTATE CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Greene, N.] MCPHS Univ, Medford, MA USA; [Greene, M.] Georgia State Univ, Medford, MA USA",University System of Georgia; Georgia State University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN287,A481,A481,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400803,0
J,"Greene, N; Greene, M",,,,"Greene, N.; Greene, M.",,,CHARACTERISTICS OF PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS TAKING ONCE DAILY FINGOLIMOD CAPSULES IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Greene, N.] MCPHS Univ, Medford, MA USA; [Greene, M.] Georgia State Univ, Medford, MA USA",University System of Georgia; Georgia State University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND87,A764,A764,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400473,0
J,"Growiec, J; Groth, C",,,,"Growiec, Jakub; Groth, Christian",,,On aggregating human capital across heterogeneous cohorts,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,GROWTH,"This paper studies the question: Can the microeconomic Mincerian (log-linear) functional relationship between human capital, years of schooling and work experience be recovered in some similar form at the macroeconomic level? A large macroeconomic literature assumes so, warranting that the question is of interest. We first examine the question at a theoretical level and find that except under very special assumptions, the answer is in the negative. On the other hand, we also show numerically that a macro-Mincer relationship can nevertheless be perceived as a quantitatively reasonable approximation of the theoretically derived true relationship, at least if the observed heterogeneity comes only from differences in the number of years of schooling, retirement age, or demographic survival laws. (C) 2015 Elsevier B.V. All rights reserved.","[Growiec, Jakub] Warsaw Sch Econ, Dept Quantitat Econ, Warsaw, Poland; [Growiec, Jakub] Narodowy Bank Polski, Warsaw, Poland; [Groth, Christian] Univ Copenhagen, Dept Econ, DK-1168 Copenhagen, Denmark",Warsaw School of Economics; Narodowy Bank Polski; University of Copenhagen,"Growiec, J (通讯作者)，Katedra Ekon Ilosciowej SGH, Al Niepodleglosci 162, PL-02554 Warsaw, Poland.",jakub.growiec@sgh.waw.pl; chr.groth@econ.ku.dk,"Growiec, Jakub/AAB-8623-2019","Growiec, Jakub/0000-0003-2222-1691",,,,,20,0,0,0,6,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,NOV,2015,78.0,,,,,,21,38,,10.1016/j.mathsocsci.2015.09.003,0.0,,,18,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CZ0BI,,Green Submitted,,,2024-03-09,WOS:000366769700004,0
J,"Guillemin, I; Marrel, A; Arnould, B; Capuron, L; Dupuy, A; Ginon, E; Layé, S; Lecerf, J; Prost, M; Rogeaux, M; Urdapilleta, I; Allaert, FA",,,,"Guillemin, I; Marrel, A.; Arnould, B.; Capuron, L.; Dupuy, A.; Ginon, E.; Laye, S.; Lecerf, J.; Prost, M.; Rogeaux, M.; Urdapilleta, I; Allaert, F. A.",,,"HOW FRENCH SUBJECTS DESCRIBE WELL-BEING FROM FOOD AND EATING HABITS? DEVELOPMENT, AND SCORING DEFINITION OF THE WELL-BEING RELATED TO FOOD QUESTIONNAIRE (WELL-BFQ©)",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Guillemin, I; Arnould, B.] Patient Ctr Outcomes Mapi, Lyon, France; [Capuron, L.] INRA, UMR 1286, Lab Nutr & Integrat Neurobiol NutriNeuro, Bordeaux, France; [Dupuy, A.] CERTOP UMR CNRS 5044, Toulouse, France; [Ginon, E.] Lab Expt Social Sci & Behav Anal LESSAC ESC, Dijon, France; [Laye, S.] INRA UMR 1286, Bordeaux, France; [Lecerf, J.] Inst Pasteur, Lille, France; [Prost, M.] LARA SPIRAL, Coutermon, France; [Rogeaux, M.] DANONE Nutr Res, Palaiseau, France; [Urdapilleta, I] Social Psychol Lab Paris LAPPS EA 4386, St Denis, France; [Allaert, F. A.] CEN Biotech, CEN Nutriment, Dijon, France",INRAE; Universite de Bordeaux; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille; Institut Pasteur Lille; Danone Nutricia,,,"Laye, Sophie/AAX-2501-2020","Laye, Sophie/0000-0002-3843-1012; URDAPILLETA, ISABEL/0000-0002-4239-1455",,,,,0,0,0,1,9,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM170,A712,A712,,10.1016/j.jval.2015.09.2684,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400186,0
J,"Gupta, J; Sehgal, M",,,,"Gupta, J.; Sehgal, M.",,,A SYSTEMATIC REVIEW TO ASSESS THE ASSOCIATION BETWEEN THE USE OF ANTIDEPRESSANTS AND MALE-ONLY CANCERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gupta, J.] PAREXEL Int, New Delhi, India; [Sehgal, M.] PAREXEL Int, Chandigarh, India",Parexel International; Parexel International,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN7,A430,A430,,10.1016/j.jval.2015.09.1022,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400524,0
J,"Hadji, P; Schweikert, B; Ansorge, S; Toth, E",,,,"Hadji, P.; Schweikert, B.; Ansorge, S.; Toth, E.",,,PATIENT CHARACTERISTICS AND DISEASE BURDEN OF OSTEOPOROSIS IN POST MENOPAUSAL WOMEN AT INCREASED RISK OF FRACTURE IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Hadji, P.] Krankenhaus NW Frankfurt, Frankfurt, Germany; [Schweikert, B.] Mapi, Munich, Germany; [Ansorge, S.] Gesundheitsforen Leipzig GmbH, Munich, Germany; [Toth, E.] UCB Biopharma Sprl, Brussels, Belgium",Krankenhaus Nordwest,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS43,A641,A641,,10.1016/j.jval.2015.09.2288,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300757,0
J,"Ho, V; Song, Y; Brown, C; Vennettilli, A; Eng, L; Zarrin, A; Dobriyal, A; Chen, L; Mirshams, M; Patel, D; Hon, H; Pat, V; Ho, A; Solomon, H; Tíessen, K; Thai, H; Irwin, M; Mahler, M; Xu, W; Liu, G; Howell, D",,,,"Ho, V; Song, Y.; Brown, C.; Vennettilli, A.; Eng, L.; Zarrin, A.; Dobriyal, A.; Chen, L.; Mirshams, M.; Patel, D.; Hon, H.; Pat, V; Ho, A.; Solomon, H.; Tiessen, K.; Thai, H.; Irwin, M.; Mahler, M.; Xu, W.; Liu, G.; Howell, D.",,,THE WILLINGNESS OF CANCER OUTPATIENTS TO COMPLETE PATIENT-REPORTED OUTCOME MEASURES OUTSIDE OF THE CLINIC,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ho, V; Song, Y.; Vennettilli, A.; Eng, L.; Zarrin, A.; Dobriyal, A.; Chen, L.; Mirshams, M.; Patel, D.; Hon, H.; Pat, V; Ho, A.; Solomon, H.; Tiessen, K.; Thai, H.; Irwin, M.; Mahler, M.] Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Brown, C.; Xu, W.; Liu, G.; Howell, D.] Princess Margaret Canc Ctr, Toronto, ON, Canada",University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre,,,"Eng, Lawson/AAB-8539-2020; Howell, Doris/S-8927-2016","Howell, Doris/0000-0002-0683-8715",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN228,A470,A471,,10.1016/j.jval.2015.09.1246,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400745,0
J,"Holbrook, T; Wood, R; Black, C; Hu, X; Kachroo, S",,,,"Holbrook, T.; Wood, R.; Black, C.; Hu, X.; Kachroo, S.",,,AVOIDABLE BURDEN AND UNMET NEED ASSOCIATED WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATMENT: A CROSS-SECTIONAL EUROPEAN STUDY IN THE REAL WORLD SETTING,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Holbrook, T.; Wood, R.] Adelphi Real World, Macclesfield, Cheshire, England; [Black, C.; Hu, X.; Kachroo, S.] Merck & Co Inc, Rahway, NJ 07065 USA",Adelphi Group Ltd; Merck & Company,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS111,A653,A653,,10.1016/j.jval.2015.09.2356,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300824,0
J,"Hughes, R; Chawla, R",,,,"Hughes, R.; Chawla, R.",,,RELATIONSHIP BETWEEN THE PREVALENCE OF CANCERS IN ENGLAND AND WALES AND THE PERFORMANCE OF TECHNOLOGY APPRAISALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hughes, R.] AccuScript Consultancy, Reading, Berks, England; [Chawla, R.] AccuScript Solut, Ludhiana, Punjab, India",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN342,A490,A491,,10.1016/j.jval.2015.09.1360,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400856,0
J,"Jumpa, D; Galván, S",,,,"Jumpa, D.; Galvan, S.",,,"MEDICATION COSTS IN THE FRAMEWORK OF A BUDGET PROGRAM FOR HIV/AIDS IN PERU, 2012-2014",VALUE IN HEALTH,,,Spanish,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Jumpa, D.; Galvan, S.] Univ Nacl Mayor San Marcos, Lima, Peru",Universidad Nacional Mayor de San Marcos,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN33,A873,A873,,10.1016/j.jval.2015.09.027,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400873,0
J,"Kalf, R; Makady, A; Meijboom, K; Goettsch, W",,,,"Kalf, R.; Makady, A.; Meijboom, K.; Goettsch, W.",,,THE USE OF SOCIAL MEDIA TO GENERATE HEALTH DATA FOR EFFECTIVENESS RESEARCH: A SCOPING REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kalf, R.; Makady, A.; Meijboom, K.; Goettsch, W.] Natl Healthcare Inst ZIN, Diemen, Netherlands",,,,,"Kalf, Rachel/0000-0002-9029-4713",,,,,0,0,0,1,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN229,A471,A471,,10.1016/j.jval.2015.09.1247,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400746,0
J,"Kernkamp, CD; Massuda, EM",,,,"Kernkamp, C. D.; Massuda, E. M.",,,POPULATION AGING AND PUBLIC HEALTH POLICIES IN BRAZIL,VALUE IN HEALTH,,,Portuguese,Meeting Abstract,,,,,,,,,"[Kernkamp, C. D.; Massuda, E. M.] Unicesumar, Ctr Univ Maringa, Maringa, Parana, Brazil",UniCesumar - Centro Universitario Cesumar,,,,,,,,,0,0,0,2,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH25,A836,A836,,10.1016/j.jval.2015.09.348,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400664,0
J,"Kotowa, W; Reindl, S; Mathes, J; Doyno, T; Höer, A",,,,"Kotowa, W.; Reindl, S.; Mathes, J.; Doyno, T.; Hoeer, A.",,,IS THE PROOF OF AN ADDITIONAL BENEFIT UNDER AMNOG IN GERMANY MORE DIFFICULT FOR CERTAIN DRUGS THAN FOR OTHER ONES?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kotowa, W.; Reindl, S.; Mathes, J.; Doyno, T.] IGES Inst GmbH, Nurnberg, Germany; [Hoeer, A.] IGES Inst GmbH, Berlin, Germany",IGES Institut GmbH; IGES Institut GmbH,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP53,A523,A523,,10.1016/j.jval.2015.09.1607,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300095,0
J,"Kozhanova, I; Romanova, I; Gavrilenko, L; Sachek, M; Shepelkevich, A; Artsiomenka, A; Balabkova, A; Shybko, K",,,,"Kozhanova, I; Romanova, I; Gavrilenko, L.; Sachek, M.; Shepelkevich, A.; Artsiomenka, A.; Balabkova, A.; Shybko, K.",,,COST OF ILLNESS ANALYSIS IN PATIENTS WITH DIABETIC FOOT SYNDROME IN HEALTH CARE OF REPUBLIC OF BELARUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kozhanova, I; Romanova, I; Gavrilenko, L.; Shepelkevich, A.; Artsiomenka, A.; Balabkova, A.; Shybko, K.] BSMU, Minsk, BELARUS; [Sachek, M.] Republican Sci & Pract Ctr Med Technol Informat A, Minsk, BELARUS",Belarusian State Medical University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB38,A604,A604,,10.1016/j.jval.2015.09.2078,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300550,0
J,"Lachaine, J; Gaudet, D; Miron, A; Tremblay, K",,,,"Lachaine, J.; Gaudet, D.; Miron, A.; Tremblay, K.",,,"HOSPITALIZATIONS IN HYPERCHYLOMICRONEMIA PATIENTS IN QUEBEC, CANADA; RESULTS FROM A REAL-WORLD OBSERVATIONAL STUDY",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Lachaine, J.; Miron, A.] Univ Montreal, Montreal, PQ, Canada; [Gaudet, D.; Tremblay, K.] Univ Montreal, Ctr Med Genique Communautaire, ECOGENE 21, Chicoutimi, PQ, Canada",Universite de Montreal; Universite de Montreal,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY118,A679,A679,,10.1016/j.jval.2015.09.2018,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400005,0
J,"Lam, CL; Guo, V; Wong, CK; Yu, EY; Fung, CS",,,,"Lam, C. L.; Guo, V; Wong, C. K.; Yu, E. Y.; Fung, C. S.",,,"HEALTH-RELATED QUALITY OF LIFE OF PEOPLE FROM LOW-INCOME FAMILIES IN HONG KONG, CHINA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lam, C. L.; Guo, V; Wong, C. K.; Yu, E. Y.; Fung, C. S.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China",University of Hong Kong,,,"Guo, Vivian/ABB-5803-2022; Wong, Carlos King Ho/B-4322-2011; Fung, Siu Cheung/E-9860-2010","Wong, Carlos King Ho/0000-0002-6895-6071; Guo, Vivian Yawei/0000-0001-9399-1808; Yu, Yee Tak Esther/0000-0001-7472-7083",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH72,A745,A745,,10.1016/j.jval.2015.09.2872,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400369,0
J,"Lefevre, C; Benhaddi, H; Lacoin, L; Cuervo, HD; Lee, Y; Evans, D; Budd, D",,,,"Lefevre, C.; Benhaddi, H.; Lacoin, L.; Diaz Cuervo, H.; Lee, Y.; Evans, D.; Budd, D.",,,"PERSISTENCE TO VITAMIN-K ANTAGONISTS (VKA) AND NOVEL ORAL ANTICOAGULANTS (NOACS) IN NON-VALVULAR ATRIAL FIBRILLATION (NVAF): AN OBSERVATIONAL STUDY USING A COMPREHENSIVE REGIONAL DATABASE IN CATALONIA, SPAIN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lefevre, C.; Evans, D.; Budd, D.] Bristol Myers Squibb, Rueil Malmaison, France; [Benhaddi, H.] Bristol Myers Squibb, Braine Lalleud, Belgium; [Lacoin, L.] Bristol Myers Squibb, Uxbridge, Middx, England; [Diaz Cuervo, H.] Laser Outcomes, Oviedo, Spain; [Lee, Y.] Laser Outcomes, New York, NY USA",Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb,,,,"Diaz-Cuervo, Helena/0009-0006-7610-4238",,,,,0,2,3,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV168,A403,A403,,10.1016/j.jval.2015.09.938,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400378,0
J,"Li, X; Theodorou, E; Standaert, B",,,,"Li, X.; Theodorou, E.; Standaert, B.",,,EPIDEMIOLOGICAL DATA USED IN ROTAVIRUS VACCINATION COST-EFFECTIVENESS ANALYSIS IN EUROPE: A LITERATURE REVIEW UPDATE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Li, X.; Standaert, B.] GSK Vaccines, Wavre, Belgium; [Theodorou, E.] GSK Vaccines UK, UK PHARMA, Brentford, Middx, England",GlaxoSmithKline; GlaxoSmithKline,,,,,,,,,0,2,2,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN19,A579,A579,,10.1016/j.jval.2015.09.1929,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300412,0
J,"Lim, S; Ferko, N; Tibensky, B; Danker, WI; Jamous, N; Batiller, J; Kocharian, R",,,,"Lim, S.; Ferko, N.; Tibensky, B.; Danker, W., I; Jamous, N.; Batiller, J.; Kocharian, R.",,,ECONOMIC ANALYSIS OF EVICEL® COMPARED WITH STANDARD OF CARE FOR DURAL CLOSURE IN ELECTIVE CRANIAL SURGERY: A UNITED KINGDOM HOSPITAL PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lim, S.; Kocharian, R.] Ethicon Inc, Somerville, NJ USA; [Ferko, N.] Cornerstone Res Grp Inc, Burlington, ON, Canada; [Tibensky, B.] Cornerstone Res Grp, Burlington, ON, Canada; [Danker, W., I] Ethicon Biosurg, Somerville, NJ USA; [Jamous, N.] Ethicon Biosurg, Wokingham, Berks, England; [Batiller, J.] Ethicon Inc, Somerville, NJ USA",Johnson & Johnson; Johnson & Johnson USA; Cornerstone Research Group; Cornerstone Research Group; Johnson & Johnson; Johnson & Johnson USA,,,"Danker, Walt/AAP-5078-2020","Danker, Walt/0000-0002-9741-5821",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD140,A369,A369,,10.1016/j.jval.2015.09.742,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400188,0
J,"Macioch, T; Sobol, E; Mrozikiewicz-Rakowska, B; Krakowiecki, A; Hermanowski, TR",,,,"Macioch, T.; Sobol, E.; Mrozikiewicz-Rakowska, B.; Krakowiecki, A.; Hermanowski, T. R.",,,HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH DIABETIC FOOT ULCERATION - OBSERVATIONAL STUDY IN POLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Macioch, T.; Sobol, E.; Mrozikiewicz-Rakowska, B.; Hermanowski, T. R.] Med Univ Warsaw, Warsaw, Poland; [Krakowiecki, A.] Podos Wound Healing Clin, Warsaw, Poland",Medical University of Warsaw,,,"Mrozikiewicz-Rakowska, Beata/GPW-7146-2022",,,,,,0,0,1,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB107,A616,A616,,10.1016/j.jval.2015.09.2147,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300618,0
J,"Maduma, G; Odeyerni, IA; Pollock, RF",,,,"Maduma, G.; Odeyerni, I. A.; Pollock, R. F.",,,EVALUATING THE COST-EFFECTIVENESS OF PROLONGED-RELEASE TACROLIMUS RELATIVE TO IMMEDIATE-RELEASE TACROLIMUS IN LIVER TRANSPLANT PATIENTS BASED ON DATA FROM ROUTINE CLINICAL PRACTICE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Maduma, G.; Odeyerni, I. A.] Astellas Pharma Europe Ltd, Chertsey, England; [Pollock, R. F.] Ossian Hlth Econ & Commun, Basel, Switzerland",Astellas Pharmaceuticals,,,,"Pollock, Richard/0000-0002-9873-7507",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI24,A626,A626,,10.1016/j.jval.2015.09.2205,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300675,0
J,"Mahalaxmi, I; Sasikala, K; Arun, M; Balachandar, V",,,,"Mahalaxmi, I; Sasikala, K.; Arun, M.; Balachandar, V",,,CYTOGENETICS AND DOPAM INE RECEPTOR (DRD2) GENE POLYMORPHISM IN SCHIZOPHRENIA PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mahalaxmi, I; Sasikala, K.; Balachandar, V] Bharathiar Univ, Coimbatore, Tamil Nadu, India; [Arun, M.] BHMG, Coimbatore, Tamil Nadu, India",Bharathiar University,,,"Vellingiri, Balachandar/AAG-2976-2020",,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD3,A344,A344,,10.1016/j.jval.2015.09.604,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400052,0
J,"Manuel, L; Milligan, G; Graham, A; Taylor-Stokes, G",,,,"Manuel, L.; Milligan, G.; Graham, A.; Taylor-Stokes, G.",,,ASSESSING THE LEVEL OF RESISTANCE/INTOLERANCE TO HYDROXYUREA THERAPY AMONGST PATIENTS WITH POLYCYTHEMIA VERA IN EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Manuel, L.; Graham, A.; Taylor-Stokes, G.] Adelphi Real World, Manchester, Lancs, England; [Milligan, G.] Adelphi Real World, Bollington, England",Adelphi Group Ltd; Adelphi Group Ltd,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN39,A436,A436,,10.1016/j.jval.2015.09.1054,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400556,0
J,"Martin, A",,,,"Martin, A.",,,"ECONOMIC EVALUATIONS IN INFECTIOUS DISEASE: WHICH INFECTIONS, WHAT SETTINGS AND WHAT TYPE OF ECONOMIC EVALUATIONS WERE REPORTED IN PAPERS PUBLISHED IN 2014?",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Martin, A.] Crystallise Ltd, London, England",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN77,A589,A589,,10.1016/j.jval.2015.09.1510,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300469,0
J,"Mastiliakova, D; Bielik, J; Tuzincinova, K; Bystricky, B; Melus, V; Kliment, J; Sokol, R",,,,"Mastiliakova, D.; Bielik, J.; Tuzincinova, K.; Bystricky, B.; Melus, V; Kliment, J.; Sokol, R.",,,QUALITY OF LIFE IN PATIENTS WITH KIDNEY CANCER IN SLOVAKIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mastiliakova, D.; Bielik, J.; Tuzincinova, K.; Melus, V] Trencin Univ, Trencin, Slovakia; [Bystricky, B.] Trencin Hosp, Trencin, Slovakia; [Kliment, J.] Martin Univ, Martin, Slovakia; [Sokol, R.] Urol Out Patients, Trencin, Slovakia",Alexander Dubcek University Trencin,,,"Meluš, Vladimír/AAH-3355-2019","Bystricky, Branislav/0000-0002-9622-8557",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN255,A475,A475,,10.1016/j.jval.2015.09.1273,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400772,0
J,"Mitchell, D; Habib, M; Pericleous, L; Petrella, RJ",,,,"Mitchell, D.; Habib, M.; Pericleous, L.; Petrella, R. J.",,,MANAGEMENT OF STATIN INTOLERANCE (SI) IN PATIENTS AT HIGH RISK FOR CARDIOVASCULAR (CV) EVENTS: RESULTS OF A CANADIAN STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mitchell, D.] Univ Montreal, Montreal, PQ, Canada; [Habib, M.; Pericleous, L.] Amgen Canada Inc, Mississauga, ON, Canada; [Petrella, R. J.] Individual Hlth Outcomes Inc, London, ON, Canada; [Petrella, R. J.] Western Univ, London, ON, Canada",Universite de Montreal; Amgen Canada Inc; Western University (University of Western Ontario),,,"Petrella, Robert J/G-6557-2018",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV29,A378,A378,,10.1016/j.jval.2015.09.797,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400241,0
J,"Mlcoch, T; Jircikova, J; Mandelikova, M; Kruntoradova, K; Dolezal, T",,,,"Mlcoch, T.; Jircikova, J.; Mandelikova, M.; Kruntoradova, K.; Dolezal, T.",,,"THE IMPACT OF ANTI-TNF (ETANERCEPT) THERAPY ON WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND PSORIASIS IN THE CZECH REPUBLIC",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Mlcoch, T.; Jircikova, J.; Mandelikova, M.; Kruntoradova, K.; Dolezal, T.] Value Outcomes, Prague, Czech Republic",,,,,,,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS89,A649,A649,,10.1016/j.jval.2015.09.2334,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300802,0
J,"Mo, J",,,,"Mo, J.",,,EFFICACY OF THE MICA ANTIBODY FOR TRANSPLANT PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Mo, J.] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea",National Evidence-based Healthcare Collaborating Agency (NECA),,,,,,,,,0,0,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY3,A659,A659,,10.1016/j.jval.2015.09.2387,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300853,0
J,"Moïse, P; Yocolly, A",,,,"Moise, P.; Yocolly, A.",,,MANUFACTURERS' REACTIONS IN RESPONSE TO THE NEW REQUIREMENT FOR COST-EFFECTIVENESS IN FRANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Moise, P.; Yocolly, A.] Quintiles, Levallois Perret, France",IQVIA,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP263,A560,A560,,10.1016/j.jval.2015.09.1818,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300303,0
J,"Molina, JA; Ismail, NH; Heng, BH; Leong, IY",,,,"Molina, J. A.; Ismail, N. H.; Heng, B. H.; Leong, I. Y.",,,EFFECTIVENESS OF A COMMUNITY-BASED FALLS PREVENTION PROGRAM FOR THE ELDERLY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Molina, J. A.; Heng, B. H.] Natl Healthcare Grp, Singapore, Singapore; [Ismail, N. H.; Leong, I. Y.] Tan Tock Seng Hosp, Singapore, Singapore",Tan Tock Seng Hospital,,,"Molina, Joseph Antonio/S-6181-2019",,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP154,A540,A541,,10.1016/j.jval.2015.09.1708,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300194,0
J,"Motte, A; Mourlat, B; Kujas, P; Eliaszewicz, M",,,,"Motte, A.; Mourlat, B.; Kujas, P.; Eliaszewicz, M.",,,A NEW METHODOLOGY TO DEFINE THE SCOPE OF THE FRENCH LISTE-EN-SUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Motte, A.; Mourlat, B.; Kujas, P.; Eliaszewicz, M.] French Minist Hlth, Paris, France",,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP7,A515,A515,,10.1016/j.jval.2015.09.1561,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300049,0
J,"Ogden, K; Thompson, JC; Halfpenny, NJ; Scott, DA",,,,"Ogden, K.; Thompson, J. C.; Halfpenny, N. J.; Scott, D. A.",,,A CONCEPTUAL SEARCH FILTER TO IDENTIFY REAL-WORLD EVIDENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ogden, K.] ICON, San Francisco, CA USA; [Thompson, J. C.; Halfpenny, N. J.] ICON Hlth Econ, Oxford, England; [Scott, D. A.] ICON Hlth Econ & Epidemiol, Oxford, England",ICON plc; ICON plc; ICON plc,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM261,A728,A728,,10.1016/j.jval.2015.09.2775,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400276,0
J,"Orengo, JC; Arbalaez, F; Lutz, M; Baker-Ivey, T; Marques-Goyco, C; Monsanto, H; Green, VS",,,,"Orengo, J. C.; Arbalaez, F.; Lutz, M.; Baker-Ivey, T.; Marques-Goyco, C.; Monsanto, H.; Green, V. S.",,,CHANGE IN THE DEMOGRAPHIC PROFILE AND IMPACT IN THE MORTALITY OF MELANOMA AND LUNG CANCER IN PUERTO RICO 2000-2010,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Orengo, J. C.; Arbalaez, F.; Marques-Goyco, C.] MSD Caribbean Reg, Carolina, PR USA; [Lutz, M.] MSD Caribbean Reg, San Jose, Costa Rica; [Baker-Ivey, T.] MSD Caribbean Reg, Kingston, Jamaica; [Monsanto, H.] MSD Latin Amer Reg, Carolina, PR USA; [Green, V. S.] Ponce Hlth Sci Univ, Ponce, PR USA",Ponce Health Sciences University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN67,A827,A827,,10.1016/j.jval.2015.09.295,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400611,0
J,"Blas, LAO; Figueroa, A; Kuster, R; Fernández, R; Molina, JGG",,,,"Ortiz Blas, L. A.; Figueroa, A.; Kuster, R.; Fernandez, R.; Gay Molina, J. G.",,,ECONOMIC EVALUATION FOR THE RAPID TEST DPP® HIV-SYPHILIS ASSAY WITH IMMUNOCHROMATOGRAPHY IN PREGNANT WOMEN IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Ortiz Blas, L. A.; Kuster, R.; Fernandez, R.; Gay Molina, J. G.] TI Salud, Mexico City, DF, Mexico",,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD16,A860,A860,,10.1016/j.jval.2015.09.485,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400797,0
J,"Parini, R; Schiffmann, R; Fotheringham, I; Todorova, I",,,,"Parini, R.; Schiffmann, R.; Fotheringham, I; Todorova, I",,,A SYSTEMATIC REVIEW OF THE HUMANISTIC BURDEN OF DISEASE IN PATIENTS WITH FABRY DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Parini, R.] San Gerardo Hosp, Monza, Italy; [Schiffmann, R.] Baylor Univ, Med Ctr, Dallas, TX USA; [Fotheringham, I] Oxford PharmaGenesis Ltd, Oxford, England; [Todorova, I] Shire Int GmbH, Zug, Switzerland",San Gerardo Hospital; Baylor University Medical Center; Baylor University,,,"Parini, Rossella/J-9202-2018","Parini, Rossella/0000-0003-4505-1306",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND79,A762,A762,,10.1016/j.jval.2015.09.2494,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400465,0
J,"Park, D",,,,"Park, D.",,,CLINICAL EFFECTIVENESS AND SAFETY OF ROBOT-ASSISTED LAPAROSCOPIC HYSTERECTOMY VERSUS TRADITIONAL LAPAROTOMY FOR ENDOMETRIAL CANCER: A SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Park, D.] Natl Evidence Based Collaborating Agcy, Seoul, South Korea",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN24,A433,A433,,10.1016/j.jval.2015.09.1039,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400541,0
J,"Park, H; Adeyemi, A; Roane, T",,,,"Park, H.; Adeyemi, A.; Roane, T.",,,IMPACT OF A TELEPHONIC OUTREACH PROGRAM ON MEDICATION ADHERENCE IN MEDICARE ADVANTAGE PRESCRIPTION DRUG (MAPD) PLAN BENEFICIARIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Park, H.; Adeyemi, A.; Roane, T.] Univ Florida, Gainesville, FL USA",State University System of Florida; University of Florida,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB79,A611,A611,,10.1016/j.jval.2015.09.2119,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300590,0
J,"Paveliu, MS",,,,"Paveliu, M. S.",,,SURVEY ON ROMANIAN HOSPITALS FINANCING REVEALS MAJOR DYSFUNCTIONS IN COVERING DRUG TREATMENT DURING HOSPITALIZATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Paveliu, M. S.] Titu Maiorescu Univ, Bucharest, Romania",Titu Maiorescu University,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP163,A542,A542,,10.1016/j.jval.2015.09.1717,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300203,0
J,"Pawaskar, M; Vokó, Z; Agh, T; Sheehan, DV; McElroy, SL; Radewonuk, J; Merész, G; Herman, BK; Gasior, M",,,,"Pawaskar, M.; Voko, Z.; Agh, T.; Sheehan, D., V; McElroy, S. L.; Radewonuk, J.; Meresz, G.; Herman, B. K.; Gasior, M.",,,LONGITUDINAL MODELING THE EFFECT OF LISDEXAMFETAMINE DIMESYLATE AND CHANGES IN BINGE EATING FREQUENCY ON DISABILITY IN PATIENTS WITH BINGE EATING DISORDER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pawaskar, M.; Radewonuk, J.; Herman, B. K.; Gasior, M.] Shire, Wayne, PA USA; [Voko, Z.; Agh, T.; Meresz, G.] Syreon Res Inst, Budapest, Hungary; [Sheehan, D., V] Univ S Florida, Tampa, FL USA; [McElroy, S. L.] Lindner Ctr HOPE, Mason, OH USA",Shire Pharmaceuticals Limited; State University System of Florida; University of South Florida,,,"Vokó, Zoltán/O-3747-2019","Vokó, Zoltán/0000-0002-1004-1848",,,,,0,1,1,2,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,,A407,A407,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400399,0
J,"Prada, M; Bertozzi, C; Proietti, B; Urbinati, D",,,,"Prada, M.; Bertozzi, C.; Proietti, B.; Urbinati, D.",,,"ITALIAN LAW 326/2003 FOR THE REIMBURSEMENT OF ORPHAN AND LIFE SAVING DRUGS AWAITING MARKET ENTRY: APPROVALS, REJECTIONS AND METHODS IN AIFA'S EVALUATION PROCESS BETWEEN JANUARY 2013 AND MAY 2015",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Prada, M.; Bertozzi, C.; Proietti, B.] Intexo, Rome, Italy; [Urbinati, D.] IMS Hlth, Milan, Italy",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP176,A544,A544,,10.1016/j.jval.2015.09.1730,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300216,0
J,"Pyadushkina, E; Avxentyeva, M; Frolov, M",,,,"Pyadushkina, E.; Avxentyeva, M.; Frolov, M.",,,THE BUDGET IMPACT ANALYSIS OF ADJUNCTIVE THERAPY FOR PATIENTS WITH PARTIAL EPILEPSY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pyadushkina, E.; Avxentyeva, M.] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia; [Frolov, M.] Volgograd State Med Univ, Volgograd, Russia",Russian Presidential Academy of National Economy & Public Administration; Volgograd State Medical University,,,"Frolov, Maxim Yu./F-8355-2015; Frolov, Maxim/P-6228-2019; Avxentyeva, Maria/AAC-8141-2019","Frolov, Maxim Yu./0000-0002-0389-560X; Frolov, Maxim/0000-0002-0389-560X; Avxentyeva, Maria/0000-0001-6660-0402",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND24,A752,A752,,10.1016/j.jval.2015.09.2915,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400412,0
J,"Quitian, H; Aschner, P; Muñoz, O; Iragorri, N; Girón, D; Gomez-Restrepo, C; Rosselli, D",,,,"Quitian, H.; Aschner, P.; Munoz, O.; Iragorri, N.; Giron, D.; Gomez-Restrepo, C.; Rosselli, D.",,,ECONOMIC EVALUATION OF SECOND LINE ORAL ANTIDIABETICS FOR TYPE 2 DIABETES IN COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Quitian, H.; Aschner, P.; Munoz, O.; Iragorri, N.; Giron, D.; Gomez-Restrepo, C.; Rosselli, D.] Pontificia Univ Javeriana, Bogota, Colombia",Pontificia Universidad Javeriana,,,"Muñoz, Oscar/Q-2906-2019; Gomez-Restrepo, Carlos/ISA-2919-2023","Muñoz, Oscar/0000-0001-5401-0018; Gomez-Restrepo, Carlos/0000-0002-9013-5384; Berrio Parra, Felipe Leopoldo/0000-0001-9297-6016; Quitian-Reyes, Hoover/0000-0001-8286-4977",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB65,A608,A609,,10.1016/j.jval.2015.09.2104,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300576,0
J,"Rencz, F; Gulácsi, L; Tamási, B; Kárpáti, S; Brodszky, V",,,,"Rencz, F.; Gulacsi, L.; Tamasi, B.; Karpati, S.; Brodszky, V",,,SOCIAL UTILITY VALUES FOR PEMPHIGUS VULGARIS AND FOLIACEUS: A COMPOSITE TIME TRADE-OFF STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Rencz, F.; Gulacsi, L.; Brodszky, V] Corvinus Univ Budapest, Budapest, Hungary; [Tamasi, B.; Karpati, S.] Semmelweis Univ, Budapest, Hungary",Corvinus University Budapest; Semmelweis University,,,"Brodszky, Valentin/AFN-4112-2022; Gulacsi, Laszlo/HMD-6274-2023; Karpati, Sarolta/E-5786-2018","Brodszky, Valentin/0000-0002-6095-2295; Gulacsi, Laszlo/0000-0002-9285-8746; Karpati, Sarolta/0000-0002-8472-0712",,,,,0,1,1,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY81,A673,A673,,10.1016/j.jval.2015.09.1981,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300931,0
J,"Rivera-Peña, G; Gutiérrez-Delgado, C",,,,"Rivera-Pena, G.; Gutierrez-Delgado, C.",,,FINANCIAL IMPACT OF NOT PRESCRIBING BY THE BOOK: ART AND SUSTAINABILITY OF SEGURO POPULAR,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Rivera-Pena, G.; Gutierrez-Delgado, C.] Econ Anal Unit, Mexico City, DF, Mexico",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN34,A873,A874,,10.1016/j.jval.2015.09.028,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400874,0
J,"Romero, M; Huerfano, LM; Sanabria, M",,,,"Romero, M.; Huerfano, L. M.; Sanabria, M.",,,"ANALYSIS OF THE BEHAVIOR OF DREPANOCYTOSIS IN COLOMBIA, FROM THE PERSPECTIVE OF THE HEALTH SERVICES",VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Romero, M.] Salutia Fdn, Bogota, Colombia; [Huerfano, L. M.] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia; [Sanabria, M.] Salutias Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia",,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PYS21,A844,A845,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400712,0
J,"Romero, M; Marrugo, R; Paez, ML",,,,"Romero, M.; Marrugo, R.; Paez, M. L.",,,ANALYSIS OF COST-EFFECTIVENESS AND COST-BENEFIT OF THE RIVAROXABAN ADDITION IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN COLOMBIA,VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Romero, M.; Marrugo, R.] Salutia Fdn, Bogota, Colombia; [Paez, M. L.] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV19,A830,A830,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400630,0
J,"Saiyed, MM; Shah, C",,,,"Saiyed, M. M.; Shah, C.",,,HEMATOLOGICAL TOXICITIES ASSOCIATED WITH PAZOPANIB USE IN CANCER PATIENTS: A META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saiyed, M. M.] Natl Univ Singapore, Singapore, Singapore; [Shah, C.] SJM Coll Pharm, Chitradurga, India",National University of Singapore,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN3,A816,A816,,10.1016/j.jval.2015.09.231,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400547,0
J,"Salfer, B; Somfay, I; Nagy, B",,,,"Salfer, B.; Somfay, I; Nagy, B.",,,THE BURDEN OF ADULT PNEUMOCOCCAL DISEASE IN 50+POPULATION IN HUNGARY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Salfer, B.; Somfay, I; Nagy, B.] Healthware Consulting Ltd, Budapest, Hungary",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH6,A733,A733,,10.1016/j.jval.2015.09.2805,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400304,0
J,"Sebestyén, A; Gajdácsi, J; Boncz, I; Molics, B; Peter, I; Laczó, A; Juhász, K",,,,"Sebestyen, A.; Gajdacsi, J.; Boncz, I; Molics, B.; Peter, I; Laczo, A.; Juhasz, K.",,,WINTERTIME SURGERY INCREASES THE RISK OF OSTEONECROSIS AFTER INTERNAL FIXATION OF FEMORAL NECK FRACTURE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Sebestyen, A.; Juhasz, K.] Natl Hlth Insurance Fund Adm, Pecs, Hungary; [Gajdacsi, J.] Natl Hlth Insurance Fund Adm, Budapest, Hungary; [Boncz, I; Molics, B.] Univ Pecs, Pecs, Hungary; [Peter, I] Zsigmondy Vilmos SPA Hosp, Harkany, Hungary; [Laczo, A.] Natl Healthcare Serv Ctr, Pecs, Hungary",University of Pecs,,,"Boncz, Imre/A-8940-2013","Boncz, Imre/0000-0003-3699-6236",,,,,0,1,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS23,A637,A638,,10.1016/j.jval.2015.09.2268,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300737,0
J,"Shin, M; Shin, S; Lee, JY; Kim, J; Park, J; Kwon, H",,,,"Shin, M.; Shin, S.; Lee, J. Y.; Kim, J.; Park, J.; Kwon, H.",,,"COST-EFFECTIVENESS OF FIRST-LINE TYROSINE KINASE INHIBITORS (TKIS) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN KOREA: COMPARISON OF DASATINIB (100MG), NILOTINIB (600MG) AND IMATINIB (400MG)",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shin, M.; Shin, S.; Lee, J. Y.; Kim, J.; Park, J.; Kwon, H.] Natl Evidence Based Health Care Collaborating Agc, Seoul, South Korea",,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN160,A458,A458,,10.1016/j.jval.2015.09.1177,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400677,0
J,"Shin, S; Lee, J; Kim, J; Shin, M; Kwon, H",,,,"Shin, S.; Lee, J.; Kim, J.; Shin, M.; Kwon, H.",,,"A REAL-WORLD ANALYSIS OF KOREAN NATION-WIDE DATABASE: PATTERN, ADHERENCE, AND ASSOCIATED HEATLHCARE COSTS OF IMATINIB AMONG PATIENTS WITH CHRONIC MYELOID LEUKEMIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shin, S.; Kim, J.; Shin, M.; Kwon, H.] Natl Evidence Based Hlth Care Collaborating Agcy, Seoul, South Korea; [Lee, J.] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea",National Evidence-based Healthcare Collaborating Agency (NECA),,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN30,A434,A434,,10.1016/j.jval.2015.09.1045,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400547,0
J,"Silva, AS; Silveira, LC",,,,"Silva, A. S.; Silveira, L. C.",,,PUBLIC CONSULTATIONS: A TOOL FOR THE INCLUSION OF SOCIETY IN THE BRAZILIAN HTA PROCESS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Silva, A. S.; Silveira, L. C.] Brazilian Minist Hlth, Brasilia, DF, Brazil",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM278,A731,A731,,10.1016/j.jval.2015.09.2794,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400293,0
J,"Soni, P; Gupta, SK",,,,"Soni, P.; Gupta, S. K.",,,NEED FOR NEW PHARMACOECONOMICS POLICY FOR REGULATING PRICES OF MEDICAL DEVICES IN INDIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Soni, P.] Delhi Inst Pharmaceut Sci & Res, Delhi, India; [Gupta, S. K.] Univ Delhi, Delhi Inst Pharmaceut Sci & Res, Delhi, India",Delhi Pharmaceutical Sciences & Research University (DPSRU); Delhi Institute of Pharmaceutical Sciences & Research; University of Delhi; Delhi Pharmaceutical Sciences & Research University (DPSRU); Delhi Institute of Pharmaceutical Sciences & Research,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP342,A573,A573,,10.1016/j.jval.2015.09.1896,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300380,0
J,"Soto-Molina, H; Martínez, JD; Ceballos, R",,,,"Soto-Molina, H.; Diaz Martinez, J.; Ceballos, R.",,,ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS FOR MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Soto-Molina, H.] HS Estudios Farmacoecon, Mexico City, DF, Mexico; [Diaz Martinez, J.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [Ceballos, R.] Medtronic, Mexico City, DF, Mexico",Universidad Nacional Autonoma de Mexico; Medtronic,,,,,,,,,0,0,0,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB10,A863,A864,,10.1016/j.jval.2015.09.506,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400818,0
J,"Stetka, R; Ondrusova, M; Psenkova, M; Pastorek, T; Salek, T",,,,"Stetka, R.; Ondrusova, M.; Psenkova, M.; Pastorek, T.; Salek, T.",,,A COST-UTILITY ANALYSIS OF NAB-PACLITAXEL (ABRAXANE) PLUS GEMCITABINE IN METASTATIC PANCREATIC CANCER IN SLOVAK REPUBLIC,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stetka, R.; Ondrusova, M.; Psenkova, M.] Pharm In Ltd, Bratislava, Slovakia; [Pastorek, T.] Celgene Ltd, Bratislava, Slovakia; [Salek, T.] Narodny Onkol Ustav, Bratislava, Slovakia",,,,,,,,,,0,1,1,1,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN193,A464,A464,,10.1016/j.jval.2015.09.1210,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400710,0
J,"Stewart, G; Kusel, J; Montgomery, S",,,,"Stewart, G.; Kusel, J.; Montgomery, S.",,,DOES BUDGET IMPACT AFFECT REIMBURSEMENT DECISIONS MADE BY THE CANCER DRUGS FUND IN ENGLAND?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stewart, G.; Kusel, J.; Montgomery, S.] Costello Med Consulting Ltd, Cambridge, England",Costello Medical Consulting,,,"Montgomery, Stephen/B-5683-2011","Montgomery, Stephen/0000-0002-8481-5850",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN323,A487,A487,,10.1016/j.jval.2015.09.1341,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400838,0
J,"Tanabe, K; Sugimoto, N; Fujimoto, Y",,,,"Tanabe, K.; Sugimoto, N.; Fujimoto, Y.",,,A WEB-BASED SURVEY TO INVESTIGATE THE EXTENT OF AWARENESS AND UNDERSTANDING FOR BIOSIMILAR AMONG JAPANESE PHYSICIANS AND PHARMACISTS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Tanabe, K.; Sugimoto, N.; Fujimoto, Y.] Pfizer Japan Inc, Tokyo, Japan",Pfizer,,,,,,,,,0,8,8,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS137,A658,A658,,10.1016/j.jval.2015.09.2381,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300849,0
J,"Tanabe, K; Takahashi, S; Ii, Y; Kitazaki, S; Yamamoto, Y; Fujimoto, Y",,,,"Tanabe, K.; Takahashi, S.; Ii, Y.; Kitazaki, S.; Yamamoto, Y.; Fujimoto, Y.",,,"A RETROSPECTIVE, CROSS SECTIONAL STUDY ON THE PREVALENCE OF HYPERTENSION AND TREATMENT STATUS IN OBESE PATIENTS USING A HEALTHCARE DATABASE IN JAPAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tanabe, K.; Takahashi, S.; Ii, Y.; Fujimoto, Y.] Pfizer Japan Inc, Tokyo, Japan; [Kitazaki, S.; Yamamoto, Y.] MinaCare Co Ltd, Tokyo, Japan",Pfizer,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV40,A380,A380,,10.1016/j.jval.2015.09.808,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400252,0
J,"Thorn, JC; Ridyard, CH; Riley, R; Brookes, S; Hughes, D; Wordsworth, S; Noble, S; Hollingworth, W",,,,"Thorn, J. C.; Ridyard, C. H.; Riley, R.; Brookes, S.; Hughes, D.; Wordsworth, S.; Noble, S.; Hollingworth, W.",,,IDENTIFICATION OF ITEMS FORA STANDARDISED RESOURCE-USE MEASURE: REVIEW OF CURRENT INSTRUMENTS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Thorn, J. C.; Riley, R.; Brookes, S.; Noble, S.; Hollingworth, W.] Univ Bristol, Bristol, Avon, England; [Ridyard, C. H.; Hughes, D.] Bangor Univ, Bangor, Gwynedd, Wales; [Wordsworth, S.] Univ Oxford, Oxford, England",University of Bristol; Bangor University; University of Oxford,,,"Riley, Ruth/ABA-7824-2021; Hughes, Dyfrig/H-5252-2012","Hughes, Dyfrig/0000-0001-8247-7459",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM33,A688,A688,,10.1016/j.jval.2015.09.2549,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400053,0
J,"Tolentino, AC; Schutz, V; Peregrino, AA",,,,"Tolentino, A. C.; Schutz, V; Peregrino, A. A.",,,"COST-EFFECTIVENESS ANALYSIS OF ONE-PIECE DRAINABLE POUCH VERSUS TWO-PIECE DRAINABLE POUCH FOR COLOSTOMATES UNDER THE PERSPECTIVE OF PATIENT'S OUT-OF-POCKET EXPENSES, IN BRAZIL",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Tolentino, A. C.] Inst Cardiol Aloysio de Castro, Rio De Janeiro, Brazil; [Schutz, V] Univ Fed Estado Rio de Janeiro, Rio De Janeiro, Brazil; [Peregrino, A. A.] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil",Universidade Federal do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD15,A860,A860,,10.1016/j.jval.2015.09.484,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400796,0
J,"Tsourougiannis, D; Odeyemi, IA",,,,"Tsourougiannis, D.; Odeyemi, I. A.",,,DRUG PRICING INFORMATION MANAGEMENT: DEVELOPMENT OF A WEB BASED E-PRICING SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tsourougiannis, D.] Astellas Pharma EMEA, Chertsey, England; [Odeyemi, I. A.] Astellas Pharma Europe Ltd, Chertsey, England",Astellas Pharmaceuticals,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP137,A537,A538,,10.1016/j.jval.2015.09.1690,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300177,0
J,"ul Haq, N; Iqbal, Q; Nasim, A; Razaq, G; Shafi, M; Akram, A; Raiz, S; Haque, N",,,,"ul Haq, N.; Iqbal, Q.; Nasim, A.; Razaq, G.; Shafi, M.; Akram, A.; Raiz, S.; Haque, N.",,,"HEALTH RELATED QUALITY OF LIFE IN TB PATIENTS QUETTA, PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[ul Haq, N.; Iqbal, Q.; Nasim, A.; Razaq, G.; Shafi, M.; Akram, A.; Raiz, S.; Haque, N.] Univ Balochistan, Quetta, Pakistan",University of Balochistan,,,"Nasim, Aqeel/AAX-1823-2021","Nasim, Aqeel/0000-0003-1270-4753; Riaz, Sohail/0000-0002-4188-5162",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS63,A504,A504,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400932,0
J,"van Engen, A; Wu, Y; Tchoukouaha, T; Terol, PA; Gandhi, SK",,,,"van Engen, A.; Wu, Y.; Tchoukouaha, T.; Terol, Aran P.; Gandhi, S. K.",,,COST OF DRUG-RELATED MONITORING REQUIREMENTS FOR GLATIRAMER ACETATE AND OTHER MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES (DMTS),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[van Engen, A.] Quintiles Advisory Serv, Hoofddorp, Netherlands; [Wu, Y.; Gandhi, S. K.] Teva Pharmaceut Inc, Malvern, PA USA; [Tchoukouaha, T.; Terol, Aran P.] Quintiles Advisory Serv, Reading, Berks, England",IQVIA; Teva Pharmaceutical Industries; Teva Pharmaceutical Industries USA; IQVIA,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND26,A753,A753,,10.1016/j.jval.2015.09.2917,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400414,0
J,"Valencia, JV; Prieto, VA",,,,"Vargas Valencia, J.; Prieto, V. A.",,,ANALYSIS OF COST MINIMIZATION OF TOFACITINIB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS THAT HAVE PRESENTED IMPROPER RESPONSE TO METOTREXATE IN COLOMBIA,VALUE IN HEALTH,,,Spanish,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Vargas Valencia, J.] Econopharma Consulting, Mexico City, DF, Mexico; [Prieto, V. A.] Pfizer SAS, Bogota, Colombia",Pfizer,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS9,A875,A875,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400885,0
J,"Wasserman, M; Amin, A",,,,"Wasserman, M.; Amin, A.",,,BEYOND THE MIDDLE: EVALUATING SURROGACY OF CLINICAL TRIAL ENDPOINTS ACROSS TRIAL DURATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Wasserman, M.] Double Helix Consulting, New York, NY USA; [Amin, A.] Double Helix Consulting, London, England",,,,,"Wasserman, Matthew/0000-0003-3300-2742",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM12,A684,A684,,10.1016/j.jval.2015.09.2528,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400032,0
J,"Wetten, S; Li, X; Haas, J; Worth, G; Jacob, C; Braun, S; Tzivelekis, S",,,,"Wetten, S.; Li, X.; Haas, J.; Worth, G.; Jacob, C.; Braun, S.; Tzivelekis, S.",,,COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF) FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA (FN) -RELATED HOSPITALIZATION: A RETROSPECTIVE COHORT STUDY USING GERMAN CLAIMS DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wetten, S.] Amgen Ltd, Uxbridge, Middx, England; [Li, X.; Tzivelekis, S.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Haas, J.; Jacob, C.; Braun, S.] Xcenda GmbH, Hannover, Germany; [Worth, G.] Amgen Ltd, Zug, Switzerland",Amgen; Amgen Limited; Amgen,,,,,,,,,0,3,3,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN27,A434,A434,,10.1016/j.jval.2015.09.1042,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400544,0
J,"Wilke, T; Boettger, B; Berg, B; Williams, J; Botteman, M; Yu, S; Fuchs, A; Maywald, U",,,,"Wilke, T.; Boettger, B.; Berg, B.; Williams, J.; Botteman, M.; Yu, S.; Fuchs, A.; Maywald, U.",,,"DISEASE BURDEN AND COSTS ASSOCIATED WITH URINARY TRACT INFECTIONS IN TYPE 2 DIABETES MELLITUS PATIENTS: AN ANALYSIS BASED ON A LARGE SAMPLE OF 456,586 GERMAN PATIENTS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wilke, T.] Ingress Hlth, Wismar, Germany; [Boettger, B.; Berg, B.] IPAM, Wismar, Germany; [Williams, J.; Yu, S.] Merck Sharp & Dohme Co, Whitehouse Stn, NJ USA; [Botteman, M.] Pharmerit US Bethesda, Bethesda, MD USA; [Fuchs, A.; Maywald, U.] AOK PLUS, Dresden, Germany",Merck & Company; Pharmerit North America LLC,,,"Botteman, Marc/AAA-9134-2021",,,,,,0,0,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PUK31,A513,A513,,10.1016/j.jval.2015.09.1486,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300038,0
J,"Yang, Z",,,,"Yang, Z.",,,INCONSISTENCY IN THE VALUATIONS OF EUROQOL EQ-5D-5L HEALTH STATES IN CHINA WAS MORE RELATED TO INTERVIEWER AND TO INTERVIEW PROCESS THAN TO RESPONDENTS' CHARACTERISTICS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yang, Z.] Erasmus Univ, Rotterdam, Netherlands",Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University Rotterdam,,,,,,,,,0,4,4,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH31,A737,A738,,10.1016/j.jval.2015.09.2829,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400328,0
J,"Zaim, R; van der Putten, L; de Groot, S; van Tinteren, H; Boers, M; Comans, E; van der Laan, B; Janssen, L; Takes, R; van den Brekel, M; Oyen, W; Valdés-Olmos, R; Hobbelink, M; Wedman, J; Leemans, C; Hoekstra, O; de Bree, R; Uyl-de Groot, C",,,,"Zaim, R.; van der Putten, L.; de Groot, S.; van Tinteren, H.; Boers, M.; Comans, E.; van der Laan, B.; Janssen, L.; Takes, R.; van den Brekel, M.; Oyen, W.; Valdes-Olmos, R.; Hobbelink, M.; Wedman, J.; Leemans, C.; Hoekstra, O.; de Bree, R.; Uyl-de Groot, C.",,,RECURRENT LARYNGEAL CARCINOMA PET STUDY (RELAPS): COST ANALYSIS OF 18F-FDG PET IN PATIENTS WITH SUSPECTED RECURRENT LARYNGEAL CANCER PREVIOUSLY TREATED WITH RADIOTHERAPY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zaim, R.; de Groot, S.; Uyl-de Groot, C.] Erasmus Univ, Rotterdam, Netherlands; [van der Putten, L.; Boers, M.; Comans, E.; Leemans, C.; Hoekstra, O.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Tinteren, H.; van den Brekel, M.; Valdes-Olmos, R.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [van der Laan, B.; Wedman, J.] Univ Med Ctr Groningen, Groningen, Netherlands; [Janssen, L.; Hobbelink, M.; de Bree, R.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Takes, R.; Oyen, W.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands",Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Groningen; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen,,,"van den Brekel, Michiel/AFV-7985-2022; van der Laan, Bernard/O-7723-2019; Van Den Brekel, Michiel W./ABG-8695-2020; Oyen, Wim J.G./AAD-3373-2020; Takes, R.P./L-4680-2015","van den Brekel, Michiel/0000-0002-6338-6743; van der Laan, Bernard/0000-0002-5016-2871; Oyen, Wim J.G./0000-0001-8235-7078;",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD51,A353,A353,,10.1016/j.jval.2015.09.652,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,"Green Published, hybrid",,,2024-03-09,WOS:000384252400100,0
J,"Boneva, L; Linton, O; Vogt, M",,,,"Boneva, Lena; Linton, Oliver; Vogt, Michael",,,A semiparametric model for heterogeneous panel data with fixed effects,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Heterogeneous panel data; Kernel smoothing; Semiparametric estimation; Factor structure,NONPARAMETRIC REGRESSION; CONVERGENCE; SELECTION; NUMBER; RATES; RISK,"This paper develops methodology for semiparametric panel data models in a setting where both the time series and the cross section are large. Such settings are common in finance and other areas of economics. Our model allows for heterogeneous nonparametric covariate effects as well as unobserved time and individual specific effects that may depend on the covariates in an arbitrary way. To model the covariate effects parsimoniously, we impose a dimensionality reducing common component structure on them. In the theoretical part of the paper, we derive the asymptotic theory for the proposed procedure. In particular, we provide the convergence rates and the asymptotic distribution of our estimators. In the empirical part, we apply our methodology to a specific application that has been the subject of recent policy interest, that is, the effect of trading venue fragmentation on market quality. We use a unique dataset that reports the location and volume of trading on the FTSE 100 and FTSE 250 companies from 2008 to 2011 at the weekly frequency. We find that the effect of fragmentation on market quality is nonlinear and non-monotonic. The implied quality of the market under perfect competition is superior to that under monopoly provision, but the transition between the two is complicated. (C) 2015 Elsevier B.V. All rights reserved.","[Boneva, Lena] London Sch Econ, London, England; [Boneva, Lena] Bank England, London, England; [Linton, Oliver] Univ Cambridge, Cambridge CB2 1TN, England; [Vogt, Michael] Univ Konstanz, Constance, Germany",University of London; London School Economics & Political Science; Bank of England; University of Cambridge; University of Konstanz,"Vogt, M (通讯作者)，Dept Math & Stat, D-78457 Constance, Germany.",l.m.koerber@lse.ac.uk; obl20@cam.ac.uk; michael.vogt@uni-konstanz.de,,,"Economic and Social Science Research Council; Cusanuswerk; ESRC [ES/H021221/1, ES/I034021/1] Funding Source: UKRI; Economic and Social Research Council [ES/I034021/1, ES/H021221/1, 1014038] Funding Source: researchfish",Economic and Social Science Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Cusanuswerk; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"The first author gratefully acknowledges financial support by the Economic and Social Science Research Council and Cusanuswerk. The second and third author would like to thank the European Research Council for financial support (grant name: Namsefadg). The authors thank participants at the 19th International Panel Data Conference and the UCL-LSE-cemmap Ph.D. student conference for their helpful comments. The views in this paper are those of the authors and do not necessarily reflect the views of the Bank of England, the Monetary Policy Committee, the Financial Policy Committee or the Prudential Regulation Authority.",,51,16,16,0,32,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,OCT,2015,188.0,2.0,,,,,327,345,,10.1016/j.jeconom.2015.03.003,0.0,,,19,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CQ2GF,,Green Submitted,,,2024-03-09,WOS:000360417300003,0
J,"Li, T; Oka, T",,,,"Li, Tong; Oka, Tatsushi",,,Set identification of the censored quantile regression model for short panels with fixed effects,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Conditional quantiles; Partial identification; Panel data; Fixed effects; Censoring,MOMENT INEQUALITIES; ECONOMETRIC-MODELS; SEMIPARAMETRIC ANALYSIS; CONSISTENT ESTIMATION; ASYMPTOTIC PROPERTIES; LINEAR-MODELS; INFERENCE; PARAMETERS; RESTRICTIONS; ESTIMATOR,"This paper studies identification and estimation of a censored quantile regression model for short panel data with fixed effects. Using the redistribution-of-mass idea, we obtain bounds on the conditional distribution of differences of the model across periods, under conditional quantile restrictions together with a weak conditional independence assumption along the lines of Rosen (2012). The inversion of the distribution bounds characterizes the sharp identified set via a set of inequalities based on conditional quantile functions. Due to the presence of censoring, some of the inequalities defining the identified set hold trivially and have no identification power. Moreover, those trivial inequalities cause a difficulty in estimating the identified set. To deal with the issue, we propose a two-step estimation method, where the first step consists of excluding trivial inequalities and the second step performs minimization of a convex criterion function using the remaining inequalities. We establish asymptotic properties of the set estimator and also consider sufficient conditions under which point identification can be attained. (C) 2015 Elsevier B.V. All rights reserved.","[Li, Tong] Vanderbilt Univ, Dept Econ, Nashville, TN 37240 USA; [Oka, Tatsushi] Natl Univ Singapore, Dept Econ, Singapore 117570, Singapore",Vanderbilt University; National University of Singapore,"Oka, T (通讯作者)，Natl Univ Singapore, Dept Econ, AS2 06-02,1 Arts Link, Singapore 117570, Singapore.",tong.li@vanderbilt.edu; oka@nus.edu.sg,"Oka, Tatsushi/HTR-1004-2023","Oka, Tatsushi/0000-0002-8868-6136",Singapore Ministry of Education Academic Research Fund Tire 1 [FY2013-FRC2-003],"Singapore Ministry of Education Academic Research Fund Tire 1(Ministry of Education, Singapore)","We thank two anonymous referees for their constructive comments which have greatly improved the paper. We also thank Ivan Fernandez-Val, Hidehiko Ichimura, Hiroaki Kaido, Kengo Kato, Yoshihiko Nishiyama, Ryo Okui, Adam Rosen, Yoon-Jae Whang, and participants at the seminar in Kyoto University, the 2013 Asian Meeting of the Econometric Society, the 10th International Symposium on Econometric Theory and Applications and the 2014 China Meeting of Econometric Society for useful suggestions. The work in this paper was initiated and part of it was developed when Li was visiting the National University of Singapore as Goh Keng Swee visiting professor in August 2012 and August 2013. Li gratefully acknowledges the hospitality and support from the Department of Economics at the National University of Singapore during his visits. Oka gratefully acknowledges financial support from Singapore Ministry of Education Academic Research Fund Tire 1 (FY2013-FRC2-003).",,55,6,7,0,20,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,OCT,2015,188.0,2.0,,,,,363,377,,10.1016/j.jeconom.2015.03.005,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CQ2GF,,,,,2024-03-09,WOS:000360417300005,0
J,"Petrou, S; Rivero-Arias, O; Dakin, H; Longworth, L; Oppe, M; Froud, R; Gray, A",,,,"Petrou, Stavros; Rivero-Arias, Oliver; Dakin, Helen; Longworth, Louise; Oppe, Mark; Froud, Robert; Gray, Alastair",,,Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,QUALITY-OF-LIFE; HEALTH UTILITIES; CHECKLIST; TRIALS,"Background 'Mapping' onto generic preference-based outcome measures is increasingly being used as a means of generating health utilities for use within health economic evaluations. Despite publication of technical guides for the conduct of mapping research, guidance for the reporting of mapping studies is currently lacking. The MAPS (MApping onto Preference-based measures reporting Standards) statement is a new checklist, which aims to promote complete and transparent reporting of mapping studies. Methods In the absence of previously published reporting checklists or reporting guidance documents, a de novo list of reporting items was created by a working group comprising six health economists and one Delphi methodologist. A two-round, modified Delphi survey, with representatives from academia, consultancy, health technology assessment agencies and the biomedical journal editorial community, was used to identify a list of essential reporting items from this larger list. Results From the initial de novo list of 29 candidate items, a set of 23 essential reporting items was developed. The items are presented numerically and categorized within six sections: (1) title and abstract; (2) introduction; (3) methods; (4) results; (5) discussion; and (6) other. The MAPS statement is best applied in conjunction with the accompanying MAPS Explanation and Elaboration paper. Conclusion It is anticipated that the MAPS statement will improve the clarity, transparency and completeness of the reporting of mapping studies. To facilitate dissemination and uptake, the MAPS statement is being co-published by seven health economics and quality-of-life journals, and broader endorsement is encouraged. The MAPS working group plans to assess the need for an update of the reporting checklist in 5 years' time.","[Petrou, Stavros; Froud, Robert] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Rivero-Arias, Oliver] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England; [Dakin, Helen; Gray, Alastair] Univ Oxford, Hlth Econ Res Ctr, Nuffield Dept Populat Hlth, Oxford, England; [Longworth, Louise] Brunel Univ, Hlth Econ Res Grp, London, Uxbridge, England; [Oppe, Mark] EuroQol Res Fdn, Rotterdam, Netherlands; [Froud, Robert] Norges Helsehoyskole, Oslo, Norway",University of Warwick; University of Oxford; University of Oxford; Brunel University,"Petrou, S (通讯作者)，Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.",S.Petrou@warwick.ac.uk,"Froud, Robert/AAQ-2429-2021; Dakin, Helen A/X-2860-2018; Petrou, Stavros/ABD-8323-2021","Froud, Robert/0000-0002-9193-2297; Dakin, Helen A/0000-0003-3255-748X; Petrou, Stavros/0000-0003-3121-6050; Longworth, Louise/0000-0003-2512-4862; Gray, Alastair/0000-0003-0239-7278; Rivero-Arias, Oliver/0000-0003-2233-6544","MRC [G0700452, G0501681] Funding Source: UKRI; Economic and Social Research Council [1499410] Funding Source: researchfish; Medical Research Council [G0700452, G0501681] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10206] Funding Source: researchfish",MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institutes of Health Research (NIHR)),,,27,3,3,0,1,SPRINGER INT PUBL AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,OCT,2015,13.0,5.0,,,,,437,443,,10.1007/s40258-015-0191-4,0.0,,,7,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CR8PC,26231987.0,"Green Published, hybrid",,,2024-03-09,WOS:000361615200002,0
J,"Shields, GE; Bates, AE; Chapman, AM",,,,"Shields, Gemma E.; Bates, Alexander E.; Chapman, Ann-Marie",,,Implementing Guidelines: The Cost and Clinical Impact of Anticoagulants in the UK Atrial Fibrillation Population,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,STROKE PREVENTION; ORAL ANTICOAGULATION; CARE COSTS; WARFARIN; RISK; ASPIRIN; METAANALYSIS; PREVALENCE; DABIGATRAN; APIXABAN,"Background Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the UK, and highlight a current shortfall in the prescription of anticoagulants to patients with AF for stroke prevention. Objective To design a budget impact model as a planning tool for UK Clinical Commissioning Groups (CCGs) looking to budget for greater use of anticoagulants in the AF population. Methods An Excel (R) model was developed to estimate the five-year impact of gradually treating all eligible patients with AF who are currently not being prescribed anticoagulants, both in terms of the effect on key clinical outcomes (strokes, major bleeds and mortality) and the associated financial impact. Results For a population of 251,693 (average CCG size) with an estimated 2626 prevalent patients and an additional 546 incident cases annually, the model estimated that increasing the proportion of the eligible AF patient population receiving anticoagulation by a fraction would require an additional budget of GBP139,961 in Year 1 to treat an additional 314 patients. This would rise to GBP1,004,900 in Year 5 to treat an additional 2242 patients, with all eligible patients treated by this year. The price year was 2014. Over the 5-year timeframe, this could lead to the prevention of 24 strokes and 29 deaths, with an increase of 31 major bleeds. Conclusions The clinical benefits of appropriate anticoagulation are widely recognised; however, full implementation can be difficult and costly. Therefore, the development of models can support the planning process by facilitating discussion among stakeholders on how best they can reach full implementation. The model is flexible and can be adapted to suit different payers.","[Shields, Gemma E.; Chapman, Ann-Marie] BresMed, Sheffield S1 2DW, S Yorkshire, England; [Bates, Alexander E.] Yorkshire & Humber Commissioning Support, Bradford, W Yorkshire, England",,"Shields, GE (通讯作者)，BresMed, North Church House,84 Queen St, Sheffield S1 2DW, S Yorkshire, England.",gshields@bresmed.co.uk,"Shields, Gemma/F-2042-2018","Shields, Gemma/0000-0003-4869-7524",,,,,43,4,5,0,6,SPRINGER INT PUBL AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,OCT,2015,13.0,5.0,,,,,543,551,,10.1007/s40258-015-0180-7,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CR8PC,26077910.0,,,,2024-03-09,WOS:000361615200011,0
J,"Giuntella, O; Mazzonna, F",,,,"Giuntella, Osea; Mazzonna, Fabrizio",,,Do immigrants improve the health of natives?,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Health; Immigration; Occupational choice,IMPACT; EMPLOYMENT; DEMAND,"This paper studies the effects of immigration on health. Specifically, we merge information on individual characteristics from the German Socio-Economic Panel (1984-2009) with detailed local labour market characteristics, and we then exploit the longitudinal component of the data to determine how immigration affects the health of both immigrants and natives over time. We find that immigrants to Germany are healthier than natives upon their arrival (the healthy immigrant effect) but that immigrants' health deteriorates over time. We show that the convergence in health is heterogeneous across immigrants and occurs more rapidly among those working in more physically demanding jobs. Because immigrants are significantly more likely to work in strenuous occupations, we investigate whether changes in the spatial concentration of immigrants affect the health of the native population. Our results suggest that immigration reduces the likelihood that residents will report negative health outcomes. We show that these effects are concentrated in blue-collar occupations and are stronger among low-educated natives. Improvements in natives' average working conditions and workloads help explain the positive effects of immigration on the health of the native population. (C) 2015 Elsevier B.V. All rights reserved.","[Giuntella, Osea] Univ Oxford, Nuffield Coll, Oxford OX1 4JJ, England; [Giuntella, Osea] Univ Oxford, Blavatnik Sch Govt, Oxford OX1 4JJ, England; [Giuntella, Osea] Inst Study Labor IZA, Bonn, Germany; [Mazzonna, Fabrizio] USI, Dept Econ, CH-6904 Lugano, Switzerland; [Mazzonna, Fabrizio] Munich Ctr Econ Ageing MEA, Munich, Germany",University of Oxford; University of Oxford; IZA Institute Labor Economics; Universita della Svizzera Italiana,"Mazzonna, F (通讯作者)，USI, CH-6904 Lugano, Switzerland.",osea.giuntella@nuffield.ox.ac.uk; fabrizio.mazzonna@usi.ch,"Mazzonna, Fabrizio/AFV-5184-2022","Mazzonna, Fabrizio/0000-0002-9065-0474",,,,,58,46,53,3,28,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,SEP,2015,43.0,,,,,,140,153,,10.1016/j.jhealeco.2015.06.006,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CT8PN,26299191.0,,,,2024-03-09,WOS:000363078600011,0
J,"Lainé, J",,,,"Laine, Jean",,,Hyper-stable collective rankings,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,,"We introduce a new consistency property for social welfare functions (SWF), called hyper-stability. An SWF is hyper-stable if at any profile over finitely many alternatives where a weak order R is chosen, there exists a profile of linear orders over linear orders, called hyper-profile, at which only linearizations of R are ranked first by the SWF. Profiles induce hyper-profiles according to some minimal compatibility conditions. We provide sufficient conditions for hyper-stability, and we investigate hyper-stability for several Condorcet SWFs. An important conclusion is that there are non-dictatorial hyper-stable SWFs. (C) 2015 Elsevier B.V. All rights reserved.","[Laine, Jean] LIRSA, Conservatoire Natl Arts & Metiers, Paris, France; [Laine, Jean] Istanbul Bilgi Univ, Murat Sertel Ctr Adv Econ Studies, Istanbul, Turkey",heSam Universite; Conservatoire National Arts & Metiers (CNAM); Istanbul Bilgi University,"Lainé, J (通讯作者)，EFAB LIRSA, Conservatoire Natl Arts & Metiers, 40 Rue Jeuneurs, F-75002 Paris, France.",jean.laine@cnam.fr,,"LAINE, Jean/0000-0002-7305-7556",,,,,9,0,0,0,4,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2015,77.0,,,,,,70,80,,10.1016/j.mathsocsci.2015.06.002,0.0,,,11,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CR3RN,,,,,2024-03-09,WOS:000361250900010,0
J,"Possajennikov, A",,,,"Possajennikov, Alex",,,Conjectural variations in aggregative games: An evolutionary perspective,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,STABILITY,"Suppose that in symmetric aggregative games, in which payoffs depend only on a player's strategy and on an aggregate of all players' strategies, players have conjectures about the reaction of the aggregate to marginal changes in their strategy. The players play a conjectural variation equilibrium, which determines their fitness payoffs. The paper shows that only consistent conjectures can be evolutionarily stable in an infinite population, where a conjecture is consistent if it is equal to the marginal change in the aggregate determined by the actual best responses. In the finite population case, only zero conjectures representing aggregate-taking behavior can be evolutionarily stable. (C) 2015 Elsevier B.V. All rights reserved.","Univ Nottingham, Sch Econ, Nottingham NG7 2RD, England",University of Nottingham,"Possajennikov, A (通讯作者)，Univ Nottingham, Sch Econ, Univ Pk, Nottingham NG7 2RD, England.",alex.possajennikov@nottingham.ac.uk,"Possajennikov, Alex/ABG-8223-2021","Possajennikov, Alex/0000-0001-8887-8165",,,,,22,5,5,0,9,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2015,77.0,,,,,,55,61,,10.1016/j.mathsocsci.2015.07.003,0.0,,,7,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CR3RN,,Green Submitted,,,2024-03-09,WOS:000361250900008,0
J,"Aït-Sahalia, Y; Amengual, D; Manresa, E",,,,"Ait-Sahalia, Yacine; Amengual, Dante; Manresa, Elena",,,Market-based estimation of stochastic volatility models,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,HJM approach; Variance swaps; Maximum likelihood estimation,OPTIONS; JUMP,"We propose a method for estimating stochastic volatility models by adapting the HJM approach to the case of volatility derivatives. We characterize restrictions that observed variance swap dynamics have to satisfy to prevent arbitrage opportunities. When the drift of variance swap rates are affine under the pricing measure, we obtain closed form expressions for those restrictions and formulas for forward variance curves. Using data on the S&P500 index and variance swap rates on different time to maturities, we find that linear mean-reverting one factor models provide inaccurate representation of the dynamics of the variance swap rates while two-factor models significantly outperform the former both in and out of sample. (C) 2015 Elsevier B.V. All rights reserved.","[Ait-Sahalia, Yacine] Princeton Univ, Dept Econ, Princeton, NJ 08544 USA; [Ait-Sahalia, Yacine] NBER, Cambridge, MA 02138 USA; [Amengual, Dante] Ctr Estudios Monetarios & Financieros, Madrid 28014, Spain; [Manresa, Elena] MIT, Sloan Sch Management, Cambridge, MA 02142 USA",Princeton University; National Bureau of Economic Research; Massachusetts Institute of Technology (MIT),"Aït-Sahalia, Y (通讯作者)，Bendheim Ctr Finance, 26 Prospect Ave, Princeton, NJ 08540 USA.",yacine@princeton.edu; amengual@cemfi.es; manresa@cemfi.es,"Amengual, Dante/AAD-9439-2021",,"Direct For Social, Behav & Economic Scie; Divn Of Social and Economic Sciences [0850533] Funding Source: National Science Foundation","Direct For Social, Behav & Economic Scie; Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))",,,39,8,8,1,22,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,AUG,2015,187.0,2.0,,,,,418,435,,10.1016/j.jeconom.2015.02.028,0.0,,,18,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CM0DJ,,hybrid,,,2024-03-09,WOS:000357348300003,0
J,"Andersen, TG; Bondarenko, O; Todorov, V; Tauchen, G",,,,"Andersen, Torben G.; Bondarenko, Oleg; Todorov, Viktor; Tauchen, George",,,The fine structure of equity-index option dynamics,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,High-frequency data; Implied volatility; Jump activity; Kolmogorov-Smirnov test; Stable process; Stochastic volatility; VIX index,LIMIT-THEOREMS; MICROSTRUCTURE NOISE; JUMPS; SEMIMARTINGALES; VOLATILITY,"We analyze the high-frequency dynamics of S&P 500 equity-index option prices by constructing an assortment of implied volatility measures. This allows us to infer the underlying fine structure behind the innovations in the latent state variables driving the evolution of the volatility surface. In particular, we focus attention on implied volatilities covering a wide range of moneyness (strike/underlying stock price), which load differentially on the different latent state variables. We conduct a similar analysis for high-frequency observations on the VIX volatility index as well as on futures written on it. We find that the innovations over small time scales in the risk-neutral intensity of the negative jumps in the S&P 500 index, which is the dominant component of the short-maturity out-of-the-money put implied volatility dynamics, are best described via non-Gaussian shocks, i.e., jumps. On the other hand, the innovations over small time scales of the diffusive volatility, which is the dominant component in the short-maturity at-the-money option implied volatility dynamics, are best modeled as Gaussian with occasional jumps. (C) 2015 Elsevier B.V. All rights reserved.","[Andersen, Torben G.; Todorov, Viktor] Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA; [Andersen, Torben G.] NBER, Cambridge, MA 02138 USA; [Andersen, Torben G.] CREATES, Aarhus, Denmark; [Bondarenko, Oleg] Univ Illinois, Dept Finance, Chicago, IL 60607 USA; [Tauchen, George] Duke Univ, Dept Econ, Durham, NC 27708 USA",Northwestern University; National Bureau of Economic Research; CREATES; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Duke University,"Andersen, TG (通讯作者)，Northwestern Univ, Kellogg Sch Management, Dept Finance, Evanston, IL 60208 USA.",t-andersen@northwestern.edu; olegb@uic.edu; v-todorov@northwestern.edu; george.tauchen@duke.edu,"Todorov, Viktor/KCX-9394-2024","Todorov, Viktor/0000-0002-2360-7812","CREATES, Center for Research in Econometric Analysis of Time Series - Danish National Research Foundation [DNRF78]; National Science Foundation [SES-0957330]; CME Group","CREATES, Center for Research in Econometric Analysis of Time Series - Danish National Research Foundation; National Science Foundation(National Science Foundation (NSF)); CME Group","Andersen gratefully acknowledges support from CREATES, Center for Research in Econometric Analysis of Time Series (DNRF78), funded by the Danish National Research Foundation. Todorov's work was partially supported by National Science Foundation grant SES-0957330. We are also grateful for support from a grant by the CME Group. We thank Makoto Takahashi for providing assistance with collecting the VIX futures data.",,24,16,18,1,23,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,AUG,2015,187.0,2.0,,,,,532,546,,10.1016/j.jeconom.2015.02.037,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CM0DJ,,Green Submitted,,,2024-03-09,WOS:000357348300012,0
J,"Fortin, B; Yazbeck, M",,,,"Fortin, Bernard; Yazbeck, Myra",,,"Peer effects, fast food consumption and adolescent weight gain",JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Obesity; Overweight; Peer effects; Social interactions; Fast food,SOCIAL NETWORK; PANEL-DATA; OBESITY; IDENTIFICATION; CONTAGION; PRICES; MODELS; HEALTH,"This paper aims at opening the black box of peer effects in adolescent weight gain. Using Add Health data on secondary schools in the U.S., we investigate whether these effects partly flow through the eating habits channel. Adolescents are assumed to interact through a friendship social network. We propose a two-equation model. The first equation provides a social interaction model of fast food consumption. To estimate this equation we use a quasi maximum likelihood approach that allows us to control for common environment at the network level and to solve the simultaneity (reflection) problem. Our second equation is a panel dynamic weight production function relating an individual's Body Mass Index z-score (zBMI) to his fast food consumption and his lagged zBMI, and allowing for irregular intervals in the data. Results show that there are positive but small peer effects in fast food consumption among adolescents belonging to a same friendship school network. Based on our preferred specification, the estimated social multiplier is 1.15. Our results also suggest that, in the long run, an extra day of weekly fast food restaurant visits increases zBMI by 4.45% when ignoring peer effects and by 5.11%, when they are taken into account. (C) 2015 Elsevier B.V. All rights reserved.","[Fortin, Bernard] Univ Laval, CIRPEE, IZA, CIRANO, Quebec City, PQ G1K 7P4, Canada; [Fortin, Bernard] Univ Laval, Dept Econ, Quebec City, PQ G1K 7P4, Canada; [Yazbeck, Myra] Univ Queensland, Sch Econ, Brisbane, Qld 4072, Australia",Laval University; Laval University; University of Queensland,"Fortin, B (通讯作者)，Univ Laval, CIRPEE, IZA, CIRANO, Quebec City, PQ G1K 7P4, Canada.",Bernard.Fortin@ecn.ulaval.ca; m.yazbeck@uq.edu.au,"Lacroix, Guy/H-9015-2017",,"Canada Research Chair in the Economics of Social Policies and Human Resources; le Centre interuniversitaire sur le risque, les politiques economiques et l'emploi; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]","Canada Research Chair in the Economics of Social Policies and Human Resources(Canada Research Chairs); le Centre interuniversitaire sur le risque, les politiques economiques et l'emploi; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))","We wish to thank Christopher Auld, Charles Bellemare, Luc Bissonnette, Vincent Boucher, Paul Frijters, Guy Lacroix, Paul Makdissi, Daniel L. Millimet, Kevin Moran, Bruce Shearer for useful comments and Yann Bramoulle, Badi Baltagi, Rokhaya Dieye, Habiba Djebbari, Tue Gorgens, Bob Gregory, Louis Hotte, Linda Khalaf, Lung fei Lee, Xin Meng and Rabee Tourky for useful discussions. The suggestions of two anonymous referees have substantially improved the paper. We are grateful to Rokhaya Dieye for outstanding assistance research, The usual disclaimer applies. Financial support from the Canada Research Chair in the Economics of Social Policies and Human Resources and le Centre interuniversitaire sur le risque, les politiques economiques et l'emploi is gratefully acknowledged. This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed, by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations.",,58,49,59,4,51,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JUL,2015,42.0,,,,,,125,138,,10.1016/j.jhealeco.2015.03.005,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CL8NC,25935739.0,"Green Published, Green Submitted",,,2024-03-09,WOS:000357230400011,0
J,"Ruggeri, M; Manca, A; Coretti, S; Codella, P; Iacopino, V; Romano, F; Mascia, D; Orlando, V; Cicchetti, A",,,,"Ruggeri, Matteo; Manca, Andrea; Coretti, Silvia; Codella, Paola; Iacopino, Valentina; Romano, Federica; Mascia, Daniele; Orlando, Valentina; Cicchetti, Americo",,,Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review,VALUE IN HEALTH,,,English,Review,,,,,,economic evaluation; model based economic evaluation; review; trial-based economic evaluation,COST-EFFECTIVENESS ANALYSIS; RANDOMIZED CLINICAL-TRIAL; PERCUTANEOUS RADIOFREQUENCY ABLATION; HELICOBACTER-PYLORI ERADICATION; LIFE-STYLE INTERVENTION; CORONARY-HEART-DISEASE; TOTAL HIP-REPLACEMENT; HEPATOCELLULAR-CARCINOMA; VENOUS THROMBOEMBOLISM; HEPATITIS-C,"Objectives: To assess the methodological quality of Italian health economic evaluations and their generalizability or transferability to different settings. Methods: A literature search was performed on the PubMed search engine to identify trial based, nonexperimental prospective studies or model-based full economic evaluations carried out in Italy from 1995 to 2013. The studies were randomly assigned to four reviewers who applied a detailed checklist to assess the generalizability and quality of reporting. The review process followed a three-step blinded procedure. The reviewers who carried out the data extraction were blind as to the name of the author(s) of each study. Second, after the first review, articles were reassigned through a second blind randomization to a second reviewer. Finally, any disagreement between the first two reviewers was solved by a senior researcher. Results: One hundred fifty-one economic evaluations eventually met the inclusion criteria. Over time, we observed an increasing transparency in methods and a greater generalizability of results, along with a wider and more representative sample in trials and a larger adoption of transition-Markov models. However, often context specific economic evaluations are carried out and not enough effort is made to ensure the transferability of their results to other contexts. In recent studies, cost-effectiveness analyses and the use of incremental cost-effectiveness ratio were preferred. Conclusions: Despite a quite positive temporal trend, generalizability of results still appears as an unsolved question, even if some indication of improvement within Italian studies has been observed. (C) 2015 Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research (ISPOR).","[Ruggeri, Matteo; Coretti, Silvia; Codella, Paola; Iacopino, Valentina; Romano, Federica; Mascia, Daniele; Cicchetti, Americo] Univ Cattolica Sacro Cuore, Postgrad Sch Hlth Econ & Management ALTEMS, I-00168 Rome, Italy; [Manca, Andrea] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Orlando, Valentina] Univ Naples Federico II, Ctr Pharmacoecon, Interdept Res Ctr PharmacoEcon & Drug Utilizat CI, Naples, Italy",Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of York - UK; University of Naples Federico II,"Coretti, S (通讯作者)，Univ Cattolica Sacro Cuore, Sch Econ, Francesco Vito Sq, I-00168 Rome, Italy.",silvia.coretti@rm.unicatt.it,"Ruggeri, Mirella/E-6091-2010; Mascia, Daniele/AAB-9384-2022; Orlando, Valentina/AAD-1791-2019; Cicchetti, Americo/AAP-9403-2021","Mascia, Daniele/0000-0002-9255-3520; Orlando, Valentina/0000-0002-8209-8878; ruggeri, matteo/0000-0002-5703-7424; Cicchetti, Americo/0000-0002-4633-9195",,,,,164,13,13,2,12,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUL,2015,18.0,5.0,,,,,709,720,,10.1016/j.jval.2015.03.1795,0.0,,,12,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CP7VR,26297100.0,hybrid,,,2024-03-09,WOS:000360097700021,0
J,"Basch, E; Spertus, J; Dudley, RA; Wu, A; Chuahan, C; Cohen, P; Smith, ML; Black, N; Crawford, A; Christensen, K; Blake, K; Goertz, C",,,,"Basch, Ethan; Spertus, John; Dudley, R. Adams; Wu, Albert; Chuahan, Cynthia; Cohen, Perry; Smith, Mary Lou; Black, Nick; Crawford, Amaris; Christensen, Ken; Blake, Kathleen; Goertz, Christine",,,Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs),VALUE IN HEALTH,,,English,Article,,,,,,patient-reported outcome; performance measurement; PRO-PM; quality,QUALITY-OF-LIFE; TASK-FORCE; CARE; RECOMMENDATIONS; COMMUNICATION; IMPACT,"Objective: To recommend methods for assessing quality of care via patient-reported outcome-based performance measures (PRO-PMs) of symptoms, functional status, and quality of life. Methods: A Technical Expert Panel was assembled by the American Medical Association-convened Physician Consortium for Performance Improvement. An environmental scan and structured literature review were conducted to identify quality programs that integrate PRO-PMs. Key methodological considerations in the design, implementation, and analysis of these PRO PM data were systematically identified. Recommended methods for addressing each identified consideration were developed on the basis of published patient-reported outcome (PRO) standards and refined through public comment. Literature review focused on programs using PROs to assess performance and on PRO guidance documents. Results: Thirteen PRO programs and 10 guidance documents were identified. Nine best practices were developed, including the following: provide a rationale for measuring the outcome and for using a PRO PM; describe the context of use; select a measure that is meaningful to patients with adequate psychometric properties; provide evidence of the measure's sensitivity to differences in care; address missing data and risk adjustment; and provide a framework for implementation, interpretation, dissemination, and continuous refinement. Conclusion: methods for integrating PROs into performance measurement are available.","[Basch, Ethan] Univ N Carolina, Chapel Hill, NC 27599 USA; [Spertus, John] Univ Missouri, Kansas City, MO 64110 USA; [Dudley, R. Adams] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Wu, Albert] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Chuahan, Cynthia] Mayo Clin, Rochester, MN USA; [Cohen, Perry] Parkinson Pipeline Project, Washington, DC USA; [Smith, Mary Lou] Res Advocacy Network, Plano, TX USA; [Black, Nick] London Sch Hyg & Trop Med, London WC1, England; [Crawford, Amaris; Christensen, Ken; Blake, Kathleen] Amer Med Assoc, Chicago, IL 60610 USA; [Goertz, Christine] Palmer Coll Chiropract W, Davenport, IA USA",University of North Carolina; University of North Carolina Chapel Hill; University of Missouri System; University of Missouri Kansas City; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine; American Medical Association,"Basch, E (通讯作者)，Univ N Carolina, Canc Outcomes Res Program, 170 Manning Dr, Chapel Hill, NC 27599 USA.",ebasch@med.unc.edu,"Spertus, John/ABD-3075-2021; Wu, Albert/AAJ-4780-2021; Goertz, Christine/HJZ-4370-2023","Wu, Albert/0000-0001-6189-7120; Spertus, John/0000-0002-2839-2611; King, Tekisha/0000-0002-3122-6323",,,,,57,91,95,0,21,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUN,2015,18.0,4.0,,,,,493,504,,10.1016/j.jval.2015.02.018,0.0,,,12,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CK6SQ,26091604.0,"Green Published, hybrid",,,2024-03-09,WOS:000356358600017,0
J,"Berg, J; Lindgren, P; Mejhert, M; Edner, M; Dahlström, U; Kahan, T",,,,"Berg, Jenny; Lindgren, Peter; Mejhert, Marit; Edner, Magnus; Dahlstrom, Ulf; Kahan, Thomas",,,Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry,VALUE IN HEALTH,,,English,Article,,,,,,chronic heart failure; EQ-5D; value set; utilities,QUALITY-OF-LIFE; IMPORTANT DIFFERENCE; HEALTH STATES; DISEASE; EQ-5D; CARE; EPIDEMIOLOGY; APPROPRIATE; PREDICTORS; MORTALITY,"Background: There is limited information on drivers of utilities in patients with chronic heart failure (CHF). Objectives: To analyze determinants of utility in CHF and drivers of change over 1 year in a large sample from clinical practice. Methods: We included 5334 patients from the Swedish Heart Failure Registry with EuroQol five-dimensional questionnaire information available following inpatient or outpatient care during 2008 to 2010; 3495 had 1-year follow-up data Utilities based on Swedish and UK value sets were derived. We applied ordinary least squares (OLS) and two-part models for utility at inclusion and OLS regression for change over 1 year, all with robust standard errors. We assessed the predictive accuracy of both models using cross-validation. Results: Patients' mean age was 73 years, 65% were men, 19% had a left ventricular ejection fraction of 50% or more, 23% had 40% to 49%, 27% had 30% to 39%, and 31% had less than 30%. For both models and value sets, utility at inclusion was affected by sex, age, New York Heart Association class, ejection fraction, hemoglobin, blood pressure, lung disease, diabetes, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, nitrates, antiplatelets, and diuretics. The OLS model performed slightly better than did the two-part model on a population level and for capturing utility ranges. Change in utility over 1 year was influenced by age, sex, and (measured at inclusion) disease duration, New York Heart Association class, blood pressure, ischemic heart disease, lung disease, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and antiplatelets. Conclusions: Utilities in CHF and their change over time are influenced by diverse demographic and clinical factors. Our findings can be used to target clinical interventions and for economic evaluations of new therapies.","[Berg, Jenny] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, Solna, Sweden; [Berg, Jenny] OptumInsight, Stockholm, Sweden; [Lindgren, Peter] Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Solna, Sweden; [Lindgren, Peter] IVBAR, Stockholm, Sweden; [Mejhert, Marit] Ersta Hosp, Dept Med, Stockholm, Sweden; [Mejhert, Marit] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Edner, Magnus] Karolinska Univ Hosp, Karolinska Inst, Heart Res Unit, Solna, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden",Karolinska Institutet; Optum; Karolinska Institutet; Ersta Sjukhus; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University,"Berg, J (通讯作者)，Karolinska Inst, Inst Environm Med, Box 210, SE-17177 Stockholm, Sweden.",jenny.berg@ki.se,"Francolini, Iolanda/I-3025-2019; Kahan, Thomas/CAE-8515-2022; Lindgren, Peter/AID-5379-2022","Francolini, Iolanda/0000-0002-0180-2334; Lindgren, Peter/0000-0002-8238-8189",,,,,39,24,25,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUN,2015,18.0,4.0,,,,,439,448,,10.1016/j.jval.2015.02.003,0.0,,,10,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CK6SQ,26091598.0,hybrid,,,2024-03-09,WOS:000356358600011,0
J,"al Jumah, KA; Hassali, AA",,,,"al Jumah, K. A.; Hassali, A. A.",,,DEVELOPMENT AND VALIDATION OF PATIENT DECISION AID REGARDING ANTIDEPRESANT MEDICATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[al Jumah, K. A.] MOH, Riyadh, Saudi Arabia; [Hassali, A. A.] Univ Sains Malaysia, George Town, Malaysia",Universiti Sains Malaysia,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS78,A260,A260,,10.1016/j.jval.2015.03.1517,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504198,0
J,"Alkelya, M; Alenezi, MG; Alsultan, MM; AlJeraisy, M",,,,"Alkelya, M.; Alenezi, M. G.; Alsultan, M. M.; AlJeraisy, M.",,,THE CHARACTERISTICS OF PHARMACY AND THERAPEUTIC COMMITTEES IN SAUDI HOSPITALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alkelya, M.] KAIMRC, Ryiadh, Saudi Arabia; [Alenezi, M. G.; Alsultan, M. M.] King Saud Univ, Riyadh, Saudi Arabia; [AlJeraisy, M.] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Ryiadh, Saudi Arabia",King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud University; King Saud Bin Abdulaziz University for Health Sciences,,,"Aljeraisy, Majed/ABD-5228-2021; alkelya, Mohamed a/F-5137-2012; Alkelya, Mohamed/B-1732-2017","Aljeraisy, Majed/0000-0001-9787-6815; Alkelya, Mohamed/0000-0002-9431-3280",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP23,A74,A74,,10.1016/j.jval.2015.03.433,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498501107,0
J,"Allaert, F; Quantin, C; Benzenine, M",,,,"Allaert, F.; Quantin, C.; Benzenine, M.",,,VENOUS THROMBOEMBOLISM PREVALENCE IN FRENCH AND US HOSPITALS: COMPARISON ON THE BASIS OF THE NATIONAL DATA BASES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Allaert, F.] Med Evaluat Chair ESC Dijon, Dijon, France; [Quantin, C.; Benzenine, M.] Univ Hosp Dijon, Dijon, France",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV34,A135,A135,,10.1016/j.jval.2015.03.787,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502128,0
J,"Alzarea, AI; Alharbi, A; Algarni, M; Seoane-Vazquez, E; Rodriguez-Monguio, R",,,,"Alzarea, A., I; Alharbi, A.; Algarni, M.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.",,,COMPARATIVE ANALYSIS OF HIV ANTIRETROVIRAL DRUGS APROVALS AND PRICES IN THE US AND SAUDI ARABIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alzarea, A., I; Alharbi, A.; Algarni, M.; Seoane-Vazquez, E.] MCPHS Univ, Boston, MA USA; [Rodriguez-Monguio, R.] Univ Massachusetts, Amherst, MA 01003 USA",University of Massachusetts System; University of Massachusetts Amherst,,,"Alzarea, Abdulaziz I./AAE-8140-2019","Alzarea, Abdulaziz I./0000-0003-0604-6299",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN35,A234,A234,,10.1016/j.jval.2015.03.1359,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504051,0
J,"Ariza, SAS",,,,"Ariza, Saenz S. A.",,,TIME AND MOTION STUDY FOR RITUXIMAB SC VS IV IN COLOMBIAN PATIENTS WITH NON-HODGKIN LYMPHOMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ariza, Saenz S. A.] Productos Roche, Bogota, Colombia",,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN103,A207,A207,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498503216,0
J,"Baser, O; Kariburyo, MF; Du, J; Xie, L",,,,"Baser, O.; Kariburyo, M. F.; Du, J.; Xie, L.",,,COMPARING HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG SCHIZOPHRENIC PATIENTS WHO INITIATED TYPICAL VS. ATYPICAL LONG-ACTING INJECTABLES IN THE US VETERAN POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Baser, O.] MEF Univ, Univ Michigan, STATinMED Res, Ann Arbor, MI USA; [Kariburyo, M. F.; Du, J.; Xie, L.] STATinMED Res, Ann Arbor, MI USA",University of Michigan System; University of Michigan; MEF Universitesi,,,"Library, MEF/O-1457-2019; Xie, Lin/AAX-2889-2020",,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH26,A119,A119,,10.1016/j.jval.2015.03.698,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,"hybrid, Green Submitted",,,2024-03-09,WOS:000354498502041,0
J,"Belk, K; Craver, C",,,,"Belk, K.; Craver, C.",,,ASSESSING THE BURDEN OF ILLNESS AND HOSPITAL UTILIZATION OF POLYCEMIA VERA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Belk, K.] MedAssets, Mooresville, NC USA; [Craver, C.] MedAssets, Huntersville, NC USA",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN102,A207,A207,,10.1016/j.jval.2015.03.1199,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503215,0
J,"Doshi, JA; Li, P; Yu, X; Dahodwala, NA; Chahin, S",,,,"Doshi, J. A.; Li, P.; Yu, X.; Dahodwala, N. A.; Chahin, S.",,,SPECIALTY TIER COST SHARING AND USE OF DISEASE MODIFYING THERAPIES AMONG MEDICARE BENEFICIARIES WITH MULTIPLE SCLEROSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Doshi, J. A.; Li, P.; Yu, X.; Dahodwala, N. A.] Univ Penn, Philadelphia, PA 19104 USA; [Chahin, S.] Univ Penn Hlth Syst, Philadelphia, PA USA",University of Pennsylvania; University of Pennsylvania,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PND67,A289,A289,,10.1016/j.jval.2015.03.1687,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505042,0
J,"Eichmann, F; Klamert, A; Potthoff, P; Kanitscheider, C",,,,"Eichmann, F.; Klamert, A.; Potthoff, P.; Kanitscheider, C.",,,"SAMPLE STRUCTURE IN A PROSPECTIVE STUDY OF 22,000 WOMEN USING HORMONE REPLACEMENT THERAPY (HRT) RETAINED UNBIASED AFTER A FIVE-YEAR FOLLOW-UP",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Eichmann, F.; Klamert, A.; Potthoff, P.; Kanitscheider, C.] Kantar Hlth Germany, Munich, Germany",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH4,A104,A104,,10.1016/j.jval.2015.03.610,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501275,0
J,"Epstein, AJ; Barry, CL; Fiellin, DA; Busch, SH",,,,"Epstein, A. J.; Barry, C. L.; Fiellin, D. A.; Busch, S. H.",,,PATIENT VALUATION OF DIFFERENT APPROACHES TO MENTAL HEALTH AND SUBSTANCE USE DISORDER TREATMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Epstein, A. J.] Univ Penn, Philadelphia, PA 19104 USA; [Barry, C. L.] Johns Hopkins Univ, Baltimore, MD USA; [Fiellin, D. A.; Busch, S. H.] Yale Univ, New Haven, CT USA",University of Pennsylvania; Johns Hopkins University; Yale University,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS176,A277,A277,,10.1016/j.jval.2015.03.1616,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504288,0
J,"Ezenduka, CC",,,,"Ezenduka, C. C.",,,TREATMENT COSTS FOR UNCOMPLICATED MALARIA AT A SECONDARY HEALTH CARE FACILITY IN NIGERIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ezenduka, C. C.] Nnamdi Azikiwe Univ, Awka, Nigeria",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN47,A236,A236,,10.1016/j.jval.2015.03.1371,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504062,0
J,"Fanourgiakis, JA; Simantirakis, E; Kanoupakis, E; Chrysostomakis, S; Maniadakis, N; Kourlamba, G; Vardas, P",,,,"Fanourgiakis, J. A.; Simantirakis, E.; Kanoupakis, E.; Chrysostomakis, S.; Maniadakis, N.; Kourlamba, G.; Vardas, P.",,,ANNUAL MEDICATION COST ATTRIBUTED TO EACH KIND OF TREATMENT OF PATIENTS SUBJECTED TO CRMDS IMPLANTATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fanourgiakis, J. A.] Heraklion Univ Hosp, Dept Cardiol, Iraklion, Greece; [Fanourgiakis, J. A.] TEI Heraklion, Sch Econ & Management, Dept Accounting & Finance, Iraklion, Greece; [Fanourgiakis, J. A.] TEI Agios Nikolaos, Dept Business Adm, Iraklion, Greece; [Simantirakis, E.; Kanoupakis, E.; Chrysostomakis, S.; Vardas, P.] Heraklion Univ Hosp, Dept Cardiol, Iraklion, Greece; [Maniadakis, N.; Kourlamba, G.] Natl Sch Publ Hlth, Dept Hlth Serv Management, Athens, Greece",University Hospital of Heraklion; Hellenic Mediterranean University; University Hospital of Heraklion; National & Kapodistrian University of Athens,,,"Vardas, Panos/AAD-5219-2022; Maniadakis, Nikos/AAZ-6794-2021; vardas, panos/ABF-7144-2020; Chrysostomakis, Stavros/AAV-3536-2020; Vardas, Panos/AAP-5694-2021","Fanourgiakis, John/0000-0001-5364-7412",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV62,A140,A140,,10.1016/j.jval.2015.03.815,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502155,0
J,"Foos, V; Lamotte, M; McEwan, P",,,,"Foos, V; Lamotte, M.; McEwan, P.",,,"CONTRASTING THE RELATIVE RISK REDUCTION OF CARDIOVASCULAR EVENTS IN THE CORE DIABETES MODEL ASSOCIATED WITH SINGLE RISK FACTOR CHANGES ACROSS ALTERNATIVE RISK ENGINES: UKPDS68, UKPDS82 AND SWEDISH NATIONAL DIABETES REGISTRY EQUATIONS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Foos, V] IMS Hlth, Basel, Switzerland; [Lamotte, M.] IMS Hlth Consulting, Brussels, Belgium; [McEwan, P.] Hlth Econ & Outcomes Res Ltd, Monmouth, Mons, Wales",Health Economics & Outcomes Research Ltd,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM73,A22,A23,,10.1016/j.jval.2015.03.139,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500115,0
J,"Foxon, G; Fox, G; Craddy, P",,,,"Foxon, G.; Fox, G.; Craddy, P.",,,ARE EU PAYERS ADAPTING BIOSIMILAR PRICING AND REIMBURSEMENT APPROVAL PROCESSES TO OPTIMIZE HEALTHCARE SAVINGS?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Foxon, G.; Fox, G.] Remap Consulting, Alderley Edge, Cheshire, England; [Craddy, P.] Remap Consulting, Bern, Switzerland",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP106,A88,A88,,10.1016/j.jval.2015.03.516,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501186,0
J,"Fujii, RK; Restrepo, M; Fernandes, RA; Haas, L; Pepe, C; Junqueira, M",,,,"Fujii, R. K.; Restrepo, M.; Fernandes, R. A.; Haas, L.; Pepe, C.; Junqueira, M.",,,"COST-EFFECTIVENESS ANA LYSIS AND BUDGET IMPACT OF AN EXTENDED VERSUS IMMEDIATE RELEASE FORMULATION OF METFORMIN IN TYPE-2 DIABETES MELLITUS TREATMENT, FROM THE PERSPECTIVE OF THE BRAZILIAN PUBLIC HEALTH SYSTEM",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fujii, R. K.; Junqueira, M.] Merck Serono, Sao Paulo, Brazil; [Restrepo, M.] Merck Serono, Bogota, Colombia; [Fernandes, R. A.; Haas, L.] Grp Resulta, Sao Paulo, Brazil; [Pepe, C.] NewBD Medinsight Grp Resulta, Sao Paulo, Brazil",,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB36,A59,A59,,10.1016/j.jval.2015.03.343,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501022,0
J,"Harless, P",,,,"Harless, Patrick",,,Solidarity with respect to small changes in preferences in public good economies with single-peaked preferences,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,STRATEGY-PROOFNESS; SOCIAL-WELFARE; EGALITARIANISM; REPLACEMENT; SUFFICIENT,"We study the problem of choosing a point on an interval when agents have single-peaked preferences. Our primary concern is solidarity: When the environment changes, agents should gain or lose together. Welfare dominance under preference replacement requires this conclusion when the preferences of one agent change. Instead of requiring solidarity for all possible changes in preferences, we introduce a parameterized solidarity property, epsilon-welfare dominance, which requires the conclusion of welfare dominance only for arbitrarily small changes in preferences. In this model, welfare dominance and efficiency characterize a class of target rules, each of which selects the efficient point nearest to its target (Thomson, 1993). Although our property is weaker than and distinct from welfare dominance, it also characterizes the target rules when combined with efficiency. (C) 2015 Elsevier B.V. All rights reserved.","Univ Rochester, Dept Econ, Rochester, NY 14627 USA",University of Rochester,"Harless, P (通讯作者)，Univ Rochester, Dept Econ, Rochester, NY 14627 USA.",pdharless@gmail.com,,"Harless, Patrick/0000-0002-1981-478X",,,,,17,3,3,0,6,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,MAY,2015,75.0,,,,,,81,86,,10.1016/j.mathsocsci.2015.02.006,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CI8TH,,,,,2024-03-09,WOS:000355044100007,0
J,"Hatfield, MD; Fleming, ML",,,,"Hatfield, M. D.; Fleming, M. L.",,,USE OF HYDROCODONE/ACETAMINOPHEN: PREVALENCE AND ESTIMATING EMERGENCY DEPARTMENT VISITS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hatfield, M. D.; Fleming, M. L.] Univ Houston, Houston, TX USA",University of Houston System; University of Houston,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PSY15,A294,A294,,10.1016/j.jval.2015.03.1713,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505067,0
J,"Hsiao, C; Clymer, JW; Cheng, H",,,,"Hsiao, C.; Clymer, J. W.; Cheng, H.",,,ECONOMIC IMPACT OF USING HARMONIC SCALPEL TECHNOLOGY IN SURGERY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hsiao, C.; Clymer, J. W.; Cheng, H.] Ethicon Inc, Cincinnati, OH USA",,,,"Clymer, Jeffrey/AAO-5504-2021",,,,,,0,1,1,1,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD78,A51,A51,,10.1016/j.jval.2015.03.302,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498500273,0
J,"Iqbal, MS; Iqbal, MZ; Iqbal, MW; Bahari, MB; Nasir, S",,,,"Iqbal, M. S.; Iqbal, M. Z.; Iqbal, M. W.; Bahari, M. B.; Nasir, S.",,,"IMPACT OF PHARMACISTS-LED INTERVENTIONS TO ASSESS KNOWLEDGE, ATTITUDE AND PERCEPTION AMONG TUBERCULOSIS PATIENTS IN PAKISTAN: AN INSIGHT FROM A RANDOMIZED CONTROLLED NON CLINICAL TRIAL",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Iqbal, M. S.] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Iqbal, M. S.; Iqbal, M. Z.; Bahari, M. B.] AIMST Univ, Dept Clin Pharm & Pharm Practice, Fac Pharm, Kedah, Malaysia; [Iqbal, M. Z.] Univ Sains Malaysia, Dept Clin Pharm, Sch Pharmaceut Sci, George Town, Malaysia; [Iqbal, M. W.] Univ Malaya, Fac Law, Kualalumpur, Malaysia; [Nasir, S.] Nishtar Hosp, Multan, Pakistan",Bahauddin Zakariya University; AIMST University; Universiti Sains Malaysia; Universiti Malaya,,,"Haseeb, Abdul/T-7419-2017; Iqbal, Muhammad Waqas/GWV-3185-2022; Iqbal, M. Javaid/AAN-8624-2021; Iqbal, Muhammad/HJH-2369-2023","Haseeb, Abdul/0000-0003-2455-5054; Iqbal, Muhammad Waqas/0000-0003-2465-8862; Iqbal, M. Javaid/0000-0001-6073-3052;",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS36,A175,A175,,10.1016/j.jval.2015.03.1014,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498503043,0
J,"Ji, X; Liu, S; Solem, CT; Shelbaya, A; Walker, C; Cappelleri, JC; Gao, X; Stephens, JM",,,,"Ji, X.; Liu, S.; Solem, C. T.; Shelbaya, A.; Walker, C.; Cappelleri, J. C.; Gao, X.; Stephens, J. M.",,,Generic Switch Evaluation of Celebrex In Patients With Osteoarthritis (OA) Using A Retrospective Claims Database,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ji, X.; Liu, S.; Solem, C. T.; Gao, X.; Stephens, J. M.] Pharmerit Int, Bethesda, MD USA; [Shelbaya, A.] Pfizer Inc, New York, NY USA; [Walker, C.] Pfizer Inc, Tadworth, Surrey, England; [Cappelleri, J. C.] Pfizer Inc, Groton, CT 06340 USA",Pharmerit North America LLC; Pfizer; Pfizer; Pfizer,,,"Gao, Xin/D-5487-2013",,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS31,A158,A158,,10.1016/j.jval.2015.03.916,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502252,0
J,"Knight, JM; Campbell, DJ; Meyer, KL; Clark, RS",,,,"Knight, J. M.; Campbell, D. J.; Meyer, K. L.; Clark, R. S.",,,ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT REQUIREMENTS IN 7 ASIA OCEANIA COUNTRIES/REGIONS: COMPARISON OF EVIDENTIARY REQUIREMENTS FOR STANDARD AND ORPHAN DRUGS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Knight, J. M.; Campbell, D. J.; Meyer, K. L.; Clark, R. S.] Xcenda, Palm Harbor, FL USA","AmerisourceBergen Corporation; Xcenda, LLC",,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP143,A94,A94,,10.1016/j.jval.2015.03.553,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501221,0
J,"Lefebvre, P; Pilon, D; Robitaille, M; Lafeuille, M; Chow, W; Pfeifer, M; Duh, MS",,,,"Lefebvre, P.; Pilon, D.; Robitaille, M.; Lafeuille, M.; Chow, W.; Pfeifer, M.; Duh, M. S.",,,GLYCATED HEMOGLOBIN (HBA1C) CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) TREATED WITH CANAGLIFLOZIN IN A REAL-WORLD SETTING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lefebvre, P.; Robitaille, M.; Lafeuille, M.] ItA E, Grp Anal, Montreal, PQ, Canada; [Pilon, D.] LtA E, Grp Anal, Montreal, PQ, Canada; [Chow, W.; Pfeifer, M.] Janssen Sci Affairs LLC, Raritan, NJ USA; [Duh, M. S.] Anal Grp Inc, Boston, MA USA",Johnson & Johnson; Janssen Pharmaceuticals; Analysis Group Inc.,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB27,A57,A57,,10.1016/j.jval.2015.03.334,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501014,0
J,"Legesse, B; Shewamene, Z",,,,"Legesse, B.; Shewamene, Z.",,,TRADITIONAL MEDICINE USE AND ITS IMPACT ON ANTIRETROVIRAL THERAPY ADHERENCE AMONG HIV PATIENTS IN ETHIOPIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Legesse, B.] Karolinska Inst, Stockholm, Sweden; [Shewamene, Z.] Univ Gondar, Gondar, Ethiopia",Karolinska Institutet; University of Gondar,,,"Wubishet, Befikadu/AAI-6038-2020","Wubishet, Befikadu/0000-0001-9896-8893; Sabe, Zewdneh Shewamene/0000-0003-1490-9672",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN80,A241,A241,,10.1016/j.jval.2015.03.1404,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504092,0
J,"Lin, I; Sung, JC; Sanchez, R; Mallya, UG; Friedman, M; Panaccio, M; Koren, A; Neumann, PJ; Menzin, J",,,,"Lin, I; Sung, J. C.; Sanchez, R.; Mallya, U. G.; Friedman, M.; Panaccio, M.; Koren, A.; Neumann, P. J.; Menzin, J.",,,REAL-WORLD STATIN UTILIZATION AMONG PATIENTS AT HIGH RISK FOR CARDIOVASCULAR EVENTS: US ANALYSES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lin, I; Friedman, M.; Menzin, J.] Boston Hlth Econ Inc, Waltham, MA USA; [Sung, J. C.; Mallya, U. G.; Panaccio, M.; Koren, A.] Sanofi US Inc, Bridgewater, NJ USA; [Sanchez, R.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Neumann, P. J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA","Boston Health Economics, Inc.; Sanofi-Aventis; Regeneron; Tufts Medical Center",,,"Panaccio, Mary/HTT-4920-2023",,,,,,0,0,0,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV129,A152,A152,,10.1016/j.jval.2015.03.882,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498502219,0
J,"Lionnet, L; Fader, A",,,,"Lionnet, L.; Fader, A.",,,AN ANALYSIS OF WARNING LETTERS ISSUED TO PHARMACEUTICAL COMPANIES REGARDING MISLEADING HEALTH OUTCOMES CLAIMS 2009-2013,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lionnet, L.; Fader, A.] MedVal Sci Informat Serv, Skillman, NJ USA",,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP34,A76,A76,,10.1016/j.jval.2015.03.444,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501118,0
J,"Liu, Y; Ren, X",,,,"Liu, Y.; Ren, X.",,,THE FINANCIAL IMPACT OF BLOOD SPECIMEN REJECTION DUE TO THE POOR PRE-ANALYTICAL QUALITY IN HEALTHCARE FACILITY IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Liu, Y.] Shenyang Pharmaceut Univ, Shenyang, Peoples R China; [Ren, X.] BD China, Shanghai, Peoples R China",Shenyang Pharmaceutical University,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP74,A83,A83,,10.1016/j.jval.2015.03.484,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501155,0
J,"Moore, R; Lewis, C",,,,"Moore, R.; Lewis, C.",,,REIMBURSMENT AND PRESCRIBING IN EXCHANGE-BASED PLANS: HOW DOES FORMULARY GENEROSITY DIFFER FROM COMMERCIAL PLANS AND IS INDICATION A KEY FACTOR?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Moore, R.; Lewis, C.] Decis Resources Grp, Nashville, TN USA",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS50,A178,A178,,10.1016/j.jval.2015.03.1028,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503057,0
J,"Muñoz-Galindo, IM; Moreno, JA; Guarin, NE; Diaz, JA; Arevalo, HO",,,,"Munoz-Galindo, I. M.; Moreno, J. A.; Guarin, N. E.; Diaz, J. A.; Arevalo, H. O.",,,"DIRECT COSTS OF HEALTHCARE OF MULTIPLE SCLEROSIS, THE CASE OF A HEALTH MANTEINANCE ORGANIZATION IN COLOMBIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Munoz-Galindo, I. M.; Moreno, J. A.; Guarin, N. E.; Arevalo, H. O.] Salud Total EPS, Bogota, Colombia; [Diaz, J. A.] Univ Nacl Colombia, Bogota, Colombia",Total SA; Universidad Nacional de Colombia,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS34,A253,A253,,10.1016/j.jval.2015.03.1473,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504157,0
J,"Nazarian, S; Reynolds, MR; Ryan, MP; Wolff, SD; Mollenkopf, S; Turakhia, MP",,,,"Nazarian, S.; Reynolds, M. R.; Ryan, M. P.; Wolff, S. D.; Mollenkopf, S.; Turakhia, M. P.",,,EVIDENCE OF A GAP IN CARE: UTILIZATION OF RADIOLOGIC DIAGNOSTIC IMAGING IN PATIENTS WITH AND WITHOUT IMPLANTABLE DEFIBRILLATORS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nazarian, S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Reynolds, M. R.] Harvard Clin Res Inst, Boston, MA USA; [Ryan, M. P.] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA; [Wolff, S. D.] Carnegie Hill Radiol, New York, NY USA; [Mollenkopf, S.] Medtronic Inc, Mounds View, MN USA; [Turakhia, M. P.] Stanford Univ, Stanford, CA 94305 USA",Johns Hopkins University; Harvard University; Harvard Medical School; Medtronic; Stanford University,,,,"Turakhia, Minang/0000-0001-8025-0904",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD55,A47,A47,,10.1016/j.jval.2015.03.279,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498500250,0
J,"Ng-Mak, DS; Brook, RA; Rajagopalan, K; Taitel, MS; Lou, Y; Loebel, A",,,,"Ng-Mak, D. S.; Brook, R. A.; Rajagopalan, K.; Taitel, M. S.; Lou, Y.; Loebel, A.",,,COMPARATIVE ANALYSIS OF PRESCRIPTION UTILIZATION AND COSTS OF LURASIDONE AND ARIPIPRAZOLE: A PHARMACY-DATABASE STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ng-Mak, D. S.; Rajagopalan, K.] Sunov Pharmaceut Inc, Marlborough, MA USA; [Brook, R. A.] Better Hlth Worldwide, Newfoundland, NJ USA; [Taitel, M. S.; Lou, Y.] Walgreen Co, Deerfield, IL USA; [Loebel, A.] Sunov Pharmaceut Inc, Ft Lee, NJ USA",Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.; Dainippon Sumitomo Pharmaceutical Company; Sunovion Pharmaceuticals Inc.,,,"Taitel, Michael/AAR-5837-2021; Brook, Richard A/A-8010-2009",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH22,A118,A118,,10.1016/j.jval.2015.03.694,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502037,0
J,"Nsiah-Boateng, E",,,,"Nsiah-Boateng, E.",,,REDUCING MATERNAL AND CHILD MORTALITY IN GHANA: IS NATIONAL HEALTH INSURANCE SCHEME'S FREE MATERNAL CARE PROGRAMME HELPING?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nsiah-Boateng, E.] Natl Hlth Insurance Author, Accra, Ghana",,,,"Nsiah-Boateng, Eric/I-7095-2019","Nsiah-Boateng, Eric/0000-0001-5217-9805",,,,,0,1,2,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS117,A267,A267,,10.1016/j.jval.2015.03.1556,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504235,0
J,"Otsu, T; Xu, KL; Matsushita, Y",,,,"Otsu, Taisuke; Xu, Ke-Li; Matsushita, Yukitoshi",,,Empirical likelihood for regression discontinuity design,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Empirical likelihood; Nonparametric methods; Regression discontinuity design; Treatment effect; Bartlett correction,CONFIDENCE-INTERVALS; IDENTIFICATION; STATISTICS; SIZE; GMM,"This paper proposes empirical likelihood based inference methods for causal effects identified from regression discontinuity designs. We consider both the sharp and fuzzy regression discontinuity designs and treat the regression functions as nonparametric. The proposed inference procedures do not require asymptotic variance estimation and the confidence sets have natural shapes, unlike the conventional Wald-type method. These features are illustrated by simulations and an empirical example which evaluates the effect of class size on pupils' scholastic achievements. Furthermore, for the sharp regression discontinuity design, we show that the empirical likelihood statistic admits a higher-order refinement, so-called the Bartlett correction. Bandwidth selection methods are also discussed. (C) 2014 Elsevier B.V. All rights reserved.","[Otsu, Taisuke] Univ London London Sch Econ & Polit Sci, Dept Econ, London WC2A 2AE, England; [Xu, Ke-Li] Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA; [Matsushita, Yukitoshi] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 1528550, Japan",University of London; London School Economics & Political Science; Texas A&M University System; Texas A&M University College Station; Tokyo Institute of Technology,"Otsu, T (通讯作者)，Univ London London Sch Econ & Polit Sci, Dept Econ, Houghton St, London WC2A 2AE, England.",t.otsu@lse.ac.uk; keli.xu@econmail.tamu.edu,"Matsushita, Yukitoshi/B-8862-2015; Xu, Keli/ITU-4079-2023",,"National Science Foundation [SES-0720961]; University of Alberta School of Business through the Canadian utilities faculty award; Grants-in-Aid for Scientific Research [26780133, 24730191] Funding Source: KAKEN","National Science Foundation(National Science Foundation (NSF)); University of Alberta School of Business through the Canadian utilities faculty award; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","We would like to thank Li Gan, Timothy Gronberg, Hidehiko Ichimura, Susumu Imai, Steven Lehrer, Qi Li, James MacKinnon, Vadim Marmer, Thanasis Stengos, an associate editor, anonymous referees, and seminar participants at Queen's University, Texas A&M University, University of Guelph, University of Tokyo, SETA 2009 in Kyoto, and FEMES 2009 in Tokyo for helpful comments. Our research is supported by the National Science Foundation under SES-0720961 (Otsu) and University of Alberta School of Business through the Canadian utilities faculty award (Xu).",,31,16,21,7,47,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAY,2015,186.0,1.0,,,,,94,112,,10.1016/j.jeconom.2014.04.023,0.0,,,19,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CF6IY,,"Green Accepted, Green Submitted",,,2024-03-09,WOS:000352661600007,0
J,"Pasupathy, K; Sir, M",,,,"Pasupathy, K.; Sir, M.",,,NON-DISCRETIONARY INPUTS ARE IMPORTANT FACTORS IN HOSPITAL EFFICIENCY STUDIES AND POLICY EVALUATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pasupathy, K.; Sir, M.] Mayo Clin, Rochester, MN USA",Mayo Clinic,,,,,,,,,0,0,0,1,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM36,A16,A16,,10.1016/j.jval.2015.03.102,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500080,0
J,"Skovgaard, R; Ploug, UJ; Hunt, B; Valentine, WJ",,,,"Skovgaard, R.; Ploug, U. J.; Hunt, B.; Valentine, W. J.",,,EVALUATING THE COST OF BRINGING PEOPLE WITH TYPE 2 DIABETES MELLITUS TO MULTIPLE TARGETS OF TREATMENT IN CANADA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Skovgaard, R.] Novo Nordisk Canada Inc, Mississauga, ON, Canada; [Ploug, U. J.] Novo Nordisk AS SA, Borg, Denmark; [Hunt, B.; Valentine, W. J.] Ossian Hlth Econ & Commun, Basel, Switzerland",Novo Nordisk,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB59,A63,A63,,10.1016/j.jval.2015.03.366,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501044,0
J,"Tarr, A; Nguyen, H; Dufour, R; Bullano, M",,,,"Tarr, A.; Nguyen, H.; Dufour, R.; Bullano, M.",,,REAL-WORLD ADHERENCE IN MEDICARE PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOR EXENATIDE QW AND LIRAGLUTIDE QD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tarr, A.; Dufour, R.] Comprehens Hlth Insights Inc, Louisville, KY USA; [Nguyen, H.; Bullano, M.] AstraZeneca, Ft Washington, MD USA",AstraZeneca,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB26,A57,A57,,10.1016/j.jval.2015.03.333,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501013,0
J,"Troske, S; Freeman, PR; Goodin, AJ; Blumenschein, K; Talbert, J",,,,"Troske, S.; Freeman, P. R.; Goodin, A. J.; Blumenschein, K.; Talbert, J.",,,THE RELATIONSHIP BETWEEN PSEUDOEPHEDRINE SALES AND CLANDESTINE METHAMPHETAMINE LABS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Troske, S.; Freeman, P. R.; Goodin, A. J.; Blumenschein, K.; Talbert, J.] Univ Kentucky, Coll Pharm, Lexington, KY USA",University of Kentucky,,,"Goodin, Amie/Z-3189-2019; Talbert, Jeffery/F-3929-2011","Goodin, Amie/0000-0002-0020-8720; Talbert, Jeffery/0000-0002-4304-5167",,,,,0,0,0,0,11,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH56,A125,A125,,10.1016/j.jval.2015.03.728,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502071,0
J,"Udupa, N; Vohra, Y; Ahmed, Z; Lavu, A; Jain, P",,,,"Udupa, N.; Vohra, Y.; Ahmed, Z.; Lavu, A.; Jain, P.",,,GENERIC MEDICINES-PERCEPTIONS AND ATTITUDES OF FUTURE HEALTHCARE DECISION MAKERS IN SOUTHERN KARNATAKA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Udupa, N.; Jain, P.] Manipal Univ, Manipal, Karnataka, India; [Vohra, Y.; Ahmed, Z.; Lavu, A.] Manipal Coll Pharamaceut Sci, Manipal, Karnataka, India",Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE),,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP131,A92,A92,,10.1016/j.jval.2015.03.541,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501209,0
J,"Valenzuela-Lara, M; Magis-Rodríguez, CL; Bautista-Arredondo, S",,,,"Valenzuela-Lara, M.; Magis-Rodriguez, C. L.; Bautista-Arredondo, S.",,,ONCE-DAILY SINGLE-TABLET REGIMEN REDUCE LOSS TO FOLLOW-UP IN PEOPLE LIVING WITH HIV,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Valenzuela-Lara, M.; Magis-Rodriguez, C. L.] Natl Ctr Prevent & Control HIV & Aids Mexico CENS, Mexico City, DF, Mexico; [Bautista-Arredondo, S.] Natl Inst Publ Hlth Mexico INSP, Cuernavaca, Morelos, Mexico",Instituto Nacional de Salud Publica,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN28,A232,A232,,10.1016/j.jval.2015.03.1352,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498504044,0
J,"Vohra, R; Madhavan, SS; Sambamoorthi, U",,,,"Vohra, R.; Madhavan, S. S.; Sambamoorthi, U.",,,NATIONAL TRENDS AND CHARACTERISTICS OF PSYCHIATRIC ADMISSIONS IN US EMERGENCY DEPARTMENTS: 2006-2011,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vohra, R.; Madhavan, S. S.; Sambamoorthi, U.] W Virginia Univ, Morgantown, WV 26506 USA",West Virginia University,,,"Vohra, Rini/AAI-6406-2021",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS19,A250,A250,,10.1016/j.jval.2015.03.1458,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504143,0
J,[Anonymous],,,,[Anonymous],,,EDITORIAL STATEMENT ON NEGATIVE FINDINGS,HEALTH ECONOMICS,,,English,Editorial Material,,,,,,,,,,,,,,,,,,,0,3,3,0,2,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,MAY,2015,24.0,5.0,,,,,505,505,,10.1002/hec.3172,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CF5XT,25740415.0,,,,2024-03-09,WOS:000352631300001,0
J,"Hall, PG; Racine, JS",,,,"Hall, Peter G.; Racine, Jeffrey S.",,,Infinite order cross-validated local polynomial regression,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Model selection; Efficiency; Rates of convergence,EIGENVALUES,"Many practical problems require nonparametric estimates of regression functions, and local polynomial regression has emerged as a leading approach. In applied settings practitioners often adopt either the local constant or local linear variants, or choose the order of the local polynomial to be slightly greater than the order of the maximum derivative estimate required. But such ad hoc determination of the polynomial order may not be optimal in general, while the joint determination of the polynomial order and bandwidth presents some interesting theoretical and practical challenges. In this paper we propose a data-driven approach towards the joint determination of the polynomial order and bandwidth, provide theoretical underpinnings, and demonstrate that improvements in both finite-sample efficiency and rates of convergence can thereby be obtained. In the case where the true data generating process (DGP) is in fact a polynomial whose order does not depend on the sample size, our method is capable of attaining the rate often associated with correctly specified parametric models, while the estimator is shown to be uniformly consistent for a much larger class of DGPs. Theoretical underpinnings are provided and finite-sample properties are examined. (C) 2014 Elsevier B.V. All rights reserved.","[Hall, Peter G.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Racine, Jeffrey S.] McMaster Univ, Dept Econ, Grad Program Stat, Hamilton, ON, Canada",University of Melbourne; McMaster University,"Racine, JS (通讯作者)，McMaster Univ, Dept Econ, Grad Program Stat, Hamilton, ON, Canada.",racinej@mcmaster.ca,"Racine, Jeffrey/N-9476-2014","Racine, Jeffrey/0000-0002-5680-3705",Social Sciences and Humanities Research Council of Canada (SSHRC; Shared Hierarchical Academic Research Computing Network (SHARCNET); Division Of Mathematical Sciences; Direct For Mathematical & Physical Scien [1301377] Funding Source: National Science Foundation,Social Sciences and Humanities Research Council of Canada (SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Shared Hierarchical Academic Research Computing Network (SHARCNET); Division Of Mathematical Sciences; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)),"Racine would like to gratefully acknowledge support from the Social Sciences and Humanities Research Council of Canada (SSHRC: www.sshrc.ca), and the Shared Hierarchical Academic Research Computing Network (SHARCNET: www.sharcnet.ca).",,17,16,20,0,17,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,APR,2015,185.0,2.0,,,,,510,525,,10.1016/j.jeconom.2014.06.003,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CD0QH,,Green Submitted,,,2024-03-09,WOS:000350778500014,0
J,"Hellinger, FJ",,,,"Hellinger, Fred Joseph",,,Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Editorial Material,,,,,,,PREEXPOSURE PROPHYLAXIS; OUTCOMES; ERA,,"Agcy Healthcare Res & Qual, Rockville, MD 20850 USA",Agency for Healthcare Research & Quality,"Hellinger, FJ (通讯作者)，Agcy Healthcare Res & Qual, Rockville, MD 20850 USA.",fred.hellinger@ahrq.hhs.gov,,,,,,,19,0,0,0,2,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,APR,2015,13.0,2.0,,,,,129,133,,10.1007/s40258-015-0158-5,0.0,,,5,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CQ2YN,25724918.0,Bronze,,,2024-03-09,WOS:000360468600003,0
J,"Pechlivanoglou, P; Wieringa, JE; de Jager, T; Postma, MJ",,,,"Pechlivanoglou, Petros; Wieringa, Jaap E.; de Jager, Tim; Postma, Maarten J.",,,THE EFFECT OF FINANCIAL AND EDUCATIONAL INCENTIVES ON RATIONAL PRESCRIBING. A STATE-SPACE APPROACH,HEALTH ECONOMICS,,,English,Article,,,,,,financial incentives; health insurers; drug prescribing; the Netherlands; state space; time series; Kalman filter,GUIDELINE DISSEMINATION; EFFICIENCY; PERFORMANCE; MANAGEMENT; BEHAVIOR; POLICIES; EUROPE; PAY,"In 2005, a Dutch health insurer introduced a financial incentive directed to general practitioners to promote rational prescribing of statins and proton pump inhibitors (PPIs). Concomitantly, a regional institution that develops pharmacotherapeutic guidelines implemented two educational interventions also aiming at promoting rational statin and PPI prescribing. Utilizing a prescription database, we estimated the effect of the interventions on drug utilization and cost of statins and PPIs over time. We measured the effect of the interventions within an implementation and a control region. The implementation region included prescriptions from the province of Groningen where the educational intervention was implemented and where the health insurer is most active. The control region comprised all other provinces covered by the database. We modelled the effect of the intervention using a state-space approach. Significant differences in prescribing and cost patterns between regions were observed for statins and PPIs. These differences however were mostly related to the concurrent interventions of Proeftuin Farmacie Groningen. We found no evidence indicating a significant effect of the rational prescribing intervention on the prescription patterns of statins and PPIs. Our estimates on the economic impact of the Proeftuin Farmacie Groningen interventions indicate that educational activities as such can achieve significant cost savings. Copyright (C) 2014 John Wiley & Sons, Ltd.","[Pechlivanoglou, Petros; de Jager, Tim; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Pechlivanoglou, Petros] Univ Toronto, Toronto Hlth Econ & Technol Assessment Collaborat, Dept Pharm, Toronto, ON, Canada; [Wieringa, Jaap E.] Univ Groningen, Fac Econ & Business, Dept Mkt, Groningen, Netherlands",University of Groningen; University of Toronto; University of Groningen,"Pechlivanoglou, P (通讯作者)，Univ Toronto, Toronto Hlth Econ & Technol Assessment Collaborat, Dept Pharm, Toronto, ON, Canada.",petros.pechlivanoglou@theta.utoronto.ca,"Wieringa, Jaap/AAJ-4861-2021","Postma, Maarten/0000-0002-6306-3653",,,,,46,5,5,0,11,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,APR,2015,24.0,4.0,,,,,439,453,,10.1002/hec.3030,0.0,,,15,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD6DS,24519732.0,Green Published,,,2024-03-09,WOS:000351180300004,0
J,"Chang, JY; Chen, SX; Chen, XH",,,,"Chang, Jinyuan; Chen, Song Xi; Chen, Xiaohong",,,High dimensional generalized empirical likelihood for moment restrictions with dependent data,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Generalized empirical likelihood; High dimensionality; Penalized likelihood; Variable selection; Over-identification test; Weak dependence,CENTRAL-LIMIT-THEOREM; ESTIMATING EQUATIONS; VARIABLE SELECTION; SAMPLE PROPERTIES; MODELS; ESTIMATORS; GMM; CONVERGENCE; BOOTSTRAP,"This paper considers the maximum generalized empirical likelihood (GEL) estimation and inference on parameters identified by high dimensional moment restrictions with weakly dependent data when the dimensions of the moment restrictions and the parameters diverge along with the sample size. The consistency with rates and the asymptotic normality of the GEL estimator are obtained by properly restricting the growth rates of the dimensions of the parameters and the moment restrictions, as well as the degree of data dependence. It is shown that even in the high dimensional time series setting, the GEL ratio can still behave like a chi-square random variable asymptotically. A consistent test for the over-identification is proposed. A penalized GEL method is also provided for estimation under sparsity setting. (C) 2014 Elsevier B.V. All rights reserved.","[Chang, Jinyuan] Southwestern Univ Finance & Econ, Sch Stat, Chengdu 611130, Peoples R China; [Chang, Jinyuan] Univ Melbourne, Dept Math & Stat, Parkville, Vic 3010, Australia; [Chen, Song Xi] Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China; [Chen, Song Xi] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Chen, Xiaohong] Yale Univ, Dept Econ, New Haven, CT 06520 USA",Southwestern University of Finance & Economics - China; University of Melbourne; Peking University; Peking University; Yale University,"Chen, SX (通讯作者)，Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China.",csx@gsm.pku.edu.cn,"Chen, Song Xi/ABH-2789-2020; Chen, Song Xi/AAN-4984-2021; Chang, Jinyuan/C-4833-2014","Chen, Song Xi/0000-0002-2338-0873; Chang, Jinyuan/0000-0003-4633-587X; Chang, Jinyuan/0000-0001-7933-4449","National Natural Science Foundation of China [11131002, G0113]; Center for Statistical Science at Peking University; LMEQF at Peking University; Australian Research Council",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Statistical Science at Peking University; LMEQF at Peking University; Australian Research Council(Australian Research Council),"The authors are grateful to the co-editor Jianqing Fan, an Associate Editor, two anonymous referees and Qiwei Yao for constructive comments and suggestions. This work is based on part of Jinyuan Chang's Ph.D. thesis at Peking University. We thank Jean-Michel Zakoian for sharing a longer version of his paper, and Chenlei Leng and Cheng Yong Tang for sharing their R code. Jinyuan Chang and Song Xi Chen were supported by National Natural Science Foundation of China Grants 11131002 and G0113, Center for Statistical Science and LMEQF at Peking University. Jinyuan Chang was also supported by the Australian Research Council.",,54,34,38,3,48,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAR,2015,185.0,1.0,,,,,283,304,,10.1016/j.jeconom.2014.10.011,0.0,,,22,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CB4IH,,Green Submitted,,,2024-03-09,WOS:000349590900015,0
J,"Chen, QS; Ayer, T; Nastoupil, LJ; Rose, AC; Flowers, CR",,,,"Chen, Qiushi; Ayer, Turgay; Nastoupil, Loretta J.; Rose, Adam C.; Flowers, Christopher R.",,,Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Folio First-Line Therapy in Patients with Follicular Lymphoma,VALUE IN HEALTH,,,English,Article,,,,,,cost-effectiveness; follicular lymphoma; lymphoma; maintenance; non-Hodgkin lymphoma; radioimmunotherapy; rituximab,NON-HODGKIN-LYMPHOMA; PHASE-II TRIAL; FOLLOW-UP; IBRITUMOMAB TIUXETAN; LOW-GRADE; ECONOMIC-EVALUATION; PLUS RITUXIMAB; 1ST REMISSION; CHEMOTHERAPY; CYCLOPHOSPHAMIDE,"Background: Phase 3 randomized trials have shown that maintenance rituximab (MR) therapy or radioimmunotherapy (R11) consolidation following frontline therapy can improve progression-free survival for patients with follicular lymphoma (FL), but the costeffectiveness of these approaches with respect to observation has not been examined using a common modeling framework. Objectives: To evaluate and compare the economic impact of MR and RI!' consolidation versus observation, respectively, following the firstline induction therapy for patients with advanced-stage FL. Methods: We developed Markov models to estimate patients' lifetime costs, quality-adjusted life-years (QALYs), and life-years (LYs) after MR, RI'!', and observation following frontline FL treatment from the US payer's perspective. Progression risks, adverse event probabilities, costs, and utilities were estimated from clinical data of Primary Rltuximab and MAintenance (PRIMA) trial, Eastern Cooperative Oncology Group (ECOG) trial (for MR), and First line Indolent Trial (for RIT) and the published literature. We evaluated the incremental cost-effectiveness ratio for direct comparisons between MR/RI!' and observation. Model robustness was addressed by one-way and probabilistic sensitivity analyses. Results: Compared with observation, MR provided an additional 1.089 QALYs (1.099 LYs) and 1.399 QALYs (1.391 LYs) on the basis of the PRIMA trial and the ECOG trial, respectively, and RIT provided an additional 1.026 QALYs (1.034 LYs). The incremental cost per QALY gained was $40,335 (PRIMA) or $37,412 (ECOG) for MR and $40,851 for RIT. MR and RIT had comparable incremental QALYs before first progression, whereas RI'!' had higher incremental costs of adverse events due to higher incidences of cytopenias. Conclusions: MR and RIT following frontline FL therapy demonstrated favorable and similar cost-effectiveness profiles. The model results should be interpreted within the specific clinical settings of each trial. Selection of MR, RIT, or observation should be based on patient characteristics and expected trade-offs for these alternatives.","[Chen, Qiushi; Ayer, Turgay] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA; [Nastoupil, Loretta J.; Rose, Adam C.; Flowers, Christopher R.] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA; [Nastoupil, Loretta J.; Flowers, Christopher R.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA",University System of Georgia; Georgia Institute of Technology; Emory University; Emory University,"Flowers, CR (通讯作者)，Emory Univ, 1365 Clifton Rd,NE Bldg B,Suite 4302, Atlanta, GA 30322 USA.",crflowe@emory.edu,"Flowers, Christopher R/F-1953-2010; Chen, Qiushi/AAE-5002-2020","Rose, Adam/0000-0002-3054-7088",Spectrum,Spectrum,Partial support for this study was provided by Spectrum.,,49,29,32,0,4,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,189,197,,10.1016/j.jval.2014.12.017,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773554.0,"hybrid, Green Accepted",,,2024-03-09,WOS:000351115300009,0
J,"Janssens, A; Coon, JT; Rogers, M; Allen, K; Green, C; Jenkinson, C; Tennant, A; Logan, S; Morris, C",,,,"Janssens, Astrid; Coon, Jo Thompson; Rogers, Morwenna; Allen, Karen; Green, Colin; Jenkinson, Crispin; Tennant, Alan; Logan, Stuart; Morris, Christopher",,,"A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive Characteristics",VALUE IN HEALTH,,,English,Review,,,,,,children and young people; health-related quality of life; patient-reported outcome measures; review,QUALITY-OF-LIFE; HEALTH-STATUS; PARENT-REPORT; FUNCTIONAL STATUS; MEASUREMENT MODEL; REPORT FORM; ADOLESCENTS; RELIABILITY; VALIDITY; VALIDATION,"Objectives: To identify generic, multidimensional patient-reported outcome measures (PROMs) for children up to 18 years old and describe their characteristics and content assessed using the International Classification of functioning, Disability and Health Children and Youth version (ICF-CY). Methods: The search strategy, developed by an information specialist, included four groups of terms related to measure, health, children and young people, and psychometric performance. The search was limited to publications from 1992. Five electronic databases and two online specific PROM databases were searched. Two groups of reviewers independently screened all abstracts for eligible PROMs. Descriptive characteristics of the eligible PROMs were collected, and items and domains of each questionnaire were mapped onto the ICS-CY chapters. Results: We identified 35 PROMs, of which 29 were generic PROMs and 6 were preference-based measures. Many PROMs cover a range of aspects of health; however, social functioning is represented most often. Content covered differs both in which aspects of health are assessed and whether individual questions focus on functioning (what the subject can or does do) and/or wellbeing (how the subject feels about a certain aspect of his or her health). Conclusions: A broad variety of PROMs is available to assess children's health. Nevertheless, only a few PROMs can be used across all age ranges to 18 years. When mapping their content on the ICF-CY, it seems that most PROMs exclude at least one major domain, and all conflate aspects of functioning and well-being in the scales.","[Janssens, Astrid; Coon, Jo Thompson; Rogers, Morwenna; Allen, Karen; Green, Colin; Logan, Stuart; Morris, Christopher] Univ Exeter, Sch Med, Peninsula Cerebra Res Unit, Exeter EX2 4SG, Devon, England; [Janssens, Astrid; Coon, Jo Thompson; Rogers, Morwenna; Allen, Karen; Green, Colin; Logan, Stuart; Morris, Christopher] Univ Exeter, Sch Med, NIHR PenCLAHRC, Exeter EX2 4SG, Devon, England; [Jenkinson, Crispin] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Tennant, Alan] Univ Leeds, Dept Rehabil Med, Leeds, W Yorkshire, England",University of Exeter; University of Exeter; University of Oxford; University of Leeds,"Janssens, A (通讯作者)，Univ Exeter, PenCRU, Salmon Pool Lane, Exeter EX2 4SG, Devon, England.",a.janssens@exeter.ac.uk,"Janssens, Astrid/I-1227-2019; Coon, Jo Thompson/C-7923-2017","Janssens, Astrid/0000-0001-8419-0937; Thompson Coon, Jo/0000-0002-5161-0234; Morris, Christopher/0000-0002-9916-507X; Rogers, Morwenna/0000-0002-6039-238X; Logan, Stuart/0000-0002-9279-261X; Tennant, Alan/0000-0002-0728-2130",National Institute for Health Research Library [10/2002/16]; National Institute for Health Research (NIHR) Health Services [10/2002/16]; NIHR Collaboration for Leadership in Applied Health Research and Care of the South West Peninsula (PenCLAHRC); charity Cerebra; National Institute for Health Research [10/2002/16] Funding Source: researchfish,National Institute for Health Research Library; National Institute for Health Research (NIHR) Health Services(National Institutes of Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care of the South West Peninsula (PenCLAHRC); charity Cerebra; National Institute for Health Research(National Institutes of Health Research (NIHR)),"This article is part of a report published by the National Institute for Health Research Library (Project 10/2002/16). Where possible, we have made substantial changes to avoid direct duplication; however, some content remains the same.; Source of financial support: This study was part of research funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme (Project 10/2002/16; http://www.nets.nihr.ac.uk/projects/hsdr/10200216). The work also benefited from support from the NIHR Collaboration for Leadership in Applied Health Research and Care of the South West Peninsula (PenCLAHRC) and the charity Cerebra. The views and opinions expressed in this article are those of the authors and not necessarily those of the National Health Service, the NIHR, the Department of Health, or Cerebra.",,92,50,51,0,12,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,315,333,,10.1016/j.jval.2014.12.006,0.0,,,19,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773568.0,"Green Published, hybrid",,,2024-03-09,WOS:000351115300023,0
J,"Neumann, PJ; Thorat, T; Shi, J; Saret, CJ; Cohen, JT",,,,"Neumann, Peter J.; Thorat, Teja; Shi, Jennifer; Saret, Cayla J.; Cohen, Joshua T.",,,"The Changing Face of the Cost-Utility Literature, 1990-2012",VALUE IN HEALTH,,,English,Article,,,,,,cost-effectiveness analysis; cost-utility analysis; quality-adjusted life-year; review,RECOMMENDATIONS; GUIDELINES; QUALITY,"Objectives: Cost-utility analyses (CUAs) have been published widely over the years to measure the value of health care interventions. We investigated the growth and characteristics of CUAs in the peerreviewed English-language literature through 2012. Methods: We analyzed data from the 'tufts Medical Center Cost Effectiveness Analysis (CEA) Registry, a database containing more than 3700 English-language CUAs published through 2012. We summarized various study characteristics (e g, intervention type, funding source, and journal of publication) and methodological practices (e g, use of probabilistic sensitivity analysis) over three time periods: 1990 to 1999, 2000 to 2009, and 2010 to 2012. We also examined CUAs by country, region, and the degree to which diseases studied correlate with disease burden. Results: The number of published CUAs rose from 34 per year from 1990 to 1999 to 431 per year from 2010 to 2012. The proportion of studies focused on the United States declined from 61% during 1990 to 1999 to 35% during 2010 to 2012 (P < 0.0001). Although still small compared with CUAs in higher income countries, the number of CUAs focused on lower and middle-income countries has risen sharply. A large fraction of studies pertain to pharmaceuticals (46% during 2010-2012). In recent years, most studies included probabilistic sensitivity analysis (67% during 2010-2012). Journals publishing CUAs vary widely in the percentage of their studies funded by drug companies. Some conditions, such as injuries, have high burden but few CUAs. Conclusions: Our review reveals considerable growth and some change in the cost-utility literature in recent years. The data suggest growing interest in cost-utility methodology, particularly in non Western countries.","[Neumann, Peter J.; Thorat, Teja; Shi, Jennifer; Saret, Cayla J.; Cohen, Joshua T.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA",Tufts Medical Center,"Neumann, PJ (通讯作者)，800 Washington St,Box 63, Boston, MA 02111 USA.",pneumann@tuftsmedicalcenter.org,,"Cohen, Joshua/0000-0003-1737-0991",Center for the Evaluation of Value and Risk in Health at Tufts Medical Center,Center for the Evaluation of Value and Risk in Health at Tufts Medical Center,"This study was funded by internal sources at the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center. The center receives funding from government, private foundation, and industry sources.",,18,77,83,0,10,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,271,277,,10.1016/j.jval.2014.12.002,0.0,,,7,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773562.0,hybrid,,,2024-03-09,WOS:000351115300017,0
J,"Avraham, R; Schanzenbach, M",,,,"Avraham, Ronen; Schanzenbach, Max",,,The impact of tort reform on intensity of treatment: Evidence from heart patients,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Tort reform; Defensive medicine; Induced demand; Health insurance; Treatment intensity; Offensive Medicine,MEDICAL MALPRACTICE LITIGATION; RISK,"This paper analyzes the effect of non-economic damage caps on the treatment intensity of heart attack victims. We focus on whether a patient receives a major intervention in the form of either a coronary artery by-pass or angioplasty. We find strong evidence that treatment intensity declines after a cap on non-economic damages. The probability of receiving a major intervention in the form of either an angioplasty or bypass declines by 1.25-2 percentage points after non-economic damage caps are enacted, and this effect is larger a year or two after reform. However, we also find clear evidence of substitution between major interventions. When doctors have discretion to perform a by-pass and patients have insurance coverage, caps on non-economic damages increase the probability that a by-pass is performed. The effect of non-economic damage caps on costs is not always statistically significant, but in models with state-specific trends, total costs decline by as much as four percent. We conclude that tort reform reduces treatment intensity overall, even though it changes the mix of treatments. Using the Center for Disease Control's Vital Statistics data, we find that tort reform is not associated with an increase in mortality from coronary heart disease; if anything, mortality declines. (C) 2014 Elsevier B.V. All rights reserved.","[Avraham, Ronen] Univ Texas, Austin, TX USA; [Schanzenbach, Max] Northwestern Univ, Evanston, IL 60208 USA",University of Texas System; University of Texas Austin; Northwestern University,"Schanzenbach, M (通讯作者)，Northwestern Univ, Evanston, IL 60208 USA.",ravraham@law.utexas.edu; m-schanzenbach@law.northwestern.edu,,,"Searle Center on Law, Regulation, and Economic Growth at Northwestern University","Searle Center on Law, Regulation, and Economic Growth at Northwestern University","We thank Bernie Black, Anup Malani, Ity Shurtz, and seminar participants at University of Chicago Law and Economics Workshop, Conference on Empirical Legal Studies, and American Law and Economics Association Annual Meetings. We thank Daniel Lenhoff and Carlos Ramos for excellent research assistance and the Searle Center on Law, Regulation, and Economic Growth at Northwestern University for a grant which permitted us to purchase the data.",,40,32,35,1,16,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JAN,2015,39.0,,,,,,273,288,,10.1016/j.jhealeco.2014.08.002,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CA9TD,25175788.0,,,,2024-03-09,WOS:000349266800019,0
C,"Bi, KX; Wang, XX",,"Qi, E; Shen, J; Dou, R",,"Bi, Ke-xin; Wang, Xiang-xiang",,,Study on the Performance of Chinese Manufacturing Low-carbon Technology Innovation in the Global Value Chain,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Global value chain; low-carbon technology; low-carbon technology innovation performance,REDUCTION; FIRMS,"Based on global value chain, this paper builds manufacturing low-carbon technology innovation performance evaluation index system from the perspective of innovation input and output, then analyzes Chinese manufacturing low-carbon technology innovation performance in the global value chain with data reduction factor (DRF) and data envelopment analysis (DEA). The results show that there is a large difference among low-carbon technology innovation performance of manufacturing industries, and technical efficiency is not high. Resource allocation efficiency of Chinese manufacturing low-carbon technology innovation in the global value chain is low. And most manufacturing industries are in the increasing returns stage of scale, manufacturing industries should increase investment in low-carbon technology innovation, and improve the efficiency of resource allocation.","[Bi, Ke-xin; Wang, Xiang-xiang] Harbin Univ Sci & Technol, Sch Management, Harbin, Peoples R China; [Bi, Ke-xin] Harbin Engn Univ, Sch Econ & Management, Harbin, Peoples R China",Harbin University of Science & Technology; Harbin Engineering University,"Bi, KX (通讯作者)，Harbin Univ Sci & Technol, Sch Management, Harbin, Peoples R China.",bikx@hrbust.edu.cn,,,,,,,24,2,2,2,36,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,265,270,,10.2991/978-94-6239-102-4_56,0.0,,,6,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700056,0
J,"Dunn, A; Shapiro, AH",,,,"Dunn, Abe; Shapiro, Adam Hale",,,Physician payments under health care reform,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Massachusetts health care reform; Physician payments,INSURANCE; MARKETS; DEMAND,"This study examines the impact of major health insurance reform on payments made in the health care sector. We study the prices of services paid to physicians in the privately insured market during the Massachusetts health care reform. The reform increased the number of insured individuals as well as introduced an online marketplace where insurers compete. We estimate that, over the reform period, physician payments increased at least 11 percentage points relative to control areas. Payment increases began around the time legislation passed the House and Senate the period in which their was a high probability of the bill eventually becoming law. This result is consistent with fixed-duration payment contracts being negotiated in anticipation of future demand and competition. Published by Elsevier B.V.","[Dunn, Abe] Bur Econ Anal, Chicago, IL USA; [Shapiro, Adam Hale] Fed Reserve Bank San Francisco, San Francisco, CA 94105 USA",Federal Reserve System - USA; Federal Reserve Bank - San Francisco,"Shapiro, AH (通讯作者)，Fed Reserve Bank San Francisco, San Francisco, CA 94105 USA.",abe.dunn@bea.gov; adam.shapiro@sf.frb.org,,,,,,,44,10,15,1,11,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JAN,2015,39.0,,,,,,89,105,,10.1016/j.jhealeco.2014.09.004,0.0,,,17,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CA9TD,25497755.0,Green Submitted,,,2024-03-09,WOS:000349266800007,0
J,"Jensen, VM; Wüst, M",,,,"Jensen, Vibeke Myrup; Wust, Miriam",,,Can Caesarean section improve child and maternal health? The case of breech babies,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Caesarean section; Child health; Regression discontinuity design; Procedure use; Maternal health,REGRESSION DISCONTINUITY DESIGNS; PHYSICIAN FINANCIAL INCENTIVES; UNITED-STATES; APGAR SCORES; TERM; BIRTH; TRIAL; DELIVERY; BEHAVIOR; RETURNS,"This paper examines the health effects of Caesarean section (CS) for children and their mothers. We use exogenous variation in the probability of CS in a fuzzy regression discontinuity design. Using administrative Danish data, we exploit an information shock for obstetricians that sharply altered CS rates for breech babies. We find that CS decreases the child's probability of having a low APGAR score and the number of family doctor visits in the first year of life. We find no significant effects for severe neonatal morbidity or hospitalizations. While mothers are hospitalized longer after birth, we find no effects of CS for maternal post-birth complications or infections. Although the change in mode of delivery for the marginal breech babies increases direct costs, the health benefits show that CS is the safest option for these children. (C) 2014 Elsevier B.V. All rights reserved.","[Jensen, Vibeke Myrup; Wust, Miriam] Danish Natl Ctr Social Res, DK-1052 Copenhagen, Denmark; [Wust, Miriam] Aarhus Univ, RECEIV Res Ctr Early Intervent, DK-8210 Aarhus, Denmark",Aarhus University,"Wüst, M (通讯作者)，Aarhus Univ, RECEIV Res Ctr Early Intervent, Fuglesangs Alle, DK-8210 Aarhus, Denmark.",vmj@sfi.dk; miw@sfi.dk,,"Wust, Miriam/0000-0001-7171-7146","Danish Agency for Science, Technology and Innovation; [09-065167]","Danish Agency for Science, Technology and Innovation;","We thank two anonymous referees, Paul Bingley, Anna Pill Damm, Nabanita Datta Gupta, Mette Ejrnaes, Tor Eriksson, Christina Gathmann, Rafael Lalive, Soren Leth-Petersen, Dean Lillard, Maarten Lindeboom, Sean Nicholson, Henrik Nyholm, Steffen Reinhold, Maya Rossin-Slater, and participants at the Workshop Children's Human Capital Development (Aarhus University), the EALE 2012 conference (Bonn), and seminars at Aarhus University, the University of Lund, the Erasmus University Rotterdam, Cornell University, and SFI for helpful comments. The authors acknowledge financial support by the Danish Agency for Science, Technology and Innovation through a grant to the Graduate School for Integration, Production and Welfare (Wust) and grant number 09-065167 (Jensen).",,53,19,22,0,20,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JAN,2015,39.0,,,,,,289,302,,10.1016/j.jhealeco.2014.07.004,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CA9TD,25179865.0,,,,2024-03-09,WOS:000349266800020,0
C,"Ji, H; Sui, YT; Wang, XW",,"Lan, H",,Ji Hao; Sui Ya-ting; Wang Xue-wei,,,The Mechanism of Communities of Practice on Innovation Performance Based on Social Capital Perspective,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,communities of practice (COP); innovation performance; intellectual capital; psychological safety; social capital,PSYCHOLOGICAL SAFETY; KNOWLEDGE; TECHNOLOGY,"Communities of Practice (COP) is an informal professional cooperation and communication network, which is an efficient and low cost route to promote innovation, but few studies have been done in this area. Based on social capital theory, this paper explores the role of COP on innovation performance and its mechanism. Based on 325 samples from China's creative industry, our analysis finds: social capital of COP has positively significant impact on innovation performance through the intermediary variables intellectual capital and psychological safety. Therefore, to enhance innovation capability, enterprises should pay attention to a delicate balance between the formal and informal knowledge system; cultivate psychological safety environment; further develop intellectual capital and encourage their employee to participate more professional activities of COP.","[Ji Hao; Sui Ya-ting; Wang Xue-wei] Beijing Union Univ, Bussiness Coll, Beijing 100025, Peoples R China",Beijing Union University,"Ji, H (通讯作者)，Beijing Union Univ, Bussiness Coll, Beijing 100025, Peoples R China.",,,,Social Sciences Foundation of Ministry of Education of China [12YJC630069],Social Sciences Foundation of Ministry of Education of China,Supported by the Social Sciences Foundation of Ministry of Education of China for Young Scholar (12YJC630069),,32,0,0,0,2,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,178,187,,,,,,10,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600025,0
J,"Kamihigashi, T; Stachurski, J",,,,"Kamihigashi, Takashi; Stachurski, John",,,Perfect simulation for models of industry dynamics,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Regeneration; Simulation; Coupling from the past; Perfect sampling,FIRM DYNAMICS; EQUILIBRIUM,"In this paper we introduce a technique for perfect simulation from the stationary distribution of a standard model of industry dynamics. The method can be adapted to other, possibly non-monotone, regenerative processes found in industrial organization and other fields of economics. The algorithm we propose is a version of coupling from the past. It is straightforward to implement and exploit the regenerative property of the process in order to achieve rapid coupling. (C) 2014 Elsevier B.V. All rights reserved.","[Kamihigashi, Takashi] Kobe Univ, Res Inst Econ & Business Adm, Kobe, Hyogo, Japan; [Kamihigashi, Takashi] IPAG Business Sch, Paris, France; [Stachurski, John] Australian Natl Univ, Res Sch Econ, Canberra, ACT 0200, Australia",Kobe University; IPAG Business School; Australian National University,"Stachurski, J (通讯作者)，Australian Natl Univ, Res Sch Econ, Canberra, ACT 0200, Australia.",tkamihig@rieb.kobe-u.ac.jp; john.stachurski@anu.edu.au,,"Stachurski, John/0000-0001-6716-0111",ARC [DP120100321]; Japan Society for the Promotion of Science KAKENHI [24243044],"ARC(Australian Research Council); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))",We are grateful for financial support from ARC Discovery Award DP120100321 and the Japan Society for the Promotion of Science KAKENHI 24243044.,,14,1,1,0,5,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,JAN,2015,56.0,,,,,,9,14,,10.1016/j.jmateco.2014.11.004,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CC0FY,,Green Submitted,,,2024-03-09,WOS:000350012400002,0
C,"Kong, YJ",,"Lan, H",,Kong Ya-jie,,,Research on Motivation and Influence of Users Participating in Nike Online Design,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,Nike online design; participation motivation; participation behavior; theoretical model,,"This study derives from observing and thinking of an interesting phenomenon on current network: online design. Nowadays consumers focus not only on product's function, but also on their purchasing experience of satisfaction by participating in the design process. Taking Nike exclusive customization website as an example, the writer further discusses the motivations of users participating in Nike online design and the impact of these motivations for online design participation behavior. The results indicate that the motivations for users' participation can be divided into five categories, the product demand motivation, interest motivation, community interaction motivation, cognitive motivation and sentiment motivation. Product demand motivation has the dominant influence on consumers' participation behavior, followed by interest motivation, while cognitive motivation has the least influence. This study provides theoretical support for marketing strategies of Nike's exclusive customization website and other online designing companies.","[Kong Ya-jie] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China",Harbin Institute of Technology,"Kong, YJ (通讯作者)，Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China.",,,,,,,,38,0,0,0,7,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,134,141,,,,,,8,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600019,0
C,"Li, HY; Zhang, L; Lyu, WC",,"Lan, H",,Li Hui-yun; Zhang Lin; Lyu Wen-chao,,,Regulatory Study on Voluntary Disclosure of Listed Companies,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,voluntary disclosure; status; regulatory; regulatory framework,,"With Chinese capital market's continuous development and maturing, investors are getting higher and higher quality requirements of information disclosure of listed companies. Mandatory disclosure cannot fully meet the diverse information needs of investors, what they indeed need is voluntary disclosure. This paper selected at random 401 Chinese manufacturing companies at the Shenzhen Stock Exchange in 2013 as the research objective in order to study the current situation of the voluntary disclosure. This paper found and summarized the problems of small number, low quality, and accuracy, lack of fixed and standardized forms in the process of the disclosure. Finally based on the study, this paper put forward effective advices on improving voluntary disclosure of listed companies and effective advices on building regulatory framework of voluntary disclosure in China.","[Li Hui-yun; Zhang Lin; Lyu Wen-chao] Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China",Beijing Institute of Technology,"Li, HY (通讯作者)，Beijing Inst Technol, Sch Management & Econ, Beijing 100081, Peoples R China.",,"zhang, Weihua/JJD-6447-2023",,State Key Program of National Social Science Foundation of China [13ATJ003]; National Natural Science Foundation of China [71140006]; China Scholarship Council,State Key Program of National Social Science Foundation of China(National Office of Philosophy and Social Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council),This research was supported by the State Key Program of National Social Science Foundation of China (No. 13ATJ003) and the National Natural Science Foundation of China (No. 71140006). This research was partially supported by China Scholarship Council.,,28,0,0,2,3,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,651,657,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600086,0
C,"Li, P; Song, J; Chen, BJ",,"Qi, E; Shen, J; Dou, R",,"Li, Ping; Song, Jing; Chen, Bojie",,,Pricing of Chinese Defaultable Bonds Based on Stochastic Recovery Rate,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Defaultable bond; reduced-form model; stochastic recovery rate,TERM STRUCTURE; CREDIT RISK; CORPORATE; SECURITIES; SPREADS; MODEL; DEBT,"In order to price corporate bonds more precisely, a stochastic recovery rate (RR) has been used in this paper instead of a fixed RR used by most researchers. The main contribution is to consider the negative correlation between the recovery rate and default probability by using an exponential function. Based on this function and reduced-form model, a pricing formula is obtained and solved by a characteristic equation. At last, this paper selects seven Chinese corporate bonds to do empirical research. The estimated parameters showed that a fixed RR will lead to great errors and thus stochastic RR is necessary. The results also indicate that the hazard rate has positive correlation with the interest rate, which means that the level of interest rate is still the main reason influencing a firm's credit risk. And the theoretical price obtained from the model fits the market price very well, which demonstrates the validity of the model.","[Li, Ping; Song, Jing; Chen, Bojie] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China",Beihang University,"Song, J (通讯作者)，Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.",songjing.heng@163.com,,,,,,,15,1,1,0,4,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,583,587,,10.2991/978-94-6239-102-4_119,0.0,,,5,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700119,0
C,"Mu, LL; Bi, X",,"Qi, E; Shen, J; Dou, R",,"Mu, Lin-lin; Bi, Xing",,,Investment Risk Analysis of Gas and Pipeline Construction Project Based on the Gray Analytic Hierarchy Process,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Investment risk; oil and gas pipeline projects; risk analysis; the gray analytic hierarchy process,,"The oil and gas pipeline projects are often faced with risks of many aspects in the process of development and construction. The article describes the process of the gray analytic hierarchy process for risk analysis, and calculates the comprehensive evaluation index of the project via a real case, namely the overall risk of investment projects, so that the investors make right investment decisions according to the results of the risk analysis to make sure the safe state of the pipeline project construction maintain an acceptable risk level, which helps to form security for the safety after putting into production.","[Mu, Lin-lin; Bi, Xing] Tianjin Univ, Dept Manage & Econ, Tianjin 300072, Peoples R China",Tianjin University,"Mu, LL (通讯作者)，Tianjin Univ, Dept Manage & Econ, Tianjin 300072, Peoples R China.",mulinlin119@163.com,"Mu, Linlin/JPY-0177-2023",,,,,,15,1,1,0,4,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,467,471,,10.2991/978-94-6239-102-4_94,0.0,,,5,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700094,0
C,"Shen, J; Xing, J; Xu, M",,"Qi, E; Shen, J; Dou, R",,"Shen, Jiang; Xing, Jin; Xu, Man",,,Research on CBR-RBR Fusion Reasoning Model and its Application in Medical Treatment,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,CBR/RBR; complex systems; fusion mechanism; robust,KNOWLEDGE; SYSTEM; TEXT,"The phenomenon exist in the reasoning process of medical decision-making system are insufficient or incomplete information, information singularity, imprecise measurement, low reliability, susceptible outside interference, which make the inference efficiency and accuracy lower in complex medical decision-making system, with the existence of risk influencing factor, such as low levels of knowledge sharing and human error. In this paper, we attempt to build CBR/RBR knowledge base and the process of acquainting and transferring knowledge, research the decision-making tools based on robustly inference fusion, in order to improve the quality and efficiency of health care decision-making system.","[Shen, Jiang; Xing, Jin] Tianjin Univ, Dept Management & Econ, Tianjin 300072, Peoples R China; [Xu, Man] Nankai Univ, Dept Ind Engn, Tianjin 300457, Peoples R China",Tianjin University; Nankai University,"Xu, M (通讯作者)，Nankai Univ, Dept Ind Engn, Tianjin 300457, Peoples R China.",td_xuman@nankai.edu.cn,,,,,,,16,4,5,2,12,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,431,434,,10.2991/978-94-6239-102-4_87,0.0,,,4,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700087,0
C,"Xu, LY; Bélec, L; Liu, W; Gu, QF; Li, AP",,"Qi, E; Shen, J; Dou, R",,"Xu, Li-yun; Belec, Loic; Liu, Wei; Gu, Qi-fang; Li, Ai-ping",,,Improved Computer Methods for Sequencing Operations for U-shaped Assembly Lines,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Assembly line balancing; heuristic; stochastic; U-shaped,ALGORITHM; MODEL,"U-shaped lines are considered to have a number of advantages over traditional lines. COMSOAL is a recurrent procedure for assembly lines balancing, and it stands for computer method for sequencing operations for assembly lines. In this paper, an improved U-COMSOAL is proposed to solve some problems of COMSOAL, the random picking part of the COMSOAL method is substituted by a ranked positional weight method, and takes both the predecessors and successors of the tasks into the account. Finally, a comparison of between the improved method and a classical method suggested by O. F. Baykoc was done, which illustrate the efficiency of U-COMSOAL.","[Xu, Li-yun; Belec, Loic; Liu, Wei; Li, Ai-ping] Tongji Univ, Inst Adv Mfg Technol, Shanghai 200092, Peoples R China; [Gu, Qi-fang] Faw Jiefang Automot CO Ltd, Wuxi Diesel Engine Works, Shanghai, Peoples R China",Tongji University,"Xu, LY (通讯作者)，Tongji Univ, Inst Adv Mfg Technol, Shanghai 200092, Peoples R China.",Lyxu@tongji.edu.cn,,,,,,,22,0,0,0,6,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,51,55,,10.2991/978-94-6239-102-4_11,0.0,,,5,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700011,0
C,"Yang, ZG",,"Lan, H",,Yang Zhen-guo,,,A Research on the Outsourcing Strategy of Enterprise Human Resources Management,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,human resources management; outsourcing; advantages; decision-making process; risk management,,"With the advent of economic globalization and the development of information technology, a new kind of human resources management operation mode like human resource management outsourcing has gradually become a new trend of enterprise human resource management. Human resource management outsourcing helps to focus on the main business, streamline government organs, reduce the operation cost of enterprises and obtain professional services. However, Human resource management outsourcing also has certain risks and negative effects, which asks for a sufficient analysis of enterprises' internal and external environments, confirmation of proper outsourcing content and form, a choice of proper outsourcing service providers and a good risk management of outsourcing.","[Yang Zhen-guo] Chongqing Univ Posts & Telecommun, Coll Econ & Management, Chongqing 400065, Peoples R China",Chongqing University of Posts & Telecommunications,"Yang, ZG (通讯作者)，Chongqing Univ Posts & Telecommun, Coll Econ & Management, Chongqing 400065, Peoples R China.",,,,,,,,30,0,0,0,8,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1154,1160,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600154,0
C,"Yao, T; Qiu, Q; Zheng, QY; Mu, L; Xiao, WQ",,"Lan, H",,Yao Tang; Qiu Qi; Zheng Qiu-ying; Mu Lin; Xiao Wei-qun,,,What Will Influence Psychology and Behavior of Consumer Online Cocreation?: A View Base on Self-Determination Theory,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,online customer co-creation behavior; self-determination theory; website familiarity; website service quality,CO-CREATION; PARTICIPATION; MODEL; CUSTOMERS; QUALITY; LOGIC,"Now, with the growth of web 2.0 concept in E-commercial environment, customers could co-create with E-commercial companies and other consumers by participating in online websites. In this research, one consumer sample survey was employed to test the psychological and behavioral mechanism of self-determination for online shopping customer co-creation, and proved that website familiarity and website service quality were the effective factors triggering the consumers' perception of self-determination and online customer participation in co-creation. The conclusion shows that the shopping websites with high familiarity and high service quality will help to promote the online customers' perception of autonomy, competence and relatedness, and then enable consumers to more involve in online co-creation behavior. Moreover, the results also give suggestions for marketing theory and website practice.","[Yao Tang] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China; [Qiu Qi] Capital Univ Econ & Business, Coll Business Adm, Beijing 100070, Peoples R China; [Zheng Qiu-ying] Beijing Univ Chinese Med, Sch Management, Beijing 100029, Peoples R China; [Mu Lin] Tianjin Univ Finance & Econ, Business Inst, Tianjin 300222, Peoples R China; [Xiao Wei-qun] Beijing WUZI Univ, Sch Business, Beijing 101149, Peoples R China",Beihang University; Capital University of Economics & Business; Beijing University of Chinese Medicine; Tianjin University of Finance & Economics; Beijing Wuzi University,"Yao, T (通讯作者)，Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.",,,,"National Natural Science Foundation of China [71202015, 71402009, 71402106]; Fundamental Research Funds for the Central Universities [YWF-14-JGXY-005]; Beijing Higher Education Young Elite Teacher Project [YETP0801]; National Social Science Fund [13BGL026]; Business Operation & Service Innovation Platform of Beijing Wuzi University; Scientific Research Project of Beijing Municipal Commission of Education; Social Science Research Program in Higher Education of Tianjin Municipal Commission of Education [20132128]; Social Science Foundation of Beijing Municipal Commission of Education [SM201510038010]; Science Foundation of CUEB",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Higher Education Young Elite Teacher Project; National Social Science Fund; Business Operation & Service Innovation Platform of Beijing Wuzi University; Scientific Research Project of Beijing Municipal Commission of Education; Social Science Research Program in Higher Education of Tianjin Municipal Commission of Education; Social Science Foundation of Beijing Municipal Commission of Education; Science Foundation of CUEB,"Supported by the National Natural Science Foundation of China (71202015, 71402009, 71402106), Fundamental Research Funds for the Central Universities (YWF-14-JGXY-005), Beijing Higher Education Young Elite Teacher Project (YETP0801), National Social Science Fund (13BGL026), Business Operation & Service Innovation Platform of Beijing Wuzi University, 2013 Scientific Research Project of Beijing Municipal Commission of Education, Social Science Research Program in Higher Education of Tianjin Municipal Commission of Education (20132128), Social Science Foundation of Beijing Municipal Commission of Education (SM201510038010), Science Foundation of CUEB in 2014",,36,0,0,2,10,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,639,644,,,,,,6,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600084,0
C,"Ye, B; Liu, HL; Cai, J",,"Lan, H",,Ye Bei; Liu Han-lin; Cai Juan,,,"Board Characteristics, Behavior and Governance Effectiveness: A Survey on Joint Stock Limited Companies in China","2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,behavior; board of directors; characteristics; governance; survey,CORPORATE GOVERNANCE; DIRECTORS; NETWORK,"The board of directors is regarded as the core of modern corporate governance, of which the major functions include monitoring, strategy and counseling. However as board behavior is mostly behind the scenes and the board works indirectly on corporate performance in a long run, empirical data on board characteristics, behavior and effectiveness are scant. This has greatly confined knowledge about board governance. Taking the reality of Chinese companies into account, this study carries out a questionnaire survey among 208 Chinese companies with the aim to provide first-hand insight into the characteristics, behavior and governance effectiveness of Chinese companies so as to facilitate future related research. The findings contribute to potential countermeasures to prevent board governance failures which often occur in corporate scandals.","[Ye Bei; Liu Han-lin; Cai Juan] Wuhan Univ Sci & Technol, Coll Humanities Law & Econ, Wuhan 430081, Peoples R China",Wuhan University of Science & Technology,"Ye, B (通讯作者)，Wuhan Univ Sci & Technol, Coll Humanities Law & Econ, Wuhan 430081, Peoples R China.",,,,National Social Science Foundation of China [12BGL047],National Social Science Foundation of China(National Office of Philosophy and Social Sciences),Supported by the National Social Science Foundation of China (12BGL047),,29,0,0,0,4,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,834,840,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600110,0
C,"Zhang, YM; Nie, YH; Ding, RJ",,"Lan, H",,Zhang Yu-ming; Nie Yan-hua; Ding Run-jian,,,An Empirical Study on the Relationship between Ownership Structure and R&D Investment of Listed SMEs,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,R&D investment; ownership structure; nature of shareholders with power balance; small and medium sized enterprise (SME),AGENCY,"In this paper, the company in SMEs Board of listing would be taken as a sample if its' R&D expenditure has been disclosed at year 2011-2013, based on the heterogeneity perspective of controlling shareholder and shareholder with power balance, the fixed effect model and random effect model of panel data are used to make an empirical test on the relationship between ownership structure and R&D investment for the listing of small and medium enterprises (SME). The regression results show that, R&D investment intensity of small and medium-sized state owned enterprise is higher than that of non state owned enterprises; the nonlinear relationship between the proportion of the first largest shareholder and R&D investment intensity is U; the second largest shareholder lack of checks and balances to the first largest shareholder in improving the corporate R&D investment; state owned enterprises shareholders checks and balances' effect is better than that of non state owned enterprises, but there is no significant difference in the effect on the enterprise R&D investment for them.","[Zhang Yu-ming; Nie Yan-hua; Ding Run-jian] Bohai Univ, Sch Econ & Law, Jinzhou 121013, Peoples R China",Bohai University,"Zhang, YM (通讯作者)，Bohai Univ, Sch Econ & Law, Jinzhou 121013, Peoples R China.",,"zhang, yu/HNS-5948-2023",,,,,,21,0,0,0,0,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1574,1580,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600210,0
C,"Zhong, M; Ge, T",,"Lan, H",,Zhong Ma; Ge Tao,,,Consistency of Historical High Performance and Overinvestment: Evidence from China,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,financial performance consistency; self-serving attribution bias; managerial overconfidence; corporate investment,SELF-ATTRIBUTION BIAS; CORPORATE-INVESTMENT; CEO OVERCONFIDENCE; ACQUISITIONS; EFFICIENCY,"The relationship between CEO's irrational behavior and corporate investment has received widespread attention from corporate financial researchers. This paper aims to examine the relationship between consistent historical high performance and firm overinvestment. Based on analysis of China's listed firms during 2001-2013, we calculate overinvestment level based on the methods of Biddle et al. and Chen et al. Based on pooled-sample, firm fixed effect and quantile regression models, this study finds that the overinvestment level are higher in the firms with consistent high historical performances. This phenomenon may be due to the problem of managerial self-attribution bias. Moreover, higher quality of corporate government can reduce this relationship though elevated supervision on top executives. It indicates that corporate governance mechanism may restrain managerial bias.","[Zhong Ma] Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Jiangsu, Peoples R China; [Ge Tao] China Nucl Ind Huaxing Construct Co Ltd, Nanjing 210019, Jiangsu, Peoples R China",Nanjing University of Science & Technology,"Zhong, M (通讯作者)，Nanjing Univ Sci & Technol, Sch Econ & Management, Nanjing 210094, Jiangsu, Peoples R China.",,,,"National Natural Science Foundation of China [71172104, 71472088, 71173108]; Graduate Innovation Foundation of Jiangsu Province [CXZZI3_0227]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Foundation of Jiangsu Province,"Supported by the National Natural Science Foundation of China (71172104, 71472088, 71173108), the Graduate Innovation Foundation of Jiangsu Province (CXZZI3_0227)",,29,0,0,2,6,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1364,1369,,,,,,6,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600184,0
C,"Zu, XQ; Zhang, L; Wu, YX",,"Lan, H",,Zu Xiao-qian; Zhang Li; Wu Yong-xiang,,,Impact of Stressors on Withdrawal Behavior: The Moderating Effect of Psychological Flexibility,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,challenge stressor; hindrance stressor; psychological flexibility; work withdrawal behavior,PERCEIVED ORGANIZATIONAL SUPPORT; METAANALYTIC TEST; ACCEPTANCE; PERFORMANCE; MODEL,"Work withdrawal behavior deeply inhibits the growth of corporation. The problem that Chinese firm has faced is no longer about staff's capability; delay in mission completion and work withdrawal appears to be the major issue of the firm due to the work stress. Thus, employees should strengthen their psychological construction, and organization managers should choose the appropriate stressor to improve the performance. This purpose of this study is to conduct a moderating model to investigate the effect of stress on withdrawal behavior and its boundary condition. Date We choose 3 variable: Challenge stressor-hindrance Stressor, Psychological flexibility, Work withdrawal behavior, and used the hierarchical regression to test the research model, and the result showed that financial service staffs in northeast China are suffered with high level stress. We also give out the suggestions to enhance psychological flexibility and reduce the withdrawal behaviors.","[Zu Xiao-qian; Zhang Li; Wu Yong-xiang] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China",Harbin Institute of Technology,"Zu, XQ (通讯作者)，Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China.",,,,National Natural Science Foundation of China [71472054],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),Supported by the National Natural Science Foundation of China (71472054),,32,0,0,0,12,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1092,1098,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600145,0
J,"Brekke, KR; Levaggi, R; Siciliani, L; Straume, OR",,,,"Brekke, Kurt R.; Levaggi, Rosella; Siciliani, Luigi; Straume, Odd Rune",,,Patient mobility and health care quality when regions and patients differ in income,JOURNAL OF HEALTH ECONOMICS,,,English,Article; Proceedings Paper,16th European Health Economics Workshop,"MAY 28-29, 2015","Toulouse, FRANCE",,,Patient mobility; Health care quality; Income inequalities; Regional welfare; Salop model,COMPETITION; INVESTMENTS; SERVICES,"We study the effects of cross-border patient mobility on health care quality and welfare when income varies across and within regions. We use a Salop model with a high-, middle-, and low-income region. In each region, a policy maker chooses health care quality to maximise the utility of its residents when health care costs are financed by general income taxation. In equilibrium, regions with higher income offer better quality, which creates an incentive for patient mobility from lower- to higher-income regions. Assuming a prospective payment scheme based on DRG-pricing, we find that lower non-monetary (administrative) mobility costs have (i) no effect on quality or welfare in the high-income region; (ii) a negative effect on quality but a positive effect on welfare for the middle-income region; and (iii) ambiguous effects on quality and welfare for the low-income region. Lower monetary mobility costs (copayments) might reduce welfare in both the middle- and low-income region. Thus, health policies that stimulate cross border patient mobility can be counterproductive when regions differ in income. (C) 2016 Elsevier B.V. All rights reserved.","[Brekke, Kurt R.] Norwegian Sch Econ, Dept Econ, Helleveien 30, N-5045 Bergen, Norway; [Levaggi, Rosella] Univ Brescia, Dept Econ & Management, Via San Faustino 74B, I-25100 Brescia, Italy; [Siciliani, Luigi] Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England; [Straume, Odd Rune] Univ Minho, Dept Econ NIPE, Campus Gualtar, P-4710057 Braga, Portugal; [Straume, Odd Rune] Univ Bergen, Dept Econ, N-5020 Bergen, Norway",Norwegian School of Economics (NHH); University of Brescia; University of York - UK; Universidade do Minho; University of Bergen,"Siciliani, L (通讯作者)，Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England.",kurt.brekke@nhh.no; rosella.levaggi@unibs.it; luigi.siciliani@york.ac.uk; o.r.straume@eeg.uminho.pt,"Levaggi, Rosella/Q-6920-2019; siciliani, luigi/AAE-8686-2020; Straume, Odd Rune/B-6090-2009","Levaggi, Rosella/0000-0002-6018-1283; Straume, Odd Rune/0000-0002-6889-2717",COMPETE [POCI-01-0145-FEDER-006683]; FCT/MEC; ERDF,COMPETE; FCT/MEC(Fundacao para a Ciencia e a Tecnologia (FCT)); ERDF(European Union (EU)),"This work was carried out with funding from COMPETE reference no. POCI-01-0145-FEDER-006683, with the FCT/MEC's financial support through national funding and by the ERDF through the Operational Programme on Competitiveness and Internationalization - COMPETE 2020 under the PT2020 Partnership Agreement. The paper has benefited from being presented at the European Health Economics Workshop 2015 in Toulouse. We are grateful for comments by Christoph Schottmuller, Helmuth Cremer, and three anonymous referees.",,22,19,20,2,30,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,DEC,2016,50.0,,,,,,372,387,,10.1016/j.jhealeco.2016.05.003,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,EF7HN,27344297.0,"Green Accepted, Green Submitted",,,2024-03-09,WOS:000390500800029,0
J,"Kirsch, F",,,,"Kirsch, Florian",,,Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic Review,VALUE IN HEALTH,,,English,Review,,,,,,chronic disease; cost-effectiveness; DMP; Markov model; review,QUALITY-OF-LIFE; COST-EFFECTIVENESS; HEART-FAILURE; MULTIDISCIPLINARY CARE; SECONDARY PREVENTION; MEDICATION ADHERENCE; DECISION-MAKING; HEALTH; INTERVENTIONS; GUIDELINES,"Background: Disease management programs (DMPs) for chronic diseases are being increasingly implemented worldwide. Objectives: To present a systematic overview of the economic effects of DMPs with Markov models. The quality of the models is assessed, the method by which the DMP intervention is incorporated into the model is examined, and the differences in the structure and data used in the models are considered. Methods: A literature search was conducted; the Preferred Reporting Items for Systematic Reviews and Meta Analyses statement was followed to ensure systematic selection of the articles. Study characteristics e.g. results, the intensity of the DMP and usual care, model design, time horizon, discount rates, utility measures, and cost-of-illness were extracted from the reviewed studies. Model quality was assessed by two researchers with two different appraisals: one proposed by Philips et al. (Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality asessment. Pharmacoeconomics 2006;24:355-71) and the other proposed by Caro et al. (Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value Health 2014;17:174-82). Results: A total of 16 studies (9 on chronic heart disease, 2 on asthma, and 5 on diabetes) met the inclusion criteria. Five studies reported cost savings and 11 studies reported additional costs. In the quality, the overall score of the models ranged from 39% to 65%, it ranged from 34% to 52%. Eleven models integrated effectiveness derived from a clinical trial or a meta-analysis of complete DMPs and only five models combined intervention effects from different sources into a DMP. The main limitations of the models are bad reporting practice and the variation in the selection of input parameters. Conclusions: Eleven of the 14 studies reported cost-effectiveness results of less than $30,000 per quality-adjusted life-year and the remaining two studies less than $30,000 per life-year gained. Nevertheless, if the reporting and selection of data problems are addressed, then Markov models should provide more reliable information for decision makers, because understanding under what circumstances a DMP is cost-effective is an important determinant of efficient resource allocation.","[Kirsch, Florian] Ludwig Maximilians Univ Munchen, Munich Sch Management, Munich, Germany; [Kirsch, Florian] Ludwig Maximilians Univ Munchen, Munich Ctr Hlth Sci, Munich, Germany; [Kirsch, Florian] Helmholtz Zentrum Munchen, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany; [Kirsch, Florian] German Ctr Diabet Res DZD, Neuherberg, Germany",University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health,"Kirsch, F (通讯作者)，Ludwig Maximilians Univ Munchen, Hlth Econ & Management, Ludwigstr 28 RG, D-80539 Munich, Germany.",UUf.kirsch@bwl.lmu.deUU,,,,,,,51,9,9,0,15,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2016,19.0,8.0,,,,,1039,1054,,10.1016/j.jval.2016.07.004,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO1HD,27987631.0,,,,2024-03-09,WOS:000396448300018,0
J,"Pugliese, L; Woodriff, M",,,,"Pugliese, L.; Woodriff, Molly",,,"Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit (vol 18, pg A536, 2015)",VALUE IN HEALTH,,,English,Correction,,,,,,,,,"[Pugliese, L.; Woodriff, Molly] HITLAB, New York, NY 10032 USA",,"Pugliese, L (通讯作者)，HITLAB, New York, NY 10032 USA.",,,,,,,,1,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2016,19.0,8.0,,,,,1068,1068,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO1HD,,,,,2024-03-09,WOS:000396448300023,0
J,"Rheinberger, CM; Herrera-Araujo, D; Hammitt, JK",,,,"Rheinberger, Christoph M.; Herrera-Araujo, Daniel; Hammitt, James K.",,,The value of disease prevention vs treatment,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Health risk valuation; Chronic disease; Willingness-to-pay; Probability weighting; Value of prevention,WILLINGNESS-TO-PAY; UTILITY-FUNCTIONS; PROSPECT-THEORY; HEALTH; PROBABILITY; REDUCTIONS; MORTALITY; IMPROVE; LATENCY; DOMAIN,"We present an integrated valuation model for diseases that are life-threatening. The model extends the standard one-period value-per-statistical-life model to three health prospects: healthy, ill, and dead. We derive willingness-to-pay values for prevention efforts that reduce a disease's incidence rate as well as for treatments that lower the corresponding health deterioration and mortality rates. We find that the demand value of prevention always exceeds that of treatment. People often overweight small risks and underweight large ones. We use the rank dependent utility framework to explore how the demand for prevention and treatment alters when people evaluate probabilities in a non-linear manner. For incidence and mortality rates associated with common types of cancers, the inverse-S shaped probability weighting found in experimental studies leads to a significant increase in the demand values of both treatment and prevention. (C) 2016 Elsevier B.V. All rights reserved.","[Rheinberger, Christoph M.] European Chem Agcy ECHA, Helsinki, Finland; [Herrera-Araujo, Daniel] Paris Sch Econ Hospinn, Paris, France; [Herrera-Araujo, Daniel] Assistance Publ Hop Paris, Paris, France; [Hammitt, James K.] Harvard Univ, Ctr Risk Anal, Cambridge, MA 02138 USA; [Hammitt, James K.] Toulouse Sch Econ, Toulouse, France",European Chemicals Agency; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP; Harvard University; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics,"Rheinberger, CM (通讯作者)，European Chem Agcy ECHA, Helsinki, Finland.",rheinberger.cm@gmail.com,,"Herrera-Araujo, Daniel/0000-0002-2044-6718",INRA Scientific Package; European Research Council [230589]; European Research Council (ERC) [230589] Funding Source: European Research Council (ERC),INRA Scientific Package; European Research Council(European Research Council (ERC)); European Research Council (ERC)(European Research Council (ERC)Spanish Government),"This work was sponsored by an INRA Scientific Package. JKH acknowledges additional support from the European Research Council (FP7/2007-2013, grant no. 230589). The views expressed in this paper are solely those of the authors and do not represent the views or position of the European Chemicals Agency.",,41,16,18,1,18,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,DEC,2016,50.0,,,,,,247,255,,10.1016/j.jhealeco.2016.08.005,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EF7HN,27616486.0,Green Accepted,,,2024-03-09,WOS:000390500800019,0
J,"Abala, AT; Bautista, T",,,,"Abala, A. T.; Bautista, T.",,,ESTIMATED RANGE OF COST OF TREATMENT OF ADULT SCHIZOPHRENIA PATIENTS AT A TERTIARY HOSPITAL AS OF OCTOBER 2015,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Abala, A. T.; Bautista, T.] Univ Philippines, Philippine Gen Hosp, Manila, Philippines",University of the Philippines System; University of the Philippines Manila,,,"Bautista, Tomás/A-9082-2011","Bautista, Tomás/0000-0002-5368-3680",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMH11,A841,A841,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606303009,0
J,"Abramowitz, L; Guily, JLS; Moyal-Barracco, M; Jacquard, A; Largeron, N; Dahlab, A; Uhart, M; Bresse, X; Bergeron, C; Borne, H; Cancalon, C; Catella, L; Bénard, S",,,,"Abramowitz, L.; Guily, Lacau Saint J.; Moyal-Barracco, M.; Jacquard, A.; Largeron, N.; Dahlab, A.; Uhart, M.; Bresse, X.; Bergeron, C.; Borne, H.; Cancalon, C.; Catella, L.; Benard, S.",,,"EPIDEMIOLOGY, TREATMENT PATHWAYS AND COSTS OF CANCERS POTENTIALLY RELATED TO HPV INFECTION IN FRANCE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Abramowitz, L.] Hop Bichat Claude Bernard, Paris, France; [Guily, Lacau Saint J.] Hop Tenon, Paris, France; [Jacquard, A.] Sanofi Pasteur MSD France, Lyon, France; [Largeron, N.; Dahlab, A.; Uhart, M.; Bresse, X.] Sanofi Pasteur MSD, Lyon, France; [Bergeron, C.] Lab Cerba, St Ouen, France; [Cancalon, C.; Catella, L.; Benard, S.] Steve Consultants, Oullins, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital Universitaire Tenon - APHP; Sanofi-Aventis; Sanofi France,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS34,A609,A610,,10.1016/j.jval.2016.09.1514,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301611,0
J,"Aissaoui, N; Bin Sawad, A; Turkistani, F",,,,"Aissaoui, N.; Bin Sawad, A.; Turkistani, F.",,,"CONTINENTAL COMPARISON OF INNOVATIVE DRUGS PRICES, THE CASE OF ONCOLOGY USED FOR TREATMENT OF SOLID TUMORS IN GERMANY AND THE UNITED STATES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aissaoui, N.] Univ Paris 09, Paris, France; [Bin Sawad, A.; Turkistani, F.] MCPHS Univ, Boston, MA USA",Universite PSL; Universite Paris-Dauphine,,,"Bin Sawad, Aseel/AAS-7750-2020","Bin Sawad, Aseel/0000-0001-6620-0716",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN276,A758,A758,,10.1016/j.jval.2016.09.2352,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302555,0
J,"Alhammad, A; Lecca, SG",,,,"Alhammad, A.; Lecca, Garrido S.",,,COST-EFFECTIVENESS OF NIVOLUMAB FOR THE TREATMENT OF ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) IN SAUDI ARABIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alhammad, A.] King Abdul Aziz Med City, Riyadh, Saudi Arabia; [Lecca, Garrido S.] Bristol Myers Squibb, Dubai, U Arab Emirates",Bristol-Myers Squibb,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN181,A741,A741,,10.1016/j.jval.2016.09.2254,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302462,0
J,"Ankarfeldt, MZ; Thorsted, BL; Groenwold, RH; Adalsteinsson, E; Sanni, A; Klungel, O",,,,"Ankarfeldt, M. Z.; Thorsted, B. L.; Groenwold, R. H.; Adalsteinsson, E.; Sanni, A.; Klungel, O.",,,ASSESSMENT OF CHANNELLING BIAS AMONG INITIATORS OF GLUCOSE LOWERING DRUGS - A COHORT STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ankarfeldt, M. Z.; Thorsted, B. L.; Adalsteinsson, E.] Novo Nordisk AS, Soborg, Denmark; [Groenwold, R. H.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Sanni, A.] Univ Oxford, Oxford, England; [Klungel, O.] Univ Utrecht, Utrecht, Netherlands",Novo Nordisk; Utrecht University; Utrecht University Medical Center; University of Oxford; Utrecht University,,,"Ankarfeldt, Mikkel Zöllner/HPE-4105-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB13,A667,A667,,10.1016/j.jval.2016.09.1842,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,"Green Published, hybrid",,,2024-03-09,WOS:000396606302062,0
J,"Antoh, E; Davies-Teye, B; Vanotoo, L",,,,"Antoh, E.; Davies-Teye, B.; Vanotoo, L.",,,"DEVELOPING A GEOSPATIAL WEB AND MOBILE APPLICATION TO IMPROVE EXPANDED PROGRAM ON IMMUNIZATION IN GHANA: A MHEALTH TECHNOLOGY NOVELTY, 2015",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Antoh, E.] GeoGrafix Solut, Accra, Ghana; [Antoh, E.] USAID GHANA RING, Accra, Ghana; [Davies-Teye, B.] Drifney Consult Ltd, Accra, Ghana; [Davies-Teye, B.; Vanotoo, L.] Ghana Hlth Serv, Accra, Ghana; [Vanotoo, L.] Promise Ghana, Accra, Ghana",United States Agency for International Development (USAID); Ghana Health Service,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN39,A914,A914,,10.1016/j.jval.2016.08.123,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303418,0
J,"Aras, D; Aydogdu, S; Bozkurt, E; Cavusoglu, Y; Eren, M; Erol, E; Gulec, S; Sarioz, F; Ongen, Z; Ozdemir, O; Tokgozoglu, L; Yeter, E; Yilmaz, MB",,,,"Aras, D.; Aydogdu, S.; Bozkurt, E.; Cavusoglu, Y.; Eren, M.; Erol, E.; Gulec, S.; Sarioz, F.; Ongen, Z.; Ozdemir, O.; Tokgozoglu, L.; Yeter, E.; Yilmaz, M. B.",,,THE DIRECT COST COMPONENTS IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HF-REF) IN TURKEY: THE RESULTS OF A DELPHI PANEL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aras, D.; Aydogdu, S.] Karabuk Univ, Fac Med, Zonguldak, Turkey; [Bozkurt, E.; Yeter, E.] Yildirim Beyazit Univ, Fac Med, Ankara, Turkey; [Cavusoglu, Y.] Eskisehir Osmangazi Univ, Fac Med, Eskisehir, Turkey; [Eren, M.] Siyami Ersek Cardiovasc Surg Training & Res Hosp, Istanbul, Turkey; [Erol, E.; Gulec, S.] Ankara Univ, Fac Med, Ankara, Turkey; [Sarioz, F.] Novartis, Istanbul, Turkey; [Ongen, Z.] Istanbul Univ, Cerrahpasa Fac Med, Istanbul, Turkey; [Ozdemir, O.] Yorum Consulting Ltd, Istanbul, Turkey; [Tokgozoglu, L.] Hacettepe Univ, Fac Med, Ankara, Turkey; [Yilmaz, M. B.] Cumhuriyet Univ, Fac Med, Sivas, Turkey",Bulent Ecevit University; Karabuk University; Ankara Yildirim Beyazit University; Eskisehir Osmangazi University; Dr. Siyami Ersek Cardiac & Vascular Surgery Training & Research Hospital; Ankara University; Novartis; Novartis Turkey; Istanbul University - Cerrahpasa; Istanbul University; Yorum Consultancy Ltd; Hacettepe University; Cumhuriyet University,,,"Ongen, Zeki/HZL-8534-2023; Cavusoglu, Yuksel/JWA-0879-2024; YILMAZ, Mehmet Birhan/Y-1372-2019; Ongen, Zeki/AAD-1179-2021; Eren, Miraç/AAH-9512-2019","YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Eren, Miraç/0000-0002-5150-9144",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV55,A646,A646,,10.1016/j.jval.2016.09.1723,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301811,0
J,"Arbel, R; Hammerman, A; Triki, N; Greenberg, D",,,,"Arbel, R.; Hammerman, A.; Triki, N.; Greenberg, D.",,,PCSK9 INHIBITORS MAY IMPROVE CARDIOVASCULAR OUTCOMES- CAN WE AFFORD THEM?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Arbel, R.] Sapir Coll, Sderot, Israel; [Hammerman, A.] Clalit Hlth Serv, Tel Aviv, Israel; [Triki, N.] Maccabi Healthcare Serv, Tel Aviv, Israel; [Greenberg, D.] Ben Gurion Univ Negev, Beer Sheva, Israel",Clalit Health Services; Ben Gurion University,,,"Arbel, Ronen/AFL-5178-2022; Hammerman, Ariel/AAG-4399-2020","Arbel, Ronen/0000-0002-6058-8665; Hammerman, Ariel/0000-0002-4396-5246",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV16,A865,A865,,10.1016/j.jval.2016.08.383,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303141,0
J,"Avetisyan, R; Hareendran, A; Stringer, S; Tan, S; Sanson, B; Hass, S",,,,"Avetisyan, R.; Hareendran, A.; Stringer, S.; Tan, S.; Sanson, B.; Hass, S.",,,QUALITATIVE RESEARCH APPROACHES IN RARE DISEASES: ACID SPHINGOMYELINASE DEFICIENCY (ASMD) SYMPTOMS AND IMPACT AS REPORTED BY PATIENTS AND CAREGIVERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Avetisyan, R.; Tan, S.; Sanson, B.; Hass, S.] Sanofi Genzyme, Cambridge, MA USA; [Hareendran, A.] Evidera, London, England; [Stringer, S.] Evidera, Bethesda, MD USA",Sanofi-Aventis; Genzyme Corporation; Evidera; Evidera,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM168,A388,A388,,10.1016/j.jval.2016.09.235,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300219,0
J,"Bae, S; Koh, H; Kim, Y",,,,"Bae, S.; Koh, H.; Kim, Y.",,,PRODUCTIVITY LOSS OF RHEUMATOID ARTHRITIS PATIENTS BY THEIR LEVEL OF DISEASE ACTIVITY SCORE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bae, S.] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea; [Koh, H.; Kim, Y.] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea",Hanyang University; Hanyang University Hospital; Pfizer,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS16,A917,A918,,10.1016/j.jval.2016.08.105,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606303436,0
J,"Bartakova, J; Moravcikova, D; Rogalewicz, V; Jiskra, J",,,,"Bartakova, J.; Moravcikova, D.; Rogalewicz, V; Jiskra, J.",,,BARRIERS INFLUENCING IMPLEMENTATION OF GUIDELINES INTO CLINICAL PRACTICE IN CZECH REPUBLIC,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bartakova, J.] Charles Univ Prague, Fac Med 1, Prague 2, Czech Republic; [Moravcikova, D.] Czech Med Assoc Jan Evangelista Purkyne, Prague 10, Czech Republic; [Rogalewicz, V] Czech Tech Univ, Prague, Kladno, Czech Republic; [Jiskra, J.] Gen Fac Hosp Prague, Prague 2, Czech Republic",Charles University Prague; University of Jan Evangelista Purkyne; Czech Technical University Prague; General University Hospital Prague,,,"Rogalewicz, Vladimír/H-6246-2011; Jiskra, Jan/M-1894-2017","Rogalewicz, Vladimír/0000-0001-5432-4148; Jiskra, Jan/0000-0003-0920-4854",,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS182,A635,A635,,10.1016/j.jval.2016.09.1665,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301755,0
J,"Belay, YB",,,,"Belay, Y. B.",,,"INFLUENCE OF MEDICAL REPRESENTATIVES ON PRESCRIBING PRACTICES IN MEKELLE, NORTHERN ETHIOPIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Belay, Y. B.] Mekelle Univ, Mekelle, Ethiopia",Mekelle University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP316,A495,A495,,10.1016/j.jval.2016.09.862,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,"Green Published, hybrid",,,2024-03-09,WOS:000396606300811,0
J,"Berry, LJ; Eddowes, LA",,,,"Berry, L. J.; Eddowes, L. A.",,,ADAPTING TO THE CHALLENGE: HOW ARE INNOVATIVE STUDY DESIGNS BEING USED IN RARE DISEASES?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Berry, L. J.; Eddowes, L. A.] Costello Med Consulting Ltd, Cambridge, England",Costello Medical Consulting,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM210,A395,A396,,10.1016/j.jval.2016.09.279,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300261,0
J,"Blanch, C; Comellas, M; Prada, C; Lizan, L",,,,"Blanch, C.; Comellas, M.; Prada, C.; Lizan, L.",,,ECONOMIC BURDEN OF ANKYLOSING SPONDYLITIS IN EUROPE. A SYSTEMATIC REVIEW OF THE LITERATURE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Blanch, C.] Novartis Pharmaceut, Barcelona, Spain; [Comellas, M.; Prada, C.; Lizan, L.] Univ Jaume 1, Outcomes 10, Castellon de La Plana, Spain",Novartis; Universitat Jaume I,,,"lizan, luis/AAF-1953-2020",,,,,,0,2,2,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS63,A541,A541,,10.1016/j.jval.2016.09.1130,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301246,0
J,"Buchs, S; Weatherall, J; DiBonaventura, M; Wisniewski, T",,,,"Buchs, S.; Weatherall, J.; DiBonaventura, M.; Wisniewski, T.",,,NON-ADHERENT BEHAVIOUR AND GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH INSULIN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Buchs, S.] Novo Nordisk AS, Soborg, Denmark; [Weatherall, J.; Wisniewski, T.] Novo Nordisk Inc, Plainsboro, NJ USA; [DiBonaventura, M.] Kantar Hlth, New York, NY USA",Novo Nordisk; Novo Nordisk,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB63,A676,A676,,10.1016/j.jval.2016.09.1894,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302112,0
J,"Burruss, RA; Olson, T; Garofalo, DF; Arikian, V; Oleru, K; Malik, F; Wood, A; Traurig, T; Feinberg, BA",,,,"Burruss, R. A.; Olson, T.; Garofalo, D. F.; Arikian, V; Oleru, K.; Malik, F.; Wood, A.; Traurig, T.; Feinberg, B. A.",,,PATIENT COUNSELING BY A SPECIALTY PHARMACIST INCREASES PAIN MEDICATION ADHERENCE AND PERSISTENCY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Burruss, R. A.; Olson, T.; Garofalo, D. F.; Oleru, K.; Malik, F.; Wood, A.; Feinberg, B. A.] Cardinal Hlth, Dublin, OH USA; [Arikian, V] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Traurig, T.] OncoSource Rx, Columbia, MD USA",Cardinal Health Inc; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center,,,"Malik, Farzana/JQW-8021-2023; Feinberg, Bruce/AAX-9378-2021","Feinberg, Bruce/0000-0001-9267-9994",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS66,A615,A615,,10.1016/j.jval.2016.09.1547,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301643,0
J,"Buyuktuna, N; Sumer, F",,,,"Buyuktuna, N.; Sumer, F.",,,COMPARISON OF MIRENA INTRAUTERINE DEVICE WITH ORAL PROGESTERONE TREATMENT AND SURGICAL TREATMENT IN IDIOPATHIC MENORRHAGIA PATIENTS: RESULTS OF A COST-MINIMISATION ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Buyuktuna, N.; Sumer, F.] Bayer Turk Kimya San Ltd Sti, Istanbul, Turkey",Bayer Turkey,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD78,A698,A698,,10.1016/j.jval.2016.09.2019,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302234,0
J,"Castonguay, A; Mathurin, K; Savoie, M; Lachaine, J",,,,"Castonguay, A.; Mathurin, K.; Savoie, M.; Lachaine, J.",,,DEVELOPMENT OF A GLOBAL MODEL FOR THE ECONOMIC EVALUATION OF A BIOMARKER FOR THE TREATMENT OF UNCONTROLLED MODERATE TO SEVERE ASTHMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Castonguay, A.; Mathurin, K.] PeriPharm Inc, Montreal, PQ, Canada; [Savoie, M.; Lachaine, J.] Univ Montreal, Montreal, PQ, Canada",Universite de Montreal,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS44,A556,A556,,10.1016/j.jval.2016.09.1212,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301323,0
J,"Chen, Y; Zhang, YL; Zhang, X; Wu, SH",,,,"Chen, Y.; Zhang, Y. L.; Zhang, X.; Wu, S. H.",,,POTENTIAL FACTORS PREDICTING THE RESPONSE IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER CHILDREN WITH ATOMOXETINE IN ASIA PACIFIC REGION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chen, Y.; Zhang, Y. L.; Zhang, X.; Wu, S. H.] Lilly Suzhou Pharmaceut Co Ltd, Shanghai, Peoples R China",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND6,A874,A874,,10.1016/j.jval.2016.08.352,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303191,0
J,"Clark, LA; Blanchette, CM; Noone, JM; Howden, R; Zacherle, E; Whitmire, S; Gordon, BD",,,,"Clark, L. A.; Blanchette, C. M.; Noone, J. M.; Howden, R.; Zacherle, E.; Whitmire, S.; Gordon, B. D.",,,KIDNEY-RELATED COMPLICATIONS ARE ASSOCIATED WITH WORSE OUTCOMES AMONG HOSPITALIZED CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Clark, L. A.; Noone, J. M.; Howden, R.; Zacherle, E.; Whitmire, S.; Gordon, B. D.] Univ North Carolina Charlotte, Charlotte, NC USA; [Blanchette, C. M.] Precis Hlth Econ, Davidson, NC USA",University of North Carolina; University of North Carolina Charlotte,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY5,A575,A575,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301423,0
J,"Czira, A; Pacheco, L",,,,"Czira, A.; Pacheco, L.",,,CANCER DRUGS IN THE EU5 AND USA: CROSS-COUNTRY PRICING COMPARISON AND CORRELATION ANALYSIS BETWEEN OVERALL SURVIVAL (OS) AND PROGRESSION-FREE SURVIVAL (PFS),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Czira, A.] GfK, London, England; [Pacheco, L.] GfK Market Access, London, England",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN51,A717,A717,,10.1016/j.jval.2016.09.2123,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302334,0
J,"Deepthy, B",,,,"Deepthy, B.",,,A COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN AGAINST ATORVASTATIN IN CARDIOVASCULAR DISEASES AND STROKE: AN AMBISPECTIVE STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Deepthy, B.] St Peters Inst Pharmaceut Sci, Warangal, Andhra Pradesh, India",,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV96,A653,A653,,10.1016/j.jval.2016.09.1764,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301852,0
J,"Devarakonda, S",,,,"Devarakonda, S.",,,APPLICATION OF HEALTHCARE FAILURE MODE & EFFECT ANALYSIS IN IMPROVING PATIENT EDUCATION AT AN OUTPATIENT DEPARTMENT OF A TERTIARY CARE HOSPITAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Devarakonda, S.] Armed Forces Med Coll, Pune, Maharashtra, India",Armed Forces Medical College,,,,,,,,,0,1,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP103,A831,A831,,10.1016/j.jval.2016.08.614,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302734,0
J,"Diels, J; Gatopoulou, X; Besson, H; Vesela, S; Hájek, R; Jarkovsky, J; Ito, T",,,,"Diels, J.; Gatopoulou, X.; Besson, H.; Vesela, S.; Hajek, R.; Jarkovsky, J.; Ito, T.",,,ADJUSTED COMPARISON OF DARATUMUMAB MONOTHERAPY VERSUS REAL-WORLD HISTORICAL CONTROL DATA FROM THE CZECH REPUBLIC IN HEAVILY PRE-TREATED AND HIGHLY REFRACTORY MULTIPLE MYELOMA PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Diels, J.; Besson, H.] Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium; [Gatopoulou, X.] Janssen Hlth Econ & Market Access EMEA, Athens, Greece; [Vesela, S.] Market Access Janssen Cilag Sro, Prague, Czech Republic; [Hajek, R.] Univ Hosp Ostrava, Ostrava, Czech Republic; [Hajek, R.] Fac Med, Ostrava, Czech Republic; [Jarkovsky, J.] Masaryk Univ, Brno, Czech Republic; [Ito, T.] Janssen Hlth Econ & Market Access EMEA, High Wycombe, Bucks, England",University Hospital Ostrava; Masaryk University Brno,,,"Ito, Tetsuro/I-6806-2018; Hajek, Roman/I-6639-2017","Hajek, Roman/0000-0001-6955-6267",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN18,A711,A711,,10.1016/j.jval.2016.09.2090,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302301,0
J,"Duteil, E; Cariou, C; Schmidt, A; Benjamin, K; Duco, J",,,,"Duteil, E.; Cariou, C.; Schmidt, A.; Benjamin, K.; Duco, J.",,,COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB COMPARED TO CURRENT BIOLOGICS SEQUENCES FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN FRANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Duteil, E.; Cariou, C.; Benjamin, K.; Duco, J.] Novartis Pharmaceut, Rueil Malmaison, France; [Schmidt, A.] Steve Consultants, Oullins, France",Novartis,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY80,A589,A589,,10.1016/j.jval.2016.09.1395,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301498,0
J,"Elias, I; Giménez, M; Alvarez, M; Quirós, C; Conget, I",,,,"Elias, I; Gimenez, M.; Alvarez, M.; Quiros, C.; Conget, I",,,BUDGET IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION COMPARED WITH MULTIPLE DAILY INSULIN INJECTIONS FOR THE TREATMENT OF TYPE 1 DIABETES IN SPAIN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Elias, I; Alvarez, M.] Medtron Iber SA, Madrid, Spain; [Gimenez, M.; Quiros, C.] Hosp Clin Barcelona, Dept Endocrinol, Diabet Unit, Barcelona, Spain; [Gimenez, M.; Quiros, C.] Univ Barcelona, IDIBAPS, Barcelona, Spain",University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS,,,"Quirós, Carmen/JXW-5532-2024",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD29,A689,A690,,10.1016/j.jval.2016.09.1970,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302185,0
J,"Filipovic-Pierucci, A; Zarca, K; Durand-Zaleski, I",,,,"Filipovic-Pierucci, A.; Zarca, K.; Durand-Zaleski, I",,,MARKOV MODELS FOR HEALTH ECONOMIC EVALUATION MODELLING IN R WITH THE HEEMOD PACKAGE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Filipovic-Pierucci, A.; Zarca, K.; Durand-Zaleski, I] APHP, Paris, France",Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP,,,,,,,,,0,15,15,1,12,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM68,A369,A369,,10.1016/j.jval.2016.09.133,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300119,0
J,"Gericke, CA; Mohasseb, I; Duncan, E; Younger, J",,,,"Gericke, C. A.; Mohasseb, I; Duncan, E.; Younger, J.",,,ADOPTION OF INNOVATIVE TECHNOLOGIES AND SUBSTITUTION EFFECTS: COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY IN AUSTRALIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gericke, C. A.] Univ Queensland, Brisbane, Qld, Australia; [Mohasseb, I; Younger, J.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Duncan, E.] Queensland Univ Technol, Brisbane, Qld, Australia",University of Queensland; Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT),,,"Gericke, Christian A/H-1005-2012",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,CV4,A812,A812,,10.1016/j.jval.2016.08.703,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302624,0
J,"Gheorghe, M",,,,"Gheorghe, M.",,,PREDICTING PATIENT-REPORTED OUTCOMES FROM DISEASE-SPECIFIC QUESTIONNAIRES: A COMPARISON OF SEVEN METHODOLOGIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gheorghe, M.] Erasmus Univ, Rotterdam, Netherlands",Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM132,A381,A381,,10.1016/j.jval.2016.09.198,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300183,0
J,"Gielen, V; Gondos, A; Alexopoulos, S",,,,"Gielen, V; Gondos, A.; Alexopoulos, S.",,,REAL-WORLD HOSPITALISATION AND MORTALITY OF INCIDENT AND PREVALENT PATIENTS WITH HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN ENGLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gielen, V; Alexopoulos, S.] Novartis Pharmaceut UK Ltd, Camberley, Surrey, England; [Gondos, A.] IMS HLTH GmbH & Co OHG, Munich, Germany",Novartis,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV23,A640,A640,,10.1016/j.jval.2016.09.1690,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301779,0
J,"Gkinou, C; Kani, C; Souliotis, K; Karalis, V; Markantonis, S",,,,"Gkinou, C.; Kani, C.; Souliotis, K.; Karalis, V; Markantonis, S.",,,GENERIC DRUGS- DO THEY OFFER THE SAME SAFETY AND EFFICACY AS ORIGINATOR MEDICINES? -PERCEPTIONS AND ATTITUDES OF FINAL YEAR PHARMACY STUDENTS IN GREECE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gkinou, C.; Karalis, V; Markantonis, S.] Univ Athens, Athens, Greece; [Kani, C.; Souliotis, K.] Univ Peloponnese, Corinth, Greece",National & Kapodistrian University of Athens; University of Peloponnese,,,"SOULIOTIS, KYRIAKOS/AAM-3164-2021; Karalis, Vangelis/L-9642-2019; Markantonis, Sophia/HGB-3468-2022","SOULIOTIS, KYRIAKOS/0000-0003-1624-9444; Karalis, Vangelis/0000-0003-0492-0712;",,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP126,A461,A461,,10.1016/j.jval.2016.09.667,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300625,0
J,"Goetghebeur, MM; Samaha, D; Khoury, H; O'Neil, B; Lavoie, L; Bennetts, L; Wagner, M; Badgley, D; Gabriel, S; Berthon, A; Dolan, J; Kulke, M",,,,"Goetghebeur, M. M.; Samaha, D.; Khoury, H.; O'Neil, B.; Lavoie, L.; Bennetts, L.; Wagner, M.; Badgley, D.; Gabriel, S.; Berthon, A.; Dolan, J.; Kulke, M.",,,TO TREAT OR WATCH? IDENTIFYING DRIVERS OF DECISIONS FOR PATIENTS WITH GEP-NET USING REFLECTIVE MULTI-CRITERIA DECISION ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Goetghebeur, M. M.] Univ Montreal, LASER Analyt, Montreal, PQ, Canada; [Goetghebeur, M. M.] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Samaha, D.; Khoury, H.; O'Neil, B.; Lavoie, L.; Bennetts, L.; Wagner, M.; Badgley, D.] LASER Analyt, Montreal, PQ, Canada; [Gabriel, S.] IPSEN Pharma, Boulogne, France; [Berthon, A.] IPSEN, Boulogne, France; [Dolan, J.] Univ Rochester, Rochester, NY USA; [Kulke, M.] Dana Farber Canc Inst, Boston, MA 02115 USA",Universite de Montreal; Universite de Montreal; Ipsen; University of Rochester; Harvard University; Dana-Farber Cancer Institute,,,"L, L/HGA-1686-2022; -, Li/JMB-7112-2023; l, l/GZH-2874-2022; L, L/KCY-3050-2024; l, l/HJH-2933-2023; l, l/HTL-7067-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM156,A385,A386,,10.1016/j.jval.2016.09.223,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300207,0
J,"Goodall, S; Zhao, F; Street, D; Viney, R",,,,"Goodall, S.; Zhao, F.; Street, D.; Viney, R.",,,ESTIMATING THE IMPACT OF DIRECT-TO-CONSUMER ADVERTISING OF PHARMACY ONLY MEDICINE USING DISCRETE CHOICE EXPERIMENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Goodall, S.; Zhao, F.; Street, D.; Viney, R.] Univ Technol Sydney, Sydney, NSW, Australia",University of Technology Sydney,,,,"Viney, Rosalie/0000-0002-0039-9635",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM39,A855,A855,,10.1016/j.jval.2016.08.451,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303085,0
J,"Gottschalk, F; Müller, S; Torka, S; Ingenhaag, M; Wilke, T",,,,"Gottschalk, F.; Mueller, S.; Torka, S.; Ingenhaag, M.; Wilke, T.",,,FACTORS ASSOCIATED WITH THE MENTAL AND PHYSICAL HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF ASTHMA PATIENTS: A CROSS-SECTIONAL ANALYSIS BASED ON 673 PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gottschalk, F.; Mueller, S.] IPAM, Wismar, Germany; [Torka, S.; Ingenhaag, M.] GlaxoSmithKline GmbH & Co KG, Munich, Germany; [Wilke, T.] INGRESS Hlth HWM GmbH, Wismar, Germany",GlaxoSmithKline,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS57,A558,A559,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301336,0
J,"Gunsoy, N; Cockle, S; Nelsen, L; Albers, F; Doyle, S",,,,"Gunsoy, N.; Cockle, S.; Nelsen, L.; Albers, F.; Doyle, S.",,,"ASSOCIATION BETWEEN EQ-5D AND CHANGES IN ASTHMA SYMPTOMS, SEVERITY, AND QOL IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gunsoy, N.] GSK, Stockley Pk, Uxbridge, Middx, England; [Cockle, S.; Doyle, S.] GSK, Brentford, Middx, England; [Nelsen, L.] GSK, Collegeville, PA USA; [Albers, F.] GSK, Res Triangle Pk, NC USA",GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline,,,"Nelsen, Linda/GZL-1004-2022",,,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS56,A558,A558,,10.1016/j.jval.2016.09.1225,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301335,0
J,"Harmand, S; El Mouaddin, N",,,,"Harmand, S.; El Mouaddin, N.",,,METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Harmand, S.; El Mouaddin, N.] IMS Hlth, Puteaux La Defense, France",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM131,A381,A381,,10.1016/j.jval.2016.09.197,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300182,0
J,"Hayran, KM; Erman, M; Kilickap, S; Dizdar, Ö; Yuce, D; Huseyin, B; Celik, I",,,,"Hayran, K. M.; Erman, M.; Kilickap, S.; Dizdar, O.; Yuce, D.; Huseyin, B.; Celik, I",,,USING GEOGRAPHICAL INFORMATION SYSTEMS TO DESCRIBE QUALITY OF LIFE AS A FUNCTION OF DISTANCE IN CANCER PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hayran, K. M.; Erman, M.; Kilickap, S.; Dizdar, O.; Yuce, D.; Huseyin, B.; Celik, I] Hacettepe Univ, Inst Canc, Ankara, Turkey",Hacettepe University,,,"Kilickap, Saadettin/AAP-3732-2021; CELIK, ISMAIL/J-1229-2013","Kilickap, Saadettin/0000-0003-1637-7390;",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN47,A892,A892,,10.1016/j.jval.2016.08.256,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303291,0
J,"Hinteregger, M; Janzek-Hawlat, S; Reichardt, B",,,,"Hinteregger, M.; Janzek-Hawlat, S.; Reichardt, B.",,,SEASONAL VARIATIONS OF OUTPATIENT ANTIBIOTIC USE IN AUSTRIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hinteregger, M.; Janzek-Hawlat, S.] Main Assoc Austrian Social Secur Inst HVB, Vienna, Austria; [Reichardt, B.] Sickness Fund Burgenland BGKK, Eisenstadt, Austria",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN81,A421,A421,,10.1016/j.jval.2016.09.432,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300405,0
J,"Hirst, A; Vlachaki, I; Shephard, C; Wang-Silvanto, J",,,,"Hirst, A.; Vlachaki, I; Shephard, C.; Wang-Silvanto, J.",,,COST MINIMISATION ANALYSIS: WHEN AND WHERE? A REVIEW OF HTA GUIDANCE ON COST MINIMISATION ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hirst, A.; Vlachaki, I; Shephard, C.; Wang-Silvanto, J.] WG Access Ltd, London, England",,,,,,,,,,0,0,0,2,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP244,A482,A482,,10.1016/j.jval.2016.09.785,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300740,0
J,"Hollis, K; Abuzakouk, M; Balp, M; Berard, F; Canonica, GW; Gimenez-Arnau, A; Grattan, C; Khalil, S; Knulst, AC; Lacour, J; Lynde, C; Maurer, M; McBride, D; Nakonechna, A; de Frutoz, O FJO; Elberink, JO; Proctor, C; Sussman, G; Sweeney, C; Tian, H; Weller, K; Marsland, A",,,,"Hollis, K.; Abuzakouk, M.; Balp, M.; Berard, F.; Canonica, G. W.; Gimenez-Arnau, A.; Grattan, C.; Khalil, S.; Knulst, A. C.; Lacour, J.; Lynde, C.; Maurer, M.; McBride, D.; Nakonechna, A.; Ortiz de Frutoz, F. J.; Elberink, Oude J.; Proctor, C.; Sussman, G.; Sweeney, C.; Tian, H.; Weller, K.; Marsland, A.",,,ASSESSING HEALTH-UTILITY VALUES FOR CHRONIC SPONTANEOUS/IDIOPATHIC URTICARIA IN REAL-WORLD USING THE EQ-5D: RESULTS FROM ASSURE-CSU STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hollis, K.; Proctor, C.; Sweeney, C.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Abuzakouk, M.] Cleveland Clin Abu Dhabi, Abu Dhabi, U Arab Emirates; [Balp, M.; Khalil, S.] Novartis Pharma AG, Basel, Switzerland; [Berard, F.] Claude Bernard Univ Lyon, Lyon, France; [Canonica, G. W.] Univ Genoa, Genoa, Italy; [Gimenez-Arnau, A.] Hosp del Mar, Parc Salut Mar, Barcelona, Spain; [Grattan, C.] Guys Hosp, London, England; [Knulst, A. C.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Lacour, J.] Univ Nice Sophia Antipolis, Nice 2, France; [Lynde, C.] Lynderm Res Inc, Toronto, ON, Canada; [Maurer, M.; Weller, K.] Charite, Berlin, Germany; [McBride, D.] RTI Hlth Solut, Manchester, Lancs, England; [Nakonechna, A.] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Ortiz de Frutoz, F. J.] Hosp 12 Octubre, Madrid, Spain; [Elberink, Oude J.] Univ Groningen, Groningen, Netherlands; [Sussman, G.] Univ Toronto, Toronto, ON, Canada; [Tian, H.] Novartis Pharmaceut, E Hanover, NJ USA; [Marsland, A.] Salford Royal Hosp, Salford, Lancs, England; [Marsland, A.] Univ Manchester, Salford, Lancs, England",Research Triangle Institute; Cleveland Clinic Foundation; Novartis; Universite Claude Bernard Lyon 1; University of Genoa; Hospital del Mar Research Institute; Hospital del Mar; Guy's & St Thomas' NHS Foundation Trust; Utrecht University; Utrecht University Medical Center; Universite Cote d'Azur; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Research Triangle Institute; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Hospital Universitario 12 de Octubre; University of Groningen; University of Toronto; Novartis; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester,,,"canonica, giorgio walter/ABF-2037-2020; Maurer, Marcus/ABG-2174-2020","canonica, giorgio walter/0000-0001-8467-2557; Maurer, Marcus/0000-0002-4121-481X",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS50,A570,A571,,10.1016/j.jval.2016.09.1295,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301401,0
J,"Kamusheva, M; Doneva, M; Dimitrova, M; Petrova, G",,,,"Kamusheva, M.; Doneva, M.; Dimitrova, M.; Petrova, G.",,,COST ANALYSIS OF THERAPY WITH IDURSULFASE FOR HUNTER SYNDROME IN BULGARIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kamusheva, M.; Doneva, M.; Dimitrova, M.; Petrova, G.] Med Univ Sofia, Fac Pharm, Sofia, Bulgaria",Medical University Sofia,,,"Doneva, Miglena/AAQ-3522-2021; Petrova, Guenka/I-6863-2019; Kamusheva, Maria/HKW-3799-2023","Doneva, Miglena/0000-0002-8187-8952; Petrova, Guenka/0000-0001-8116-5138; Kamusheva, Maria/0000-0002-4379-5283",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY64,A586,A586,,10.1016/j.jval.2016.09.1379,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301482,0
J,"Kempers, J; Narvestad, J; Kofod, M; Mikkelsen, RM",,,,"Kempers, J.; Narvestad, J.; Kofod, M.; Mikkelsen, R. M.",,,BUDGET IMPACT ANALYSIS OF NATIONAL CERVICAL CANCER SCREENING PROGRAM IN DENMARK: CYTOLOGY WITH HPV TRIAGE VS. HPV PRIMARY SCREENING WITH REFLEX CYTOLOGY TRIAGE & CINTEC PLUS CYTOLOGY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kempers, J.] Roche Diagnost, Almere, Netherlands; [Narvestad, J.; Kofod, M.; Mikkelsen, R. M.] Roche Diagnost, Hvidovre, Denmark",Roche Holding,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD27,A689,A689,,10.1016/j.jval.2016.09.1968,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302183,0
J,"Knoblauch, V",,,,"Knoblauch, Vicki",,,Elections generate all binary relations on infinite sets,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,UTILITY; THEOREM; REPRESENTATIONS,"Every binary relation on an infinite set can be represented by an election in which each voter's preferences are quasi-transitive and complete (except possibly not reflexive) and in which the electorate has smaller cardinality than or the same cardinality as the set of alternatives, depending on the cardinality of that set. (C) 2016 Elsevier B.V. All rights reserved.","[Knoblauch, Vicki] Univ Connecticut, Dept Econ, Oak Hall, Storrs, CT 06269 USA",University of Connecticut,"Knoblauch, V (通讯作者)，Univ Connecticut, Dept Econ, Oak Hall, Storrs, CT 06269 USA.",vicki.knoblauch@uconn.edu,,,,,,,11,2,2,0,2,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,NOV,2016,84.0,,,,,,105,108,,10.1016/j.mathsocsci.2016.10.002,0.0,,,4,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,EF1LB,,,,,2024-03-09,WOS:000390085200011,0
J,"Krajnovic, D; Arsic, J; Milijic, S; Georgiev, AM",,,,"Krajnovic, D.; Arsic, J.; Milijic, S.; Georgiev, Milosevic A.",,,ANALYSIS OF ANTIBIOTICS' USE IN THE TREATMENT OF TONSILL PHARYNGITIS IN CHILDREN POPULATION OF NIS DISTRICT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Krajnovic, D.; Georgiev, Milosevic A.] Univ Belgrade, Belgrade, Serbia; [Arsic, J.] Materna Medika, Vranje, Serbia; [Milijic, S.] Republ Fund Hlth Insurance, Nish, Serbia",University of Belgrade,,,"Krajnović, Dušanka/L-1617-2019","Krajnović, Dušanka/0000-0003-1699-7944",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIH33,A405,A405,,10.1016/j.jval.2016.09.340,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300317,0
J,"Lee, B; Kim, E; Yang, B; Kwon, H",,,,"Lee, B.; Kim, E.; Yang, B.; Kwon, H.",,,HEALTH RELATED QUALITY OF LIFE AMONG PATIENTS WITH HEART FAILURE IN SOUTH KOREA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, B.; Kim, E.; Yang, B.] Seoul Natl Univ, Seoul, South Korea; [Kwon, H.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA",Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV45,A870,A870,,10.1016/j.jval.2016.08.380,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303169,0
J,"Lewsey, J; Leelahavarong, P; Briggs, A",,,,"Lewsey, J.; Leelahavarong, P.; Briggs, A.",,,"DEVELOPMENT OF AN ALCOHOL POLICY MODEL THAT PREDICTS LIFE YEARS, QALYS, AND HEALTH CARE COSTS ACCOUNTING FOR ALCOHOL USE DISORDER IDENTIFICATION TEST",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lewsey, J.; Leelahavarong, P.; Briggs, A.] Univ Glasgow, Glasgow, Lanark, Scotland",University of Glasgow,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,CU4,A808,A808,,10.1016/j.jval.2016.08.723,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302604,0
J,"Li, CX; Chen, DC",,,,"Li, Chenxu; Chen, Dachuan",,,Estimating jump-diffusions using closed-form likelihood expansions,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Maximum-likelihood estimation; Jump-diffusion; Discrete observations; Transition density; Expansion,STOCHASTIC VOLATILITY; ASYMPTOTIC EXPANSIONS; POINT-PROCESSES; RISK PREMIA; MODEL; APPROXIMATIONS; DISTRIBUTIONS; VARIABLES; IMPLICIT; OPTIONS,"The indispensable role of likelihood expansions in financial econometrics for continuous-time models has been established since the ground-breaking work of Ait-Sahalia (1999, 2002a, 2008). Jump-diffusions play an important role in modeling a variety of economic and financial variables. As a significant generalization of Li (2013), we propose a new closed-form expansion for transition density of Poisson driven jump-diffusion models and its application in maximum-likelihood estimation based on discretely sampled data. Technically speaking, our expansion is obtained by perturbing paths of the underlying model; correction terms can be calculated explicitly using any symbolic software. Numerical examples and Monte Carlo evidence for illustrating the performance of density expansion and the resulting approximate MLE are provided in order to demonstrate the practical applicability of the method. Using the theoretical results in Hayashi and Ishikawa (2012), some convergence properties related to the density expansion and the approximate MLE method can be justified under some standard sufficient (but not necessary) conditions. (C) 2016 Elsevier B.V. All rights reserved.","[Li, Chenxu] Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China; [Chen, Dachuan] Univ Illinois, Liautaud Grad Sch Business, Chicago, IL 60607 USA",Peking University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital,"Li, CX (通讯作者)，Peking Univ, Guanghua Sch Management, Beijing 100871, Peoples R China.",cxli@gsm.pku.edu.cn; dchen57@uic.edu,,,Guanghua School of Management at Peking University; Center for Statistical Sciences at Peking University; Key Laboratory of Mathematical Economics and Quantitative Finance (Ministry of Education) at Peking University; National Natural Science Foundation of China [11201009]; University of Illinois at Chicago; Division Of Mathematical Sciences; Direct For Mathematical & Physical Scien [1407820] Funding Source: National Science Foundation,Guanghua School of Management at Peking University; Center for Statistical Sciences at Peking University; Key Laboratory of Mathematical Economics and Quantitative Finance (Ministry of Education) at Peking University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Illinois at Chicago; Division Of Mathematical Sciences; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)),"We are grateful to Yacine Ait-Sahalia (the editor) and two anonymous referees for very helpful comments and suggestions. Chenxu Li also benefited from discussions with Jose Blanchet, Mark Broadie, Peter Carr, Kay Giesecke, Ioannis Karatzas, Arturo Kohatsu-higa, Per Mykland, Philip Protter, Yasutaka Shimizu, Masayuki Uchida, Dacheng Xiu, Nakahiro Yoshida, Lan Zhang, and seminar participants at Morgan Stanley, Columbia University, Shanghai Jiaotong University, Bernoulli Society Satellite Meeting to the ISI World Statistics Congress 2013 in Tokyo, International Symposium on Financial Engineering and Risk Management 2014 in Beijing, and Tsinghua-PKU-Stanford conference on quantitative finance 2015. Chenxu Li's research was supported by the Guanghua School of Management, the Center for Statistical Sciences, and the Key Laboratory of Mathematical Economics and Quantitative Finance (Ministry of Education) at Peking University, as well as the National Natural Science Foundation of China (Grant 11201009). Dachuan Chen is grateful to the scholarship from the University of Illinois at Chicago.",,67,17,19,3,46,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,NOV,2016,195.0,1.0,,,,,51,70,,10.1016/j.jeconom.2016.07.001,0.0,,,20,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DY0GR,,,,,2024-03-09,WOS:000384775800004,0
J,"Liao, C; Tan, EC; Yang, M",,,,"Liao, C.; Tan, E. C.; Yang, M.",,,A COMPARISON OF EUROQOL EQ-5D AND SF-36 FOR ESTIMATING HEALTH ADJUSTED LIFE-EXPECTANCY (HALE) IN TAIWAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Liao, C.; Tan, E. C.; Yang, M.] Natl Taiwan Univ, Taipei, Taiwan",National Taiwan University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM31,A854,A854,,10.1016/j.jval.2016.08.456,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303078,0
J,"Locatelli, I; Venisnik, K",,,,"Locatelli, I; Venisnik, K.",,,"A NETWORK META-ANALYSIS OF ATOMOXETINE, METHYLPHENIDATE, LISDEXAMFETAMINE, AND BUPROPION FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN AND ADOLESCENTS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Locatelli, I; Venisnik, K.] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia",University of Ljubljana,,,"Locatelli, Igor/I-4259-2019","Locatelli, Igor/0000-0002-0052-8986",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMH5,A521,A522,,10.1016/j.jval.2016.09.1017,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301139,0
J,"Lucey, S; Tilson, L; Fogarty, E; Walshe, V; Barry, M",,,,"Lucey, S.; Tilson, L.; Fogarty, E.; Walshe, V; Barry, M.",,,A REVIEW OF THE QUALITY AND ACCURACY OF BUDGET IMPACT MODELS FOR HIGH COST DRUGS IN IRELAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lucey, S.; Tilson, L.; Fogarty, E.; Barry, M.] Natl Ctr Pharmacoecon, Dublin, Ireland; [Walshe, V] Hlth Serv, Cork, Ireland",,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP110,A458,A458,,10.1016/j.jval.2016.09.651,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300609,0
J,"Mahuteau, S; Zhu, R",,,,"Mahuteau, Stephane; Zhu, Rong",,,Crime Victimisation and Subjective Well-Being: Panel Evidence From Australia,HEALTH ECONOMICS,,,English,Article,,,,,,victimisation; subjective well-being; quantile regression,LABOR-MARKET OUTCOMES; CRIMINAL VICTIMIZATION; PSYCHIATRIC-DISORDERS; HAPPINESS; LIFE; HEALTH; FEAR,"This paper estimates the effect of physical violence and property crimes on subjective well-being in Australia. Our methodology improves on previous contributions by (i) controlling for the endogeneity of victimisation and (ii) analysing the heterogeneous effect of victimisation along the whole distribution of well-being. Using fixed effects panel estimation, we find that both types of crimes reduce reported well-being to a large extent, with physical violence exerting a larger average effect than property crimes. Furthermore, using recently developed panel data quantile regression model with fixed effects, we show that the negative effects of both crimes are highly heterogeneous, with a monotonic decrease over the distribution of subjective well-being. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Mahuteau, Stephane; Zhu, Rong] Flinders Univ S Australia, Natl Inst Labour Studies, Adelaide, SA, Australia; [Mahuteau, Stephane] Inst Study Labor IZA, Bonn, Germany",Flinders University South Australia; IZA Institute Labor Economics,"Zhu, R (通讯作者)，Flinders Univ S Australia, Natl Inst Labour Studies, Adelaide, SA, Australia.",rong.zhu@flinders.edu.au,"Mahuteau, Stephane/O-7881-2018","Mahuteau, Stephane/0000-0002-6420-6150; Zhu, Rong/0000-0002-6872-1571",Australian Government Department of Social Services (DSS),Australian Government Department of Social Services (DSS)(Australian Government),"We thank James Burgess (the Editor) and two anonymous referees for helpful comments. This paper uses unit record data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The HILDA Project was initiated and is funded by the Australian Government Department of Social Services (DSS) and is managed by the Melbourne Institute of Applied Economic and Social Research (Melbourne Institute). The findings and views reported in this paper, however, are those of the authors and should not be attributed to either DSS or the Melbourne Institute. The authors assume jointly the first authorship of this article.",,39,36,39,0,20,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2016,25.0,11.0,,,,,1448,1463,,10.1002/hec.3230,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ8SO,26315327.0,Green Submitted,,,2024-03-09,WOS:000386142000009,0
J,"Manan, MM",,,,"Manan, M. M.",,,MEDICATION COST OF ACUTE MYELOID LEUKEMIA: A DESCRIPTIVE STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Manan, M. M.] KPJ Healthcare Univ Coll, Nilai, Malaysia",,,,"MANSOR, MANAN MOHAMED/AAU-6040-2020",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY23,A883,A883,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606303244,0
J,"Mantovani, LG; Cortesi, PA; Senni, M; Deschaseaux, C; Haroun, R; Pitotti, C",,,,"Mantovani, L. G.; Cortesi, P. A.; Senni, M.; Deschaseaux, C.; Haroun, R.; Pitotti, C.",,,COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION IN ITALY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mantovani, L. G.; Cortesi, P. A.] Univ Milano Bicocca, Monza, Italy; [Senni, M.] ASST Papa Giovanni XXIII, Bergamo, Italy; [Deschaseaux, C.; Haroun, R.] Novartis Pharma AG, Basel, Switzerland; [Pitotti, C.] Novartis Farma, Origgio, Italy",University of Milano-Bicocca; ASST Papa Giovanni XXIII; Novartis; Novartis,,,"Cortesi, Paolo Angelo/AAD-7926-2020; Mantovani, Lorenzo Giovanni/AAC-4263-2021",,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV80,A650,A650,,10.1016/j.jval.2016.09.1748,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301836,0
J,"Braga, SM; Souza, MC; Oliveira, RR; Andrade, EI; AcurcioFd; Cherchiglia, ML",,,,"Mendes Braga, S.; Souza, M. C.; Oliveira, R. R.; Andrade, E., I; AcurcioFd; Cherchiglia, M. L.",,,SURVIVAL AND DEATH RISK OF PATIENTS WITH PROSTATE CANCER TREATED IN THE BRAZILIAN PUBLIC HEALTH SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mendes Braga, S.; Oliveira, R. R.; Andrade, E., I; Cherchiglia, M. L.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Souza, M. C.] Inst Nacl Canc, Rio De Janeiro, Brazil; [AcurcioFd] Univ Fed Minas Gerais, Coll Pharm, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais; National Cancer Institute (Inca); Universidade Federal de Minas Gerais,,,"Cherchiglia, Mariangela/Z-3216-2019; Andrade, Eli Iola Gurgel/AAP-9854-2021","Cherchiglia, Mariangela/0000-0001-5622-567X;",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS113,A624,A624,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301690,0
J,"Meng, Y; Hertel, N; Ellis, J; Johnson, H; Philips, Z; Roskell, N; Lee, D",,,,"Meng, Y.; Hertel, N.; Ellis, J.; Johnson, H.; Philips, Z.; Roskell, N.; Lee, D.",,,COST EFFECTIVENESS OF NIVOLUMAB MONOTHERAPY FOR THE TREATMENT OF ADVANCED MELANOMA PATIENTS IN THE UNITED KINGDOM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Meng, Y.; Philips, Z.; Roskell, N.; Lee, D.] BresMed Hlth Solut, Sheffield, S Yorkshire, England; [Hertel, N.; Ellis, J.] Bristol Myers Squibb Pharmaceut, Uxbridge, Middx, England; [Johnson, H.] Helen Johnson Consulting Ltd, Welwyn Garden City, Herts, England",Bristol-Myers Squibb,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,EE4,A354,A354,,10.1016/j.jval.2016.09.047,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300039,0
J,"Mettam, SR; Bajaj, H; Kansal, AR; Kandaswamy, P",,,,"Mettam, S. R.; Bajaj, H.; Kansal, A. R.; Kandaswamy, P.",,,COST EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH T2DM AND HIGH CV RISK IN CANADA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mettam, S. R.] Boehringer Ingelheim GmbH & Co KG, Burlington, ON, Canada; [Bajaj, H.] LMC Diabet & Endocrinol, Brampton, ON, Canada; [Kansal, A. R.] Evidera, Bethesda, MD USA; [Kandaswamy, P.] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany",Boehringer Ingelheim; Evidera; Boehringer Ingelheim,,,,,,,,,0,13,13,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB52,A674,A674,,10.1016/j.jval.2016.09.1882,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302101,0
J,"Mocarski, M; Tian, Y; Buysman, EK; Wolbeck, R",,,,"Mocarski, M.; Tian, Y.; Buysman, E. K.; Wolbeck, R.",,,HEMOGLOBIN A1C (A1C) REDUCTION AND DIABETES-RELATED HEALTH CARE COSTS AMONG TYPE 2 DIABETES (T2DM) PATIENTS TREATED WITH LIRAGLUTIDE OR EXENATIDE: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mocarski, M.; Tian, Y.] Novo Nordisk Inc, Plainsboro, NJ USA; [Buysman, E. K.; Wolbeck, R.] Optum, Eden Prairie, MN USA",Novo Nordisk; Optum,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB10,A666,A666,,10.1016/j.jval.2016.09.1839,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302059,0
J,"Mytelka, DS; Lorenzo, M; Stafkey-Mailey, D; D'Yachkova, Y; Nagar, SP; Candrilli, SD; Kaye, JA; Kasper, B",,,,"Mytelka, D. S.; Lorenzo, M.; Stafkey-Mailey, D.; D'Yachkova, Y.; Nagar, S. P.; Candrilli, S. D.; Kaye, J. A.; Kasper, B.",,,ADVANCED SOFT TISSUE SARCOMA: SYSTEMIC TREATMENT PATTERNS AND SURVIVAL IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mytelka, D. S.] Eli Lilly, Indianapolis, IN USA; [Lorenzo, M.] Eli Lilly & Co Ltd, Windlesham, Surrey, England; [Stafkey-Mailey, D.] Xcenda LLC, Palm Harbor, FL USA; [D'Yachkova, Y.] Eli Lilly Austria GmbH, Vienna, Austria; [Nagar, S. P.; Candrilli, S. D.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Kaye, J. A.] RTI Hlth Solut, Waltham, MA USA; [Kasper, B.] Univ Mannheim, Med Ctr, Mannheim, Germany","Eli Lilly; Eli Lilly; AmerisourceBergen Corporation; Xcenda, LLC; Eli Lilly; Research Triangle Institute; Research Triangle Institute; University of Mannheim",,,,"Mytelka, Daniel/0000-0001-7669-8634",,,,,0,1,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN286,A760,A760,,10.1016/j.jval.2016.09.2362,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302565,0
J,"Nemeth, B; Kulchaitanaroaj, P; Lester-George, A; Huic, M; Pokhrel, S; Coyle, D; Coyle, K; KaloKaló, Z; Jozwiak-HagymasyJózwiak-Hagymásy, J",,,,"Nemeth, B.; Kulchaitanaroaj, P.; Lester-George, A.; Huic, M.; Pokhrel, S.; Coyle, D.; Coyle, K.; KaloKalo, Z.; Jozwiak-HagymasyJozwiak-Hagymasy, J.",,,IDENTIFYING THE KEY PARAMETERS OF THE EUROPEAN-STUDY ON QUANTIFYING UTILITY OF INVESTMENT IN PROTECTION FROM TOBACCO (EQUIPT) MODEL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nemeth, B.; Jozwiak-HagymasyJozwiak-Hagymasy, J.] Syreon Res Inst, Budapest, Hungary; [Kulchaitanaroaj, P.; Pokhrel, S.; Coyle, K.] Brunel Univ, Uxbridge, Middx, England; [Lester-George, A.] LeLan Solut, Bristol, Avon, England; [Huic, M.] Agcy Qual & Accreditat Hlth Care & Social Welf, Zagreb, Croatia; [Coyle, D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [KaloKalo, Z.] Eotvos Lorand Univ, Budapest, Hungary",Brunel University; University of Ottawa; Eotvos Lorand University,,,"Pokhrel, Subhash/AAO-8648-2020; Huic, Mirjana/CAA-0289-2022","Lester-George, Adam/0000-0002-5342-817X",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM103,A375,A375,,10.1016/j.jval.2016.09.169,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300154,0
J,"Ogbonna, B; Eze, L; Ogbonna, C; Ejim, C",,,,"Ogbonna, B.; Eze, L.; Ogbonna, C.; Ejim, C.",,,QUINOLONES UTILIZATION IN TWO TERTIARY HOSPITALS IN NIGERIA; A PHARMACOEPIDEMIOLOGICAL SURVEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ogbonna, B.; Eze, L.] Nnamdi Azikiwe Univ, Awka, Anambra State, Nigeria; [Ogbonna, C.; Ejim, C.] Enugu State Univ Teaching Hosp, Enugu, Nigeria",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP18,A817,A817,,10.1016/j.jval.2016.08.677,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302653,0
J,"Olveira, G; Martinez-Olmos, MA; de Bobadilla, BF; Ferrer, M; Virgili, N; Vega, B; Blanco, M; Layola, M; Lizan, L; de Suarez, MT",,,,"Olveira, G.; Martinez-Olmos, M. A.; de Bobadilla, Fernandez B.; Ferrer, M.; Virgili, N.; Vega, B.; Blanco, M.; Layola, M.; Lizan, L.; de Suarez, Tribaldos M.",,,PREFERENCES FOR THE CHARACTERISTICS OF HOME ENTERAL NUTRITION (HEN) VIA TUBE FEEDING: A DISCRETE-CHOICE EXPERIMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Olveira, G.] Hosp Reg Univ Malaga, Malaga, Spain; [Martinez-Olmos, M. A.] Hosp Univ Santiago, Santiago De Compostela, Spain; [de Bobadilla, Fernandez B.] Hosp Gen Univ Ciudad Real, Ciudad Real, Spain; [Ferrer, M.] Hosp Clin Univ Virgen de Arrixaca de Murcia, Murcia, Spain; [Virgili, N.] Bellvitge Hosp, Barcelona, Spain; [Vega, B.] Hosp Univ Ramon & Cajal, Madrid, Spain; [Blanco, M.; Layola, M.] Nestle Hlth Sci, Barcelona, Spain; [Lizan, L.] Univ Jaume 1, Outcomes 10, Castellon de La Plana, Spain",Hospital Clinico Universitario Virgen de la Arrixaca; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitario Ramon y Cajal; Universitat Jaume I,,,"lizan, luis/AAF-1953-2020; OLVEIRA, GABRIEL/K-8778-2012","OLVEIRA, GABRIEL/0000-0002-7646-2899",,,,,0,0,0,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP185,A472,A472,,10.1016/j.jval.2016.09.728,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300683,0
J,"Pan, J; Lei, XY; Liu, GG",,,,"Pan, Jay; Lei, Xiaoyan; Liu, Gordon G.",,,Health Insurance and Health Status: Exploring the Causal Effect from a Policy Intervention,HEALTH ECONOMICS,,,English,Article,,,,,,health insurance; health status; China Urban Resident Basic Medical Insurance; government subsidy,RURAL CHINA; CARE; COVERAGE; MORTALITY; MEDICARE; SCHEME; ACCESS; REFORM; IMPACT,"Whether health insurance matters for health has long been a central issue for debate when assessing the full value of health insurance coverage in both developed and developing countries. In 2007, the government-led Urban Resident Basic Medical Insurance (URBMI) program was piloted in China, followed by a nationwide implementation in 2009. Different premium subsidies by government across cities and groups provide a unique opportunity to employ the instrumental variables estimation approach to identify the causal effects of health insurance on health. Using a national panel survey of the URBMI, we find that URBMI beneficiaries experience statistically better health than the uninsured. Furthermore, the insurance health benefit appears to be stronger for groups with disadvantaged education and income than for their counterparts. In addition, the insured receive more and better inpatient care, without paying more for services. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Pan, Jay] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Peoples R China; [Pan, Jay] Sichuan Univ, Western China Res Ctr Rural Hlth Dev, Chengdu, Peoples R China; [Lei, Xiaoyan; Liu, Gordon G.] Peking Univ, Natl Sch Dev, China Ctr Econ Res, 5 Yiheyuan Rd, Beijing 100871, Peoples R China",Sichuan University; Sichuan University; Peking University,"Lei, XY (通讯作者)，Peking Univ, Natl Sch Dev, China Ctr Econ Res, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.",xylei@nsd.pku.edu.cn,"Pan, Jay/Z-4492-2019","Pan, Jay/0000-0001-9501-1535","National Natural Science Foundation of China [71303165]; Sichuan University [skqx201401, 2015SCU04A19]; China Medical Board [13-167]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University(Sichuan University); China Medical Board,"We would like to thank the National Natural Science Foundation of China (71303165), Sichuan University (skqx201401 and 2015SCU04A19) and China Medical Board (grant no. 13-167) for their financial support.",,36,54,58,4,83,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2016,25.0,11.0,,,,,1389,1402,,10.1002/hec.3225,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ8SO,26350053.0,,,,2024-03-09,WOS:000386142000004,0
J,"Park, JJ; Rhee, J; Park, D",,,,"Park, J. J.; Rhee, J.; Park, D.",,,CLINICAL EFFECTIVENES OF CARBAPENEM VERSUS ALTERNATIVE ANTIBIOTICS FOR URINARY TRACT INFECTION DUE TO ENTEROBACTERIACEAE PRODUCING ESBL: A SYSTMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Park, J. J.] Natl Evidence Based Collaborating Agcy, Seoul, South Korea; [Rhee, J.; Park, D.] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea",National Evidence-based Healthcare Collaborating Agency (NECA),,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PUK2,A846,A846,,10.1016/j.jval.2016.08.504,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303035,0
J,"Pawlik, M; Karwala, P; Zyla, A; Parkitny, M; Walczak, J; Pieniazek, I; Augustynska, J; Zawodnik, A",,,,"Pawlik, M.; Karwala, P.; Zyla, A.; Parkitny, M.; Walczak, J.; Pieniazek, I; Augustynska, J.; Zawodnik, A.",,,ECONOMIC EVALUATION OF TIOTROPIUM/OLODATEROL ADMINISTRATED THROUGH THE RESPIMAT INHALER AS MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN POLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pawlik, M.; Karwala, P.; Zyla, A.; Parkitny, M.; Walczak, J.; Pieniazek, I; Augustynska, J.] Arcana Inst Ltd, Krakow, Poland; [Zawodnik, A.] Boehringer Ingelheim Poland, Warsaw, Poland",Boehringer Ingelheim,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS34,A554,A554,,10.1016/j.jval.2016.09.1202,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301313,0
J,"Pedrero, V; Oyarte, M; Espinoza, MA",,,,"Pedrero, V; Oyarte, M.; Espinoza, M. A.",,,THE INVARIANCE ANALYSIS OF SF12V2: CARE COMPARABLE THE QUALITY OF LIFE RESULTS OF MEN AND WOMEN?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pedrero, V; Oyarte, M.] Univ Desarrollo, Santiago, Chile; [Espinoza, M. A.] Pontificia Univ Catolica Chile, Santiago, Chile",Universidad del Desarrollo; Pontificia Universidad Catolica de Chile,,,"Pedrero, Victor/AAM-4507-2020; Espinoza, Manuel/AAU-5178-2020","Pedrero, Victor/0000-0002-0861-4432; Espinoza, Manuel/0000-0001-9564-9512",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP197,A474,A474,,10.1016/j.jval.2016.09.739,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300694,0
J,"Phanudulkitti, C; Nawkij, P; Sungkaeo, A; Thanmarak, P; Auamnoy, T",,,,"Phanudulkitti, C.; Nawkij, P.; Sungkaeo, A.; Thanmarak, P.; Auamnoy, T.",,,EXERCISE AND FACTORS INFLUENCE MENTAL HEALTH OF UNDERGRADUATED STUDENTS AT BURAPHA UNIVERSITY IN 2014,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Phanudulkitti, C.; Nawkij, P.; Sungkaeo, A.; Thanmarak, P.; Auamnoy, T.] Burapha Univ, Chon Buri, Thailand",Burapha University,,,,,,,,,0,1,1,0,12,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMH26,A843,A844,,10.1016/j.jval.2016.08.520,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303022,0
J,"Phillips, AL; Corvino, FA",,,,"Phillips, A. L.; Corvino, F. A.",,,"HEALTHCARE RESOURCE USE OF PATIENTS NEWLY DIAGNOSED WITH MULTIPLE SCLEROSIS INITIATING ORAL OR SELF-INJECTABLE DISEASE-MODIFYING DRUGS: A LARGE, NATIONWIDE ANALYSIS OF US ELECTRONIC HEALTH RECORD DATA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Phillips, A. L.] EMD Serono Inc, Rockland, MA USA; [Corvino, F. A.] Genesis Res LLC, Hoboken, NJ USA",Merck KGaA; EMD Serono Inc.,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND74,A438,A438,,10.1016/j.jval.2016.09.530,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300498,0
J,"Poulos, C; Standaert, B; Sloesen, B; Hauber, AB",,,,"Poulos, C.; Standaert, B.; Sloesen, B.; Hauber, A. B.",,,WHAT MOTIVATES MOTHERS TO PAY FOR A VACCINE AGAINST CHILDREN'S DIARRHEA? PREFERENCES FOR VACCINES AGAINST CHILDREN'S DIARRHEAL ILLNESS AMONG MOTHERS IN POLAND AND HUNGARY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Poulos, C.; Hauber, A. B.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Standaert, B.; Sloesen, B.] GSK Vaccines, Wavre, Belgium",Research Triangle Institute; GlaxoSmithKline,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN71,A419,A419,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606300395,0
J,"Prada, M; Sansone, C; Bertozzi, C; Mantovani, M",,,,"Prada, M.; Sansone, C.; Bertozzi, C.; Mantovani, M.",,,"TIMELINE OF AUTHORIZATION AND REIMBURSEMENT FOR ONCOLOGICAL DRUGS IN ITALY: AN INTEGRATED ANALYSIS, ACROSS LEGISLATION'S LEVERAGE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Prada, M.; Sansone, C.; Bertozzi, C.; Mantovani, M.] Intexo, Rome, Italy",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN265,A756,A756,,10.1016/j.jval.2016.09.2341,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302545,0
J,"Pwee, KH",,,,"Pwee, K. H.",,,RAPID HEALTH TECHNOLOGY ASSESSMENT - VALVELESS TROCAR SYSTEM FOR ADVANCED LAPAROSCOPIC / ROBOTIC SURGERY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pwee, K. H.] Eastern Hlth Alliance, Singapore, Singapore",,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD28,A861,A861,,10.1016/j.jval.2016.08.422,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303122,0
J,"Raj, A",,,,"Raj, A.",,,ACUTE RESPIRATORY DISTRESS SYNDROME PROFILE AT A TERTIARY CARE TEACHING HOSPITAL IN SOUTH INDIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Raj, A.] Manipal Univ, Manipal, Karnataka, India",Manipal Academy of Higher Education (MAHE),,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS13,A878,A878,,10.1016/j.jval.2016.08.317,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303214,0
J,"Reed, C; Lebrec, J; Andrews, JS; Bruno, G; Jones, RW",,,,"Reed, C.; Lebrec, J.; Andrews, J. S.; Bruno, G.; Jones, R. W.",,,PREDICTORS OF DISEASE PROGRESSION IN MILD ALZHEIMER'S DISEASE DEMENTIA PATIENTS - RESULTS FROM THE GERAS REAL WORLD COHORT AND EXPEDITION TRIALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Reed, C.] Eli Lilly & Co Ltd, Windlesham, Surrey, England; [Lebrec, J.] Lilly Deutschland GmbH, Bad Homburg, Germany; [Andrews, J. S.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Bruno, G.] Univ Rome, Rome, Italy; [Jones, R. W.] Res Inst Care Older People, Bath, Avon, England",Eli Lilly; Eli Lilly; Lilly Deutschland GmbH; Eli Lilly; Sapienza University Rome,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND5,A425,A426,,10.1016/j.jval.2016.09.458,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300430,0
J,"Reed, SD; Yang, J; Disantostefano, R; Streffer, J; Levitan, B; Johnson, FR",,,,"Reed, S. D.; Yang, J.; Disantostefano, R.; Streffer, J.; Levitan, B.; Johnson, F. R.",,,HETEROGENEOUS PREFERENCES FOR DELAYING ONSET OF ALZHEIMER'S DISEASE AMONG OLDER ADULTS IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Reed, S. D.; Yang, J.; Johnson, F. R.] Duke Clin Res Inst, Durham, NC USA; [Disantostefano, R.; Levitan, B.] Janssen R&D, Titusville, NJ USA; [Streffer, J.] Janssen R&D, Beerse, Belgium",Duke University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PP2,A352,A352,,10.1016/j.jval.2016.09.035,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300029,0
J,"Rémuzat, C; Kapuniak, A; Lach, S; Dziwisz, M; Toumi, M",,,,"Remuzat, C.; Kapuniak, A.; Lach, S.; Dziwisz, M.; Toumi, M.",,,BIOSIMILARS: WHICH VALUE FOR SOCIETY?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Remuzat, C.] Creat Ceut, Paris, France; [Kapuniak, A.] Creat Ceut, Krakow, Poland; [Lach, S.; Dziwisz, M.] Creat Ceut, Krakow, Poland; [Toumi, M.] Aix Marseille Univ, Lab Sante Publ, Fac Med, Marseille, France",Aix-Marseille Universite,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP116,A459,A459,,10.1016/j.jval.2016.09.657,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300615,0
J,"Richards, A; Mead, H; Towns, L",,,,"Richards, A.; Mead, H.; Towns, L.",,,FORE! SWEEPING GENERALISATIONS DO NOT BOWL OVER ALL CULTURES... CULTURAL ADAPTATION IN THE KIDNEY DISEASE QUALITY OF LIFE QUESTIONNAIRE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Richards, A.; Mead, H.; Towns, L.] ICON Plc, Abingdon, Oxon, England",ICON plc,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM169,A388,A388,,10.1016/j.jval.2016.09.236,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300220,0
J,"Roccia, A; Rigoni, L; Cawson, MR; McBride, D; Canonica, GW; Balp, M",,,,"Roccia, A.; Rigoni, L.; Cawson, M. R.; McBride, D.; Canonica, G. W.; Balp, M.",,,ASSURE-CSU: RESOURCE USE AND ECONOMIC BURDEN IN PATIENTS WITH REFRACTORY CHRONIC SPONTANEOUS/IDIOPATHIC URTICARIA IN ITALY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Roccia, A.; Rigoni, L.] Novartis Farma, Origgio, Italy; [Cawson, M. R.; McBride, D.] RTI Hlth Solut, Manchester, Lancs, England; [Canonica, G. W.] Univ Genoa, Genoa, Italy; [Balp, M.] Novartis Pharma AG, Basel, Switzerland",Novartis; Research Triangle Institute; University of Genoa; Novartis,,,"canonica, giorgio walter/ABF-2037-2020","canonica, giorgio walter/0000-0001-8467-2557",,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS58,A614,A614,,10.1016/j.jval.2016.09.1538,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301635,0
J,"Rojas, R; Balmaceda, C; Vargas, C; Espinoza, MA",,,,"Rojas, R.; Balmaceda, C.; Vargas, C.; Espinoza, M. A.",,,COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN VERSUS ANGIOTENSINCONVERTING-ENZYME INHIBITOR FOR THE TREATMENT OF HEART FAILURE FROM PUBLIC HEALTH PERSPECTIVE IN CHILE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rojas, R.; Balmaceda, C.; Vargas, C.; Espinoza, M. A.] Pontificia Univ Catolica Chile, Santiago, Chile",Pontificia Universidad Catolica de Chile,,,"Espinoza, Manuel/AAU-5178-2020","Espinoza, Manuel/0000-0001-9564-9512",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV109,A656,A656,,10.1016/j.jval.2016.09.1778,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302001,0
J,"Ruhm, CJ",,,,"Ruhm, Christopher J.",,,HEALTH EFFECTS OF ECONOMIC CRISES,HEALTH ECONOMICS,,,English,Article,,,,,,macroeconomic conditions; economic crises; health; mortality,HEART-DISEASE MORTALITY; GREAT-DEPRESSION; BUSINESS-CYCLE; EUROPEAN-UNION; PANEL ANALYSIS; RECESSIONS; UNEMPLOYMENT; TIMES; MIGRATION; COUNTRIES,"This analysis summarizes prior research and uses national, US state and county-level data from 1976 to 2013 to examine whether the mortality effects of economic crises differ in kind from those of the more typical fluctuations. The tentative conclusion is that economic crises affect mortality rates (and presumably other measures of health) in the same way as less severe downturns - leading to improvements in physical health. The effects of severe national recessions in the USA appear to have a beneficial effect on mortality that is roughly twice as strong as that predicted by the elevated unemployment rates alone, while the higher predicted rate of suicides during typical periods of economic weakness is approximately offset during severe recessions. No consistent pattern is obtained for more localized economic crises occurring at the state level - some estimates suggest larger protective mortality effects while others indicate offsetting deleterious consequences. Copyright (C) 2016 John Wiley & Sons, Ltd.","[Ruhm, Christopher J.] Univ Virginia, Charlottesville, VA USA; [Ruhm, Christopher J.] Natl Bur Econ Res, Cambridge, MA 02138 USA",University of Virginia; National Bureau of Economic Research,"Ruhm, CJ (通讯作者)，Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, MA USA.",ruhm@virginia.edu,,,,,,,55,56,59,0,18,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2016,25.0,,,2.0,,,6,24,,10.1002/hec.3373,0.0,,,19,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,FP8VJ,27870301.0,Green Published,,,2024-03-09,WOS:000417923900002,0
J,"Sacks, NC; Miller, DJ; Louie, AC; Chiarella, MT; Cyr, P; Sharma, A; Liu, Y",,,,"Sacks, N. C.; Miller, D. J.; Louie, A. C.; Chiarella, M. T.; Cyr, P.; Sharma, A.; Liu, Y.",,,OUTCOMES FOR OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): MULTIPLE HOSPITALIZATIONS AND HIGH MORTALITY RATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sacks, N. C.; Cyr, P.; Sharma, A.; Liu, Y.] Precis Hlth Econ, Boston, MA USA; [Miller, D. J.; Louie, A. C.; Chiarella, M. T.] Celator Pharmaceut Inc, Ewing, NJ USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS43,A611,A611,,10.1016/j.jval.2016.09.1523,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301620,0
J,"Sanchez, JJG; Hill, CA",,,,"Sanchez, Garcia J. J.; Hill, C. A.",,,REVIEW OF THE RECOMMENDATIONS MADE BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) AND THE SCOTTISH MEDICIAL CONSORTIUM (SMC) RELATING TO TREATMENTS FOR RARE DISEASES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sanchez, Garcia J. J.; Hill, C. A.] MAP BioPharma Ltd, Cambridge, England",,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP280,A489,A489,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606300775,0
J,"Sharif, Z; Peikanpour, M; Rangchian, M; Moghadam, MJF",,,,"Sharif, Z.; Peikanpour, M.; Rangchian, M.; Moghadam, Foroughi M. J.",,,COST-UTILITY ANALYSIS OF LORCASERIN IN THE TREATMENT OF OBESITY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sharif, Z.; Peikanpour, M.; Rangchian, M.; Moghadam, Foroughi M. J.] Shahid Beheshti Univ Med Sci, Sch Pharm, Tehran, Iran",Shahid Beheshti University Medical Sciences,,,"Sharif, Zahra/AAB-9538-2022; Rangchian, Maryam/GSM-9127-2022",,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY90,A590,A591,,10.1016/j.jval.2016.09.1405,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301508,0
J,"Shmueli, L; Shmueli, E; Pliskin, JS; Balicer, RD; Davidovitch, N; Hekselman, I; Greenfield, G",,,,"Shmueli, L.; Shmueli, E.; Pliskin, J. S.; Balicer, R. D.; Davidovitch, N.; Hekselman, I; Greenfield, G.",,,SECOND MEDICAL OPINION: UTILIZATION RATES AND CHARACTERISTICS OF SEEKERS IN A GENERAL POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shmueli, L.; Pliskin, J. S.; Davidovitch, N.] Ben Gurion Univ Negev, Beer Sheva, Israel; [Shmueli, E.] Tel Aviv Univ, Tel Aviv, Israel; [Balicer, R. D.] Clalit Res Inst, Tel Aviv, Israel; [Hekselman, I] Clalit Mushlam Hlth Insurance, Bnei Braq, Israel; [Greenfield, G.] Imperial Coll London, London, England",Ben Gurion University; Tel Aviv University; Imperial College London,,,"PLISKIN, JOSEPH/ABM-1424-2022","PLISKIN, JOSEPH/0000-0002-1554-0371",,,,,0,0,0,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS124,A625,A626,,10.1016/j.jval.2016.09.1606,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,"hybrid, Green Submitted",,,2024-03-09,WOS:000396606301700,0
J,"Sieper, J; Kivitz, A; van Tubergen, A; Deodhar, A; Harris, K; Nurminen, T; Landewé, R",,,,"Sieper, J.; Kivitz, A.; van Tubergen, A.; Deodhar, A.; Harris, K.; Nurminen, T.; Landewe, R.",,,"CERTOLIZUMAB PEGOL IS ASSOCIATED WITH LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA STUDY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sieper, J.] Charite Univ Med Berlin, Berlin, Germany; [Kivitz, A.] Altoona Ctr Clin Res, Duncansville, PA USA; [van Tubergen, A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Deodhar, A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Harris, K.] UCB Pharma, Brussels, Belgium; [Nurminen, T.] UCB Pharma, Monheim, Germany; [Landewe, R.] Zuyderland Med Ctr, Heerlen, Netherlands",Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Altoona Center for Clinical Research; Maastricht University; Oregon Health & Science University; UCB Pharma SA; UCB Pharma SA; Zuyderland Medical Center,,,"LANDEWE, ROBERT B.M./ABD-7388-2021","LANDEWE, ROBERT B.M./0000-0002-0577-6620",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY114,A595,A595,,10.1016/j.jval.2016.09.1430,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301531,0
J,"Miguel, LS; Lopes, FV; Pinheiro, B; Wang, J; Xu, R; Pellissier, J; Laires, PA",,,,"Silva Miguel, L.; Vargas Lopes, F.; Pinheiro, B.; Wang, J.; Xu, R.; Pellissier, J.; Laires, P. A.",,,COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR ADVANCED MELANOMA TREATMENT IN PORTUGAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Silva Miguel, L.; Pinheiro, B.] Res Ctr Portuguese Econ ISEG ULisboa, Lisbon, Portugal; [Vargas Lopes, F.; Laires, P. A.] Merck Sharp & Dohme Ltd, Oeiras, Portugal; [Wang, J.; Xu, R.; Pellissier, J.] Merck & Co Inc, N Wales, PA USA",Merck & Company,,,"Miguel, Luís Silva/T-7970-2018; Laires, Pedro A/AAA-7663-2021; Lopes, Felipe/N-8272-2017","Miguel, Luís Silva/0000-0003-4363-7389; Lopes, Felipe/0000-0001-6465-8045",,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN118,A729,A729,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302401,0
J,"Smith, A; Hashemi, L; Ma, I",,,,"Smith, A.; Hashemi, L.; Ma, I",,,COST-UTILITY ANALYSIS OF ALEMTUZUMAB VERSUS NATALIZUMAB FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS: US PAYER PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Smith, A.; Hashemi, L.; Ma, I] Sanofi Genzyme, Cambridge, MA USA",Sanofi-Aventis; Genzyme Corporation,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND36,A431,A431,,10.1016/j.jval.2016.09.490,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300460,0
J,"Soleymani, F; Kebriaeezadeh, A",,,,"Soleymani, F.; Kebriaeezadeh, A.",,,EVALUATION OF SOCIAL SECURITY ORGANIZATION'(SSO) REGULATIONS ON PHYSICIAN PRESCRIBING PATTERN IN IRAN IN 2014,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Soleymani, F.] Univ Tehran Med Sci, Tehran, Iran; [Kebriaeezadeh, A.] Univ Tehran Med Sci, Fac Pharm, Tehran, Iran",Tehran University of Medical Sciences; Tehran University of Medical Sciences,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP119,A834,A834,,10.1016/j.jval.2016.08.570,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302750,0
J,"Stevens, B; Verdian, L; Pezzullo, L; Tomlinson, J; Lui, V",,,,"Stevens, B.; Verdian, L.; Pezzullo, L.; Tomlinson, J.; Lui, V",,,THE ECONOMIC BURDEN OF HEART FAILURE IN LATIN AMERICA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stevens, B.; Verdian, L.; Pezzullo, L.; Tomlinson, J.; Lui, V] Deloitte Access Econ, Sydney, NSW, Australia",Deloitte Touche Tohmatsu Limited,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV52,A645,A645,,10.1016/j.jval.2016.09.1720,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301808,0
J,"Stürzlinger, H; Eisenmann, A; Antony, K; Laschkolnig, A; Pertl, D",,,,"Stuerzlinger, H.; Eisenmann, A.; Antony, K.; Laschkolnig, A.; Pertl, D.",,,PHARMACOTHERAPIES FOR THE TREATMENT OF BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA - A SYSTEMATIC REVIEW ON RECENT EVIDENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stuerzlinger, H.; Eisenmann, A.; Antony, K.; Laschkolnig, A.; Pertl, D.] Gesundheit Osterreich GmbH, Vienna, Austria",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND14,A427,A427,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606300439,0
J,"Stutzer, A; Meier, AN",,,,"Stutzer, Alois; Meier, Armando N.",,,"Limited Self-control, Obesity, and the Loss of Happiness",HEALTH ECONOMICS,,,English,Article,,,,,,obesity; revealed preference; self-control problem; subjective well-being,LIFE SATISFACTION; UNITED-STATES; BODY-WEIGHT; OVERWEIGHT; ECONOMICS; STRESS; HEALTH,"Is obesity the consequence of an optimally chosen lifestyle or do people consume too much relative to their long-term preferences? The latter perspective accepts that people might face self-control problems when exposed to the immediate gratification from food. We exploit unique survey data for Switzerland in multinomial logit and ordered probit regressions to study (i) the covariates of obesity including indicators of self-control and (ii) the consequences of obesity on the subjective well-being of people with limited willpower. Our main finding is that obesity decreases the well-being of individuals who report having limited self-control, but not otherwise. (c) 2015 John Wiley & Sons, Ltd.","[Stutzer, Alois; Meier, Armando N.] Univ Basel, Fac Business & Econ, Ctr Res Econ & Well Being, Peter Merian Weg 6, CH-4002 Basel, Switzerland",University of Basel,"Stutzer, A (通讯作者)，Univ Basel, Fac Business & Econ, Ctr Res Econ & Well Being, Peter Merian Weg 6, CH-4002 Basel, Switzerland.",alois.stutzer@unibas.ch,"Stutzer, Alois/A-2302-2013","Stutzer, Alois/0000-0002-7410-5513; Meier, Armando N./0000-0001-7977-8875",,,,,46,22,23,3,45,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2016,25.0,11.0,,,,,1409,1424,,10.1002/hec.3227,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ8SO,26315147.0,"Bronze, Green Submitted, Green Accepted",,,2024-03-09,WOS:000386142000006,0
J,"Suh, JK; Lee, S",,,,"Suh, J. K.; Lee, S.",,,"EFFECT OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN II RECEPTOR BLOCKERS, AND STATINS ON SEPSIS-RELATED OUTCOMES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Suh, J. K.] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea; [Lee, S.] Seoul Natl Univ Hosp, Seoul, South Korea",National Evidence-based Healthcare Collaborating Agency (NECA); Seoul National University (SNU); Seoul National University Hospital,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN3,A908,A908,,10.1016/j.jval.2016.08.151,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303383,0
J,"Szabo, SM; Hirji, I; Johnston, KM; Juarez-Garcia, A; Subar, M; Connors, JM",,,,"Szabo, S. M.; Hirji, I; Johnston, K. M.; Juarez-Garcia, A.; Subar, M.; Connors, J. M.",,,REAL-WORLD TREATMENT PATTERNS AND COSTS OF CARE AMONG BRENTUXIMAB VENDOTIN-TREATED PATIENTS WITH HODGKIN LYMPHOMA IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Szabo, S. M.; Johnston, K. M.] Broad St Hlth Econ & Outcomes Res, Vancouver, BC, Canada; [Hirji, I; Subar, M.] Bristol Myers Squibb, Princeton, NJ USA; [Juarez-Garcia, A.] Bristol Myers Squibb Co, Mexico City, DF, Mexico; [Connors, J. M.] BCCA, CLC, Vancouver, BC, Canada",Bristol-Myers Squibb; Bristol-Myers Squibb,,,"Connors, Joseph/AAF-5284-2019","Connors, Joseph/0000-0002-1361-7531",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN108,A727,A728,,10.1016/j.jval.2016.09.2181,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302391,0
J,"Topachevskyi, O; Siabro, V; Volovyk, A",,,,"Topachevskyi, O.; Siabro, V; Volovyk, A.",,,INTERACTIVE HEALTH ECONOMIC MODELS CONFIGURED WITH GOOGLE ANALYTICS. DATA AND METRICS APPLICABLE FOR A HEALTHCARE RESEARCH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Topachevskyi, O.] Digital Hlth Outcomes, Brussels, Belgium; [Siabro, V; Volovyk, A.] Digital Hlth Outcomes, Kiev, Ukraine",,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM225,A398,A398,,10.1016/j.jval.2016.09.295,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300276,0
J,"Tuletova, A; Dochshanova, A",,,,"Tuletova, A.; Dochshanova, A.",,,DETERMINATION OF CLINICAL AND COST-EFFECTIVENESS OF VARIOUS METHODS OF PREDICTING PRETERM BIRTH IN WOMEN WITH HIGH RISK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tuletova, A.; Dochshanova, A.] Astana Med Univ, Astana, Kazakhstan",Astana Medical University,,,,,,,,,0,0,0,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIH3,A400,A400,,10.1016/j.jval.2016.09.307,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300287,0
J,"Tunis, SL; Klinkenbijl, B; Graham, C; Weaver, D",,,,"Tunis, S. L.; Klinkenbijl, B.; Graham, C.; Weaver, D.",,,ECONOMIC AND HUMANISTIC IMPACT ASSUMPTIONS FOR HYPOGLYCEMIC EVENTS: IMPLICATIONS FOR COST-EFFECTIVENESS ANALYSES IN INSULIN-TREATED DIABETES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Klinkenbijl, B.] Dexcom Inc, Essertines Sur Rolle, Switzerland; [Graham, C.; Weaver, D.] Dexcom Inc, San Diego, CA USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM31,A362,A362,,10.1016/j.jval.2016.09.095,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300082,0
J,"Vadziuk, Y",,,,"Vadziuk, Y.",,,IMPROVING THE SYSTEM OF HEALTHCARE PROVISION FOR PATIENTS WITH DIFFUSE TOXIC GOITER IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vadziuk, Y.] Ivan Horbachevsky Ternopil State Med Univ, Ternopol, Ukraine",I. Horbachevsky Ternopil State Medical University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB91,A681,A681,,10.1016/j.jval.2016.09.1923,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302140,0
J,"Vajda, R; Szabó, SN; Kívés, ZH; Boncz, I; Danku, N; Gyuró, M; Pakai, A",,,,"Vajda, R.; Szabo, Novakne S.; Kives, Horvathne Z.; Boncz, I; Danku, N.; Gyuro, M.; Pakai, A.",,,KNOWLEDGE AND PARTICIPATION RATE ON CERVICAL CANCER SCREENING AMONG ROMANY MINORITY POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vajda, R.; Szabo, Novakne S.; Kives, Horvathne Z.; Boncz, I; Danku, N.; Gyuro, M.] Univ Pecs, Pecs, Hungary; [Pakai, A.] Univ Pecs, Zalaegerszeg, Hungary",University of Pecs; University of Pecs,,,"Pakai, Annamaria/AAS-2610-2020; Boncz, Imre/A-8940-2013","Pakai, Annamaria/0000-0002-2849-1310; Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS87,A619,A619,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301664,0
J,"van Hout, B; Gumbs, PD; Cohen, AT; Verhamme, P",,,,"van Hout, B.; Gumbs, P. D.; Cohen, A. T.; Verhamme, P.",,,AN ANALYSIS OF THE EFFICACY AND SAFETY OF EDOXABAN IN COMPARISON WITH RIVAROXABAN IN THE TREATMENT OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[van Hout, B.] Univ Sheffield, Sheffield, S Yorkshire, England; [Gumbs, P. D.] Dauchi Sankyo Europe GmbH, Munich, Germany; [Cohen, A. T.] Guys & St Thomas NHS Fdn Trust, London, England; [Verhamme, P.] Univ Hosp Leuven, Leuven, Belgium",University of Sheffield; Daiichi Sankyo Company Limited; Guy's & St Thomas' NHS Foundation Trust; KU Leuven; University Hospital Leuven,,,"Verhamme, Peter/JEF-6302-2023","Verhamme, Peter/0000-0001-8698-2858",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV11,A637,A638,,10.1016/j.jval.2016.09.1678,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301767,0
J,"Wade, AG; Crawford, GM; McLennan, K",,,,"Wade, A. G.; Crawford, G. M.; McLennan, K.",,,THE ECONOMIC IMPACT OF INFLUENZA-LIKE ILLNESS ON FAMILIES LIVING IN THE UK DEMONSTRATED BY THE COLLECTION OF ONLINE DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wade, A. G.; Crawford, G. M.; McLennan, K.] Patients Direct, Glasgow, Lanark, Scotland",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM193,A392,A392,,10.1016/j.jval.2016.09.260,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300244,0
J,"Wójcik, A; Mlynczak, K; Dobrowolska, I; Jaskowiak, K; Niewada, M; Golicki, D",,,,"Wojcik, A.; Mlynczak, K.; Dobrowolska, I; Jaskowiak, K.; Niewada, M.; Golicki, D.",,,SYSTEMATIC REVIEW OF EQ-5D BASED UTILITY SCORES IN LEUKEMIAS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wojcik, A.; Mlynczak, K.; Dobrowolska, I; Jaskowiak, K.] HealthQuest, Warsaw, Poland; [Niewada, M.; Golicki, D.] Med Univ Warsaw, Dept Expt & Clin Pharmacol, Warsaw, Poland",Medical University of Warsaw,,,"Golicki, Dominik/N-5656-2018","Golicki, Dominik/0000-0001-7741-4760",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY99,A592,A592,,10.1016/j.jval.2016.09.1415,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301517,0
J,"Wu, J; Liu, J; Zhu, B; Mao, Y",,,,"Wu, J.; Liu, J.; Zhu, B.; Mao, Y.",,,A CONCEPTUAL FRAMEWORK OF BASELINE EQUITY FOR RURAL BASIC MEDICAL INSURANCE IN CHINA: BASED ON POLICY PROCESS THEORY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wu, J.; Liu, J.; Zhu, B.; Mao, Y.] Xi An Jiao Tong Univ, Xian, Peoples R China",Xi'an Jiaotong University,,,,,,,,,0,0,0,2,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP135,A837,A837,,10.1016/j.jval.2016.08.559,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302766,0
J,"Yamabe, K; Umareddy, I; Flores, NM",,,,"Yamabe, K.; Umareddy, I; Flores, N. M.",,,THE BURDEN OF DEPRESSION IN JAPAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yamabe, K.] Takeda Pharmaceut Co Ltd, Tokyo, Japan; [Umareddy, I] Kantar Hlth, Singapore, Singapore; [Flores, N. M.] Kantar Hlth, Foster City, CA USA",Takeda Pharmaceutical Company Ltd,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMH33,A527,A527,,10.1016/j.jval.2016.09.1047,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301167,0
J,"Zolotarev, AV; Tselina, ME; Iskhakova, A",,,,"Zolotarev, A., V; Tselina, M. E.; Iskhakova, A.",,,CLINICO-ECONOMIC EVALUATION OF COMBINED TREATMENT OF DIABETIC MACULAR EDEMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zolotarev, A., V; Tselina, M. E.] Samara Med Univ, Samara, Russia; [Iskhakova, A.] Samara Reg Ophthalm Hosp, Samara, Russia",Samara State Medical University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS46,A570,A570,,10.1016/j.jval.2016.09.1290,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301397,0
J,"Zou, D; Kendall, R; Lin, Q; Huang, Y; Tieng, J; Tseng, J; Sajosi, P",,,,"Zou, D.; Kendall, R.; Lin, Q.; Huang, Y.; Tieng, J.; Tseng, J.; Sajosi, P.",,,COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT IN TAIWAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zou, D.; Kendall, R.] ICON Plc, Vancouver, BC, Canada; [Lin, Q.; Huang, Y.] Kantar Hlth, Taipei, Taiwan; [Tieng, J.; Tseng, J.] Takeda Pharmaceut Taiwan, Taipei, Taiwan; [Sajosi, P.] Takeda Pharmaceut Int AG, Zurich, Switzerland","ICON plc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.",,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN24,A888,A888,,10.1016/j.jval.2016.08.269,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303269,0
J,"Aït-Sahalia, Y; Xiu, DC",,,,"Ait-Sahalia, Yacine; Xiu, Dacheng",,,"Increased correlation among asset classes: Are volatility or jumps to blame, or both?",JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Quadratic covariation; Continuous and jump components; Overnight jumps; News surprises; Financial crisis,FINANCIAL-MARKETS; DIFFUSION; MATRIX; PRICE; ESTIMATORS; MODELS; NOISE,"We develop estimators and asymptotic theory to decompose the quadratic covariation between two assets into its continuous and jump components, in a manner that is robust to the presence of market microstructure noise. Using high frequency data on different assets classes, we find that the recent financial crisis led to an increase in both the quadratic variations of the assets and their correlations. However, we find little evidence to suggest a change between the relative contributions of the Brownian and jump components, as both comove. Co-jumps stem from surprising news announcements that occur primarily before the opening of the US market, and are also accompanied by an increase in Brownian driven correlations. (C) 2016 Elsevier B.V. All rights reserved.","[Ait-Sahalia, Yacine] Princeton Univ, Dept Econ, 26 Prospect Ave, Princeton, NJ 08540 USA; [Xiu, Dacheng] Univ Chicago, Booth Sch Business, 5807 S Woodlawn Ave, Chicago, IL 60637 USA",Princeton University; University of Chicago,"Xiu, DC (通讯作者)，Univ Chicago, Booth Sch Business, 5807 S Woodlawn Ave, Chicago, IL 60637 USA.",yacine@princeton.edu; dacheng.xiu@chicagobooth.edu,,,,,,,52,41,46,0,14,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,OCT,2016,194.0,2.0,,,,,205,219,,10.1016/j.jeconom.2016.05.002,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DV0GR,,,,,2024-03-09,WOS:000382596500002,0
J,"Bergman, MA; Johansson, P; Lundberg, S; Spagnolo, G",,,,"Bergman, Mats A.; Johansson, Per; Lundberg, Sofia; Spagnolo, Giancarlo",,,Privatization and quality: Evidence from elderly care in Sweden,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Competition; Incomplete contracts; Mortality; Outsourcing; Public procurement,CONTRACT ENFORCEMENT; COMPETITION; OWNERSHIP; MORTALITY; PERFORMANCE; PROCUREMENT; COLOMBIA; VOUCHERS; ACCESS; POLICY,"Non-contractible quality dimensions are at risk of degradation when the provision of public services is privatized. However, privatization may increase quality by fostering performance-improving innovation, particularly if combined with increased competition. We assemble a large data set on elderly care services in Sweden between 1990 and 2009 and estimate how opening to private provision affected mortality rates - an important and not easily contractible quality dimension - using a difference-in-difference in-difference approach. The results indicate that privatization and the associated increase in competition significantly improved non-contractible quality as measured by mortality rates. (C) 2016 The Authors. Published by Elsevier B.V.","[Bergman, Mats A.] Sodertorn Univ, Stockholm, Sweden; [Johansson, Per] Uppsala Univ, Inst Study Labor IZA, Dept Stat, IFAU Inst Labour Market & Educ Policy Evaluat, Uppsala, Sweden; [Lundberg, Sofia] Umea Univ, Umea Sch Business & Econ, Dept Econ, S-90187 Umea, Sweden; [Spagnolo, Giancarlo] Univ Roma Tor Vergata, Ctr Econ Policy Res, EIEF, Stockholm Sch Econ SITE, Rome, Italy",Sodertorn University; Uppsala University; Umea University; University of Rome Tor Vergata,"Lundberg, S (通讯作者)，Umea Univ, Dept Econ, SE-90187 Umea, Sweden.",sofia.lundberg@umu.se,"Bergman, Mats/AGK-4123-2022; Johansson, Per/AAD-2929-2020; Lundberg, Sofia/AAI-2665-2020","Johansson, Per/0000-0001-6140-9123; Lundberg, Sofia/0000-0001-6094-9099; SPAGNOLO, GIANCARLO/0000-0003-4117-6283","Swedish Research Council [2008-22664-58604-33]; Swedish Competition Authority [111/2008]; Swedish Research Council for Health, Working Life and Welfare [2013-2482]","Swedish Research Council(Swedish Research Council); Swedish Competition Authority; Swedish Research Council for Health, Working Life and Welfare(Swedish Research Council for Health Working Life & Welfare (Forte))","Financial support from the Swedish Research Council (grant no. 2008-22664-58604-33), the Swedish Competition Authority (grant no. 111/2008) and the Swedish Research Council for Health, Working Life and Welfare (grant no. 2013-2482) is gratefully acknowledged. We would also like to thank seminar participants at Karlstad University, Norway University of Science and Technology, the Swedish Competition Authority, Sodertorn University, Uppsala University, Umea University, the 4th IPPC in Seoul, EARIE in Istanbul, 29th Arne Ryde Symposium in Lund, 12th Journees Louis-Andre Gerard-Varet, Southern Economic Association's 83rd Annual Meeting, the EEA 2013 Annual Conference and The Research Institute of Industrial Economics.",,55,33,33,0,35,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,SEP,2016,49.0,,,,,,109,119,,10.1016/j.jhealeco.2016.06.010,0.0,,,11,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DY1QL,27394007.0,"Green Published, Green Submitted, hybrid",,,2024-03-09,WOS:000384869400009,0
J,"Li, JL; Lin, SL",,,,"Li, Jinlu; Lin, Shuanglin",,,Optimal income taxation with discrete skill distribution,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,MARGINAL TAX RATES; U-SHAPED PATTERN; RESPONSES; EXAMPLE,"This-paper studies the pattern of the optimal marginal income tax rates in a discrete model allowing all forms of individual skill distribution. It derives an explicit solution to the optimal marginal income tax rates in terms of the parameters of the model, and then rigorously shows the optimal marginal tax rate can be U-shaped, inverse U-shaped, strictly increasing, or strictly decreasing in the interior of skill levels, depending crucially on skill distribution. The numerical examples indicate that the optimal marginal tax rates can be W-shaped and inverse W-shaped in the interior of skill levels. The explicit solution to the optimal marginal income tax rate derived in this discrete model can be used to find optimal marginal income tax rates for an economy with any empirical skill distribution, without the need to estimate the density function of skill. (C) 2016 Elsevier B.V. All rights reserved.","[Li, Jinlu] Shawnee State Univ, Dept Math, Portsmouth, OH 45662 USA; [Lin, Shuanglin] Peking Univ, China Ctr Publ Finance, Natl Sch Dev, Beijing 100871, Peoples R China; [Lin, Shuanglin] Univ Nebraska, Dept Econ, Coll Business Adm, Omaha, NE 68182 USA",University System of Ohio; Shawnee State University; Peking University; University of Nebraska System,"Lin, SL (通讯作者)，Peking Univ, China Ctr Publ Finance, Natl Sch Dev, Beijing 100871, Peoples R China.",jli@shawnee.edu; slin@unomaha.edu,,,,,,,24,0,0,0,10,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2016,83.0,,,,,,58,70,,10.1016/j.mathsocsci.2016.07.005,0.0,,,13,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DW8ZC,,,,,2024-03-09,WOS:000383943000008,0
J,"Rydén, A; Leavy, OC; Halling, K; Stone, AA",,,,"Ryden, Anna; Leavy, Olivia C.; Halling, Katarina; Stone, Arthur A.",,,Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy,VALUE IN HEALTH,,,English,Article,,,,,,ecological validity; frequency; gastroesophageal reflux disease; intensity; patient-reported outcome instruments,REPORTED OUTCOMES; WEEKLY PAIN; RECALL; VALIDATION; ACCURACY; FATIGUE; SLEEP; DIARY; PEAK,"Background: The Reflux Symptom Questionnaire electronic Diary (RESQ-eD) and the Reflux Symptom Questionnaire 7-day recall (RESQ-7) are versions of a patient-reported outcome instrument that was developed and validated for measuring the frequency and intensity of symptoms in patients with gastroesophageal reflux disease (GERD) who have a partial response to proton pump inhibitor (PPI) therapy. Objective: The aim of these analyses was to assess the ability of the RESQ-7 to reproduce findings based on RESQ-eD reports of the same symptoms. Methods: These analyses are based on data from patients with GERD with a partial response to PPI (ClinicalTrials.govidentifier: NCT00703534). Participants completed the RESQ-eD twice daily for 7 days and the RESQ-7 on day 7. Results: Data from 446 patients were available for these analyses. Symptom-level analyses showed that, for intensity, mean domain scores were higher for the RESQ-7 (range 1.49-2.72) than for the RESQ-eD (range 1.45-2.57); for frequency, scores were lower for the RESQ-7 (range 2.58-4.82) than for the RESQ-eD (range 4.22-6.24). Correspondence analyses of RESQ-7 and RESQ-eD mean domain scores indicated excellent agreement for intensity (correlation-concordance coefficient 0.77-0.83) and fair agreement for frequency (correlation-concordance coefficient 0.40-0.58). Mean RESQ-eD subscale intensity scores for GERD symptoms were higher for symptoms experienced during the daytime than for those occurring at nighttime. Symptom recall was not associated with peak or recency effects. Conclusions: Patients with GERD slightly overestimated the intensity of their reflux symptoms and markedly underestimated the frequency on weekly recall compared with twice daily reporting.","[Ryden, Anna; Halling, Katarina] AstraZeneca Gothenburg, S-43183 Molndal, Sweden; [Leavy, Olivia C.] Oxford Brookes Univ, Oxford, England; [Stone, Arthur A.] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA; [Stone, Arthur A.] Univ Southern Calif, USC Dornsife Ctr Self Report Sci, Los Angeles, CA USA",AstraZeneca; Oxford Brookes University; University of Southern California; University of Southern California,"Rydén, A (通讯作者)，AstraZeneca Gothenburg, S-43183 Molndal, Sweden.",anna.ryden@astrazeneca.com,"Stone, Arthur A./AAC-3610-2019","Leavy, Olivia/0000-0002-1503-5535","AstraZeneca Gothenburg, Sweden","AstraZeneca Gothenburg, Sweden(AstraZeneca)","This study was funded by AstraZeneca Gothenburg, Sweden. Writing support was provided by Dr. Anja Becher, from Oxford PharmaGenesis, Oxford, UK, and was funded by AstraZeneca Gothenburg, Sweden.",,25,4,4,0,1,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,SEP-OCT,2016,19.0,6.0,,,,,829,833,,10.1016/j.jval.2016.05.007,0.0,,,5,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ5VS,27712711.0,hybrid,,,2024-03-09,WOS:000385930500020,0
J,"Muto, N; Sato, S",,,,"Muto, Nozomu; Sato, Shin",,,Bounded response of aggregated preferences,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Arrow's impossibility theorem; Independence of irrelevant alternatives; Bounded response; Social welfare function,ARROW IMPOSSIBILITY THEOREM; FIXED-POINT THEOREM; EQUIVALENCE; NONMANIPULABILITY; INDEPENDENCE,"We propose a new axiom called bounded response, which says that the smallest change in an agent's preference leads to the smallest or no change in the aggregated preference in the society. This axiom can be interpreted as continuity or insensitivity of aggregated preferences with respect to the reported preferences. We show that bounded response together with a weak axiom imply dictatorship whenever there are four or more alternatives. This result shows that the continuity or the insensitivity of aggregated preferences, formulated as bounded response, with respect to the reported preferences is achieved only by dictatorship. Our result also offers a new perspective on Arrow's theorem: neither independence property nor informational efficiency in independence of irrelevant alternatives is necessary for the impossibility. Our result has an interesting implication also for individual problem of formulating an aggregated preference based on several criteria. A new technique is employed in the proof. (C) 2016 Elsevier B.V. All rights reserved.","[Muto, Nozomu] Yokohama Natl Univ, Dept Econ, Hodogaya Ku, 79-3 Tokiwadai, Yokohama, Kanagawa 2408501, Japan; [Sato, Shin] Fukuoka Univ, Fac Econ, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan",Yokohama National University; Fukuoka University,"Muto, N (通讯作者)，Yokohama Natl Univ, Dept Econ, Hodogaya Ku, 79-3 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.",nozomu.muto@gmail.com; shinsato@adm.fukuoka-u.ac.jp,,"Muto, Nozomu/0000-0001-6882-6296","JSPS KAKENHI [26780116, 25780142]; Grants-in-Aid for Scientific Research [26780116, 25780142] Funding Source: KAKEN","JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","We are grateful to Atsushi Kajii, Tomoyuki Kamo, Toyotaka Sakai, John Weymark, and seminar/conference participants at Keio University, Kyoto University, Otaru University of Commerce, Sophia University, and Waseda University for helpful comments. This research is supported by JSPS KAKENHI 26780116 (Nozomu Muto) and JSPS KAKENHI 25780142 (Shin Sato).",,28,4,4,0,4,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2016,65.0,,,,,,1,15,,10.1016/j.jmateco.2016.04.006,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DT1MD,,,,,2024-03-09,WOS:000381245900001,0
J,"Wang, JL; Li, JY",,,,"Wang, Jianli; Li, Jingyuan",,,Lattice-based monotone comparative statics on saving with Selden/Kreps-Porteus preferences,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Monotone comparative statics; Saving; Selden/Kreps-Porteus preferences; Prudence,STRATEGIC COMPLEMENTARITIES; UNCERTAINTY; RISK; EQUILIBRIUM; DECISIONS; DEMAND,This study examines saving with general Selden/Kreps-Porteus preferences. It shows that lattice-based monotone comparative statics can be used to weaken the existing sufficient conditions in a two-period model with Kreps-Porteus preferences for prudence and for a definitive relationship between risk aversion and the strength of the saving motive. The effects of a change in risk and a change in initial wealth are also examined. (C) 2016 Elsevier B.V. All rights reserved.,"[Wang, Jianli] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing 211106, Jiangsu, Peoples R China; [Li, Jingyuan] Lingnan Univ, Dept Finance & Insurance, Hong Kong, Hong Kong, Peoples R China",Nanjing University of Aeronautics & Astronautics; Lingnan University,"Li, JY (通讯作者)，Lingnan Univ, Dept Finance & Insurance, Hong Kong, Hong Kong, Peoples R China.",jianliwang2013@gmail.com; jingyuanli@ln.edu.hk,"wang, jian/GVS-0711-2022; Jiang, Yalin/ITV-2565-2023; Wu, Lijuan/JJG-0701-2023","Jiang, Yalin/0009-0003-3726-8828; Jingyuan, Li/0000-0002-4434-2673","National Natural Science Foundation of China [71401074, 71461009]; General Research Fund of the Hong Kong Research Grants Council [LU13500814]; Faculty Research Grant of Lingnan University [DB15A2, DB16A1]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Research Fund of the Hong Kong Research Grants Council; Faculty Research Grant of Lingnan University,The authors are grateful to the Editor and an anonymous referee for constructive comments and suggestions that led significant improvement of an early manuscript. The research described here was supported by the National Natural Science Foundation of China with Grant Numbers 71401074 and 71461009; General Research Fund of the Hong Kong Research Grants Council under Research Project No. LU13500814; the Faculty Research Grant of Lingnan University under Research Project No. DB15A2 and No. DB16A1.,,19,4,4,0,7,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2016,65.0,,,,,,132,138,,10.1016/j.jmateco.2016.06.004,0.0,,,7,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DT1MD,,,,,2024-03-09,WOS:000381245900012,0
J,"Mercadante, S; Cuomo, A",,,,"Mercadante, Sebastiano; Cuomo, Arturo",,,Breakthrough Cancer Pain: Ten Commandments,VALUE IN HEALTH,,,English,Article,,,,,,breakthrough cancer pain; cancer pain; opioids,TRANSMUCOSAL FENTANYL CITRATE; BASAL OPIOID REGIMEN; PECTIN NASAL SPRAY; PALLIATIVE CARE-UNIT; INTRAVENOUS MORPHINE; INTRANASAL FENTANYL; DOSE-TITRATION; EPISODIC-PAIN; BUCCAL TABLET; DOUBLE-BLIND,"The term breakthrough cancer pain (BTcP) was introduced about 25 years ago. Peaks of pain intensity reported in patients with cancer had been invariably examined in the past years, providing relevant information for a better knowledge of this phenomenon and its treatment. The aim of this critical review was to provide the golden rules, namely, the 10 commandments, for a correct diagnostic pathway of BTcP and a consequent personalized pharmacological treatment. These are as follows: 1) assessment of background analgesia, 2) drugs used for background analgesia, 3) BTcP is a frequent phenomenon, 4) characteristics of BTcP, 5) diagnosis of BTcP, 6) continuous assessment, 7) tailored pharmacological treatment of BTcP, 8) selection of BTcP medication, 9) dosing BTcP medications, and 10) education. These steps may help clinicians to recognize and treat BTcP adequately.","[Mercadante, Sebastiano] La Maddalena Canc Ctr, Anesthesia & Intens Care & Pain Relief & Palliat, Via San Lorenzo 312, I-901456 Palermo, Italy; [Cuomo, Arturo] Natl Canc Inst, Anesthesia Intens Care & Pain Therapy, Naples, Italy",IRCCS Fondazione Pascale,"Mercadante, S (通讯作者)，La Maddalena Canc Ctr, Anesthesia & Intens Care & Pain Relief & Palliat, Via San Lorenzo 312, I-901456 Palermo, Italy.",terapiadeldolore@lamaddalenanet.it,"cuomo, arturo/AAL-4416-2020","mercadante, sebastiano/0000-0001-9859-6487",,,,,63,12,14,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUL-AUG,2016,19.0,5.0,,,,,531,536,,10.1016/j.jval.2016.03.002,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DU5MA,27565269.0,hybrid,,,2024-03-09,WOS:000382254600006,0
J,"Craig, BM; Greiner, W; Brown, DS; Reeve, BB",,,,"Craig, Benjamin M.; Greiner, Wolfgang; Brown, Derek S.; Reeve, Bryce B.",,,VALUATION OF CHILD HEALTH-RELATED QUALITY OF LIFE IN THE UNITED STATES,HEALTH ECONOMICS,,,English,Article,,,,,,quality-adjusted life years; discrete choice experiments; patient-reported outcomes; health-related quality of life; child HRQoL,DISCRETE-CHOICE EXPERIMENT; PARENT PREFERENCES; UTILITY; OUTCOMES; POPULATION; SYSTEM; VALUES; QALYS; DALYS,"Many economic analyses fail to incorporate evidence on child health-related quality of life because of a paucity of quality-adjusted life year (QALY) estimates. This health valuation study is the first to summarize the EQ-5D-Y on a QALY scale. Drawn from a nationally representative panel, 5207 adult respondents were asked to choose between two losses in child health-related quality of life. Based on their choices, a 1-year increase in child pain/discomfort from 'some' to 'a lot' equals a loss of 4 QALYs (95% CI, 3.8-4.4). Likewise, a 1-year increase in child anxiety/depression from 'a bit' to 'very worried, sad, or unhappy' equals a loss of 2 QALYs (95% CI, 1.9-2.2). These findings enable the integration of child-reported outcomes with adult preferences to inform economic analysis. Results inform both clinical practice and resource allocation decisions by enhancing understanding of difficult tradeoffs in child-reported outcomes. Copyright (C) 2015 John Wiley & Sons, Ltd.","[Craig, Benjamin M.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Craig, Benjamin M.] Univ S Florida, Tampa, FL USA; [Greiner, Wolfgang] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany; [Brown, Derek S.] Washington Univ, Brown Sch, St Louis, MO USA; [Brown, Derek S.] Washington Univ, Inst Publ Hlth, St Louis, MO USA; [Reeve, Bryce B.] Univ N Carolina, Chapel Hill, NC USA",H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Bielefeld; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill,"Craig, BM (通讯作者)，MRC CANCONT, Moffitt Canc Ctr, 12902 Magnolia Dr, Tampa, FL 33612 USA.",benjamin.craig@moffitt.org,"Reeve, Bryce/AAE-7657-2019; Brown, Derek/J-3035-2013","Brown, Derek/0000-0001-9908-9882; Craig, Benjamin Matthew/0000-0003-1121-1316",NCI R01 grant [1R01CA160104],NCI R01 grant,"The authors thank Catherine Blackburn, Zein Kattih, Michelle Owens, and Carol Templeton at Moffitt Cancer Center for their contributions to the research and creation of this paper. The opinions expressed in this paper do not represent those of the reviewers. Funding support for this research was provided by an NCI R01 grant (1R01CA160104) and Dr Craig's support account at Moffitt Cancer Center.",,39,27,28,0,10,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JUN,2016,25.0,6.0,,,,,768,777,,10.1002/hec.3184,0.0,,,10,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DK5QT,25926161.0,,,,2024-03-09,WOS:000374975500010,0
J,"Raza, WA; Van de Poel, E; Bedi, A; Rutten, F",,,,"Raza, Wameq A.; Van de Poel, Ellen; Bedi, Arjun; Rutten, Frans",,,IMPACT OF COMMUNITY-BASED HEALTH INSURANCE ON ACCESS AND FINANCIAL PROTECTION: EVIDENCE FROM THREE RANDOMIZED CONTROL TRIALS IN RURAL INDIA,HEALTH ECONOMICS,,,English,Article,,,,,,community-based health insurance; randomized control trial; India,MODELS; POOR,"Since the 1990s, community-based health insurance (CBHI) schemes have been proposed to reduce the financial consequences of illness and enhance access to healthcare in developing countries. Convincing evidence on the ability of such schemes to meet their objectives is scarce. This paper uses randomized control trials conducted in rural Uttar Pradesh and Bihar (India) to evaluate the effects of three CBHI schemes on healthcare utilization and expenditure. We find that the schemes have no effect on these outcomes. The results suggest that CBHI schemes of the type examined in this paper are unlikely to have a substantial impact on access and financial protection in developing countries. Copyright (C) 2015 John Wiley & Sons, Ltd.","[Raza, Wameq A.; Van de Poel, Ellen; Rutten, Frans] Erasmus Univ, Inst Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands; [Raza, Wameq A.] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Bedi, Arjun] Erasmus Univ, Int Inst Social Studies, NL-3000 DR Rotterdam, Netherlands",Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC; Bangladesh Rural Advancement Committee BRAC; Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC,"Raza, WA (通讯作者)，Erasmus Univ, Inst Hlth Policy & Management, POB 1738, NL-3000 DR Rotterdam, Netherlands.",wameq.r@gmail.com,"Raza, Wameq Azfar/H-6570-2019","Raza, Wameq Azfar/0000-0001-6663-3220","European Commission seventh framework program in India [HEALTH-F2-2009-223518-CBHI]; Netherlands Organization for Scientific Research, Innovational Research Incentives Scheme, Veni project [451-11-031]","European Commission seventh framework program in India(European Union (EU)); Netherlands Organization for Scientific Research, Innovational Research Incentives Scheme, Veni project","This work was funded by the European Commission seventh framework program, grant ID HEALTH-F2-2009-223518-CBHI in India. Ellen Van de Poel received funding support from the Netherlands Organization for Scientific Research, Innovational Research Incentives Scheme, Veni project 451-11-031.",,36,25,27,0,27,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JUN,2016,25.0,6.0,,,,,675,687,,10.1002/hec.3307,0.0,,,13,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DK5QT,26708298.0,,,,2024-03-09,WOS:000374975500004,0
J,"Afantchao, G; Benbrahim, L; Benchekroun, B; Rkain, H; Hajjaj-Hassouni, N; Ahid, S",,,,"Afantchao, G.; Benbrahim, L.; Benchekroun, B.; Rkain, H.; Hajjaj-Hassouni, N.; Ahid, S.",,,BUDGET IMPACT OF THE INTRODUCTION OF RITUXIMAB AFTER FAILURE OF METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: EL AYACHI HOSPITAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Afantchao, G.; Ahid, S.] Mohammed V Univ, Rabat, Morocco; [Benbrahim, L.; Benchekroun, B.; Rkain, H.; Hajjaj-Hassouni, N.] El Ayachi Hosp, Sale, Morocco",Mohammed V University in Rabat; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS25,A229,A229,,10.1016/j.jval.2016.03.1125,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600107,0
J,"Aggarwal, S; Kumar, S; Topaloglu, H",,,,"Aggarwal, S.; Kumar, S.; Topaloglu, H.",,,LATEST TRENDS IN DESIGN OF PIVOTAL PHASE III CLINICAL TRIALS FOR HEMOPHILIA A AND B,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA; [Kumar, S.] Inst Global Policy Res, Washington, DC USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM180,A103,A103,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000008,0
J,"Aggarwal, S; Kumar, S; Topaloglu, H",,,,"Aggarwal, S.; Kumar, S.; Topaloglu, H.",,,LATEST TRENDS IN DESIGN OF PIVOTAL CLINICAL TRIALS FOR HUNTINGTON'S DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA; [Kumar, S.] Inst Global Policy Res, Washington, DC USA",,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM35,A77,A77,,10.1016/j.jval.2016.03.641,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000423,0
J,"Ajmera, MR; Davis, KL; Li, L; Huang, Y; Price, GL; Goyal, RK; John, WJ; Carter, GC; Kaye, JA; Boye, ME",,,,"Ajmera, M. R.; Davis, K. L.; Li, L.; Huang, Y.; Price, G. L.; Goyal, R. K.; John, W. J.; Carter, Cuyun G.; Kaye, J. A.; Boye, M. E.",,,ECONOMIC OUTCOMES ASSOCIATED WITH TUMOR HISTOLOGY AMONG ELDERLY PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ajmera, M. R.; Davis, K. L.; Goyal, R. K.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Li, L.; Huang, Y.; Price, G. L.; John, W. J.; Carter, Cuyun G.; Boye, M. E.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Kaye, J. A.] RTI Hlth Solut, Waltham, MA USA",Research Triangle Institute; Eli Lilly; Research Triangle Institute,,,,"Goyal, Ravi/0000-0003-1632-036X; Kaye, James A./0000-0002-9357-4227; Davis, Keith/0000-0002-0044-7107",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN179,A165,A165,,10.1016/j.jval.2016.03.1512,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000350,0
J,"Algatan, R; Rittenhouse, B",,,,"Algatan, R.; Rittenhouse, B.",,,EXAMINING UNCERTAINTY AROUND THE AMERICAN COLLEGE OF MEDICAL GENETICS RECOMMENDATION FOR NEWBORN SCREENING FOR 2-METHYLBUTYRYLL-COA DEHYDROGENASE DEFICIENCY (2MBG),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Algatan, R.; Rittenhouse, B.] MCPHS Univ, Boston, MA USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS168,A39,A39,,10.1016/j.jval.2016.03.403,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000214,0
J,"Allaire, JC; Gamaldo, AA; Whitfield, KE",,,,"Allaire, J. C.; Gamaldo, A. A.; Whitfield, K. E.",,,EXAMINING THE UTILITY OF THE EVERYDAY COGNITION MEMORY TEST TO IDENTIFY MILD COGNITIVE IMPAIRMENT IN AFRICAN AMERICAN ELDERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Allaire, J. C.] Generat Solut Grp, Cary, NC USA; [Gamaldo, A. A.] Univ S Florida, Tampa, FL USA; [Whitfield, K. E.] Duke Univ, Durham, NC USA",State University System of Florida; University of South Florida; Duke University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH53,A191,A191,,10.1016/j.jval.2016.03.1339,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000492,0
J,"Zakzuk, JA; Mejía, FS; Guzman, NA; Zakzuk, JYA; Zakzuk, NRA",,,,"Alvis Zakzuk, J.; Salcedo Mejia, F.; Alvis Guzman, N.; Alvis Zakzuk, J. Y.; Alvis Zakzuk, N. R.",,,PREVALENCE OF USE OF CONTRACEPTIVE METHODS IN YOUNG POOR PEOPLE FROM A REGION OF COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Alvis Zakzuk, J.; Alvis Zakzuk, N. R.] Alzak Fdn, Cartagena, Colombia; [Salcedo Mejia, F.] Univ Cartagena, Cartagena De Indias, Colombia; [Alvis Guzman, N.] Univ Cartagena, Cartagena, Colombia; [Alvis Zakzuk, J. Y.] Mutual Ser EPS, Cartagena, Colombia",Universidad de Cartagena; Universidad de Cartagena,,,"Alvis-Zakzuk, Nelson J./HSH-0822-2023; Alvis-Guzman, Nelson/D-4913-2013","Alvis-Guzman, Nelson/0000-0001-9458-864X",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM164,A100,A100,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000552,0
J,"Atif, M; Sarwar, MR; Azeem, M; Qamar-Uz-Zaman, M; Arslan, B; Nauman, A; Zeshan, M",,,,"Atif, M.; Sarwar, Rehan M.; Azeem, M.; Qamar-Uz-Zaman, M.; Arslan, B.; Nauman, A.; Zeshan, M.",,,ASSESSMENT OF WHO/INRUD PATIENT-CARE AND FACILITY-SPECIFIC INDICATORS IN THE OPHTHALMOLOGY WARDS OF TWO TERTIARY CARE HOSPITALS IN PAKISTAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Atif, M.; Sarwar, Rehan M.; Azeem, M.; Qamar-Uz-Zaman, M.; Arslan, B.; Nauman, A.; Zeshan, M.] Islamia Univ Bahawalpur, Bahawalpur, Pakistan",Islamia University of Bahawalpur,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS6,A10,A11,,10.1016/j.jval.2016.03.255,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000054,0
J,"Baradaran, S; Keyloun, KR; Chin, L; Pham, J; Canestaro, W; Devine, B",,,,"Baradaran, S.; Keyloun, K. R.; Chin, L.; Pham, J.; Canestaro, W.; Devine, B.",,,CLINICAL EVIDENCE SUPORTING PHARMACOGENOMIC BIOMARKER TESTING PROVIDED IN US FOOD AND DRUG ADMINISTRATION DRUG LABELS: AN UPDATE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Baradaran, S.; Keyloun, K. R.; Chin, L.; Pham, J.; Canestaro, W.; Devine, B.] Univ Washington, Seattle, WA 98195 USA",University of Washington; University of Washington Seattle,,,"Devine, Beth/ITU-0067-2023; Lee, Chin/AAR-5222-2020","Lee, Chin/0000-0002-8651-2204",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP182,A289,A289,,10.1016/j.jval.2016.03.756,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600442,0
J,"Bedenbaugh, A; Soi, S; Ahmed, E",,,,"Bedenbaugh, A.; Soi, S.; Ahmed, E.",,,PATIENT-LED RESEARCH: CHARACTERIZING USE OF A NOVEL MEDICAL RECORD TECHNOLOGY AMONGST AN INFLAMMATORY BOWEL DISEASE COHORT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bedenbaugh, A.] Betterpath Inc, Douglasville, GA USA; [Soi, S.; Ahmed, E.] Betterpath Inc, New York, NY USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM59,A81,A81,,10.1016/j.jval.2016.03.1771,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000447,0
J,"Belousov, D; Cheberda, A",,,,"Belousov, D.; Cheberda, A.",,,PHARMACOECONOMIC ANALYSIS OF NAFTIDROFURYL FOR ISCHEMIC STROKE TREATMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Belousov, D.; Cheberda, A.] Ctr Pharmacoecon Res LLC, Moscow, Russia",,,,"Belousov, Dmitry/F-2665-2018","Belousov, Dmitry/0000-0002-2164-8290",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV32,A44,A45,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000246,0
J,"Bennette, CS; Basu, A; Richards, C; Sullivan, SD; Ramsey, S",,,,"Bennette, C. S.; Basu, A.; Richards, C.; Sullivan, S. D.; Ramsey, S.",,,TRENDS IN EXPENDITURES FOR ORAL CHEMOTHERAPY AFTER MARKET ENTRY (2007-2013),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bennette, C. S.; Basu, A.; Sullivan, S. D.; Ramsey, S.] Univ Washington, Seattle, WA 98195 USA; [Richards, C.] Aetion Inc, New York, NY USA",University of Washington; University of Washington Seattle,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN164,A163,A163,,10.1016/j.jval.2016.03.1497,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000336,0
J,"Bhattacharya, K; Noori, W; Khanna, R",,,,"Bhattacharya, K.; Noori, W.; Khanna, R.",,,IMPACT OF DEPRESSION ON HEALTH-RELATED QUALITY OF LIFE AMONG SURVIVORS OF SKIN CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bhattacharya, K.] Univ Mississippi, Oxford, MS USA; [Noori, W.] Univ Mississippi, University, MS 38677 USA; [Khanna, R.] Univ Mississippi, Sch Pharm, University, MS 38677 USA",University of Mississippi; University of Mississippi; University of Mississippi,,,"Bhattacharya, Kaustuv/ABK-7808-2022","Bhattacharya, Kaustuv/0000-0001-8857-1817",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN150,A160,A161,,10.1016/j.jval.2016.03.1484,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000323,0
J,"Bin Sawad, A; Seoane-Vazquez, E; Rodriguez-Monguio, R; Turkistani, F",,,,"Bin Sawad, A.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.; Turkistani, F.",,,COST-EFFECTIVENESS OF DIFFERENT STRATEGIES FOR TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bin Sawad, A.; Seoane-Vazquez, E.; Turkistani, F.] MCPHS Univ, Boston, MA USA; [Rodriguez-Monguio, R.] Univ Massachusetts, Amherst, MA 01003 USA",University of Massachusetts System; University of Massachusetts Amherst,,,"Bin Sawad, Aseel/AAS-7750-2020","Bin Sawad, Aseel/0000-0001-6620-0716",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PND19,A62,A62,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000340,0
J,"Byun, D; Moon, S; Kim, T; Kim, Y; Seo, B; Min, Y",,,,"Byun, D.; Moon, S.; Kim, T.; Kim, Y.; Seo, B.; Min, Y.",,,PREVALENCE OF GASTROINTESTINAL RISK FACTORS AND TREATMENT PATTERNS OF OSTEOPOROSIS MEDICATION IN POSTMENOPAUSAL WOMEN OF KOREA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Byun, D.] Soonchunhyang Univ Hosp, Seoul, South Korea; [Moon, S.] Yonsei Univ, Coll Med, Seoul, South Korea; [Kim, T.] Korea Univ, Coll Med, Seoul, South Korea; [Kim, Y.; Seo, B.] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea; [Min, Y.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea",Soonchunhyang University; Soonchunhyang University Hospital; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Pfizer; Sungkyunkwan University (SKKU); Samsung Medical Center,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS75,A237,A238,,10.1016/j.jval.2016.03.1105,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600155,0
J,"Carrasquilla-Sotomayor, M; Alvis-Zakzuk, N; Alvis-Guzmán, N; Paz-Wilches, J; Mclean, M; Jeréz-Arias, M; Alvis-Zakzuk, NR",,,,"Carrasquilla-Sotomayor, M.; Alvis-Zakzuk, N.; Alvis-Guzman, N.; Paz-Wilches, J.; Manrrique Mclean, J.; Jerez-Arias, M.; Alvis-Zakzuk, N. R.",,,SOCIAL DETERMINANTS OF SUICIDE ATTEMPTS IN YOUNG PEOPLE IN A COLOMBIAN REGION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Carrasquilla-Sotomayor, M.; Alvis-Zakzuk, N. R.] ALZAK Fdn, Cartagena, Colombia; [Alvis-Zakzuk, N.] Inst Nacl Salud, Bogota, Colombia; [Alvis-Guzman, N.] Univ Cartagena, Hosp Infantil Napoleon Franco Pareja, Ctr Invest & Docencia, Cartagena De Indias, Colombia; [Paz-Wilches, J.; Manrrique Mclean, J.; Jerez-Arias, M.] Mutual Ser, Cartagena, Colombia",Instituto Nacional de Salud (Colombia); Universidad de Cartagena,,,"Alvis-Guzman, Nelson/D-4913-2013; Alvis-Zakzuk, Nelson J./HSH-0822-2023","Alvis-Guzman, Nelson/0000-0001-9458-864X;",,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH25,A186,A186,,10.1016/j.jval.2016.03.1406,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000464,0
J,"Cui, B; Xiong, X; Wang, L; Li, J",,,,"Cui, B.; Xiong, X.; Wang, L.; Li, J.",,,ANALYSIS ON THE ANNUAL MEDICAL BURDEN OF BASIC MEDICAL INSURANCE PARTICIPANTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cui, B.] Peking Univ, Beijing, Peoples R China; [Xiong, X.; Wang, L.; Li, J.] China Hlth Insurance Res Assoc, Beijing, Peoples R China",Peking University,,,,,,,,,0,0,0,1,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP89,A273,A273,,10.1016/j.jval.2016.03.886,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600353,0
J,"DiMasi, JA; Grabowski, HG; Hansen, RW",,,,"DiMasi, Joseph A.; Grabowski, Henry G.; Hansen, Ronald W.",,,Innovation in the pharmaceutical industry: New estimates of R&D costs,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Innovation; R&D cost; Pharmaceutical industry; Discount rate; Technical success rates,REQUIRE EXTRAORDINARY EVIDENCE; DEVELOPMENT SUCCESS RATES; DRUG DEVELOPMENT; INVESTIGATIONAL DRUGS; RECORD STRAIGHT; UNITED-STATES; PRODUCTIVITY; IMPACT; TIMES,"The research and development costs of 106 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug and biologics development. The costs of compounds abandoned during testing were linked to the costs of compounds that obtained marketing approval. The estimated average out-of-pocket cost per approved new compound is $1395 million (2013 dollars). Capitalizing out-of-pocket costs to the point of marketing approval at a real discount rate of 10.5% yields a total pre-approval cost estimate of $2558 million (2013 dollars). When compared to the results of the previous study in this series, total capitalized costs were shown to have increased at an annual rate of 8.5% above general price inflation. Adding an estimate of post-approval R&D costs increases the cost estimate to $2870 million (2013 dollars). (C) 2016 Elsevier B.V. All rights reserved.","[DiMasi, Joseph A.] Tufts Univ, Tufts Ctr Study Drug Dev, 75 Kneeland St,Suite 1100, Boston, MA 02111 USA; [Grabowski, Henry G.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Hansen, Ronald W.] Univ Rochester, Simon Business Sch, Rochester, NY 14627 USA",Tufts University; Duke University; University of Rochester,"DiMasi, JA (通讯作者)，Tufts Univ, Tufts Ctr Study Drug Dev, 75 Kneeland St,Suite 1100, Boston, MA 02111 USA.",joseph.dimasi@tufts.edu,,,Tufts CSDD,Tufts CSDD,"We thank the surveyed firms for providing data, and individuals in those firms who kindly gave their time when we needed some of the responses clarified. All errors and omissions are the responsibility of the authors. The Tufts Center for the Study of Drug development (CSDD) is funded in part by unrestricted grants from pharmaceutical and biotechnology firms, as well as companies that provide related services (e.g., contract research, consulting, and technology firms) to the research-based industry. Tufts CSDD's financial disclosure statement can be found here: http://csdd.tufts.edu/about/financial_disclosure. The authors and Tufts CSDD did not receive any external funding to conduct this study. The R&D cost and expenditure data for individual compounds and companies are proprietary and cannot be redistributed. Other data used were obtained from subscription databases and the Food and Drug Administration (FDA) and other websites.",,50,1673,1950,34,621,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,MAY,2016,47.0,,,,,,20,33,,10.1016/j.jhealeco.2016.01.012,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DL3EM,26928437.0,,Y,N,2024-03-09,WOS:000375517000002,0
J,"Fillman, J; Klinefelter, P; Drenning, J; Feinberg, BA",,,,"Fillman, J.; Klinefelter, P.; Drenning, J.; Feinberg, B. A.",,,PROVIDER PERCEPTION OF HEOR ANA LYSES USING REAL-WORLD DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fillman, J.; Feinberg, B. A.] Cardinal Hlth, Dublin, OH USA; [Klinefelter, P.; Drenning, J.] Cardinal Hlth, Dallas, TX USA",Cardinal Health Inc; Cardinal Health Inc,,,"Feinberg, Bruce/AAX-9378-2021","Feinberg, Bruce/0000-0001-9267-9994",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN142,A159,A159,,10.1016/j.jval.2016.03.1476,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000315,0
J,"Freire, P; Cabrera, F; García, L; Cabezas, M; Fornasini, M; Albert, A",,,,"Freire, P.; Cabrera, F.; Garcia, L.; Cabezas, M.; Fornasini, M.; Albert, A.",,,COST-EFFECTIVENESS OF BIOLOGIC THERAPIES IN PSORIASIS BASED ON A 24-WEEK EVALUATION STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Freire, P.; Cabrera, F.; Garcia, L.] Carlos Andrade Marin Hosp, Quito, Ecuador; [Cabezas, M.] Pontifical Catholic Univ, Quito, Ecuador; [Fornasini, M.] Amer Univ, Quito, Ecuador; [Albert, A.] Univ Liege, Liege, Belgium",Pontificia Universidad Catolica del Ecuador; Universidad de Las Americas - Ecuador; University of Liege,,,"GARCIA, LILIANA SARAHI/HKO-4860-2023; Garcia, Lara/JZT-3470-2024; CABEZAS, MARIA/AFJ-9939-2022","Garcia, Lara/0000-0001-9803-4708;",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSY39,A248,A248,,10.1016/j.jval.2016.03.1062,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600211,0
J,"Garces, K; Thorne, C; Boire, G; Chow, A; Poulin-Costello, M; Walker, V; Haraoui, B",,,,"Garces, K.; Thorne, C.; Boire, G.; Chow, A.; Poulin-Costello, M.; Walker, V; Haraoui, B.",,,"COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Garces, K.; Poulin-Costello, M.] Amgen Canada Inc, Mississauga, ON, Canada; [Thorne, C.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Boire, G.] CHUS, Sherbrooke, PQ, Canada; [Chow, A.] Credit Valley Rheumatol, Mississauga, ON, Canada; [Walker, V] Optum, Burlington, ON, Canada; [Haraoui, B.] Inst Rhumatol Montreal, Montreal, PQ, Canada",Amgen Canada Inc; Southlake Regional Health Centre; University of Sherbrooke; Optum; Universite de Montreal,,,,,,,,,0,2,3,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS29,A229,A230,,10.1016/j.jval.2016.03.1129,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600111,0
J,"Geneus, CJ; Davis, RE",,,,"Geneus, C. J.; Davis, R. E.",,,PREDICTORS OF ELECTRONIC CIGARETTE USE AMONG INDIVIDUALS WITH ASTHMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Geneus, C. J.; Davis, R. E.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA",Tulane University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS16,A112,A112,,10.1016/j.jval.2016.03.436,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000062,0
J,"Goldsmith, D; Eriksson, D; Teitsson, S; Jackson, J; van Nooten, FE",,,,"Goldsmith, D.; Eriksson, D.; Teitsson, S.; Jackson, J.; van Nooten, F. E.",,,"REAL-WORLD, CROSS-SECTIONAL, DESCRIPTIVE STUDY OF THE QUALITY OF LIFE OF PATIENTS WITH ANEMIA AND CHRONIC KIDNEY DISEASE ACROSS EUROPE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Goldsmith, D.] Guys & St Thomas NHS Fdn Hosp, London, England; [Eriksson, D.; Teitsson, S.] Quantify Res, Stockholm, Sweden; [Jackson, J.] Adelphi Grp, Bollington, England; [van Nooten, F. E.] Astellas Pharma BV, Leiden, Netherlands",Adelphi Group Ltd; Astellas Pharmaceuticals,,,"Goldsmith, David J A/H-6965-2018","Goldsmith, David J A/0000-0002-4349-9193",,,,,0,1,1,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PUK21,A132,A132,,10.1016/j.jval.2016.03.548,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000169,0
J,"Gomes, RM; Lemos, LL; Barbosa, WB; Costa, JD; Acurcio, FA; Guerra, AA",,,,"Gomes, R. M.; Lemos, L. L.; Barbosa, W. B.; Costa, J. D.; Acurcio, F. A.; Guerra Jr, A. A.",,,ASSOCIATED FACTORS WITH GRAFT LOSS IN KIDNEY TRANSPLANTATION PATIENTS WHO USED MAINTENANCE IMMUNOSUPRESSIVE REGIMENS CONTAINING CYCLOSPORINE OR TACROLIMUS IN SUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gomes, R. M.; Lemos, L. L.; Barbosa, W. B.; Costa, J. D.; Acurcio, F. A.; Guerra Jr, A. A.] Univ Fed Minas Gerais, CCATES, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais,,,"Guerra, Augusto Afonso/AAS-6584-2020; Acurcio, Francisco A/G-2583-2012; de Oliveira Costa, Juliana/P-8550-2019","Guerra, Augusto Afonso/0000-0001-5256-0577; de Oliveira Costa, Juliana/0000-0002-8355-023X",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PUK6,A129,A130,,10.1016/j.jval.2016.03.528,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000155,0
J,"Gonzalez-McQuire, S; Yong, K; Flinois, A; Gazzola, C; Schoen, P; Mennini, FS; Campioni, M; DeCosta, L; Fink, L",,,,"Gonzalez-McQuire, S.; Yong, K.; Flinois, A.; Gazzola, C.; Schoen, P.; Mennini, F. S.; Campioni, M.; DeCosta, L.; Fink, L.",,,RETROSPECTIVE CHART REVIEW STUDY TO EVALUATE HEALTH CARE RESOURCE UTILIZATION IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA IN ITALY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gonzalez-McQuire, S.; Schoen, P.; Campioni, M.] Amgen Europe GmbH, Zug, Switzerland; [Yong, K.] UCL, London, England; [Flinois, A.; Gazzola, C.; Fink, L.] Kantar Hlth, Paris, France; [Mennini, F. S.] Univ Roma Tor Vergata, Fac Econ, CEIS, Econ Evaluat & HTA EEHTA, Rome, Italy; [DeCosta, L.] Amgen Ltd, Uxbridge, Middx, England",Amgen; AMGEN Europe; University of London; University College London; University of Rome Tor Vergata; Amgen; Amgen Limited,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN123,A155,A156,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000296,0
J,"Hammoudi-Bendib, N; Mahi, L; Cherif, A; Girerd, X",,,,"Hammoudi-Bendib, N.; Mahi, L.; Cherif, A.; Girerd, X.",,,FEASIBILITY SURVEY ON OUTPATIENT MANAGEMENT OF HYPERTENSION IN ALGERIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hammoudi-Bendib, N.] EHS Dr Maouche CNMS, Algiers, Algeria; [Mahi, L.] Axelys Sante DZ, Algiers, Algeria; [Cherif, A.] Merinal Labs, Algiers, Algeria; [Girerd, X.] Grp Hosp Univ Pitie Salpetriere, Paris, France",Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD4,A297,A297,,10.1016/j.jval.2016.03.732,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600490,0
J,"Henkhaus, LE; Hay, JW",,,,"Henkhaus, L. E.; Hay, J. W.",,,COST EFFECTIVENESS OF EMPAGLIFLOZIN/LINAGLIPTIN AS 2ND-LINE THERAPY FOR ADULTS WITH TYPE 2 DIABETES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Henkhaus, L. E.; Hay, J. W.] Univ Southern Calif, Los Angeles, CA USA",University of Southern California,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB35,A202,A203,,10.1016/j.jval.2016.03.1297,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000555,0
J,"Rodriguez, MH; Redondo, HP; Guzman, NA",,,,"Herrera Rodriguez, M.; Pinzon Redondo, H.; Alvis Guzman, N.",,,RISK FACTORS AND SOCIOECONOMIC DETERMINANTS OF CHILD ABUSE: A CASE-CONTROL STUDY IN PATIENTS IN A PEDIATRIC HOSPITAL IN COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Herrera Rodriguez, M.; Pinzon Redondo, H.; Alvis Guzman, N.] Univ Cartagena, Ctr Invest & Docencia, Hosp Infantil Napoleon Franco Pareja, Cartagena De Indias, Colombia",Universidad de Cartagena,,,"Alvis-Guzman, Nelson/D-4913-2013","Alvis-Guzman, Nelson/0000-0001-9458-864X",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIH14,A174,A174,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000399,0
J,"Hudgens, S; Taylor-Strokes, G; De Courcy, J; Kontoudis, I; Tremblay, G; Forsythe, A; Lloyd, A",,,,"Hudgens, S.; Taylor-Strokes, G.; De Courcy, J.; Kontoudis, I; Tremblay, G.; Forsythe, A.; Lloyd, A.",,,REAL-WORLD EVIDENCE ON HEALTH STATES UTILITIES IN IN METASTATIC BREAST CANCER PATIENTS: DATA FROM A RETROSPECTIVE PATIENT RECORD FORM STUDY AND A CROSS-SECTIONAL PATIENT SURVEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hudgens, S.] Clin Outcomes Solut, Tucson, AZ USA; [Taylor-Strokes, G.] Adelphi Grp, Bollington, Cheshire, England; [De Courcy, J.] Adelphi Real World, Bollington, England; [Kontoudis, I] Eisai Europe Ltd, Hatfield, Herts, England; [Tremblay, G.; Forsythe, A.] Eisai Inc, Woodcliff Lake, NJ USA; [Lloyd, A.] Baldon Associates, Oxford, England",Adelphi Group Ltd; Adelphi Group Ltd; Eisai Co Ltd; Eisai Co Ltd,,,,,,,,,0,3,3,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN132,A157,A157,,10.1016/j.jval.2016.03.1466,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000305,0
J,"Huo, J; Smith, BD; Giordano, SH; Reece, GP; Shih, YT",,,,"Huo, J.; Smith, B. D.; Giordano, S. H.; Reece, G. P.; Shih, Y. T.",,,POST-MASTECTOMY BREAST RECONSTRUCTION AND ITS SUBSEQUENT COMPLICATIONS: A COMPARISON BETWEEN OBESE AND NON-OBESE WOMEN WITH BREAST CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Huo, J.; Smith, B. D.; Giordano, S. H.; Reece, G. P.; Shih, Y. T.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA",University of Texas System; UTMD Anderson Cancer Center,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN169,A164,A164,,10.1016/j.jval.2016.03.1502,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000341,0
J,"Hwang, M",,,,"Hwang, M.",,,CONSUMERS' INTENDED INFORMATION-SEEKING BEHAVIOR AFTER VIEWING DIRECT-TO-CONSUMER ADVERTISEMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hwang, M.] St Johns Univ, Queens, NY USA",Saint John's University,,,,,,,,,0,0,0,1,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP91,A273,A273,,10.1016/j.jval.2016.03.888,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600355,0
J,"Iqbal, MS; Iqbal, MZ; Bahari, MB",,,,"Iqbal, M. S.; Iqbal, M. Z.; Bahari, M. B.",,,COMMUNITY PHARMACISTS VIEWS ABOUT PHARMACOVIGILANCE IN PAKISTAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Iqbal, M. S.] BZU, Fac Pharm, Multan, Pakistan; [Iqbal, M. S.] MAHSA Univ, Fac Pharm, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Iqbal, M. Z.; Bahari, M. B.] AIMST Univ, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kedah, Malaysia",Bahauddin Zakariya University; Mahsa University; AIMST University,,,"Iqbal, Muhammad/HJH-2369-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP123,A279,A279,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600386,0
J,"Kale, HP; Varghese, D; Carroll, NV",,,,"Kale, H. P.; Varghese, D.; Carroll, N., V",,,TREATMENT PATTERNS OF DEPRESSION AMONG NON-INSTITUTIONALIZED CANCER SURVIVORS IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kale, H. P.; Varghese, D.; Carroll, N., V] Virginia Commonwealth Univ, Richmond, VA USA",Virginia Commonwealth University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN39,A140,A140,,10.1016/j.jval.2016.03.1661,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000213,0
J,"Kanukula, R; Likhar, N; Mothe, RK; Dang, A",,,,"Kanukula, R.; Likhar, N.; Mothe, R. K.; Dang, A.",,,EFFICACY AND SAFETY OF DULAGLUTIDE IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"MarksMan Healthcare Solut LLP, HEOR, Navi Mumbai, India; MarksMan Healthcare Solut LLP, RWE, Navi Mumbai, India",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB12,A198,A199,,10.1016/j.jval.2016.03.1319,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000532,0
J,"Khan, MU; Ahmad, A; Hassali, MA; Elkalmi, RM; Zaidi, ST",,,,"Khan, M. U.; Ahmad, A.; Hassali, M. A.; Elkalmi, R. M.; Zaidi, S. T.",,,A CROSS-SECTIONAL SURVEY OF COMMUNITY PHARMACISTS TOWARDS ANTIMICROBIAL STEWARDSHIP IN MALAYSIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Khan, M. U.; Ahmad, A.] UCSI Univ, Kuala Lumpur, Malaysia; [Hassali, M. A.] Univ Sains Malaysia, George Town, Malaysia; [Elkalmi, R. M.] Int Islamic Univ Malaysia, Kuantan, Malaysia; [Zaidi, S. T.] Univ Tasmania, Hobart, Tas, Australia",UCSI University; Universiti Sains Malaysia; International Islamic University Malaysia; University of Tasmania,,,"ELKALMI, RAMADAN M./ABG-1872-2021; Ahmad, Akram/P-7368-2015","ELKALMI, RAMADAN M./0000-0002-6659-5049; Ahmad, Akram/0000-0002-9998-5860",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS88,A25,A25,,10.1016/j.jval.2016.03.323,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000134,0
J,"Kum, H; Ohsfeldt, R",,,,"Kum, H.; Ohsfeldt, R.",,,COMPARISON OF DATA TO DECISION MODELS FOR A DATA CONSORTIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kum, H.; Ohsfeldt, R.] Texas A&M Hlth Sci Ctr, College Stn, TX USA",Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center,,,"Kum, Hye-Chung/ABE-5562-2020; Kum, Hye-Chung/GWN-0869-2022","Kum, Hye-Chung/0000-0002-6882-8053;",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM62,A82,A82,,10.1016/j.jval.2016.03.1774,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000450,0
J,"Lachaine, J; Kouroukis, CT",,,,"Lachaine, J.; Kouroukis, C. T.",,,BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lachaine, J.] Univ Montreal, Montreal, PQ, Canada; [Kouroukis, C. T.] McMaster Univ, Hamilton, ON, Canada",Universite de Montreal; McMaster University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSY22,A244,A245,,10.1016/j.jval.2016.03.1045,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600194,0
J,"Leleka, M; Zaliska, O; Kit, S",,,,"Leleka, M.; Zaliska, O.; Kit, S.",,,USE OF COST-BENEFIT ANALYSIS TO SUPPORT THE VACCINATION AGAINST INFLUENZA IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Leleka, M.; Zaliska, O.] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine; [Kit, S.] Lviv Reg Infect Hosp, Lvov, Ukraine",Danylo Halytsky Lviv National Medical University,,,"Zaliska, Olha/E-1135-2018; Zaliska, Olha/AAN-6078-2020","Zaliska, Olha/0000-0003-1845-7909",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIN28,A216,A216,,10.1016/j.jval.2016.03.1216,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600039,0
J,"Li, M; Lu, K",,,,"Li, M.; Lu, K.",,,PREDICTORS OF ERYTHROPOIESIS-STIMULATING AGENTS USE UNDER MEDICARE PART D,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Li, M.; Lu, K.] Univ South Carolina, Columbia, SC USA",University of South Carolina System; University of South Carolina Columbia,,,"liu, feng/HPC-8076-2023",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSY83,A255,A256,,10.1016/j.jval.2016.03.1022,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600254,0
J,"Likhar, N; Kanukula, R; Mothe, RK; Vsn, M; Dang, A",,,,"Likhar, N.; Kanukula, R.; Mothe, R. K.; Vsn, M.; Dang, A.",,,INVESTIGATING THE VALUE OF OMALIZUMAB IN THE TREATMENT OF SEVERE PERSISTENT ALLERGIC ASTHMA: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS STUDIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Likhar, N.; Kanukula, R.; Mothe, R. K.; Vsn, M.; Dang, A.] MarksMan Healthcare Solut LLP, HEOR & RWE, Navi Mumbai, India",,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS34,A115,A115,,10.1016/j.jval.2016.03.455,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000080,0
J,"Lo-Ciganic, W; Gellad, WF; Hiskamp, HA; Choudhry, NK; Zhang, R; Chang, C; Jones, BL; Richards-Shubik, S; Guclu, H; Donohue, JM",,,,"Lo-Ciganic, W.; Gellad, W. F.; Hiskamp, H. A.; Choudhry, N. K.; Zhang, R.; Chang, C.; Jones, B. L.; Richards-Shubik, S.; Guclu, H.; Donohue, J. M.",,,WHO WERE THE EARLY ADOPTERS OF DABIGATRAN? AN APPLICATION OF GROUP-BASED TRAJECTORY MODELS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lo-Ciganic, W.] Univ Arizona, Tucson, AZ USA; [Gellad, W. F.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Hiskamp, H. A.; Choudhry, N. K.] Harvard Med Sch, Boston, MA USA; [Choudhry, N. K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zhang, R.; Chang, C.; Guclu, H.; Donohue, J. M.] Univ Pittsburgh, Pittsburgh, PA USA; [Jones, B. L.] Carnegie Univ, Tucson, AZ USA; [Richards-Shubik, S.] Leigh Univ, Bethlehem, PA USA",University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,,,"Guclu, Hasan/B-7080-2008; Guclu, Hasan/HJB-1612-2022","Guclu, Hasan/0000-0003-3582-9460; Guclu, Hasan/0000-0003-3582-9460",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV106,A58,A58,,10.1016/j.jval.2016.03.157,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000320,0
J,"Macaulay, R; McDonough, A",,,,"Macaulay, R.; McDonough, A.",,,WHAT ARE THE WELSH UP TO? A SYSTEMATIC REVIEW OF AWMSG APPRAISALS OVER THE PAST 18 MONTHS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Macaulay, R.] PAREXEL Access Consulting, London, England; [McDonough, A.] PAREXEL, London, England",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP26,A262,A263,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600293,0
J,"Mahmoud, MA; Aljadhey, H; Hassali, MA",,,,"Mahmoud, M. A.; Aljadhey, H.; Hassali, M. A.",,,INCIDENCE OF PRESCRIBING ERORS IN HOSPITALIZED PATIENTS IN SAUDI ARABIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mahmoud, M. A.; Hassali, M. A.] Univ Sains Malaysia, George Town, Malaysia; [Aljadhey, H.] King Saud Univ, Riyadh, Saudi Arabia",Universiti Sains Malaysia; King Saud University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM1,A71,A71,,10.1016/j.jval.2016.03.607,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000389,0
J,"Marquez, M; Sanchez, K; Guzman, S; Soto, H; De Sarachaga, A; Cervantes, A; Rodriguez, M",,,,"Marquez, M.; Sanchez, K.; Guzman, S.; Soto, H.; De Sarachaga, A.; Cervantes, A.; Rodriguez, M.",,,"ESTIMATING THE OUT-OF-POCKET EXPENSES AND TRANSPORT, CAREGIVER, HOME ADAPTATION AND OR SPECIAL EQUIPMENT ACQUISITION COSTS ASSOCIATED WITH PARKINSON'S DISEASE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Marquez, M.; Sanchez, K.; Guzman, S.; Soto, H.] HS Estudios Farmacoecon, Mexico City, DF, Mexico; [De Sarachaga, A.; Cervantes, A.; Rodriguez, M.] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Mexico City, DF, Mexico",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PND31,A64,A64,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000351,0
J,"Martinez, G; Sir, M; Pasupathy, K",,,,"Martinez, G.; Sir, M.; Pasupathy, K.",,,IMPROVING ACCESS FOR SURGICAL PATIENTS USING VARIOUS POLICIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Martinez, G.; Sir, M.; Pasupathy, K.] Mayo Clin, Rochester, MN USA",Mayo Clinic,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS99,A27,A27,,10.1016/j.jval.2016.03.334,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000145,0
J,"Milenkovski, RB; Yunger, S; Shum, D",,,,"Milenkovski, R. B.; Yunger, S.; Shum, D.",,,REIMBURSEMENT RECOMMENDATIONS BASED ON PHASE II CLINICAL EVIDENCE FOR ONCOLOGY DRUGS IN CANADA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Milenkovski, R. B.; Yunger, S.; Shum, D.] Hoffmann La Roche, Mississauga, ON, Canada",Roche Holding,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN163,A163,A163,,10.1016/j.jval.2016.03.1496,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000335,0
J,"Nuamah, GB; Agyei-Baffour, P; Akohene, KM; Boateng, D; Dobin, D; Donkor, KA",,,,"Nuamah, G. B.; Agyei-Baffour, P.; Akohene, K. M.; Boateng, D.; Dobin, D.; Donkor, K. A.",,,INCENTIVES TO HONOR MATERNAL HEALTH REFERRALS IN A SETTING WITH INEQUITABLE ACCESS TO HEALTH CARE IN THE AMANSIE WEST DISTRICT IN ASHANTI REGION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nuamah, G. B.; Akohene, K. M.; Boateng, D.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Agyei-Baffour, P.] KNUST, Kumasi, Ghana; [Dobin, D.] Ghana Hlth Serv, Manso Nkwanta, Ghana; [Donkor, K. A.] Ghana Hlth Serv, Accra, Ghana",Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Ghana Health Service,,,"Boateng, Daniel/H-2918-2019","Boateng, Daniel/0000-0001-7568-7298",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS147,A35,A35,,10.1016/j.jval.2016.03.382,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000193,0
J,"Null, KD; Xu, Y; Pasquale, MK; Su, C; Marren, A; Harnett, J; Mardekian, J; Manuchehri, A; Healey, P",,,,"Null, K. D.; Xu, Y.; Pasquale, M. K.; Su, C.; Marren, A.; Harnett, J.; Mardekian, J.; Manuchehri, A.; Healey, P.",,,ULCERATIVE COLITIS TREATMENT PATTERNS AND COST OF CARE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Null, K. D.; Xu, Y.; Pasquale, M. K.] Comprehens Hlth Insights, Humana, Louisville, KY USA; [Su, C.; Marren, A.] Pfizer Inc, Collegeville, PA USA; [Harnett, J.; Mardekian, J.] Pfizer Inc, New York, NY USA; [Manuchehri, A.] Pfizer Inc, Tadworth, England; [Healey, P.] Pfizer Inc, Groton, CT USA",Humana Inc.; Pfizer; Pfizer; Pfizer; Pfizer,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PGI11,A314,A314,,10.1016/j.jval.2016.03.979,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600581,0
J,"Paliwal, Y; Shah, A; Slattum, P",,,,"Paliwal, Y.; Shah, A.; Slattum, P.",,,POTENTIALLY INAPPROPRIATE MEDICATION USE IN US OLDER ADULTS: PREVALENCE AND HEALTH CARE EXPENDITURES 2012-2013,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Paliwal, Y.; Shah, A.; Slattum, P.] Virginia Commonwealth Univ, Richmond, VA USA",Virginia Commonwealth University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP45,A266,A266,,10.1016/j.jval.2016.03.823,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600312,0
J,"Paredes, J; Liu, C; Yunusa, I; Ndikumukiza, C; Seoane-Vazquez, E",,,,"Paredes, J.; Liu, C.; Yunusa, I; Ndikumukiza, C.; Seoane-Vazquez, E.",,,PRICE ANALYSIS OF ORAL ANTIDEPRESSANT DRUGS WITH GENERIC COMPETITION MARKETED IN THE UNITED STATES (1988-2015),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Paredes, J.; Liu, C.; Yunusa, I; Ndikumukiza, C.] Massachusetts Coll Pharm & Allied Hlth Sci, Boston, MA USA; [Seoane-Vazquez, E.] MCPHS Univ, Boston, MA USA",,,,"Yunusa, Ismaeel/X-2390-2019","Yunusa, Ismaeel/0000-0002-9107-8561",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH36,A188,A188,,10.1016/j.jval.2016.03.1376,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000475,0
J,"Park, KH; Kim, CY; Cha, J; Kim, Y",,,,"Park, K. H.; Kim, C. Y.; Cha, J.; Kim, Y.",,,TREATMENT PATTERNS AND MEDICATION ADHERENCE OF GLAUCOMA PATIENTS IN SOUTH KOREA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Park, K. H.] Seoul Natl Univ Hosp, Seoul, South Korea; [Kim, C. Y.] Yonsei Univ, Coll Med, Seoul, South Korea; [Cha, J.; Kim, Y.] Pfizer Pharmaceut Korea Ltd, Seoul, South Korea",Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Pfizer,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSS23,A126,A126,,10.1016/j.jval.2016.03.514,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000135,0
J,"Patterson-Lomba, O; Signorovitch, J",,,,"Patterson-Lomba, O.; Signorovitch, J.",,,MEASURING OPORTUNITIES TO IMPROVE HEALTH OUTCOMES VIA INDIVIDUALIZED TREATMENT ASSIGNMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Patterson-Lomba, O.; Signorovitch, J.] Anal Grp Inc, Boston, MA USA",Analysis Group Inc.,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM166,A100,A100,,10.1016/j.jval.2016.03.1722,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000554,0
J,"Petrova, G; Dimitrova, M; Voycheva, H; Georgiev, O; Petrova, D",,,,"Petrova, G.; Dimitrova, M.; Voycheva, H.; Georgiev, O.; Petrova, D.",,,COPD PHARMACOTHERAPY IN BULGARIA AND ITS ADHERENCE TO GOLD GUIDELINES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Petrova, G.; Voycheva, H.; Georgiev, O.; Petrova, D.] Med Univ Sofia, Sofia, Bulgaria; [Dimitrova, M.] Med Univ Sofia, Fac Pharm, Sofia, Bulgaria",Medical University Sofia; Medical University Sofia,,,"Petrova, Guenka/I-6863-2019; Petrova, Daniela/GXA-2866-2022; Dimitrova, Maria Jordanova/AAE-4435-2021","Petrova, Guenka/0000-0001-8116-5138; Petrova, Daniela/0000-0003-1235-2786; Dimitrova, Maria Jordanova/0000-0002-4868-7775",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS64,A121,A121,,10.1016/j.jval.2016.03.485,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000110,0
J,"Ran, T; Chattopadhyay, S; Hahn, R",,,,"Ran, T.; Chattopadhyay, S.; Hahn, R.",,,ECONOMIC EVALUATION OF SCHOOL-BASED HEALTH CENTERS: A COMMUNITY GUIDE SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ran, T.; Chattopadhyay, S.; Hahn, R.] CDC, Atlanta, GA 30333 USA",Centers for Disease Control & Prevention - USA,,,"Chattopadhyay, Sajal/GWU-8667-2022","Chattopadhyay, Sajal/0000-0002-7245-1631",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS91,A25,A25,,10.1016/j.jval.2016.03.326,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,"hybrid, Green Accepted",,,2024-03-09,WOS:000376886000137,0
J,"Romero, M; Sanabria, M; Huerfano, LM",,,,"Romero, M.; Sanabria, M.; Huerfano, L. M.",,,HEALTH-RELATED QUALITY OF LIFE OF SICKLE CELL DISEASE PATIENTS AND FAMILIES IN COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Romero, M.] Salutia Fdn, Bogota, Colombia; [Sanabria, M.; Huerfano, L. M.] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM139,A96,A96,,10.1016/j.jval.2016.03.1753,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000527,0
J,"Sakharkar, P; Deb, S",,,,"Sakharkar, P.; Deb, S.",,,LIVER FUNCTION STATUS AMONG US ADULTS HAVING BOTH HYPERLIPIDEMIA AND HYPERGLYCEMIA: A CROSS SECTIONAL STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sakharkar, P.; Deb, S.] Roosevelt Univ, Coll Pharm, Schaumburg, IL USA",,,,"Sakharkar, Prashant/G-9584-2018",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV18,A42,A42,,10.1016/j.jval.2016.03.083,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000233,0
J,"Samuelson, D; Kageleiry, A; Duh, MS; Lefebvre, P; Campbell, JY; DerSarkissian, M; Haider, BA; Skotko, BG",,,,"Samuelson, D.; Kageleiry, A.; Duh, M. S.; Lefebvre, P.; Campbell, J. Y.; DerSarkissian, M.; Haider, B. A.; Skotko, B. G.",,,INCOME GROWTH TRAJECTORY FOR PARENTS OF CHILDREN WITH DOWN SYNDROME IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Samuelson, D.; Kageleiry, A.; Duh, M. S.; Haider, B. A.] Anal Grp Inc, Boston, MA USA; [Lefebvre, P.] Grp Anal Ltee, Montreal, PQ, Canada; [Campbell, J. Y.] Harvard Univ, Cambridge, MA 02138 USA; [DerSarkissian, M.] Anal Grp Inc, Los Angeles, CA USA; [Skotko, B. G.] Massachusetts Gen Hosp, Boston, MA 02114 USA",Analysis Group Inc.; Harvard University; Analysis Group Inc.; Harvard University; Massachusetts General Hospital,,,"Skotko, Brian G/D-1375-2013","Skotko, Brian G/0000-0002-5232-9882",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS45,A17,A17,,10.1016/j.jval.2016.03.295,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,"Green Submitted, Bronze",,,2024-03-09,WOS:000376886000092,0
J,"Serafini, P; Pike, J; Jones, E; Machado, M",,,,"Serafini, P.; Pike, J.; Jones, E.; Machado, M.",,,"TREATMENT WITH INTERFERON BETA-1A IN BRAZIL IS ASOCIATED WITH FEWER HOSPITALIZATIONS DUE TO RELAPSE, BETTER ADHERENCE AND A BETTER RESPONSE COMPARED TO OTHER PLATFORM THERAPIES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Serafini, P.; Machado, M.] Biogen, Sao Paulo, Brazil; [Pike, J.; Jones, E.] Adelphi Real World, Manchester, Lancs, England",Adelphi Group Ltd,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PND34,A64,A65,,10.1016/j.jval.2016.03.234,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000354,0
J,"Shewale, AR; Bhandari, NR; Kathe, N; Hammond, D; Painter, JT",,,,"Shewale, A. R.; Bhandari, N. R.; Kathe, N.; Hammond, D.; Painter, J. T.",,,CHARACTERIZATION OF ON-LABEL AND OFF-LABEL USE OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shewale, A. R.; Bhandari, N. R.; Kathe, N.; Hammond, D.; Painter, J. T.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA",University of Arkansas System; University of Arkansas Medical Sciences,,,"Bhandari, Naleen Raj/W-3669-2018; KATHE, NIRANJAN/AAI-5014-2020","Bhandari, Naleen Raj/0000-0002-4452-8021; KATHE, NIRANJAN/0000-0003-4932-6426",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP21,A262,A262,,10.1016/j.jval.2016.03.799,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600288,0
J,"Sohn, M; Moga, DC; Blumenschein, K; Talbert, J",,,,"Sohn, M.; Moga, D. C.; Blumenschein, K.; Talbert, J.",,,NATIONAL TRENDS IN OFF-LABEL USE OF ATYPICAL ANTIPSYCHOTICS IN CHILDREN AND ADOLESCENTS IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sohn, M.] Ferris State Univ, Big Rapids, MI USA; [Moga, D. C.; Blumenschein, K.] Univ Kentucky, Lexington, KY USA; [Talbert, J.] Univ Kentucky, Coll Pharm, Lexington, KY USA",Ferris State University; University of Kentucky; University of Kentucky,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH68,A194,A194,,10.1016/j.jval.2016.03.1353,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,"hybrid, Green Published",,,2024-03-09,WOS:000394931000507,0
J,"Tremblay, G; Pelletier, C; Copher, R; Forsythe, A; Majethia, U",,,,"Tremblay, G.; Pelletier, C.; Copher, R.; Forsythe, A.; Majethia, U.",,,COST-EFFECTIVENESS ANALYSIS OF LENVATINIB AS A TREATMENT FOR RADIOACTIVE IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tremblay, G.; Pelletier, C.] Eisai, Woodcliff Lake, NJ USA; [Copher, R.; Forsythe, A.; Majethia, U.] Eisai Inc, Woodcliff Lake, NJ USA",Eisai Co Ltd; Eisai Co Ltd,,,,,,,,,0,3,3,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN96,A151,A151,,10.1016/j.jval.2016.03.1595,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000270,0
J,"Turner, M; Monk, B; Bodurka, D; Sen, G; Look, K; Leung, G; Harding-Peets, G; Cleeland, C",,,,"Turner, M.; Monk, B.; Bodurka, D.; Sen, G.; Look, K.; Leung, G.; Harding-Peets, G.; Cleeland, C.",,,PATIENT-REPORTED SYMPTOMS IN OVARIAN CANCER BEFORE AND AFTER DISEASE PROGRESSION IN CONJUNCTION WITH BEVACIZUMAB MAINTENANCE THERAPY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Turner, M.; Sen, G.] ICON Clin Res, San Francisco, CA USA; [Monk, B.] Univ Arizona, Ctr Canc, Phoenix, AZ USA; [Monk, B.] Creighton Univ, Sch Med, Dign Hlth St Josephs Hosp & Med Ctr, Phoenix, AZ USA; [Bodurka, D.; Cleeland, C.] UT MD Andersen Canc Ctr, Houston, TX USA; [Look, K.; Leung, G.] Genentech Inc, San Francisco, CA USA; [Harding-Peets, G.] SHARE, New York, NY USA",ICON plc; University of Arizona; St. Joseph's Hospital and Medical Center; Creighton University; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN138,A158,A158,,10.1016/j.jval.2016.03.1472,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000311,0
J,"Vasireddy, VK",,,,"Vasireddy, V. K.",,,"A STUDY ON KNOWLEDGE AND AWARENESS ON ORAL CANCER IN A COMMUNITY OF SUZHOU, CHINA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vasireddy, V. K.] Soochow Univ, Suzhou, Peoples R China",Soochow University - China,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM121,A92,A92,,10.1016/j.jval.2016.03.1735,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000509,0
J,"Walker, MS; Wong, W; Ravelo, A; Hazard, S; Miller, PJ; Schwartzberg, L",,,,"Walker, M. S.; Wong, W.; Ravelo, A.; Hazard, S.; Miller, P. J.; Schwartzberg, L.",,,IMPACT OF DISEASE PROGRESSION ON PATIENT REPORTED OUTCOMES IN ADVANCED NSCLC: EVIDENCE FROM PATIENTS TREATED IN REAL WORLD COMMUNITY ONCOLOGY SETTINGS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Walker, M. S.; Miller, P. J.] Vector Oncol, Memphis, TN USA; [Wong, W.; Ravelo, A.; Hazard, S.] Genentech Inc, South San Francisco, CA USA; [Schwartzberg, L.] West Clin, Memphis, TN USA",Roche Holding; Genentech,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN147,A160,A160,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000320,0
J,"Wang, M; Cyhaniuk, A; Cooper, DL; Iyer, NN",,,,"Wang, M.; Cyhaniuk, A.; Cooper, D. L.; Iyer, N. N.",,,IDENTIFICATION OF PERSONS WITH CONGENITAL HEMOPHILIA IN A LARGE ELECTRONIC HEALTH RECORD DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, M.] Childrens Hosp Colorado, Aurora, CO USA; [Cyhaniuk, A.] AC Analyt Solut, Barrington, IL USA; [Cooper, D. L.; Iyer, N. N.] Novo Nordisk Inc, Plainsboro, NJ USA; [Cooper, D. L.; Iyer, N. N.] RTI Hlth Solut, Plainsboro, NJ USA",Children's Hospital Colorado; Novo Nordisk; Research Triangle Institute,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM53,A80,A80,,10.1016/j.jval.2016.03.1765,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000441,0
J,"Yu, YM; Koo, B; Jeong, K; Choi, KH; Kang, L; Oh, JM; Shin, WG; Lee, E",,,,"Yu, Y. M.; Koo, B.; Jeong, K.; Choi, K. H.; Kang, L.; Oh, J. M.; Shin, W. G.; Lee, E.",,,SPONTANEOUS REPORTING OF ADVERSE DRUG REACTIONS IN COMMUNITY PHARMACY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yu, Y. M.; Koo, B.; Kang, L.; Oh, J. M.; Shin, W. G.; Lee, E.] Seoul Natl Univ, Seoul, South Korea; [Jeong, K.] Chung Ang Univ, Seoul, South Korea; [Choi, K. H.] Suncheon Univ, Sunchon, South Korea",Seoul National University (SNU); Chung Ang University; Sunchon National University,,,,,,,,,0,0,0,1,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP181,A289,A289,,10.1016/j.jval.2016.03.755,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600441,0
J,"Zhang, Q; Zhao, Y; Keshishian, A; Xie, L; Yuce, H; Baser, O",,,,"Zhang, Q.; Zhao, Y.; Keshishian, A.; Xie, L.; Yuce, H.; Baser, O.",,,EVALUATING ASTHMA-RELATED EXPENSES AND HEALTH CARE RESOURCE UTILIZATION AMONG CHILDREN IN THE UNITED STATES MEDICAID POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhang, Q.; Zhao, Y.; Keshishian, A.; Xie, L.] STATinMED Res, Ann Arbor, MI USA; [Yuce, H.] CUNY, New York City Coll Technol, New York, NY 10021 USA; [Yuce, H.; Baser, O.] STATinMED Res, New York, NY USA; [Baser, O.] Columbia Univ, New York, NY USA",City University of New York (CUNY) System; Columbia University,,,"Xie, Lin/AAX-2889-2020",,,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS28,A114,A114,,10.1016/j.jval.2016.03.449,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000074,0
J,"Zhao, R; Gunnarsson, C; Kotlarz, H; Martinsen, BJ; Palli, S; Bell, E; Rizzo, JA",,,,"Zhao, R.; Gunnarsson, C.; Kotlarz, H.; Martinsen, B. J.; Palli, S.; Bell, E.; Rizzo, J. A.",,,AN INCREMENTAL COST ANALYSIS OF ORBITAL ATHERECTOMY PLUS ANGIOPLASTY COMPARED TO ANGIOPLASTY ALONE FOR THE TREATMENT OF CRITICAL LIMB ISCHEMIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhao, R.; Kotlarz, H.; Martinsen, B. J.] Cardiovasc Syst Inc, St Paul, MN USA; [Gunnarsson, C.; Palli, S.] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA; [Bell, E.] One Tall Tree Consulting LLC, Seattle, WA USA; [Rizzo, J. A.] SUNY Stony Brook, Stony Brook, NY 11794 USA",State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV34,A45,A45,,10.1016/j.jval.2016.03.099,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000248,0
J,"Zhu, M; Quinn, C; McKendrick, J; Aristides, M",,,,"Zhu, M.; Quinn, C.; McKendrick, J.; Aristides, M.",,,A PRINCIPAL COMPONENT ANALYSIS OF OVERALL SURVIVAL OUTCOMES AND LIST PRICES OF ONCOLOGY DRUGS IN EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhu, M.; Quinn, C.; McKendrick, J.; Aristides, M.] PRMA Consulting, Fleet, Hants, England",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN79,A147,A148,,10.1016/j.jval.2016.03.1578,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000253,0
J,"Hollin, IL; Robinson, KA",,,,"Hollin, Ilene L.; Robinson, Karen A.",,,A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Review,,,,,,,DIRECT MEDICAL COSTS; PSEUDOMONAS-AERUGINOSA; ECONOMIC BURDEN; UNITED-STATES; IMPACT; TOBRAMYCIN; INSURANCE; FAMILIES; COVERAGE; CHILDREN,"Background Cystic fibrosis (CF), one of the most common life-shortening genetic diseases, has no cure, but people living with it have seen improvements in their health and survival. The rising life expectancy and increased availability of treatment options has likely increased the lifetime costs of people living with CF. In addition, a recent drug approval for a therapy that targets the cause of the disease is one of the most expensive drugs worldwide. In light of these circumstances, it is important to have an updated understanding of the costs of CF therapy and management. This study aims to determine the extent of available literature that quantifies CF costs. Methods We used a scoping review framework to identify the sources and types of evidence available to determine the costs of CF therapy and management compared to the general population or a comparable population of people with other complex chronic conditions. We searched 14 databases for peer-reviewed studies and grey literature published in English since 1998. The search was conducted in August 2013 and updated in October 2014. Results We identified 28 studies that estimated overall, general CF costs. Of these, three studies compare CF costs to healthcare costs of a general population and only one of those provides a direct comparison of CF costs to the general population in order to calculate the incremental cost associated with CF. We estimate there are 98 systematic reviews that quantify the costs of comparable conditions and potentially provide a comparison group for people with CF. Conclusions There is evidence available that attempts to quantify overall, general healthcare costs of people with CF, although much of it is outdated. However, there is much less evidence available that provides a comparison of these costs with either the general population or people with comparable conditions.","[Hollin, Ilene L.; Robinson, Karen A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 691, Baltimore, MD 21205 USA; [Robinson, Karen A.] Johns Hopkins Sch Med, Dept Med, 1830 E Monument St,Room 8068, Baltimore, MD 21287 USA",Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine,"Hollin, IL (通讯作者)，Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 691, Baltimore, MD 21205 USA.",ilene.hollin@jhu.edu,"Hollin, Ilene/KDA-6056-2024","Hollin, Ilene/0000-0003-1405-8687",Cystic Fibrosis Foundation,Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation),"The research and one author were funded by a grant from the Cystic Fibrosis Foundation. There was no funding for manuscript preparation and the funding body played no role in the collection, analysis, or interpretation of data or in the manuscript preparation or decision to submit the manuscript for publication. The funding body did provide expert feedback on the protocol design.",,43,6,7,0,12,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,APR,2016,14.0,2.0,,,,,151,159,,10.1007/s40258-015-0211-4,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DG9ZC,26649564.0,,,,2024-03-09,WOS:000372441300004,0
J,"Heckman, JJ; Raut, LK",,,,"Heckman, James J.; Raut, Lakshmi K.",,,Intergenerational long-term effects of preschool-structural estimates from a discrete dynamic programming model,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Preschool investment; Early childhood development; Intergenerational social mobility; Structural dynamic programming,CHILD-CARE; CHOICE; TECHNOLOGY; PSYCHOLOGY; INVESTMENT; ECONOMICS; TRANSFERS,"This paper formulates a structural dynamic programming model of preschool investment choices of altruistic parents and then empirically estimates the structural parameters of the model using the NLSY79 data. The paper finds that preschool investment significantly boosts cognitive and non-cognitive skills, which enhance earnings and school outcomes. It also finds that a standard Mincer earnings function, by omitting measures of non-cognitive skills on the right-hand side, overestimates the rate of return to schooling. From the estimated equilibrium Markov process, the paper studies the nature of within generation earnings distribution, intergenerational earnings mobility, and schooling mobility. The paper finds that a tax-financed free preschool program for the children of poor socioeconomic status generates positive net gains to the society in terms of average earnings, higher intergenerational earnings mobility, and schooling mobility. (C) 2015 Elsevier B.V. All rights reserved.","[Heckman, James J.] Univ Chicago, Dept Econ, 1126 E 59th St, Chicago, IL 60637 USA; [Raut, Lakshmi K.] Social Secur Adm, 400 Virginia Ave SW,Suite 300, Washington, DC 20024 USA",University of Chicago,"Raut, LK (通讯作者)，Social Secur Adm, 400 Virginia Ave SW,Suite 300, Washington, DC 20024 USA.",jjh@uchicago.edu; Lakshmi.Raut@ssa.gov,"Raut, Lakshmi/CAH-1020-2022",,"American Bar Foundation [3203]; Pritzker Children's Initiative; Buffett Early Childhood Fund; NICHD [R37 HD065072, R01 HD054702]; Human Capital and Economic Opportunity Global Working Group - an initiative of the Becker Friedman Institute for Research in Economics - Institute for New Economic Thinking (INET) [INO14-00035]",American Bar Foundation; Pritzker Children's Initiative; Buffett Early Childhood Fund; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Capital and Economic Opportunity Global Working Group - an initiative of the Becker Friedman Institute for Research in Economics - Institute for New Economic Thinking (INET),"We would like to thank the anonymous Associate Editor and two referees of the Journal of Econometrics for many valuable comments. An earlier draft was presented at the Centre for Development Studies, Institute of Economic Growth, Indian Statistical Institute, Indira Gandhi Institute of Development Research, Center for Development Studies, Nanyang Technological University, Periyar University, Singapore National University, University of Nevada at Las Vegas, Tokyo University, University of Southern California, the Western Economic Association Meeting 2003, and the Public Economic Theory (PET) 2006, Hanoi, Vietnam. Comments of the participants of these workshops, especially of Juan Pantano as a discussant of the Western Economic Association conference, Lien H. Tran for presenting and commenting on the paper at the PET 2006 conference, and comments from Han A.T. Raut and T.N. Srinivasan are gratefully acknowledged. This research was supported in part by the American Bar Foundation (3203), the Pritzker Children's Initiative, the Buffett Early Childhood Fund, NICHD R37 HD065072, R01 HD054702, the Human Capital and Economic Opportunity Global Working Group - an initiative of the Becker Friedman Institute for Research in Economics - funded by the Institute for New Economic Thinking (INET) (INO14-00035), and an anonymous funder. The views expressed in this paper are those of the authors and not necessarily those of the funders or commentators mentioned here.",,55,29,36,5,57,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAR,2016,191.0,1.0,,,,,164,175,,10.1016/j.jeconom.2015.10.001,0.0,,,12,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DC1FV,26709326.0,"Green Accepted, Green Submitted, Green Published",,,2024-03-09,WOS:000368963100010,0
J,"Koufopoulou, M; Sutton, AJ; Breheny, K; Diwakar, L",,,,"Koufopoulou, Maria; Sutton, Andrew John; Breheny, Katie; Diwakar, Lavanya",,,Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review,VALUE IN HEALTH,,,English,Review,,,,,,economic evaluations; interferon gamma release assays; screening; systematic review; tuberculin skin tests; tuberculosis,COST-EFFECTIVENESS; STRATEGIES SINGLE; DIAGNOSIS; HEALTH; THERAPY; INITIATION; CONTACTS; GOLD,"Background: Latent tuberculosis infection (LTBI) provides a constant pool of new active tuberculosis cases; a third of the earth's population is estimated to be infected with LTBI. Objective: The objective of this systematic review was to assess the quality and summarize the available evidence from published economic evaluations reporting on the cost-effectiveness of tuberculin skin tests (TSTs) compared with interferon gamma release assays (IGRAs) for the screening of LTBI. Methods: An extensive systematic review of the published literature was conducted. A two-step process was adopted to identify relevant articles: information was extracted into evidence tables and then analyzed. The quality of the publications was assessed using a 10-item checklist specific for economic evaluations. Results: Twenty-eight studies were identified for inclusion in this review. Most of the studies found IGRAs to be more cost-effective than TSTs; however, the conclusions from the studies varied significantly. Most studies scored highly on the checklist although only one fulfilled all the stipulated criteria. A wide variety of methodological approaches were documented; identified differences included the type of economic evaluation and model, time horizon, perspective, and outcomes measures. Conclusions: The lack of consistent methods across studies makes it difficult to draw any firm conclusions about the most cost-effective option between TSTs and IGRAs. This problem can be solved by improving the quality of economic evaluation studies in the field of LTBI screening, through adherence to quality checklists.","[Koufopoulou, Maria; Sutton, Andrew John; Breheny, Katie; Diwakar, Lavanya] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England",University of Birmingham,"Sutton, AJ (通讯作者)，Univ Leeds, Leeds Inst Hlth Sci, Charles Thackrah Bldg,101 Clarendon Rd, Leeds LS2 9LJ, W Yorkshire, England.",a.j.sutton@leeds.ac.uk,"Diwakar, Lavanya/G-7425-2016","Diwakar, Lavanya/0000-0003-4369-6637; Breheny, Katie/0000-0001-6886-4049",,,,,49,6,11,0,7,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR-APR,2016,19.0,2.0,,,,,267,276,,10.1016/j.jval.2015.11.006,0.0,,,10,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DH8WY,27021762.0,hybrid,,,2024-03-09,WOS:000373078800019,0
J,"Rowen, D; Brazier, J; Keetharuth, A; Tsuchiya, A; Mukuria, C",,,,"Rowen, Donna; Brazier, John; Keetharuth, Anju; Tsuchiya, Aki; Mukuria, Clara",,,Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,PUBLIC PREFERENCES; HEALTH-CARE; VALUATION; SEVERITY,"Background Proposals for value-based assessment, made by the National Institute of Health and Care Excellence (NICE) in the UK, recommended that burden of illness (BOI) should be used to weight QALY gain. This paper explores some of the methodological issues in eliciting societal preferences for BOI. Aims This study explores the impact of mode of administration and framing in a survey for eliciting societal preferences for BOI. Methods A pairwise comparison survey with six arms was conducted online and via face-to-face interviews, involving two different wordings of questions and the inclusion/exclusion of pictures. Respondents were asked which of two patient groups they thought a publically funded health service should treat, where the groups varied by life expectancy without treatment, health-related quality of life (HRQOL) without treatment, survival gain from treatment, and HRQOL gain from treatment. Responses across different modes of administration, wording and use of pictures were compared using chi-squared tests and probit regression analysis controlling for respondent socio-demographic characteristics. Results The sample contained 371 respondents: 69 were interviewed and 302 completed the questionnaire online. There were some differences in socio-demographic characteristics across the online and interview samples. Online respondents were less likely to choose the group with higher BOI and more likely to treat those with a higher QALY gain, but there were no statistically significant differences by wording or the inclusion of pictures for the majority of questions. Regression analysis confirmed these results. Respondents chose to treat the group with larger treatment gain, but there was little support for treating the group with higher BOI. Respondents also preferred to treat the group with treatment gains in life expectancy rather than HRQOL. Conclusions Mode of administration did impact on responses, whereas question wording and pictures did not impact on responses, even after controlling for the socio-demographic characteristics of respondents in the regression analysis.","[Rowen, Donna; Brazier, John; Keetharuth, Anju; Tsuchiya, Aki; Mukuria, Clara] Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Econ & Decis Sci, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Tsuchiya, Aki] Univ Sheffield, Dept Econ, Sheffield S1 4DA, S Yorkshire, England",University of Sheffield; University of Sheffield,"Brazier, J (通讯作者)，Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Econ & Decis Sci, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.",j.e.brazier@sheffield.ac.uk,"brazier, john e/B-1936-2008; Keetharuth, Anju/AAF-6799-2020; Tsuchiya, Aki/A-2167-2010","Tsuchiya, Aki/0000-0003-4245-5399; Rowen, Donna/0000-0003-3018-5109; Keetharuth, Anju/0000-0001-8889-6806; Brazier, John/0000-0001-8645-4780",Department of Health Funding Source: Medline,Department of Health,,,17,24,25,0,3,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,FEB,2016,14.0,1.0,,,,,89,104,,10.1007/s40258-015-0197-y,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DD0MI,26445967.0,"hybrid, Green Accepted, Green Published",,,2024-03-09,WOS:000369613700009,0
J,"Wiseman, V; Mitton, C; Doyle-Waters, MM; Drake, T; Conteh, L; Newall, AT; Onwujekwe, O; Jan, S",,,,"Wiseman, Virginia; Mitton, Craig; Doyle-Waters, Mary M.; Drake, Tom; Conteh, Lesong; Newall, Anthony T.; Onwujekwe, Obinna; Jan, Stephen",,,Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks,HEALTH ECONOMICS,,,English,Article,,,,,,priority setting; low-income and lower-middle-income countries; developing countries; economic evaluation,MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS; MARGINAL ANALYSIS; STRATEGIES; GUIDELINES; AGREEMENT; GUIDANCE; SECTOR; VALUES; HIV,"Policy makers in low-income and lower-middle-income countries (LMICs) are increasingly looking to develop evidence-based' frameworks for identifying priority health interventions. This paper synthesises and appraises the literature on methodological frameworks - which incorporate economic evaluation evidence - for the purpose of setting healthcare priorities in LMICs. A systematic search of Embase, MEDLINE, Econlit and PubMed identified 3968 articles with a further 21 articles identified through manual searching. A total of 36 papers were eligible for inclusion. These covered a wide range of health interventions with only two studies including health systems strengthening interventions related to financing, governance and human resources. A little under half of the studies (39%) included multiple criteria for priority setting, most commonly equity, feasibility and disease severity. Most studies (91%) specified a measure of efficiency' defined as cost per disability-adjusted life year averted. Ranking of health interventions using multi-criteria decision analysis and generalised cost-effectiveness were the most common frameworks for identifying priority health interventions. Approximately a third of studies discussed the affordability of priority interventions. Only one study identified priority areas for the release or redeployment of resources. The paper concludes by highlighting the need for local capacity to conduct evaluations (including economic analysis) and empowerment of local decision-makers to act on this evidence.","[Wiseman, Virginia; Newall, Anthony T.] Univ New S Wales, Sydney, NSW, Australia; [Wiseman, Virginia] London Sch Hyg & Trop Med, London WC1, England; [Mitton, Craig; Doyle-Waters, Mary M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Drake, Tom] Univ Oxford, Oxford, England; [Drake, Tom] Mahidol Univ, Bangkok 10700, Thailand; [Conteh, Lesong] Univ London Imperial Coll Sci Technol & Med, London, England; [Onwujekwe, Obinna] Univ Nigeria, Nsukka, Nigeria; [Jan, Stephen] Univ Sydney, Sydney, NSW 2006, Australia; [Jan, Stephen] George Inst Global Hlth, Sydney, NSW, Australia",University of New South Wales Sydney; University of London; London School of Hygiene & Tropical Medicine; University of British Columbia; University of Oxford; Mahidol University; Imperial College London; University of Nigeria; University of Sydney; University of Sydney; George Institute for Global Health,"Wiseman, V (通讯作者)，Univ New S Wales, Sch Publ Hlth & Community Med, Samuels Bldg,Kensington Campus, Sydney, NSW 2052, Australia.",Virginia.wiseman@lshtm.ac.uk,"Conteh, Lesong/ABE-9550-2020; Jan, Stephen/AAG-3333-2021; Wiseman, Virginia/AAH-5011-2021; Onwujekwe, Obinna/O-6232-2014","Conteh, Lesong/0000-0002-0719-3672; Jan, Stephen/0000-0003-2839-1405; Onwujekwe, Obinna/0000-0002-1214-4285; Drake, Tom/0000-0002-6781-6632; Wiseman, Virginia/0000-0002-7911-0741; Newall, Anthony/0000-0003-0836-1065","NHMRC; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish",NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),"We would like to thank two anonymous reviewers for their helpful comments. We also appreciate the insightful and constructive suggestions made by Kalipso Chalkidou, Nattha Tritasavit and Ulla Griffiths on earlier drafts of this paper. Lastly, we acknowledge Catherine Pitt who was responsible for developing this supplement. Authors are funded by their own institutions with S. J. funded by an NHMRC Senior Research Fellowship.",,49,53,55,3,21,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,,,1.0,,,140,161,,10.1002/hec.3299,0.0,,,22,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DB9TF,26804361.0,"Green Accepted, Green Published, hybrid",,,2024-03-09,WOS:000368859100012,0
J,"Demuynck, T; De Rock, B; Ginsburgh, V",,,,"Demuynck, Thomas; De Rock, Bram; Ginsburgh, Victor",,,The transfer paradox in welfare space,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Welfare equilibrium; Exchange economy; Transfer paradox,INTERNATIONAL-TRADE; PURE THEORY; EQUILIBRIA; STABILITY,"The transfer paradox describes a situation in which a transfer of endowments between two agents results in a welfare decrease for the recipient and a welfare increase for the donor. It is known that in a two-agent regular exchange economy with an arbitrary number of goods, the transfer paradox occurs only if the price equilibrium is unstable. In this paper, we show that in the space of welfare weights, the set of stable equilibria and the set of no-transfer paradox equilibria coincide. As a corollary we also obtain that for two agents and an arbitrary number of goods, the index of an equilibrium in price space coincides with its index in welfare space. (C) 2015 Elsevier B.V. All rights reserved.","[Demuynck, Thomas] Maastricht Univ, Tongersestr 53, NL-6370 Maastricht, Netherlands; [De Rock, Bram; Ginsburgh, Victor] Univ Libre Bruxelles, ECARES, Ave FD Roosevelt 50,CP 114, B-1050 Brussels, Belgium",Maastricht University; Universite Libre de Bruxelles,"De Rock, B (通讯作者)，Univ Libre Bruxelles, ECARES, Ave FD Roosevelt 50,CP 114, B-1050 Brussels, Belgium.",t.demuynck@maastrichtuniversity.nl; bderock@ulb.ac.be; vginsburg@ulb.ac.be,,"Demuynck, Thomas/0000-0003-2957-9223",European Research Council (ERC) [263707]; European Research Council (ERC) [263707] Funding Source: European Research Council (ERC),European Research Council (ERC)(European Research Council (ERC)Spanish Government); European Research Council (ERC)(European Research Council (ERC)Spanish Government),Bram De Rock gratefully acknowledges the European Research Council (ERC) for his Starting Grant 263707.,,23,3,3,0,9,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,JAN,2016,62.0,,,,,,1,4,,10.1016/j.jmateco.2015.10.006,0.0,,,4,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DD8XP,,"Green Submitted, Green Accepted",,,2024-03-09,WOS:000370210500001,0
J,"Hallin, M; van den Akker, R; Werker, BJM",,,,"Hallin, Marc; van den Akker, Ramon; Werker, Bas J. M.",,,Semiparametric error-correction models for cointegration with trends: Pseudo-Gaussian and optimal rank-based tests of the cointegration rank,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Cointegration model; Cointegration rank; Elliptical densities; Error-correction model; Lagrange multiplier test; Local asymptotic Brownian functional; Local asymptotic mixed normality; Local asymptotic normality; Multivariate ranks; Quasi-likelihood procedures; Rank tests; Semiparametric efficiency,LIKELIHOOD RATIO TESTS; ADAPTIVE ESTIMATION; AFFINE-INVARIANT; R-ESTIMATION; MULTIVARIATE; INFERENCE; PRINCIPAL; INTERDIRECTIONS; CONVERGENCE; ESTIMATORS,"This paper provides pseudo-Gaussian and locally optimal rank-based tests for the cointegration rank in linear cointegrated error-correction models with common trends and i.i.d. elliptical innovations. The proposed tests are asymptotically distribution-free, hence their validity does not depend on the actual distribution of the innovations. The proposed rank-based tests depend on the choice of scores, associated with a reference density that can freely be chosen. Under appropriate choices they are achieving the semiparametric efficiency bounds; when based on Gaussian scores, they moreover uniformly dominate their pseudo-Gaussian counterparts. Simulations show that the asymptotic analysis provides an accurate approximation to finite-sample behavior. The theoretical results are based on a complete picture of the asymptotic statistical structure of the model under consideration. (C) 2015 Elsevier B.V. All rights reserved.","[Hallin, Marc] Univ Libre Bruxelles, ECARES, Brussels, Belgium; [Hallin, Marc] Princeton Univ, ORFE, Princeton, NJ 08544 USA; [Hallin, Marc; van den Akker, Ramon; Werker, Bas J. M.] Tilburg Univ, Econometr Grp, CentER, NL-5000 LE Tilburg, Netherlands; [Werker, Bas J. M.] Tilburg Univ, Finance Grp, CentER, NL-5000 LE Tilburg, Netherlands",Universite Libre de Bruxelles; Princeton University; Tilburg University; Tilburg University,"Hallin, M (通讯作者)，Univ Libre Bruxelles, ECARES, Brussels, Belgium.",mhallin@ulb.ac.be; R.vdnAkker@TilburgUniversity.edu; Werker@TilburgUniversity.edu,"van den Akker, R./AAG-4246-2020","van den Akker, R./0000-0002-5062-0617; Werker, Bas J.M./0000-0001-9007-0755","IAP-network P7/06; Belgian Science Policy Office, a Credit aux Chercheurs of Belgian FNRS; Discovery grant of Australian Research Council [DP150100210]","IAP-network P7/06; Belgian Science Policy Office, a Credit aux Chercheurs of Belgian FNRS(Fonds de la Recherche Scientifique - FNRS); Discovery grant of Australian Research Council(Australian Research Council)","First author was supported by the IAP-network P7/06, Belgian Science Policy Office, a Credit aux Chercheurs of the Belgian FNRS, and the Discovery grant DP150100210 of the Australian Research Council. The authors are grateful to two anonymous Referees and an Editor for a very careful reading of the manuscript, and their many constructive comments, which led to substantial improvements of the paper. They also wish to thank Peter Boswijk for pointing out a clever local parameterization of the cointegration model.",,67,4,4,0,9,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JAN,2016,190.0,1.0,,,,,46,61,,10.1016/j.jeconom.2015.08.003,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CY6QX,,,,,2024-03-09,WOS:000366535000003,0
J,"Kaiser, B; Schmid, C",,,,"Kaiser, Boris; Schmid, Christian",,,DOES PHYSICIAN DISPENSING INCREASE DRUG EXPENDITURES? EMPIRICAL EVIDENCE FROM SWITZERLAND,HEALTH ECONOMICS,,,English,Article,,,,,,healthcare costs; drug expenditures; physician dispensing; supply-induced demand; treatment effects,PRESCRIPTION DECISION; ESTIMATORS; BEHAVIOR; DOCTORS; AGENCY; JAPAN,"This paper analyzes whether the opportunity for physicians to dispense drugs increases healthcare expenditures. We study the case of Switzerland, where dispensing physicians face financial incentives to overprescribe and sell more expensive pharmaceuticals. Using comprehensive physician-level data, we exploit the regional variation in the dispensing regime to estimate causal effects. The empirical strategy consists of a doubly-robust estimation that combines inverse probability weighting with regression. Our main finding suggests that dispensing leads to higher drug costs on the order of 34% per patient. Copyright (C) 2014 John Wiley & Sons, Ltd.","[Schmid, Christian] Univ Bern, Dept Econ, CH-3001 Bern, Switzerland; Univ Bern, Ctr Reg Econ Dev, CH-3001 Bern, Switzerland",University of Bern; University of Bern,"Schmid, C (通讯作者)，Univ Bern, Dept Econ, Schanzeneckstr 1, CH-3001 Bern, Switzerland.",christian.schmid@vwi.unibe.ch,,"Schmid, Christian/0000-0002-6020-385X; Kaiser, Boris/0000-0003-4936-8618",,,,,33,17,19,0,13,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JAN,2016,25.0,1.0,,,,,71,90,,10.1002/hec.3124,0.0,,,20,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DA9YS,25393362.0,,,,2024-03-09,WOS:000368166300006,0
C,"Khan, MA; Suzuki, T",,"Kusuoka, S; Maruyama, T",,"Khan, M. Ali; Suzuki, Takashi",,,On Differentiated and Indivisible Commodities: An Expository Re-framing of Mas-Colell's 1975 Model,"ADVANCES IN MATHEMATICAL ECONOMICS, VOL 20",Advances in Mathematical Economics,,English,Proceedings Paper,6th Conference on Mathematical Analysis in Economic Theory,"JAN 26-29, 2015","Keio Univ, Tokyo, JAPAN","Japanese Soc Math Econ,Keio Econ Soc,Top Global Univ Project,Oak Soc Inc",Keio Univ,Exchange economy; Differentiated commodities; Indivisible commodities; Large distributionalized economy; Large individualized economy; Cardinality of the set of consumers,COMPETITIVE EQUILIBRIA; EXCHANGE ECONOMY; EXISTENCE; CONTINUUM; GAMES; THEOREM; INFORMATION; CONVEXITY; MARKETS; SPACE,"With a pure exchange economy and its Walrasian equilibrium formalized as a distribution on the space of consumer characteristics, Mas-Colell [50] showed the existence of equilibrium in a pure exchange economy with differentiated and indivisible commodities. We present a variant of Mas-Colell's theorem; but more than for its own sake, we use it to expose and illustrate recent techniques due to Keisler-Sun [31], as developed in Khan-Rath-Yu-Zhang [38], to translate a result on a large distributionalized economy (LDE) to a large individualized economy (LIE), when the former can be represented by a saturated or super-atomless measure space of consumers, as formalized in Keisler-Sun [31], Carmona-Podczeck [12] and Podczeck [63] respectively. This also leads us to identify, hitherto unnoticed, open problems concerning symmetrization of distributionalized equilibria of economies in their distributionalized formulations. In relating our result to the antecedent literature, we bring into salience the notions of (i)overriding desirability of the indivisible commodity, as in Hicks [25], Mas-Colell [51] and Yamazaki [83, 84], and of (ii) bounded marginal rates of substitution, as in Jones [29, 30] and Ostroy-Zame [60]. Our work also relies heavily on the technical notion of Gelfand integration.","[Khan, M. Ali] Johns Hopkins Univ, Dept Econ, Baltimore, MD 21218 USA; [Suzuki, Takashi] Meiji Gakuin Univ, Dept Econ, Minato Ku, 1-2-37 Shirokanedai, Tokyo 1088636, Japan",Johns Hopkins University,"Khan, MA (通讯作者)，Johns Hopkins Univ, Dept Econ, Baltimore, MD 21218 USA.",akhan@jhu.edu; takashisuz@jcom.home.ne.jp,,,,,,,85,1,1,0,1,SPRINGER-VERLAG SINGAPORE PTE LTD,SINGAPORE,"152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE",1866-2226,,978-981-10-0476-6; 978-981-10-0475-9,ADV MATH ECON,,,2016,20.0,,,,,,103,128,,10.1007/978-981-10-0476-6_5,0.0,,,26,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,BG6QS,,,,,2024-03-09,WOS:000390822500005,0
J,"Boucekkine, R; Nishimura, K; Venditti, A",,,,"Boucekkine, Raouf; Nishimura, Kazuo; Venditti, Alain",,,Introduction to financial frictions and debt constraints,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Credit and borrowing constraints; Public debt constraints; (In)complete markets; Constrained efficiency; Heterogeneous agents; Sunspot fluctuations; Rational bubbles,MULTIPLE GROWTH PATHS; BALANCED-BUDGET RULES; RAMSEY EQUILIBRIUM; AGGREGATE INSTABILITY; CONSUMPTION TAXES; POLICY RULE; BUBBLES; MODEL; MARKETS; INDETERMINACY,This is an introduction to the special section on financial frictions and debt constraints. (C) 2015 Elsevier B.V. All rights reserved.,"[Boucekkine, Raouf; Venditti, Alain] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, EHESS, Marseille, France; [Boucekkine, Raouf] Inst Adv Study IMERA, Paris, France; [Boucekkine, Raouf] IUF, Paris, France; [Nishimura, Kazuo] Kobe Univ, RIEB, Kobe, Hyogo, Japan; [Nishimura, Kazuo] Kyoto Univ, KIER, Kyoto 6068501, Japan; [Venditti, Alain] EDHEC Business Sch, Paris, France",Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Kobe University; Kyoto University; Universite Catholique de Lille; EDHEC Business School,"Boucekkine, R (通讯作者)，Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, EHESS, Marseille, France.",raouf.boucekkine@univ-amu.fr,,,Grants-in-Aid for Scientific Research [23000001] Funding Source: KAKEN,"Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))",,,37,1,1,0,6,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,DEC,2015,61.0,,,,,,271,275,,10.1016/j.jmateco.2015.10.003,0.0,,,5,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CZ0HN,,Green Submitted,,,2024-03-09,WOS:000366785800026,0
J,"Chan, NH; Yau, CY; Zhang, RM",,,,"Chan, Ngai Hang; Yau, Chun Yip; Zhang, Rong-Mao",,,LASSO estimation of threshold autoregressive models,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Group lasso; Information criterion; Least angle regression (LARS); Multiple regimes,TIME-SERIES; ERGODICITY; REGRESSION; SELECTION,"This paper develops a novel approach for estimating a threshold autoregressive (TAR) model with multiple-regimes and establishes its large sample properties. By reframing the problem in a regression variable selection context, a least absolute shrinkage and selection operator (LASSO) procedure is proposed to estimate a TAR model with an unknown number of thresholds, where the computation can be performed efficiently. It is further shown that the number and the location of the thresholds can be consistently estimated. A near optimal convergence rate of the threshold parameters is also established. Simulation studies are conducted to assess the performance in finite samples. The results are illustrated with an application to the quarterly US real GNP data over the period 1947-2009. (C) 2015 Elsevier B.V. All rights reserved.","[Chan, Ngai Hang] Southwestern Univ Finance & Econ, Chengdu, Peoples R China; [Chan, Ngai Hang; Yau, Chun Yip] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Zhang, Rong-Mao] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China",Southwestern University of Finance & Economics - China; Chinese University of Hong Kong; Zhejiang University,"Zhang, RM (通讯作者)，Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China.",rmzhang@zju.edu.cn,,"Chan, Ngai Hang/0000-0002-4755-5180; Yau, Chun Yip/0000-0002-4628-8324","General Research Fund of HKSAR-RGC-GRF [400313, 400410]; NSFC [11171074, 11371318]; Fundamental Research Funds for the Central Universities; HKSAR-RGC-ECS [405012]; HKSAR-RGC-GRF [405113]; RUC",General Research Fund of HKSAR-RGC-GRF; NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); HKSAR-RGC-ECS; HKSAR-RGC-GRF(Hong Kong Research Grants Council); RUC,"We would like to thank the editor and two anonymous referees for helpful comments, which led to an improved version of this paper. This research was supported in part by grants from the General Research Fund of HKSAR-RGC-GRF Nos. 400313 and 400410 (Chan), NSFC Nos. 11171074, 11371318 and the Fundamental Research Funds for the Central Universities (Zhang), HKSAR-RGC-ECS 405012, HKSAR-RGC-GRF 405113 (Yau). Part of this research was conducted when NH Chan was the Visiting Chang-Jiang Professor at Renmin University of China (RUC). Research support from RUC is gratefully acknowledged.",,25,30,37,1,38,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,DEC,2015,189.0,2.0,,,,,285,296,,10.1016/j.jeconom.2015.03.023,0.0,,,12,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CV9NJ,,,,,2024-03-09,WOS:000364613600005,0
J,"Costa-Scharplatz, M; Ställberg, B; Goyal, P; Asukai, Y; Gruenberger, JB; Price, D",,,,"Costa-Scharplatz, Madlaina; Stallberg, Bjorn; Goyal, Pankaj; Asukai, Yumi; Gruenberger, Jean-Bernard; Price, David",,,Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden,APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,COPD; EFFICACY; HEALTH; POPULATION; PREVALENCE; SEVERITY; PLACEBO; SAFETY,"Objectives The objective of this study was to compare the cost effectiveness of once-daily Seebri Breezhaler (R) (glycopyrronium bromide) 50 mu g with Spiriva (R) (tiotropium bromide) 18 mu g in the maintenance treatment of chronic obstructive pulmonary disease (COPD) in the Swedish setting. Methods A previously published COPD Markov model accounting for disease progression and treatment discontinuation was used. Disease progression included the annual decline in forced expiratory volume in the first second (FEV1) and occurrence of any exacerbations. Efficacy in the model consisted of FEV1 improvement between baseline and 12 weeks and the annual risk ratio of having an exacerbation compared to placebo. These clinical efficacy inputs were derived from a 1-year head-to-head trial comparing glycopyrronium 50 mu g to tiotropium 18 mu g. Utility values and cost estimates were obtained from the literature. The base-case analysis was performed for a 3-year time horizon. Cost and effects were discounted with 3 % in accordance to Swedish guidelines. Uncertainty was assessed by one-way and probabilistic sensitivity analyses. Results Glycopyrronium was found to be less costly and more effective than tiotropium in moderate to severe COPD patients with cost savings of 5197 Swedish kronor ((sic)570, US$725) per patient over a 3-year time horizon. The probabilistic sensitivity analysis indicated that over 99 % of the iterations produced dominant results for glycopyrronium. Conclusion Glycopyrronium bromide 50 mu g once daily can be considered a cost effective alternative to tiotropium bromide 18 mu g once daily in the maintenance treatment of COPD patients in Sweden.","[Costa-Scharplatz, Madlaina] Novartis Pharma AB, Box 1150, S-18379 Stockholm, Sweden; [Stallberg, Bjorn] Uppsala Univ, Dept Publ Hlth & Caring Sci, Family Med & Prevent Med, Uppsala, Sweden; [Goyal, Pankaj; Gruenberger, Jean-Bernard] Novartis Pharma AG, Basel, Switzerland; [Asukai, Yumi] IMS Hlth, London, England; [Price, David] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland",Novartis; Uppsala University; Novartis; University of Aberdeen,"Costa-Scharplatz, M (通讯作者)，Novartis Pharma AB, Box 1150, S-18379 Stockholm, Sweden.",madlaina.costa-scharplatz@novartis.com,"Price, David/H-2837-2019","Price, David/0000-0002-9728-9992",,,,,30,7,7,0,5,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,DEC,2015,13.0,6.0,,,,,637,645,,10.1007/s40258-015-0193-2,0.0,,,9,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DC2XV,26324401.0,,,,2024-03-09,WOS:000369083000007,0
J,"Khademi, A; Saure, D; Schaefer, A; Nucifora, K; Braithwaite, S; Roberts, MS",,,,"Khademi, Amin; Saure, Denis; Schaefer, Andrew; Nucifora, Kimberly; Braithwaite, Scott; Roberts, Mark S.",,,HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights,VALUE IN HEALTH,,,English,Article,,,,,,antiretroviral therapy; coverage; HIV treatment; resource-limited; simulation,COMBINATION ANTIRETROVIRAL THERAPY; SEXUALLY-TRANSMITTED-DISEASES; COST-EFFECTIVENESS; ADHERENCE; AIDS,"Background: The effects of antiretroviral treatment on the HIV epidemic are complex. HIV-infected individuals survive longer with treatment, but are less likely to transmit the disease. The standard coverage measure improves with the deaths of untreated individuals and does not consider the fact that some individuals may acquire the disease and die before receiving treatment, making it susceptible to overestimating the long-run performance of antiretroviral treatment programs. Objective: The objective was to propose an alternative coverage definition to better measure the long-run performance of HIV treatment programs. Methods: We introduced cumulative incidence-based coverage as an alternative to measure an HIV treatment program's success. To numerically compare the definitions, we extended a simulation model of HIV disease and treatment to represent a dynamic population that includes uninfected and HIV-infected individuals. Also, we estimated the additional resources required to implement various treatment policies in a resource-limited setting. Results: In a synthetic population of 600,000 people of which 44,000 (7.6%) are infected, and eligible for treatment with a CD4 count of less than 500 cells/mm(3), assuming a World Health Organization (WHO)-defined coverage rate of 50% of eligible people, and treating these individuals with a single treatment regimen, the gap between the current WHO coverage definition and our proposed one is as much as 16% over a 10-year planning horizon. Conclusions: Cumulative incidence-based definition of coverage yields a more accurate representation of the long-run treatment success and along with the WHO and other definitions of coverage provides a better understanding of the HIV treatment progress.","[Khademi, Amin] Clemson Univ, Dept Ind Engn, Clemson, SC 29634 USA; [Roberts, Mark S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Schaefer, Andrew; Roberts, Mark S.] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA USA; [Roberts, Mark S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Saure, Denis] Univ Chile, Dept Ind Engn, Santiago, Chile; [Nucifora, Kimberly; Braithwaite, Scott] NYU, Sch Med, Sect Value & Comparat Effectiueness, New York, NY USA",Clemson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidad de Chile; New York University,"Khademi, A (通讯作者)，Clemson Univ, 130-D Freeman Hall, Clemson, SC 29634 USA.",Khadesni@clemson.edu,"; Saure, Denis/F-5598-2016","Schaefer, Andrew/0000-0002-0379-741X; Braithwaite, Ronald Scott/0000-0001-7067-3655; Saure, Denis/0000-0002-8123-5009","NIAAA NIH HHS [U24AA022007-01, R01 AA017385, U24 AA022007, R01AA017385-01] Funding Source: Medline",NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)),,,30,0,0,0,17,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2015,18.0,8.0,,,,,1113,1119,,10.1016/j.jval.2015.10.003,0.0,,,7,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DF3GG,26686798.0,"hybrid, Green Accepted",,,2024-03-09,WOS:000371231500022,0
J,"Noor, J; Takeoka, N",,,,"Noor, Jawwad; Takeoka, Norio",,,Menu-dependent self-control,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Temptation; Self-control; Menu-dependence,UTILITY-THEORY; RISK; TEMPTATION; CERTAINTY; IMMEDIACY,"The literature on self-control problems has typically put forth models that imply behavior that is consistent with the weak axiom of revealed preference (WARP). We argue that when choice is the outcome of some underlying internal conflict, the resulting choices may not be perfectly consistent across choice problems: an agent's ability to resist temptation may well depend on what alternatives are available to him. We generalize Gul and Pesendorfer (2001) so that self-control weakens in the presence of temptation. To model choices from menus explicitly, we consider a choice correspondence as well as a preference over menus and relax both the Independence axiom for the preference and the WARP condition for the choice correspondence. The model is shown to unify a range of well-known findings in the experimental literature on choice under risk and over time within a single specification. (C) 2015 Elsevier B.V. All rights reserved.","[Noor, Jawwad] Boston Univ, Dept Econ, Boston, MA 02215 USA; [Takeoka, Norio] Yokohama Natl Univ, Fac Econ, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan",Boston University; Yokohama National University,"Noor, J (通讯作者)，Boston Univ, Dept Econ, 270 Bay State Rd, Boston, MA 02215 USA.",jnoor@bu.edu; takeoka@ynu.ac.jp,"Takeoka, Norio/C-6118-2015",,,,,,35,16,19,0,3,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,DEC,2015,61.0,,,,,,1,20,,10.1016/j.jmateco.2015.07.004,0.0,,,20,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CZ0HN,,,,,2024-03-09,WOS:000366785800001,0
J,"Aggarwal, S; Topaloglu, H; Kumar, S",,,,"Aggarwal, S.; Topaloglu, H.; Kumar, S.",,,SYSTEMATIC REVIEW OF COST EFFECTIVENES OF ULTRA-ORPHAN THERAPIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA; [Kumar, S.] GLOBAL ACCESS Monitor, Bethesda, MD USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP107,A533,A533,,10.1016/j.jval.2015.09.1662,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300149,0
J,"Ali, S",,,,"Ali, S.",,,MEASURING HEALTH CARE PERFORMANCE ON EQUITY: A FRAMEWORK USING NATIONAL ADMINISTRATIVE DATA FROM 2004/5 TO 2011/12,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ali, S.] Univ York, York, N Yorkshire, England",University of York - UK,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP221,A552,A552,,10.1016/j.jval.2015.09.1776,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300261,0
J,"Arun, A; Pennington, B",,,,"Arun, A.; Pennington, B.",,,LAPAROSCOPIC SURGERY VERSUS TRADITIONAL OPEN SURGERY FOR KIDNEY IMPLANTATION: A COST-EFFECTIVENESS MODEL,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Arun, A.; Pennington, B.] BresMed Hlth Solut Pvt Ltd, Panaji, India",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PUK18,A511,A511,,10.1016/j.jval.2015.09.1473,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300025,0
J,"Asano, EW; Teich, V; Amaral, LM; Fernandes, RA; Fahham, L",,,,"Asano, E. W.; Teich, V; Amaral, L. M.; Fernandes, R. A.; Fahham, L.",,,HOSPITAL READMISSIONS AND MORTALITY PATTERNS IN A COHORT WITH HEART FAILURE: 1 YEAR FOLLOW-UP FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Asano, E. W.; Teich, V; Fahham, L.] Sense Co, Sao Paulo, Brazil; [Amaral, L. M.; Fernandes, R. A.] Sense Co, Rio De Janeiro, Brazil",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV47,A381,A381,,10.1016/j.jval.2015.09.815,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400258,0
J,"Au, N; Johnston, DW",,,,"Au, Nicole; Johnston, David W.",,,Too Much of a Good Thing? Exploring the Impact of Wealth on Weight,HEALTH ECONOMICS,,,English,Article,,,,,,obesity; BMI; wealth; instrumental variables; panel data,BODY-MASS-INDEX; SOCIOECONOMIC-STATUS; PHYSICAL-ACTIVITY; OBESITY; HEALTH; LOTTERY; INCOME; CONSEQUENCES; DISPARITIES; ENVIRONMENT,"Obesity, like many health conditions, is more prevalent among the socioeconomically disadvantaged. In our data, very poor women are three times more likely to be obese and five times more likely to be severely obese than rich women. Despite this strong correlation, it remains unclear whether higher wealth causes lower obesity. In this paper, we use nationally representative panel data and exogenous wealth shocks (primarily inheritances and lottery wins) to shed light on this issue. Our estimates show that wealth improvements increase weight for women, but not men. This effect differs by initial wealth and weightan average-sized wealth shock received by initially poor and obese women is estimated to increase weight by almost 10 lb. Importantly, for some females, the effects appear permanent. We also find that a change in diet is the most likely explanation for the weight gain. Overall, the results suggest that additional wealth may exacerbate rather than alleviate weight problems. Copyright (c) 2014 John Wiley & Sons, Ltd.","[Au, Nicole; Johnston, David W.] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3800, Australia",Monash University,"Johnston, DW (通讯作者)，Monash Univ, Ctr Hlth Econ, Bldg 75, Clayton, Vic 3800, Australia.",david.johnston@monash.edu,,"Johnston, David/0000-0003-3185-2890; Black, Nicole/0000-0002-6396-7054","Australian Government Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA)","Australian Government Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA)(Australian Government)","This paper uses unit record data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The HILDA project was initiated and is funded by the Australian Government Department of Families, Housing, Community Services and Indigenous Affairs (FaHCSIA) and is managed by the Melbourne Institute of Applied Economic and Social Research (MIAESR). The findings and view reported in this article, however, are those of the authors, and should not be attributed to FaHCSIA or the MIAESR.",,59,20,20,1,16,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2015,24.0,11.0,,,,,1403,1421,,10.1002/hec.3094,0.0,,,19,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CT0PG,25099141.0,,,,2024-03-09,WOS:000362498000002,0
J,"Baatar, A",,,,"Baatar, A.",,,STUDY ON QUALITY OF NURSING CARE AND ASSESSMENT OF SAFETY,VALUE IN HEALTH,,,English,Meeting Abstract,18th Annual European Congress of the International-Society-for-Pharmacoeconomics-and-Outcomes-Research (ISPOR),"NOV 07-11, 2015","Milan, ITALY",Int Soc Pharmacoecon & Outcomes Res,,,,,"[Baatar, A.] Sch Nursing, Ulaanbaatar, Mongolia",Mongolian National University of Medical Sciences,,,"Baatar, Azjargal/ABF-7015-2020","Baatar, Azjargal/0000-0003-4949-0269",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP35,A853,A853,,10.1016/j.jval.2015.09.444,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400757,0
J,"Bektur, C; Nurgozhin, T; Abdukhakimova, D",,,,"Bektur, C.; Nurgozhin, T.; Abdukhakimova, D.",,,COST-EFFECTIVENESS OF SIMEPREVIR VS. TELAPREVIR FOR THE TRIPLE THERAPY OF HEPATITIS C IN KAZAKHSTAN,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Bektur, C.; Nurgozhin, T.] Nazarbayev Univ, Natl Lab Astana, Astana, Kazakhstan; [Abdukhakimova, D.] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan",Nazarbayev University; Nazarbayev University,,,"Bektur, Çisem/G-3292-2013","Bektur, Çisem/0000-0001-9220-5932",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI28,A627,A627,,10.1016/j.jval.2015.09.2209,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300679,0
J,"Body, J; Henry, D; von Moos, R; Rider, A; De Courcy, J; Murray, G; Bhowmik, D; Gatta, F; Arellano, J; Hechmati, G; Qian, Y",,,,"Body, J.; Henry, D.; von Moos, R.; Rider, A.; De Courcy, J.; Murray, G.; Bhowmik, D.; Gatta, F.; Arellano, J.; Hechmati, G.; Qian, Y.",,,BONE PAIN AND BONE TARGETING AGENT (BTA) TREATMENT PATTERN IN PATIENTS WITH BONE METASTASES (BMS) FROM PROSTATE CANCER (PC) IN REAL WORLD SETTING IN EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Body, J.] CHU Brugmann, Brussels, Belgium; [Henry, D.] Penn Hosp, Joan Karnell Canc Ctr, Philadelphia, PA 19107 USA; [von Moos, R.] Kantonsspital Graubunden, Chur, Switzerland; [Rider, A.; De Courcy, J.; Murray, G.] Adelphi Real World, Bollington, England; [Bhowmik, D.; Arellano, J.; Qian, Y.] Amgen Inc, Thousand Oaks, CA USA; [Gatta, F.; Hechmati, G.] Amgen Europe GmbH, Zug, Switzerland",University of Pennsylvania; Kantonsspital Graubunden; Adelphi Group Ltd; Amgen; Amgen; AMGEN Europe,,,"Body, Jean-Jacques/G-9785-2015; qian, yi/HZH-4175-2023; Henry, David/AAJ-4332-2020; Henry, David/AAU-4650-2020","Henry, David/0000-0003-2934-2242; Henry, David/0000-0001-7169-7704",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN356,A493,A493,,10.1016/j.jval.2015.09.1373,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400869,0
J,"Brod, M; Hojbjerre, L; Wilkinson, L; Alolga, SL; Rasmussen, MH",,,,"Brod, M.; Hojbjerre, L.; Wilkinson, L.; Alolga, S. L.; Rasmussen, M. H.",,,ASSESSING THE IMPACT OF GROWTH HORMONE DEFICIENCY (GHD) IN CHILDREN: CONCEPT ELICITATION RESULTS SUPPORTING THE DEVELOPMENT OF THE TREATMENT-RELATED IMPACT MEASURE FOR CHILDHOOD GHD (TRIM-CGHD),VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Brod, M.; Alolga, S. L.] Brod Grp, Mill Valley, CA USA; [Hojbjerre, L.; Wilkinson, L.; Rasmussen, M. H.] Novo Nordisk AS, Soborg, Denmark",The Brod Group; Novo Nordisk,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY90,A674,A674,,10.1016/j.jval.2015.09.1990,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300940,0
J,"Broekhuizen, H; IJzerman, MJ; Hauber, AB; Groothuis-Oudshoorn, CG",,,,"Broekhuizen, H.; IJzerman, M. J.; Hauber, A. B.; Groothuis-Oudshoorn, C. G.",,,BUILDING A BRIDGE BETWEEN CLINICAL EVIDENCE RESEARCH AND PATIENT PREFERENCE RESEARCH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Broekhuizen, H.; IJzerman, M. J.; Groothuis-Oudshoorn, C. G.] Univ Twente, Enschede, Netherlands; [Hauber, A. B.] RTI Hlth Solut, Res Triangle Pk, NC USA",University of Twente; Research Triangle Institute,,,"Broekhuizen, Henk/P-9889-2017; IJzerman, Maarten/AAB-6894-2020","IJzerman, Maarten/0000-0001-5788-5805; Hauber, Brett/0000-0003-3129-7268",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP231,A554,A554,,10.1016/j.jval.2015.09.1786,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300271,0
J,"Bryden, P; Welton, NJ; Thom, H; Sterne, J; Bodalia, P; Davies, P; López-López, J; Okoli, GN; Caldwell, DM; Dias, S; Eaton, D; Higgins, J; Salisbury, C; Savovic, J; Sofat, R; Stephens-Boal, A; Hingorani, A; Hollingworth, W",,,,"Bryden, P.; Welton, N. J.; Thom, H.; Sterne, J.; Bodalia, P.; Davies, P.; Lopez-Lopez, J.; Okoli, G. N.; Caldwell, D. M.; Dias, S.; Eaton, D.; Higgins, J.; Salisbury, C.; Savovic, J.; Sofat, R.; Stephens-Boal, A.; Hingorani, A.; Hollingworth, W.",,,A COST-EFFECTIVENESS ANALYSIS OF NOVEL ORAL ANTICOAGULANTS FOR ACUTE TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bryden, P.; Welton, N. J.; Thom, H.; Sterne, J.; Davies, P.; Lopez-Lopez, J.; Okoli, G. N.; Caldwell, D. M.; Dias, S.; Higgins, J.; Salisbury, C.; Savovic, J.; Hollingworth, W.] Univ Bristol, Bristol, Avon, England; [Bodalia, P.; Sofat, R.; Hingorani, A.] UCL, London, England; [Eaton, D.] Anticoagulat Europe, Bromley, Kent, England; [Stephens-Boal, A.] Thrombosis UK, Llanwrda, Wales",University of Bristol; University of London; University College London,,,"Savović, Jelena/O-4107-2019; Salisbury, Chris/C-6724-2008; López-López, José Antonio/A-2865-2013; López-López, José/Q-9395-2019; Higgins, Julian/H-4008-2011; Dias, Sofia/F-1922-2010; Sterne, Jonathan/Z-3106-2019","Savović, Jelena/0000-0002-2861-0578; Salisbury, Chris/0000-0002-4378-3960; López-López, José/0000-0002-9655-3616; Higgins, Julian/0000-0002-8323-2514; Dias, Sofia/0000-0002-2172-0221; Sterne, Jonathan/0000-0001-8496-6053; Caldwell, Deborah/0000-0001-8014-7480; Davies, Philippa/0000-0002-2678-7126; Hollingworth, William/0000-0002-0840-6254; Welton, Nicky J/0000-0003-2198-3205","Medical Research Council [MR/M005232/1] Funding Source: researchfish; National Institute for Health Research [11/92/17, NF-SI-0611-10168] Funding Source: researchfish; MRC [MR/M005232/1] Funding Source: UKRI",Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institutes of Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),,,0,1,1,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV95,A390,A390,,10.1016/j.jval.2015.09.864,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400305,0
J,"Caban, A; Jaros, P; Toumi, M",,,,"Caban, A.; Jaros, P.; Toumi, M.",,,PRMA REFORM IN POLAND - IMPACT ON PHARMACEUTICAL INDUSTRY AND MARKET ACCESS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Caban, A.; Jaros, P.] Creativ Ceut, Krakow, Poland; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP27,A519,A519,,10.1016/j.jval.2015.09.1581,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300069,0
J,"Cano, S; Cleanthous, S; Marquis, P; Hobart, J; Naoshy, S; Mikol, D; Petrillo, J; Steiner, D; Watson, C",,,,"Cano, S.; Cleanthous, S.; Marquis, P.; Hobart, J.; Naoshy, S.; Mikol, D.; Petrillo, J.; Steiner, D.; Watson, C.",,,"MEASURING THE IMPACT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) IN THE ASCEND TRIAL: EQUATING THE MSIS-29, MSWS-12, ABILHAND-56 AND SF-36",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cano, S.; Cleanthous, S.] Modus Outcomes, Stotfold, England; [Marquis, P.] Modus Outcomes, Newton, MA USA; [Hobart, J.] Univ Plymouth, Plymouth, Devon, England; [Naoshy, S.; Mikol, D.; Petrillo, J.; Steiner, D.; Watson, C.] Biogen, Cambridge, MA USA",University of Plymouth; Biogen,,,,,,,,,0,0,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM174,A713,A713,,10.1016/j.jval.2015.09.2688,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400190,0
J,"Chambers, J; Salem, M; Neumann, PJ",,,,"Chambers, J.; Salem, M.; Neumann, P. J.",,,DISINVESTING IN LOW-VALUE CARE: OPPORTUNITIES AND CHALLENGES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chambers, J.] Tufts Med Ctr, Boston, MA USA; [Salem, M.; Neumann, P. J.] Tufts Med Ctr, Inst Clin Res & Hlth Policy, Ctr Evaluat Value & Risk Hlth, Boston, MA USA",Tufts Medical Center; Tufts Medical Center,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP91,A530,A530,,10.1016/j.jval.2015.09.1646,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300133,0
J,"Colombo, GL; Valentino, MC; Di Matteo, S; Bruno, GM",,,,"Colombo, G. L.; Valentino, M. C.; Di Matteo, S.; Bruno, G. M.",,,INTEGRATED CLINICAL PATHWAY IN SCHIZOPHRENIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Colombo, G. L.] Univ Pavia, Milan, Italy; [Valentino, M. C.; Di Matteo, S.; Bruno, G. M.] SAVE Studi Hlth Econ & Outcomes Res, Milan, Italy",University of Pavia,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMH51,A415,A415,,10.1016/j.jval.2015.09.1002,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400441,0
J,"Danese, M; Gleeson, M; Kutikova, L; Griffiths, R; Khunti, K; Seshasai, SRK; Ray, KK",,,,"Danese, M.; Gleeson, M.; Kutikova, L.; Griffiths, R.; Khunti, K.; Seshasai, Kondapally S. R.; Ray, K. K.",,,LIPID MODIFYING THERAPY TREATMENT PATTERNS AND CHOLESTEROL CONTROL AFTER CARDIOVASCULAR EVENTS IN THE UNITED KINGDOM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Danese, M.; Gleeson, M.; Griffiths, R.] Outcomes Insights Inc, Westlake Village, CA USA; [Kutikova, L.] Amgen Europe GmbH, Zug, Switzerland; [Khunti, K.] Univ Leicester, Leicester, Leics, England; [Seshasai, Kondapally S. R.] St Georges Univ London, London, England; [Ray, K. K.] Imperial Coll London, Sch Publ Hlth, London, England",Amgen; AMGEN Europe; University of Leicester; St Georges University London; Imperial College London,,,"/ABC-9527-2021; Ray, Kausik/Z-2055-2019; /GQB-2573-2022","Ray, Kosh/0000-0002-7166-060X; Ray, Kausik/0000-0003-0508-0954",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV183,A406,A406,,10.1016/j.jval.2015.09.953,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400392,0
J,"Davey, P; Ball, M",,,,"Davey, P.; Ball, M.",,,MODELLING TO DETERMINE THE PRICE AND IDENTIFY CRITICAL DATA GAPS DURING VACCINE DEVELOPMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Davey, P.; Ball, M.] Illuminate Hlth Consulting, Chatswood, NSW, Australia",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM273,A730,A730,,10.1016/j.jval.2015.09.2787,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400288,0
J,"Davey, P",,,,"Davey, P.",,,A COMPARISON OF ON-PATENT MEDICINE PRICES USING AN EKS METHOD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Davey, P.] Illuminate Hlth Consulting, Chatswood, NSW, Australia",,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP200,A549,A549,,10.1016/j.jval.2015.09.1754,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300240,0
J,"Delarue, A; Zkik, A; Berdeaux, G",,,,"Delarue, A.; Zkik, A.; Berdeaux, G.",,,PREVALENCE OF ACNE VULGARIS IN EUROPE AND IMPACT OF LIFESTYLE FACTORS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Delarue, A.] Pierre Fabre DermatoCosmet, Lavaur, France; [Zkik, A.; Berdeaux, G.] Pierre Fabre, Boulogne Billancourt, France",,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS11,A417,A417,,10.1016/j.jval.2015.09.1013,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400452,0
J,"Dewilde, S; Lloyd, AJ; Holm, MV; Lee, AY",,,,"Dewilde, S.; Lloyd, A. J.; Holm, M., V; Lee, A. Y.",,,QUALITY OF LIFE OF PATIENTS EXPERIENCING CANCER-ASSOCIATED THROMBOSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dewilde, S.] SHE, Brussels, Belgium; [Dewilde, S.] UGent, Brussels, Belgium; [Lloyd, A. J.] Bladon Associates, Oxford, England; [Holm, M., V] LEO Pharma AS, Ballerup, Denmark; [Lee, A. Y.] Univ British Columbia, Vancouver, BC, Canada; [Lee, A. Y.] Vancouver Coastal Hlth, Vancouver, BC, Canada",Ghent University; LEO Pharma; University of British Columbia; Vancouver Coastal Health Research Institute,,,,,,,,,0,6,6,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV136,A397,A398,,10.1016/j.jval.2015.09.906,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400346,0
J,"Dimitrova, M; Kamusheva, M; Mitov, K; Petkova, V; Dimitrov, J; Petrova, G",,,,"Dimitrova, M.; Kamusheva, M.; Mitov, K.; Petkova, V; Dimitrov, J.; Petrova, G.",,,NEW COPD MEDICINAL PRODUCTS ENTRANCE ANALYSIS AND THEIR INFLUENCE ON THE NUMBER AND COST OF HOSPITALIZATONS DUE TO COPD EXACERBATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dimitrova, M.; Kamusheva, M.; Mitov, K.; Petkova, V; Petrova, G.] Med Univ Sofia, Fac Pharm, Sofia, Bulgaria; [Dimitrov, J.] Univ Hosp Specialized Treatment Pulm Dis, Sofia, Bulgaria",Medical University Sofia,,,"Kamusheva, Maria/HKW-3799-2023; Dimitrova, Maria Jordanova/AAE-4435-2021; Petkova, Valentina/X-5479-2018; Petrova, Guenka/I-6863-2019","Kamusheva, Maria/0000-0002-4379-5283; Dimitrova, Maria Jordanova/0000-0002-4868-7775; Petkova, Valentina/0000-0002-6938-1054; Petrova, Guenka/0000-0001-8116-5138",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS35,A499,A500,,10.1016/j.jval.2015.09.1409,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400905,0
J,"Divino, V; DeKoven, M; Kim, T; Kleinrock, M; Wade, RL; Kaura, S",,,,"Divino, V; DeKoven, M.; Kim, T.; Kleinrock, M.; Wade, R. L.; Kaura, S.",,,THE BUDGET IMPACT OF ORPHAN DRUGS IN THE US AND CANADA: A 2007-2013 MIDAS SALES DATA ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Divino, V; DeKoven, M.; Kleinrock, M.; Wade, R. L.] IMS Hlth, Fairfax, VA USA; [Kim, T.] Celgene Corp, Mississauga, ON, Canada; [Kaura, S.] Celgene Corp, Summit, NJ USA",Bristol-Myers Squibb; Celgene Corporation,,,,,,,,,0,1,2,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY45,A666,A666,,10.1016/j.jval.2015.09.2429,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300895,0
J,"Dong, P; Chen, Y; Jaros, P; Kornfeld, A; Yan, J; Toumi, M",,,,"Dong, P.; Chen, Y.; Jaros, P.; Kornfeld, A.; Yan, J.; Toumi, M.",,,DRUG PRICING REFORM IN CHINA - IMPACT OF THE REFORM FROM A SOCIETAL PERPSECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dong, P.; Chen, Y.] Pfizer Investment Co Ltd, Beijing, Peoples R China; [Jaros, P.] Creativ Ceut, Krakow, Poland; [Kornfeld, A.] Creativ Ceut, Paris, France; [Yan, J.] Creativ Ceut, London, England; [Toumi, M.] Univ Aix Marseilles, Marseille, France",Pfizer; Aix-Marseille Universite,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP38,A521,A521,,10.1016/j.jval.2015.09.1592,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300080,0
J,"Edson-Heredia, E; Barrows, S; Masaquel, C; Nikai, E; Mallbris, L; Puig, L",,,,"Edson-Heredia, E.; Barrows, S.; Masaquel, C.; Nikai, E.; Mallbris, L.; Puig, L.",,,THE VALUE OF ACHIEVING COMPLETE OR NEAR COMPLETE RESOLUTION OF PSORIASIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Edson-Heredia, E.; Mallbris, L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Barrows, S.; Masaquel, C.] RTI Hlth Solut, Ann Arbor, MI USA; [Nikai, E.] Eli Lilly & Co, Brussels, Belgium; [Puig, L.] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Puig, L.] Univ Autonoma Barcelona, Barcelona, Spain",Eli Lilly; Research Triangle Institute; Eli Lilly; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona,,,"Mallbris, Lotus/L-8607-2019","Barrows, Stephanie/0000-0001-5692-557X; Masaquel, Catherine/0000-0002-5983-7863",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS66,A427,A427,,10.1016/j.jval.2015.09.590,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400507,0
J,"Eggington, S; Brandt, A; Rasmussen, ER; Grifi, M; Nyberg, J",,,,"Eggington, S.; Brandt, A.; Rasmussen, Reimer E.; Grifi, M.; Nyberg, J.",,,COST-EFFECTIVENESS OF DEEP BRAIN STIMULATION (DBS) IN THE MANAGEMENT OF ADVANCED PARKINSON'S DISEASE: A SWEDISH PAYER PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Eggington, S.; Grifi, M.] Medtron Int Trading Sarl, Tolochenaz, Switzerland; [Brandt, A.; Rasmussen, Reimer E.] Medtron Danmark AS, Copenhagen, Denmark; [Nyberg, J.] Stortorgets Neurol Mottagning, Helsingborg, Sweden",Medtronic,,,,,,,,,0,3,4,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD46,A352,A352,,10.1016/j.jval.2015.09.647,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400095,0
J,"Einarson, TR; Bereza, BG; Bobro, I; Efremova, E; Lelli, F",,,,"Einarson, T. R.; Bereza, B. G.; Bobro, I; Efremova, E.; Lelli, F.",,,ECONOMIC ANALYSIS OF USTEKINUMAB FOR PSORIATIC ARTHRITIS IN RUSSIA,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Einarson, T. R.; Bereza, B. G.] Univ Toronto, Toronto, ON, Canada; [Bobro, I; Efremova, E.] Janssen Cilag, Moscow, Russia; [Lelli, F.] Janssen Cilag SpA, Cologno Monzese, MI, Italy",University of Toronto; Johnson & Johnson; Janssen Pharmaceuticals,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS80,A648,A648,,10.1016/j.jval.2015.09.2325,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300793,0
J,"Eliasson, L; Bewley, T; Mughal, F; Johnston, K; Kuznik, A; Lloyd, AJ",,,,"Eliasson, L.; Bewley, T.; Mughal, F.; Johnston, K.; Kuznik, A.; Lloyd, A. J.",,,EVALUATION OF PSORIASIS PATIENTS' ATTITUDE TO RISK: BENEFIT AND THERAPEUTIC TRADEOFFS IN THEIR CHOICE OF TREATMENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Eliasson, L.; Lloyd, A. J.] ICON PRO, Oxford, England; [Bewley, T.] Whipps Cross Univ Hosp, London, England; [Bewley, T.] Royal London Hosp, London, England; [Mughal, F.] Celgene Ltd, Uxbridge, Middx, England; [Johnston, K.] ICON Epidemiol, Vancouver, BC, Canada; [Kuznik, A.] Celgene Corp, Warren, NJ USA",ICON plc; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; ICON plc; Bristol-Myers Squibb; Celgene Corporation,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS56,A425,A425,,10.1016/j.jval.2015.09.580,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400497,0
J,"Emmanuel, A; Christensen, P; Kumar, G; Passananti, V; Mealing, S; Stoerling, ZM; Andersen, F; Soerensen, J; Kirshblum, S",,,,"Emmanuel, A.; Christensen, P.; Kumar, G.; Passananti, V; Mealing, S.; Stoerling, Z. M.; Andersen, F.; Soerensen, J.; Kirshblum, S.",,,LONG-TERM COST-EFFECTIVENESS OF TRANSANAL IRRIGATION IN PATIENTS WITH NEUROGENIC BOWEL DYSFUNCTION WHO HAVE FAILED STANDARD BOWEL CARE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Emmanuel, A.; Passananti, V] Univ Coll London Hosp, London, England; [Christensen, P.] Aarhus Univ Hosp, Aarhus, Denmark; [Kumar, G.] ICON Hlth Econ, Oxford, England; [Mealing, S.] ICON Hlth Econ & Epidemiol, Oxford, England; [Stoerling, Z. M.; Andersen, F.; Soerensen, J.] Coloplast AS, Humlebaek, Denmark; [Kirshblum, S.] Rutgers New Jersey Med Sch, Newark, NJ USA",University College London Hospitals NHS Foundation Trust; University of London; University College London; Aarhus University; ICON plc; ICON plc; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences,,,,,,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD89,A360,A360,,10.1016/j.jval.2015.09.691,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400138,0
J,"Ferreira, D; Félix, J; Almeida, J; Mota, M; Silva, MA; Silva, P; Vandewalle, B; Velosa, J; Marinho, R; Aldir, I; Carvalho, A; Valente, C; Macedog, G; Castro, RSE; Pedroto, I",,,,"Ferreira, D.; Felix, J.; Almeida, J.; Mota, M.; Afonso Silva, M.; Silva, P.; Vandewalle, B.; Velosa, J.; Marinho, R.; Aldir, I; Carvalho, A.; Valente, C.; Macedog, G.; Sarmento e Castro, R.; Pedroto, I",,,HIGH THERAPEUTIC EFFICIENCY WITH LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PORTUGAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ferreira, D.; Felix, J.; Almeida, J.; Mota, M.; Afonso Silva, M.; Silva, P.; Vandewalle, B.] Exigo Consultores, Alhos Vedros, Portugal; [Velosa, J.; Marinho, R.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, EPE, Lisbon, Portugal; [Aldir, I] Ctr Hosp Lisboa Ocident, Hosp Egas Moniz, Lisbon, Portugal; [Carvalho, A.] Ctr Hosp & Univ Coimbra, Coimbra, Portugal; [Valente, C.] Ctr Hosp & Univ Coimbra, EPE, Coimbra, Portugal; [Macedog, G.] Hosp Sao Joao, Oporto, Portugal; [Sarmento e Castro, R.] Ctr Hosp Porto, EPE, Oporto, Portugal; [Pedroto, I] Ctr Hosp Porto, Oporto, Portugal","Universidade de Lisboa; Hospital Santa Maria; Egas Moniz Hospital; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Sao Joao Hospital",,,"Carvalho, Armando/P-6134-2018","Carvalho, Armando/0000-0003-2455-8781",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN14,A578,A578,,10.1016/j.jval.2015.09.1924,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300407,0
J,"Friedman, B; Schwarz, R; Freiberg, M; Wilschke, J; Meyer, H",,,,"Friedman, B.; Schwarz, R.; Freiberg, M.; Wilschke, J.; Meyer, H.",,,REGULATIONS OF THE GERMAN DRUG MARKET,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Friedman, B.; Schwarz, R.; Freiberg, M.; Wilschke, J.; Meyer, H.] Quintiles Commercial, Mannheim, Germany",IQVIA,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP192,A547,A547,,10.1016/j.jval.2015.09.1746,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300232,0
J,"Gabriel, A; Champaneria, MC; Macarios, D; Gritfin, I; Makwell, GP",,,,"Gabriel, A.; Champaneria, M. C.; Macarios, D.; Gritfin, I; Makwell, G. P.",,,A COMPARISON OF FAT GRAFTING METHODS ON OPERATING ROOM EFFICIENCY AND COST,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Gabriel, A.; Champaneria, M. C.] PeaceHlth Med Grp, Vancouver, WA USA; [Macarios, D.] LifeCell, Bridgewater, NJ USA; [Gritfin, I] Acelity, San Antonio, TX USA; [Makwell, G. P.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA",LifeCell Corporation; Loma Linda University,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM31,A687,A688,,10.1016/j.jval.2015.09.2547,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400051,0
J,"Gaddy, DF; Becker, C; Li, H; Bennett, R; Yang, Y; Fitzgerald, JB; Bayever, E",,,,"Gaddy, D. F.; Becker, C.; Li, H.; Bennett, R.; Yang, Y.; Fitzgerald, J. B.; Bayever, E.",,,A SYSTEMATIC LITERATURE REVIEW TO IDENTIFY AND COMPA RE CLINICAL TRIALS EVALUATING NOVEL THERAPEUTIC AGENTS IN POST-GEMCITABINE ADVANCED PANCREATIC CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gaddy, D. F.; Becker, C.; Li, H.; Bennett, R.; Fitzgerald, J. B.; Bayever, E.] Merrimack Pharmaceut Inc, Cambridge, MA USA; [Yang, Y.] Baxalta Inc, Cambridge, MA USA","Merrimack Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA)",,,,,,,,,0,1,7,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN29,A434,A434,,10.1016/j.jval.2015.09.1044,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400546,0
J,"Gagliardino, JJ; Granell, RA; Eliaschewitz, FG; Iglay, K; Brodovicz, K; Yu, S; González, CD; Shankar, R; Heisel, O; Bloomfield, S; Keown, P; Tunceli, K",,,,"Gagliardino, J. J.; Granell, R. A.; Eliaschewitz, F. G.; Iglay, K.; Brodovicz, K.; Yu, S.; Gonzalez, C. D.; Shankar, R.; Heisel, O.; Bloomfield, S.; Keown, P.; Tunceli, K.",,,ARETAEUS: RETROSPECTIVE STUDY OF MEDICATION USAGE PATTERNS FOLLOWING THE DIAGNOSIS OF TYPE 2 DIABETES IN LATIN AMERICA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gagliardino, J. J.] UNLP, CONICET La Plata, Ctr Endocrinol Expt & Aplicada, Buenos Aires, DF, Argentina; [Granell, R. A.] Inst Mexicano Seguro Social, Guadalajara, Jalisco, Mexico; [Eliaschewitz, F. G.] CPClin Clin Res Ctr, Sao Paulo, Brazil; [Iglay, K.; Brodovicz, K.; Yu, S.; Gonzalez, C. D.; Shankar, R.] Merck & Co Inc, Kenilworth, NJ USA; [Heisel, O.; Bloomfield, S.; Keown, P.] Syreon Corp, Vancouver, BC, Canada; [Tunceli, K.] Merck & Co Inc, N Wales, PA USA",Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Instituto Mexicano del Seguro Social; Merck & Company; Merck & Company,,,"Shankar, Ravi/HSF-1169-2023; Keown, Paul Anthony/JNE-2511-2023","Gonzalez, Claudio/0000-0002-3772-8850",,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,CV3,A809,A809,,10.1016/j.jval.2015.09.098,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400513,0
J,"Genderello, G; Artioli, S; Gaggero, D; Pasa, A; Dentone, C; Fraguglia, C; Giacomini, M; Giannini, B; Pastorino, G; Viscoli, C; Cassola, G; Di Biagio, A",,,,"Genderello, G.; Artioli, S.; Gaggero, D.; Pasa, A.; Dentone, C.; Fraguglia, C.; Giacomini, M.; Giannini, B.; Pastorino, G.; Viscoli, C.; Cassola, G.; Di Biagio, A.",,,BUDGET IMPACT ANALYSIS OF SOFOSBUVIR-BASED REGIMENS FOR THE TREATMENT OF HIV/HCV CO-INFECTED PATIENTS IN NORTHERN ITALY: THE LIGURIA REGION SIMULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Genderello, G.; Gaggero, D.; Pasa, A.; Fraguglia, C.; Cassola, G.] EO Osped Galliera, Genoa, Italy; [Artioli, S.] ASL 5 Spezzina, La Spezia, Italy; [Dentone, C.] ASL 1 Imperiese, San Remo, Italy; [Giacomini, M.; Giannini, B.; Viscoli, C.; Di Biagio, A.] Univ Genoa, Genoa, Italy; [Pastorino, G.] ASi 1 Imperiese, San Remo, Italy",Ente Ospedaliero Ospedali Galliera; University of Genoa,,,"Di Biagio, Antonio/J-4901-2019; Giacomini, Mauro/D-3194-2013","Di Biagio, Antonio/0000-0003-1436-5089; Giacomini, Mauro/0000-0001-5646-2034",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN23,A579,A580,,10.1016/j.jval.2015.09.1933,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300416,0
J,"Ghali, N",,,,"Ghali, N.",,,IMPACT OF FINANCIAL INCENTIVES ON ACCESS TO SERVICES AND QUALITY OF CARE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Ghali, N.] Univ Laval, Quebec City, PQ, Canada",Laval University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS5,A875,A875,,10.1016/j.jval.2015.09.035,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400881,0
J,"Hammerman, A; Greenberg-Dotan, S; Feldhamer, I; Birnbaum, Y; Cherny, NI",,,,"Hammerman, A.; Greenberg-Dotan, S.; Feldhamer, I; Birnbaum, Y.; Cherny, N., I",,,THE ESMO MAGNITUDE OF CLINICAL BENEFIT SCALE FOR NOVEL CANCER MEDICINES - CORRESPONDENCE WITH PRIORITIZATION DECISIONS IN UPDATING THE ISRAELI NATIONAL LIST OF HEALTH SERVICES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hammerman, A.; Greenberg-Dotan, S.; Feldhamer, I; Birnbaum, Y.] Clalit Hlth Serv, Tel Aviv, Israel; [Cherny, N., I] Shaare Zedek Med Ctr, Jerusalem, Israel",Clalit Health Services; Hebrew University of Jerusalem; Shaare Zedek Medical Center,,,"Hammerman, Ariel/AAG-4399-2020","Hammerman, Ariel/0000-0002-4396-5246",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,CA2,A336,A336,,10.1016/j.jval.2015.09.117,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400007,0
J,"Horbachevska, K; Zalis'ka, O; Maksymovych, N",,,,"Horbachevska, K.; Zalis'ka, O.; Maksymovych, N.",,,COST STUDY OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Horbachevska, K.; Zalis'ka, O.; Maksymovych, N.] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine",Danylo Halytsky Lviv National Medical University,,,"Maksymovych, Nataliia/R-9542-2018; Zaliska, Olha/E-1135-2018; Zaliska, Olha/AAN-6078-2020; Stasiv, Khrystyna-Olha/R-9712-2018","Zaliska, Olha/0000-0003-1845-7909; Stasiv, Khrystyna-Olha/0000-0003-4073-4327",,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH14,A734,A735,,10.1016/j.jval.2015.09.2813,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400312,0
J,"Howells, R; Trehame, C",,,,"Howells, R.; Trehame, C.",,,COST-EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 OR 4 CHRONIC HEPATITIS C IN ENGLAND AND WALES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Howells, R.] Abacus Int, Manchester, Lancs, England; [Trehame, C.] Abacus Int, Bicester, Oxon, England",,,,,,,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN75,A589,A589,,10.1016/j.jval.2015.09.1508,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300467,0
J,"Indacochea, S; Licapa, D",,,,"Indacochea, S.; Licapa, D.",,,"EVALUATION OF MEDICAL PRESCRIPTION OF ANTIHYPERTENSIVE DRUGS IN MEDICAL CARDIOLOGISTS OF THE NATIONAL HOSPITAL EDGARDO REBAGLIATI MARTINS, LIMA (PERU)",VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Indacochea, S.; Licapa, D.] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru",Seguro Social de Salud del Peru,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV28,A832,A832,,10.1016/j.jval.2015.09.323,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400639,0
J,"Jamous, N; Martini, O; Ferko, N; Hogan, A; Corral, M",,,,"Jamous, N.; Martini, O.; Ferko, N.; Hogan, A.; Corral, M.",,,ECONOMIC ANALYSIS OF EVARREST® SEALANT MATRIX COMPARED WITH STANDARD OF CARE IN SEVERE SOFT TISSUE SURGICAL BLEEDING: A GERMAN HOSPITAL PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jamous, N.] Ethicon Biosurg, Wokingham, Berks, England; [Martini, O.] Ethicon, Norderstedt, Germany; [Ferko, N.; Hogan, A.] Cornerstone Res Grp Inc, Burlington, ON, Canada; [Corral, M.] Ethicon Biosurg, Somerville, NJ USA",Cornerstone Research Group,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD142,A369,A369,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400190,0
J,"Jiménez, D; Suárez, C; Barja, P; Rodríguez, JM; Pérez-Alcántara, F",,,,"Jimenez, D.; Suarez, C.; Barja, P.; Rodriguez, J. M.; Perez-Alcantara, F.",,,IS EDOXABAN A COST-EFFECTIVE ALTERNATIVE TO VENOUS THROMBOEMBOLIM PATIENTS TREATED WITH VITAMIN K ANTAGONISTS IN SPAIN?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jimenez, D.] Hosp Univ Ramon y Cajal, Madrid, Spain; [Suarez, C.] Hosp Univ La Princesa, Madrid, Spain; [Barja, P.; Rodriguez, J. M.] Daiichi Sankyo Espana SA, Madrid, Spain; [Perez-Alcantara, F.] Oblikue Consulting SL, Barcelona, Spain",Hospital Universitario Ramon y Cajal; Hospital de La Princesa; Daiichi Sankyo Company Limited,,,,"MATUTE CARRILLO, ROBERT/0009-0008-1638-800X",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV98,A390,A391,,10.1016/j.jval.2015.09.867,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400308,0
J,"Kachroo, K; Sharma, J; Chahar, A; Dang, A; Ganji, K",,,,"Kachroo, K.; Sharma, J.; Chahar, A.; Dang, A.; Ganji, K.",,,MAMMOGRAPHY FOR BREAST CANCER SCREENING IN INDIA - A HEALTH TECHNOLOGY ASSESSMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"Govt India, Minist Hlth & Family Welf, Natl Hlth Syst Resource Ctr, New Delhi, India; [Sharma, J.] Minist Hlth & Family Welf, Natl Hlth Syst Resource Ctr, New Delhi, India; [Chahar, A.] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Dang, A.; Ganji, K.] HEOR & RWE Consulting, MarksMan Healthcare Solut LLP, Navi Mumbai, India",,,,"Chahar, Akriti/AAE-1015-2020","Chahar, Akriti/0000-0003-4886-7757",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN162,A458,A458,,10.1016/j.jval.2015.09.1179,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400679,0
J,"Kanukula, R; Vsn, M; Ganji, K; Likhar, N; Dang, A",,,,"Kanukula, R.; Vsn, M.; Ganji, K.; Likhar, N.; Dang, A.",,,PHYSICAL FUNCTIONING AND PAIN IN CHRONIC LOW BACK PAIN: A SYSTEMATIC REVIEW OF PSYCHOMETRIC PROPERTIES OF VARIOUS OUTCOMES MEASURES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kanukula, R.; Vsn, M.; Likhar, N.; Dang, A.] MarksMan Healthcare Solut LLP HEOR & REW Consulti, Novi Mumbai, India; [Ganji, K.] MarksMan Healthcare Solut, Novi Mumbai, India",,,,"Kanukula, Raju/S-9569-2019","Kanukula, Raju/0000-0003-0793-786X",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM148,A708,A709,,10.1016/j.jval.2015.09.2665,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400167,0
J,"Karanikas, H; Papadakis, M; Thireos, E",,,,"Karanikas, H.; Papadakis, M.; Thireos, E.",,,DEVELOPMENT OF PRESCRIPTION E-PROTOCOLS FOR MEDICINES AND INTEGRATION ON THE GREEK NATIONAL E-PRESCRIPTION SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Karanikas, H.; Papadakis, M.; Thireos, E.] Athens Med Soc, Athens, Greece",,,,"Karanikas, Haralampos/AAA-2385-2022",,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV66,A385,A385,,10.1016/j.jval.2015.09.835,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400277,0
J,"Kirsch, F",,,,"Kirsch, F.",,,A SYSTEMATIC REVIEW OF MARKOV MODELS EVALUATING MULTI-COMPONENT DISEASE MANAGEMENT PROGRAMS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kirsch, F.] Ludwig Maximilians Univ Munchen, Munich, Germany",University of Munich,,,,,,,,,0,0,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS48,A502,A502,,10.1016/j.jval.2015.09.1422,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400917,0
J,"Kornfeld, M; Belgaied, W; Toumi, M",,,,"Kornfeld, M.; Belgaied, W.; Toumi, M.",,,HEALTH CARE COVERAGE THROUGH PRIVATE HEALTH INSURANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kornfeld, M.] Creativ Ceut, Paris, France; [Belgaied, W.] Creativ Ceut, Tunis, Tunisia; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP334,A572,A572,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300372,0
J,"Kotze, PG; Tundia, N; Gumen, A; Macaulay, D; Chaves, L; Bao, Y",,,,"Kotze, P. G.; Tundia, N.; Gumen, A.; Macaulay, D.; Chaves, L.; Bao, Y.",,,ECONOMIC IMPACT OF EXPANDED USE OF BIOLOGIC THERAPY FOR CROHN'S DISEASE IN LATIN AMERICAN COUNTRIES,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Kotze, P. G.] Catholic Univ Parana, Curitiba, Parana, Brazil; [Tundia, N.; Chaves, L.; Bao, Y.] AbbVie Inc, N Chicago, IL USA; [Gumen, A.] Anal Grp Inc, Boston, MA USA; [Macaulay, D.] Anal Grp Inc, New York, NY USA",Pontificia Universidade Catolica do Parana; AbbVie; Analysis Group Inc.; Analysis Group Inc.,,,"Kotze, Paulo/AAC-9376-2019","Kotze, Paulo/0000-0002-9632-6691; kotze, Paulo Gustavo/0000-0002-2053-5315",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI5,A867,A867,,10.1016/j.jval.2015.09.524,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400836,0
J,"Kousoulakou, H; Kalogeropoulou, M; Panitti, E",,,,"Kousoulakou, H.; Kalogeropoulou, M.; Panitti, E.",,,COST-EFFECTIVENESS ANALYSIS OF VILDAGLIPTIN VS. GLIMEPIRIDE AS ADD-ON TO METFORMIN IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN GREECE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kousoulakou, H.] Univ Peloponnese, Corinth, Greece; [Kalogeropoulou, M.; Panitti, E.] Novartis Hellas, Metamorfosis, Greece",University of Peloponnese; Novartis,,,"Gernaey, Krist V./J-1759-2018","Gernaey, Krist V./0000-0002-0364-1773",,,,,0,1,1,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB62,A608,A608,,10.1016/j.jval.2015.09.2101,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300573,0
J,"Lachaine, J; Labarge, A; Bibeau, J; Lambert-Obry, V",,,,"Lachaine, J.; Labarge, A.; Bibeau, J.; Lambert-Obry, V",,,SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF TREATMENTS IN EPILEPSY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lachaine, J.; Bibeau, J.; Lambert-Obry, V] Univ Montreal, Montreal, PQ, Canada; [Labarge, A.] CHU St Justine, Montreal, PQ, Canada",Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND48,A756,A757,,10.1016/j.jval.2015.09.2463,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400435,0
J,"Lachaine, J; Bibeau, J; Castonguay, A; Piche-Richard, V; Barakat, S",,,,"Lachaine, J.; Bibeau, J.; Castonguay, A.; Piche-Richard, V; Barakat, S.",,,SYSTEMATIC REVIEW ON THE CORRELATION BETWEEN LUNG FUNCTION OR EOSINOPHIL LEVELS AND HEALTH CARE RESOURCE UTILIZATION IN ASTHMA,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Lachaine, J.; Bibeau, J.; Castonguay, A.; Piche-Richard, V] Univ Montreal, Montreal, PQ, Canada; [Barakat, S.] Teva Canada Innovat, Montreal, PQ, Canada",Universite de Montreal,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS78,A507,A507,,10.1016/j.jval.2015.09.1452,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300004,0
J,"Laires, PA; Dezerto, R; Mesquita, R; Fonseca, JE; Cernadas, R; Miranda, LC; Silva, JC; Costa, L; Nogueira, AM",,,,"Laires, P. A.; Dezerto, R.; Mesquita, R.; Fonseca, J. E.; Cernadas, R.; Miranda, L. C.; Silva, J. C.; Costa, L.; Nogueira, A. M.",,,EFFECTIVENESS OF A REFERRAL PROGRAM FOR EARLY ARTHRITIS DIAGNOSIS AT PRIMARY CARE CENTERS IN PORTUGAL - PRELIMINARY RESULTS FROM THE SIARA STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Laires, P. A.; Dezerto, R.; Mesquita, R.; Nogueira, A. M.] Merck Sharp & Dohme Ltd, Oeiras, Portugal; [Fonseca, J. E.] Hosp Santa Maria, EPE, Ctr Hosp Lisboa Norte, Lisbon, Portugal; [Cernadas, R.] ARS Norte, Oporto, Portugal; [Miranda, L. C.] Inst Portugues Reumatol, Lisbon, Portugal; [Silva, J. C.] Garcia Orta Hosp, Almada, Portugal; [Costa, L.] Ctr Hosp Sao Joao, Hosp Sao Joao, EPE, Oporto, Portugal",Universidade de Lisboa; Hospital Santa Maria; Hospital Garcia de Orta; Sao Joao Hospital,,,"Laires, Pedro A/AAA-7663-2021","Laires, Pedro/0000-0002-1930-7913; Cunha-Miranda, Luis/0000-0003-4459-8190",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS136,A658,A658,,10.1016/j.jval.2015.09.2380,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300848,0
J,"Laires, PA; Conceiçao, J; Araújo, F; Dores, J; Silva, C; Radican, L; Nogueira, AM",,,,"Laires, P. A.; Conceicao, J.; Araujo, F.; Dores, J.; Silva, C.; Radican, L.; Nogueira, A. M.",,,THE NHS EXPENDITURE MANAGING SEVERE HYPOGLYCEMIA EPISODES IN TYPE 2 DIABETIC PATIENTS IN PORTUGAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Laires, P. A.; Conceicao, J.; Nogueira, A. M.] Merck Sharp & Dohme Ltd, Oeiras, Portugal; [Araujo, F.] Hosp Beatriz Angelo, Loures, Portugal; [Dores, J.] Hosp Santo Antonio, Oporto, Portugal; [Silva, C.] Eurotrials, Sci Consultants, Lisbon, Portugal; [Radican, L.] Merch Sharp & Dohme Corp, Rahway, NJ USA",,,,"Laires, Pedro A/AAA-7663-2021","Laires, Pedro/0000-0002-1930-7913",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB25,A601,A601,,10.1016/j.jval.2015.09.2065,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300537,0
J,"Langham, S; Kenworthy, JJ; Dunlop, W; Chetty, M",,,,"Langham, S.; Kenworthy, J. J.; Dunlop, W.; Chetty, M.",,,A SYSTEMATIC REVIEW OF MODEL-BASED ECONOMIC EVALUATIONS OF DRUG SUBSTITUTION THERAPIES IN MAINTENANCE TREATMENT OF NON-PRESCRIPTION OPIOID DEPENDENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Langham, S.; Chetty, M.] PHMR, London, England; [Kenworthy, J. J.; Dunlop, W.] Mundipharma Int Ltd, Cambridge, England",,,,,"Dunlop, William/0000-0002-9794-8978",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMH28,A411,A411,,10.1016/j.jval.2015.09.981,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400420,0
J,"Layer, P; Andresen, V; Diemert, S; Mackinnon, J; Bertsch, J; Fortea, J; Tack, J",,,,"Layer, P.; Andresen, V; Diemert, S.; Mackinnon, J.; Bertsch, J.; Fortea, J.; Tack, J.",,,DIAGNOSIS AND MANAGEMENT OF MODERATE-TO-SEVERE IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN GERMANY: RESULTS FROM THE IBIS-C STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Layer, P.; Andresen, V] Israelit Hosp, Hamburg, Germany; [Diemert, S.; Fortea, J.] Almirall SA, Barcelona, Spain; [Mackinnon, J.; Bertsch, J.] TFS Develop SL, Barcelona, Spain; [Tack, J.] Univ Hosp Gasthuisberg, Leuven, Belgium",Almirall; KU Leuven; University Hospital Leuven,,,,"Tack, Jan/0000-0002-3206-6704",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI52,A631,A631,,10.1016/j.jval.2015.09.2233,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300703,0
J,"Lee, J; Lee, Y; Bae, S",,,,"Lee, J.; Lee, Y.; Bae, S.",,,ECONOMIC AND CLINICAL IMPACT OF SECONDHAND SMOKING IN KOREA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, J.; Lee, Y.; Bae, S.] Ewha Womans Univ, Seoul, South Korea",Ewha Womans University,,,"Bae, SeungJin/J-6011-2016",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM97,A699,A700,,10.1016/j.jval.2015.09.2614,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400117,0
J,"Li, X; Standaert, B",,,,"Li, X.; Standaert, B.",,,ECONOMIC EVALUATION OF THE ROTAVIRUS VACCINATION AMONG CHILDREN UNDER 5 YEARS OF AGE IN SWITZERLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Li, X.; Standaert, B.] GSK Vaccines, Wavre, Belgium",GlaxoSmithKline,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN52,A585,A585,,10.1016/j.jval.2015.09.1962,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300445,0
J,"Liao, C; Yang, M; Hung, Y; Chen, S; Tang, C",,,,"Liao, C.; Yang, M.; Hung, Y.; Chen, S.; Tang, C.",,,A DISCRETE CHOICE EXPERIMENT FOR ENGAGING PATIENTS IN REIMBURSEMENT DECISION MAKING: PATIENT PREFERENCES ON ADJUVANT CHEMOTHERAPY IN BREAST CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Liao, C.; Yang, M.] Natl Taiwan Univ, Taipei, Taiwan; [Hung, Y.; Tang, C.] Taipei Med Univ, Taipei, Taiwan; [Chen, S.] Chang Gung Mem Hosp Linkou, Taoyuan, Taoyuan County, Taiwan",National Taiwan University; Taipei Medical University; Chang Gung Memorial Hospital,,,,,,,,,0,1,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN225,A470,A470,,10.1016/j.jval.2015.09.1243,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400742,0
J,"Lorenzi, M; Ploug, UJ; Vega, G; Jansen, JP",,,,"Lorenzi, M.; Ploug, U. J.; Vega, G.; Jansen, J. P.",,,LIRAGLUTIDE VS OTHER DAILY GLP-1 ANALOGUES IN PEOPLE WITH TYPE 2 DIABETES: A NETWORK META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lorenzi, M.; Jansen, J. P.] Redwood Outcomes, San Francisco, CA USA; [Ploug, U. J.] Novo Nordisk AS, Soborg, Denmark; [Vega, G.] Novo Nordisk Ltd, Gatwick, England",Novo Nordisk; Novo Nordisk,,,,"Ploug, Uffe Jon/0000-0001-5365-8058",,,,,0,2,2,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB9,A598,A599,,10.1016/j.jval.2015.09.2049,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300521,0
J,"Luque, A; Nobre, MR; Abrahao, MT",,,,"Luque, A.; Nobre, M. R.; Abrahao, M. T.",,,COST-UTILITY OF STATIN IN SECONDARY PREVENTION: A PROPENSITY SCORE METHOD OF ADMINISTRATIVE DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Luque, A.; Nobre, M. R.; Abrahao, M. T.] Univ Sao Paulo, Sao Paulo, Brazil",Universidade de Sao Paulo,,,"Abrahao, Maria Tereza Fernandes/V-2160-2019; Nobre, Moacyr R.C./G-6735-2011",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV125,A395,A396,,10.1016/j.jval.2015.09.894,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400335,0
J,"Macaulay, R",,,,"Macaulay, R.",,,COULD GIVING COST-UTILITY HTA BODIES NEGOTIATING POWERS HELPOBRIDGE THE GAP BETWEEN COST-CONTAINMENT AND BROADENING COVERAGE? A SYSTEMATIC REVIEW OF ALL SWEDISH NLT APPRAISALS OF HOSPITAL PHARMACEUTICALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Macaulay, R.] PAREXEL, London, England",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP42,A521,A521,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300084,0
J,"Mahmood, T; Akhtar, N",,,,"Mahmood, T.; Akhtar, N.",,,SKIN WHITENING MULTIPLE EMULSIONS LOADED WITH GREEN TEA AND LOTUS EXTRACTS: AN EFFICACY STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mahmood, T.] Univ Cent Punjab, Lahore, Pakistan; [Akhtar, N.] Islamia Univ Bahawalpur, Bahawalpur, Pakistan",University of Central Punjab; Islamia University of Bahawalpur,,,"AKHTAR, NAVEED/AAT-1283-2020","AKHTAR, NAVEED/0000-0003-3406-673X",,,,,0,0,0,0,10,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS5,A416,A416,,10.1016/j.jval.2015.09.1007,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400446,0
J,"Majer, I; Pichardo-Piña, CA; Sanchez-Casillas, JL; Schmidt, R; Vo, P",,,,"Majer, I; Pichardo-Pina, C. A.; Sanchez-Casillas, J. L.; Schmidt, R.; Vo, P.",,,COST-EFFECTIVENESS OF PALIVIZUMAB IN CHILDREN WITH CONGENITAL HEART DISEASE IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Majer, I] Pharmerit Int, Rotterdam, Netherlands; [Pichardo-Pina, C. A.; Sanchez-Casillas, J. L.] AbbVie, Mexico City, DF, Mexico; [Schmidt, R.] Pharmerit Int, Berlin, Germany; [Vo, P.] AbbVie, N Chicago, IL USA",AbbVie; AbbVie,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV18,A830,A830,,10.1016/j.jval.2015.09.313,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400629,0
J,"Sánchez, BRM; Hernandez, JJH; del Aquila, DIF; Gainza, EG; Bellesteros, WCP; Rojas, JH; Otero, GP; Marroquin, Y; Velarde, LEZ",,,,"Martinez Sanchez, B. R.; Hernandez Hernandez, J. J.; Franco del Aquila, D., I; Gryzhowski Gainza, E.; Paz Bellesteros, W. C.; Herrera Rojas, J.; Peniche Otero, G.; Marroquin, Y.; Zambrano Velarde, L. E.",,,"AN OPEN LABEL, ONE ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CEREBROLYSIN IN PATIENTS WITH ACUTE SEVERE ISCHEMIC STROKE IN MEXICO",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Martinez Sanchez, B. R.; Hernandez Hernandez, J. J.; Franco del Aquila, D., I; Zambrano Velarde, L. E.] Cruz Verde, Guadalajara, Jalisco, Mexico; [Gryzhowski Gainza, E.; Paz Bellesteros, W. C.; Herrera Rojas, J.; Peniche Otero, G.] Informat Technol Squad, Sa De Cv, DF, Mexico; [Marroquin, Y.] EVER Pharma Mexico, Sa De Cv, DF, Mexico",,,,,,,,,,0,4,4,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV3,A827,A828,,10.1016/j.jval.2015.09.298,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400614,0
J,"McFarlane, M; Chambers, S; Dhaliwal, A; Lee, B; Sung, E; Nwokolo, C; Waugh, N; Arasaradnam, R",,,,"McFarlane, M.; Chambers, S.; Dhaliwal, A.; Lee, B.; Sung, E.; Nwokolo, C.; Waugh, N.; Arasaradnam, R.",,,IS NICE TOO OPTIMISTIC ABOUT SAVINGS FROM FAECAL CALPROTECTIN TESTING?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[McFarlane, M.; Chambers, S.; Dhaliwal, A.; Nwokolo, C.; Arasaradnam, R.] UHCW, Coventry, W Midlands, England; [Lee, B.] Warwick Hosp, Warwick, England; [Sung, E.] George Eliot Hosp, Nuneaton, England; [Waugh, N.] Univ Warwick, Coventry, W Midlands, England",University of Warwick; University of Warwick,,,,,,,,,0,2,3,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI8,A623,A623,,10.1016/j.jval.2015.09.2189,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300659,0
J,"Medoza, C; Ionescu, D; Radière, G; Rémuzat, C; Young, KE; Toumi, M",,,,"Medoza, C.; Ionescu, D.; Radiere, G.; Remuzat, C.; Young, K. E.; Toumi, M.",,,BIOSIMILAR SUBSTITUTION POLICIES: AN OVERVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Medoza, C.; Ionescu, D.; Radiere, G.] Sandoz Int GmbH, Holzkirchen, Germany; [Remuzat, C.] Creat Ceut, Paris, France; [Young, K. E.] Creat Ceut, Milan, Italy; [Toumi, M.] Aix Marseille Univ, Marseille, France",Novartis; Sandoz; Aix-Marseille Universite,,,,,,,,,0,4,4,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP62,A525,A525,,10.1016/j.jval.2015.09.1616,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300104,0
J,"Minacori, R; Bonastre, J; Lueza, B; Marguet, S; Levy, P",,,,"Minacori, R.; Bonastre, J.; Lueza, B.; Marguet, S.; Levy, P.",,,HOW TO MODEL SURVIVAL IN COST-EFFECTIVENESS ANALYSIS? DIFFERENCES BETWEEN MARKOV AND PARTITIONED SURVIVAL ANALYSIS MODELS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Minacori, R.; Levy, P.] Univ Paris 09, Paris, France; [Bonastre, J.; Lueza, B.; Marguet, S.] Gustave Roussy, Villejuif, France",Universite PSL; Universite Paris-Dauphine; UNICANCER; Gustave Roussy,,,,"Lueza, Beranger/0000-0001-8399-4458; bonastre, julia/0000-0001-9884-0072",,,,,0,11,11,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM123,A704,A704,,10.1016/j.jval.2015.09.2639,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400142,0
J,"Mita, N; Iwata, R; Kazuo, K; Onda, T; Adachi, K; Aitoku, Y",,,,"Mita, N.; Iwata, R.; Kazuo, K.; Onda, T.; Adachi, K.; Aitoku, Y.",,,ASSESSING JAPAN'S THREE EARLY ACCESS PROGRAMS BASED ON RECENT DISCUSSIONS: SCOPE AND FINANCIAL AID,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mita, N.; Iwata, R.; Kazuo, K.; Onda, T.; Adachi, K.] Bayer Yakuhin Ltd, Tokyo, Japan; [Aitoku, Y.] Bayer Yakuhin Ltd, Osaka, Japan",Bayer AG; Bayer AG,,,"Mita, Naoyuki/HTR-6115-2023",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP67,A526,A526,,10.1016/j.jval.2015.09.1622,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300109,0
J,"Mitchell, D; Habib, M; Pericleous, L; Petrella, RJ",,,,"Mitchell, D.; Habib, M.; Pericleous, L.; Petrella, R. J.",,,BURDEN OF DYSLIPIDAEMIA IN PATIENTS AT HIGH RISK FOR CARDIOVASCULAR (CV) EVENTS: RESULTS OF A CANADIAN STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mitchell, D.] Univ Montreal, Montreal, PQ, Canada; [Habib, M.; Pericleous, L.] Amgen Canada Inc, Mississauga, ON, Canada; [Petrella, R. J.] Individual Hlth Outcomes Inc, London, ON, Canada; [Petrella, R. J.] Western Univ, London, ON, Canada",Universite de Montreal; Amgen Canada Inc; Western University (University of Western Ontario),,,"Petrella, Robert J/G-6557-2018",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,,A379,A379,,10.1016/j.jval.2015.09.802,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400246,0
J,"Montgomery, S; Stewart, G; Kusel, J",,,,"Montgomery, S.; Stewart, G.; Kusel, J.",,,AN UNDEVELOPED PICTURE: THE AVAILABILITY OF UTILITY VALUATIONS IN LATIN AMERICA - HOW WILL THEY AFFECT QALYS?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Montgomery, S.; Stewart, G.; Kusel, J.] Costello Med Consulting Ltd, Cambridge, England",Costello Medical Consulting,,,"Montgomery, Stephen/B-5683-2011","Montgomery, Stephen/0000-0002-8481-5850",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PP4,A811,A811,,10.1016/j.jval.2015.09.106,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400521,0
J,"Naberhuis, JK; Bell, JD; Goates, S; Nuijten, M",,,,"Naberhuis, J. K.; Bell, J. D.; Goates, S.; Nuijten, M.",,,GLOBAL PUBLICATION TRENDS IN MEDICAL NUTRITION HEALTH ECONOMICS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Naberhuis, J. K.] Univ Illinois, Urbana, IL USA; [Bell, J. D.; Goates, S.] Abbott Nutr, Columbus, OH USA; [Nuijten, M.] Ars Accessus Med, Jisp, Netherlands",University of Illinois System; University of Illinois Urbana-Champaign,,,"Nuijten, Mark/AAN-6924-2021","Naberhuis, Jane/0000-0003-2455-2195",,,,,0,2,2,1,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP225,A553,A553,,10.1016/j.jval.2015.09.1780,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300265,0
J,"Naoshy, S; Pike, J; Jones, E; Watson, C",,,,"Naoshy, S.; Pike, J.; Jones, E.; Watson, C.",,,THE IMPACT OF INCREASING MULTIPLE SCLEROSIS (MS) SEVERITY LEVEL ON EMPLOYMENT AND CAREGIVER BURDEN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Naoshy, S.; Watson, C.] Biogen, Cambridge, MA USA; [Pike, J.; Jones, E.] Adelphi Real World, Manchester, Lancs, England",Biogen; Adelphi Group Ltd,,,,,,,,,0,0,1,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND63,A759,A759,,10.1016/j.jval.2015.09.2478,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400450,0
J,"Napiecek, D; Shah, S; Ramesh, V",,,,"Napiecek, D.; Shah, S.; Ramesh, V",,,"ASSESSING THE POTENTIAL FOR TIERED PRICING OF HIGH PRICED THERAPIES WITHIN ARGENTINA, COLUMBIA, MEXICO, INDONESIA, AND THAILAND",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Napiecek, D.; Shah, S.; Ramesh, V] Market Access Solut LLC, Raritan, NJ USA",,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP201,A549,A549,,10.1016/j.jval.2015.09.1755,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300241,0
J,"Nguyen, TP; Nguyen, T; Postma, M",,,,"Nguyen, T. P.; Nguyen, T.; Postma, M.",,,ECONOMIC BURDEN OF ACUTE MYOCARDIAL INFARCTION IN VIETNAM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nguyen, T. P.; Postma, M.] Univ Groningen, Groningen, Netherlands; [Nguyen, T.] Thai Nguyen Gen Hosp, Thai Nguyen, Netherlands",University of Groningen,,,,"Postma, Maarten/0000-0002-6306-3653",,,,,0,5,5,1,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV88,A389,A389,,10.1016/j.jval.2015.09.857,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400299,0
J,"Nobre, M; Gomes, R",,,,"Nobre, M.; Gomes, R.",,,RISK FACTORS FOR CORONARY ARTERY DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Nobre, M.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil; [Gomes, R.] FURB Univ Biumenau, Sao Paulo, Brazil",Universidade de Sao Paulo; Universidade Regional de Blumenau (FURB),,,"Nobre, Moacyr R.C./G-6735-2011",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS21,A637,A637,,10.1016/j.jval.2015.09.2266,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300735,0
J,"Pakai, A; Millei, K; Boncz, I; Máté, O; Kívés, ZH; Szabó-Gabara, K; Karacsony, I; Vajda, R",,,,"Pakai, A.; Millei, K.; Boncz, I; Mate, O.; Kives, Horvathne Z.; Szabo-Gabara, K.; Karacsony, I; Vajda, R.",,,EXAMINATION OF KNOWLEDGE ABOUT HPV INFECTION AMONG MOTHERS AND DAUGHTERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pakai, A.; Millei, K.] Univ Pecs, Zalaegerszeg, Hungary; [Boncz, I; Mate, O.; Kives, Horvathne Z.; Szabo-Gabara, K.; Vajda, R.] Univ Pecs, Pecs, Hungary; [Karacsony, I] Univ Pecs, Szombathely, Hungary",University of Pecs; University of Pecs; University of Pecs,,,"Pakai, Annamaria/AAS-2610-2020; Boncz, Imre/A-8940-2013","Pakai, Annamaria/0000-0002-2849-1310; Boncz, Imre/0000-0003-3699-6236",,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH91,A748,A748,,10.1016/j.jval.2015.09.2891,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400388,0
J,"Pakai, A; Varga, K; Horváth, AV; Tóth, M; Szebeni-Kovács, G; Szabó-Gabara, K; Boncz, I; Oláh, A",,,,"Pakai, A.; Varga, K.; Horvath, Varadyne A.; Toth, M.; Szebeni-Kovacs, G.; Szabo-Gabara, K.; Boncz, I; Olah, A.",,,LIFE QUALITY OF YOUNG ADULT PATIENTS WITH INFLAMMABLE BOWEL DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Pakai, A.; Varga, K.] Univ Pecs, Zalaegerszeg, Hungary; [Horvath, Varadyne A.; Toth, M.; Szebeni-Kovacs, G.; Szabo-Gabara, K.; Boncz, I; Olah, A.] Univ Pecs, Pecs, Hungary",University of Pecs; University of Pecs,,,"Pakai, Annamaria/AAS-2610-2020; Boncz, Imre/A-8940-2013","Pakai, Annamaria/0000-0002-2849-1310; Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI50,A631,A631,,10.1016/j.jval.2015.09.2231,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300701,0
J,"Paladio-Hernández, JA; Rosas, R; Pozo, L; Del Cid, O; Robles-Valencia, JA",,,,"Paladio-Hernandez, J. A.; Rosas, R.; Pozo, L.; Del Cid, O.; Robles-Valencia, J. A.",,,ECONOMIC EVALUATION OF ULIPRISTAL ACETATE FOR THE TREATMENT OF PATIENTS WITH MODERATE AND SEVERE SYMPTOMS OF UTERINE FIBROIDS BEFORE SURGERY IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rosas, R.; Pozo, L.] GRUFESA, Mexico City, DF, Mexico; [Del Cid, O.; Robles-Valencia, J. A.] Gedeon Richter Mexico, Tlalnepantla, Mexico",,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH14,A834,A834,,10.1016/j.jval.2015.09.337,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400653,0
J,"Patel, P; Nair, SR; Jha, D; Pagada, A; Jamdade, V; Basa, P",,,,"Patel, P.; Nair, S. R.; Jha, D.; Pagada, A.; Jamdade, V; Basa, P.",,,A SYSTEMATIC LITERATURE REVIEW TO ASSESS THE IMPACT OF SOCIAL NETWORKS ON HEALTHCARE IN INDIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Patel, P.; Nair, S. R.; Jha, D.; Pagada, A.; Jamdade, V; Basa, P.] Capita India Pvt Ltd, Bombay, Maharashtra, India",,,,,"Jamdade, Vinayak/0000-0002-1197-0446",,,,,0,0,0,1,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP227,A553,A553,,10.1016/j.jval.2015.09.1782,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300267,0
J,"Pereira, MJ; Coombes, BK; Bisset, LM; Vicenzino, B; Connelly, L",,,,"Pereira, M. J.; Coombes, B. K.; Bisset, L. M.; Vicenzino, B.; Connelly, L.",,,ESTIMATING THE MONETARY VALUE OF RELIEF OF TENNIS ELBOW: A CONTINGENT VALUATION STUDY OF WILLINGNESS-TO-PAY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Pereira, M. J.; Coombes, B. K.; Vicenzino, B.; Connelly, L.] Univ Queensland, Brisbane, Qld, Australia; [Bisset, L. M.] Griffith Univ, Gold Coast, Australia",University of Queensland; Griffith University; Griffith University - Gold Coast Campus,,,"Coombes, Brooke/AAV-9060-2021; Connelly, Luke B/F-6578-2010; Bisset, Leanne/AAS-8947-2021; Vicenzino, Bill/A-8492-2011","Bisset, Leanne/0000-0001-8807-7093; Connelly, Luke/0000-0002-1734-4809",,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS113,A654,A654,,10.1016/j.jval.2015.09.2358,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300826,0
J,"Pichardo-Piña, CA; Sanchez-Casillas, JL",,,,"Pichardo-Pina, C. A.; Sanchez-Casillas, J. L.",,,ANALYSIS OF COST MINIMIZATION OF ADALIMUMAB COMPARED WITH INFLIXIMAB FOR THE TREATMENT OF ULCERATIVE COLITIS IN THE PUBLIC MARKET IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Pichardo-Pina, C. A.; Sanchez-Casillas, J. L.] AbbVie, Mexico City, DF, Mexico",AbbVie,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI7,A867,A867,,10.1016/j.jval.2015.09.526,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400838,0
J,"Priyendu, A; Ahmed, Z; Varma, M; K, EV; Nagappa, AN",,,,"Priyendu, A.; Ahmed, Z.; Varma, M.; K, E., V; Nagappa, A. N.",,,COMPARISON OF DIRECT HOSPITALIZATION COSTS AND LENGTH OF STAY IN CARBAPENEM RESISTANT VERSUS CARBAPENEM SENSITIVE KLEBSIELLA PNEUMONIAE INFECTIONS IN A TERTIARY CARE HOSPITAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Priyendu, A.; Varma, M.; K, E., V] Manipal Univ, Manipal, Karnataka, India; [Ahmed, Z.] Manipal Coll Pharaceut Sci, Manipal, Karnataka, India; [Nagappa, A. N.] Manipal Univ, Dept Pharm Management, MCOPS, Manipal, Karnataka, India",Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE),,,"Nagappa, Anantha/ABC-4941-2020; Nagappa, Anantha Naik/X-8065-2019","Nagappa, Anantha Naik/0000-0002-9930-4711",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN32,A581,A581,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300425,0
J,"Radu, PC; Chiriac, ND; Pravat, MA",,,,"Radu, P. C.; Chiriac, N. D.; Pravat, M. A.",,,ACCES TO NEW THERAPIES IN ROMANIA THROUGH THE SCORECARD HTA SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Radu, P. C.; Chiriac, N. D.; Pravat, M. A.] Roche Romania Srl, Bucharest, Romania",,,,"Radu, Ciprian Paul/IWM-5645-2023","Radu, Ciprian Paul/0000-0001-5666-5296",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,HT1,A341,A342,,10.1016/j.jval.2015.09.148,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400036,0
J,"Rey-Ares, L; Garay, U; García-Martí, S; Gilardino, R; Cabra, HA; Pichón-Riviere, A; Augustovski, F",,,,"Rey-Ares, L.; Garay, U.; Garcia-Marti, S.; Gilardino, R.; Cabra, H. A.; Pichon-Riviere, A.; Augustovski, F.",,,"MEDICAL DEVICES - FROM LICENSING TO COVERAGE: HIGHLIGHTS FROM ARGENTINA, BRAZIL, COLOMBIA, AND MEXICO",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rey-Ares, L.; Garay, U.; Garcia-Marti, S.; Pichon-Riviere, A.; Augustovski, F.] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Gilardino, R.] Johnson & Johnson Med Argentina, Buenos Aires, DF, Argentina; [Cabra, H. A.] Johnson & Johnson Med, Mexico City, DF, Mexico",Johnson & Johnson,,,"Gilardino, Ramiro/ABC-5333-2021; Gilardino, Ramiro E./AGX-6637-2022","Gilardino, Ramiro E./0000-0002-9238-7729",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,MD2,A807,A807,,10.1016/j.jval.2015.09.086,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400501,0
J,"Romero, M; Benavides, M; Alzate, P; Barrios, E",,,,"Romero, M.; Benavides, M.; Alzate, P.; Barrios, E.",,,ANALYSIS OF THE BEHAVIOR OF BREAST CANCER IN A COLOMBIAN INSURER,VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Romero, M.; Benavides, M.; Alzate, P.] Salutia Fdn, Bogota, Colombia; [Barrios, E.] Coorneva Grp, Cali, Colombia",,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN63,A826,A826,,10.1016/j.jval.2015.09.291,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400607,0
J,"Sadler, A; Shi, L; Bethge, S; Mühlbacher, AC",,,,"Sadler, A.; Shi, L.; Bethge, S.; Muehlbacher, A. C.",,,ASSESSMENT OF EFFECTIVE INCENTIVES FOR BLOOD DONATIONS. HOW CAN CITIZENS BE MOTIVATED TO DONATE BLOOD?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sadler, A.; Bethge, S.; Muehlbacher, A. C.] Hsch Neubrandenburg, Neubrandenburg, Germany; [Shi, L.] Univ Massachusetts, Boston, MA 02125 USA",University of Massachusetts System; University of Massachusetts Boston,,,"Mühlbacher, Axel/AAZ-6577-2020","Mühlbacher, Axel/0000-0003-4402-9211",,,,,0,0,0,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH52,A741,A741,,10.1016/j.jval.2015.09.2850,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400349,0
J,"Santos-Moreno, P; Saavedra-Martínez, G; Bello-Gualtero, J; Gómez-Mora, D",,,,"Santos-Moreno, P.; Saavedra-Martinez, G.; Bello-Gualtero, J.; Gomez-Mora, D.",,,COST REDUCTION FORA HEALTH SYSTEM THROUGH DECREASING NUMBER OF ELIGIBLE PATIENTS FOR BIOLOGICAL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS USING THE TREAT TO TARGET RECOMMENDATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Santos-Moreno, P.; Saavedra-Martinez, G.; Bello-Gualtero, J.; Gomez-Mora, D.] Biomab, Ctr Artritis Reumatoide, Bogota, Colombia",,,,,,,,,,0,3,3,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,BI1,A808,A808,,10.1016/j.jval.2015.09.092,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400507,0
J,"Scott, RA; Jones, J; Steen, RG",,,,"Scott, R. A.; Jones, J.; Steen, R. G.",,,WHEN IS A BONE FRACTURE NO LONGER FRESH?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Scott, R. A.; Jones, J.; Steen, R. G.] Bioventus LLC, Durham, NC USA",Smith & Nephew,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD129,A367,A367,,10.1016/j.jval.2015.09.731,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400177,0
J,"Shah, S; Rice, B; Blanchette, CM",,,,"Shah, S.; Rice, B.; Blanchette, C. M.",,,PATIENT CHARACTERISTICS AND HEALTH CARE BURDEN OF CANCER HOSPITALIZATIONS IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shah, S.; Rice, B.] Univ North Carolina Charlotte, Charlotte, NC USA; [Blanchette, C. M.] Precis Med, New York, NY USA",University of North Carolina; University of North Carolina Charlotte,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN53,A438,A439,,10.1016/j.jval.2015.09.1068,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400570,0
J,"Sicras-Mainar, A; Ferrer, V; Navarro, R; Collar, JM",,,,"Sicras-Mainar, A.; Ferrer, V; Navarro, R.; Collar, J. M.",,,COPD ICS/LABA TREATMENT INHALERS AND THEIR IMPACT ON ADHERENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sicras-Mainar, A.] Badalona Serv Assistencials, Barcelona, Spain; [Ferrer, V] EAP La Roca del Valles, Barcelona, Spain; [Navarro, R.] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Collar, J. M.] Mundipharma Pharmaceut SL, Madrid, Spain",Hospital Germans Trias i Pujol,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD100,A362,A362,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400149,0
J,"Sobrevilla-Ricci, A; Mosqueira-Lovon, R; Gutierrez-Aguado, A; Escobedo-Palza, S; Timana-Ruiz, R",,,,"Sobrevilla-Ricci, A.; Mosqueira-Lovon, R.; Gutierrez-Aguado, A.; Escobedo-Palza, S.; Timana-Ruiz, R.",,,COST OF CERVICAL CANCER IN THE HEALTH ESTABLISHMENTS OF PERU,VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Sobrevilla-Ricci, A.; Mosqueira-Lovon, R.] Abt Associates HFG Peru, Lima, Peru; [Gutierrez-Aguado, A.] UNMSM, Lima, Peru; [Escobedo-Palza, S.] SPEAS, Lima, Peru; [Timana-Ruiz, R.] SOMPEGS, Lima, Peru",ABT Associates; Universidad Nacional Mayor de San Marcos,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN27,A820,A820,,10.1016/j.jval.2015.09.255,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400571,0
J,"Solem, CT; Penrod, JR; Lees, M; Daumont, MM; Macahilig, CP; Baeten, S; Verleger, K; Wilke, T",,,,"Solem, C. T.; Penrod, J. R.; Lees, M.; Daumont, Manley M.; Macahilig, C. P.; Baeten, S.; Verleger, K.; Wilke, T.",,,"RESOURCE UTILIZATION AMONG ADVANCED SQUAMOUS AND NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING SECOND-LINE TREATMENT IN FRANCE, GERMANY, ITALY, AND SPAIN: RESULTS OF A RETROSPECTIVE MEDICAL CHART REVIEW",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Solem, C. T.] Pharmerit Int, Bethesda, MD USA; [Penrod, J. R.] Bristol Myers Squibb Co, Princeton, NJ USA; [Lees, M.] Bristol Myers Squibb Co, Rueil Malmaison, France; [Daumont, Manley M.] Bristol Myers Squibb Co, Paris, France; [Macahilig, C. P.] Med Data Analyt, Parsippany, NJ USA; [Baeten, S.] Pharmerit Int, Rotterdam, Netherlands; [Verleger, K.] Pharmerit Int, Berlin, Germany; [Wilke, T.] IPAM Inst Pharmacoecon & Medicat Logist, Wismar, Germany",Pharmerit North America LLC; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb,,,,"Solem, Caitlyn/0000-0002-4914-8052",,,,,0,2,2,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN117,A450,A450,,10.1016/j.jval.2015.09.1133,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400634,0
J,"Tsoumani, E; McCann, E; Tham, R; Yu, E",,,,"Tsoumani, E.; McCann, E.; Tham, R.; Yu, E.",,,DISPENSING FREQUENCY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH RI TUXIMAB IN ENGLAND,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Tsoumani, E.; McCann, E.] MSD, Hoddesdon, England; [Tham, R.; Yu, E.] IMS Hlth, London, England",Merck & Company,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS90,A649,A650,,10.1016/j.jval.2015.09.2335,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300803,0
J,"Turongkaravee, S",,,,"Turongkaravee, S.",,,PREVALENCE AND BURDEN COST OF ADVERSE DRUG REACTIONS (ADRS) IN THE FACULTY OF MEDICINE VAJIRA HOSPITAL NAVAMINTHRADHIRAJ UNIVERSITY : A RESEARCH IMPLEMENTED TO POLICY RECOMMENDATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Turongkaravee, S.] Navaminthradhiraj Univ, Bangkok, Thailand",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS2,A494,A494,,10.1016/j.jval.2015.09.1377,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400873,0
J,"Vasquez, A; Cabieses, B",,,,"Vasquez, A.; Cabieses, B.",,,SPATIAL CONFIGURATION OF THE SOCIAL VULNERABILITY OF INTERNATIONAL IMMIGRANTS IN IQUIQUE 2002-2012 AND ITS RELATIONSHIP TO THE LOCALIZATION OF PRIMARY HEALTH CARE NETWORK,VALUE IN HEALTH,,,Spanish,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Vasquez, A.] Pontificia Univ Catolica Chile, Santiago, Chile; [Cabieses, B.] Univ Desarrollo, Santiago, Chile",Pontificia Universidad Catolica de Chile; Universidad del Desarrollo,,,"Cabieses, Baltica/V-5024-2017",,,,,,0,1,1,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP49,A855,A855,,10.1016/j.jval.2015.09.458,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400771,0
J,"Verbeek, NA; Tsiachristas, A; Franken, M; Koopmanschap, MA; Rutten-van Mölken, MP",,,,"Verbeek, N. A.; Tsiachristas, A.; Franken, M.; Koopmanschap, M. A.; Rutten-van Molken, M. P.",,,PERFORMANCE SCORE EXTRACTION FROM PANEL DATA FOR MULTI-CRITERIA DECISION ANALYSIS (MCDA) USING A REGRESSION-BASED APPROACH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Verbeek, N. A.; Franken, M.; Koopmanschap, M. A.; Rutten-van Molken, M. P.] Erasmus Univ, Rotterdam, Netherlands; [Tsiachristas, A.] Univ Oxford, Oxford, England",Erasmus University Rotterdam; Erasmus University Rotterdam - Excl Erasmus MC; University of Oxford,,,"Franken, Margreet MG/H-3200-2013; Molken, Maureen PMH Rutten-van/G-8481-2014; Molken, Maureen Rutten-van/X-8712-2019","Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Molken, Maureen Rutten-van/0000-0001-8706-3159; Tsiachristas, Apostolos/0000-0002-4662-8915",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM203,A718,A718,,10.1016/j.jval.2015.09.2717,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400219,0
J,"Vietri, J; Tian, H; Gabriel, S; Balp, M; Khalil, S; Zuberbier, T",,,,"Vietri, J.; Tian, H.; Gabriel, S.; Balp, M.; Khalil, S.; Zuberbier, T.",,,ECONOMIC BURDEN OF CHRONIC SPONTANEOUS URTICARIA AND PSORIASIS: PATIENTS PERSPECTIVE FROM EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vietri, J.] Kantar Hlth, Horsham, PA USA; [Tian, H.; Gabriel, S.] Novartis Pharmaceut, E Hanover, NJ USA; [Balp, M.; Khalil, S.] Novartis Pharma AG, Basel, Switzerland; [Zuberbier, T.] Allergie Ctr Charite, Berlin, Germany",Novartis; Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin,,,,,,,,,0,2,2,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS53,A424,A424,,10.1016/j.jval.2015.09.577,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400494,0
J,"Zara, AL; Martelli, CM; Siqueira, JB; Parente, MP; Braga, C; Oliveira, CS; Pimenta, FG; Cortes, F; Bahia, LR; Mendes, MC; Quarti, M; Siqueira, NT; Souza, WV; Toscano, CM",,,,"Zara, A. L.; Martelli, C. M.; Siqueira-Jr, J. B.; Parente, M. P.; Braga, C.; Oliveira, C. S.; Pimenta-Jr, F. G.; Cortes, F.; Bahia, L. R.; Mendes, M. C.; Quarti, M.; Siqueira-Filha, N. T.; Souza, W., V; Toscano, C. M.",,,"HEALTH SERVICES UTILIZATION BY DENGUE PATIENT IN BRAZIL, 2012-2013: A MULTICENTER STUDY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zara, A. L.; Siqueira-Jr, J. B.; Toscano, C. M.] Univ Fed Goias, Goiania, Go, Brazil; [Martelli, C. M.; Braga, C.; Souza, W., V] Fundacao Oswaldo Cruz CPqAM Pernambuco, Recife, PE, Brazil; [Parente, M. P.] Univ Estadual Piaui, Teresina, Brazil; [Oliveira, C. S.] Univ Estado Para, Belem, Para, Brazil; [Pimenta-Jr, F. G.; Mendes, M. C.] Secretaria Municipal Saude Belo Horizonte, Belo Horizonte, MG, Brazil; [Cortes, F.] IATS, Recife, PE, Brazil; [Bahia, L. R.; Quarti, M.] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil; [Siqueira-Filha, N. T.] London Sch Hyg & Trop Med, London, England",Universidade Federal de Goias; Universidade Estadual do Piaui (UESPI); Universidade do Estado do Para (UEPA); Universidade do Estado do Rio de Janeiro; University of London; London School of Hygiene & Tropical Medicine,,,"Parente, Marco/H-8113-2013; Toscano, Cristiana Maria/N-4019-2014; de Sene Amâncio Zara, Ana Laura/P-3993-2019; Zara, Ana Laura S. A./C-3952-2018","Parente, Marco/0000-0002-3326-6345; de Sene Amâncio Zara, Ana Laura/0000-0001-7012-9078;",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP87,A529,A529,,10.1016/j.jval.2015.09.1642,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300129,0
J,"Zhang, L; Chen, W; Wang, Y; Ma, R; Du, M; Xu, X",,,,"Zhang, L.; Chen, W.; Wang, Y.; Ma, R.; Du, M.; Xu, X.",,,COST-EFFECTIVENESS ANALYSIS OF GESTATIONAL DIABETES MELLITUS SCREENING IN URBAN CHINESE SETTING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhang, L.; Chen, W.; Wang, Y.] Fudan Univ, Shanghai, Peoples R China; [Ma, R.; Du, M.] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China; [Xu, X.] Shanghai Gen Hosp, Shanghai, Peoples R China",Fudan University; Kunming Medical University,,,,,,,,,0,3,3,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB60,A607,A608,,10.1016/j.jval.2015.09.2099,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300571,0
J,"Zheng, BH; Zheng, C",,,,"Zheng, Buhong; Zheng, Charles",,,Fuzzy ranking of human development: A proposal,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,ROBUSTNESS,In this paper we propose to measure human development as a fuzzy concept. We stress that there exists a great deal of vagueness in quantifying a country's level of human development; one such source of vagueness is the weighting scheme embedded in the well-publicized UNDP's Human Development Index (HDI). We propose to evaluate the resulting fuzziness in human development ranking with a truth value function. A truth value is simply a function of the probability that a randomly drawn bundle of weights will rank one country to have a higher HDI than another country. We derive simple and easily computable formulae for calculating the truth value. The method derived is equally applicable to fuzzy rankings with other composite indices. (C) 2015 Elsevier B.V. All rights reserved.,"[Zheng, Buhong] Univ Colorado Denver, Dept Econ, Denver, CO 80204 USA; [Zheng, Charles] Stanford Univ, Dept Stat, Stanford, CA 94305 USA",Children's Hospital Colorado; University of Colorado System; University of Colorado Denver; University of Colorado Anschutz Medical Campus; Stanford University,"Zheng, BH (通讯作者)，Univ Colorado Denver, Dept Econ, Denver, CO 80204 USA.",buhong.zheng@ucdenver.edu,,"Zheng, Charles/0000-0003-3427-0845",,,,,31,10,10,0,7,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,NOV,2015,78.0,,,,,,39,47,,10.1016/j.mathsocsci.2015.09.002,0.0,,,9,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CZ0BI,,,,,2024-03-09,WOS:000366769700005,0
J,"Dagsvik, JK",,,,"Dagsvik, John K.",,,Stochastic models for risky choices: A comparison of different axiomatizations,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Stochastic choice under uncertainty; Random tastes; Bounded rationality; Independence from irrelevant alternatives,EXPECTED-UTILITY; INEQUALITY CONSTRAINTS; PROBABILISTIC CHOICE; PREFERENCES; BEHAVIOR,"For a long time researchers have recognized the need for applying stochastic models for analyzing data generated from agents' choice under risk. This paper compares and discusses recent axiomatizations of stochastic models for risky choice given by Blavatskyy (2008) and Dagsvik (2008). We show that some of Blavatskyy's axioms are equivalent to some of Dagsvik's axioms. We also propose new axioms and derive their implications. Specifically, we show that some of the results of Dagsvik (2008) can be derived under weaker axioms than those he proposed originally. (C) 2015 Elsevier B.V. All rights reserved.","Stat Norway, Res Dept, N-0033 Oslo, Norway",Statistics Norway,"Dagsvik, JK (通讯作者)，Stat Norway, Res Dept, POB 8131 Dept, N-0033 Oslo, Norway.",john.dagsvik@ssb.no,,,,,,,49,6,6,0,6,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,OCT,2015,60.0,,,,,,81,88,,10.1016/j.jmateco.2015.06.013,0.0,,,8,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CS0VS,,,,,2024-03-09,WOS:000361780900010,0
J,"Gan, L; Gong, G; Hurd, M; McFadden, D",,,,"Gan, Li; Gong, Guan; Hurd, Michael; McFadden, Daniel",,,Subjective mortality risk and bequests,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Subjective mortality risk; Bequest; Life-cycle model; Median regression,INTERGENERATIONAL TRANSFERS; HEALTH,"This paper investigates the ability of subjective expectations about life expectancy to predict wealth holding patterns in later life. Based on panel data from the Asset and Health Dynamics among the Oldest Old, we estimate a structural life-cycle model with bequests. Each individual's subjective survival rates in the future are estimated with data on his belief of survival probabilities to a target age. This estimation is build upon a Bayesian updating method developed in Gan et al. (2005). We find that life-cycle model using subjective survival rates performs better than using life-table survival rates in predicting wealth holdings. This result suggests that subjective survival expectations play an important role in deciding consumption and savings. In addition, the estimation results show that most bequests are involuntary or accidental. (C) 2015 Elsevier B.V. All rights reserved.","[Gan, Li] Southwestern Univ Finance & Econ, Chengdu, Peoples R China; [Gan, Li] Texas A&M Univ, College Stn, TX 77843 USA; [Gong, Guan] Shanghai Univ Finance & Econ, Sch Econ, Shanghai 200433, Peoples R China; [Gong, Guan] Shanghai Univ Finance & Econ, Key Lab Math Econ, Shanghai 200433, Peoples R China; [Hurd, Michael] RAND Corp, Santa Monica, CA 90401 USA; [Hurd, Michael] NBER, Santa Monica, CA 90401 USA; [McFadden, Daniel] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA; [McFadden, Daniel] NBER, Berkeley, CA 94720 USA",Southwestern University of Finance & Economics - China; Texas A&M University System; Texas A&M University College Station; Shanghai University of Finance & Economics; Shanghai University of Finance & Economics; RAND Corporation; National Bureau of Economic Research; University of California System; University of California Berkeley; National Bureau of Economic Research,"Gan, L (通讯作者)，Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA.",gan@econmail.tamu.edu; ggong@mail.shufe.edu.cn; mhurd@rand.org; mcfadden@econ.berkeley.edu,,,National Institute on Aging; National Science Foundation of China [71273162]; Shanghai Shuguang Project [08SG37],National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shuguang Project,"We are grateful for comments from Moshe Buchinsky, Dan Hamermesh, Charles North, James Smith, and seminar participants at the NBER Summer Institute, UT Austin Department of Economics, and the RAND Corporation. Research Support for this paper was provided to NBER by a grant from the National Institute on Aging. Gong benefited from supports from a National Science Foundation of China (#71273162) and a Shanghai Shuguang Project (#08SG37). Hurd received additional support from a grant to RAND from the National Institute on Aging.",,33,20,25,2,39,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,OCT,2015,188.0,2.0,,,,,514,525,,10.1016/j.jeconom.2015.03.015,0.0,,,12,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CQ2GF,31649415.0,"Green Published, Green Submitted, Green Accepted",,,2024-03-09,WOS:000360417300015,0
J,"Tian, GQ",,,,"Tian, Guoqiang",,,On the existence of equilibria in games with arbitrary strategy spaces and preferences,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Nash equilibrium; Discontinuous games; Arbitrary topological spaces; Recursive transfer continuity,NASH EQUILIBRIUM; MAXIMAL ELEMENTS; DISCONTINUOUS PAYOFFS; BINARY RELATIONS; COMPACT; THEOREMS,"This paper provides necessary and sufficient conditions for the existence of pure strategy Nash equilibria by replacing the assumptions concerning continuity and quasiconcavity with a unique condition, passing strategy space from topological vector spaces to arbitrary topological spaces. Preferences may also be nontotal/nontransitive, discontinuous, nonconvex, or nonmonotonic. We define a single condition, recursive diagonal transfer continuity (RDTC) for aggregator payoff function and recursive weak transfer quasi-continuity (RWTQC) for individuals' preferences, respectively, which establishes the existence of pure strategy Nash equilibria in games with arbitrary (topological) strategy spaces and preferences without imposing any kind of quasiconcavity-related conditions. (C) 2015 Elsevier B.V. All rights reserved.","[Tian, Guoqiang] Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA; [Tian, Guoqiang] Shanghai Univ Finance & Econ, Sch Econ, Shanghai 200433, Peoples R China",Texas A&M University System; Texas A&M University College Station; Shanghai University of Finance & Economics,"Tian, GQ (通讯作者)，Texas A&M Univ, Dept Econ, College Stn, TX 77843 USA.",gtian@tamu.edu,,,National Natural Science Foundation of China [NSFC-71371117]; Key Laboratory of Mathematical Economics (SUFE) at Ministry of Education of China,"National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mathematical Economics (SUFE) at Ministry of Education of China(Ministry of Education, China)","I shall thank two anonymous referees for helpful comments and suggestions that significantly improved the exposition of the paper. I shall also thank Beth Allen, Xiaoyong Cao, John Chipman, Bernard Cornet, Theodore Groves, Ron Harstad, Itai Sher, Hugo F. Sonnenschein, especially Kim Sau Chung, Eric Maskin, David Rahman, Jan Werner, Adam Chi Leung Wong, and Mingjun Xiao for many constructive comments and suggestions. Financial support from the National Natural Science Foundation of China (NSFC-71371117) and the Key Laboratory of Mathematical Economics (SUFE) at Ministry of Education of China is gratefully acknowledged.",,44,15,17,2,15,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,1873-1538,,J MATH ECON,J. Math. Econ.,OCT,2015,60.0,,,,,,9,16,,10.1016/j.jmateco.2015.06.001,0.0,,,8,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CS0VS,,,,,2024-03-09,WOS:000361780900002,0
J,"Wagstaff, A; Kanbur, R",,,,"Wagstaff, Adam; Kanbur, Ravi",,,INEQUALITY OF OPPORTUNITY: THE NEW MOTHERHOOD AND APPLE PIE?,HEALTH ECONOMICS,,,English,Editorial Material,,,,,,Inequality of opportunity; Health,EQUALITY; HEALTH,,"[Wagstaff, Adam] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Kanbur, Ravi] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Kanbur, Ravi] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA",The World Bank; Cornell University; Cornell University,"Wagstaff, A (通讯作者)，World Bank, Dev Res Grp, 1818 H St, Washington, DC 20433 USA.",awagstaff@worldbank.org,"Wagstaff, Adam/A-7667-2009","Wagstaff, Adam/0000-0003-4442-5070",,,,,16,5,5,2,26,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,OCT,2015,24.0,10.0,,,,,1243,1247,,10.1002/hec.3192,0.0,,,5,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CQ7NL,26122915.0,"Bronze, Green Submitted",,,2024-03-09,WOS:000360790800001,0
J,"Hoots, L; Powers, RC",,,,"Hoots, Lucas; Powers, Robert C.",,,Anonymous and positively responsive aggregation rules,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,,"May's Theorem characterizes simple majority rule with the conditions of anonymity, neutrality, and positive responsiveness. We characterize the class of rules satisfying anonymity and positive responsiveness using the concept of a strong quota pair system. (C) 2015 Elsevier B.V. All rights reserved.","[Hoots, Lucas; Powers, Robert C.] Univ Louisville, Dept Math, Louisville, KY 40292 USA",University of Louisville,"Hoots, L (通讯作者)，Univ Louisville, Dept Math, Louisville, KY 40292 USA.",lahoot01@louisville.edu; rcpowe01@louisville.edu,,,,,,,13,2,2,0,5,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2015,77.0,,,,,,9,14,,10.1016/j.mathsocsci.2015.06.003,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CR3RN,,,,,2024-03-09,WOS:000361250900002,0
J,"Kapetanios, G; Mitchell, J; Price, S; Fawcett, N",,,,"Kapetanios, G.; Mitchell, J.; Price, S.; Fawcett, N.",,,Generalised density forecast combinations,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Density forecasting; Model combination; Scoring rules,SCORING RULES; INFERENCE; MODELS; PREDICTION; TESTS,"Density forecast combinations are becoming increasingly popular as a means of improving forecast 'accuracy', as measured by a scoring rule. In this paper we generalise this literature by letting the combination weights follow more general schemes. Sieve estimation is used to optimise the score of the generalised density combination where the combination weights depend on the variable one is trying to forecast. Specific attention is paid to the use of piecewise linear weight functions that let the weights vary by region of the density. We analyse these schemes theoretically, in Monte Carlo experiments and in an empirical study. Our results show that the generalised combinations outperform their linear counterparts. (C) 2015 Bank of England. Published by Elsevier B.V. All rights reserved.","[Kapetanios, G.] Univ London, London WC1E 7HU, England; [Mitchell, J.] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Price, S.; Fawcett, N.] Bank England, London, England; [Price, S.] Citta Univ, Oporto, Portugal; [Price, S.] Ctr Macroecon, London, England",University of London; University of Warwick; Bank of England,"Mitchell, J (通讯作者)，Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.",james.Mitchell@wbs.ac.uk,,"Mitchell, James/0000-0003-0532-4568; Kapetanios, george/0000-0001-8557-4289",ESRC [ES/K010611/1]; ESRC [ES/K010611/1] Funding Source: UKRI; Economic and Social Research Council [ES/K010611/1] Funding Source: researchfish,ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"We thank Gianni Amisano, Sheheryar Malik, Anne Opschoor, Neil Shephard, Dick van Dijk, ions Wauters, three anonymous referees, a Co-Editor, and participants at the UCL/Bank of England workshop in honour of Mark Watson (2013), ESEM 2013, MMF 2013, The Econometric Analysis of Recurrent Events in Macroeconomics & Finance Workshop in Rotterdam (2014), the MMF Birmingham Econometrics and Macroeconomics Conference 2014 and the ECB Forecasting Workshop 2014 for helpful comments and advice. George Kapetanios would like to thank the ESRC for financial support under the grant ES/K010611/1.",,31,38,42,0,30,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,SEP,2015,188.0,1.0,,,,,150,165,,10.1016/j.jeconom.2015.02.047,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CO3AI,,Green Submitted,,,2024-03-09,WOS:000359028200008,0
J,"Leung, MP",,,,"Leung, Michael P.",,,Two-step estimation of network-formation models with incomplete information,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Social networks; Network formation; Multiple equilibria; Discrete games of incomplete information,GAMES; RISK,"We model network formation as a simultaneous game of incomplete information, allowing linking decisions to depend on the structure of the network as well as the attributes of agents. When the data is rationalized by a symmetric equilibrium, meaning observationally equivalent agents choose the same ex-ante strategies, the model can be estimated using a computationally simple two-step estimator. We derive its asymptotic properties under a sequence of models sending the number of agents to infinity, which enables inference with only a single network observation. Our procedure generalizes dyadic regression, allowing the latent index to be a function of endogenous regressors that depend on the network. We apply the estimator to study trust networks in rural Indian villages. (C) 2015 Elsevier B.V. All rights reserved.","Stanford Univ, Dept Econ, Stanford, CA 94305 USA",Stanford University,"Leung, MP (通讯作者)，Stanford Univ, Dept Econ, Stanford, CA 94305 USA.",mpleung@stanford.edu,,,B.F. Haley and E.S. Shaw Fellowship through Stanford Institute for Economic Policy Research; Ric Weiland Graduate Fellowship,B.F. Haley and E.S. Shaw Fellowship through Stanford Institute for Economic Policy Research; Ric Weiland Graduate Fellowship,"I thank Han Hong for guidance and many helpful discussions and close readings. I also thank Trevor Davis, Caroline Hoxby, Guido Imbens, Matt Jackson, and participants at the Stanford structural I.O. lunch for feedback and criticism. This work was supported by a B.F. Haley and E.S. Shaw Fellowship through the Stanford Institute for Economic Policy Research and a Ric Weiland Graduate Fellowship.",,39,30,50,2,16,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,SEP,2015,188.0,1.0,,,,,182,195,,10.1016/j.jeconom.2015.04.001,0.0,,,14,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CO3AI,,,,,2024-03-09,WOS:000359028200010,0
J,"Nazir, J; Maman, K; Neine, ME; Briquet, B; Odeyemi, IAO; Hakimi, Z; Garnham, A; Aballéa, S",,,,"Nazir, Jameel; Maman, Khaled; Neine, Mohamed-Elmoctar; Briquet, Benjamin; Odeyemi, Isaac A. O.; Hakimi, Zalmai; Garnham, Andy; Aballea, Samuel",,,Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults Overactive Bladder in the United Kingdom,VALUE IN HEALTH,,,English,Article,,,,,,antimuscarinic drugs; cost-effectiveness analysis; mirabegron; overactive bladder,TOLTERODINE EXTENDED-RELEASE; BETA(3)-ADRENOCEPTOR AGONIST; IMMEDIATE-RELEASE; TOLERABILITY; EFFICACY; SAFETY; FESOTERODINE; PERSISTENCE; PHASE-3,"Background: Mirabegron, a first-in-class selective oral beta(3)-adrenoceptor agonist, has similar efficacy to most antimuscarinic agents and a lower incidence of dry mouth in patients with overactive bladder (OAB). Objectives: To evaluate the cost-effectiveness of mirabegron 50 mg compared with oral antimuscarinic agents in adults with OAB from a UK National Health Service perspective. Methods: A Markov model including health states for symptom severity, treatment status, and adverse events was developed. Cycle length was 1 month, and the time horizon was 5 years. Antimuscarinic comparators were tolterodine extended release, solifenacin, fesoterodine, oxybutynin extended release and immediate release (IR), darifenacin, and trospium chloride modified release. Transition probabilities for symptom severity levels and adverse events were estimated from a mirabegron trial and a mixed treatment comparison. Estimates for other inputs were obtained from published literature or expert opinion. Quality adjusted life years (QALYs) and total health care costs, including costs of drug acquisition, physician visits, incontinence pad use, and botox injections, were modeled. Deterministic and probabilistic sensitivity analyses were performed. Results: Base-case incremental cost-effectiveness ratios ranged from 367 (vs. solifenacin 10 mg) to 15,593 (vs. oxybutynin IR 10 mg) per QALY gained. Probabilistic sensitivity analyses showed that at a willingness-to-pay threshold of E20,000/QALY gained, the probability of mirabegron 50 mg being cost-effective ranged from 70.2% versus oxybutynin IR 10 mg to 97.8% versus darifenacin 15 mg. A limitation of our analysis is the uncertainty due to the lack of direct comparisons of mirabegron with other agents; a mixed treatment comparison using rigorous methodology provided the data for the analysis, but the studies involved showed heterogeneity. Conclusions: Mirabegron 50 mg appears to be cost-effective compared with standard oral antimuscarinic agents for the treatment of adults with OAB from a UK National Health Service perspective.","[Nazir, Jameel; Odeyemi, Isaac A. O.; Garnham, Andy] Astellas Pharma Europe Ltd, Chertsey KT16 0RS, Surrey, England; [Maman, Khaled] Creat Ceut Ltd, London, England; [Neine, Mohamed-Elmoctar; Briquet, Benjamin; Aballea, Samuel] Creat Ceut SARL, Paris, France; [Hakimi, Zalmai] Astellas Pharma Global Dev, Leiden, Netherlands",Astellas Pharmaceuticals; Astellas Pharmaceuticals,"Nazir, J (通讯作者)，Astellas Pharma Europe Ltd, 2000 Hillswood Dr, Chertsey KT16 0RS, Surrey, England.",Jameel.Nazir@astellas.com,"Hakimi, Zalmai/AAZ-5620-2021",,Astellas Pharma Global Development,Astellas Pharma Global Development(Astellas Pharmaceuticals),This study was sponsored by Astellas Pharma Global Development. Editorial support provided by Andy Noble of Bioscript Medical was also funded by Astellas Pharma Global Development.,,33,18,21,0,7,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,SEP,2015,18.0,6.0,,,,,783,790,,10.1016/j.jval.2015.05.011,0.0,,,8,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CU4EN,26409605.0,hybrid,,,2024-03-09,WOS:000363479800007,0
J,"Rudoler, D; Deber, R; Barnsley, J; Glazier, RH; Dass, AR; Laporte, A",,,,"Rudoler, David; Deber, Raisa; Barnsley, Janet; Glazier, Richard H.; Dass, Adrian Rohit; Laporte, Audrey",,,Paying for Primary Care: The Factors Associated with Physician Self-selection into Payment Models,HEALTH ECONOMICS,,,English,Article; Proceedings Paper,23rd European Workshop on Econometrics and Health Economics,"SEP 04-06, 2014","Starnberg, GERMANY","Univ Munich, Dept Econ,Munich Centre Econ Aging",,physician payment; self-selection; financial incentives; primary care; risk selection,ONTARIO; BEHAVIOR; QUALITY; COST; INCENTIVES,"To determine the factors associated with primary care physician self-selection into different payment models, we used a panel of eight waves of administrative data for all primary care physicians who practiced in Ontario between 2003/2004 and 2010/2011. We used a mixed effects logistic regression model to estimate physicians' choice of three alternative payment models: fee for service, enhanced fee for service, and blended capitation. We found that primary care physicians self-selected into payment models based on existing practice characteristics. Physicians with more complex patient populations were less likely to switch into capitation-based payment models where higher levels of effort were not financially rewarded. These findings suggested that investigations aimed at assessing the impact of different primary care reimbursement models on outcomes, including costs and access, should first account for potential selection effects. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Rudoler, David; Deber, Raisa; Barnsley, Janet; Glazier, Richard H.; Dass, Adrian Rohit; Laporte, Audrey] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada; [Rudoler, David; Deber, Raisa; Barnsley, Janet; Glazier, Richard H.; Laporte, Audrey] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Glazier, Richard H.] St Michaels Hosp, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Glazier, Richard H.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Rudoler, David; Deber, Raisa; Dass, Adrian Rohit; Laporte, Audrey] Canadian Ctr Hlth Econ, Toronto, ON, Canada; [Glazier, Richard H.] Univ Toronto, St Michaels Hosp, Family & Community Med, Toronto, ON, Canada",University of Toronto; University of Toronto; University of Toronto; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Saint Michaels Hospital Toronto,"Rudoler, D (通讯作者)，Univ Toronto, Inst Hlth Policy Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M6, Canada.",david.rudoler@utoronto.ca,,"Deber, Raisa/0000-0003-0598-3926","ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research (CIHR) [MOP-114928, DHE-121276]","ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))","We thank Alex Kopp and Nathaniel Jembere at the Institute for Clinical Evaluative Sciences (ICES) for their support with data collection for this project. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. This study was supported by an operating grant (#MOP-114928) and a doctoral award (DHE-121276) provided by the Canadian Institutes of Health Research (CIHR).",,39,29,36,0,23,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,SEP,2015,24.0,9.0,,,,,1229,1242,,10.1002/hec.3221,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,CO3PH,26190516.0,Green Submitted,,,2024-03-09,WOS:000359070000013,0
J,"Sackett, DL",,,,"Sackett, David L.",,,Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?,VALUE IN HEALTH,,,English,Editorial Material,,,,,,randomized controlled trials (RCTs),,,"[Sackett, David L.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada",McMaster University,"Sackett, DL (通讯作者)，Kilgore Trout Res & Educ Ctr, 154 Pinewood Dr,Irish Lake,RR 1, Markdale, ON N0C 1H0, Canada.",sackett@bmts.com,,,,,,,13,10,11,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUL,2015,18.0,5.0,,,,,550,552,,10.1016/J.JVAL.2015.04.001,0.0,,,3,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CP7VR,26297081.0,Bronze,,,2024-03-09,WOS:000360097700002,0
J,"Wen, HF; Hockenberry, JM; Cummings, JR",,,,"Wen, Hefei; Hockenberry, Jason M.; Cummings, Janet R.",,,"The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances",JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Medical marijuana law; Marijuana use; Alcohol use; Natural experiment,LEGAL DRINKING AGE; DRUG-USE; BINGE DRINKING; ENDOCANNABINOID SYSTEM; IN-DIFFERENCES; CONSUMPTION; CANNABINOIDS; SMOKING; COCAINE; INVOLVEMENT,"We estimate the effect of medical marijuana laws (MMLs) in ten states between 2004 and 2012 on adolescent and adult use of marijuana, alcohol, and other psychoactive substances. We find increases in the probability of current marijuana use, regular marijuana use and marijuana abuse/dependence among those aged 21 or above. We also find an increase in marijuana use initiation among those aged 12-20. For those aged 21 or above, MMLs further increase the frequency of binge drinking. MMLs have no discernible impact on drinking behavior for those aged 12-20, or the use of other psychoactive substances in either age group. (C) 2015 Elsevier B.V. All rights reserved.","[Wen, Hefei; Hockenberry, Jason M.; Cummings, Janet R.] Emory Univ, Dept Hlth Policy & Management, 1518 Clifton Rd, Atlanta, GA 30322 USA; [Hockenberry, Jason M.] NBER, Cambridge, MA 02138 USA",Emory University; National Bureau of Economic Research,"Wen, HF (通讯作者)，Emory Univ, Dept Hlth Policy & Management, 1518 Clifton Rd, Atlanta, GA 30322 USA.",hwen2@emory.edu; jason.hockenberry@emory.edu; jrcummi@emory.edu,,,,,,,64,241,298,2,53,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JUL,2015,42.0,,,,,,64,80,,10.1016/j.jhealeco.2015.03.007,0.0,,,17,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CL8NC,25863001.0,,Y,N,2024-03-09,WOS:000357230400006,0
J,"Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P",,,,"Asaria, Miqdad; Griffin, Susan; Cookson, Richard; Whyte, Sophie; Tappenden, Paul",,,DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS OF HEALTH CARE PROGRAMMES - A METHODOLOGICAL CASE STUDY OF THE UK BOWEL CANCER SCREENING PROGRAMME,HEALTH ECONOMICS,,,English,Article,,,,,,health inequality; equity; cost-effectiveness analysis,COLORECTAL-CANCER; INEQUALITIES; ENGLAND; PARTICIPATION,"This paper presents an application of a new methodological framework for undertaking distributional cost-effectiveness analysis to combine the objectives of maximising health and minimising unfair variation in health when evaluating population health interventions. The National Health Service bowel cancer screening programme introduced in 2006 is expected to improve population health on average and to worsen population health inequalities associated with deprivation and ethnicity - a classic case of intervention-generated inequality'. We demonstrate the distributional cost-effectiveness analysis framework by examining two redesign options for the bowel cancer screening programme: (i) the introduction of an enhanced targeted reminder aimed at increasing screening uptake in deprived and ethnically diverse neighbourhoods and (ii) the introduction of a basic universal reminder aimed at increasing screening uptake across the whole population. Our analysis indicates that the universal reminder is the strategy that maximises population health, while the targeted reminder is the screening strategy that minimises unfair variation in health. The framework is used to demonstrate how these two objectives can be traded off against each other, and how alternative social value judgements influence the assessment of which strategy is best, including judgements about which dimensions of health variation are considered unfair and judgements about societal levels of inequality aversion. (c) 2014 The Authors. Health Economics published by John Wiley & Sons Ltd.","[Asaria, Miqdad; Griffin, Susan; Cookson, Richard] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Whyte, Sophie; Tappenden, Paul] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England",University of York - UK; University of Sheffield,"Asaria, M (通讯作者)，Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.",miqdad.asaria@york.ac.uk,"Cookson, Richard/AAO-3225-2021; Griffin, Susan/AAE-8970-2020; Asaria, Miqdad/T-9980-2019","Griffin, Susan/0000-0003-2188-8400; Asaria, Miqdad/0000-0002-3538-4417; Cookson, Richard/0000-0003-0052-996X",Department of Health Policy Research Programme; National Institute for Health Research [SRF-2013-06-015] Funding Source: researchfish; National Institutes of Health Research (NIHR) [SRF-2013-06-015] Funding Source: National Institutes of Health Research (NIHR),Department of Health Policy Research Programme; National Institute for Health Research(National Institutes of Health Research (NIHR)); National Institutes of Health Research (NIHR),"The work was undertaken by the authors as part of the Public Health Research Consortium. The Public Health Research Consortium is funded by the Department of Health Policy Research Programme. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the DCEA project is available at http://www.york.ac.uk/che/research/equity/d-c-e-a/phrc/, and information about the wider programme of the PHRC is available from http://www.phrc.lshtm.ac.uk.",,27,66,69,1,23,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JUN,2015,24.0,6.0,,,,,742,754,,10.1002/hec.3058,0.0,,,13,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CG1RV,24798212.0,Green Accepted,,,2024-03-09,WOS:000353052400008,0
J,"Gonçalves, S; Kaffo, M",,,,"Goncalves, Silvia; Kaffo, Maximilien",,,Bootstrap inference for linear dynamic panel data models with individual fixed effects,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Bootstrap; Panel data autoregression; Fixed effects; Incidental parameter bias,WILD BOOTSTRAP; BIAS; EFFICIENCY,"This paper's main contribution is to propose and theoretically justify the application of bootstrap methods for inference in autoregressive panel data models with fixed effects. Whereas the focus of the existing literature has been on bias correcting the standard fixed effects OLS estimator (due to the well known incidental parameter bias), our focus here is on improving the quality of inference by relying on the bootstrap instead of the standard normal distribution when computing critical values for test statistics. In particular, we show by simulation that confidence intervals based on the normal distribution can be very distorted in finite samples. Instead, a bootstrap that resamples the residuals and generates the bootstrap observations recursively using the estimated autoregressive panel data model greatly reduces these distortions. We show that this recursive-design residual-based bootstrap fixed effects OLS estimator contains a built-in bias correction term that mimics the incidental parameter bias. Thus, this method can be used to approximate the bias (as well as the entire distribution) of the (biased) fixed effects OLS estimator. This is in contrast with two other methods we consider (a fixed-design residual-based bootstrap and a pairs bootstrap) whose distributions are incorrectly centered at zero. As it turns out, both the recursive-design and the pairs bootstrap are asymptotically valid when applied to the bias-corrected estimator, but the fixed-design bootstrap is not. In the simulations, the recursive-design bootstrap is the method that does best overall. (C) 2015 Elsevier B.V. All rights reserved.","[Kaffo, Maximilien] Univ Montreal, CIREQ, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Sci Econ, Montreal, PQ H3C 3J7, Canada",Universite de Montreal; Universite de Montreal,"Kaffo, M (通讯作者)，Univ Montreal, CIREQ, Montreal, PQ H3C 3J7, Canada.",maxkaffo@yahoo.fr,,,NSERC [RGPIN/341322-2009]; FQRSC [2012-QF-163871],NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRSC,"We would like to thank participants at the CEA conference in Calgary (June 2012), the NBER/NSF Time Series conference at Texas A&M (October 2012), and the CESG conference at Queen's University (October 2012). A special thanks to Russell Davidson and James MacKinnon for useful comments and discussions. Goncalves acknowledges financial support from the NSERC (RGPIN/341322-2009). Kaffo acknowledges financial support from the FQRSC (2012-QF-163871).",,34,20,20,0,25,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUN,2015,186.0,2.0,,,,,407,426,,10.1016/j.jeconom.2015.02.017,0.0,,,20,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CJ3AT,,,,,2024-03-09,WOS:000355356500009,0
J,"Aggarwal, S; Kumar, S; Topaloglu, H",,,,"Aggarwal, S.; Kumar, S.; Topaloglu, H.",,,OVERVIEW AND IMPORTANCE OF NUB PROCESS FOR MARKET ACCESS OF IN-PATIENT DRUGS AND DEVICES IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA; [Kumar, S.] GLOBAL ACCESS Monitor, Bethesda, MD USA",,,,,,,,,,0,0,0,1,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP109,A89,A89,,10.1016/j.jval.2015.03.519,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498501189,0
J,"Al-Mutairi, R; Seoane-Vazquez, E",,,,"Al-Mutairi, R.; Seoane-Vazquez, E.",,,CHANGES IN THE SAFETY PROFILE OF ORAL DIABETES MEDICATIONS APPROVED BY THE FDA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Al-Mutairi, R.; Seoane-Vazquez, E.] MCPHS Univ, Boston, MA USA",,,,,"Almutairi, Reem/0000-0002-4391-5345",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB34,A58,A58,,10.1016/j.jval.2015.03.341,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501020,0
J,"Almogbel, Y; Abughosh, S; Essien, EJ; Sansgiry, SS",,,,"Almogbel, Y.; Abughosh, S.; Essien, E. J.; Sansgiry, S. S.",,,PREDICTORS OF CIGARETTE SMOKING IN THREE ASIAN COUNTRIES: CHINA INDIA AND TAIWAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Almogbel, Y.; Abughosh, S.; Essien, E. J.; Sansgiry, S. S.] Univ Houston, Houston, TX USA",University of Houston System; University of Houston,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS14,A249,A250,,10.1016/j.jval.2015.03.1453,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504138,0
J,"Andrade, TR; Segreto, H; Segreto, R; Nazario, A; Fonseca, M",,,,"Andrade, T. R.; Segreto, H.; Segreto, R.; Nazario, A.; Fonseca, M.",,,HYPOFRACTIONED RADIOTHERAPY IN THE TREATMENT OF EARLY BREAST CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Andrade, T. R.] AxiaBio, Sao Paulo, Brazil; [Segreto, H.; Segreto, R.; Nazario, A.; Fonseca, M.] Univ Fed Sao Paulo, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),,,"Nazario, Afonso/AHA-5340-2022",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN4,A190,A190,,10.1016/j.jval.2015.03.1101,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503125,0
J,"Ara, R; Paisley, S; Robinson, AA; Azough, A; Mensah, L",,,,"Ara, R.; Paisley, S.; Robinson, A. A.; Azough, A.; Mensah, L.",,,USING FACT DATA TO PREDICT PREFERENCE-BASED UTILITY MEASURES FOR PEOPLE WITH MALIGNANT MELANOMA: A REVIEW OF THE EVIDENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ara, R.; Paisley, S.; Robinson, A. A.] Univ Sheffield, Sheffield, S Yorkshire, England; [Azough, A.; Mensah, L.] Amgen Ltd, Uxbridge, Middx, England",University of Sheffield; Amgen; Amgen Limited,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN112,A208,A209,,10.1016/j.jval.2015.03.1209,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503225,0
J,"Asche, CV; Barker, L; Ren, J; Kim, M; Kirkness, CS; McGarvey, J; Short, J; Vozenilek, J",,,,"Asche, C., V; Barker, L.; Ren, J.; Kim, M.; Kirkness, C. S.; McGarvey, J.; Short, J.; Vozenilek, J.",,,ECONOMIC IMPACT OF SIMULATION-BASED TRAINING (SBT) FOR CENTRAL VENOUS CATHETER (CVC) INSERTION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Asche, C., V; Ren, J.; Kim, M.; Kirkness, C. S.] Univ Illinois, Coll Med Peoria, Peoria, IL USA; [Barker, L.; McGarvey, J.; Short, J.; Vozenilek, J.] Jump Trading Simulat & Educ Ctr, Peoria, IL USA; [Barker, L.; McGarvey, J.; Short, J.; Vozenilek, J.] OSF Healthcare, Peoria, IL USA",University of Illinois System; University of Illinois Peoria,,,"Vozenilek, John/AAF-7394-2021; Barker, Lisa/AAE-6091-2022","Vozenilek, John/0000-0001-7955-4089; Barker, Lisa/0000-0001-9373-2486",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN57,A237,A238,,10.1016/j.jval.2015.03.1381,0.0,,,3,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498504072,0
J,"Baker, TM; Kuan, R; Crothers, TA; Wang, Y",,,,"Baker, T. M.; Kuan, R.; Crothers, T. A.; Wang, Y.",,,ESTIMATING THE BUDGET IMPACT OF CLEVIDIPINE FOR THE MANAGEMENT OF PERIOPERATIVE BLOOD PRESSURE IN CARDIAC SURGERY: A US PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Baker, T. M.] ICON Plc, Morristown, NJ USA; [Crothers, T. A.; Wang, Y.] Medicines Co, Parsippany, NJ USA",ICON plc; Novartis,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV45,A137,A137,,10.1016/j.jval.2015.03.798,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502139,0
J,"Belger, M; Brnabic, A; Kadziola, Z; Petto, H; Faries, D",,,,"Belger, M.; Brnabic, A.; Kadziola, Z.; Petto, H.; Faries, D.",,,ALTERNATIVE WEIGHTING APROACHES FOR MATCHING ADJUSTED INDIRECT COMPARISONS (MAIC),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Belger, M.] Eli Lilly & Co Lilly UK, Surrey, England; [Brnabic, A.] Eli Lilly, Sydney, NSW, Australia; [Kadziola, Z.; Petto, H.] Eli Lilly Reg Operat GmbH, Vienna, Austria; [Faries, D.] Eli Lilly, Indianapolis, IN USA",Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly,,,,,,,,,0,3,3,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM124,A31,A32,,10.1016/j.jval.2015.03.190,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498500164,0
J,"Belleudi, V; Sciattella, P; Agabiti, N; Di Martino, M; Di Domenicantonio, R; Davoli, M; Fusco, D",,,,"Belleudi, V; Sciattella, P.; Agabiti, N.; Di Martino, M.; Di Domenicantonio, R.; Davoli, M.; Fusco, D.",,,"SOCIOECONOMIC DIFFERENTIAL IN ONE-YEAR SURVIVAL AFTER HOSPITALIZATION FOR ISCHEMIC STROKE: THE EFFECT OF ACUTE AND POST-ACUTE CARE-PATHWAYS IN LAZIO REGION, ITALY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Belleudi, V; Sciattella, P.; Agabiti, N.; Di Martino, M.; Di Domenicantonio, R.; Davoli, M.; Fusco, D.] Reg Hlth Serv Lazio, Dept Epidemiol, Rome, Italy",,,,"Davoli, Marina/K-1975-2016; Fusco, Danilo/AAB-8646-2019; Belleudi, Valeria/J-9070-2016; belleudi, valeria/AAR-4553-2021; Di Martino, Mirko/K-6543-2018; Fusco, Danilo/K-1383-2016; Agabiti, Nera/K-1053-2016","Fusco, Danilo/0000-0003-1759-5621; belleudi, valeria/0000-0002-8286-443X; Di Martino, Mirko/0000-0002-6033-7591; Fusco, Danilo/0000-0003-1759-5621; Agabiti, Nera/0000-0003-3385-1197",,,,,0,1,1,0,14,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS108,A266,A266,,10.1016/j.jval.2015.03.1547,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504227,0
J,"Bensimon, AG; Hernan, MA; Gibson, T; Fung, V; Chernew, M; Landrum, MB; Newhouse, JP; Schuster, M; Hsu, J",,,,"Bensimon, A. G.; Hernan, M. A.; Gibson, T.; Fung, V; Chernew, M.; Landrum, M. B.; Newhouse, J. P.; Schuster, M.; Hsu, J.",,,COMPARATIVE EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINATION AGAINST CERVICAL ABNORMALITIES BY DOSE LEVEL IN A COHORT OF PRIVATELY-INSURED US GIRLS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bensimon, A. G.] Harvard Univ, Cambridge, MA 02138 USA; [Hernan, M. A.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Gibson, T.; Fung, V; Chernew, M.; Schuster, M.] Harvard Univ, Sch Med, Boston, MA USA; [Landrum, M. B.; Newhouse, J. P.] Harvard Univ, Boston, MA 02115 USA",Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University,,,"Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN16,A192,A192,,10.1016/j.jval.2015.03.1113,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503135,0
J,"Benson, C; Chirila, C; Graham, J; Radder, C; Zheng, Q; Woodruff, K",,,,"Benson, C.; Chirila, C.; Graham, J.; Radder, C.; Zheng, Q.; Woodruff, K.",,,"HEALTH RESOURCE USE AND COST ANALYSIS OF SCHIZOPHRENIA PATIENTS PARTICIPATING IN A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, RELAPSE PREVENTION STUDY OF PALIPERIDONE PALMITATE 3-MONTH FORMULATION",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Benson, C.] Janssen Sci Affairs LLC, Titusville, NJ USA; [Chirila, C.; Graham, J.; Radder, C.; Zheng, Q.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Woodruff, K.] Janssen Global Serv LLC, Titusville, NJ USA",Johnson & Johnson; Janssen Pharmaceuticals; Research Triangle Institute; Johnson & Johnson; Janssen Pharmaceuticals,,,"Woodruff, Kimberly J/HLQ-3063-2023","Chirila, Costel/0000-0002-7495-382X; Graham, Jonathan/0000-0002-3227-5928",,,,,0,1,1,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH27,A119,A119,,10.1016/j.jval.2015.03.699,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502042,0
J,"Bhansali, A; Sansgiry, SS",,,,"Bhansali, A.; Sansgiry, S. S.",,,DOES AZILSARTAN MEDOXIMIL - CHLORTHALIDONE LOWER RISK OF CORONARY HEART DISEASE THAN OLMESARTAN MEDOXIMIL HYDROCHLORTHIAZIDE IN PATIENTS WITH ESENTIAL HYPERTENSION: A COST-EFFECTIVE ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bhansali, A.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Sansgiry, S. S.] Univ Houston, Houston, TX USA",University of Houston System; University of Houston; University of Houston System; University of Houston,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV79,A143,A143,,10.1016/j.jval.2015.03.832,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502170,0
J,"Bouwer, A",,,,"Bouwer, A.",,,ANALYSIS OF SURVEY DATA FOR LEARNING EFFECTIVENESS EVALUATION OF A TALENT MANAGEMENT PROGRAM FOR DAIRIES AND FEEDLOTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bouwer, A.] Zoetis LLC, Florham Pk, NJ USA",Zoetis,,,,,,,,,0,0,0,0,15,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH43,A110,A111,,10.1016/j.jval.2015.03.649,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501312,0
J,"Bress, A; Unni, S; Biltaji, E; Sass, RS; Mamiya, T; Ye, X; Yu, B; Biskupiak, JE; Brixner, D",,,,"Bress, A.; Unni, S.; Biltaji, E.; Sass, R. S.; Mamiya, T.; Ye, X.; Yu, B.; Biskupiak, J. E.; Brixner, D.",,,EVALUATION OF THE POTENTIAL IMPACT OF DRUG-GENE INTERACTION RISK (DGIR) ON HEALTH RESOURCE UTILIZATION (HRU),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bress, A.; Unni, S.; Biltaji, E.; Ye, X.; Yu, B.; Biskupiak, J. E.; Brixner, D.] Univ Utah, Salt Lake City, UT USA; [Sass, R. S.; Mamiya, T.] Genelex Inc, Seattle, WA USA",Utah System of Higher Education; University of Utah,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH61,A113,A113,,10.1016/j.jval.2015.03.667,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502011,0
J,"Cabieses, B; Delgado, I; Bernales, M; Obach, A",,,,"Cabieses, B.; Delgado, I; Bernales, M.; Obach, A.",,,THE RELATIONSHIP BETWEEN DISABILITY AND MIGRATION STATUS IN CHILE: PRELIMINARY ANALYSIS FROM REPEATED CROSS-SECTIONAL SURVEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cabieses, B.; Delgado, I; Bernales, M.; Obach, A.] Univ Desarrollo, Santiago, Chile",Universidad del Desarrollo,,,"Obach, Alexandra/HNI-3919-2023; Cabieses, Baltica/V-5024-2017",,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP161,A98,A98,,10.1016/j.jval.2015.03.572,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501239,0
J,"Cardoso, LB",,,,"Cardoso, L. B.",,,SUGAR-SWEETENED BEVERAGES CONSUMPTION AND PRICE SENSITIVITY AMONG BRAZILIAN ADULTS: IMPLICATIONS FOR OBESITY POLICIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cardoso, L. B.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil",Universidade Federal do Rio Grande do Sul,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PSY79,A305,A305,,10.1016/j.jval.2015.03.1777,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505130,0
J,"Chen, H; Shen, L; Hsu, P; Shen, C; Hall, SA; Hsiao, F",,,,"Chen, H.; Shen, L.; Hsu, P.; Shen, C.; Hall, S. A.; Hsiao, F.",,,RISK OF GLUCOCORTICOID-RELATED ADVERSE EVENTS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS: FINDINGS FROM A 12-YEAR LONGITUDINAL FOLLOW-UP STUDY IN TAIWAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chen, H.; Shen, L.; Hsu, P.; Shen, C.; Hsiao, F.] Natl Taiwan Univ, Taipei 10764, Taiwan; [Hall, S. A.] Biogen Idec Inc, Cambridge, MA USA",National Taiwan University; Biogen,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PSY1,A291,A291,,10.1016/j.jval.2015.03.1699,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505053,0
J,"Du, D; McKean, S; Kelman, JA; Laschinger, J; Johnson, C; Warnock, R; Worrall, CM; Sedrakyan, A; Liu, X; Encinosa, W; MaCurdy, TE; Izurieta, HS",,,,"Du, D.; McKean, S.; Kelman, J. A.; Laschinger, J.; Johnson, C.; Warnock, R.; Worrall, C. M.; Sedrakyan, A.; Liu, X.; Encinosa, W.; MaCurdy, T. E.; Izurieta, H. S.",,,COMPARE EARLY MORTALITY AFTER AORTIC VALVE REPLACEMENT WITH MECHANICAL PROSTHETIC VS BIOPROSTHETIC VALVES AMONG MEDICARE BENEFICIARIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Du, D.; Laschinger, J.; Izurieta, H. S.] US FDA, Silver Spring, MD USA; [McKean, S.; Johnson, C.; Warnock, R.] Acumen LLC, Burlingame, CA USA; [Kelman, J. A.; Liu, X.] CMS, Washington, DC USA; [Worrall, C. M.] CMS, Baltimore, MD USA; [MaCurdy, T. E.] Weill Cornell Med Coll, New York, NY USA; [Encinosa, W.] Agcy Healthcare Res & Qual, Rockville, MD USA","US Food & Drug Administration (FDA); Acumen, LLC; Cornell University; Weill Cornell Medicine; Agency for Healthcare Research & Quality",,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV22,A133,A133,,10.1016/j.jval.2015.03.775,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502116,0
J,"Flores, NM",,,,"Flores, N. M.",,,UNDERSTANDING APARENT HEALTH OUTCOME DISPARITIES BETWEN ETHNIC GROUPS IN THE U.S,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Flores, N. M.] Kantar Hlth, Foster City, CA USA",,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH39,A110,A110,,10.1016/j.jval.2015.03.645,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501308,0
J,"Gagne, JJ; Najafzadeh, M; Choudhry, NK; Bykov, K; Kahler, K; Martin, DP; Rogers, JR; Schneeweiss, S",,,,"Gagne, J. J.; Najafzadeh, M.; Choudhry, N. K.; Bykov, K.; Kahler, K.; Martin, D. P.; Rogers, J. R.; Schneeweiss, S.",,,COMPARISON OF BENEFIT-RISK ASSESSMENT METHODS FOR PROSPECTIVE MONITORING OF NEWLY MARKETED DRUGS: A SIMULATION STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gagne, J. J.; Najafzadeh, M.; Choudhry, N. K.; Bykov, K.; Rogers, J. R.; Schneeweiss, S.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gagne, J. J.; Najafzadeh, M.; Choudhry, N. K.; Schneeweiss, S.] Harvard Univ, Sch Med, Boston, MA USA; [Kahler, K.; Martin, D. P.] Novartis Pharmaceut, E Hanover, NJ USA",Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Novartis,,,"Schneeweiss, Sebastian/C-2125-2013","Schneeweiss, Sebastian/0000-0003-2575-467X",,,,,0,0,0,1,3,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM9,A11,A11,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500054,0
J,"Ganiyu, KA; Erah, PO",,,,"Ganiyu, K. A.; Erah, P. O.",,,"MEDICATION COST IMPLICATION FOR THE MANAGEMENT OF HYPERTENSION AND DIABETES IN NIGER DELTA: TERTIARY HOSPITAL BASED STUDY IN BAYELSA STATE, NIGERIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ganiyu, K. A.] Niger Delta Univ, Wilberforce Isl, Bayelsa State, Nigeria; [Erah, P. O.] Univ Benin, Benin, Nigeria",University of Benin,,,"Erah, Patrick/AAK-9482-2020","Erah, Patrick/0000-0001-7281-7771",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV51,A138,A138,,10.1016/j.jval.2015.03.804,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502145,0
J,"Hagiwara, M; Sun, SX; Moynahan, A; Bornheimer, R; Oster, G",,,,"Hagiwara, M.; Sun, S. X.; Moynahan, A.; Bornheimer, R.; Oster, G.",,,CHANGE IN HEALTHCARE UTILIZATION AND COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INITIATING ADJUNCTIVE THERAPY WITH SECOND-GENERATION ANTIPSYCHOTICS (SGAS),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hagiwara, M.; Moynahan, A.; Bornheimer, R.; Oster, G.] PAI, Brookline, MA USA; [Sun, S. X.] Forest Res Inst, Jersey City, NJ USA; [Oster, G.] MINERVA Hlth Econ Network, Brookline, MA USA",Policy Analysis Inc; Forest Research Institute Inc.,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH25,A119,A119,,10.1016/j.jval.2015.03.697,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502040,0
J,"Haider, MR; Qureshi, Z; Horner, R; Bennett, C",,,,"Haider, M. R.; Qureshi, Z.; Horner, R.; Bennett, C.",,,FACTORS PREDICTING RECEIPT OF PROSTATE SPECIFIC ANTIGEN (PSA) TESTING: EVIDENCE FROM THE NATIONAL AMBULATORY MEDICAL CARE SURVEY (NAMCS) DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Haider, M. R.; Qureshi, Z.; Horner, R.] Univ S Carolina, Columbia, SC 29208 USA; [Bennett, C.] Univ S Carolina, Coll Pharm, Columbia, SC 29208 USA",University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia,,,"Haider, Mohammad Rifat/N-9987-2016","Haider, Mohammad Rifat/0000-0002-0690-8242",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS158,A274,A274,,10.1016/j.jval.2015.03.1598,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504271,0
J,"Han, E; Park, S",,,,"Han, E.; Park, S.",,,DO PHYSICIANS CHANGE THEIR PRESCRIPTIONS IN RESPONSE TO FINANCIAL INCENTIVES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Han, E.] Yonsei Univ, Inchon, South Korea; [Park, S.] Korea Inst Hlth & Social Affairs, Seoul, South Korea",Yonsei University; Korea Institute for Health and Social Affairs,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PGI34,A227,A227,,10.1016/j.jval.2015.03.1320,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504016,0
J,"Han, X; Hay, JW",,,,"Han, X.; Hay, J. W.",,,"COST-EFFECTIVENES ANALYSIS OF CERTOLIZUMAB, ETANERCEPT, GOLIMUMAB AND TOFACITINIB FOR THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Han, X.; Hay, J. W.] Univ So Calif, Los Angeles, CA USA",University of Southern California,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS52,A162,A162,,10.1016/j.jval.2015.03.937,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502273,0
J,"Hussain, T; Jamal, M; Nighat, F; Andleeb, S",,,,"Hussain, T.; Jamal, M.; Nighat, F.; Andleeb, S.",,,"INCREASING PREVALENCE OF CTX-M, TEM AND SHV BETA-LACTAMASES IN CLINICAL PATHOGENIC E. COLI CAUSES SIGNIFICANT HEALTH AND ECONOMIC LOSSES-A PERSPECTIVE FROM PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hussain, T.; Jamal, M.; Andleeb, S.] Natl Univ Sci & Technol, Islamabad, Pakistan; [Nighat, F.] Riphah Int Univ, Rawalpindi, Pakistan",National University of Sciences & Technology - Pakistan,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN9,A229,A229,,10.1016/j.jval.2015.03.1333,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504026,0
J,"Iakovlieva, L; Mishchenko, O; Bezditko, N; Gerasymova, O; Kyrychenko, O; Tkachova, O; Matyashova, N",,,,"Iakovlieva, L.; Mishchenko, O.; Bezditko, N.; Gerasymova, O.; Kyrychenko, O.; Tkachova, O.; Matyashova, N.",,,VOLUME AND STRUCTURE OF ANTIHYPERTENSIVE DRUGS CONSUMPTION IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Iakovlieva, L.; Mishchenko, O.; Bezditko, N.; Gerasymova, O.; Kyrychenko, O.; Tkachova, O.; Matyashova, N.] Natl Univ Pharm, Kharkov, Ukraine",National University of Pharmacy,,,"Iakovlieva, Larysa V./R-8174-2018; Tkachova, Oksana/V-2669-2018; Gerasymova, Olga/AAF-9347-2021","Iakovlieva, Larysa V./0000-0002-9961-4664; Gerasymova, Olga/0000-0003-0278-5705",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV28,A134,A134,,10.1016/j.jval.2015.03.781,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502122,0
J,"Karve, S; Hackett, J; Levinson, J",,,,"Karve, S.; Hackett, J.; Levinson, J.",,,ASSESSING OUTCOMES WITH CEFTAROLINE TREATMENT COMPARED WITH STANDARD OF CARE AMONG HOSPITALIZED PATIENTS WITH COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS (CSSSI),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Karve, S.; Hackett, J.; Levinson, J.] AstraZeneca, Gaithersburg, MD USA",AstraZeneca,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN11,A229,A230,,10.1016/j.jval.2015.03.1335,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504028,0
J,"Kingswood, C; Dew, R; Gray, E",,,,"Kingswood, C.; Dew, R.; Gray, E.",,,MANAGEMENT OF TUBEROUS SCLEROSIS COMPLEX IN ENGLAND: INSIGHTS INTO REAL-WORLD CLINICAL PRACTICE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kingswood, C.] Royal Sussex Cty Hosp, TSC Clin Network, Brighton BN2 5BE, E Sussex, England; [Dew, R.] pH Associates Ltd, Marlow, Bucks, England; [Gray, E.] Novartis Pharmaceut UK Ltd, Frimley, Surrey, England",University of Brighton; Novartis,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS13,A249,A249,,10.1016/j.jval.2015.03.1452,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504137,0
J,"Kozma, C; Muser, E; Benson, C; Mao, L; Starr, HL; Alphs, L",,,,"Kozma, C.; Muser, E.; Benson, C.; Mao, L.; Starr, H. L.; Alphs, L.",,,HEALTH RESOURCE AND CRIMINAL JUSTICE SYSTEM COSTS FOR YOUNG CLINICAL TRIAL PATIENTS WITH SCHIZOPHRENIA AND PRIOR INCARERATION BY TREATMENT FAILURE STATUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kozma, C.] C K Consulting, St Helena Isl, SC USA; [Muser, E.; Benson, C.; Starr, H. L.; Alphs, L.] Janssen Sci Affairs LLC, Titusville, NJ USA; [Mao, L.] Janssen Res & Dev, Titusville, NJ USA",Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals,,,"Alphs, Larry D/O-3683-2017",,,,,,0,1,1,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH43,A122,A122,,10.1016/j.jval.2015.03.715,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502058,0
J,"Lai, L; Sanabria, S",,,,"Lai, L.; Sanabria, S.",,,GENDER DISPARITIES IN MIGRAINE PHARMACOTHERAPY: APLICATION OF PROPENSITY SCORE-MATCHED ANALYSES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lai, L.] Nova SE Univ, Dav, FL USA; [Sanabria, S.] Nova SE Univ, Ft Lauderdale, FL 33314 USA",Nova Southeastern University; Nova Southeastern University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH64,A114,A114,,10.1016/j.jval.2015.03.670,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502014,0
J,"Lee, JS; Sun, P; Conrad, CM; Lew, HC; Solow, BK; Stockl, KM",,,,"Lee, J. S.; Sun, P.; Conrad, C. M.; Lew, H. C.; Solow, B. K.; Stockl, K. M.",,,PREDICTING MEDICATION ADHERENCE AND HEALTHCARE COSTS IN A MANAGED CARE POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, J. S.; Sun, P.; Conrad, C. M.; Lew, H. C.; Solow, B. K.; Stockl, K. M.] OptumRx, Irvine, CA USA",Optum,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH27,A108,A108,,10.1016/j.jval.2015.03.633,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498501296,0
J,"Leleka, M; Zalis'ka, O; Paparyha, V; Kosyachenko, K",,,,"Leleka, M.; Zalis'ka, O.; Paparyha, V; Kosyachenko, K.",,,ECONOMIC ASPECTS OF INFLUENZA VACCINATION IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Leleka, M.] Ternopil State Med Univ Named IYa Gorbachevskyy, Ternopol, Ukraine; [Zalis'ka, O.] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine; [Paparyha, V] Kyiv Natl Econ Univ, Kiev, Ukraine; [Kosyachenko, K.] HTA Ukraine, Kiev, Ukraine",I. Horbachevsky Ternopil State Medical University; Danylo Halytsky Lviv National Medical University; Ministry of Education & Science of Ukraine; Kyiv National Economic University named after Vadym Hetman,,,"Zaliska, Olha/AAN-6078-2020","Zaliska, Olha/0000-0003-1845-7909",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN37,A234,A234,,10.1016/j.jval.2015.03.1361,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504052,0
J,"Li, L; Shrestha, S; Baser, O; Yuce, H; Wang, L",,,,"Li, L.; Shrestha, S.; Baser, O.; Yuce, H.; Wang, L.",,,MORTALITY AND REHOSPITALIZATION RATES AMONG HOSPITALIZED PNEUMONIA PATIENTS IN THE US MEDICARE POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Li, L.; Shrestha, S.; Wang, L.] STATinMED Res, Plano, TX USA; [Baser, O.] MEF Univ, Univ Michigan, STATinMED Res, Ann Arbor, MI USA; [Yuce, H.] CUNY, New York, NY 10021 USA; [Yuce, H.] STATinMED Res, New York, NY USA",MEF Universitesi; University of Michigan System; University of Michigan; City University of New York (CUNY) System,,,"Library, MEF/O-1457-2019",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS12,A171,A171,,10.1016/j.jval.2015.03.990,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503021,0
J,"Liu, S; Xu, Y; Sisco, J; Begelman, SM; Shi, L",,,,"Liu, S.; Xu, Y.; Sisco, J.; Begelman, S. M.; Shi, L.",,,ECONOMIC BURDEN AND POOR QUALITY OF LIFE ASSOCIATED WITH ACROMEGALY IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Liu, S.; Shi, L.] Tulane Univ, New Orleans, LA 70118 USA; [Xu, Y.; Begelman, S. M.] Genentech Inc, San Francisco, CA 94080 USA; [Sisco, J.] Acromegaly Community, Grove, OK USA",Tulane University; Roche Holding; Genentech,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB41,A59,A59,,10.1016/j.jval.2015.03.348,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501026,0
J,"Mauskopf, JA; Mitchell, S; Samuel, M; Samp, JC",,,,"Mauskopf, J. A.; Mitchell, S.; Samuel, M.; Samp, J. C.",,,SYSTEMATIC LITERATURE REVIEW TO IDENTIFY COST ESTIMATES OF LIVER DISEASE IN THOSE WITH CHRONIC HEPATITIS C VIRUS (HCV) IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mauskopf, J. A.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Mitchell, S.] RTI Hlth Solut, Manchester, NC USA; [Samuel, M.] RTI Hlth Solut, Manchester, Lancs, England; [Samp, J. C.] AbbVie Inc, N Chicago, IL USA",Research Triangle Institute; Research Triangle Institute; Research Triangle Institute; AbbVie,,,,"Mauskopf, Josephine/0000-0002-6098-5548",,,,,0,1,1,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN50,A236,A236,,10.1016/j.jval.2015.03.1374,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504065,0
J,"Menon, J; Thomas, J",,,,"Menon, J.; Thomas, J., III",,,ASSOCIATION BETWEEN OSTEOARTHRITIS AND WORKPLACE ABSENTEEISM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Menon, J.; Thomas, J., III] Purdue Univ, W Lafayette, IN 47907 USA",Purdue University System; Purdue University West Lafayette Campus; Purdue University,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS59,A163,A163,,10.1016/j.jval.2015.03.944,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502280,0
J,"Meysner, S; Willgoss, TG; Kitchen, H; Trigg, A; Humphrey, L",,,,"Meysner, S.; Willgoss, T. G.; Kitchen, H.; Trigg, A.; Humphrey, L.",,,INNOVATION IN THE DEVELOPMENT AND VALIDATION OF CLINICAL OUTCOME ASSESSMENTS (COA): AN EXPLORATION OF PATIENT-CENETERED CREATIVE METHODOLOGIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Meysner, S.; Willgoss, T. G.; Kitchen, H.; Trigg, A.; Humphrey, L.] Abacus Int, Manchester, Lancs, England",,,,"Kitchen, Helen/AAZ-3760-2020",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM148,A36,A36,,10.1016/j.jval.2015.03.213,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500188,0
J,"Mueller, E; Schmidt, E; Schrank, L; Neeser, K",,,,"Mueller, E.; Schmidt, E.; Schrank, L.; Neeser, K.",,,"ACCESS TO MEDICINE, REIMBURSEMENT AND PRICING IN GERMANY: WHAT ARE THE IMPLICATIONS OF AMNOG?",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mueller, E.; Schmidt, E.; Schrank, L.; Neeser, K.] LASER ANALYT, Lorrach, Germany",,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP153,A96,A96,,10.1016/j.jval.2015.03.564,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498501231,0
J,"Narayanan, S; Lu, Y; Hutchings, R; Baskett, A",,,,"Narayanan, S.; Lu, Y.; Hutchings, R.; Baskett, A.",,,RELATIONSHIP BETWEEN PHYSICIAN ASSESSMENT OF DISEASE SEVERITY (PER CLINICAL JUDGMENT) AND OBJECTIVE MEASURES OF DISEASE SEVERITY IN RHEUMATOID ARTHRITIS (RA): OBSERVATIONS FROM THE EUROPEAN UNION (EU) AND UNITED STATES (US),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Narayanan, S.] Ipsos Healthcare, Columbia, MD USA; [Lu, Y.; Hutchings, R.; Baskett, A.] Ipsos Healthcare, London, England",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS81,A167,A167,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498502302,0
J,"Newton, J",,,,"Newton, Jonathan",,,Stochastic stability on general state spaces,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Learning; Stochastic stability; General state space,EQUILIBRIUM SELECTION; EVOLUTION; GAMES; DYNAMICS; MODEL; COOPERATION,"This paper studies stochastic stability methods applied to processes on general state spaces. This includes settings in which agents repeatedly interact and choose from an uncountable set of strategies. Dynamics exist for which the stochastically stable states differ from those of any reasonable finite discretization. When there are a finite number of rest points of the unperturbed dynamic, sufficient conditions for analogues of results from the finite state space literature are derived and studied. Illustrative examples are given. (C) 2015 Elsevier B.V. All rights reserved.","Univ Sydney, Sch Econ, Sydney, NSW 2006, Australia",University of Sydney,"Newton, J (通讯作者)，Univ Sydney, Sch Econ, Sydney, NSW 2006, Australia.",jonathan.newton@sydney.edu.au,,"Newton, Jonathan/0000-0003-3290-9721",Australian Research Council [DE130101768]; Australian Research Council [DE130101768] Funding Source: Australian Research Council,Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council),"I wish to thank Heather Battey, Yossi Feinberg, Johannes Homer, George Mailath and the audience at the Econometric Society Australasian Meetings for helpful comments. The author is the recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council (Grant Number: DE130101768).",,28,4,4,0,8,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAY,2015,58.0,,,,,,46,60,,10.1016/j.jmateco.2015.03.007,0.0,,,15,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CJ2XP,,Green Submitted,,,2024-03-09,WOS:000355348300007,0
J,"Oishi, TS; Ali, NSS; Wingate, LT",,,,"Oishi, T. S.; Ali, Shubar N. S.; Wingate, L. T.",,,A COST-EFFECTIVENESS ANALYSIS OF DAPAGLIFLOZIN IN COMPARISON TO DIPEPTIDYL PEPDTIDASE 4-INHIBITORS USING A META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Oishi, T. S.; Ali, Shubar N. S.; Wingate, L. T.] Howard Univ, Washington, DC 20059 USA",Howard University,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB51,A61,A61,,10.1016/j.jval.2015.03.358,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501036,0
J,"Ondrejicka, DA; Hazel, M",,,,"Ondrejicka, D. A.; Hazel, M.",,,BUDGET IMPACT OF PERCUTANEOUS ENDOVASCULAR ABDOMINAL AORTA ANEURYSM (AA) REPAIR COMPARED TO STANDARD ENDOVASCULAR REPAIR IN CANADIAN HOSPITALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ondrejicka, D. A.; Hazel, M.] Johnson & Johnson Med Co, Markham, ON, Canada",Johnson & Johnson,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD19,A41,A41,,10.1016/j.jval.2015.03.243,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500215,0
J,"Palmer, JB; Li, Y; Herrera, V; Tsang, Y; Liao, M; Ozturk, Z",,,,"Palmer, J. B.; Li, Y.; Herrera, V; Tsang, Y.; Liao, M.; Ozturk, Z.",,,TREATMENT MODIFICATIONS AND COSTS OF BIOLOGIC THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Palmer, J. B.; Li, Y.; Herrera, V; Tsang, Y.; Ozturk, Z.] Novartis Pharmaceut, E Hanover, NJ USA; [Liao, M.] KMK Consulting Inc, Florham Pk, NJ USA",Novartis,,,"palmer, jacqueline/GRR-3935-2022",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS19,A156,A156,,10.1016/j.jval.2015.03.904,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502240,0
J,"Parekh, MH; Ipatova, A; Dashputre, AA; Kamal, KM",,,,"Parekh, M. H.; Ipatova, A.; Dashputre, A. A.; Kamal, K. M.",,,QUALITY OF LIFE IN ADULT PATIENTS WITH CYSTIC FIBROSIS ($)over-cap(sic) A SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Parekh, M. H.; Ipatova, A.; Dashputre, A. A.; Kamal, K. M.] Duquesne Univ, Mylan Sch Pharm, Pittsburgh, PA 15219 USA",Duquesne University,,,,,,,,,0,1,1,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PND60,A288,A288,,10.1016/j.jval.2015.03.1680,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505036,0
J,"Poulios, N; Hristova-Neeley, D; Gavaghan, M",,,,"Poulios, N.; Hristova-Neeley, D.; Gavaghan, M.",,,IMPACT OF SAMPLE COLLECTION METHOD FOR EGFR MUTATION TESTING: RESULTS OF BLOOD-BASED AND TISSUE-BASED COBASA® EGFR MUTATION TESTING IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NSCLC IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Poulios, N.] Roche Mol Syst Inc, Pleasanton, CA USA; [Hristova-Neeley, D.; Gavaghan, M.] GfK, Wayland, MA USA",Roche Holding,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD23,A41,A42,,10.1016/j.jval.2015.03.247,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500219,0
J,"Quigley, JM; Halfpenny, NJ; Thompson, JC; Scott, DA",,,,"Quigley, J. M.; Halfpenny, N. J.; Thompson, J. C.; Scott, D. A.",,,DATA EXTRACTION FOR SYSTEMATIC REVIEW - WHERE TO LOOK FOR DATA OUTSIDE THE PRIMARY PUBLICATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Quigley, J. M.; Halfpenny, N. J.; Thompson, J. C.; Scott, D. A.] ICON Hlth Econ, Oxford, England",ICON plc,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM13,A12,A12,,10.1016/j.jval.2015.03.079,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500058,0
J,"Reese, ES; Kurosky, SK; Candrilli, S",,,,"Reese, E. S.; Kurosky, S. K.; Candrilli, S.",,,RECENT TRENDS IN URGENT ANTIBACTERIAL THREAT-RELATED HOSPITALIZATION IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Reese, E. S.; Kurosky, S. K.; Candrilli, S.] RTI Hlth Solut, Res Triangle Pk, NC USA",Research Triangle Institute,,,,"Candrilli, Sean/0000-0002-2062-1192",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN41,A234,A235,,10.1016/j.jval.2015.03.1365,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504056,0
J,"Richardson, T; Claeys, C; Wasserman, D; Tomaszewski, K",,,,"Richardson, T.; Claeys, C.; Wasserman, D.; Tomaszewski, K.",,,"AN EXAMINATION OF PATIENTS WITH OBESITY AMONG A NATIONALLY REPRESENTATIVE POPULATION: COMORBIDITY, HEALTHCARE COSTS AND SATISFACTION",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Richardson, T.; Claeys, C.; Wasserman, D.; Tomaszewski, K.] KJT Grp Inc, Honeoye Falls, NY USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH70,A127,A127,,10.1016/j.jval.2015.03.742,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502085,0
J,"Rosado-Buzzo, A; Luna-Casas, G; Garcia-Molliendo, L; Albuja, M",,,,"Rosado-Buzzo, A.; Luna-Casas, G.; Garcia-Molliendo, L.; Albuja, M.",,,ECONOMIC EVALUATION OF TREATMENT SEQUENCES FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN THE ECUATORIAN PUBLIC HEALTHCARE SECTOR,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rosado-Buzzo, A.] Linkd & Links, Mexico City, DF, Mexico; [Luna-Casas, G.; Garcia-Molliendo, L.] Links & Links, Mexico City, DF, Mexico; [Albuja, M.] Pfizer Ecuador, Quito, Mexico",Pfizer,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS53,A162,A162,,10.1016/j.jval.2015.03.938,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498502274,0
J,"Rudell, K; Bobula, J; Fu, C; Mardekian, J; Sadosky, A; Essex, M; Taylor, W",,,,"Rudell, K.; Bobula, J.; Fu, C.; Mardekian, J.; Sadosky, A.; Essex, M.; Taylor, W.",,,COMPARING BURDEN OF ILLNESS OF TOPHACEOUS WITH NON-TOPHACEOUS GOUT PATIENTS USING A LARGE US ELECTRONIC HEALTH RECORDS DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rudell, K.] Pfizer Ltd, Tadworth, Surrey, England; [Bobula, J.] Pfizer Inc, Collegeville, PA USA; [Fu, C.] Inventiv Hlth, Chesterbrook, PA USA; [Mardekian, J.; Sadosky, A.; Essex, M.] Pfizer Inc, New York, NY USA; [Taylor, W.] Univ Otago, Wellington, New Zealand",Pfizer; Pfizer; Pfizer; University of Otago,,,"Rudell, Katja/AFL-6928-2022; Rudell, Katja/AAG-7004-2022",,,,,,0,3,3,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS33,A158,A158,,10.1016/j.jval.2015.03.918,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502254,0
J,"Shah, K; Devlin, N; Mulhern, B; van Hout, B",,,,"Shah, K.; Devlin, N.; Mulhern, B.; van Hout, B.",,,DIRECTLY ELICITING PERSONAL UTILITY FUNCTIONS: A NEW WAY TO VALUE HEALTH-RELATED QUALITY OF LIFE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shah, K.; Devlin, N.] Off Hlth Econ, London, England; [Mulhern, B.; van Hout, B.] Univ Sheffield, Sheffield, S Yorkshire, England",University of Sheffield,,,"Shah, Koonal/M-9123-2014; Devlin, Nancy/M-3816-2014","Shah, Koonal/0000-0002-4927-7858; Mulhern, Brendan/0000-0003-3656-8063",,,,,0,1,1,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM156,A37,A37,,10.1016/j.jval.2015.03.223,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500196,0
J,"Turbeville, S; Francis, KM; Behm, I; Chiu, GR; Sanchez, H; Morgan, J; Yakovich, A; Ward, R; Hyare, P",,,,"Turbeville, S.; Francis, K. M.; Behm, I; Chiu, G. R.; Sanchez, H.; Morgan, J.; Yakovich, A.; Ward, R.; Hyare, P.",,,THE BURDEN OF AML WITHIN THE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Turbeville, S.; Morgan, J.; Yakovich, A.; Ward, R.; Hyare, P.] Sunesis Pharmaceut, South San Francisco, MA USA; [Francis, K. M.; Behm, I; Chiu, G. R.; Sanchez, H.] Trinity Partners, Waltham, MA USA",Sunesis Pharmaceutical Inc,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCN11,A191,A191,,10.1016/j.jval.2015.03.1108,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503132,0
J,"Urs, SS; Chandwani, S",,,,"Urs, S. S.; Chandwani, S.",,,"BENEFITS OF BREASTFEEDING ON DEVELOPMENT OF DIABETES MELLITUS, IN WOMEN WITH HISTORY OF GESTATIONAL DIABETES MELLITUS USING THE NATIONAL HEALTH AND NUTRITION EXAMINIATION SURVEY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Urs, S. S.] ICON Plc, Morristown, NJ USA; [Chandwani, S.] Rutgers Sch Publ Hlth, Piscataway, NJ USA",ICON plc; Rutgers University System,,,,,,,,,0,3,3,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB97,A70,A70,,10.1016/j.jval.2015.03.404,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501082,0
J,"Virabhak, S; Johnson, S; Parise, H; Saab, S; Juday, T; Marx, S; Sanchez, Y; Wang, A",,,,"Virabhak, S.; Johnson, S.; Parise, H.; Saab, S.; Juday, T.; Marx, S.; Sanchez, Y.; Wang, A.",,,LONG-TERM COST PER SUSTAINED VIROLOGIC RESPONSE IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C VIRUS TREATED WITH VIEKIRA PAK plus /- RIBAVIRIN AND STANDARD OF CARE IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Virabhak, S.; Johnson, S.; Parise, H.] Medicus Econ LLC, Milton, MA USA; [Saab, S.] Pfleger Liver Inst, Los Angeles, IL USA; [Juday, T.; Marx, S.; Sanchez, Y.; Wang, A.] AbbVie, N Chicago, IL USA",AbbVie,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PGI25,A226,A226,,10.1016/j.jval.2015.03.1311,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498504007,0
J,"Wang, W; Park, H",,,,"Wang, W.; Park, H.",,,COMPARISON ON PEDIATRIC ASTHMA HOSPITAL ADMISIONS THROUGH EMERGENCY DEPARTMENT: MEDICAID VS PRIVATE INSURANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, W.; Park, H.] Univ Florida, Gainesville, FL USA",State University System of Florida; University of Florida,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS11,A171,A171,,10.1016/j.jval.2015.03.989,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503020,0
J,"Wang, X; Serna, O; Henges, C; Essien, EJ; Chung, N; Fleming, M; Abughosh, S",,,,"Wang, X.; Serna, O.; Henges, C.; Essien, E. J.; Chung, N.; Fleming, M.; Abughosh, S.",,,IMPACT OF A PHARMACIST TELEPHONE INTERVENTION ON PREVENTING MEDICATION DISCONTINUATION AMONG HYPERTENSIVE PATIENTS WITH DIABETES IN A MEDICARE ADVANTAGE PLAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, X.; Essien, E. J.; Fleming, M.; Abughosh, S.] Univ Houston, Houston, TX USA; [Serna, O.; Henges, C.] Cigna HealthSpring, Houston, TX USA; [Chung, N.] Univ Houston, Houston, TX USA",University of Houston System; University of Houston; University of Houston System; University of Houston,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PDB64,A63,A64,,10.1016/j.jval.2015.03.371,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501049,0
J,"Xie, L; Keshishian, A; Wang, Y; Baser, O",,,,"Xie, L.; Keshishian, A.; Wang, Y.; Baser, O.",,,EVALUATING FRACTURE-RELATED EXPENSES AND HEALTH CARE RESOURCE UTILIZATION AMONG POST-MENOPAUSAL WOMEN IN THE US MEDICAID POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Xie, L.; Keshishian, A.; Wang, Y.] STATinMED Res, Ann Arbor, MI USA; [Baser, O.] MEF Univ, STATinMED Res, Univ Michigan, Ann Arbor, MI USA",MEF Universitesi; University of Michigan System; University of Michigan,,,"Xie, Lin/AAX-2889-2020; Library, MEF/O-1457-2019",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH60,A113,A113,,10.1016/j.jval.2015.03.666,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498502010,0
J,"Xu, XB; Lee, LF",,,,"Xu, Xingbai; Lee, Lung-fei",,,A spatial autoregressive model with a nonlinear transformation of the dependent variable,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Nonlinear spatial autoregressive model; Near-epoch dependence; Maximum likelihood; Instrumental variables; Asymptotic distribution of estimators,REGRESSION,"This paper develops a nonlinear spatial autoregressive model. Of particular interest is a structural interaction model for share data. We consider possible instrumental variable (IV) and maximum likelihood estimation (MLE) for this model, and analyze asymptotic properties of the IV and MLE based on the notion of spatial near-epoch dependence. We also design a statistical test to compare the nonlinear transformation against alternatives. Monte Carlo experiments are designed to investigate finite sample performance of the proposed estimates and the sizes and powers of the test. (C) 2015 Elsevier B.V. All rights reserved.","[Xu, Xingbai; Lee, Lung-fei] Ohio State Univ, Dept Econ, Columbus, OH 43210 USA",University System of Ohio; Ohio State University,"Lee, LF (通讯作者)，Ohio State Univ, Dept Econ, Columbus, OH 43210 USA.",lee.1777@osu.edu,,,,,,,30,26,32,1,24,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAY,2015,186.0,1.0,,,,,1,18,,10.1016/j.jeconom.2014.12.005,0.0,,,18,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CF6IY,,,,,2024-03-09,WOS:000352661600001,0
J,"Younis, M; Forgione, D; Alkatib, A; Jabr, S; Hartmann, M; Kisa, A",,,,"Younis, M.; Forgione, D.; Alkatib, A.; Jabr, S.; Hartmann, M.; Kisa, A.",,,A COST ANALYSIS OF KIDNEY THERAPY OPTIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Younis, M.] Jackson State Univ, New Orleans, LA USA; [Forgione, D.] UTSA, San Antonio, TX USA; [Alkatib, A.] Al Watani Hosp, Ramallah, Palestine; [Jabr, S.] Minsitry Hlth, Ramallah, Palestine; [Hartmann, M.] Univ Jena, Jena, Germany; [Kisa, A.] Zirve Univ, Gazyianteap, Turkey",Jackson State University; University of Texas System; University of Texas at San Antonio (UTSA); Friedrich Schiller University of Jena; Zirve University,,,"Kisa, Adnan/Q-2081-2019; Hartmann, Michael/Y-2331-2019","Kisa, Adnan/0000-0001-7825-3436;",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM34,A16,A16,,10.1016/j.jval.2015.03.100,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500078,0
J,"Yue, X; Guo, JJ; Xia, Y; Almalki, ZS; Wigle, PR",,,,"Yue, X.; Guo, J. J.; Xia, Y.; Almalki, Z. S.; Wigle, P. R.",,,"UTILIZATION, PRICE, AND SPENDING TRENDS FOR FLUOROQUINOLONES IN THE US MEDICAID PROGRAM: 1991-2013",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yue, X.; Guo, J. J.; Xia, Y.; Almalki, Z. S.; Wigle, P. R.] Univ Cincinnati, Cincinnati, OH USA",University System of Ohio; University of Cincinnati,,,"Yue, Xiaomeng/GYJ-1728-2022; Almalki, Ziyad/O-5553-2015","Yue, Xiaomeng/0000-0002-4418-7079; Almalki, Ziyad/0000-0003-1618-4142",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PSS40,A185,A186,,10.1016/j.jval.2015.03.1072,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503100,0
J,"Hu, YY; Sasaki, Y",,,,"Hu, Yingyao; Sasaki, Yuya",,,Closed-form estimation of nonparametric models with non-classical measurement errors,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Closed form; Non-classical measurement errors; Nonparametric regressions,NONLINEAR MODELS; OBESITY; REGRESSION; VARIABLES,"This paper proposes closed-form estimators for nonparametric regressions using two measurements with non-classical errors. One (administrative) measurement has location-/scale-normalized errors, but the other (survey) measurement has endogenous errors with arbitrary location and scale. For this setting of data combination, we derive closed-form identification of nonparametric regressions, and practical closed-form estimators that perform well with small samples. Applying this method to NHANES III, we study how obesity explains health care usage. Clinical measurements and self reports of BMI are used as two measurements with normalized errors and endogenous errors, respectively. We robustly find that health care usage increases with obesity. (C) 2014 Elsevier B.V. All rights reserved.","[Hu, Yingyao; Sasaki, Yuya] Johns Hopkins Univ, Dept Econ, Baltimore, MD 21218 USA",Johns Hopkins University,"Hu, YY (通讯作者)，Johns Hopkins Univ, Dept Econ, 440 Mergenthaler Hall,3400 N Charles St, Baltimore, MD 21218 USA.",yhu@jhu.edu; sasaki@jhu.edu,,,,,,,26,18,20,0,12,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,APR,2015,185.0,2.0,,,,,392,408,,10.1016/j.jeconom.2014.11.004,0.0,,,17,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CD0QH,,Green Submitted,,,2024-03-09,WOS:000350778500007,0
J,"Carlson, JJ; Ogale, S; Dejonckheere, F; Sullivan, SD",,,,"Carlson, Josh J.; Ogale, Sarika; Dejonckheere, Fred; Sullivan, Sean D.",,,Economic Evaluation of Tocilizumab Monoth.erapy Compared to Adalimumab Monoth.erapy in the Treatment of Severe Active Rheumatoid Arthritis,VALUE IN HEALTH,,,English,Article,,,,,,anti-TNF-alpha; cost-effectiveness; rheumatoid arthritis; tocilizumab,INTERLEUKIN-6 RECEPTOR INHIBITION; MODIFYING ANTIRHEUMATIC DRUGS; QUALITY-OF-LIFE; COST-EFFECTIVENESS; HEALTH ECONOMICS; DISEASE-ACTIVITY; BIOLOGIC AGENTS; DOUBLE-BLIND; COMBINATION; MONOTHERAPY,"Objectives: To estimate the cost-effectiveness of tocilizumab (TCZ) monotherapy (Mono) versus adalimumab (ADA) Mono from the US payer perspective in patients with rheumatoid arthritis for whom methotrexate is inappropriate. Methods: We compared TCZ Mono (8 mg/kg monthly) with ADA Mono (40 mg every other week), using efficacy results from a head-to-head study, ADalimumab ACTemrA (ADACTA). We calculated the incremental cost per responder (achievement of American College of Rheumatology [ACR] 20% improvement criteria, ACR 50% improvement criteria, ACR 70% improvement criteria, or low disease activity score) for 'I'CZ versus ADA at 6 months. A patient level simulation was used to estimate the lifetime incremental cost per quality-adjusted life-year (QALY) of initiating treatment with TCZ Mono versus ADA Mono. Both drugs are followed by an etanerceptcertolizumab-palliative care sequence. Nonresponders discontinue at 6 months; responders experience a constant probability of discontinuation. Discontinuers move to the next treatment. ACR responses produce changes in the Health Assessment Questionnaire (HAQ) score. We mapped the HAQ score to utility to estimate QALYs. Costs include those related to hospitalization and those related to treatment (drug acquisition, administration, and monitoring). Probabilistic and one-way sensitivity analyses were conducted, along with several scenario analyses. Results: Compared with ADA, TCZ was more effective, with an estimated 6-month incremental cost ranging from $6,570 per additional low disease activity score achiever to $14,265 per additional ACR 70% improvement criteria responder. The lifetime incremental costeffectiveness ratio was $36,944/QALY. Conclusions: TCZ Mono is projected to be cost-effective compared with ADA Mono in patients with severe rheumatoid arthritis for whom methotrexate is not appropriate, from a US payer perspective.","[Carlson, Josh J.; Sullivan, Sean D.] Univ Washington, Sch Pharm, Seattle, WA 98195 USA; [Ogale, Sarika] Genentech Inc, San Francisco, CA 94080 USA; [Dejonckheere, Fred] F Hoffmann La Roche, Basel, Switzerland",University of Washington; University of Washington Seattle; Roche Holding; Genentech; Roche Holding,"Carlson, JJ (通讯作者)，Univ Washington, Sch Pharm, 1959 NE Pacific Ave,H-375Q,Box 357630, Seattle, WA 98195 USA.",carlsojj@u.washington.edu,,,"Genentech, Inc.","Genentech, Inc.(Roche HoldingGenentech)","Source of financial support: This research was supported by a contract from Genentech, Inc.",,37,25,29,0,9,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,173,179,,10.1016/j.jval.2014.10.013,0.0,,,7,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773552.0,hybrid,,,2024-03-09,WOS:000351115300007,0
J,"Cope, S; Clemens, A; Hammès, F; Noack, H; Jansen, JP",,,,"Cope, Shannon; Clemens, Andreas; Hammes, Florence; Noack, Herbert; Jansen, Jeroen P.",,,Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials,VALUE IN HEALTH,,,English,Article,,,,,,atrial fibrillation; network meta-analysis; new oral anticoagulant; systematic review,JAPANESE PATIENTS; DECISION-MAKING; CLINICAL-TRIALS; WARFARIN; DABIGATRAN; RIVAROXABAN; APIXABAN; RISK; HETEROGENEITY; ASPIRIN,"Objectives: To critically appraise published network meta-analyses (NMAs) evaluating the efficacy or safety of the new oral anticogulants (NOACs) dabigatan, rivaroxaban, and apixaban for the prevention of stoke in patients with nonvalvular atrial fibrillation (Al). Methods: A systematic literature review was performed to identify the relevant NMAs using MEDLINE, EMBASE, Cochrane Library, Database of Abstracts of Reviews of Effects, and Health 'technology Assessment. The synthesis studies were evaluated using the Questionnaire to assess the relevance and credibility of the NMA. Results: Eleven NMAs evaluating NOACs among adults with nonvalvular AF were identified. Most NMAs included three large phase Ill randomized controlled trials, comparing NOACs to adjusted-dose warfarin (Randomized Evaluation of LongTerm Anticoagulation Therapy [RE-LY], Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [ROCKETAF], and Apixaban for Reduction of Stroke and Other Thromboembolic Events in Atial Fibrillation [ARISTOTLE]). The main differences identified related to potential treatment effect modifiers regarding the mean time spent in therapeutic range (TTR) in the warfarin arm, the risk of stroke or systemic embolism across the trials (mean CHADS2 score: C = congestive heart failure, H = hypertension, A = older than age 75 years, D = diabetes mellitus, S2 = pfior stroke or history of transient ischemic attack) or primary versus secondary prevention, and type of populations used in the analysis. Kansal et al [Kansal AR, Sharma M, BradleyKennedy C, et al. Dabigatran versus rivaroxaban for the prevention of stoke and systemic embolism in atrial fibrillation in Canada: comparative efficacy and cost-effectiveness. Thromb Haemost 2012;108:672 82] appropriately adjusted the ROCKET -AF TIR to match the RE-LY population on the basis of individual patient data Meta-regressions are not expected to minimize confounding bias given limited data, whereas subgroup analyses had some impact on the point estimates for the treatment comparisons. Conclusions: Results of the synthesis studies were generally comparable and suggested that the NOACs had similar efficacy, although some differences were identified depending on the outcome. The extent to which differences in the distribution of TTR, CHADS2 score, or primary versus secondary prevention biased the results remains unclear.","[Cope, Shannon] Mapi, Hlth Econ & Outcomes Res, Toronto, ON, Canada; [Clemens, Andreas] Boehringer Ingelheim Pharma GmbH & Co KG, TA Cardiol, Corp Div Med, Ingelheim, Germany; [Clemens, Andreas] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Hammes, Florence] Boehringer Ingelheim GmbH & Co KG, Paris, France; [Noack, Herbert] Boehringer Ingelheim Pharma GmbH & Co KG, Med Data Serv, Ingelheim, Germany; [Jansen, Jeroen P.] Tufts Univ, Sch Med, Boston, MA 02111 USA",Boehringer Ingelheim; Johannes Gutenberg University of Mainz; Boehringer Ingelheim; Boehringer Ingelheim; Tufts University,"Cope, S (通讯作者)，33 Bloor St East,Suite 1300, Toronto, ON M4W 3H1, Canada.",scope@mapigroup.com,,"Noack, Herbert/0000-0002-3194-2039; Jansen, Jeroen Paul/0000-0003-2686-9217",Boehringer Ingelheim,Boehringer Ingelheim(Boehringer Ingelheim),Source of financial support: Boehringer Ingelheim funded this study.,,76,22,23,1,18,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,234,249,,10.1016/j.jval.2014.10.012,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773559.0,hybrid,,,2024-03-09,WOS:000351115300014,0
J,"Costa-Font, J; Fernandez, JL; Swartz, K",,,,"Costa-Font, Joan; Fernandez, Jose-Luis; Swartz, Katherine",,,TRANSITIONING BETWEEN 'THE OLD' AND 'THE NEW' LONG-TERM CARE SYSTEMS FOREWORD,HEALTH ECONOMICS,,,English,Editorial Material,,,,,,long term care; long term care insurance; long term care systems,,,"[Costa-Font, Joan; Fernandez, Jose-Luis] London Sch Econ, LSE Hlth & Social Care, London WC2A 2AE, England; [Swartz, Katherine] Harvard Univ, Dept Hlth Policy & Management, Boston, MA 02115 USA",University of London; London School Economics & Political Science; Harvard University,"Costa-Font, J (通讯作者)，London Sch Econ, LSE Hlth & Social Care, London WC2A 2AE, England.",j.costa-font@lse.ac.uk,"Fernandez, Jose-Luis/D-2451-2010; Costa-i-Font, Joan/C-9609-2013","Fernandez, Jose-Luis/0000-0002-4190-7341; Costa-i-Font, Joan/0000-0001-7174-7919",,,,,0,3,3,25,120,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,MAR,2015,24.0,,,1.0,,,1,3,,10.1002/hec.3156,0.0,,,3,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD6DU,25760578.0,Green Published,,,2024-03-09,WOS:000351180500001,0
J,"Crown, WH",,,,"Crown, William H.",,,Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions,VALUE IN HEALTH,,,English,Editorial Material,,,,,,machine learning; outcomes research; treatment effects,,"Traditional analytic methods are often ill-suited to the evolving world of health care big data characterized by massive volume, complexity, and velocity. In particular, methods are needed that can estimate models efficiently using very large datasets containing healthcare utilization data, clinical data, data from personal devices, and many other sources. Although very large, such datasets can also be quite sparse (ag., device data may only be available for a small subset of individuals), which creates problems for traditional regression models. Many machine learning methods address such limitations effectively but are still subject to the usual sources of bias that commonly arise in observational studies. Researchers using machine learning methods such as lasso or ridge regression should assess these models using conventional specification tests.","Optum Labs, Cambridge, MA 02142 USA",Optum,"Crown, WH (通讯作者)，Optum Labs, One Main St,10th Floor,Suite 1040, Cambridge, MA 02142 USA.",william.crown@optum.com,,,,,,,9,58,68,0,22,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,137,140,,10.1016/j.jval.2014.12.005,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773546.0,hybrid,,,2024-03-09,WOS:000351115300001,0
J,"Kaló, Z; Holtorf, AP; Alfonso-Cristancho, R; Shen, J; Agh, T; Inotai, A; Brixner, D",,,,"Kalo, Zoltan; Holtorf, Anke-Peggy; Alfonso-Cristancho, Rafael; Shen, Jie; Agh, Tamas; Inotai, Andras; Brixner, Diana",,,Need for Multicriteria Evaluation of Generic Drug Policies,VALUE IN HEALTH,,,English,Article,,,,,,adherence; drug policies; generic drug; multicriteria decision analysis; price erosion; real-world evidence,ANTIEPILEPTIC DRUGS; BRAND-NAME; SUBSTITUTION; HEALTH; IMPACT; COST; BIOEQUIVALENCE; PERSISTENCE; MEDICATION; DEPRESSION,"Policymakers tend to focus on improving patented drug policies because they are under pressure from patients, physicians, and manufacturers to increase access to novel therapies. The success of pharmaceutical innovation over the last few decades has led to the availability of many off-patent drugs to treat disease areas with the greatest public health need. Therefore, the success of public health programs in improving the health status of the total population is highly dependent on the efficiency of generic drug policies. The objective of this article was to explore factors influencing the true efficiency of generic prescription drug policies in supporting public health initiatives in the developed world. Health care decision makers often assess the efficiency of generic drug policies by the level of price erosion and market share of generics. Drug quality, bioequivalence, in some cases drug formulations, supply reliability, medical adherence and persistence, health outcomes, and nondrug costs, however, are also attributes of success for generic drug policies. Further methodological research is needed to measure and improve the efficiency of generic drug policies. This also requires extension of the evidence base of the impact of generic drugs, partly based on real world evidence. Multicriteria decision analysis may assist policymakers and researchers to evaluate the true value of generic drugs.","[Kalo, Zoltan] Eatvos Lorand Univ ELTE, Fac Social Sci, Dept Hlth Policy & Hlth Econ, H-1117 Budapest, Hungary; [Kalo, Zoltan; Agh, Tamas; Inotai, Andras] Syreon Res Inst, Budapest, Hungary; [Holtorf, Anke-Peggy] Hlth Outcomes Strategies, Basel, Switzerland; [Holtorf, Anke-Peggy; Brixner, Diana] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Alfonso-Cristancho, Rafael] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA; [Shen, Jie] Abbott Prod Operat AG, Allschwil, Switzerland",Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; ABB,"Kaló, Z (通讯作者)，Eotvos Lorand Univ, Fac Social Sci, Dept Hlth Policy & Hlth Econ, Pazmany P 1a, H-1117 Budapest, Hungary.",kalo@tatk.elte.hu,"Kalo, Zoltan/G-7582-2011","Kalo, Zoltan/0000-0001-7762-2607; Agh, Tamas/0000-0002-9609-0236; Holtorf, Anke-Peggy/0000-0002-4638-5351",Abbott,Abbott(Abbott Laboratories),"The writing of this article was supported in part by Abbott. However, the authors summarized their independent professional opinion and take full responsibility for potential errors in the article.",,51,29,30,3,33,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAR,2015,18.0,2.0,,,,,346,351,,10.1016/j.jval.2014.12.012,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CD5GF,25773570.0,Bronze,,,2024-03-09,WOS:000351115300025,0
J,"Olaizola, N; Valenciano, F",,,,"Olaizola, Norma; Valenciano, Federico",,,Unilateral vs. bilateral link-formation: A transition without decay,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,MODEL,"We provide a model that bridges the gap between the simplest variation of two benchmark models of strategic network formation: Bala and Goyal's two-way flow model without decay, where links can be unilaterally formed, and a variation of Jackson and Wolinsky's model based on bilateral formation of links assuming no decay. In the model introduced and studied here a link can be created unilaterally. When it is only supported by one of the two players the flow through the link suffers some degree of decay, but when it is supported by both the flow runs without friction. When the decay in links supported by only one player is maximal (i.e. there is no flow) we have a simple variation of Jackson and Wolinsky's connections model assuming no decay, while when flow in those links is perfect we have Bala and Goyal's two-way flow model without decay. We study Nash, strict Nash and pairwise Nash stability for the intermediate models. Efficiency and dynamics are also examined. (C) 2014 Elsevier B.V. All rights reserved.","[Olaizola, Norma] Univ Basque Country, Dept Fundamentos Anal Econ 1, BRiDGE Grp, Bilbao 48015, Spain; [Valenciano, Federico] Univ Basque Country, Dept Econ Aplicada 4, BRiDGE Grp, Bilbao 48015, Spain",University of Basque Country; University of Basque Country,"Valenciano, F (通讯作者)，Univ Basque Country, Dept Econ Aplicada 4, BRiDGE Grp, Ave Lehendakari Aguirre 83, Bilbao 48015, Spain.",norma.olaizola@ehu.es; federico.valenciano@ehu.es,"Olaizola, Norma/JBR-9301-2023; Olaizola, Norma/H-5201-2015; Valenciano, Federico/H-5440-2015","Olaizola, Norma/0000-0003-3876-7648; Valenciano, Federico/0000-0001-8750-9122","Spanish Ministerio de Economia y Competitividad [ECO2012-31626, ECO2012-31346]; Basque Government Departamento de Educacion, Politica Linguistica y Cultura [IT869-13, IT568-13]","Spanish Ministerio de Economia y Competitividad(Spanish Government); Basque Government Departamento de Educacion, Politica Linguistica y Cultura(Basque Government)","We thank an anonymous referee/editor for his/her valuable comments which helped us to improve the paper considerably. This research is supported by the Spanish Ministerio de Economia y Competitividad under projects ECO2012-31626 and ECO2012-31346. Both authors also benefit from the Basque Government Departamento de Educacion, Politica Linguistica y Cultura funding for Grupos Consolidados IT869-13 and IT568-13.",,18,2,3,0,8,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,MAR,2015,74.0,,,,,,13,28,,10.1016/j.mathsocsci.2014.12.002,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CD2VV,,,,,2024-03-09,WOS:000350938000003,0
J,"Rischatsch, M",,,,"Rischatsch, Maurus",,,Who joins the network? Physicians' resistance to take budgetary co-responsibility,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Physician reimbursement; Managed Care; Physician networks; Latent-class logit; Discrete choice experiment,FINANCIAL INCENTIVES; DOCTORS,"Managed Care (MC) is expected to provide health care at a lower cost than conventional provision. Therefore, Switzerland intends to promote MC by forcing health insurers to write MC contracts and introducing budgetary co-responsibility for ambulatory care physicians. A discrete choice experiment conducted in 2011 including 872 physicians reveals a strong preference heterogeneity with respect to network participation and alternative remuneration schemes. The number of physicians working in networks is unlikely to rise on a voluntary basis, while general practitioners are more likely to join networks than specialists with surgical activities. For physicians considering joining networks, cost savings are predicted to be higher than the estimated willingness-to-accept payments. (C) 2014 Elsevier B.V. All rights reserved.","Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland",University of Zurich,"Rischatsch, M (通讯作者)，Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland.",maurus.rischatsch@econ.uzh.ch,,,,,,,36,6,6,0,9,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,MAR,2015,40.0,,,,,,109,121,,10.1016/j.jhealeco.2014.12.002,0.0,,,13,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CF1SC,25637711.0,,,,2024-03-09,WOS:000352327200009,0
J,"Jochmans, K",,,,"Jochmans, Koen",,,Multiplicative-error models with sample selection,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Count data; Fixed-effect model; Nonlinear model; Sample selection; Semiparametric inference; Two-stage estimation,PANEL-DATA MODELS; SEMIPARAMETRIC ESTIMATION; COUNT DATA; BIAS; ENDOGENEITY,"This paper presents a simple approach to deal with sample selection in models with multiplicative errors. Models for non-negative limited dependent variables such as counts fit this framework. The approach builds on a specification of the conditional mean of the outcome only and is, therefore, semiparametric in nature. GMM estimators are constructed for both cross-section data and for panel data. We derive distribution theory and present Monte Carlo evidence on the finite-sample performance of the estimators. (C) 2014 Elsevier B.V. All rights reserved.","Sci Po, Dept Econ, F-75007 Paris, France",Institut d'Etudes Politiques Paris (Sciences Po),"Jochmans, K (通讯作者)，Sci Po, Dept Econ, 28 Rue St Peres, F-75007 Paris, France.",koen.jochmans@sciencespo.fr,,,Sciences Po's SAB,Sciences Po's SAB,"A previous version of this paper was circulated under the title 'Simple estimators for count data models with sample selection'. I am grateful to Han Hong, an associate editor, and two referees for very constructive comments. Financial support from Sciences Po's SAB is gratefully acknowledged.",,50,2,2,3,34,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,FEB,2015,184.0,2.0,,,,,315,327,,10.1016/j.jeconom.2014.09.011,0.0,,,13,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CA6XE,,Green Submitted,,,2024-03-09,WOS:000349060000007,0
J,"Béal, S; Rémila, E; Solal, P",,,,"Beal, Sylvain; Remila, Eric; Solal, Philippe",,,Preserving or removing special players: What keeps your payoff unchanged in TU-games?,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,SHAPLEY VALUE; SOLIDARITY VALUE; DIFFERENCE; NULL,"If a player is removed from a game, what keeps the payoff of the remaining players unchanged? Is it the removal of a special player or its presence among the remaining players? This article answers this question in a complement study to Kamijo and Kongo (2012). We introduce axioms of invariance from player deletion in presence of a special player. In particular, if the special player is a nullifying player (resp. dummifying player), then the equal division value (resp. equal surplus division value) is characterized by the associated axiom of invariance plus efficiency and balanced cycle contributions. There is no type of special player from such a combination of axioms that characterizes the Shapley value. (C) 2014 Elsevier B.V. All rights reserved.","[Beal, Sylvain] Univ Franche Comte, CRESE, F-25009 Besancon, France; [Remila, Eric; Solal, Philippe] Univ St Etienne, CNRS UMR GATE Lyon St Etienne 5824, St Etienne, France",Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Jean Monnet,"Béal, S (通讯作者)，Univ Franche Comte, CRESE, 30 Ave Observ, F-25009 Besancon, France.",sylvain.beal@univ-fcomte.fr; eric.remila@univ-st-etienne.fr; philippe.solal@univ-st-etienne.fr,,,National Agency for Research (ANR) [ANR-13-BSHS1-0010]; Mathematiques de la decision pour l'ingenierie physique et sociale (MODMAD) project,National Agency for Research (ANR)(Agence Nationale de la Recherche (ANR)); Mathematiques de la decision pour l'ingenierie physique et sociale (MODMAD) project,"Financial support by the National Agency for Research (ANR) - research program DynaMITE: Dynamic Matching and Interactions; Theory and Experiments, contract ANR-13-BSHS1-0010 - and the Mathematiques de la decision pour l'ingenierie physique et sociale (MODMAD) project is gratefully acknowledged.",,19,15,15,0,4,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,JAN,2015,73.0,,,,,,23,31,,10.1016/j.mathsocsci.2014.11.003,0.0,,,9,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,AZ5KR,,Green Submitted,,,2024-03-09,WOS:000348260500004,0
C,"Bi, KX; Huang, P",,"Lan, H",,Bi Ke-xin; Huang Ping,,,Bibliometric Analysis of Industrial Upgrading of Manufacturing Sector Under Global Value Chain,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,industrial upgrading; global value chain; manufacturing sector; comparative analysis,INTERNATIONAL-TRADE; PRODUCTION NETWORKS; CLUSTERS,"As the world factory, China's manufacturing sector occupies a crucial position in the global manufacturing network. However, the extensive development model makes the majority of China's manufacturing sector at the bottom of the global value chains for a long time, industrial transformation and upgrading of manufacturing is urgently in need. Based on this background, this paper comparatively analyzes the current research of industrial upgrading of manufacturing in China and abroad, in order to reveal the current status of domestic and foreign research and possible future trends. The study found that the global value chain is the core of the knowledge base and analysis framework for the study on industrial upgrading of manufacturing, and the traditional manufacturing sector in the developing countries is the main object of study. Through the further comparative analysis of industrial upgrading research in China and abroad under the global value chain, we found that our related research focus on the path and strategy of industrial upgrading of various sectors too much, but ignore the influencing factors' mechanism of industrial upgrading; focus on the industrial upgrading of traditional manufacturing too much, but ignore the leaping development of high-tech industry.","[Bi Ke-xin; Huang Ping] Harbin Engn Univ, Sch Econ & Management, Harbin 150001, Peoples R China; [Bi Ke-xin; Huang Ping] Harbin Univ Sci & Technol, Sch Management, Harbin 150080, Peoples R China",Harbin Engineering University; Harbin University of Science & Technology,"Bi, KX (通讯作者)，Harbin Engn Univ, Sch Econ & Management, Harbin 150001, Peoples R China.",,,,"National Natural Science Foundation of China [71472057, 71273073, 71073041, 70872024]; National Soft Science Project [2012GXS4D080]; Specialized Research Fund for the Doctoral Program of Higher Education Project [20122304110026]; Soft Science Project of State Intellectual Property Office [SS 13-A-13]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Soft Science Project; Specialized Research Fund for the Doctoral Program of Higher Education Project; Soft Science Project of State Intellectual Property Office,"Supported by the National Natural Science Foundation of China (71472057,71273073,71073041,70872024), the National Soft Science Project (2012GXS4D080), the Specialized Research Fund for the Doctoral Program of Higher Education Project (20122304110026) and the Soft Science Project of State Intellectual Property Office (SS 13-A-13)",,33,1,1,1,14,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,241,249,,,,,,9,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600033,0
C,"Bi, X; Chen, ZY; Li, L",,"Qi, E; Shen, J; Dou, R",,"Bi, Xing; Chen, Zhiyuan; Li, Lei",,,A New Algorithm for the Risk of Project Time Based on Monte Carlo Simulation,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Completion time; crystal ball; Monte Carlo Simulation; minimum crucial path; risk management,,"The risk of project time was analyzed and a new algorithm was proposed based on the previous outcomes and Monte Carlo Simulation. The computing process under the new algorithm was demonstrated combing with an example, which suggested that the new algorithm could reduce the calculated amount effectively and thus provide a reference for the risk management of project completion","[Bi, Xing; Chen, Zhiyuan; Li, Lei] Tianjin Univ, Sch Management, Tianjin 300072, Peoples R China",Tianjin University,"Bi, X (通讯作者)，Tianjin Univ, Sch Management, Tianjin 300072, Peoples R China.",bistar@126.com,,,,,,,15,0,0,0,2,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,463,466,,10.2991/978-94-6239-102-4_93,0.0,,,4,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700093,0
J,"Böhme, MH; Persian, R; Stöhr, T",,,,"Boehme, Marcus H.; Persian, Ruth; Stoehr, Tobias",,,Alone but better off? Adult child migration and health of elderly parents in Moldova,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,International migration; Elderly health,GENDER-DIFFERENCES; TESTS; INSTRUMENTS; OBESITY; IMPACT,"Increasing labor migration and simultaneous aging of societies are two important demographic developments many poor countries face. Elderly people who are left behind may experience a decrease in welfare when their children migrate. This paper investigates the effect of migration on various dimensions of elderly health using unique data from Moldova, which has one of the highest emigration rates in the world. We find positive migration effects on body mass index (BMI), mobility and self-reported health. No effects are found on depression and cognitive capacity. We find evidence that these positive outcomes are linked to an income effect which leads to improvements in diet and identify a reallocation of time use from subsistence farming to leisure and sleep which may have further beneficial effects. These positive effects seem to compensate the elderly for decreasing social contact with their migrant family members. (C) 2014 Elsevier B.V. All rights reserved.","[Boehme, Marcus H.; Stoehr, Tobias] Kiel Inst World Econ, D-24105 Kiel, Germany; [Persian, Ruth] Minist Sante Publ & Lutte Ctr Sida, ODI Fellow, Bujumbura, Burundi",Institut fur Weltwirtschaft an der Universitat Kiel (IFW),"Stöhr, T (通讯作者)，Kiel Inst World Econ, Hindenburgufer 66, D-24105 Kiel, Germany.",tobias.stoehr@ifw-kiel.de,,,EuropeAid project [DCI-MIGR/210/229-604],EuropeAid project,"We thank Rainer Thiele, the editor Andrew Street, and two anonymous referees for valuable comments. All errors remain our own. Financial support from EuropeAid project DCI-MIGR/210/229-604 is acknowledged.",,51,60,66,3,56,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JAN,2015,39.0,,,,,,211,227,,10.1016/j.jhealeco.2014.09.001,0.0,,,17,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CA9TD,25443619.0,Green Submitted,,,2024-03-09,WOS:000349266800015,0
C,"Fang, JC; Ke, C; Chen, H",,"Qi, E; Shen, J; Dou, R",,"Fang, Jin-cheng; Ke, Chang; Chen, Hua",,,Optimization of Supply Chain Network with Grey Uncertainty Demand by Improved Artificial Fish Swarm Algorithm,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Equal weight whitenization; grey uncertainty demand; improved artificial fish swarm algorithm; supply chain network optimization,,"This paper analyzed supply chain network optimization problem with the grey uncertainty of customer demand information, and established its mathematical models by grey system method. Then, an improved artificial fish swarm algorithm was put forward to solve the models based on binary encoding. Finally, the paper testified the effectiveness of the models and algorithm by using dynamic particle swarm optimization algorithm to solve the same calculation examples.","[Fang, Jin-cheng; Ke, Chang] Fujian Univ Technol, Dept Transportat, Fuzhou, Peoples R China; [Chen, Hua] Gulou Dist Party Comm Org Dept, Fuzhou, Peoples R China",Fujian University of Technology,"Fang, JC (通讯作者)，Fujian Univ Technol, Dept Transportat, Fuzhou, Peoples R China.",fjcba@139.com,,,,,,,10,0,0,1,5,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,79,83,,10.2991/978-94-6239-102-4_17,0.0,,,5,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700017,0
C,"Garg, A",,"Pham, TML; Soukup, J; Phan, D; Phung, MT",,"Garg, Anshul",,,"Influence of Mechanic, Humanic and Functional Clues on Customers' Dining Experience in Fine Dining Restaurants",PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON FINANCE AND ECONOMICS 2015,,,English,Proceedings Paper,2nd International Conference on Finance and Economics (ICFE),"JUN 04-06, 2015","Ton Duc Thang Univ, Ho Chi Minh City, VIETNAM","Corvinus Univ Budapest,Taylors Univ,Nanhua Univ,Univ Econ,Asian Inst Technol,Vysoka Skola Ekonomicka",Ton Duc Thang Univ,Mechanic Clues; Humanic Clues; Functional Clues; Dining Experience,SERVICE ENCOUNTERS; PHYSICAL SURROUNDINGS; SATISFACTION; QUALITY; MODEL; UTILITARIAN; ENVIRONMENT; PERCEPTION; BEHAVIOR,"There was a time when individuals used to buy services on the basis of quality only. Today, the time has changed and now the customers wish to experience an overall service delivery including the physical environment, employee behavior and food quality. Quality dining experience is an important factor for both the customers as well as the restaurants. Studies in the past have discussed that how food quality, physical environment, employee behavior and service carry out important effect on customers' dining experience. Thus the concept of customers' experiential value will be the key in restaurant service-quality studies. This paper throws light on how food and service quality, physical environment and employee behavior impacts on customers' dining experience. The objective of this study is to investigate the combined effects of mechanic, functional, and humanic clues on customer's dining experience in fine dining restaurants in Malaysian hospitality industry. Consequently, this leads to a quantitative research which examines the combined effects of the physical environment (Mechanic clues), behavior of employees (Humanic clues) and the quality of the food (Functional clues).","[Garg, Anshul] Taylors Univ, Subang Jaya, Malaysia",Taylor's University,"Garg, A (通讯作者)，Taylors Univ, Subang Jaya, Malaysia.",Anshul.garg@taylors.edu.my,"Garg, Anshul/I-8862-2019","Garg, Anshul/0000-0001-8297-9256",,,,,68,0,0,1,9,TON DUC THANG UNIV,HO CHI MINH CITY,"98 NGO TAT TO STR, WARD 129, HO CHI MINH CITY, 00000, VIETNAM",,,978-80-87990-04-9,,,,2015,,,,,,,695,712,,,,,,18,"Business; Business, Finance; Economics; Hospitality, Leisure, Sport & Tourism",Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Social Sciences - Other Topics,BF6YZ,,,,,2024-03-09,WOS:000383851900050,0
C,"Habova, M; Pospisilova, L",,"Polak, O; Cerkal, R; Belcredi, NB",,"Habova, Magdalena; Pospisilova, Lubica",,,EFFECT OF SOIL CONDITIONERS APPLICATION ON NUTRIENTS AND HUMIC SUBSTANCES CONTENT IN POT EXPERIMENTS,MENDELNET 2015,,,English,Proceedings Paper,22nd International PhD Students Conference,"NOV 11-12, 2015","Mendel Univ, Fac Agron, Brno, CZECH REPUBLIC",,"Mendel Univ, Fac Agron",nutrients; soil conditioners; humic substances,,"The aim of our work was to study the effect of selected soil conditioners on nutrients and humic substances content in pot experiments (Phytotron CLF PlantMaster, Wertingen, Germany). Object of our study was Haplic Cambisol reached from locality Vatin (Czech Republic). For pot experiments we used 835 g of soil and 50 g of each conditioners (biochar, digestate, lignite, compost), except lignohumate. Lignohumate was applied in dose 5 g and 835 g of soil, because of high content of soluble salts. As tested plant we chose lettuce (Lactuca sativa). Nutrients content was determined by Mehlich III. Humic substances fractionation was made by Kononova and Belchikova method. All studied conditioners mainly effected total carbon content in soil. Application of lignohumate had the highest effect on nutrients content and fractional composition of humus.","[Habova, Magdalena; Pospisilova, Lubica] Mendel Univ Brno, Dept Agrochem Soil Sci Microbiol & Plant Nutr, Brno 61300, Czech Republic",Mendel University in Brno,"Habova, M (通讯作者)，Mendel Univ Brno, Dept Agrochem Soil Sci Microbiol & Plant Nutr, Zemedelska 1, Brno 61300, Czech Republic.",xhabova1@node.mendelu.cz,"Hábová, Magdalena/N-9002-2019; Pospisilova, Lubica/G-7090-2017","Hábová, Magdalena/0000-0001-8071-9944; Pospisilova, Lubica/0000-0001-7883-9138",,,,,13,0,0,0,10,"MENDEL UNIV BRNO, FAC AGRONOMY",BRNO,"ZEMEDELSKA 1665-1, BRNO, 613 00, CZECH REPUBLIC",,,978-80-7509-363-9,,,,2015,,,,,,,223,227,,,,,,5,"Agriculture, Dairy & Animal Science; Agricultural Economics & Policy; Agronomy",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BE0NZ,,,,,2024-03-09,WOS:000366466100042,0
C,"Huang, Y; Yang, ND",,"Lan, H",,Huang Yue; Yang Nai-ding,,,"A Study on Relationship among Firm Size, Managerial Discretion and R&D Investment","2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,firm size; listed companies; managerial discretion; R&D investment,EXECUTIVE-COMPENSATION; COMPETITION; INNOVATION; KNOWLEDGE,"Using the data gathered from China's public trading companies, we study the relationship between firm size and R&D with managerial discretion as the mediating variable. In particular, we propose to measure managerial discretion with three indicators: leadership power, resource operation and manager character and construct a relational model between firm size and R&D investment with managerial discretion as the mediating variable. Data from 399 public-trading companies of China are collected as samples to validate the model. Our regression analysis on such data leads to the following findings: in the context of high supervision intensity, because of the weak influence of managerial discretion towards R&D investment, the impact of firm size towards R&D investment, which is mediated through managerial discretion, is also weakened. This leads to the negative correlation between firm size and R&D investment; on the other hand, in the context of low supervision intensity, the influence of managerial discretion towards R&D investment is significantly negative, and the correlation between firm size and R&D investment is strongly positive. Our results suggest that firm size could influence R&D investment through managerial discretion or some other intermediate variables.","[Huang Yue; Yang Nai-ding] Northwestern Polytech Univ, Sch Management, Xian 710072, Peoples R China",Northwestern Polytechnical University,"Huang, Y (通讯作者)，Northwestern Polytech Univ, Sch Management, Xian 710072, Peoples R China.",,,,,,,,34,0,0,0,6,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,706,715,,,,,,10,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600094,0
J,"Hutchens, R",,,,"Hutchens, Robert",,,"Symmetric measures of segregation, segregation curves, and Blackwell's criterion",MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,,"This paper first proposes a new way to use segregation curves to examine whether one distribution of people across groups (e.g., occupations or neighborhoods) is more segregated than another. It then uses Blackwell's criterion to extend the argument to more than two types of people. The basic idea is that by introducing additional assumptions about the nature of segregation, one obtains a more complete ranking of distributions. The paper demonstrates that the assumption of symmetry in types an assumption that appears frequently in the literature on segregation measurement has implications for both segregation curves and Blackwell's criterion. (C) 2014 Elsevier B.V. All rights reserved.","Cornell Univ, Ithaca, NY 14853 USA",Cornell University,"Hutchens, R (通讯作者)，Cornell Univ, Ithaca, NY 14853 USA.",rmh2@cornell.edu,,,,,,,14,4,6,0,6,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,JAN,2015,73.0,,,,,,63,68,,10.1016/j.mathsocsci.2014.11.007,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,AZ5KR,,,,,2024-03-09,WOS:000348260500009,0
J,"Karaca-Mandic, P; Abraham, JM; Simon, K",,,,"Karaca-Mandic, Pinar; Abraham, Jean M.; Simon, Kosali",,,IS THE MEDICAL LOSS RATIO A GOOD TARGET MEASURE FOR REGULATION IN THE INDIVIDUAL MARKET FOR HEALTH INSURANCE?,HEALTH ECONOMICS,,,English,Article,,,,,,medical loss ratio; health insurance; individual market,COMPETITION; BEHAVIOR; ENTRY,"Effective January 1, 2011, individual market health insurers must meet a minimum medical loss ratio (MLR) of 80%. This law aims to encourage productive' forms of competition by increasing the proportion of premium dollars spent on clinical benefits. To date, very little is known about the performance of firms in the individual health insurance market, including how MLRs are related to insurer and market characteristics. The MLR comprises one component of the price-cost margin, a traditional gauge of market power; the other component is percent of premiums spent on administrative expenses. We use data from the National Association of Insurance Commissioners (2001-2009) to evaluate whether the MLR is a good target measure for regulation by comparing the two components of the price-cost margin between markets that are more competitive versus those that are not, accounting for firm and market characteristics. We find that insurers with monopoly power have lower MLRs. Moreover, we find no evidence suggesting that insurers' administrative expenses are lower in more concentrated insurance markets. Thus, our results are largely consistent with the interpretation that the MLR could serve as a target measure of market power in regulating the individual market for health insurance but with notable limited ability to capture product and firm heterogeneity. Copyright (c) 2013 John Wiley & Sons, Ltd.","[Karaca-Mandic, Pinar; Abraham, Jean M.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Simon, Kosali] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA",University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington,"Karaca-Mandic, P (通讯作者)，Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.",pkmandic@umn.edu,,"simon, kosali/0000-0002-3231-1466",,,,,24,18,20,0,8,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JAN,2015,24.0,1.0,,,,,55,74,,10.1002/hec.3002,0.0,,,20,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,AW1XJ,24123608.0,Bronze,,,2024-03-09,WOS:000346081700005,0
C,"Pan, L; Zhou, SY",,"Lan, H",,Pan Lin; Zhou Shui-yin,,,A Conceptual Framework for Product-Process Matrix: A Supply Chain Perspective,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,conceptual mode; case study; product-process matrix; supply chain management,COLLABORATION; PERFORMANCE; INTEGRATION; LOGISTICS; EVOLUTION; DESIGN; RISKS; CHINA,"The paper integrates insights from previous research on operation management and supply chain management into generalization and extension of the product-process matrix. We propose a conceptual model on product-process matrix from a supply chain perspective, and to discuss the impact of collaboration with supply chain partners on product-process matrix. From an operational viewpoint, the model proposes that process (included new product development, production and delivery) flexibility should be aligned with the level of product customization. Meanwhile, from a collaborative strategy viewpoint, this model indicates that collaboration with supply chain partners exert a positive impact on matching of process and product on operational level. At last, a single case study by conducting in-depth surveys and interviews in one company is employed to verify and adjust the conceptual mode.","[Pan Lin; Zhou Shui-yin] Huazhong Univ Sci & Technol, Sch Management, Wuhan 430074, Peoples R China",Huazhong University of Science & Technology,"Pan, L (通讯作者)，Huazhong Univ Sci & Technol, Sch Management, Wuhan 430074, Peoples R China.",,,,,,,,47,0,0,0,6,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,441,453,,,,,,13,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600060,0
C,"Sun, YZ; Xi, B; Li, QJ",,"Lan, H",,Sun Yu-ze; Xi Bao; Li Qing-jun,,,Study on Transformation of Development Zones in China in Public Governance: General Analysis in the Perspective of Schema,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,development zones in China; transformation; government public governance; rental incentive; reciprocity,,"Transformation of development zones in China in public governance performance determines the strategic upgrade of China's open economy. This paper assumes that the system of public governance has efficient allocation of public resources desirability. Namely, there is an interaction of rental incentive and space polarization effect among public administration, industrial upgrading, land-intensive and environmental protection, constructing three in one mathematical equilibrium models. Mathematical analysis reveals that government tax and corporate profit have integration, continuity and reciprocity of institutional incentives. Shanghai FTA experience has shown that the interaction between rent incentive and spatial polarization effect, is based on an open economic system with continuous innovation, and is kept in line with the liberalization of international trade rules. The policy implication is that the transition of development zones in China should move in direction of free trade areas to achieve its institutional evolution.","[Sun Yu-ze] Peoples Govt Heilongjiang Prov, Gen Off, Harbin 150001, Peoples R China; [Sun Yu-ze] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China; [Xi Bao] Dalian Univ Technol, Fac Humanities & Social Sci, Dalian 116024, Peoples R China; [Li Qing-jun] Heilongjiang Prov Peoples Govt, Res Lab, Harbin 150001, Peoples R China",Harbin Institute of Technology; Dalian University of Technology,"Sun, YZ (通讯作者)，Peoples Govt Heilongjiang Prov, Gen Off, Harbin 150001, Peoples R China.",,,,,,,,35,0,0,0,3,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1821,1831,,,,,,11,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600241,0
C,"Tang, MP; Wang, YC; Wang, CJ; Sun, HZ",,"Lan, H",,Tang Man-ping; Wang Yun-chen; Wang Cai-jin; Sun Hai-zhen,,,Performance of Mutual Aid Funds and Proposals to Resource Allocation Based on Sustainable Development Perspective: A Case Study of Jiang'an County,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,financial anti-poverty funds; poverty villages; mutual aid funds; resource allocation; sustainable development perspective,,"At present, mutual aid funds for impoverished villages are a new mechanism and model of utilizing and managing financial poverty alleviation funds and financing development in Chinese rural area. This paper discusses the status of pilot project in Jiang'an County, and evaluates the effectiveness and resource allocation based on integrated questionnaires with interviews. The analyses based on the facets suggest that mutual aid funds for impoverished villages help relieve the financing problems of impoverished peasant households and increase their income. Meanwhile, the paper points out the unsatisfying performances of the practice, which include low efficiency and imperfect management. At the end of the paper, relevant suggestions are put forward to promote long-term development.","[Tang Man-ping; Wang Yun-chen; Sun Hai-zhen] Sichuan Agr Univ, Sch Management, Chengdu 611130, Peoples R China; [Wang Cai-jin] Sichuan Agr Univ, Sch Econ, Chengdu 611130, Peoples R China",Sichuan Agricultural University; Sichuan Agricultural University,"Tang, MP (通讯作者)，Sichuan Agr Univ, Sch Management, Chengdu 611130, Peoples R China.",,"Wang, Minghao/JMD-0670-2023; Zhang, Lijun/JEZ-7925-2023; Wang, Xiaoman/JYP-1144-2024; ZHANG, XUCHEN/KBB-7989-2024",,Humanities & Social Science Research Foundation of the Education Department of Sichuan Provincial [13SD0203]; Annual Discipline Construction Plan Project of Sichuan Agricultural University,Humanities & Social Science Research Foundation of the Education Department of Sichuan Provincial; Annual Discipline Construction Plan Project of Sichuan Agricultural University,"Supported by Humanities & Social Science Research Foundation of the Education Department of Sichuan Provincial (13SD0203), the 2014 Annual Discipline Construction Plan Project of Sichuan Agricultural University",,34,1,1,0,0,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1884,1892,,,,,,9,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600249,0
C,"Tausova, L; Simeckova, J; Detvanova, L",,"Polak, O; Cerkal, R; Belcredi, NB",,"Tausova, Lucie; Simeckova, Jana; Detvanova, Lenka",,,INTERACTION BETWEEN LIMING AND NITROGEN FERTILIZATION ON SEMI-NATURAL GRASSLAND,MENDELNET 2015,,,English,Proceedings Paper,22nd International PhD Students Conference,"NOV 11-12, 2015","Mendel Univ, Fac Agron, Brno, CZECH REPUBLIC",,"Mendel Univ, Fac Agron",grassland; lime; soil reaction; fertilizer; inhibitor,,"The experiment monitors the changes of exchangeable soil reaction (pH) and yields of the semi-natural grassland after using dolomitic limestone and urea (with and without inhibitors). The field experiment was founded on the area of 480 m(2) in Bohemian-Moravian Highlands. These variants were followed: not limed - control (C), not limed + urea (NL + U), not limed + urea with urease inhibitor (NL + UI), not limed + urea with nitrification inhibitor (NL + NI). Likewise there were differentiated variants of nitrogen fertilization, where the liming was done: limed (L), limed + urea (L+ U), limed + urea with urease inhibitor (L+ UI), limed + urea with nitrification inhibitor (L + NI). Liming was done by dolomitic limestone at a dose of 1.8 t.ha(-1). The urea fertilizers were applied at a dose of 100 kg.ha(-1). After the first mowing in June 2014, the data from one year of the experiment were evaluated. The results showed that the interaction between liming and nitrogen fertilization was not statistically significant, maybe average values of pH observed that liming clearly increased the pH values of the soil (L, L+ U, L+ UI, L+ NI). The effect of dolomitic limestone and nitrogen fertilizers was not statistically significant, even in case of the yield of dry forage. It is however clear that all variants with liming had lower yield even than the control variant (C).","[Tausova, Lucie; Simeckova, Jana; Detvanova, Lenka] Mendel Univ Brno, Dept Agrochem Soil Sci Microbiol & Plant Nutr, Brno 61300, Czech Republic",Mendel University in Brno,"Tausova, L (通讯作者)，Mendel Univ Brno, Dept Agrochem Soil Sci Microbiol & Plant Nutr, Zemedelska 1, Brno 61300, Czech Republic.",lucie.marsalkova@mendelu.cz,"Šimečková, Jana/L-1396-2018","Šimečková, Jana/0000-0002-7493-7141",,,,,6,0,0,0,0,"MENDEL UNIV BRNO, FAC AGRONOMY",BRNO,"ZEMEDELSKA 1, BRNO, 613 00, CZECH REPUBLIC",,,978-80-7509-363-9,,,,2015,,,,,,,284,287,,,,,,4,"Agriculture, Dairy & Animal Science; Agricultural Economics & Policy; Agronomy",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BE0NZ,,,,,2024-03-09,WOS:000366466100053,0
C,"Le, TMH",,"Pham, TML; Soukup, J; Phan, D; Phung, MT",,Thi My Hanh Le,,,Evidence on the Determinants of Firm Characteristics and Inventory Accounting Policy Choice: An Empirical Study in Vietnam,PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON FINANCE AND ECONOMICS 2015,,,English,Proceedings Paper,2nd International Conference on Finance and Economics (ICFE),"JUN 04-06, 2015","Ton Duc Thang Univ, Ho Chi Minh City, VIETNAM","Corvinus Univ Budapest,Taylors Univ,Nanhua Univ,Univ Econ,Asian Inst Technol,Vysoka Skola Ekonomicka",Ton Duc Thang Univ,"Inventory Accounting Policy; FIFO (First In, First Out) Method; LIFO (Last in, First Out) method; Weighted Average Method; Specific Identification Method; Determinants; Vietnam",,"This study aims at exploring what firm characteristics influence on the intention or choice of inventory accounting methods of the listed companies on Vietnamese stock market. With an experimental study, the results give evidence that determinants such as firm size, percentage of Board of Director outside the Board of Management and chief accountant inside the Board of Management influenced the choice of inventory accounting methods of the listed companies in Vietnam. The findings show that the choice of inventory accounting methods of industries can be distributed based on specific industry. The weighted average method is often used in industries as minerals, plastic-packaging, and food while the FIFO approach is preferable in telecommunications, service-tourism, and transport-ports-taxi. The specific identification method was used in commerce.","[Thi My Hanh Le] Ton Duc Thang Univ, Fac Accounting, Ho Chi Minh City, Vietnam",Ton Duc Thang University,"Le, TMH (通讯作者)，Ton Duc Thang Univ, Fac Accounting, Ho Chi Minh City, Vietnam.",lethimyhanh@tdt.edu.vn,"LE, HANH THI MY/D-6544-2019","LE, HANH THI MY/0000-0003-0834-488X",,,,,14,0,0,0,2,TON DUC THANG UNIV,HO CHI MINH CITY,"98 NGO TAT TO STR, WARD 129, HO CHI MINH CITY, 00000, VIETNAM",,,978-80-87990-04-9,,,,2015,,,,,,,88,104,,,,,,17,"Business; Business, Finance; Economics; Hospitality, Leisure, Sport & Tourism",Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Social Sciences - Other Topics,BF6YZ,,,,,2024-03-09,WOS:000383851900006,0
C,"Tian, L; Liu, C; Huangfu, YT; Zhao, LY",,"Lan, H",,Tian Lan; Liu Cheng; Huangfu Yu-ting; Zhao Ling-yun,,,A Study on Effects of Heterogeneous Information on Corporate Credit Risk,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,credit risk; heterogeneous information; default probability; TRARCH model,RETURN VOLATILITY; TRADING VOLUME; JUMP RISK; MARKETS; MODELS; EQUITY,"This paper adds three factors, which reflect the extraordinary fluctuation, to original KMV model, including volatility clustering effect, leverage effect, and jump behavior in asset price; and builds a default probability measurement model considering the impact of heterogeneous information. The numerical simulation results show that: 1) compared to the classic KMV model, corporate default probability generated by the new model is greater; 2) both the shock strength of heterogeneous information and jump intensity of asset price are positively related to the corporate default probability. We take market factors into corporate credit risk assessment according to the principle of prudence; could comprehensive estimate corporate credit status, objectively measuring corporate credit risk, reduce the risk of creditors.","[Tian Lan; Zhao Ling-yun] Hebei Univ Econ & Business, Sch Finance, Shijiazhuang 050061, Peoples R China; [Tian Lan; Liu Cheng; Huangfu Yu-ting] Univ Sci & Technol Beijing, Dongling Sch Econ & Management, Beijing 100083, Peoples R China",Hebei University of Economics & Business; University of Science & Technology Beijing,"Tian, L (通讯作者)，Hebei Univ Econ & Business, Sch Finance, Shijiazhuang 050061, Peoples R China.",,,,,,,,35,0,0,0,1,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1411,1416,,,,,,6,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600190,0
C,"Valova, M; Komprda, T; Rozikova, V; Skultety, O; Trckova, M; Gopfert, E; Lorencova, A; Leva, L; Faldyna, M",,"Polak, O; Cerkal, R; Belcredi, NB",,"Valova, Marketa; Komprda, Tomas; Rozikova, Veronika; Skultety, Ondrej; Trckova, Martina; Gopfert, Eduard; Lorencova, Alena; Leva, Lenka; Faldyna, Martin",,,BIOCHEMICAL PARAMETERS OF BLOOD PLASMA AND FEED CONVERSION RATE DEPENDING ON THE DIET IN THE MODEL ORGANISM,MENDELNET 2015,,,English,Proceedings Paper,22nd International PhD Students Conference,"NOV 11-12, 2015","Mendel Univ, Fac Agron, Brno, CZECH REPUBLIC",,"Mendel Univ, Fac Agron",polyunsaturated fatty acids; feed conversion rate; HDL-cholesterol; LDL-cholesterol; alaninaminotransferase; aspartateamino transferase; alkaline phosphatase; urea; fish oil; palm oil,,"The aim of the present study was to determine the effect of diet enriched with 2.5% fish oil (polyunsaturated fatty acids source) resp. 2.5% palm oil (saturated fatty acids source) during the feeding experiment to the overall health status of the model organism (Sus scrofa f. domestica). Biochemical indicators of blood (alanineaminotransferase, aspartateaminotransferase, alkaline phosphatase, urea, total cholesterol, HDL-fraction and LDL-fraction) and feed conversion rate were analyzed to determine the overall health status of the experimental animal. Diet enriched with 2.5% fish oil significantly decreased (P<0.05) aspartateaminotransferase and alkaline phosphatase, but there was no change (P>0.05) in alanineaminotransferase. Diet enriched with 2.5% palm oil significantly decreased (P<0.05) aspartateaminotransferase, alkaline phosphatase and also alanineaminotransferase. Both diets decreased (P<0.05) level of total cholesterol, although we expected a reduction only in the diet enriched with fish oil and increasing in the diet enriched with palm oil. The level of HDL-fraction was increased (P<0.05) in the diet enriched with palm oil, but not in the diet enriched with fish oil (P>0.05). The level of LDL-fraction was decreased (P<0.05) in both diets, which was expected in the diet enriched with fish oil, but not with palm oil. The level of urea was decreased (P<0.05) in both diets. The effect of diet enriched with 2.5% fish resp. palm oil to the feed consumption, body weight gains and feed conversion rate was tested - there were not significant differences (P>0.05) between two experimental diets. These are only preliminary results obtained during the experiment, which are so far unclear and ambiguous, therefore further research is needed in this area.","[Valova, Marketa; Komprda, Tomas; Rozikova, Veronika] Mendel Univ Brno, Dept Food Technol, Brno 61300, Czech Republic; [Skultety, Ondrej] Mendel Univ Brno, Dept Morphol Physiol & Anim Genet, Brno 61300, Czech Republic; [Trckova, Martina; Gopfert, Eduard; Lorencova, Alena; Leva, Lenka; Faldyna, Martin] Vet Res Inst, Brno 62100, Czech Republic",Mendel University in Brno; Mendel University in Brno; Czech Veterinary Research Institute,"Valova, M (通讯作者)，Mendel Univ Brno, Dept Food Technol, Zemedelska 1, Brno 61300, Czech Republic.",marketa.valova@mendelu.cz,"Lorencova, Alena/E-2693-2019; Faldyna, Martin/H-9692-2017; Švehlová, Veronika Marie/O-3234-2018; Komprda, Tomas/N-2516-2018","Komprda, Tomas/0000-0002-2547-2368",,,,,7,1,1,0,3,"MENDEL UNIV BRNO, FAC AGRONOMY",BRNO,"ZEMEDELSKA 1, BRNO, 613 00, CZECH REPUBLIC",,,978-80-7509-363-9,,,,2015,,,,,,,389,393,,,,,,5,"Agriculture, Dairy & Animal Science; Agricultural Economics & Policy; Agronomy",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BE0NZ,,,,,2024-03-09,WOS:000366466100071,0
C,"Wang, LC; Wang, YF",,"Lan, H",,Wang Liang-cheng; Wang Yu-fang,,,"Empirical Research on Political Connections, CEO Turnover and Market Reaction","2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,CEO turnover; political connections; participation class; ruling class; stock price effects,MANAGEMENT CHANGES; WEALTH; FIRMS; CHINA; PERFORMANCE; DEPARTURES; SUCCESSION,"this paper analyzes the market reaction to political associated CEOs' turnover, using CEOs turnover data of Chinese private listing Corporation from 2007 to 2012 as a sample. This paper uses the event study method to test whether the political association background of the outgoing CEO and succession CEO has a significant stock price effect, and uses the empirical equation model to control related variables' endophytism. The results show that: the stock price effect of political association background of outgoing and succession CEO has internal consistency. The political connection background of outgoing CEO has a positive stock price effect, and participation class is more significant; the political connection background of successor has significantly negative effect on stock price, meanwhile, participation class is significantly stronger.","[Wang Liang-cheng; Wang Yu-fang] Sichuan Univ, Coll Business Adm, Chengdu 610021, Peoples R China",Sichuan University,"Wang, LC (通讯作者)，Sichuan Univ, Coll Business Adm, Chengdu 610021, Peoples R China.",,,,,,,,30,0,0,1,6,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1378,1388,,,,,,11,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600186,0
C,"Wang, R; Li, XF; Zhao, S",,"Lan, H",,Wang Rui; Li Xi-feng; Zhao Shuang,,,Research on a Multi-objective Vehicle Routing Problem with Multiple Fuzzy Times Windows,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,driver satisfaction; HMOPSO; multiple fuzzy time windows; VRPMFTW,PARTICLE SWARM OPTIMIZATION; STOCHASTIC TRAVEL-TIMES; ORIENTEERING PROBLEM; ALGORITHM,"Vehicle routing problem considers not only the minimization of the total travel distance, but also apposite satisfaction level, which includes customers' satisfaction level and drivers' satisfaction level. The VRP tackled in this paper assumes the customer has mtiltiple fuzzy time windows, which has different priority levels between them. It also presents a hybrid multi -objectives particle swarm optimization algorithm to tackle the proposed model. Basing on the Solomon VRPTW benchmark problem instances, this paper carries out the experiments, and the results show that the consideration of satisfaction level can reduce the total travel distance with a guarantee of certain satisfaction level. What more, the consideration of driver satisfaction level will lead a small increase of travel distance and a small decrease of satisfaction level, and together with that are better employee loyalty and a harmonious employment relationship, which is significant to the healthy development of the company.","[Wang Rui; Li Xi-feng; Zhao Shuang] Sichuan Univ, Sch Business, Chengdu 610064, Peoples R China",Sichuan University,"Wang, R (通讯作者)，Sichuan Univ, Sch Business, Chengdu 610064, Peoples R China.",,"huang, libo/JMB-4345-2023; li, rui/JVM-8999-2024; Zhang, Yunyi/JHS-3626-2023; Wang, Yanlin/JGC-6782-2023; zhang, shuai/IVU-7877-2023",,,,,,30,1,1,0,5,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,325,333,,,,,,9,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600045,0
C,"Yang, XY; Li, XY; Liang, J; Peng, C",,"Qi, E; Shen, J; Dou, R",,"Yang, Xiao-yue; Li, Xin-yu; Liang, Jun; Peng, Cheng",,,Bus Scheduling Optimization Based on Improved Strength Pareto,PROCEEDINGS OF THE 21ST INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT 2014,,,English,Proceedings Paper,21st International Conference on Industrial Engineering and Engineering Management 2014 (IEEM),"NOV 01-02, 2014","Zhuhai, PEOPLES R CHINA","CMES, Chinese Ind Engn Inst,Beijing Inst Technol,Tianjin Univ Sci & Technol",,Bus scheduling; bus transit information system; optimization; SPEA2,,"Bus Scheduling Problem involves conflictive objectives for bus agencies and passengers. To obtain solutions from this multi-objective problem, an optimizer SPEA2, was employed to provide a Pareto set of reliable bus schedules. The proposed approach was applied to a specific bus route using historical passenger flow data. The result obtained in this work was compared to the results provided by different optimization strategy in a quoted research, which was to solve a similar model with Immune Artificial Algorithm. Furthermore, the approach to execute real-time control was studied and an online platform was established to publish the bus transit information to improve service quality.","[Yang, Xiao-yue; Li, Xin-yu; Liang, Jun] Huazhong Univ Sci & Technol, Dept Ind & Mfg Syst Engn, Wuhan 430074, Peoples R China; [Peng, Cheng] Tsinghua Univ, Dept Ind Engn, Beijing 100084, Peoples R China",Huazhong University of Science & Technology; Tsinghua University,"Li, XY (通讯作者)，Huazhong Univ Sci & Technol, Dept Ind & Mfg Syst Engn, Wuhan 430074, Peoples R China.",lixinyu@mail.hust.edu.cn,"Li, Lambert LL/F-7146-2015; li, xin/HHS-9461-2022; li, fei/JYP-3334-2024",,,,,,15,0,0,0,3,ATLANTIS PRESS,PARIS,"29 AVENUE LAVMIERE, PARIS, 75019, FRANCE",,,978-94-6239-102-4; 978-94-6239-101-7,,,,2015,,,,,,,307,312,,10.2991/978-94-6239-102-4_64,0.0,,,6,"Economics; Engineering, Industrial; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Engineering; Operations Research & Management Science,BE5UU,,,,,2024-03-09,WOS:000373492700064,0
C,"Zacal, J; Sustr, M; Kumbar, V; Dostal, P; Votava, J; Nedomova, S",,"Polak, O; Cerkal, R; Belcredi, NB",,"Zacal, Jaroslav; Sustr, Michal; Kumbar, Vojtech; Dostal, Petr; Votava, Jiri; Nedomova, Sarka",,,ACOUSTIC EMISSION DURING TESTING INTEGRITY AND PRESSURE RESISTANCE OF JAPANESE QUAIL EGGS,MENDELNET 2015,,,English,Proceedings Paper,22nd International PhD Students Conference,"NOV 11-12, 2015","Mendel Univ, Fac Agron, Brno, CZECH REPUBLIC",,"Mendel Univ, Fac Agron",Quail Egg; Acoustic Emission; Egg Integrity; RMS,,"This paper deals with standard testing of egg shell integrity including breaking the shell with destructive pressure testing and monitoring the acoustic emission (AE) signal in real time. Purpose of this experiment was to verify the suitability of AE recording during the pressure test with continuous force load. Experiment was conducted on 18 samples of Japanese quail (Coturnix japonica) eggs, divided to four categories according to quality. Testing was also conducted on eggs with fractured shell structure. According to terminology coined in National technical standard (CSN EN 1330-9), the acoustic emission means elastic tension waves generated by dynamic release of mechanical tension inside the material structure. AE recordings show low level of impulses. It was found that RMS values are insignificant in the recordings, there is no observable elastic tension wave generated with dynamic tension inside the egg shell in course of force load.","[Zacal, Jaroslav; Sustr, Michal; Kumbar, Vojtech; Dostal, Petr; Votava, Jiri] Mendel Univ Brno, Fac Agron, Dept Technol & Automobile Transport, Brno 61300, Czech Republic; [Nedomova, Sarka] Mendel Univ Brno, Dept Food Technol, Brno 61300, Czech Republic",Mendel University in Brno; Mendel University in Brno,"Zacal, J (通讯作者)，Mendel Univ Brno, Fac Agron, Dept Technol & Automobile Transport, Zemedelska 1, Brno 61300, Czech Republic.",xzacal@mendelu.cz,"Dostál, Petr/JTV-6004-2023; Nedomova, Sarka/I-5753-2018; Šustr, Michal/S-8366-2019; Kumbár, Vojtěch/A-4330-2018; Votava, Jiri/A-7755-2018; Začal, Jaroslav/A-4382-2018; Dostal, Petr/A-4164-2018","Nedomova, Sarka/0000-0001-8840-7849; Šustr, Michal/0000-0002-3410-6888; Kumbár, Vojtěch/0000-0003-3987-4613; Votava, Jiri/0000-0003-3304-9516; Dostal, Petr/0000-0001-7489-3591",,,,,6,0,0,0,2,"MENDEL UNIV BRNO, FAC AGRONOMY",BRNO,"ZEMEDELSKA 1, BRNO, 613 00, CZECH REPUBLIC",,,978-80-7509-363-9,,,,2015,,,,,,,573,577,,,,,,5,"Agriculture, Dairy & Animal Science; Agricultural Economics & Policy; Agronomy",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BE0NZ,,,,,2024-03-09,WOS:000366466100108,0
C,"Zhang, F; Zhao, J; Zou, P; Yu, B",,"Lan, H",,Zhang Feng; Zhao Jian; Zou Peng; Yu Bo,,,The Impact of Free Experience on Consumers' Purchasing-A Study Based on the Reciprocity Theory,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,free experience; prospect theory; purchasing behavior; reciprocity theory,TRUST; COOPERATION; MOTIVATION; GRATITUDE; COGNITION; BEHAVIOR; EMOTION,"Product experience refers to a marketing tool to stimulate consumer purchase, which makes consumer cognize the quality and characteristics of goods by watching, listening, and tasting. The current studies only focus on the goods that consumers experience but ignore the interaction between the sellers and consumers during the process of free experience. This study attempts to design the new products experiences based on reciprocity theory and prospect theory. The authors examine the impact of gifts on purchase of customer in a longitudinal field experiment In the first study, we set two groups, one of which receive free experience and the other group does not, and observe the change in their purchasing. The result shows that the participants who received free products for experience purchased significantly more than those who did not. In the second study, we manipulated several factors within the gift treatment: the sequence of gift value, which improved, or worsened. A highly detrimental effect of decreasing value occurred on total purchase volume. The contribution of our study is integrating mental factor into economic benefit in product experience and customer relationship management, on the other hand, supporting Reciprocity and Prospective theory by the evidence from real business world. Management advices are proposed in order to enrich marketing theory and tools and improve the efficiency and effectiveness of marketing.","[Zhang Feng; Zhao Jian; Zou Peng; Yu Bo] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China",Harbin Institute of Technology,"Zhang, F (通讯作者)，Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China.",,"Zou, Peng/JSL-5360-2023","Zou, Peng/0009-0002-4074-0102",,,,,43,0,0,0,3,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,733,739,,,,,,7,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600097,0
C,"Zhang, SJ; Shao, LG; Wang, GS",,"Lan, H",,Zhang Shi-jing; Shao Liu-guo; Wang Guo-shun,,,Housing Price Ripple Effect Caused by Monetary Policy: A Regional Heterogeneity Perspective,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,GVAR; monetary policy; regional heterogeneity; ripple effect,EURO AREA; DIFFUSION,"This paper theoretically analyzes and empirically studies the ripple effect of regional house price caused by monetary policy using the quarterly data of 35 large and medium cities in China over a period from 2001Q1-2014Q3 from a regional heterogeneity perspective based on GVAR model. Our empirical results show that house prices heterogeneously respond to the shock from common monetary policy among regions. With time goes by, the heterogeneity will gradually converge and generate the ripple effect of house prices among regions. Ripple effect caused by interest rate is more apparent than that caused by M2. On long terms, the ripple effect caused by monetary policy is weak, the heterogeneity how regional house prices response to shock from common monetary policy still exists. Keywords: GVAR, monetary policy, regional heterogeneity, ripple effect","[Zhang Shi-jing; Shao Liu-guo] Cent S Univ, Sch Business, Changsha 410083, Hunan, Peoples R China; [Wang Guo-shun] Beijing Technol & Business Univ, Sch Business, Beijing 100037, Peoples R China",Central South University; Beijing Technology & Business University,"Zhang, SJ (通讯作者)，Cent S Univ, Sch Business, Changsha 410083, Hunan, Peoples R China.",,,,Soft Science Research Project of Hunan Province of China [2012ZK3166]; Philosophy and Social Science Funds of Hunan Province of China [08YBB041],Soft Science Research Project of Hunan Province of China; Philosophy and Social Science Funds of Hunan Province of China,"Supported by the Soft Science Research Project of Hunan Province of China (2012ZK3166), Philosophy and Social Science Funds of Hunan Province of China (08YBB041)",,31,0,0,1,11,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1660,1668,,,,,,9,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600221,0
C,"Zhou, Y; Guo, CC; Qiu, L; Zhao, CQ",,"Lan, H",,Zhou Yan; Guo Cai-cai; Qiu Ling; Zhao Chun-qi,,,Research on Free-riding Behavior under Different Punishment Conditions,"2015 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING - 22ND ANNUAL CONFERENCE PROCEEDINGS, VOLS I AND II",International Conference on Management Science and Engineering-Annual Conference Proceedings,,English,Proceedings Paper,22nd International Conference on Management Science and Engineering,"OCT 19-22, 2015","Dubai, U ARAB EMIRATES","Dubai Int Acad City,Sch Management, Harbin Inst Technol,IEEE Technol Management Council,Natl Nat Sci Fdn China,Harbin Inst Technol",,free-riding behavior; punishment conditions; group decision-making; control mechanisms,PUBLIC-GOODS EXPERIMENTS; VOLUNTARY CONTRIBUTION EXPERIMENTS; COOPERATION; HETEROGENEITY; PROVISION; MECHANISM; GAME,"In recent years, free-riding behavior is an urgent problem which has caused a heated debate. The existence of the free-riding behavior will reduce the efficiency of the group and loss the benefits. The different punishment mechanisms are introduced to this paper. The control mechanism of free-riding behavior is analyzed by different punishment levels and punishment decision-making mechanisms. First, we use z-treesoftware to collect experimental data. Second, we use the nonparametric test and the regression analysis to test the experimental results. Third, through the analysis of the degree of punishment and the method of group decision-making, we get the optimal mechanism to control free-riding behavior. We find that our results can be applicable to control free-riding behavior in reality. We can control free-riding behavior by three methods. First, the free-riding behavior can be reduced by the increasing of the punishment. Second, the free-riding behavior can be reduced by the collective decision-making. Third, we can combine the two methods to reduce free-riding behavior.","[Zhou Yan; Guo Cai-cai; Qiu Ling; Zhao Chun-qi] Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China",Harbin Institute of Technology,"Zhou, Y (通讯作者)，Harbin Inst Technol, Sch Management, Harbin 150001, Peoples R China.",,,,National Natural Science Foundation of China [71203046],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),Supported by the National Natural Science Foundation of China(71203046),,30,0,0,3,8,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2155-1847,,978-1-4673-6512-3,INT C MANAGE SCI ENG,,,2015,,,,,,,1715,+,,,,,,4,"Business, Finance; Economics; Management; Operations Research & Management Science",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Operations Research & Management Science,BH1BL,,,,,2024-03-09,WOS:000397545600228,0
J,"Beyhaghi, H; Reeve, BB; Rodgers, JE; Stearns, SC",,,,"Beyhaghi, Hadi; Reeve, Bryce B.; Rodgers, Jo E.; Stearns, Sally C.",,,Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants,VALUE IN HEALTH,,,English,Article,,,,,,causal indicator; effect indicator; factorial validity; medication adherence; reliability,SELF-REPORTED MEASURE; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALIDITY; NONADHERENCE; HOSPITALIZATION; RELIABILITY; VALIDATION,"Objectives: To evaluate the reliability and factorial validity of the four item Morisky Green Levine Medication Adherence Scale (MGLS) among Atherosclerosis Risk in Communities (ARIC) Study participants. Methods: We used the cross-sectional visit 5 data from the ARIC Study to assess the measurement properties of the MGLS. We measured the internal consistency using Cronbach a (where a > 0.70 is considered reliable for group-level measurement), the response frequency, and the inter item correlation. Factor analysis of the MGLS and five other adherence items in the survey was conducted using a polychoric correlation matrix to examine the dimensionality that underlies the MGLS. A vanishing tetrad test was conducted to assess conformity with an effect indicator model. Results: Among the ARIC visit 5 participants, 6,261 (96%) responded to the MGLS and other questions related to medication adherence in the survey (mean age 76 5 years, 59% women). The Cronbach a for the MGLS was 0.47. The inter-item correlations ranged from 0.11 to 0.26. In the factor analysis of the medication adherence survey questions, a three-factor solution was used. One factor captured the extent of nonadherence, whereas other factors focused on the reasons for nonadherence. The MGLS items spread out across the factors that reflect the extent of as well as the reasons for nonadherence. The results of the vanishing tetrad test indicated that the MGLS consists of items other than effect indicators (P < 0.0001). Conclusions: The low reliability together with the factor analysis findings imply that the MGLS may reflect causes as well as the extent of medication adherence. The findings suggest that the MGLS, as presently used, lacks consistency in an elderly population.","[Beyhaghi, Hadi; Reeve, Bryce B.; Stearns, Sally C.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, 1101 McGavran Greenberg Hall,CB 7411, Chapel Hill, NC 27599 USA; [Reeve, Bryce B.; Stearns, Sally C.] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, 1101 McGavran Greenberg Hall,CB 7411, Chapel Hill, NC 27599 USA; [Rodgers, Jo E.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, 1101 McGavran Greenberg Hall,CB 7411, Chapel Hill, NC 27599 USA",University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill,"Beyhaghi, H (通讯作者)，Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, 1101 McGavran Greenberg Hall,CB 7411, Chapel Hill, NC 27599 USA.",beyhaghi@live.unc.edu,"Reeve, Bryce/AAE-7657-2019","Rodgers, Jo/0000-0001-6016-0469; Beyhaghi, Hadi/0000-0003-2862-9663","National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN26820-1100012C]","National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))","The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by contracts of the National Heart, Lung, and Blood Institute (grant nos. HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C HHSN268201100010C, HHSN268201100011C, and HHSN26820-1100012C).",,37,35,42,0,5,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2016,19.0,8.0,,,,,996,1001,,10.1016/j.jval.2016.07.001,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO1HD,27987650.0,"Green Accepted, Green Submitted",,,2024-03-09,WOS:000396448300012,0
J,"Moysan, G; Senouci, M",,,,"Moysan, Gwenael; Senouci, Mehdi",,,A note on 2-input neoclassical production functions,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Production function; Elasticity of substitution; Capital share; Labor share; Solow model,SUBSTITUTION; ELASTICITY; GROWTH,"In this short note, we show how the space of elasticity of substitution functions maps into the space of 2-input neoclassical production functions. In doing so, we derive a general analytical formula for every 2-input neoclassical production function of class l(2). We present a simple set of sufficient conditions for the Inada conditions to hold; and prove that the Solow model under capital-augmenting (or investment specific) technical change is asymptotically balanced if and only if the capital share converges to a non degenerated limit as the capital-labor ratio tends to infinity. (C) 2016 Elsevier B.V. All rights reserved.","[Moysan, Gwenael] Global Market Solut R&D Ctr, 7 Cite Ameublement, F-75011 Paris, France; [Senouci, Mehdi] Univ Paris Saclay, Cent Supelec, Lab Genie Ind, Paris, France",Universite Paris Saclay,"Senouci, M (通讯作者)，Cent Supelec, Off C428, F-92290 Chatenay Malabry, France.",gwenael.moysan@globms.com; mehdi.senouci@centralesupelec.fr,,,,,,,12,2,2,1,7,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,DEC,2016,67.0,,,,,,80,86,,10.1016/j.jmateco.2016.09.011,0.0,,,7,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,EE5CM,,Green Submitted,,,2024-03-09,WOS:000389622300008,0
J,"Abotaleb, A",,,,"Abotaleb, A.",,,COST OF ILLNESS OF ANKYLOSING SPONDYLITIS IN EGYPT FROM PAYER PROSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Abotaleb, A.] Minist Hlth Cairo, Cairo, Egypt",Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY63,A586,A586,,10.1016/j.jval.2016.09.1378,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301481,0
J,"Aissaoui, A; Kaddar, M; Soualmi, R",,,,"Aissaoui, A.; Kaddar, M.; Soualmi, R.",,,MARKET ACCESS OF INNOVATIVE ANTICANCER DRUGS IN ALGERIA: FUNDING BASED ON CLINICAL OR ECONOMIC EVIDENCE?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aissaoui, A.] Univ Paris 09, PSL, Paris, France; [Kaddar, M.; Soualmi, R.] ISPOR Chapter Algeria, Algiers, Algeria",Universite PSL; Universite Paris-Dauphine,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN280,A759,A759,,10.1016/j.jval.2016.09.2356,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302559,0
J,"Arifin, B; Perwitasari, D; Atthobari, J; Cao, Q; Krabbe, PF; Postma, MJ",,,,"Arifin, B.; Perwitasari, D.; Atthobari, J.; Cao, Q.; Krabbe, P. F.; Postma, M. J.",,,"TRANSLATION, ADAPTATION AND VALIDATION OF THE DIABETES DISTRESS SCALE FOR INDONESIAN DIABETIC OUTPATIENTS WITH VARIOUS TYPES OF COMPLICATIONS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Arifin, B.] Univ Groningen Netherlands, Groningen, Netherlands; [Perwitasari, D.] Univ Ahmad Dahlan Yogyakarta, Yogyakarta, Indonesia; [Atthobari, J.] Univ Gadjah Mada, Fac Med, Yogyakarta, Indonesia; [Cao, Q.; Postma, M. J.] Univ Groningen, NL-9700 AB Groningen, Netherlands; [Krabbe, P. F.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands",Universitas Ahmad Dahlan; Gadjah Mada University; University of Groningen; University of Groningen,,,"Arifin, Bustanul/AGN-3880-2022; Krabbe, Paul/AAO-6590-2020; Krabbe, Paul/B-2563-2013; At Thobari, Jarir/GOP-2379-2022","Arifin, Bustanul/0000-0002-2303-310X; Krabbe, Paul/0000-0001-6042-1243; Krabbe, Paul/0000-0001-6042-1243; At Thobari, Jarir/0000-0002-7035-4846; Postma, Maarten/0000-0002-6306-3653",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB36,A900,A901,,10.1016/j.jval.2016.08.205,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,"Green Submitted, hybrid",,,2024-03-09,WOS:000396606303340,0
J,"Bellés-Obrero, C; Jiménez-Martín, S; Vall-Castello, J",,,,"Belles-Obrero, Cristina; Jimenez-Martin, Sergi; Vall-Castello, Judit",,,"BAD TIMES, SLIMMER CHILDREN?",HEALTH ECONOMICS,,,English,Article,,,,,,children's weight disorders; business cycle conditions,HEALTH; RECESSIONS; OBESITY; CONSEQUENCES; FLUCTUATIONS; OVERWEIGHT; MORTALITY; IMPACT,"Although the majority of the literature has confirmed that recessions are beneficial for adults' health and babies' outcomes at delivery, this effect should not necessarily be the same for children. In this paper, we study the effect of business cycle conditions on infant underweight, overweight, and obesity. We exploit eight waves of repeated cross-sectional data (19872012) of the Spanish National Health Survey for children aged 2-15 and use the regional unemployment rate of the trimester of the interview as a proxy for the business cycle phase at the local level. We find that an increase in the unemployment rate is associated with lower obesity incidence, especially for children under 6 years old and over 12 years old. However, economic shocks also proof to have potentially negative consequences as they increase the prevalence of infant underweight for the same age groups. Moreover, we show that the possible mechanisms through which the cycle is impacting infant obesity is the nutritional composition of the children's diet, as well as, increases in the frequency of exercise. We provide some evidence that suggests that the impact of business cycle conditions on infant weight disorders have little objective health consequences in the short run. However, the potential long-term effects may become important as underweight during childhood is associated with worse outcomes later in life. Copyright (C) 2016 John Wiley & Sons, Ltd.","[Belles-Obrero, Cristina; Jimenez-Martin, Sergi] Univ Pompeu Fabra, Dept Econ, Barcelona, Spain; [Jimenez-Martin, Sergi] Barcelona GSE, Barcelona, Spain; [Vall-Castello, Judit] Univ Pompeu Fabra, Ctr Res Econ & Hlth, Barcelona, Spain",Pompeu Fabra University; Barcelona School of Economics; Pompeu Fabra University,"Vall-Castello, J (通讯作者)，Univ Pompeu Fabra, Ctr Res Econ & Hlth, Barcelona, Spain.",judit.vall@upf.edu,"Bellés, Cristina/AAW-6962-2021; Bellés-Obrero, Cristina/AAW-9092-2021; Jimenez-Martin, Sergi/D-6744-2013","Belles-Obrero, Cristina/0000-0002-0629-5546; Jimenez-Martin, Sergi/0000-0002-7393-9612; Vall castello, Judit/0000-0002-1925-1657",[ECO2014-52238-R],,"We gratefully acknowledge the support from project ECO2014-52238-R. We thank Eddy van Doorslaer and the participants of the following seminars and gatherings: 11th World Congress: De Gustibus Disputandum Non Est! Health Economics and Nutrition: an iHEA World Congress, Workshop on consequences of the economic crisis on health and health care system (Madrid), and the Labor, Public and Development internal seminar (UPF). The usual disclaimer applies.",,48,9,9,1,6,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,NOV,2016,25.0,,,2.0,,,93,112,,10.1002/hec.3434,0.0,,,20,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,FP8VJ,27870305.0,Green Submitted,,,2024-03-09,WOS:000417923900007,0
J,"Borowiack, E; Borowiack, M; Garbacka, M; Kedziora, MK; Nowotarska, A; Raczynska, G; Bukowinska, K; Klejman, M",,,,"Borowiack, E.; Borowiack, M.; Garbacka, M.; Kedziora, Kowalska M.; Nowotarska, A.; Raczynska, G.; Bukowinska, K.; Klejman, M.",,,SEVERE ULCERATIVE COLLITIS IN CHILDREN AND ADOLESCENTS IN POLAND -IT'S TIME TO CATCH UP WITH EUROPE. BUDGET IMPACT ANALYSIS (BIA) FOR BIOSIMILAR INFLIXIMAB,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Borowiack, E.; Borowiack, M.; Garbacka, M.; Kedziora, Kowalska M.; Nowotarska, A.; Raczynska, G.] NUEVO HTA CLP, Krakow, Poland; [Bukowinska, K.; Klejman, M.] EGIS Polska LLC, Warsaw, Poland",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY37,A581,A581,,10.1016/j.jval.2016.09.1352,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301455,0
J,"Bouee, S; Laurendeau, C; Rivière, B; Thomas-Delecourt, F",,,,"Bouee, S.; Laurendeau, C.; Riviere, Bura A.; Thomas-Delecourt, F.",,,HEALTHCARE COST OF PATIENTS PRESENTING WITH PERIPHERAL ARTERY DISEASE (PAD): AN ANALYSIS USING A CLAIMS DATABASE IN FRANCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bouee, S.] CEMKA, Bourg La Reine, France; [Laurendeau, C.] Cemka Eval, Bourg La Reine, France; [Riviere, Bura A.] Toulouse Univ Hosp, Toulouse, France; [Thomas-Delecourt, F.] AstraZeneca, Courbevoie, France",Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; AstraZeneca,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV48,A644,A645,,10.1016/j.jval.2016.09.1716,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301804,0
J,"Bratus-Hrynkiv, R; Kordiyak, A",,,,"Bratus-Hrynkiv, R.; Kordiyak, A.",,,CONE BEAM COMPUTED TOMOGRAPHY USE IN OVERDENTURE ABUTMENTS EXAMINATION: RISK BENEFIT ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bratus-Hrynkiv, R.; Kordiyak, A.] Danylo Halytskyi Lviv Natl Med Univ, Lvov, Ukraine",Danylo Halytsky Lviv National Medical University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS13,A563,A564,,10.1016/j.jval.2016.09.1256,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301364,0
J,"Carroll, L; O'Hara, J; Mazza, G; Camp, C; Hoxer, CS; Wilkinson, L",,,,"Carroll, L.; O'Hara, J.; Mazza, G.; Camp, C.; Hoxer, Stentoft C.; Wilkinson, L.",,,THE RELATIONSHIP BETWEEN TARGET JOINTS AND NON-DRUG DIRECT COSTS IN SEVERE HAEMOPHILIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Carroll, L.] Haemophilia Soc, London, England; [O'Hara, J.] Univ Chester, Chester, Cheshire, England; [Mazza, G.] UCL, London, England; [Camp, C.] HCD Econ, Daresbury, England; [Hoxer, Stentoft C.] Novo Nordisk, Bagsvaerd, Denmark; [Wilkinson, L.] Novo Nordisk AS, Soborg, Denmark",University of Chester; University of London; University College London; Novo Nordisk,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY53,A584,A584,,10.1016/j.jval.2016.09.1368,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301471,0
J,"Cohan, S; Smoot, K; Kresa-Reahl, K; Kendter, J; Garland, R; Yeh, D; Wu, N; Serafini, P; Watson, C",,,,"Cohan, S.; Smoot, K.; Kresa-Reahl, K.; Kendter, J.; Garland, R.; Yeh, D.; Wu, N.; Serafini, P.; Watson, C.",,,STABLE MULTIPLE SCLEROSIS PATIENTS ON AN INTERFERON THERAPY HAVE BETTER OUTCOMES WHEN STAYING ON THERAPY THAN PATIENTS WHO SWITCH TO ANOTHER INTERFERON,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Cohan, S.; Smoot, K.; Kresa-Reahl, K.] Providence St Vicent Med Ctr, Portland, OR USA; [Kendter, J.] Biogen, Weston, MA USA; [Garland, R.; Yeh, D.; Wu, N.; Watson, C.] Biogen, Cambridge, MA USA; [Serafini, P.] Biogen, Sao Paulo, Brazil",Biogen; Biogen,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND13,A427,A427,,10.1016/j.jval.2016.09.466,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300438,0
J,"Connolly, M; Tian, Q; Sierra, M; Zhang, L; Vaskantiras, V",,,,"Connolly, M.; Tian, Q.; Sierra, M.; Zhang, L.; Vaskantiras, V.",,,ECONOMIC ASSESSMENT OF DYDROGESTERONE COMPARED WITH PROGESTERONE FOR THE TREATMENT OF THREATENED ANDHABITUAL MISCARRIAGE IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Connolly, M.] Univ Groningen, Groningen, Netherlands; [Tian, Q.] Beijing Union Med Coll Hosp, Beijing, Peoples R China; [Sierra, M.] Global Market Access Solut, St Prex, Switzerland; [Zhang, L.] Abbott China, Shanghai, Peoples R China; [Vaskantiras, V.] Abbott Prod Operat AG, Basel, Switzerland",University of Groningen; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIH5,A904,A904,,10.1016/j.jval.2016.08.176,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303358,0
J,"de Bock, E; Chekroun, M; Morisky, DE; Arnould, B",,,,"de Bock, E.; Chekroun, M.; Morisky, D. E.; Arnould, B.",,,PATIENTS' ACCEPTANCE AND ADHERENCE OF THEIR MEDICATION: RESULTS FROM A EUROPEAN MULTI-DISEASE STUDY WITH ONLINE PATIENT COMMUNITY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[de Bock, E.] Mapi Grp, Patient Ctr Outcomes, Lyon, France; [Chekroun, M.] Caren Com, Paris, France; [Morisky, D. E.] UCLA Fielding Sch Publ Hlth, Los Angeles, CA USA; [Arnould, B.] Mapi Grp, Lyon, France",University of California System; University of California Los Angeles,,,"Morisky, Donald/AAU-4679-2021; Morisky, Donald E./HLW-3036-2023",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP217,A477,A478,,10.1016/j.jval.2016.09.758,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300713,0
J,"Detzel, P",,,,"Detzel, P.",,,ESTIMATING THE CONTRIBUTION ON THE REDUCTION OF THE BURDEN OF IRON DEFICIENCY ANEMIA FROM THE CURRENT FORTIFICATION STRATEGY OF COMMERCIAL FOODS TARGETED TO INFANTS AND TODDLERS IN INDIA. SCENARIOS USING SYSTEMATIC REVIEW AND REAL WORLD EVIDENCE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Detzel, P.] Nestle Res Ctr, Lausanne, Switzerland",Nestle SA,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP117,A834,A834,,10.1016/j.jval.2016.08.574,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302748,0
J,"DiBonaventura, M; Higginbottom, K; Meyers, A; Morimoto, Y; Ilacqua, J",,,,"DiBonaventura, M.; Higginbottom, K.; Meyers, A.; Morimoto, Y.; Ilacqua, J.",,,"PREDICTORS OF FIRST LINE TREATMENT PERSISTENCE AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES, WESTERN EUROPE, AND JAPAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[DiBonaventura, M.] Ipsos Healthcare, New York, NY USA; [Higginbottom, K.; Ilacqua, J.] Ipsos Healthcare, Mahwah, NJ USA; [Meyers, A.] Ipsos Healthcare, Washington, DC USA; [Morimoto, Y.] Ipsos Healthcare, Tokyo, Japan",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN195,A743,A744,,10.1016/j.jval.2016.09.2270,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302476,0
J,"Droeschel, D; Vollmer, L; Helfrich, J; Walzer, S",,,,"Droeschel, D.; Vollmer, L.; Helfrich, J.; Walzer, S.",,,"NOTHING VENTURED, NOTHING GAINED - IS THE INNOVATION FUND THE CATAPULT TO A NEW GENERATION OF CARE CONCEPTS AND A COMPETITIVE MARKET IN HEALTH CARE IN GERMANY?",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Droeschel, D.; Vollmer, L.; Walzer, S.] MArS Market Access & Pricing Strategy GmbH, Weil Am Rhein, Germany; [Helfrich, J.] DAK Gesundheit, Hamburg, Germany",,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS181,A635,A635,,10.1016/j.jval.2016.09.1664,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301754,0
J,"Etter, K; Sutton, N; Wei, D; Yoo, A",,,,"Etter, K.; Sutton, N.; Wei, D.; Yoo, A.",,,RATE AND HEALTHCARE UTILIZATION (LOS AND COSTS) OF ADHESION RELATED COMPLICATIONS AFTER COLON RESECTION PROCEDURES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Etter, K.; Yoo, A.] Johnson & Johnson Co, New Brunswick, NJ USA; [Sutton, N.] Johnson & Johnson Med Devices, Somerville, NJ USA; [Wei, D.] Johnson & Johnson Co, Raleigh, NC USA",Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PGI8,A510,A510,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606301079,0
J,"Farhat, N; Fortin, Y; Birkett, N; Mattison, DR; Krewski, D",,,,"Farhat, N.; Fortin, Y.; Birkett, N.; Mattison, D. R.; Krewski, D.",,,PROTON PUMP INHIBITORS AND MAJOR ADVERSE CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Farhat, N.; Fortin, Y.; Birkett, N.; Krewski, D.] Univ Ottawa, Ottawa, ON, Canada; [Mattison, D. R.] Risk Sci Int, Ottawa, ON, Canada",University of Ottawa,,,"Mattison, Donald R/C-2015-2009","Farhat, Nawal/0000-0003-0291-0270",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV25,A640,A640,,10.1016/j.jval.2016.09.1692,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301781,0
J,"Farmakas, A; Theodorou, M; Kaitelidou, D",,,,"Farmakas, A.; Theodorou, M.; Kaitelidou, D.",,,RATIONING RESOURCES IN HEALTH BY INVOLVING THE PUBLIC IN PRIORITY SETTING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Farmakas, A.] Open Univ Cyprus, Latsia, Cyprus; [Theodorou, M.; Kaitelidou, D.] Open Univ Cyprus, Nicosia, Cyprus",Open University of Cyprus; Open University of Cyprus,,,"Kaitelidou, Dafni/AAA-2599-2020",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP1,A439,A439,,10.1016/j.jval.2016.09.535,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300502,0
J,"Federici, C; Fattore, G; Rudolfsson, G",,,,"Federici, C.; Fattore, G.; Rudolfsson, G.",,,THE EFFECTS OF FOOD PRICES ON WEIGHT OUTCOMES. A SYSTEMATIC REVIEW OF THE MODERATING EFFECTS OF INCOME AND INITIAL BMI,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Federici, C.; Fattore, G.; Rudolfsson, G.] Ctr Res Healthcare Management CERGAS, SDA Bocconi Sch Management, Milan, Italy",Bocconi University,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP88,A454,A455,,10.1016/j.jval.2016.09.627,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300589,0
J,"Fukushima, A; Khabtheni, W; Guelfucci, F; Onishi, Y; Toumi, M; Okamura, T",,,,"Fukushima, A.; Khabtheni, W.; Guelfucci, F.; Onishi, Y.; Toumi, M.; Okamura, T.",,,DESCRIPTION OF THE IMPACT OF HYPERTENSION ON HOSPITALISATIONS FOR CARDIOVASCULAR DISEASES IN JAPAN USING A JAPANESE CLAIMS DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fukushima, A.; Guelfucci, F.] Creat Ceut, Paris, France; [Khabtheni, W.] Creat Ceut, Tunis, Tunisia; [Onishi, Y.] Creat Ceut, Tokyo, Japan; [Toumi, M.] Univ Mediterranee, Aix Marseille Univ, Fac Med, Lab Sante Publ, Marseille, France; [Okamura, T.] Keio Univ, Sch Med, Tokyo, Japan",Aix-Marseille Universite; Keio University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV27,A640,A641,,10.1016/j.jval.2016.09.1694,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301783,0
J,"Gao, M; Wang, Y; Wang, J; Zeng, F; Yang, Q; Ren, X",,,,"Gao, M.; Wang, Y.; Wang, J.; Zeng, F.; Yang, Q.; Ren, X.",,,COST-BENEFIT ANALYSIS: A COMPARISON BETWEEN PRESET ARTERY BLOOD SAMPLERS AND DISPOSABLE SYRINGES IN ARTERIAL BLOOD SAMPLING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gao, M.] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Wang, Y.] Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China; [Wang, J.] China Japan Friendship Hosp, Beijing, Peoples R China; [Yang, Q.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Ren, X.] Becton Dickinson Med Devices Shanghai Co Ltd, Shanghai, Peoples R China",Sun Yat Sen University; China-Japan Friendship Hospital; Zhejiang University; Becton Dickinson,,,"yang, qiang/GYJ-0971-2022",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD111,A704,A704,,10.1016/j.jval.2016.09.2053,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302266,0
J,"Hankin, C; Lee, D; Wang, Z",,,,"Hankin, C.; Lee, D.; Wang, Z.",,,TWO-YEAR ANTECEDENT VERSUS SUBSEQUENT DIAGNOSES OF PATIENTS NEWLY DIAGNOSED WITH PRIMARY RESTLESS LEGS SYNDROME: A LARGE-SCALE RETROSPECTIVE CLAIMS ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hankin, C.; Lee, D.; Wang, Z.] BioMedEcon LLC, Moss Beach, CA USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND3,A425,A425,,10.1016/j.jval.2016.09.456,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300428,0
J,"Haramiova, Z; Rusnakova, L; Minarikova, D; Malovecka, I; Foltan, V",,,,"Haramiova, Z.; Rusnakova, L.; Minarikova, D.; Malovecka, I; Foltan, V",,,UTILISATION OF ANTITHROMBOTIC DRUGS IN SLOVAKIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Haramiova, Z.; Rusnakova, L.; Minarikova, D.; Malovecka, I; Foltan, V] Comenius Univ, Fac Pharm, Bratislava, Slovakia",Comenius University Bratislava,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV132,A660,A660,,10.1016/j.jval.2016.09.1803,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302024,0
J,"Heiskanen, J; Tolppanen, A; Martikainen, JA; Hartikainen, J; Miettinen, H; Hippeläinen, M; Roine, RP",,,,"Heiskanen, J.; Tolppanen, A.; Martikainen, J. A.; Hartikainen, J.; Miettinen, H.; Hippelainen, M.; Roine, R. P.",,,IDENTIFICATION OF ADVERSE EVENTS IN CORONARY ARTERY DISEASE PATIENTS BASED ON HEALTH-RELATED QUALITY OF LIFE OUTCOME DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Heiskanen, J.; Hartikainen, J.; Miettinen, H.; Hippelainen, M.] Kuopio Univ Hosp, Kuopio, Finland; [Tolppanen, A.; Martikainen, J. A.; Roine, R. P.] Univ Eastern Finland, Kuopio, Finland",University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS79,A618,A618,,10.1016/j.jval.2016.09.1560,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301656,0
J,"Huang, J; Zhang, ML; Ni, Q; Xuan, JW",,,,"Huang, J.; Zhang, M. L.; Ni, Q.; Xuan, J. W.",,,ECONOMIC BURDEN OF HEART FAILURE IN CHINESE POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Huang, J.] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China; [Zhang, M. L.; Ni, Q.] Novartis Pharmaceut China, Beijing, Peoples R China; [Xuan, J. W.] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China",Nanjing Medical University; Sun Yat Sen University,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV72,A649,A649,,10.1016/j.jval.2016.09.1740,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301828,0
J,"Jiang, N; Vaithianathan, R",,,,"Jiang, N.; Vaithianathan, R.",,,"CHILDHOOD STUNTING, WASTING AND OBESITY IN INDONESIA: EVIDENCE FROM THE INDONESIAN FAMILY LIFE SURVEY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jiang, N.] AUT Univ, Auckland, New Zealand; [Vaithianathan, R.] Singapore Management Univ, Singapore, Singapore",Auckland University of Technology; Singapore Management University,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY7,A881,A881,,10.1016/j.jval.2016.08.316,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303229,0
J,"Jonsson, E; Borgström, F; Ström, O",,,,"Jonsson, E.; Borgstrom, F.; Strom, O.",,,COST EFFECTIVENESS EVALUATION OF FRACTURE LIAISON SERVICES FOR THE MANAGEMENT OF OSTEOPOROSIS IN SWEDEN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jonsson, E.; Borgstrom, F.] Quantify Res, Stockholm, Sweden; [Strom, O.] Karolinska Inst, Stockholm, Sweden",Karolinska Institutet,,,,,,,,,0,3,3,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS49,A612,A612,,10.1016/j.jval.2016.09.1529,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301626,0
J,"Kaufman, H; Kraemer, M; Barbosa, CD; Lambert, J; Mahnke, L; Bharmal, M",,,,"Kaufman, H.; Kraemer, M.; Barbosa, Dias C.; Lambert, J.; Mahnke, L.; Bharmal, M.",,,PATIENT PERSPECTIVES ON MERKEL CELL CARCINOMA (MCC) AND ITS TREATMENT WITH A NOVEL AGENT (AVELUMAB): FINDINGS FROM IN-DEPTH QUALITATIVE PATIENT INTERVIEWS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kaufman, H.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Kraemer, M.; Bharmal, M.] Merck KGaA, Darmstadt, Germany; [Barbosa, Dias C.; Lambert, J.] Mapi Grp, Lyon, France; [Mahnke, L.] EMD Serono, Boston, MA USA",Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers Cancer Institute of New Jersey; Merck KGaA,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN206,A745,A745,,10.1016/j.jval.2016.09.2281,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302486,0
J,"Kemmler, G; Gamper, E; Nerich, V; Norman, R; King, MT; Holzner, B",,,,"Kemmler, G.; Gamper, E.; Nerich, V; Norman, R.; King, M. T.; Holzner, B.",,,"COMPARISON OF GERMAN, FRENCH AND POLISH UTILITY WEIGHTS FOR THE EORTC UTILITY INSTRUMENT QLU-C1OD",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kemmler, G.; Holzner, B.] Med Univ Innsbruck, Dept Psychiat & Psychotherapy, Innsbruck, Austria; [Gamper, E.] Med Univ Innsbruck, Innsbruck, Austria; [Nerich, V] Besancon Univ Hosp, Besancon, France; [Norman, R.] Curtin Univ, Perth, WA, Australia; [King, M. T.] Univ Sydney, Sydney, NSW, Australia",Medical University of Innsbruck; Medical University of Innsbruck; Universite de Franche-Comte; CHU Besancon; Curtin University; University of Sydney,,,"holzner, bernhard/C-5211-2011; Gamper, Eva Maria/AAI-3152-2020","Gamper, Eva Maria/0000-0002-1700-4054",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN202,A744,A745,,10.1016/j.jval.2016.09.2277,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302482,0
J,"Khachatryan, GR; Fedyaev, D; Avxentyeva, M; Dombrovskiy, VS",,,,"Khachatryan, G. R.; Fedyaev, D.; Avxentyeva, M.; Dombrovskiy, V. S.",,,COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Khachatryan, G. R.; Fedyaev, D.; Avxentyeva, M.; Dombrovskiy, V. S.] Russian Presidential Acad Natl Econ & Publ Adm, Moscow, Russia",Russian Presidential Academy of National Economy & Public Administration,,,"Avxentyeva, Maria/AAC-8141-2019; Denis, Fedyaev/W-3848-2019","Avxentyeva, Maria/0000-0001-6660-0402; Denis, Fedyaev/0000-0001-8977-5934",,,,,0,2,2,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN143,A734,A734,,10.1016/j.jval.2016.09.2217,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302425,0
J,"Kultanova, E; Lavrinenko, A; Turmukhambetova, A",,,,"Kultanova, E.; Lavrinenko, A.; Turmukhambetova, A.",,,PREVALENCE OF NOSOCOMIAL INFECTIONS IN KARAGANDA (KAZAKHSTAN) DURING 2011-2015,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kultanova, E.; Lavrinenko, A.; Turmukhambetova, A.] Karaganda State Med Univ, Karaganda, Kazakhstan",Karaganda Medical University,,,"Turmukhambetova, Anar/AAO-7668-2021",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN97,A424,A424,,10.1016/j.jval.2016.09.448,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300421,0
J,"Kumar, P; Begum, A; Attur, RP",,,,"Kumar, P.; Begum, A.; Attur, R. P.",,,USE OF ANTIHYPERTENSIVE MEDICATIONS IN DIABETIC AND NON-DIABETIC CHRONIC KIDNEY DISEASE AND HEMODIALYSIS PATIENTS: A DUE STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kumar, P.; Begum, A.; Attur, R. P.] Manipal Univ, Manipal, Karnataka, India",Manipal Academy of Higher Education (MAHE),,,"Prabhu, Ravindra/AAE-7064-2020","Prabhu, Ravindra/0000-0002-5980-7197",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PUK2,A516,A516,,10.1016/j.jval.2016.09.986,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301112,0
J,"Le, TN; Nguyen, TT; Nguyen, HT; Nguyen, NH",,,,"Le, T. N.; Nguyen, T. T.; Nguyen, H. T.; Nguyen, N. H.",,,"INPATIENT TREATMENT COST OF STROKE: AN ANALYSIS IN HO CHI MINH CITY 115 PEOPLE'S HOSPITAL, VIETNAM",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Le, T. N.; Nguyen, T. T.] Univ Med & Pharm, Ho Chi Minh City, Ho Chi Minh, Vietnam; [Nguyen, H. T.; Nguyen, N. H.] 115 Peoples Hosp, Ho Chi Minh City, Ho Chi Minh, Vietnam",Hochiminh City University of Medicine & Pharmacy,,,"Nguyen, Nhan H/HMV-3016-2023","Nguyen, Nhan H/0000-0001-8998-0145",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV74,A649,A649,,10.1016/j.jval.2016.09.1742,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301830,0
J,"Lee, Y; Ko, Y; Wu, C; Tang, C; Kuo, L",,,,"Lee, Y.; Ko, Y.; Wu, C.; Tang, C.; Kuo, L.",,,EVALUATION OF HEALTH CARE COSTS AND UTILIZATION PATTERNS FOR PATIENTS WITH GOUT IN TAIWAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, Y.; Ko, Y.; Wu, C.; Tang, C.; Kuo, L.] Taipei Med Univ, Taipei, Taiwan; [Lee, Y.; Kuo, L.] Wan Fang Hosp, Taipei, Taiwan",Taipei Medical University; Taipei Municipal WanFang Hospital,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS7,A916,A916,,10.1016/j.jval.2016.08.109,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303427,0
J,"Li, W; Yang, J; Li, SC; Ho, CL",,,,"Li, W.; Yang, J.; Li, S. C.; Ho, C. L.",,,CORRELATION BETWEEN TEA CONSUMPTION AND PREVALENCE OF HYPERTENSION AMONG SINGAPOREAN CHINESE RESIDENTS OVER 40,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Li, W.] Rutgers State Univ, Piscataway, NJ USA; [Yang, J.] Natl Univ Hosp Syst, Singapore, Singapore; [Li, S. C.] Univ Newcastle, Callaghan, NSW, Australia; [Ho, C. L.] Natl Univ Singapore, Singapore, Singapore",Rutgers University System; Rutgers University New Brunswick; National University of Singapore; University of Newcastle; National University of Singapore,,,,,,,,,0,0,0,1,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCV8,A863,A863,,10.1016/j.jval.2016.08.407,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606303133,0
J,"Marcellusi, A; Mennini, FS; Brugnoli, R; Rapinesi, C; Kotzalidis, GD; De, FS; Carrus, D; Ballerini, A; Francomano, A; Ducci, G; Del Casale, A; Girardi, P",,,,"Marcellusi, A.; Mennini, F. S.; Brugnoli, R.; Rapinesi, C.; Kotzalidis, G. D.; De, Filippis S.; Carrus, D.; Ballerini, A.; Francomano, A.; Ducci, G.; Del Casale, A.; Girardi, P.",,,ECONOMIC ASPECTS IN THE TREATMENT OF SCHIZOPHRENIA IN ITALY: COST CONSEQUENCES OF AN EARLY LONG-ACTING INJECTABLE ANTIPSYCHOTICS (LAIS) APPROACH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Marcellusi, A.; Mennini, F. S.] Univ Roma Tor Vergata, Fac Econ, Ctr Econ & Int Studies CEIS Econ Evaluat & HTA EE, Rome, Italy; [Brugnoli, R.; Rapinesi, C.; Kotzalidis, G. D.; De, Filippis S.; Carrus, D.] Univ Roma La Sapienza, Rome, Italy; [Ballerini, A.] Univ Florence, Florence, Italy; [Francomano, A.] Univ Palermo, Palermo, Italy; [Ducci, G.] DSM ASL Roma 1, Rome, Italy",University of Rome Tor Vergata; Sapienza University Rome; University of Florence; University of Palermo,,,"Del Casale, Antonio/AFK-9156-2022; Marcellusi, Andrea/AAL-6573-2020","Del Casale, Antonio/0000-0003-2427-6944;",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMH23,A525,A525,,10.1016/j.jval.2016.09.1036,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301157,0
J,"May, H",,,,"May, H.",,,ECONOMIC BENEFITS OF THE BABY FRIENDLY HOSPITAL INITIATIVE IN A SECOND CARE HOSPITAL IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[May, H.] Quintana Roo Univ, Chetmal, Mexico",Universidad de Quintana Roo,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS138,A628,A628,,10.1016/j.jval.2016.09.1620,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301714,0
J,"McEwan, P; Bennett, H; Gordon, J; Bolin, K; Bergenheim, K",,,,"McEwan, P.; Bennett, H.; Gordon, J.; Bolin, K.; Bergenheim, K.",,,QUANTIFYING THE HEALTH ECONOMIC VALUE ASSOCIATED WITH UNIT CHANGES IN HBA1C IN TYPE 1 DIABETES MELLITUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[McEwan, P.; Bennett, H.; Gordon, J.] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales; [Bolin, K.] Univ Gothenburg, Gothenburg, Sweden; [Bergenheim, K.] AstraZeneca, Molndal, Sweden",Health Economics & Outcomes Research Ltd; University of Gothenburg; AstraZeneca,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PDB59,A675,A675,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606302108,0
J,"McEwan, P; Gordon, J; Ward, T; Penrod, JR; Yuan, Y",,,,"McEwan, P.; Gordon, J.; Ward, T.; Penrod, J. R.; Yuan, Y.",,,EMPIRICAL ASSESSMENT OF THE IMPACT OF MODEL CHOICE (MARKOV STATE TRANSITION VERSUS PARTITIONED SURVIVAL) IN MODELLING SMALL-CELL LUNG CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[McEwan, P.; Gordon, J.; Ward, T.] Hlth Econ & Outcomes Res Ltd, Cardiff, S Glam, Wales; [Penrod, J. R.; Yuan, Y.] Bristol Myers Squibb, Princeton, NJ USA",Health Economics & Outcomes Research Ltd; Bristol-Myers Squibb,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM83,A372,A372,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606300134,0
J,"Mi, M; Suponcic, S; Wang, M; Liu, Y",,,,"Mi, M.; Suponcic, S.; Wang, M.; Liu, Y.",,,UPCOMING REGULATIONS ON INSURANCE REIMBURSEMENT STANDARD IN CHINA: CHANLLANGES AND OPPORTUNITES FOR MNCS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mi, M.; Liu, Y.] Navigant Life Sci, Shanghai, Peoples R China; [Suponcic, S.] Navigant Life Sci, Lawrenceville, NJ USA; [Wang, M.] Navigant Life Sci, London, England",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP69,A826,A826,,10.1016/j.jval.2016.08.652,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302703,0
J,"Muñoz-Quiles, C; López-Lacort, M; Díez-Domingo, J",,,,"Munoz-Quiles, C.; Lopez-Lacort, M.; Diez-Domingo, J.",,,HERPES ZOSTER-ASSOCIATED RESOURCES CONSUMPTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Munoz-Quiles, C.; Lopez-Lacort, M.; Diez-Domingo, J.] FISABIO Publ Hlth, Fun Fomento Invest Sanitaria & Biomed, Comunitat Valenciana, Valencia, Spain",,,,"DIEZ DOMINGO, JAVIER/IRZ-7330-2023; Domingo, Javier Diez/B-7293-2015","Diez-Domingo, Javier/0000-0003-1008-3922",,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHS1,A603,A604,,10.1016/j.jval.2016.09.1480,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301578,0
J,"Mytelka, DS; Lorenzo, M; Stafkey-Mailey, D; D'yachkova, Y; Nagar, SP; Candrilli, SD; Kaye, JA",,,,"Mytelka, D. S.; Lorenzo, M.; Stafkey-Mailey, D.; D'yachkova, Y.; Nagar, S. P.; Candrilli, S. D.; Kaye, J. A.",,,REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN THE UNITED KINGDOM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mytelka, D. S.] Eli Lilly, Indianapolis, IN USA; [Lorenzo, M.] Eli Lilly & Co Ltd, Windlesham, Surrey, England; [Stafkey-Mailey, D.] Xcenda LLC, Palm Harbor, FL USA; [D'yachkova, Y.] Eli Lilly Austria GmbH, Vienna, Austria; [Nagar, S. P.; Candrilli, S. D.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Kaye, J. A.] RTI Hlth Solut, Waltham, MA USA","Eli Lilly; Eli Lilly; AmerisourceBergen Corporation; Xcenda, LLC; Eli Lilly; Research Triangle Institute; Research Triangle Institute",,,,"Mytelka, Daniel/0000-0001-7669-8634",,,,,0,1,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN234,A751,A751,,10.1016/j.jval.2016.09.2310,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302514,0
J,"Nasim, A; Haq, N; Jameel, L; Riaz, S",,,,"Nasim, A.; Haq, N.; Jameel, L.; Riaz, S.",,,ASSESSMENT OF KNOWLEDGE AND PERCEPTION REGARDING BREAST CANCER AMONG PATIENTS ATTENDING GYNECOLOGICAL DEPARTMENT OF TERTIARY CARE HOSPITAL IN QUETTA PAKISTAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nasim, A.; Haq, N.; Jameel, L.; Riaz, S.] Univ Balochistan, Quetta, Pakistan",University of Balochistan,,,"Nasim, Aqeel/AAX-1823-2021","Nasim, Aqeel/0000-0003-1270-4753; Riaz, Sohail/0000-0002-4188-5162",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN211,A746,A746,,10.1016/j.jval.2016.09.2286,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302491,0
J,"Ng, DB; Wielage, R; Klein, TM; Klein, RW; Gooch, K",,,,"Ng, D. B.; Wielage, R.; Klein, T. M.; Klein, R. W.; Gooch, K.",,,COST-EFFECTIVENESS OF SOLIFENACIN FOR THE TREATMENT OF OVERACTIVE BLADDER FROM A US PRIVATE PAYER AND MEDICARE ADVANTAGE PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ng, D. B.; Gooch, K.] Astellas Pharma Global Dev Inc, Northbrook, IL USA; [Wielage, R.; Klein, T. M.; Klein, R. W.] Med Decis Modeling Inc, Indianapolis, IN USA",Astellas Pharmaceuticals; Medical Decision Modeling Inc. (MDM),,,"Wielage, Ronald Charles/AAW-2002-2021",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PUK15,A519,A519,,10.1016/j.jval.2016.09.1000,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301125,0
J,"Odnoletkova, I",,,,"Odnoletkova, I",,,COST-EFFECTIVENESS OF PROPHYLAXIS COMPARED TO ON-DEMAND TREATMENT IN SEVERE HAEMOPHILIA A. SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Odnoletkova, I] Plasma Prot Therapeut Assoc, Brussels, Belgium",,,,"Odnoletkova, Irina/A-3269-2015","Odnoletkova, Irina/0000-0001-5224-1250",,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY140,A599,A600,,10.1016/j.jval.2016.09.1457,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301556,0
J,"Ogbonna, BO",,,,"Ogbonna, B. O.",,,CAN PHARMACEUTICAL CARE INTERVENTION IMPROVE LIPID PROFILE IN TYPE 2 DIABETES PATIENTS; A PROSPECTIVE INTERVENTION STUDY IN A TERTIARY HOSPITAL IN NIGERIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ogbonna, B. O.] Univ Benin, Benin, Edo State, Nigeria",University of Benin,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM9,A850,A850,,10.1016/j.jval.2016.08.489,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303057,0
J,"Ordóñez, J; Serafini, P; Machado, M",,,,"Ordonez, J.; Serafini, P.; Machado, M.",,,COST-UTILITY ANALYSIS OF DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ordonez, J.] CES Univ, Medellin, Colombia; [Serafini, P.; Machado, M.] Biogen, Sao Paulo, Brazil",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND52,A434,A434,,10.1016/j.jval.2016.09.506,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606300476,0
J,"Qin, SK; Kruger, E; Tan, SC; Cheng, SQ; Yao, XX; Liang, J",,,,"Qin, S. K.; Kruger, E.; Tan, S. C.; Cheng, S. Q.; Yao, X. X.; Liang, J.",,,COST-EFFECTIVENESS ANALYSIS OF OXALIPLATIN PLUS FLUOROURACIL/LEUCOVORIN (FOLFOX4) COMPARED TO SORAFENIB FOR TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Qin, S. K.] Eight One Hosp, Dept Med Oncol, Peoples Liberat Army Canc Ctr, Nanjing, Jiangsu, Peoples R China; [Kruger, E.; Tan, S. C.] IMS Hlth, Econ & Outcomes, Real World Evidence, Singapore, Singapore; [Cheng, S. Q.] Shanghai Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg, Shanghai, Peoples R China; [Yao, X. X.] Sanofi, Hlth Econ & Outcome Res, Shanghai, Peoples R China; [Liang, J.] Peking Univ, Int Hosp, Dept Med Oncol, Tumor Hosp, Beijing, Peoples R China",Naval Medical University; Sanofi-Aventis; Peking University,,,"cheng, sq/GPT-4112-2022; Cheng, Shuqun/HTS-9930-2023","Cheng, Shuqun/0000-0001-6760-7470",,,,,0,0,0,0,9,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN32,A889,A889,,10.1016/j.jval.2016.08.277,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303276,0
J,"Sar, C; Malhan, S; Oksuz, E; Eldem, B; Unlu, N; Alp, MN; Ozmert, E; Durukan, AH; Erdal, E; Kahveci, B",,,,"Sar, C.; Malhan, S.; Oksuz, E.; Eldem, B.; Unlu, N.; Alp, M. N.; Ozmert, E.; Durukan, A. H.; Erdal, E.; Kahveci, B.",,,BURDEN OF VISUAL IMPAIRMENT DUE TO MYOPIC CHOROIDAL NE OVAS CULARISATION (MCNV) IN TURKEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sar, C.; Erdal, E.; Kahveci, B.] Bayer Turk Kimya San Ltd Sti, Istanbul, Turkey; [Malhan, S.; Oksuz, E.] Baskent Univ, Ankara, Turkey; [Eldem, B.] Hacettepe Univ, Ankara, Turkey; [Unlu, N.] Ankara Numune Training & Res Hosp, Ankara, Turkey; [Alp, M. N.] Ankara Numune Training & Res Hosp, Ankara, Turkey; [Ozmert, E.] Ankara Univ, Fac Med, Ankara, Turkey; [Durukan, A. H.] Gulhane Askeri Tip Akad, Ankara, Turkey",Bayer Turkey; Baskent University; Hacettepe University; Ankara Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; Ankara University; Gulhane Military Medical Academy,,,"Oksuz, Ergun/K-8238-2012; Durukan, Ali Hakan/GSN-1422-2022; Durukan, Ali Hakan/AFS-8050-2022","Oksuz, Ergun/0000-0002-5723-5965; Durukan, Ali Hakan/0000-0001-6571-6155;",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS28,A566,A566,,10.1016/j.jval.2016.09.1272,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301379,0
J,"Sat-MunozSat-Muñoz, D; Balderas-PenaBalderas-Peña, L; Cruz-Corona, E; Ortiz-GonzalezOrtiz-González, F; Chagollan-RamirezChagollán-Ramírez, J; Chavez-HurtadoChávez-Hurtado, J",,,,"Sat-MunozSat-Munoz, D.; Balderas-PenaBalderas-Pena, L.; Cruz-Corona, E.; Ortiz-GonzalezOrtiz-Gonzalez, F.; Chagollan-RamirezChagollan-Ramirez, J.; Chavez-HurtadoChavez-Hurtado, J.",,,BRAIN METASTASIS PREDICTION IN BREAST CANCER WOMEN: USEFULNESS OF MATHEMATICAL MODELING OF MONTECARLO,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sat-MunozSat-Munoz, D.] Univ Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Jalisco, Mexico; [Balderas-PenaBalderas-Pena, L.; Cruz-Corona, E.] UMAE Hosp Especialidades Ctr Med Nacl Occidente I, Guadalajara, Jalisco, Mexico; [Ortiz-GonzalezOrtiz-Gonzalez, F.] Ctr Med Nacl Occidente, Unidad Med Alta Especialidad Hosp Especialidades, Guadalajara, Jalisco, Mexico; [Chagollan-RamirezChagollan-Ramirez, J.] Univ Guadalajara, Ctr Univ Ciencias Econ Adm, Zapopan, Jalisco, Mexico; [Chavez-HurtadoChavez-Hurtado, J.] Univ Guadalajara, Zapopan, Mexico",Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara,,,,"Cruz Corona, Eduardo/0000-0002-0195-5402",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM135,A381,A382,,10.1016/j.jval.2016.09.201,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300186,0
J,"Saumell, Y; Sánchez, L; Cabrera, L; Cepeda, M",,,,"Saumell, Y.; Sanchez, L.; Cabrera, L.; Cepeda, M.",,,USE OF NIMOTUZUMAB IN THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL CANCER IN REAL WORLD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saumell, Y.; Cabrera, L.; Cepeda, M.] Inst Mol Immunol, Havana, Cuba; [Sanchez, L.] Ctr Mol Immunol, Havana, Cuba",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN34,A714,A714,,10.1016/j.jval.2016.09.2106,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302317,0
J,"Scalone, L; Ciampichini, R; Cesana, G; Cortesi, PA; Janssen, B; Mantovani, LG",,,,"Scalone, L.; Ciampichini, R.; Cesana, G.; Cortesi, P. A.; Janssen, B.; Mantovani, L. G.",,,THE REDUCTION OF CEILING WITH THE EQ-5D-5L INCREASES WITH AGE IN THE GENERAL ADULT POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Scalone, L.; Ciampichini, R.; Cesana, G.; Cortesi, P. A.; Mantovani, L. G.] Univ Milano Bicocca, Monza, Italy; [Janssen, B.] EuroQoL Grp, Rotterdam, Netherlands",University of Milano-Bicocca,,,"Mantovani, Lorenzo Giovanni/AAC-4263-2021; Cortesi, Paolo Angelo/AAD-7926-2020",,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP203,A475,A475,,10.1016/j.jval.2016.09.745,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300700,0
J,"Schwarzinger, M; Huguet, F; Témam, S; Pointreau, Y; Thiébaut, SP; Bec, M; Even, C; Geoffrois, L; Levy-Bachelot, L",,,,"Schwarzinger, M.; Huguet, F.; Temam, S.; Pointreau, Y.; Thiebaut, S. P.; Bec, M.; Even, C.; Geoffrois, L.; Levy-Bachelot, L.",,,INCIDENCE CANCER COSTS ASSOCIATED WITH HEAD AND NECK (H&N) CANCERS: A NATIONWIDE STUDY FROM FRANCE IN 2008-2013 (EPICORL STUDY),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Schwarzinger, M.; Thiebaut, S. P.] THEN, Paris, France; [Huguet, F.] Tenon Hosp, Paris, France; [Temam, S.; Even, C.] Inst Gustave Roussy, Villejuif, France; [Pointreau, Y.] Ctr Jean Bernard Clin Victor Hugo, Le Mans, France; [Bec, M.; Levy-Bachelot, L.] MSD France, Courbevoie, France; [Geoffrois, L.] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France",Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital Universitaire Tenon - APHP; UNICANCER; Gustave Roussy; UNICANCER; Institut de cancerologie de Lorraine (ICL),,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PCN93,A725,A725,,10.1016/j.jval.2016.09.2166,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606302376,0
J,"Senturk, A; Demir, O; Tatar, M; Ugurlu, M; Sivaci, C; Biter, E; Kucuk, I; Cankaya, M; Colak, E",,,,"Senturk, A.; Demir, O.; Tatar, M.; Ugurlu, M.; Sivaci, C.; Biter, E.; Kucuk, I; Cankaya, M.; Colak, E.",,,ORPHAN DRUG MARKET ANALYSIS IN TURKEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Senturk, A.] Polar Hlth Econ & Policy Consultancy, Ankara, Turkey; [Demir, O.] Boehringer Ingelheim GmbH & Co KG, Istanbul, Turkey; [Tatar, M.] Hacettepe Univ, Ankara, Turkey; [Ugurlu, M.; Sivaci, C.; Biter, E.; Kucuk, I; Cankaya, M.] Minist Finance, Ankara, Turkey; [Colak, E.] Turkish Pharmacists Assoc, Ankara, Turkey",Polar Health Economics & Policy; Boehringer Ingelheim; Hacettepe University; Ministry of Finance - Turkey; Phaemaceutical Industry Association of Turkey,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY38,A581,A581,,10.1016/j.jval.2016.09.1353,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301456,0
J,"Takeuchi, T; Karpouzas, G; Thorne, C; McQuarrie, K; Sheng, S; Xu, W; Peterson, S; Ganguly, R; Han, C; Fei, K; Hsu, B",,,,"Takeuchi, T.; Karpouzas, G.; Thorne, C.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B.",,,"WORK PRODUCTIVITY/INTERFERENCE AND GENERAL HEALTH STATUS IMPROVEMENTS WITH SIRUKUMAB, AN ANTI-IL-6 CYTOKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE TREATMENT WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: RESULTS FROM THE PHASE 3 SIRROUND-D STUDY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Takeuchi, T.] Keio Univ, Sch Med, Div Rheumatol, Tokyo, Japan; [Karpouzas, G.] Harbor UCLA Med Ctr, Div Rheumatol, Torrance, CA 90509 USA; [Thorne, C.] Univ Toronto, Newmarket, ON, Canada; [Thorne, C.] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Han, C.; Fei, K.; Hsu, B.] Janssen Res & Dev LLC, Spring House, PA USA; [Ganguly, R.] GlaxoSmithKline, Collegeville, PA USA",Keio University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Toronto; Southlake Regional Health Centre; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; GlaxoSmithKline,,,"Karpouzas, George/AAE-3343-2019","Hsu, Benjamin/0000-0002-0718-213X",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMS67,A542,A542,,10.1016/j.jval.2016.09.1135,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301250,0
J,"Tatar, M; Tuna, E; Senturk, A; Sarioz, F; Konya, A",,,,"Tatar, M.; Tuna, E.; Senturk, A.; Sarioz, F.; Konya, A.",,,ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tatar, M.] Hacettepe Univ, Ankara, Turkey; [Tuna, E.; Senturk, A.] Polar Hlth Econ & Policy Consultancy, Ankara, Turkey; [Sarioz, F.; Konya, A.] Novartis, Istanbul, Turkey",Hacettepe University; Polar Health Economics & Policy; Novartis; Novartis Turkey,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRS14,A551,A551,,10.1016/j.jval.2016.09.1182,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301294,0
J,"Tettamanti, A; Urbinati, D; Tucci, C",,,,"Tettamanti, A.; Urbinati, D.; Tucci, C.",,,THE IMPACT OF REGIONAL LEGISLATIVE MEASURES ON THE PRESCRIPTION OF OFF-PATENT MEDICINES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tettamanti, A.; Urbinati, D.; Tucci, C.] IMS Hlth, Milan, Italy",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP37,A446,A446,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606300538,0
J,"Ugrekhelidze, D; Yagudina, R; Kulikov, A",,,,"Ugrekhelidze, D.; Yagudina, R.; Kulikov, A.",,,BUDGET IMPACT ANALYSIS OF SUCROFERRIC OXYHYDROXIDE IN TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ugrekhelidze, D.; Yagudina, R.; Kulikov, A.] IM Sechenov First Moscow State Med Univ, Moscow, Russia",Sechenov First Moscow State Medical University,,,"Andrey, Kulikov/K-7168-2014; YAGUDINA, ROZA/L-3504-2014","Andrey, Kulikov/0000-0002-7025-1185; YAGUDINA, ROZA/0000-0002-9080-332X",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PUK6,A517,A517,,10.1016/j.jval.2016.09.991,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,Bronze,,,2024-03-09,WOS:000396606301116,0
J,"ul Haq, N; Mohaib, M; Nasim, A; Razaque, G; Riaz, S",,,,"ul Haq, N.; Mohaib, M.; Nasim, A.; Razaque, G.; Riaz, S.",,,"CHRONIC PATIENTS ATTITUDES, BELIEFS, AND EXPERIENCES REGARDING POLYPHARMACY AND WILLINGNESS TO DEPRESCRIBE IN QUETTA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[ul Haq, N.; Mohaib, M.; Nasim, A.; Razaque, G.; Riaz, S.] Univ Balochistan, Quetta, Pakistan",University of Balochistan,,,"Nasim, Aqeel/AAX-1823-2021","Nasim, Aqeel/0000-0003-1270-4753; Riaz, Sohail/0000-0002-4188-5162",,,,,0,2,2,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PHP54,A823,A823,,10.1016/j.jval.2016.08.637,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302688,0
J,"Villa, E; Trenta, A; Dalla Tomba, M; Messina, A; Brunelli, F; Cirillo, M; Mhagna, Z; Valerio, M; Troise, G",,,,"Villa, E.; Trenta, A.; Dalla Tomba, M.; Messina, A.; Brunelli, F.; Cirillo, M.; Mhagna, Z.; Valerio, M.; Troise, G.",,,USE OF SUTURELESS PROSTHESIS NEUTRALIZES EXPECTED WORSE ECONOMIC IMPACT OF HIGH RISK PATIENTS UNDERGOING AORTIC VALVE REPLACEMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Villa, E.; Trenta, A.; Dalla Tomba, M.; Messina, A.; Brunelli, F.; Cirillo, M.; Mhagna, Z.; Valerio, M.; Troise, G.] Poliambulanza Fdn Hosp, Brescia, Italy",,,,"Villa, Emmanuel/AAL-9237-2020; Villa, Emmanuel/T-5977-2019",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PMD84,A699,A699,,10.1016/j.jval.2016.09.2025,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606302240,0
J,"Wang, L; Cheng, K; Duan, Z; Chen, Y; Zhao, X; Xu, M; Wang, Y",,,,"Wang, L.; Cheng, K.; Duan, Z.; Chen, Y.; Zhao, X.; Xu, M.; Wang, Y.",,,"HBSAG SEROCLEARANCE AFTER TREATMENT-INDUCED HBEAG SERO CLEARANCE IN CHRONIC HEPATITIS B PATIENTS IN BEIJING, CHINA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, L.; Cheng, K.; Zhao, X.; Wang, Y.] Peking Union Med Coll, Chinese Acad Med Sci, Beijing, Peoples R China; [Duan, Z.; Chen, Y.; Xu, M.] Capital Med Univ, Beijing You, Beijing, Peoples R China",Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PGI4,A509,A509,,10.1016/j.jval.2016.09.945,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301075,0
J,"Wood, R; Ritchie, C; Jones, E; Hu, X; Khandker, RK; Ambegaonkar, BM; Black, CM",,,,"Wood, R.; Ritchie, C.; Jones, E.; Hu, X.; Khandker, R. K.; Ambegaonkar, B. M.; Black, C. M.",,,QUALITY OF LIFE OF PATIENTS WITH ALZHEIMER'S DISEASE - A COMPARISON WITH GENERAL POPULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wood, R.] Adelphi Real World, Bollington, England; [Ritchie, C.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Jones, E.] Adelphi Real World, Manchester, Lancs, England; [Hu, X.; Khandker, R. K.; Ambegaonkar, B. M.; Black, C. M.] Merck & Co Inc, Rahway, NJ 07065 USA",Adelphi Group Ltd; University of Edinburgh; Adelphi Group Ltd; Merck & Company,,,,,,,,,0,3,3,1,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PND64,A436,A436,,10.1016/j.jval.2016.09.519,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606300488,0
J,"Yeo, HY; Shafie, AA",,,,"Yeo, H. Y.; Shafie, A. A.",,,"THE PUBLIC ACCEPTANCE AND WILLINGNESS-TO-PAY (WTP) OF DENGUE VACCINE IN PENANG, MALAYSIA: ASSESSMENT WITH A CONTINGENT VALUATION STUDY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yeo, H. Y.; Shafie, A. A.] Univ Sains Malaysia, George Town, Malaysia",Universiti Sains Malaysia,,,"Shafie, Asrul Akmal/F-7026-2010","Shafie, Asrul Akmal/0000-0002-5629-9270",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PIN33,A913,A913,,10.1016/j.jval.2016.08.130,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303412,0
J,"Yingsakmongkol, W; Limthongkul, W; Singhatanadgige, W; Suthipinijtham, P",,,,"Yingsakmongkol, W.; Limthongkul, W.; Singhatanadgige, W.; Suthipinijtham, P.",,,QUALITY OF LIFE AND ECONOMIC IMPACT OF NEUROPATHIC PAIN AND FIBROMYALGIA SYNDROME IN CHRONIC BACK PAIN PATIENTS IN TERTIARY CARE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yingsakmongkol, W.; Limthongkul, W.; Singhatanadgige, W.] Chulalongkorn Univ, Bangkok, Thailand; [Suthipinijtham, P.] Pfizer Thailand Ltd, Bangkok, Thailand",Chulalongkorn University; Pfizer,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSY17,A882,A882,,10.1016/j.jval.2016.08.303,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606303238,0
J,"Young, H; Moncrieff, G; Greenall, G; Moller, AH",,,,"Young, H.; Moncrieff, G.; Greenall, G.; Moller, A. H.",,,EFFICACY OF THE FIXED COMBINATION OF CALCIPOTRIOL PLUS BETAMETHAS ONE DIPROPIONATE AEROSOL FOAM VS TRADITIONAL TOPICAL TREATMENT IN PSORIASIS: A BAYESIAN NETWORK META-ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Young, H.] Univ Manchester, Manchester, Lancs, England; [Young, H.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Moncrieff, G.] Bicester Hlth Ctr, Bichester, England; [Greenall, G.] DRG Abacus, Bicester, Oxon, England; [Moller, A. H.] LEO Pharma, Ballerup, Denmark",University of Manchester; University of Manchester; LEO Pharma,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PSS3,A562,A562,,10.1016/j.jval.2016.09.1246,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,hybrid,,,2024-03-09,WOS:000396606301354,0
J,"Zhou, J; Ma, F; Cheng, X; Millier, A; Aballea, S; Toumi, M",,,,"Zhou, J.; Ma, F.; Cheng, X.; Millier, A.; Aballea, S.; Toumi, M.",,,SYSTEMATIC LITERATURE REVIEW AND ASSESSMENT OF THE REPORTING QUALITY OF ECONOMIC EVALUATION STUDIES IN NON-SMALL CELL LUNG CANCER IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Zhou, J.; Ma, F.] Creativ Ceut, Beijing, Peoples R China; [Cheng, X.] Creativ Ceut, Hong Kong, Hong Kong, Peoples R China; [Millier, A.; Aballea, S.] Creativ Ceut, Paris, France; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2016,19.0,7.0,,,,PRM15,A851,A851,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EO3PI,,,,,2024-03-09,WOS:000396606303063,0
J,"Maleki-Yazdi, MR; Molimard, M; Keininger, DL; Gruenberger, JB; Carrasco, J; Pitotti, C; Sauvage, E; Chehab, S; Price, D",,,,"Maleki-Yazdi, M. Reza; Molimard, Mathieu; Keininger, Dorothy L.; Gruenberger, Jean-Bernard; Carrasco, Joao; Pitotti, Claudia; Sauvage, Elsa; Chehab, Sara; Price, David",,,"Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal",APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Article,,,,,,,SEVERE COPD EXACERBATIONS; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; SALMETEROL-FLUTICASONE; LUNG-FUNCTION; INDACATEROL; MODERATE; TIOTROPIUM; THERAPY; EFFICACY,"Objective The objective of this study was to assess the cost effectiveness of the dual bronchodilator indacaterol/glycopyrronium (IND/GLY) compared with salmeterol/fluticasone combination (SFC) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who had a history of one or no exacerbations in the previous year, in Canada, France, Italy, and Portugal. Methods A patient-level simulation was developed to compare the costs and outcomes of IND/GLY versus SFC based on data from the LANTERN trial (NCT01709903). Monte-Carlo simulation methods were employed to follow individual patients over various time horizons. Population and efficacy inputs were derived from the LANTERN trial. Considering the payers' perspective, only direct costs were included. Costs and health outcomes were discounted annually at 3.0 % for all countries. Unit costs were taken from publically available sources with all costs converted to euros (sic). The cost base year was 2015. Deterministic and probabilistic sensitivity analyses were undertaken to test the robustness of the model results. Results IND/GLY was found to be the dominant (more effective and less costly) treatment option compared with SFC in all four countries. The use of IND/GLY was associated with mean total cost savings per patient over a lifetime of (sic) 6202, (sic) 1974, (sic) 1611, and (sic) 220 in Canada, France, Italy, and Portugal, respectively. Sensitivity analysis showed that exacerbation rates had the largest impact on incremental costs and quality-adjusted life-years (QALYs). The probability of IND/GLY being cost effective was estimated to be >95 % for thresholds above (sic) 5000/QALY. Conclusion In patients with moderate to severe COPD, IND/GLY is likely to be a cost-effective treatment alternative compared with SFC.","[Maleki-Yazdi, M. Reza] Univ Toronto, Womens Coll Hosp, Div Resp Med, Toronto, ON, Canada; [Molimard, Mathieu] CHU, Dept Med Pharmacol, F-33076 Bordeaux, France; [Molimard, Mathieu] Univ Bordeaux, F-33076 Bordeaux, France; [Keininger, Dorothy L.; Gruenberger, Jean-Bernard] Novartis Pharma AG, Primary Care Franchise, CH-4002 Basel, Switzerland; [Carrasco, Joao] Novartis Farma Prod Farmaceut SA, Hlth Econ & Outcomes Res, Paco De Arcos, Portugal; [Pitotti, Claudia] Novartis Farma SpA, Hlth Econ, Largo Umberto Boccioni 1, I-21041 Origgio, VA, Italy; [Sauvage, Elsa] Novartis Pharma SAS, Strategy Pricing, 2-4,Rue Lionel Terray,BP 308, F-92506 Rueil Malmaison, France; [Chehab, Sara] Novartis Pharmaceut Canada Inc, Hlth Policy & Patient Access, CDN Dorval, 385 Blvd Bouchard, Quebec City, PQ H9S 1A9, Canada; [Price, David] Univ Aberdeen, Div Appl Hlth Sci, Acad Primary Care, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland",University of Toronto; Womens College Hospital; Universite de Bordeaux; CHU Bordeaux; Universite de Bordeaux; Novartis; Novartis; Novartis; Novartis; University of Aberdeen,"Maleki-Yazdi, MR (通讯作者)，Univ Toronto, Womens Coll Hosp, Div Resp Med, Toronto, ON, Canada.",maleki.pccrc@on.aibn.com,"Price, David/H-2837-2019; molimard, mathieu/T-2762-2019","Price, David/0000-0002-9728-9992; molimard, mathieu/0000-0002-4346-8346","Novartis Pharma AG (Basel, Switzerland)","Novartis Pharma AG (Basel, Switzerland)","The authors would like to thank Purnima Pathak (Novartis) for providing writing assistance in the development of this manuscript. The authors would also like to thank Colin Burke and Ronan Mahon (Health Economic Modelers; Novartis) for their modeling support. Medical writing support was funded by Novartis Pharma AG (Basel, Switzerland).",,58,8,8,0,6,SPRINGER INT PUBL AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,OCT,2016,14.0,5.0,,,,,579,594,,10.1007/s40258-016-0256-z,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DY8GF,27516088.0,Green Submitted,,,2024-03-09,WOS:000385366300008,0
J,"Callison, K; Levin, A",,,,"Callison, Kevin; Levin, Adelin",,,"Donor registries, first-person consent legislation, and the supply of deceased organ donors",JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Organ donation; Donor registry; First person consent; Policy evaluation; Difference-in-differences,UNITED-STATES; DONATION; PROCUREMENT; TRANSPLANTATION; IMPACT,"In this paper, we exploit the varied timing in state adoption of organ donor registries and first-person consent (FPC) legislation to examine corresponding changes in the supply of deceased organ donors. Results indicate that the establishment of a state organ donor registry leads to an increase in donation rates of approximately 8%, while the adoption of FPC legislation has no effect on the supply of organ donors. These results reinforce the need to encourage individuals to communicate their donation preferences, either explicitly via a registry or by discussing them with family. (C) 2016 Elsevier B.V. All rights reserved.","[Callison, Kevin; Levin, Adelin] Grand Valley State Univ, 50 Front Ave SW, Grand Rapids, MI 49504 USA",Grand Valley State University,"Callison, K (通讯作者)，Grand Valley State Univ, 50 Front Ave SW, Grand Rapids, MI 49504 USA.",callisok@gvsu.edu,,,Health Resources and Services Administration [234-2005-37011C],Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)),"This work was supported in part by Health Resources and Services Administration contract 234-2005-37011C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.",,31,18,21,0,10,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,SEP,2016,49.0,,,,,,70,75,,10.1016/j.jhealeco.2016.06.009,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DY1QL,27388535.0,,,,2024-03-09,WOS:000384869400006,0
J,"Jones, A; O'Donnell, O; Scott, A; Shields, M",,,,"Jones, Andrew; O'Donnell, Owen; Scott, Anthony; Shields, Michael",,,European and Australasian Econometrics and Health Economics Workshop papers Introduction,HEALTH ECONOMICS,,,English,Editorial Material,,,,,,,,,,,,,"Scott, Anthony/E-6636-2010","Scott, Anthony/0000-0002-2851-5378",,,,,0,0,0,0,9,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,SEP,2016,25.0,9.0,,,SI,,1055,1055,,10.1002/hec.3365,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DT1XA,,"Bronze, Green Published",,,2024-03-09,WOS:000381274200001,0
J,"Kuntz, KM",,,,"Kuntz, Karen M.",,,Decision Modeling for Cost-Utility Analysis,VALUE IN HEALTH,,,English,Editorial Material,,,,,,,,,"[Kuntz, Karen M.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA",University of Minnesota System; University of Minnesota Twin Cities,"Kuntz, KM (通讯作者)，Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.",,,,,,,,6,2,2,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,SEP-OCT,2016,19.0,6.0,,,,,700,701,,10.1016/j.jval.2016.06.003,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DZ5VS,27712693.0,hybrid,,,2024-03-09,WOS:000385930500002,0
J,"Mornet, P",,,,"Mornet, Pauline",,,On the axiomatization of the weakly decomposable inequality indices,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,UNEQUAL INEQUALITIES,"In this paper, we focus on a decomposition property recently introduced in the inequality literature and known as the weak decomposition. Such a property provides interesting analyses by allowing one to separate the within-group contribution to total inequality from the between-group contribution. A limitation of the current method of decomposition is that, depending on the structure absolute, relative, compromise of the inequality index, specific weights have to be used. To avoid such a problem, we propose a unique decomposition property where the weighting functions depend on the size of the population and the mean income. This allows us to characterize a large family of weakly decomposable inequality indices without any recourse to implicit invariance value judgments. (C) 2016 Elsevier B.V. All rights reserved.","[Mornet, Pauline] Univ Montpellier, IAMETA UMR5474, F-34000 Montpellier, France; [Mornet, Pauline] Fac Econ, Av Raymond Dugrand,Site Richter CS 79606, F-34960 Montpellier 2, France",Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS),"Mornet, P (通讯作者)，Univ Montpellier, IAMETA UMR5474, F-34000 Montpellier, France.",mornetpauline34@gmail.com,,"Mornet, Pauline/0000-0002-7828-8505",,,,,15,3,3,0,0,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2016,83.0,,,,,,71,78,,10.1016/j.mathsocsci.2016.07.004,0.0,,,8,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DW8ZC,,,,,2024-03-09,WOS:000383943000009,0
J,"Olafsdóttir, T; Hrafnkelsson, B; Thorgeirsson, G; Asgeirsdóttir, TL",,,,"Olafsdottir, Thorhildur; Hrafnkelsson, Birgir; Thorgeirsson, Gudmundur; Asgeirsdottir, Tinna Laufey",,,The tax-free year in Iceland: A natural experiment to explore the impact of a short-term increase in labor supply on the risk of heart attacks,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Coronary heart disease; Acute myocardial infarction; Labor supply; Natural experiment; Iceland,BUSINESS CYCLES; ECONOMIC-CONDITIONS; HEALTH BEHAVIORS; ALCOHOL-ABUSE; MORTALITY; RECESSIONS; DISEASE; TIMES; SWEDEN; DRINKING,"Evidence is mixed on whether society-wide economic conditions affect cardiovascular health and the reasons for the suggested relationship are largely untested. We explore whether a short-term increase in labor supply affects the probability of acute myocardial infarctions, using a naturalexperiment in Iceland. In 1987 personal income taxes were temporarily reduced to zero, resulting in an overall increase in labor supply. We merge and analyze individual-level, registry-based data on earnings and AMIs including all Icelandic men and women aged 45-74 during the period 1982-1992. The results support the prominent hypothesis of increased work as a mechanism explaining worsening heart health in upswings, for men aged 45-64 who were self-employed. We furthermore find a larger increase in probability of AMIs during the tax-free year in men aged 45-54 than men aged 55-64. (C) 2016 Elsevier B.V. All rights reserved.","[Olafsdottir, Thorhildur; Asgeirsdottir, Tinna Laufey] Univ Iceland, IS-101 Reykjavik, Iceland; [Hrafnkelsson, Birgir] Univ Iceland, Dunhagi 5, IS-107 Reykjavik, Iceland; [Thorgeirsson, Gudmundur] Univ Iceland, Natl Univ Hosp, Landspitali, IS-101 Reykjavik, Iceland",University of Iceland; University of Iceland; University of Iceland,"Olafsdóttir, T (通讯作者)，Univ Iceland, IS-101 Reykjavik, Iceland.",tho32@hi.is,"Ásgeirsdóttir, Tinna Laufey/ISA-3677-2023","Olafsdottir, Thorhildur/0000-0003-2003-9984",University of Iceland Research Fund; Icelandic Research Fund [130611-051]; Icelandic Student Innovation Fund,University of Iceland Research Fund; Icelandic Research Fund; Icelandic Student Innovation Fund,"We gratefully acknowledge financial support from the University of Iceland Research Fund, the Icelandic Research Fund (Grant number 130611-051) and the Icelandic Student Innovation Fund. We thank The Directorate of Health and Statistics Iceland for the use of data. We thank Hildur Sigurdardottir and Eyjolfur Sigurdsson at Statistics Iceland, Kristinn Jonsson and Gudrun Kr. Gudfinnsdottir at The Directorate of Health, and Thor Aspelund and Elias Freyr Gudmundsson at the Icelandic Heart Association for valuable help with the data. We also thank the Editor, David Cutler, and two anonymous referees for their valuable comments and suggestions. The paper greatly benefited from discussions with and comments from Michael Grossman, Theodore Joyce and Gylfi Zoega. There are no conflicts of interest to disclose.",,48,5,5,0,11,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,SEP,2016,49.0,,,,,,14,27,,10.1016/j.jhealeco.2016.06.006,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DY1QL,27372576.0,,,,2024-03-09,WOS:000384869400002,0
J,"Palomares, A; Pukelsheim, F; Ramírez, V",,,,"Palomares, Antonio; Pukelsheim, Friedrich; Ramirez, Victoriano",,,The whole and its parts: On the coherence theorem of Balinski and Young,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,APPORTIONMENT,"A new proof of the Coherence Theorem of Balinski and Young is presented. The theorem elucidates the methods used to apportion parliamentary seats among political parties proportionately to their vote counts, or among geographical districts proportionately to their population figures. A proportional apportionment method is coherent when each seat apportionment among all claimants is such that every part of it is a valid solution for the subset of claimants concerned. The Coherence Theorem states that every coherent apportionment method is compatible with a divisor method. (C) 2016 Elsevier B.V. All rights reserved.","[Palomares, Antonio; Ramirez, Victoriano] Univ Granada, Dept Matemat Aplicada, E-18071 Granada, Spain; [Pukelsheim, Friedrich] Univ Augsburg, Inst Math, Augsburg, Germany",University of Granada; University of Augsburg,"Pukelsheim, F (通讯作者)，Univ Augsburg, Inst Math, Augsburg, Germany.",anpalom@ugr.es; pukelsheim@math.uni-augsburg.de; vramirez@ugr.es,"Palomares, Antonio/M-2463-2014",,,,,,12,3,4,1,2,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2016,83.0,,,,,,11,19,,10.1016/j.mathsocsci.2016.06.001,0.0,,,9,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DW8ZC,,Green Submitted,,,2024-03-09,WOS:000383943000003,0
J,"Pintér, M",,,,"Pinter, Miklos",,,A cardinal convex game with empty core,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,,"In this note we present a cardinal convex game (Sharkey, 1981) with empty core. Sharkey assumed that V(N) is convex, we do not do so, hence we do not contradict Sharkey's result. (C) 2016 Elsevier B.V. All rights reserved.","[Pinter, Miklos] Univ Pecs, Fac Business & Econ, Pecs, Hungary; [Pinter, Miklos] Univ Pecs, MTA BCE Lendulet Strateg Interact Res Grp, Pecs, Hungary",University of Pecs; University of Pecs,"Pintér, M (通讯作者)，Univ Pecs, Fac Business & Econ, Pecs, Hungary.;Pintér, M (通讯作者)，Univ Pecs, MTA BCE Lendulet Strateg Interact Res Grp, Pecs, Hungary.",pinterm@ktk.pte.hu,"Pinter, Miklos/K-3074-2019",,"National Research, Development and Innovation Office (NKFIH) [K 101224, K 115538]","National Research, Development and Innovation Office (NKFIH)","I thank Peter Sudholter, Peter Biro, the anonymous reviewer, the AE and the participants of the Corvinus Game Theory Seminar for their comments. I acknowledge the support by the National Research, Development and Innovation Office (NKFIH, K 101224 and K 115538).",,6,0,0,0,0,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2016,83.0,,,,,,9,10,,10.1016/j.mathsocsci.2016.06.002,0.0,,,2,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DW8ZC,,,,,2024-03-09,WOS:000383943000002,0
J,"Bosi, S; Fontaine, P; Le Van, C",,,,"Bosi, Stefano; Fontaine, Patrice; Cuong Le Van",,,Interest rates parity and no arbitrage as equivalent equilibrium conditions in the international financial assets and goods markets,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,COMPETITIVE-EQUILIBRIUM; EXISTENCE,"In this paper, we consider a two-period consumption model with many financial assets. In the spirit of Hart (1974), consumers purchase financial assets in period 0 and consume in period 1. We differ from Hart by considering that each agent is a country. We provide conditions for the existence of an equilibrium in both international financial assets and goods markets. First, we introduce a weaker notion of Uncovered Interest (rate) Parity (UIP) called Weak Uncovered Interest (rate) Parity (WUIP), and we show its equivalence to the no-arbitrage condition in the international financial markets. Second, we introduce the concept of common no arbitrage and we show its equivalence to the UIP. These results bridge concepts of no arbitrage in general equilibrium theory and financial microeconomics, and of interest parity in international financial macroeconomics. In a multi-country model with many currencies and only one good, we introduce a country-specific conversion rate which transforms the returns on assets valued in local currency into units of physical good. We define also the exchange rates between currencies of different countries. The UIP is required for the existence of an equilibrium in both international financial assets and goods markets and for the existence of the Law of One Price. (C) 2016 Elsevier B.V. All rights reserved.","[Bosi, Stefano] Univ Evry, EPEE, Evry, France; [Fontaine, Patrice] Eurofidai, CNRS, Leonard Vinci Res Ctr, St Martin Dheres, France; [Cuong Le Van] IPAG Business Sch, CNRS, PSE, VCREME, Paris, France",Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); IPAG Business School; Centre National de la Recherche Scientifique (CNRS),"Le Van, C (通讯作者)，IPAG Business Sch, CNRS, PSE, VCREME, Paris, France.",levan@univ-paris1.fr,,"fontaine, patrice/0000-0002-6402-1068",project LABEX MME-DII [ANR11-LBX-0023-01],project LABEX MME-DII,We are grateful to the two Referees for their thoughtful remarks and questions. We are also grateful to Saqib Jafarey for valuable comments and to the participants of the NBER General Equilibrium Conference held in Bloomington on September 2012. This research has been conducted as part of the project LABEX MME-DII (ANR11-LBX-0023-01).,,8,2,2,0,12,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,JUL,2016,82.0,,,,,,26,36,,10.1016/j.mathsocsci.2016.04.002,0.0,,,11,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DS2KN,,Green Submitted,,,2024-03-09,WOS:000380598500003,0
J,"Hammer, J; Spears, D",,,,"Hammer, Jeffrey; Spears, Dean",,,Village sanitation and child health: Effects and external validity in a randomized field experiment in rural India,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Sanitation; Health; Experiment; External validity; India,HEIGHT; ENTEROPATHY; GROWTH; IMPROVEMENTS; BANGLADESH; MORTALITY; ECONOMICS; DIARRHEA; BEHAVIOR; DISEASE,"Over a billion people worldwide defecate in the open, with important consequences for early-life health and human capital accumulation in developing countries. We report a cluster randomized controlled trial of a village sanitation intervention conducted in rural Maharashtra, India designed to identify an effect of village sanitation on average child height, an outcome of increasing importance to economists. We find an effect of approximately 0.3 height-for-age standard deviations, which is consistent with observations and hypotheses in economic and health literatures. We further exploit details of the planning and implementation of the experiment to study treatment heterogeneity and external validity. (C) 2016 The Author(s). Published by Elsevier B.V.","[Hammer, Jeffrey; Spears, Dean] Princeton Univ, Woodrow Wilson Sch, 348 Wallace Hall, Princeton, NJ 08544 USA; [Spears, Dean] Indian Stat Inst, Econ & Planning Unit, Delhi, India",Princeton University; Indian Statistical Institute; Indian Statistical Institute Delhi,"Spears, D (通讯作者)，Princeton Univ, Woodrow Wilson Sch, 348 Wallace Hall, Princeton, NJ 08544 USA.",dspears@princeton.edu,,,Water and Sanitation Program (WSP) of the World Bank; WSP; Government of Maharashtra,Water and Sanitation Program (WSP) of the World Bank; WSP; Government of Maharashtra,"The field experiment described in this article was funded by the Water and Sanitation Program (WSP) of the World Bank, and implemented by a partnership between WSP and the Government of Maharashtra.",,58,73,86,3,15,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JUL,2016,48.0,,,,,,135,148,,10.1016/j.jhealeco.2016.03.003,0.0,,,14,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DQ3HO,27179199.0,"hybrid, Green Published",,,2024-03-09,WOS:000379093600010,0
J,"Harris, D; Leybourne, SJ; Taylor, AMR",,,,"Harris, David; Leybourne, Stephen J.; Taylor, A. M. Robert",,,Tests of the co-integration rank in VAR models in the presence of a possible break in trend at an unknown point,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Co-integration rank; Vector autoregression; Error-correction model; Trend break; Break point estimation; Information criteria,OIL-PRICE SHOCK; UNIT-ROOT TESTS; STRUCTURAL BREAKS; GREAT CRASH; INSTABILITY; TIME; NULL,"In this paper we consider the problem of testing for the co-integration rank of a vector autoregressive process in the case where a trend break may potentially be present in the data. It is known that unmodelled trend breaks can result in tests which are incorrectly sized under the null hypothesis and inconsistent under the alternative hypothesis. Extant procedures in this literature have attempted to solve this inference problem but require the practitioner to either assume that the trend break date is known or to assume that any trend break cannot occur under the co-integration rank null hypothesis being tested. These procedures also assume the autoregressive lag length is known to the practitioner. All of these assumptions would seem unreasonable in practice. Moreover in each of these strands of the literature there is also a presumption in calculating the tests that a trend break is known to have happened. This can lead to a substantial loss in finite sample power in the case where a trend break does not in fact occur. Using information criteria based methods to select both the autoregressive lag order and to choose between the trend break and no trend break models, using a consistent estimate of the break fraction in the context of the former, we develop a number of procedures which deliver asymptotically correctly sized and consistent tests of the co-integration rank regardless of whether a trend break is present in the data or not. By selecting the no break model when no trend break is present, these procedures also avoid the potentially large power losses associated with the extant procedures in such cases. (C) 2016 The Authors. Published by Elsevier B.V.","[Harris, David] Univ Melbourne, Dept Econ, Melbourne, Vic 3010, Australia; [Leybourne, Stephen J.] Univ Nottingham, Sch Econ, Nottingham NG7 2RD, England; [Taylor, A. M. Robert] Univ Essex, Essex Business Sch, Colchester CO4 3SQ, Essex, England",University of Melbourne; University of Nottingham; University of Essex,"Taylor, AMR (通讯作者)，Univ Essex, Essex Business Sch, Colchester CO4 3SQ, Essex, England.",robert.taylor@essex.ac.uk,"Harris, David/W-4786-2019","Taylor, Anthony Michael Robert/0000-0003-0567-0276; Harris, David/0000-0002-4237-6888",Economic and Social Research Council of the United Kingdom [ES/M01147X/1]; ESRC [ES/M01147X/1] Funding Source: UKRI; Economic and Social Research Council [ES/M01147X/1] Funding Source: researchfish,Economic and Social Research Council of the United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"We are grateful to the Guest Editor, Jorg Breitung, and three anonymous referees for their helpful and constructive comments on earlier versions of this paper. Taylor gratefully acknowledges financial support provided by the Economic and Social Research Council of the United Kingdom under research grant ES/M01147X/1.",,33,6,7,0,13,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUN,2016,192.0,2.0,,,,,451,467,,10.1016/j.jeconom.2016.02.010,0.0,,,17,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DL6HG,,"Green Submitted, hybrid, Green Accepted",,,2024-03-09,WOS:000375739700010,0
J,"Prosser, LA",,,,"Prosser, Lisa A.",,,Statistical Methods for the Analysis of Discrete-Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force,VALUE IN HEALTH,,,English,Editorial Material,,,,,,,,,"[Prosser, Lisa A.] Univ Michigan, Ann Arbor, MI 48109 USA",University of Michigan System; University of Michigan,"Prosser, LA (通讯作者)，Univ Michigan, Ann Arbor, MI 48109 USA.",,,,,,,,6,5,5,5,17,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUN,2016,19.0,4.0,,,,,298,299,,10.1016/j.jval.2016.05.002,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DO9GU,27325320.0,hybrid,,,2024-03-09,WOS:000378094200002,0
J,"Smieliauskas, F",,,,"Smieliauskas, Fabrice",,,CONFLICTS OF INTEREST IN MEDICAL TECHNOLOGY MARKETS: EVIDENCE FROM ORTHOPEDIC SURGERY,HEALTH ECONOMICS,,,English,Article,,,,,,financial conflicts of interest; physician agency; orthopedic surgery; medical devices; physician industry relationships,BEHAVIOR; RISK,"Financial relationships between physicians and industry are vital to biomedical innovation yet create the potential for conflicts of interest in medical practice. I consider an inducement model of the role of financial relationships in health care markets, where consulting payments induce physicians to use more devices of the firms that sponsor them. To test the model, I exploit a policy shock, whereby government monitoring of payments to joint replacement surgeons resulted in declines of over 60% in both total payments and in the number of physicians receiving payments from 2007 to 2008. Using hospital discharge data from three states, I find that the loss of payments leads physicians to switch 7 percentage points of their device utilization from their sponsoring firms' devices to other firms' devices, an effect which is concentrated among surgeons with low switching costs. These results offer support for the inducement model. I also find evidence of an increase in medical productivity following the policy intervention, which suggests conditions under which regulation of financial relationships would be socially beneficial. Copyright (C) 2015 John Wiley & Sons, Ltd.","[Smieliauskas, Fabrice] Univ Chicago, Dept Publ Hlth Sci, 5841 South Maryland Ave MC2007,Room W249, Chicago, IL 60637 USA",University of Chicago,"Smieliauskas, F (通讯作者)，Univ Chicago, Dept Publ Hlth Sci, 5841 South Maryland Ave MC2007,Room W249, Chicago, IL 60637 USA.",fsmiel@uchicago.edu,,"Smieliauskas, Fabrice/0000-0002-9466-9308",National Institute on Aging [T32-AG00186]; Canadian Social Science and Humanities Research Council,National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Canadian Social Science and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)),"This research has been funded through fellowships from the National Institute on Aging, Grant Number T32-AG00186, and the Canadian Social Science and Humanities Research Council.",,31,9,12,0,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JUN,2016,25.0,6.0,,,,,723,739,,10.1002/hec.3177,0.0,,,17,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DK5QT,25845858.0,,,,2024-03-09,WOS:000374975500007,0
J,"Aggarwal, S; Topaloglu, H",,,,"Aggarwal, S.; Topaloglu, H.",,,TRENDS IN ER VISITS DUE TO HYPERKALEMIA IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV16,A42,A42,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000231,0
J,"Akude, P; Mahjoub, R; McCabe, C; Paulden, M",,,,"Akude, P.; Mahjoub, R.; McCabe, C.; Paulden, M.",,,EVALUATING THE COST EFFECTIVENESS OF PERSONALISED MEDICINE CO-DEPENDENT TECHNOLOGIES: A CONCEPTUAL FRAMEWORK,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Akude, P.; Mahjoub, R.; McCabe, C.; Paulden, M.] Univ Alberta, Edmonton, AB, Canada",University of Alberta,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM49,A80,A80,,10.1016/j.jval.2016.03.655,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000437,0
J,"Al Suwaidi, AS",,,,"Al Suwaidi, A. S.",,,THE FUTURE OF HTA IN EVOLVING HEALTH CARE SYSTEMS: DEVELOPING HTA STRATEGY FOR THE UNITED ARAB EMIRATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Al Suwaidi, A. S.] Boston Univ, Sch Publ Hlth, Boston, MA USA",Boston University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP190,A290,A290,,10.1016/j.jval.2016.03.742,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600449,0
J,"Altundag, K; Basaran, G; Oksuzoglu, B; Oven, B; Ozguroglu, M; Aydin, D; Hacibedel, B; Helvacioglu, K; Tuna, E; Tatar, M",,,,"Altundag, K.; Basaran, G.; Oksuzoglu, B.; Oven, B.; Ozguroglu, M.; Aydin, D.; Hacibedel, B.; Helvacioglu, K.; Tuna, E.; Tatar, M.",,,COST OF TREATMENT OF HR+/HER2-POST MENOPAUSAL ADVANCED/METASTATIC BREAST CANCER PATIENTS IN TURKEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Altundag, K.; Tatar, M.] Hacettepe Univ, Ankara, Turkey; [Basaran, G.] Acibadem Hosp, Istanbul, Turkey; [Oksuzoglu, B.] Ankara Oncol Training & Res Hosp, Ankara, Turkey; [Oven, B.] Haydarpasa Numune Res & Training Hosp, Istanbul, Turkey; [Ozguroglu, M.] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey; [Aydin, D.; Hacibedel, B.; Helvacioglu, K.] Pfizer Pharmaceut Inc, Istanbul, Turkey; [Tuna, E.] Polar Hlth Econ & Policy Consultancy, Ankara, Turkey",Hacettepe University; Acibadem Hastaneleri; Acibadem Hospitals Group; Dr. Abdurrahman Yurtaslan Oncology Hospital; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul University; Istanbul University - Cerrahpasa; Pfizer; Polar Health Economics & Policy,,,"MUSTAFA, ÖZGÜROĞLU/A-8234-2016","MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628",,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN70,A146,A146,,10.1016/j.jval.2016.03.1569,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000244,0
J,"Baxi, S; Sherman, E; You, M; Bobiak, S",,,,"Baxi, S.; Sherman, E.; You, M.; Bobiak, S.",,,PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK CANCER: UNDERSTANDING THE BURDEN OF DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Baxi, S.; Sherman, E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [You, M.; Bobiak, S.] Bristol Myers Squibb, Plainsboro, NJ USA",Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN196,A168,A168,,10.1016/j.jval.2016.03.1529,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000367,0
J,"Bhattacharjee, S; Goldstone, L; Bhattacharya, R; Warholak, T",,,,"Bhattacharjee, S.; Goldstone, L.; Bhattacharya, R.; Warholak, T.",,,"PREVALENCE, PATTERNS, AND PREDICTORS OF PSYCHOTROPIC POLYPHARMACY AMONG COMUNITY-DWELLING ELDERLY INDIVIDUALS WITH PARKINSON'S DISEASE IN THE UNITED STATES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bhattacharjee, S.; Goldstone, L.; Warholak, T.] Univ Arizona, Tucson, AZ USA",University of Arizona,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PND54,A68,A68,,10.1016/j.jval.2016.03.215,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000373,0
J,"Burger, CD; Ozbay, B; Riehle, E; Montejano, LB; White, RJ",,,,"Burger, C. D.; Ozbay, B.; Riehle, E.; Montejano, L. B.; White, R. J.",,,HEALTH CARE RESOURCE UTILIZATION AND COST AMONG PULMONARY ARTERIAL HYPERTENSION PATIENTS BEFORE AND AFTER SEQUENTIAL COMBINATION THERAPY INITIATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Burger, C. D.] Mayo Clin, Jacksonville, FL 32224 USA; [Ozbay, B.] Gilead Sci, Foster City, CA USA; [Riehle, E.] Truven Hlth Analyt, Ann Arbor, MI USA; [Montejano, L. B.; White, R. J.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA",Mayo Clinic; Gilead Sciences; University of Rochester,,,,,,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV59,A49,A50,,10.1016/j.jval.2016.03.124,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000273,0
J,"Chopra, I; Sambamoorthi, U",,,,"Chopra, I; Sambamoorthi, U.",,,ANTIHYPERTENSIVE AND ANTILIPEMIC MEDICATION USE AND EMERGENCY ROOM EXPENDITURES AMONG ADULTS WITH COEXISTING HYPERTENSION AND HYPERLIPIDEMIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chopra, I; Sambamoorthi, U.] West Virginia Univ, Morgantown, WV USA",West Virginia University,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV96,A56,A57,,10.1016/j.jval.2016.03.147,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000310,0
J,"Dagenais, S; Kang, A; Scranton, R",,,,"Dagenais, S.; Kang, A.; Scranton, R.",,,ANALYSIS OF TOTAL HOSPITAL COSTS FOR MEDICARE PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY WITH BUPIVACAINE LIPOSOMAL INJECTABLE SUSPENSION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dagenais, S.; Kang, A.; Scranton, R.] Pacira Pharmaceut Inc, Parsippany, NJ USA",,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS26,A229,A229,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600108,0
J,"Davies-Teye, B; Awalime, DK; Davies-Teye, S; Vanotoo, L",,,,"Davies-Teye, B.; Awalime, D. K.; Davies-Teye, S.; Vanotoo, L.",,,ECONOMIC EVALUATION OF 2014 CHOLERA OUTBREAK IN GHANA: A PATIENT LEVEL AND HEALTH CARE SYSTEM COST ANALYSIS IN AN URBAN SETTINGS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Davies-Teye, B.; Awalime, D. K.; Davies-Teye, S.] Drifney Consult Ltd, Accra, Ghana; [Davies-Teye, B.; Vanotoo, L.] Ghana Hlth Serv, Accra, Ghana; [Awalime, D. K.] Univ Ghana Legon, Accra, Ghana; [Vanotoo, L.] Promise Ghana, Accra, Ghana",Ghana Health Service,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS34,A15,A16,,10.1016/j.jval.2016.03.284,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000082,0
J,"Delatore, P; Bourque, M; Taylor, J; Ferko, N",,,,"Delatore, P.; Bourque, M.; Taylor, J.; Ferko, N.",,,THE VALUE OF SKU REDUCTION AND STANDARDIZATION INITIATIVES WITHIN A HOSPITAL SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Delatore, P.] CR Bard Inc, Murray Hill, NJ USA; [Bourque, M.; Ferko, N.] Cornerstone Res Grp Inc, Burlington, ON, Canada; [Taylor, J.] Bard Med Div, Covington, GA USA",Cornerstone Research Group,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP206,A293,A293,,10.1016/j.jval.2016.03.843,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600465,0
J,"Feinberg, BA; Lal, L; Garofalo, DF; Mujumdar, U",,,,"Feinberg, B. A.; Lal, L.; Garofalo, D. F.; Mujumdar, U.",,,IDENTIFYING BEST PRACTICES FOR USE OF TEXT DATA IN HEALTH ECONOMICS AND OUTCOMES RESEARCH USING NATURAL LANGUAGE PROCESSING,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Feinberg, B. A.; Lal, L.; Garofalo, D. F.; Mujumdar, U.] Cardinal Hlth, Dublin, OH USA",Cardinal Health Inc,,,"Feinberg, Bruce/AAX-9378-2021","Feinberg, Bruce/0000-0001-9267-9994",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM64,A82,A82,,10.1016/j.jval.2016.03.1776,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000452,0
J,"Feinberg, BA; Garofalo, DF; Drenning, J",,,,"Feinberg, B. A.; Garofalo, D. F.; Drenning, J.",,,SELECT RESOURCE UTILIZATION DURING ADVANCED RENAL CELL CARCINOMA TREATMENT: COMPARISON OF TARGETED DRUG CLASSES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Feinberg, B. A.; Garofalo, D. F.] Cardinal Hlth, Dublin, OH USA; [Drenning, J.] Cardinal Hlth, Dallas, TX USA",Cardinal Health Inc; Cardinal Health Inc,,,"Feinberg, Bruce/AAX-9378-2021","Feinberg, Bruce/0000-0001-9267-9994",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,CO4,A2,A2,,10.1016/j.jval.2016.03.033,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000008,0
J,"Fernández-Val, I; Weidner, M",,,,"Fernandez-Val, Ivan; Weidner, Martin",,,"Individual and time effects in nonlinear panel models with large N, T",JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Panel data; Nonlinear model; Dynamic model; Asymptotic bias correction; Fixed effects; Time effects,DISCRETE-CHOICE MODELS; LINEAR-REGRESSION; DATA ESTIMATORS; BIAS REDUCTION; INFERENCE; PARAMETERS; ASYMPTOTICS,"We derive fixed effects estimators of parameters and average partial effects in (possibly dynamic) nonlinear panel data models with individual and time effects. They cover logit, probit, ordered probit, Poisson and Tobit models that are important for many empirical applications in micro and macroeconomics. Our estimators use analytical and jackknife bias corrections to deal with the incidental parameter problem, and are asymptotically unbiased under asymptotic sequences where N/T converges to a constant. We develop inference methods and show that they perform well in numerical examples, (C) 2016 The Authors. Published by Elsevier B.V.","[Fernandez-Val, Ivan] Boston Univ, Dept Econ, 270 Bay State Rd, Boston, MA 02215 USA; [Weidner, Martin] UCL, Dept Econ, Gower St, London WC1E 6BT, England; [Weidner, Martin] Inst Fiscal Studies, Ctr Microdata Methods & Practice, 7 Ridgmount St, London WC1E 7AE, England",Boston University; University of London; University College London; University of London; University College London; London School Economics & Political Science,"Fernández-Val, I (通讯作者)，Boston Univ, Dept Econ, 270 Bay State Rd, Boston, MA 02215 USA.",ivanf@bu.edu; m.weidner@ucl.ac.uk,"Fernandez-Val, Ivan/G-3455-2016","Weidner, Martin/0000-0001-6135-6164",National Science Foundation [SES-1060889]; Economic and Social Research Council through the ESRC Centre for Microdata Methods and Practice [RES-589-28-0001]; ESRC [ES/M010147/1] Funding Source: UKRI; Economic and Social Research Council [ES/M010147/1] Funding Source: researchfish,National Science Foundation(National Science Foundation (NSF)); Economic and Social Research Council through the ESRC Centre for Microdata Methods and Practice(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),Financial support from the National Science Foundation grant no. (SES-1060889) and the Economic and Social Research Council through the ESRC Centre for Microdata Methods and Practice grant RES-589-28-0001 is gratefully acknowledged.,,42,135,155,8,42,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAY,2016,192.0,1.0,,,,,291,312,,10.1016/j.jeconom.2015.12.014,0.0,,,22,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DG9EF,,"Green Submitted, Green Published, hybrid",,,2024-03-09,WOS:000372384900016,0
J,"Gaitonde, P; LyttleNguessan, CJ; Cannon-Dang, E; Shah, AB; Oehrlein, EM; Khan, ZM",,,,"Gaitonde, P.; LyttleNguessan, C. J.; Cannon-Dang, E.; Shah, A. B.; Oehrlein, E. M.; Khan, Z. M.",,,OPPORTUNITIES FOR THE ISPOR STUDENT NETWORK TO COMPLEMENT THE CURRENT ACADEMIC CURRICULUM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gaitonde, P.] Univ Maryland, Baltimore, MD 21201 USA; [LyttleNguessan, C. J.] Florida A&M Univ, Tallahassee, FL USA; [Cannon-Dang, E.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Shah, A. B.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Oehrlein, E. M.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Khan, Z. M.] Celgene Corp, Summit, NJ USA",University System of Maryland; University of Maryland Baltimore; State University System of Florida; Florida A&M University; Jefferson University; University of Arkansas System; University of Arkansas Medical Sciences; University System of Maryland; University of Maryland Baltimore; Bristol-Myers Squibb; Celgene Corporation,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP162,A285,A285,,10.1016/j.jval.2016.03.1948,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600422,0
J,"Gonzalez-McQuire, S; Yong, K; Flinois, A; Gazzola, C; Schoen, P; Campioni, M; DeCosta, L; Fink, L",,,,"Gonzalez-McQuire, S.; Yong, K.; Flinois, A.; Gazzola, C.; Schoen, P.; Campioni, M.; DeCosta, L.; Fink, L.",,,Chart Review Study to Evaluate Health Care Resource Utilization of Patients with Symptomatic Multiple Myeloma in the United Kingdom,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gonzalez-McQuire, S.; Schoen, P.; Campioni, M.] Amgen Europe GmbH, Zug, Switzerland; [Yong, K.] UCL, London, England; [Flinois, A.; Gazzola, C.; Fink, L.] Kantar Hlth, Paris, France; [DeCosta, L.] Amgen Ltd, Uxbridge, Middx, England",Amgen; AMGEN Europe; University of London; University College London; Amgen; Amgen Limited,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN124,A156,A156,,10.1016/j.jval.2016.03.1849,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000297,0
J,"Gupta, J; Kamra, S; Joshi, P; Sehgal, M",,,,"Gupta, J.; Kamra, S.; Joshi, P.; Sehgal, M.",,,A SYSTEMATIC REVIEW TO ASSESS THE IMPACT OF NON-ADHERENCE TO TREATMENTS ON HEALTH CARE COST IN CHRONIC MYELOID LEUKEMIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gupta, J.] PAREXEL Int, New Delhi, India; [Kamra, S.; Joshi, P.; Sehgal, M.] PAREXEL Int, Chandigarh, India",Parexel International; Parexel International,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN128,A156,A157,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000301,0
J,"Hanmer, J; Hess, R; Roberts, MS; Rothenberger, S; Yu, L",,,,"Hanmer, J.; Hess, R.; Roberts, M. S.; Rothenberger, S.; Yu, L.",,,"AGE, COHORT, AND HEALTH-RELATED QUALITY OF LIFE: AN AGE-PERIOD-COHORT ANALYSIS OF THE NATIONAL HEALTH INTERVIEW SURVEY",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hanmer, J.; Rothenberger, S.; Yu, L.] Univ Pittsburgh, Pittsburgh, PA USA; [Hess, R.] Univ Utah, Salt Lake City, UT USA; [Roberts, M. S.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA",Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,,,,,,,,,0,0,0,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP155,A284,A284,,10.1016/j.jval.2016.03.1941,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600415,0
J,"Hartman, JD; Craig, BM; Blackburn, C; Simmons, V",,,,"Hartman, J. D.; Craig, B. M.; Blackburn, C.; Simmons, V",,,THE ASSOCIATION BETWEEN MATERNAL SMOKING DURING PREGNANCY AND CHILD QUALITY-ADJUSTED LIFE YEARS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hartman, J. D.; Blackburn, C.; Simmons, V] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Craig, B. M.] Univ S Florida, Dept Econ, Tampa, FL USA",H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRS42,A117,A117,,10.1016/j.jval.2016.03.463,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000088,0
J,"Hytönen, ML; Roine, RP; Ruuhela, R; Sintonen, H; Virkkula, P; Ylitalo-Heikkilä, M",,,,"Hytonen, M. L.; Roine, R. P.; Ruuhela, R.; Sintonen, H.; Virkkula, P.; Ylitalo-Heikkila, M.",,,DO RHINOLOGIC PATIENTS HAVE SEASONAL VARIATION IN GENERIC OR DISEASE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hytonen, M. L.; Virkkula, P.; Ylitalo-Heikkila, M.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Roine, R. P.] Helsinki & Uusimaa Hosp Dist, Helsinki, Finland; [Ruuhela, R.] Finnish Meteorol Inst, Helsinki, Finland; [Sintonen, H.] Univ Helsinki, Helsinki, Finland",University of Helsinki; Helsinki University Central Hospital; Finnish Meteorological Institute; University of Helsinki,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM29,A76,A76,,10.1016/j.jval.2016.03.635,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000417,0
J,"Ishak, KJ; Rael, M; Proskorovsky, I",,,,"Ishak, K. J.; Rael, M.; Proskorovsky, I",,,INDIRECT TREATMENT COMPARISONS WITH GUIDED MATCHING-BASED ADJUSTMENT: A HYBRID OF THE STC AND MAIC TECHNIQUES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ishak, K. J.; Proskorovsky, I] Evidera, Montreal, PQ, Canada; [Rael, M.] Evidera, San Francisco, CA USA",Evidera,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM196,A105,A106,,10.1016/j.jval.2016.03.1685,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000024,0
J,"Kiyingi, R; Tuhebwe, D; Nalwanga, E; Ssegujja, E; Anguzu, R; Nakku-Joloba, E",,,,"Kiyingi, R.; Tuhebwe, D.; Nalwanga, E.; Ssegujja, E.; Anguzu, R.; Nakku-Joloba, E.",,,"KNOWLEDGE, ATTITUDES, AND PRACTICE TOWARDS USE OF LONG-TERM FAMILY PLANNING METHODS AMONG WOMEN AGED 15-49 YEARS: A COMMUNITY-BASED SURVEY IN AN URBAN UGANDAN SETTING",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kiyingi, R.; Tuhebwe, D.; Nalwanga, E.; Ssegujja, E.; Nakku-Joloba, E.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Anguzu, R.] El Channun Community Hlth Initiat ELCOHIN, Kampala, Uganda",Makerere University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS56,A19,A19,,10.1016/j.jval.2016.03.411,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000103,0
J,"Kogut, S; Babcock, Z",,,,"Kogut, S.; Babcock, Z.",,,ESTIMATING THE POTENTIAL COST EFFECTIVENESS OF MAINTENANCE THERAPY FOLLOWING CHEMOTHERAPY FOR MALIGNANT MESOTHELIOMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kogut, S.; Babcock, Z.] Univ Rhode Isl, Kingston, RI 02881 USA",University of Rhode Island,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN88,A149,A149,,10.1016/j.jval.2016.03.1587,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000262,0
J,"Lasalvia, P; Baquero, L; Restrepo, P; OtaloraOtálora, M; Castaneda-CardonaCastañeda-Cardona, C; Rosselli, D",,,,"Lasalvia, P.; Baquero, L.; Restrepo, P.; OtaloraOtalora, M.; Castaneda-CardonaCastaneda-Cardona, C.; Rosselli, D.",,,"COST-EFFECTIVENESS OF DULAGLUTIDE, LIRAGLUTIDE, AND GLARGINE IN ADULT PATIENTS WITH DIABETES MELLITUS IN COLOMBIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lasalvia, P.; Baquero, L.; Restrepo, P.; OtaloraOtalora, M.] Pontificia Univ Javeriana, Bogota, Colombia; [Castaneda-CardonaCastaneda-Cardona, C.] Neuroeconomix, Bogota, Colombia; [Rosselli, D.] Pontificia Univ Javeriana, Bogota, Colombia",Pontificia Universidad Javeriana; Pontificia Universidad Javeriana,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,EN3,A7,A7,,10.1016/j.jval.2016.03.052,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000035,0
J,"Lopatina, E; Marshall, DA; Lacny, SL; Emery, C",,,,"Lopatina, E.; Marshall, D. A.; Lacny, S. L.; Emery, C.",,,ECONOMIC IMPACT OF A NEUROMUSCULAR TRAINING PREVENTION STRATEGY TO REDUCE INJURIES IN YOUTH SOCCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lopatina, E.; Lacny, S. L.; Emery, C.] Univ Calgary, Calgary, AB, Canada; [Marshall, D. A.] Alberta Bone & Joint Hlth Inst, Calgary, AB, Canada",University of Calgary,,,"Emery, Carolyn/AAI-2761-2020",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS48,A233,A233,,10.1016/j.jval.2016.03.1148,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600130,0
J,"Maervoet, J; Moise, P; Naidoo, S",,,,"Maervoet, J.; Moise, P.; Naidoo, S.",,,OVERVIEW AND COMPARISON OF FRAMEWORKS FOR THE VALUATION OF ONCOLOGY DRUGS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Maervoet, J.] Quintiles Advisory Serv, Brussels, Belgium; [Moise, P.] Quintiles Advisory Serv, Paris, France; [Naidoo, S.] Astellas Med Affairs Global, Chertsey, England",IQVIA; IQVIA,,,,,,,,,0,3,3,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN194,A168,A168,,10.1016/j.jval.2016.03.1527,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000365,0
J,"Majid, T; Asamoah, B; Bridges, JF; dosReis, S",,,,"Majid, T.; Asamoah, B.; Bridges, J. F.; dosReis, S.",,,ATTRIBUTE IDENTIFICATION OF CAREGIVERS' TRADEOFFS IN CARE MANAGEMENT DECISION MAKING FOR INDIVIDUALS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Majid, T.; Asamoah, B.; dosReis, S.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA; [Bridges, J. F.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA",University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM117,A92,A92,,10.1016/j.jval.2016.03.1731,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000505,0
J,"Marra, LP; Almeida-Brasil, CC; Guerra, AA; Almeida, AM; Lemos, LL",,,,"Marra, L. P.; Almeida-Brasil, C. C.; Guerra-Junior, A. A.; Almeida, A. M.; Lemos, L. L.",,,"EFFICACY, SAFETY, AND COST EFFECTIVENESS OF TERIPARATIDE FOR THE TREATMENT OF OSTEOPOROSIS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Marra, L. P.; Almeida-Brasil, C. C.; Guerra-Junior, A. A.] Univ Fed Minas Gerais, Coll Pharm, Belo Horizonte, MG, Brazil; [Almeida, A. M.] Coll Med Sci Minas Gerais, Belo Horizonte, MG, Brazil; [Lemos, L. L.] Univ Fed Minas Gerais, CCATES, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais,,,"Brasil, Celline Cardoso Almeida/M-4025-2019; Guerra, Augusto Afonso/AAS-6584-2020","Brasil, Celline Cardoso Almeida/0000-0002-6324-4702; Guerra, Augusto Afonso/0000-0001-5256-0577",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS14,A227,A227,,10.1016/j.jval.2016.03.1171,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600096,0
J,"Mitchell, M; Smith, C; Werner, R",,,,"Mitchell, M.; Smith, C.; Werner, R.",,,BOLUS PLUS INFUSION REMAINS PREDOMINANT MODE OF GP IIB/IIA UTILIZATION: A 2015 US HOSPITAL PURCHASING STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mitchell, M.; Smith, C.; Werner, R.] Medicines Co, Parsippany, NJ USA",Novartis,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV87,A55,A55,,10.1016/j.jval.2016.03.138,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000301,0
J,"Mittal, LK; Banerjee, P; Kapoor, A; Ligade, VS",,,,"Mittal, L. K.; Banerjee, P.; Kapoor, A.; Ligade, V. S.",,,REIMBURSEMENT DECISION LANDSCAPE FOR ORPHAN DRUGS ACROSS SIX HTA AGENCIES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mittal, L. K.; Ligade, V. S.] Manipal Univ, Manipal, Karnataka, India; [Banerjee, P.; Kapoor, A.] Optum Global Solut, Noida, India",Manipal Academy of Higher Education (MAHE); Optum,,,"Ligade, Virendra S/ABF-6863-2020","Ligade, Virendra S/0000-0001-7945-3245",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSY93,A257,A257,,10.1016/j.jval.2016.03.1032,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600263,0
J,"Mogere, DM",,,,"Mogere, D. M.",,,DOES THE MOTHER'S LEVEL OF EDUCATION INFLUENCE IMMUNIZATION COVERAGE?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mogere, D. M.] Great Lakes Univ Kisumu, Kisumu, Kenya",,,,,"Mogere, Dominic M./0000-0003-4412-4489",,,,,0,2,2,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIH41,A179,A179,,10.1016/j.jval.2016.03.1414,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000424,0
J,"Narayanan, S; Busch, HM; Collins, CE; Chatham, WW; DeLaRosa, O; Narvaez, M; Hautamaki, E; Gaylis, N",,,,"Narayanan, S.; Busch, H. M.; Collins, C. E.; Chatham, W. W.; DeLaRosa, O.; Narvaez, M.; Hautamaki, E.; Gaylis, N.",,,RESPONSIVENESS AND TEST-RETEST RELIABILITY OF NEW DISEASE ASSESSMENT INSTRUMENTS IN SYSTEMATIC LUPUS ERYTHEMATOSUS (SLE) IN RELATION TO SLEDAI-2K,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Narayanan, S.; Hautamaki, E.] Ipsos Healthcare, Washington, DC USA; [Busch, H. M.; Narvaez, M.] Sci & Res Inst Inc, Jupiter, FL USA; [Collins, C. E.] MedStar Washington Hosp Ctr, Washington, DC USA; [Chatham, W. W.] Univ Alabama Birmingham, Birmingham, AL USA; [DeLaRosa, O.; Gaylis, N.] Arthrit & Rheumat Dis Specialties, Aventura, FL USA",MedStar Washington Hospital Center; University of Alabama System; University of Alabama Birmingham,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PRM32,A76,A77,,10.1016/j.jval.2016.03.638,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000420,0
J,"Nasser, S; Maskienh, C; Aissaoui, A",,,,"Nasser, S.; Maskienh, C.; Aissaoui, A.",,,PRICING AND REIMBURSEMENT OF INNOVATIVE TECHNOLOGY IN MENA AND THE DEVELOPMENT OF MANAGED ENTRY AGREEMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nasser, S.] Lebanese Amer Univ, Byblos, Lebanon; [Maskienh, C.; Aissaoui, A.] Univ Paris 09, PSL, Paris, France",Lebanese American University; Universite PSL; Universite Paris-Dauphine,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHP192,A290,A290,,10.1016/j.jval.2016.03.744,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600451,0
J,"Nunna, S; Coutinho, AD; Eaddy, M; Landsman-Blumberg, P",,,,"Nunna, S.; Coutinho, A. D.; Eaddy, M.; Landsman-Blumberg, P.",,,USE OF JOINPOINT REGRESSION TO DEFINE PHASES OF CARE IN PATIENTS WITH ADVANCED MELANOMA: AN EVALUATION FROM METASTATIC DIAGNOSIS UNTIL DEATH,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nunna, S.] Univ Mississippi, University, MS 38677 USA; [Coutinho, A. D.; Eaddy, M.; Landsman-Blumberg, P.] Xcenda LLC, Palm Harbor, FL USA","University of Mississippi; AmerisourceBergen Corporation; Xcenda, LLC",,,"Nunna, Sasikiran/AAR-3948-2020","Nunna, Sasikiran/0000-0002-8006-7306",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,CN3,A6,A6,,10.1016/j.jval.2016.03.044,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000031,0
J,"Oreagba, IA; Usman, SO; Akanmu, S",,,,"Oreagba, I. A.; Usman, S. O.; Akanmu, S.",,,"ANTIRETROVIRALS AND CO-PRESCRIBED DRUGS FOR PEOPLE LIVING WITH HIV/AIDS IN A UNIVERSITY TEACHING HOSPITAL, SOUTH WEST NIGERIA",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Oreagba, I. A.; Usman, S. O.; Akanmu, S.] Univ Lagos, Lagos, Nigeria",University of Lagos,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIN8,A212,A213,,10.1016/j.jval.2016.03.1239,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600019,0
J,"Palli, S; Gunnarsson, C; Kotlarz, H; Martinsen, BJ; Zhao, R; Rizzo, JA",,,,"Palli, S.; Gunnarsson, C.; Kotlarz, H.; Martinsen, B. J.; Zhao, R.; Rizzo, J. A.",,,IMPACT OF A LIMB SALVAGE PROGRAM ON THE ECONOMIC BURDEN OF AMPUTATION IN THE UNITED STATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Palli, S.; Gunnarsson, C.] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA; [Kotlarz, H.; Martinsen, B. J.; Zhao, R.] Cardiovasc Syst Inc, St Paul, MN USA; [Rizzo, J. A.] SUNY Stony Brook, Stony Brook, NY 11794 USA",State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook,,,,,,,,,0,4,4,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV33,A45,A45,,10.1016/j.jval.2016.03.098,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,Bronze,,,2024-03-09,WOS:000376886000247,0
J,"Pednekar, P; Peterson, AM; Heller, D",,,,"Pednekar, P.; Peterson, A. M.; Heller, D.",,,COMPARING MEDICATION ADHERENCE RATES BETWEEN PHARMACY DESERT AND NON-DESERT AREAS AMONG ELDERLY IN PENNSYLVANIA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Pednekar, P.] Univ Sci, Philadelphia, PA USA; [Peterson, A. M.] Univ Sci Philadelphia, Philadelphia, PA USA; [Heller, D.] Magellan Rx Management PACE, Pa, PA USA",,,,"Pednekar, Priti/ABG-9364-2020","Pednekar, Priti/0000-0002-0543-6677",,,,,0,3,3,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB52,A205,A206,,10.1016/j.jval.2016.03.1253,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000571,0
J,"Piniazhko, O; Zaliska, O; Pyrohova, V; Malachynska, M; Veresnyuk, N; Vernikovskyy, I",,,,"Piniazhko, O.; Zaliska, O.; Pyrohova, V; Malachynska, M.; Veresnyuk, N.; Vernikovskyy, I",,,ANALYSIS OF REAL-WORLD DATABASE: ENDOMETRIOSIS TREATMENT PRACTICE IN UKRAINE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Piniazhko, O.; Zaliska, O.; Pyrohova, V] Danylo Halytsky Lviv Natl Med Univ, Lvov, Ukraine; [Malachynska, M.; Veresnyuk, N.] Danylo Halytsky Lviv Natl Med Univ, Lviv Reg Reprod Hlth Ctr, Lvov, Ukraine; [Vernikovskyy, I] Lviv Reg Reprod Hlth Ctr, Lvov, Ukraine",Danylo Halytsky Lviv National Medical University; Danylo Halytsky Lviv National Medical University,,,"Veresnyuk, Nataliya/Y-8949-2018; Zaliska, Olha/E-1135-2018; Zaliska, Olha/AAN-6078-2020","Zaliska, Olha/0000-0003-1845-7909",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIH24,A176,A176,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000409,0
J,"Saggia, M; Follador, W; Valencia, J",,,,"Saggia, M.; Follador, W.; Valencia, J.",,,BUDGET IMPACT ANALYSIS OF ADOPTING THE VIDEO-ASSISTED THORACIC SURGERY FOR PATIENTS WITH LUNG CANCER FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saggia, M.] Asigma, Sao Paulo, Brazil; [Follador, W.] Medtronic Plc, Sao Paulo, SP, Brazil; [Valencia, J.] Medtronic, Miami, FL USA",Medtronic; Medtronic,,,"Valencia, Juan/GXN-0206-2022",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMD22,A300,A301,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600507,0
J,"Sakharkar, P",,,,"Sakharkar, P.",,,"HEALTH CARE EXPENDITURES, PRESCRIPTION DRUG COST, AND OUT-OF-POCKET SPENDING AMONG ADULTS WITH CHRONIC DISEASE CONDITION COMBINATIONS IN THE UNITED STATES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sakharkar, P.] Roosevelt Univ, Coll Pharm, Schaumburg, IL USA",,,,"Sakharkar, Prashant/G-9584-2018",,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PHS25,A14,A14,,10.1016/j.jval.2016.03.275,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000073,0
J,"Shah, A",,,,"Shah, A.",,,"PREVALENCE OF DIABETIC RETINOPATHY IN THE UNITED STATES, 2011-2014",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shah, A.] Rutgers State Univ, New Brunswick, NJ USA",Rutgers University System; Rutgers University New Brunswick,,,,,,,,,0,5,6,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB16,A199,A199,,10.1016/j.jval.2016.03.1323,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000536,0
J,"Shah, S; Young, HN; Cobran, EK",,,,"Shah, S.; Young, H. N.; Cobran, E. K.",,,COMPARATIVE EFFECTIVENESS OF CONSERVATIVE MANAGEMENT VERSUS CRYOTHERAPY FOR PATIENTS WITH LOCALIZED PROSTATE CANCER: AN ANALYSIS OF TREATMENT-RELATED COMPLICATIONS AND CANCER-SPECIFIC SURVIVAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shah, S.; Young, H. N.; Cobran, E. K.] Univ Georgia, Athens, GA 30602 USA",University System of Georgia; University of Georgia,,,"Shah, Surbhi/AAE-1915-2020","Shah, Surbhi/0000-0001-8351-0265",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCN26,A138,A138,,10.1016/j.jval.2016.03.1648,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000200,0
J,"Shelbaya, A; Deshpande, C; Pappadopulos, E; Alvir, J; Chirikov, V; Stephens, JM",,,,"Shelbaya, A.; Deshpande, C.; Pappadopulos, E.; Alvir, J.; Chirikov, V; Stephens, J. M.",,,PERSISTENCE AND CONCOMITANT DRUG USE ON BRANDED DESVENLAFAXINE COMPARED WITH OTHER ANTIDEPRESSANTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shelbaya, A.] Columbia Univ, Mailman Sch Publ Hlth, Pfizer Inc, New York, NY USA; [Deshpande, C.; Chirikov, V; Stephens, J. M.] Pharmerit Int, Bethesda, MD USA; [Pappadopulos, E.; Alvir, J.] Pfizer Inc, New York, NY USA",Pfizer; Columbia University; Pharmerit North America LLC; Pfizer,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH81,A196,A196,,10.1016/j.jval.2016.03.1366,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000520,0
J,"Shelbaya, A; Solem, CT; Walker, C; Wan, Y; Johnson, C; Cappelleri, JC",,,,"Shelbaya, A.; Solem, C. T.; Walker, C.; Wan, Y.; Johnson, C.; Cappelleri, J. C.",,,CLINICAL AND ECONOMIC BURDEN OF EARLY VERSUS LATE INITIATION OF BRANDED CELECOXIB AMONG PATIENTS WITH OSTEOARTHRITIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shelbaya, A.] Columbia Univ, Pfizer Inc, Mailman Sch Publ Hlth, New York, NY USA; [Solem, C. T.; Wan, Y.; Johnson, C.] Pharmerit Int, Bethesda, MD USA; [Walker, C.] Pfizer Inc, Tadworth, Surrey, England; [Cappelleri, J. C.] Pfizer Inc, Groton, CT 06340 USA",Columbia University; Pfizer; Pharmerit North America LLC; Pfizer; Pfizer,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMS83,A239,A239,,10.1016/j.jval.2016.03.1113,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,hybrid,,,2024-03-09,WOS:000394931600163,0
J,"Swallow, E; Fang, A; Signorovitch, J; Plumb, J; Borghs, S",,,,"Swallow, E.; Fang, A.; Signorovitch, J.; Plumb, J.; Borghs, S.",,,CAN INDIRECT COMPARISON METHODS MITIGATE EVOLVING TRIAL POPULATIONS IN ADJUNCTIVE ANTIEPILEPTIC DRUG TRIALS? A PROPENSITY-SCORE MATCHED INDIRECT COMPARISON OF BRIVARACETAM AND LEVETIRACETAM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Swallow, E.; Fang, A.; Signorovitch, J.] Anal Grp Inc, Boston, MA USA; [Plumb, J.] UCB Pharma, Brussels, Belgium; [Borghs, S.] UCB Pharma, Slough, Berks, England",Analysis Group Inc.; UCB Pharma SA; UCB Pharma SA,,,,,,,,,0,1,1,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PND6,A60,A60,,10.1016/j.jval.2016.03.182,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000327,0
J,"Szabo, S; Johnston, KM",,,,"Szabo, S.; Johnston, K. M.",,,THE CHANGING EPIDEMIOLOGY OF CHILDHOOD INFECTIOUS DISEASES IN CANADA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Szabo, S.; Johnston, K. M.] Broad St HEOR, Vancouver, BC, Canada",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PIN11,A213,A213,,10.1016/j.jval.2016.03.1242,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HP,,Bronze,,,2024-03-09,WOS:000394931600022,0
J,"ul Haq, N; Fatima, A; Nasim, A; Razaq, G; Ahmed, N; Zeeshan, M; Mohammad, S",,,,"ul Haq, N.; Fatima, A.; Nasim, A.; Razaq, G.; Ahmed, N.; Zeeshan, M.; Mohammad, S.",,,"ASSESSMENT OF DISEASE-STATE KNOWLEDGE IN HYPERTENSIVE PATIENTS IN QUETTA, PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[ul Haq, N.; Fatima, A.; Nasim, A.; Razaq, G.; Ahmed, N.; Mohammad, S.] Univ Balochistan, Quetta, Pakistan; [Zeeshan, M.] Univ Punjab, Lahore, Pakistan",University of Balochistan; University of Punjab,,,"Nasim, Aqeel/AAX-1823-2021","Nasim, Aqeel/0000-0003-1270-4753",,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PCV105,A58,A58,,10.1016/j.jval.2016.03.156,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DN2HZ,,hybrid,,,2024-03-09,WOS:000376886000319,0
J,"Vohra, R; Madhavan, SS; Sambamoorthi, U",,,,"Vohra, R.; Madhavan, S. S.; Sambamoorthi, U.",,,HIGH PRESCRIPTION DRUG USE AND POLYPHARMACY RATES AMONG ADULTS WITH AUTISM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vohra, R.] West Virginia Univ, Morgantown, WV USA; [Madhavan, S. S.; Sambamoorthi, U.] West Virginia Univ, Sch Pharm, Morgantown, WV USA",West Virginia University; West Virginia University,,,"Vohra, Rini/AAI-6406-2021",,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH69,A194,A194,,10.1016/j.jval.2016.03.1354,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000508,0
J,"Wang, K; Chen, Y; Higgins, V; Qian, L",,,,"Wang, K.; Chen, Y.; Higgins, V; Qian, L.",,,PREMIXED INSULIN TREATMENT FOR TYPE 2 DIABETES MELLITUS IN CHINA: PATIENT AND PHYSICIAN PERCEPTIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, K.; Qian, L.] Lilly Suzhou Pharmaceut Co Ltd, Shanghai, Peoples R China; [Chen, Y.; Higgins, V] Adelphi Real World, Bollington, England",Adelphi Group Ltd,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PDB59,A207,A207,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,Bronze,,,2024-03-09,WOS:000394931000578,0
J,"Wang, X; Wu, I; Chen, H; Bordnick, P; Essien, EJ; Johnson, ML; Peters, R; Abughosh, SM",,,,"Wang, X.; Wu, I; Chen, H.; Bordnick, P.; Essien, E. J.; Johnson, M. L.; Peters, R.; Abughosh, S. M.",,,COMPARISON OF CARDIOVASCULAR RISKS FOLLOWING SMOKING CESSATION TREATMENTS USING VARENICLINE VERSUS NRT AMONG SCHIZOPHRENIC SMOKERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wang, X.; Wu, I; Chen, H.; Bordnick, P.; Essien, E. J.; Johnson, M. L.; Abughosh, S. M.] Univ Houston, Houston, TX USA; [Peters, R.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA",University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PMH6,A182,A183,,10.1016/j.jval.2016.03.1387,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000445,0
J,"Wright, AK; Fadok, V; Amodie, D",,,,"Wright, A. K.; Fadok, V; Amodie, D.",,,"FIRST TREATMENT SUCCESS WITH INJECTABLE CEFOVECIN SODIUM IN DOGS FOR SUPERFICIAL PYODERMA, WOUNDS, AND ABSCESSES IN DIFFERENT DOG POPULATIONS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wright, A. K.; Fadok, V; Amodie, D.] Zoetis, Greeley, CO USA",Zoetis,,,,,,,,,0,0,0,0,0,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2016,19.0,3.0,,,,PSS4,A122,A122,,10.1016/j.jval.2016.03.493,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,EL9HJ,,hybrid,,,2024-03-09,WOS:000394931000118,0
J,"Maasoumi, E; Racine, JS",,,,"Maasoumi, Esfandiar; Racine, Jeffrey S.",,,A solution to aggregation and an application to multidimensional 'well-being' frontiers,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,,INDEXES,"We propose a new technique for identification and estimation of aggregation functions in multidimensional evaluations and multiple indicator settings. These functions may represent latent objects. They occur in many different contexts, for instance in propensity scores, multivariate measures of well-being and the related analysis of inequality and poverty, and in equivalence scales. Technical advances allow nonparametric inference on the joint distribution of continuous and discrete indicators of well-being, such as income and health, conditional on joint values of other continuous and discrete attributes, such as education and geographical groupings. In a multi-attribute setting, quantiles are frontiers that define equivalent sets of covariate values. We identify these frontiers nonparametrically at first. Then we suggest parametrically equivalent characterizations of these frontiers that reveal likely weights for, and substitutions between different attributes for different groups, and at different quantiles. These estimated parametric functionals are ideal aggregators in a certain sense which we make clear. They correspond directly to measures of aggregate well-being popularized in the earliest multidimensional inequality measures in Maasoumi (1986). This new approach resolves a classic problem of assigning weights to multiple indicators such as dimensions of well-being, as well as empirically incorporating the key component in multidimensional analysis, the relationship between the indicators. It introduces a new way for robust estimation of quantile frontiers, allowing complete assessments, such as multidimensional poverty measurements. In our substantive application, we discover extensive heterogeneity in individual evaluation functions. This leads us to perform robust, weak uniform rankings as afforded by tests for multivariate stochastic dominance. A demonstration is provided based on the Indonesian data analyzed for multidimensional poverty in Maasoumi and Lugo (2008). (C) 2015 Elsevier B.V. All rights reserved.","[Maasoumi, Esfandiar] Emory Univ, Atlanta, GA 30322 USA; [Racine, Jeffrey S.] McMaster Univ, Hamilton, ON L8S 4M4, Canada",Emory University; McMaster University,"Maasoumi, E (通讯作者)，Emory Univ, Dept Econ, 1602 Fishburne Dr, Atlanta, GA 30322 USA.",esfandiar.maasoumi@emory.edu,"Racine, Jeffrey/N-9476-2014","Racine, Jeffrey/0000-0002-5680-3705",,,,,27,11,11,2,17,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,APR,2016,191.0,2.0,,,,,374,383,,10.1016/j.jeconom.2015.12.008,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DG3BR,,,,,2024-03-09,WOS:000371945000009,0
J,"Baltagi, BH; Yen, YF",,,,"Baltagi, Badi H.; Yen, Yin-Fang",,,Welfare Reform and Children's Health,HEALTH ECONOMICS,,,English,Article,,,,,,maternal employment; children's health; welfare; fixed effects,MATERNAL EMPLOYMENT; TIME LIMITS; INCOME; WORK; INSURANCE; CARE; PARTICIPATION; CHILDHOOD; COVERAGE; IMPACT,"This study investigates the effect of the Temporary Aid to Needy Families (TANF) program on children's health outcomes using data from the Survey of Income and Program Participation over the period 1994 to 2005. The TANF policies have been credited with increased employment for single mothers and a dramatic drop in welfare caseload. Our results show that these policies also had a significant effect on various measures of children's medical utilization among low-income families. These health measures include a rating of the child's health status reported by the parents, the number of times that parents consulted a doctor, and the number of nights that the child stayed in a hospital. We compare the overall changes of health status and medical utilization for children with working and nonworking mothers. We find that the child's health status as reported by the parents is affected by the maternal employment status. Copyright (c) 2014 John Wiley & Sons, Ltd.","[Baltagi, Badi H.] Syracuse Univ, Dept Econ, 426 Eggers Hall, Syracuse, NY 13244 USA; [Baltagi, Badi H.] Syracuse Univ, Ctr Policy Res, 426 Eggers Hall, Syracuse, NY 13244 USA; [Baltagi, Badi H.] Univ Leicester, Dept Econ, Leicester, Leics, England; [Yen, Yin-Fang] Southwestern Univ Finance & Econ, Sch Publ Adm, Chengdu, Sichuan, Peoples R China",Syracuse University; Syracuse University; University of Leicester; Southwestern University of Finance & Economics - China,"Baltagi, BH (通讯作者)，Syracuse Univ, Dept Econ, 426 Eggers Hall, Syracuse, NY 13244 USA.;Baltagi, BH (通讯作者)，Syracuse Univ, Ctr Policy Res, 426 Eggers Hall, Syracuse, NY 13244 USA.;Baltagi, BH (通讯作者)，Univ Leicester, Dept Econ, Leicester, Leics, England.",bbaltagi@maxwell.syr.edu,,"Baltagi, Badi/0000-0003-0469-4479",,,,,45,7,8,0,15,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,MAR,2016,25.0,3.0,,,,,277,291,,10.1002/hec.3139,0.0,,,15,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DD2IE,25533889.0,Green Submitted,,,2024-03-09,WOS:000369745100002,0
J,"Petri, H; Voorneveld, M",,,,"Petri, Henrik; Voorneveld, Mark",,,Characterizing lexicographic preferences,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Lexicographic preferences; Lexicographic order; Characterization; Preferences,,"We characterize lexicographic preferences on product sets of finitely many coordinates. The main new axiom is a robustness property. It roughly requires this: Suppose x is preferred toy; many of its coordinates indicate that the former is better and only a few indicate the opposite. Then the decision maker is allowed a change of mind turning one coordinate in favor of x to an indifference: even if one less argument supports the preference, the fact that we started with many arguments in favor of x suggests that such a small change is not enough to give rise to the opposite preference. (C) 2016 Elsevier B.V. All rights reserved.","[Petri, Henrik] Stockholm Sch Econ, Dept Finance, Box 6501, S-11383 Stockholm, Sweden; [Voorneveld, Mark] Stockholm Sch Econ, Dept Econ, Box 6501, S-11383 Stockholm, Sweden",Stockholm School of Economics; Stockholm School of Economics,"Petri, H (通讯作者)，Stockholm Sch Econ, Dept Finance, Box 6501, S-11383 Stockholm, Sweden.",henrik.petri@hhs.se; mark.voorneveld@hhs.se,,,"Wallander-Hedelius Foundation [P2014-0189:1, P2010-0094:1]",Wallander-Hedelius Foundation,"This paper is part of the first author's ongoing PhD dissertation at Stockholm School of Economics. We thank Denis Bouyssou, Christian Hellwig, Ariel Rubinstein, Marciano Siniscalchi, Peter Wakker, and two anonymous referees for helpful comments. Financial support by the Wallander-Hedelius Foundation under Grant P2014-0189:1 (Petri) and P2010-0094:1 (Voorneveld) is gratefully acknowledged.",,12,5,5,0,1,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAR,2016,63.0,,,,,,54,61,,10.1016/j.jmateco.2015.12.003,0.0,,,8,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DI7DF,,Green Submitted,,,2024-03-09,WOS:000373658600007,0
J,"Handa, S; Peterman, A; Seidenfeld, D; Tembo, G",,,,"Handa, Sudhanshu; Peterman, Amber; Seidenfeld, David; Tembo, Gelson",,,Income Transfers and Maternal Health: Evidence from a National Randomized Social Cash Transfer Program in Zambia,HEALTH ECONOMICS,,,English,Article,,,,,,cash transfers; maternal health; Zambia,JANANI SURAKSHA YOJANA; PROMOTE SAFE DELIVERY; INCENTIVE PROGRAM; IMPACT,"There is promising recent evidence that poverty-targeted social cash transfers have potential to improve maternal health outcomes; however, questions remain surrounding design features responsible for impacts. In addition, virtually no evidence exists from the African region. This study explores the impact of Zambia's Child Grant Program on a range of maternal health utilization outcomes using a randomized design and difference-in-differences multivariate regression from data collected over 24months from 2010 to 2012. Results indicate that while there are no measurable program impacts among the main sample, there are heterogeneous impacts on skilled attendance at birth among a sample of women residing in households having better access to maternal health services. The latter result is particularly interesting because of the overall low level of health care availability in program areas suggesting that dedicated program design or matching supply-side interventions may be necessary to leverage unconditional cash transfers in similar settings to impact maternal health. Copyright (c) 2015 John Wiley & Sons, Ltd.","[Handa, Sudhanshu; Peterman, Amber] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC 27514 USA; [Handa, Sudhanshu] UNICEF Off Res, Child Poverty & Social & Econ Policy Responses, Florence, Italy; [Seidenfeld, David] Amer Inst Res, Washington, DC USA; [Tembo, Gelson] Univ Zambia, Dept Agr Econ, Lusaka, Zambia",University of North Carolina; University of North Carolina Chapel Hill; American Institutes for Research; University of Zambia,"Peterman, A (通讯作者)，Univ N Carolina, Dept Publ Policy, Chapel Hill, NC 27514 USA.",amberpeterman@gmail.com,,"Peterman, Amber/0000-0002-3921-5936",William and Flora Hewlett Foundation; DFID; UNICEF; Irish Aid; Government of Finland,William and Flora Hewlett Foundation; DFID; UNICEF; Irish Aid(CGIAR); Government of Finland,"The Child Grant impact evaluation was commissioned by the Government of Zambia (GRZ) through the Ministry of Community Development, Mother and Child Health and funded by a consortium of donors including DFID, UNICEF, Irish Aid, and the Government of Finland. Peterman received additional funding from the William and Flora Hewlett Foundation for analysis of data.",,27,25,28,1,15,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,2.0,,,,,225,236,,10.1002/hec.3136,0.0,,,12,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DA9ZC,25581062.0,Green Accepted,,,2024-03-09,WOS:000368167300007,0
J,"Malikov, E; Kumbhakar, SC; Sun, YG",,,,"Malikov, Emir; Kumbhakar, Subal C.; Sun, Yiguo",,,Varying coefficient panel data model in the presence of endogenous selectivity and fixed effects,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Credit union; Fixed effects; Selection; Semiparametric; Smooth coefficient; Switching regression; Varying coefficient,NONPARAMETRIC KERNEL REGRESSION; SEMIPARAMETRIC ESTIMATION; ESTIMATORS,"This paper considers a flexible panel data sample selection model in which (i) the outcome equation is permitted to take a semiparametric, varying coefficient form to capture potential parameter heterogeneity in the relationship of interest, (ii) both the outcome and (parametric) selection equations contain unobserved fixed effects and (iii) selection is generalized to a polychotomous case. We propose a two-stage estimator. Given consistent parameter estimates from the selection equation obtained in the first stage, we estimate the semiparametric outcome equation using data for the observed individuals whose likelihood of being selected into the sample stays approximately the same over time. The selection bias term is then asymptotically removed from the equation along with fixed effects using kernel-based weights. The proposed estimator is consistent and asymptotically normal. We showcase our estimator by applying it to study production technologies of US retail credit unions from 2002 to 2006. (C) 2015 Elsevier B.V. All rights reserved.","[Malikov, Emir] St Lawrence Univ, Dept Econ, Canton, NY 13617 USA; [Kumbhakar, Subal C.] SUNY Binghamton, Dept Econ, Binghamton, NY USA; [Sun, Yiguo] Univ Guelph, Dept Econ & Finance, Guelph, ON N1G 2W1, Canada",Saint Lawrence University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Guelph,"Malikov, E (通讯作者)，St Lawrence Univ, Dept Econ, Canton, NY 13617 USA.",emalikov@stlawu.edu; kkar@binghamton.edu; yisun@uoguelph.ca,,,,,,,59,12,15,0,15,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,FEB,2016,190.0,2.0,,,,,233,251,,10.1016/j.jeconom.2015.06.007,0.0,,,19,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,DC4TE,,Green Submitted,,,2024-03-09,WOS:000369212400004,0
J,"Samuelsen, C; Bateman, ED; Pavord, I; Lloyd, A; Baldwin, M; Esser, D",,,,"Samuelsen, Carl; Bateman, Eric D.; Pavord, Ian; Lloyd, Adam; Baldwin, Mike; Esser, Dirk",,,Comment on: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists'',APPLIED HEALTH ECONOMICS AND HEALTH POLICY,,,English,Letter,,,,,,,,,"[Samuelsen, Carl] Boehringer Ingelheim GmbH & Co KG, Asker, Norway; [Bateman, Eric D.] Univ Cape Town, Dept Med, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Pavord, Ian] Univ Oxford, Resp Med, Oxford, England; [Lloyd, Adam] IMS Hlth, Real World Evidence Solut, Hlth Econ & Outcomes Res, London, England; [Baldwin, Mike; Esser, Dirk] Boehringer Ingelheim KG, Ingelheim, Germany",Boehringer Ingelheim; University of Cape Town; University of Oxford; Boehringer Ingelheim,"Esser, D (通讯作者)，Boehringer Ingelheim KG, Ingelheim, Germany.",dirk.esser@boehringer-ingelheim.com,,"Pavord, Ian/0000-0002-4288-5973",,,,,2,0,0,0,0,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",1175-5652,1179-1896,,APPL HEALTH ECON HEA,Appl. Health Econ. Health Policy,FEB,2016,14.0,1.0,,,,,117,118,,10.1007/s40258-015-0215-0,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DD0MI,26718854.0,"Green Published, hybrid",,,2024-03-09,WOS:000369613700011,0
J,"Sweeney, S; Vassall, A; Foster, N; Simms, V; Ilboudo, P; Kimaro, G; Mudzengi, D; Guinness, L",,,,"Sweeney, Sedona; Vassall, Anna; Foster, Nicola; Simms, Victoria; Ilboudo, Patrick; Kimaro, Godfather; Mudzengi, Don; Guinness, Lorna",,,Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries,HEALTH ECONOMICS,,,English,Article,,,,,,out-of-pocket payments; catastrophic expenditures; poverty; data collection methods; economic evaluation,RESOURCE-POOR SETTINGS; HEALTH-CARE; HOUSEHOLDS; COSTS; EXPENDITURES; TUBERCULOSIS; INFECTION; TANZANIA; ILLNESS; AFRICA,"Out-of-pocket spending is increasingly recognized as an important barrier to accessing health care, particularly in low-income and middle-income countries (LMICs) where a large portion of health expenditure comes from out-of-pocket payments. Emerging universal healthcare policies prioritize reduction of poverty impact such as catastrophic and impoverishing healthcare expenditure. Poverty impact is therefore increasingly evaluated alongside and within economic evaluations to estimate the impact of specific health interventions on poverty. However, data collection for these metrics can be challenging in intervention-based contexts in LMICs because of study design and practical limitations. Using a set of case studies, this letter identifies methodological challenges in collecting patient cost data in LMIC contexts. These components are presented in a framework to encourage researchers to consider the implications of differing approaches in data collection and to report their approach in a standardized and transparent way. (c) 2016 The Authors. Health Economics published by John Wiley & Sons Ltd.","[Sweeney, Sedona; Vassall, Anna; Simms, Victoria; Guinness, Lorna] London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England; [Ilboudo, Patrick] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Foster, Nicola] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Kimaro, Godfather] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Mudzengi, Don] Aurum Inst, Johannesburg, South Africa",University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; University of Cape Town; National Institute of Medical Research,"Sweeney, S (通讯作者)，London Sch Hyg & Trop Med, 15-17 Tavistock Pl, London WC1H 9SH, England.",sedona.sweeney@lshtm.ac.uk,"Simms, Victoria/C-3278-2009; Simms, Victoria/AAU-4134-2021; Foster, Nicola/AAA-9040-2020; Guinness, Lorna/AAN-3875-2020","Simms, Victoria/0000-0002-4897-458X; Foster, Nicola/0000-0003-4630-6243; Mudzengi, Don/0000-0003-2759-3320; Guinness, Lorna/0000-0002-1013-4200; Vassall, Anna/0000-0002-2911-1375",Medical Research Council [MR/K012126/1] Funding Source: Medline; Medical Research Council [MR/K012126/1] Funding Source: researchfish,Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),,,55,19,19,0,28,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,FEB,2016,25.0,,,1.0,,,42,52,,10.1002/hec.3304,0.0,,,11,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DB9TF,26774106.0,"Green Published, Green Accepted, hybrid",,,2024-03-09,WOS:000368859100005,0
C,"Abrudan, M; You, L; Stanková, K; Thuijsman, F",,"Thuijsman, F; Wagener, F",,"Abrudan, Monica; You, Li; Stankova, Katerina; Thuijsman, Frank",,,A Game Theoretical Approach to Microbial Coexistence,"ADVANCES IN DYNAMIC AND EVOLUTIONARY GAMES: THEORY, APPLICATIONS, AND NUMERICAL METHODS",Annals of the International Society of Dynamic Games,,English,Proceedings Paper,Symposium of the International-Society-of-Dynamic-Games (ISGD),"JUL 09-12, 2014","Amsterdam, NETHERLANDS",Int Soc Dynam Games,,Local dynamics; Bacterial strains; Agent based model; Game theory,BIODIVERSITY; COMMUNICATION; NETWORKS; PROMOTES,"Huge numbers of microbes coexist in almost all habitats of our planet. Their interactions are governed by complex mechanisms, where both competition for resources and toxin production play important roles. Our goal is to understand key mechanisms that lead to coexistence. In this chapter we study many possible scenarios of microbial interactions and we analyze whether or not they can lead to coexistence of species. To achieve this we implemented agent- based models that mimic local dynamics of microbes; initially well mixed microbes from different species interact in a grid with a regular structure. Among others, we show that the coexistence rate is negatively correlated with the number of neighbors of each cell in the grid. Another observation is that the order of selection of focal cells in the grid influences the coexistence rate.","[Abrudan, Monica] Univ Manchester, Fac Life Sci, Michael Smith Bldg,Dover St, Manchester M13 9PL, Lancs, England; [Abrudan, Monica] Leiden Univ, Inst Biol, Sylvius Bldg,Sylviusweg 72, NL-2333 BE Leiden, Netherlands; [Stankova, Katerina] Maastricht Univ, Dept Data Sci & Knowledge Engn, POB 616, NL-6200 MD Maastricht, Netherlands; [Stankova, Katerina] Delft Univ Technol, Delft Inst Appl Math, Mekelweg 4, NL-2628 CD Delft, Netherlands",University of Manchester; Leiden University - Excl LUMC; Leiden University; Maastricht University; Delft University of Technology,"Stanková, K (通讯作者)，Maastricht Univ, Dept Data Sci & Knowledge Engn, POB 616, NL-6200 MD Maastricht, Netherlands.;Stanková, K (通讯作者)，Delft Univ Technol, Delft Inst Appl Math, Mekelweg 4, NL-2628 CD Delft, Netherlands.",ma14@sanger.ac.uk; li.you@maastrichtuniversity.nl; k.stankova@maastrichtuniversity.nl; f.thuijsman@maastrichtuniversity.nl,,"Stankova, Katerina/0000-0002-4519-0325; Abrudan, Monica/0000-0003-0228-4353",,,,,30,3,3,0,4,BIRKHAUSER BOSTON,CAMBRIDGE,"675 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139-2333 USA",,,978-3-319-28014-1; 978-3-319-28012-7,ANN INT SOC DYN GAME,,,2016,14.0,,,,,,267,282,,10.1007/978-3-319-28014-1_13,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,BG6CK,,,,,2024-03-09,WOS:000389946800013,0
C,"Altindisli, FO; Ozsemerci, F; Koclu, T; Akkan, Ü; Keskin, N",,"Aurand, JM",,"Altindisli, F. Ozlem; Ozsemerci, Fatma; Koclu, Turkan; Akkan, Umran; Keskin, Nese",,,"Isonet LTT, a new alternative material for mating disruption of Lobesia botrana (Den. & Schiff.) in Turkey",39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,English,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"European Grapevine Moth (EGVM), Lobesia botrana (Den. & Schiff.) (Lepidoptera: Tortricidae) is the key pest of grape in Turkey. The efficacy of Isonet LTT has been tested against L. botrana in comparison with registered Isonet L dispensers in Manisa and Canakkale, Turkey. One chemically treated vineyard was used to compare infestation levels for each location. By the emergence of the first EGVM adult, similar to 320 Isonet LTT and 650 Isonet L dispensers/ha - including borders-were installed once a year. EGVM adults have been monitored in all plots by pheromone traps from the beginning of the flight until harvest. Infestation rates were compared. We indicated that both Isonet LTT and Isonet L dispensers showed excellent performance against the pest without additional treatment in 2015 and 2016. Average infestation rates of EGVM were below the threshold of 6%. EGVM infestation has been maintained at zero level by sprayings five and four times in the chemical treated vineyard in 2015 and 2016 in Manisa. Isonet LTT dispensers released 340 and 370 mg pheromone until harvest (19 August 2015 and 16 August 2016) in Manisa, whereas they released 360 and 410 mg of until harvest (27 August 2015 and 22 August 2016) in Canakkale, respectively.","[Altindisli, F. Ozlem; Ozsemerci, Fatma; Akkan, Umran; Keskin, Nese] Plant Protect Res Inst Bornova, Izmir, Turkey; [Koclu, Turkan] Sumi Agro Turkey, Istanbul, Turkey",,"Altindisli, FO (通讯作者)，Plant Protect Res Inst Bornova, Izmir, Turkey.",,,,,,,,12,5,5,1,3,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,1029.0,10.1051/bioconf/20160701029,0.0,,,4,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"gold, Green Submitted",,,2024-03-09,WOS:000390791700029,0
C,"Boztepe, O; Altindisli, A; Isçi, B",,"Aurand, JM",,"Boztepe, Ozlem; Altindisli, Ahmet; Isci, Burcak",,,Effect of sulphur forms on colour and residue of sulphur during the storage at drying grapes by sulphur,39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,English,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"Turkey is the world leader in the manufacture and export of seedless raisins. Requirement of golden bleached raisins is increasing in food Industry of especially cake, bread and pastry year by year. In this research, the lowest residual value and the practical realization of such production was intended to determine by drying grapes with application of sulphur. In this case, sulphur residue and colour situations were determined during 12-mounth-storage according to sulphur forms. In this study sulphur studies were applied by Vitis Vinifera cv. Sultani Cekirdeksiz with Na2S2O5, which is liquid source of sulphur and SO2, which is gas source of sulphur. SO2 application were studied during 3, 6 and 8 hours and liquid form of sulphur is Na2S2O5 that was used during by 10, 20 and 30 minutes. Applications were prepared with 3 replicates which contain 20 kg fresh grape in each replicate. In conclusion, changes in dried grape have been identified in point of colour (chroma and hue) and the sulphur content was determined according to sulphur forms in packing. Gas form of sulphur (SO2) which was applied 3 hours, gave the best result during 12-mounth-storage for colour and sulphur residue.","[Boztepe, Ozlem] Hazelnut Res Inst, TR-28200 Giresun, Turkey; [Altindisli, Ahmet; Isci, Burcak] Ege Univ, Dept Hort, TR-35100 Izmir, Turkey","Ministry of Food, Agriculture & Livestock - Turkey; Ege University","Boztepe, O (通讯作者)，Hazelnut Res Inst, TR-28200 Giresun, Turkey.",,"ISCI, Burcak BI/E-7975-2015; İŞÇİ, BURÇAK/ABA-9661-2020; Boztepe, Özlem/GPS-4722-2022","ISCI, Burcak BI/0000-0002-6542-0271; Boztepe, Özlem/0000-0003-0978-7199",,,,,5,0,0,0,6,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,1005.0,10.1051/bioconf/20160701005,0.0,,,3,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"Green Published, Green Submitted, gold",,,2024-03-09,WOS:000390791700005,0
C,"Castaing, C; Godet-Thobie, C; Truong, LX; Mostefai, FZ",,"Kusuoka, S; Maruyama, T",,"Castaing, C.; Godet-Thobie, C.; Truong, L. X.; Mostefai, F. Z.",,,On a Fractional Differential Inclusion in Banach Space UnderWeak Compactness Condition,"ADVANCES IN MATHEMATICAL ECONOMICS, VOL 20",Advances in Mathematical Economics,,English,Proceedings Paper,6th Conference on Mathematical Analysis in Economic Theory,"JAN 26-29, 2015","Keio Univ, Tokyo, JAPAN","Japanese Soc Math Econ,Keio Econ Soc,Top Global Univ Project,Oak Soc Inc",Keio Univ,Fractional differential inclusion; w-R. L derivative; Pettis integral; Relaxation; Young measures,INTEGRAL-EQUATIONS,"We consider a class of boundary value problem in a separable Banach space governed by a fractional differential inclusion with integral boundary conditions {w-D-alpha u(t) is an element of F(t, u(t), w-D alpha-1 u(t)), t is an element of [0, 1] I-beta u(t)vertical bar(t=0) = 0, u(1) = integral(1)(0) u(t)dt where alpha is an element of]1, 2] beta is an element of]1, infinity [ OE are given constant and w-D-gamma is the fractional w-R. L derivative of order gamma is an element of {alpha - 1, alpha}, F is a convex weakly compact valued mapping. Topological properties of the solutions set are presented. Applications to control problems and further variants are provided.","[Castaing, C.] Univ Montpellier 2, Dept Math, Case Courrier 051, F-34095 Montpellier 5, France; [Godet-Thobie, C.] Univ Bretagne Occidentale, CNRS UMR 6205, Lab Math Bretagne Atlantique, CS 9387, 6 Ave Victor Le Gorgeu, F-29238 Brest 3, France; [Truong, L. X.] Univ Econ HoChiMinh City, Dept Math & Stat, 59C Nguyen Dinh Chieu Str Dist 3, Hochiminh City, Vietnam; [Mostefai, F. Z.] Univ Saida, Dept Math, BP 138, Cite Ennasr 20000, Saida, Algeria",Universite de Montpellier; Universite de Bretagne Occidentale; Ho Chi Minh City University Economics; Universite de Saida,"Castaing, C (通讯作者)，Univ Montpellier 2, Dept Math, Case Courrier 051, F-34095 Montpellier 5, France.",charles.castaing@gmail.com; christiane.godet-thobie@univ-brest.fr; lxuantruong@gmail.com; fatymath@gmail.com,/AAM-4011-2020,"/0000-0003-2328-6235; Godet Thobie, Christiane/0000-0003-4904-4146",,,,,37,5,5,0,0,SPRINGER-VERLAG SINGAPORE PTE LTD,SINGAPORE,"152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE",1866-2226,,978-981-10-0476-6; 978-981-10-0475-9,ADV MATH ECON,,,2016,20.0,,,,,,23,75,,10.1007/978-981-10-0476-6_2,0.0,,,53,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,BG6QS,,,,,2024-03-09,WOS:000390822500002,0
C,"Cavalcante, CM",,"Aurand, JM",,"Cavalcante, Carolina Miranda",,,An institutional approach to the history of wine in brazil,39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,English,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"The history of wine in Brazil dates back to 1532, when Bras Cubas tried to cultivate the vine on Sao Paulo coast. As we can imagine, it was not a very successful venture. Later, other efforts were made by Jesuits in the seventeenth century. In 1739 Portugal prohibited the production of grapes and wine in the colony and this prohibition lasted until the Independence of Brazil in 1822. Although it is interesting to mention those fledgling efforts to produce wine in Brazil, the decisive impetus for the Brazilian wine industry only began with the Italian immigration of the late nineteenth century. These immigrants from Veneto and Trentino Alto Adige settled in the Serra Gaucha and received land from the government, for which they had to pay later. Some of today famous Brazilian wineries, like Miolo and Casa Valduga, began as small canteens initiated by Italian immigrants. These immigrants had not the intention to build a wine industry when they arrived in Brazil. The primary intention was to make wine for their own consumption provided that wine was considered as a food, a part of Italian culture and tradition, not simply an alcoholic beverage. Therefore, wine industry in Rio Grande do Sul emerged to supply a cultural demand of the Italian immigrants. A different motive can be identified in the reasons of the implementation of a wine industry in Sao Francisco Valley, backcountry of Northeast Brazil. We could say that the region became economically interesting since the development induced by investments in irrigation, conducted mainly by CODEVASF. Therefore, the drive for wine production in Serra Gaucha was culture, while the drive for Sao Francisco Valley wine industry was the business opportunities engendered by institutional policies conducted on the region. In this article, I will consider the history of wine industry in Serra Gaucha and in Sao Francisco Valley through the lens of Institutional Economics, initiated by Thorstein Veblen in the late nineteenth century, reworked by new institutionalists like Douglass North, and continued today by authors like Geoffrey Hodgson and others. I suggest three institutional dimensions that are usually considered by the seminal authors of Institutional Economics: (i) rules of the game, they are the formal and informal rules that structure human interaction; (ii) mental models, consistent of ideologies, habits of thought and all the internalized rules of the game; (iii) organizations, that are groups of individuals acting together with an at least temporary common purpose. The objective of this article is to tell the history of wine in Brazil and to compare the different motives for wine production in those two Brazilian regions. The question proposed in this article is: which institutional dimension was more important for the emergence of a wine industry in Serra Gaucha and Sao Francisco Valley? The hypothesis is that not only government policies in the Sao Francisco Valley were important for the emergence of a wine industry in Brazilian backcountry, but also the know-how acquired in winegrowing in Serra Gaucha. This article is divided in five parts. The first section introduces the topics proposed in the article. In the second section, the institutionalist theory will be presented, based on the idea of the three institutional dimensions. In the third section, the history of wine in the Serra Gaucha will be told. In the fourth section, the motives for a wine industry in Sao Francisco Valley will be presented. Finally, the fifth section concludes the article.","[Cavalcante, Carolina Miranda] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil",Universidade Federal do Rio de Janeiro,"Cavalcante, CM (通讯作者)，Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.",cmcavalcante@gmail.com,,,,,,,26,3,3,0,6,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,3025.0,10.1051/bioconf/20160703025,0.0,,,10,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"Green Published, Green Submitted, gold",,,2024-03-09,WOS:000390791700103,0
J,"Cawley, J; Dragone, D; Scholder, SVK",,,,"Cawley, John; Dragone, Davide; Scholder, Stephanie Von Hinke Kessler",,,THE DEMAND FOR CIGARETTES AS DERIVED FROM THE DEMAND FOR WEIGHT LOSS: A THEORETICAL AND EMPIRICAL INVESTIGATION,HEALTH ECONOMICS,,,English,Article,,,,,,smoking; cigarettes; obesity; BMI; weight; derived demand; price elasticity,BODY-WEIGHT; SMOKING INITIATION; OBESITY; BMI; ADOLESCENTS; CONSEQUENCES; PREVALENCE; VALIDITY; BEHAVIOR; GROWTH,"This paper offers an economic model of smoking and body weight and provides new empirical evidence on the extent to which the demand for cigarettes is derived from the demand for weight loss. In the model, smoking causes weight loss in addition to having direct utility benefits and direct health consequences. It predicts that some individuals smoke for weight loss and that the practice is more common among those who consider themselves overweight and those who experience greater disutility from excess weight. We test these hypotheses using nationally representative data in which adolescents are directly asked whether they smoke to control their weight. We find that, among teenagers who smoke frequently, 46% of girls and 30% of boys are smoking in part to control their weight. As predicted by the model, this practice is significantly more common among those who describe themselves as too fat and among groups that tend to experience greater disutility from obesity. We conclude by discussing the implications of these findings for tax policy; specifically, the demand for cigarettes is less price elastic among those who smoke for weight loss, all else being equal. Public health efforts to reduce smoking initiation and encourage cessation may wish to design campaigns to alter the derived nature of cigarette demand, especially among adolescent girls. Copyright (C) 2014 John Wiley & Sons, Ltd.","[Cawley, John] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY 14850 USA; [Cawley, John] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Cawley, John] Univ Sydney, Sch Econ, Sydney, NSW, Australia; [Dragone, Davide] Univ Bologna, Dept Econ, Bologna, Italy; [Scholder, Stephanie Von Hinke Kessler] Univ Bristol, Sch Econ Finance & Management, Bristol, Avon, England",Cornell University; Cornell University; University of Sydney; University of Bologna; University of Bristol,"Cawley, J (通讯作者)，Cornell Univ, Dept Policy Anal & Management, Ithaca, NY 14850 USA.",jhc38@cornell.edu,"Cawley, John/E-6734-2010; Dragone, Davide/ABG-2632-2021","Cawley, John/0000-0002-4805-9883; Dragone, Davide/0000-0002-2725-4743; von Hinke, Stephanie/0000-0002-8272-076X","Robert Wood Johnson Foundation; Cornell's Institute for Health Economics, Health Behaviors, and Disparities; FarmaFactoring Foundation; UK Medical Research Council [G1002345]; Economic and Social Research Council [ES/H005803/1] Funding Source: researchfish; Medical Research Council [G1002345] Funding Source: researchfish; ESRC [ES/H005803/1] Funding Source: UKRI","Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Cornell's Institute for Health Economics, Health Behaviors, and Disparities; FarmaFactoring Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))","For helpful comments, we thank the editor John Mullahy, two anonymous referees, Charles Baum, David Frisvold, Don Kenkel, Catherine Maclean, and participants in the American Society of Health Economists biennial conference and the Food and Drug Administration's Economics of Tobacco Roundtable. We gratefully acknowledge financial support from an Investigator Award in Health Policy Research from the Robert Wood Johnson Foundation (Cawley); Cornell's Institute for Health Economics, Health Behaviors, and Disparities (Cawley); the FarmaFactoring Foundation (Dragone); and the UK Medical Research Council (von Hinke Kessler Scholder, reference number G1002345).",,74,19,23,0,14,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JAN,2016,25.0,1.0,,,,,8,23,,10.1002/hec.3118,0.0,,,16,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DA9YS,25346511.0,,,,2024-03-09,WOS:000368166300002,0
C,"Penavayre, S; Lempereur, V; Huet, AP; Gillet, S; Pernet, C; Besnier, A; Farrant, L; Jolibert, F",,"Aurand, JM",,"Penavayre, Sophie; Lempereur, Valerie; Huet, Andre-Paul; Gillet, Sarah; Pernet, Claire; Besnier, Antoine; Farrant, Laura; Jolibert, Franck",,,Using Life Cycle Assessment to identify potential environmental impacts of an agrifood sector: Application to the PDO Beaujolais and Burgundia wine sector,39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,English,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"The environmental impacts of the production system of emblematic French product under official quality marks was investigated using the Life Cycle Assessment (LCA) methodology. The study looks at the PDO Beaujolais and Burgundy sector from a broad perspective, i.e. encompassing all steps linked with the products themselves but also complementary activities that belong to this wine sector. To build the Life Cycle Inventory (LCI), a methodology deriving from both product and organizational LCA was developed and applied. The LCI was built using a bottom-up approach. Inventories were first built for a sample of 17 representative companies. Then, these inventories were scaled-up to complete the global LCI at the agrifood sector level. Potential environmental impacts were assessed for 8 indicators. The LCA results show potential environmental impacts for each life cycle step: grape production, wine making and aging, packaging, distribution and activity of stakeholders belonging to the close environment. It provided two main outcomes: (i) a methodology for the construction of an LCI adapted to the perimeter of an agrifood sector and composed by high quality data; and (ii) the identification of potential environmental impacts of the studied agrifood sector, providing assistance for the definition of their strategic orientations for the future.","[Penavayre, Sophie; Lempereur, Valerie; Huet, Andre-Paul] Inst Francais Vigne & Vin IFV, F-69661 Villefranche, France; [Gillet, Sarah; Pernet, Claire] BIVB, F-21200 Beaune, France; [Besnier, Antoine] Inst Corps Gras ITERG, F-33600 Pessac, France; [Farrant, Laura] CTCPA, F-32000 Auch, France; [Jolibert, Franck] UNGDA, F-92247 Malakoff, France",,"Penavayre, S (通讯作者)，Inst Francais Vigne & Vin IFV, F-69661 Villefranche, France.",,,,,,,,14,5,5,2,14,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,1009.0,10.1051/bioconf/20160701009,0.0,,,7,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"Green Submitted, Green Published, gold",,,2024-03-09,WOS:000390791700009,0
C,"Valeria, B; José, R; Ignacio, G; Hernán, V; Natalia, C; Andrea, C; Francisco, G",,"Aurand, JM",,"Valeria, Bergas; Jose, Rodriguez; Ignacio, Galarraga; Hernan, Vila; Natalia, Carrillo; Andrea, Corvalan; Francisco, Gomez",,,Evaluation of a new vine trellis system called Rame,39TH WORLD CONGRESS OF VINE AND WINE,BIO Web of Conferences,,Spanish,Proceedings Paper,39th World Congress of Vine and Wine,"OCT 24-28, 2016","Bento Goncalves, BRAZIL",,,,,"You should leave 10mm of space above the abstract and 15mm after the abstract. The heading Abstract should be typed in bold 9-point Arial. The body of the abstract should be typed in normal 9-point Times in a single paragraph, immediately following the heading. The text should be set to 1.15 line spacing. The abstract should be centred across the page, indented 15mm from the left and right page margins and justified. It should not normally exceed 200 words. Under this problematic context, several growers in our area proposed alternatives to conduction systems. An innovation was the system of divided canopy Rame, developed by the local viticulture Luis Alberto Ramero. This system was attempted to combine high yield with high quality grape, machanize harvest and good cinditions of canopy microclimate. It's a system of vertical shoot position, with its canopy divided into two planes. These systems are characterized, in our region, by a low foliar surface exposed per hectare, a relatively low productivity (in the case of the VSP) or difficulty to mechanize the harvest (in the case of the Parral). The objective of this study was to evaluate the ecophysiology of Rame system, determining if it behaves differently when it is planted with one or two plants by post (Rame single and double). Also the two modalities of Rame were compared with the trellis in VSP. Since this latter system is not included in the statistical, but planted design on the side of the test, the comparison kept a descriptive character. For the Rame we established an experimental trial with statistical design, with two treatments in trellis-training system. A treatment consisted in planting one vine per post, called simple Rame (RS) and two vines per post, called double Rame (RD), leaving in this way different number of plants per unit area (1600 plantas / has and 3200 plantas / has respectively). Nevertheless, regardless of the number of plants per hectare, Rame system maintain high values of anthocyanins (1, 2 mg/Kg of grapes) and IPT (43) with high production (152 qq / has). This fact, added to that the system has potential for mechanization, converts Rame in a trellis system with high potential for vine growth in the viticulture regions. The trellis VSP behaved less productive (86 qq / has), and at the same time obtained lower values of qualitative components such as anthocyanins (1.04 mg/Kg of grapes) and IPT (35).","[Valeria, Bergas; Jose, Rodriguez; Ignacio, Galarraga; Natalia, Carrillo; Andrea, Corvalan; Francisco, Gomez] UNCuyo, Fac Ciencias Agr, Catedra Viticultura, Ahnirante Brown 500, RA-5507 Mendoza, Argentina; [Hernan, Vila] INTA, Mendoza, Argentina",Instituto Nacional de Tecnologia Agropecuaria (INTA),"Valeria, B (通讯作者)，UNCuyo, Fac Ciencias Agr, Catedra Viticultura, Ahnirante Brown 500, RA-5507 Mendoza, Argentina.",vbergas@fca.uncu.edu.ar,,,,,,,5,0,0,0,8,E D P SCIENCES,CEDEX A,"17 AVE DU HOGGAR PARC D ACTIVITES COUTABOEUF BP 112, F-91944 CEDEX A, FRANCE",2117-4458,,,BIO WEB CONF,,,2016,7.0,,,,,,,,1031.0,10.1051/bioconf/20160701031,0.0,,,3,"Agricultural Economics & Policy; Agriculture, Multidisciplinary; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BG6QG,,"Green Submitted, Green Published, gold",,,2024-03-09,WOS:000390791700031,0
J,"von Hinke, S; Smith, GD; Lawlor, DA; Propper, C; Windmeijer, F",,,,"von Hinke, Stephanie; Smith, George Davey; Lawlor, Debbie A.; Propper, Carol; Windmeijer, Frank",,,Genetic markers as instrumental variables,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,ALSPAC; Genetic variants; Instrumental variables; Mendelian randomization; Potential outcomes,BODY-MASS INDEX; MENDELIAN RANDOMIZATION; BLOOD-PRESSURE; PRINCIPAL STRATIFICATION; GENERALIZED-METHOD; CAUSAL INFERENCE; FTO GENE; OBESITY; IDENTIFICATION; VARIANTS,"The use of genetic markers as instrumental variables (IV) is receiving increasing attention from economists, statisticians, epidemiologists and social scientists. Although IV is commonly used in economics, the appropriate conditions for the use of genetic variants as instruments have not been well defined. The increasing availability of biomedical data, however, makes understanding of these conditions crucial to the successful use of genotypes as instruments. We combine the econometric IV literature with that from genetic epidemiology, and discuss the biological conditions and IV assumptions within the statistical potential outcomes framework. We review this in the context of two illustrative applications. (C) 2015 The Authors. Published by Elsevier B.V.","[von Hinke, Stephanie; Smith, George Davey; Lawlor, Debbie A.; Propper, Carol; Windmeijer, Frank] Univ Bristol, Bristol, Avon, England; [Propper, Carol] Univ London Imperial Coll Sci Technol & Med, London, England",University of Bristol; Imperial College London,"von Hinke, S (通讯作者)，Univ Bristol, Bristol, Avon, England.",S.vonHinke@bristol.ac.uk,"Windmeijer, Frank/AAL-5695-2020; Lawlor, David/JOJ-7815-2023; Davey Smith, George/A-7407-2013","Davey Smith, George/0000-0002-1407-8314; von Hinke, Stephanie/0000-0002-8272-076X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Windmeijer, Frank/0000-0002-4232-2783; Lawlor, Debbie A/0000-0002-6793-2262","Economic and Social Research Council [RES-060-23-0011, PTA-026-27-2335]; MRC [G0601625, G1002345]; European Research Council [269874-DEVHEALTH]; ESRC [ES/H005803/1] Funding Source: UKRI; MRC [MC_UU_12013/1, MC_UU_12013/9, G0601625, MC_UU_12013/5, G1002345] Funding Source: UKRI; Economic and Social Research Council [RES-343-28-3001, ES/H005803/1] Funding Source: researchfish; Medical Research Council [MC_UU_12013/5, MC_UU_12013/9, MC_PC_15018, MC_UU_12013/1, G0601625, G1002345] Funding Source: researchfish",Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),"The UK Medical Research Council (MRC), the Wellcome Trust and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors, who will serve as guarantors for the contents of this paper. Funding from the Economic and Social Research Council (RES-060-23-0011 and PTA-026-27-2335), the MRC (G0601625 and G1002345), and the European Research Council (grant 269874-DEVHEALTH) is gratefully acknowledged.",,71,75,78,0,13,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,JAN,2016,45.0,,,,,,131,148,,10.1016/j.jhealeco.2015.10.007,0.0,,,18,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DG1PU,26614692.0,"Green Published, hybrid, Green Submitted",,,2024-03-09,WOS:000371840800011,0
J,"Lloyd, AJ; Kerr, C; Penton, J; Knerer, G",,,,"Lloyd, Andrew J.; Kerr, Cicely; Penton, James; Knerer, Gerhart",,,Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients,VALUE IN HEALTH,,,English,Article,,,,,,castrate-resistant prostate cancer; EORTC-8D; EQ-5D-5L; HRQOL; utilities,MAPPING FACT-P; EQ-5D; ABIRATERONE; MANAGEMENT; MCRPC; MEN,"Background: The collection of preference-based health outcomes data (or utility values) is required to support cost-effectiveness analyses. Objective: This study aimed to collect health-related quality of life (HRQOL) data in men with metastatic castration-resistant prostate cancer (CRPC) stratified by disease states. Methods: Men with metastatic CRPC were recruited via UK patient associations, patient panels, and specialist recruiters and classified into four subgroups reflecting disease state: asymptomatic/mildly symptomatic before chemotherapy, symptomatic before chemotherapy, receiving chemotherapy, and postchemotherapy. HRQOL data (including five-level EuroQol five-dimensional questionnaire [EQ-5D-5L] European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire [EORTC QLQ-C30], and 25-item prostate cancer-specific questionnaire module designed to supplement the EORTC QLQ-C30) along with background and medical history data were collected via an online survey. The EQ-5D-5L and the EORTC-8D (EORTC-8D is an 8 dimensional utility index scored from QLQ-C30 data) were both used to estimate utilities. Results: Data were collected from a total sample of 163 men with metastatic CRPC. Utility values elicited by the EQ-5D-5L ranged from 0.830 for the asymptomatic/mildly symptomatic before chemotherapy disease state (95% confidence interval [CI] 0.795-0.865) to 0.625 for the symptomatic before chemotherapy disease state (95% CI 0.577-0.673). EORTC-8D utilities ranged from 0.856 (95% CI 0.831-0.882) to 0.697 (95% CI 0.664-0.731) for the same disease/treatment states. Conclusions: This online survey was designed to capture real-world HRQOL data describing men with CRPC. The study estimated utilities using two alternative methods, and the results show good agreement, suggesting that they are robust. This methodology offers a potentially higher quality alternative to vignette-based methods that are commonly used in oncology submissions.","[Lloyd, Andrew J.; Kerr, Cicely] ICON Patient Reported Outcomes, Oxford, England; [Kerr, Cicely; Penton, James; Knerer, Gerhart] Janssen Cilag Ltd, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, Bucks, England",ICON plc; Johnson & Johnson,"Kerr, C (通讯作者)，Janssen Cilag Ltd, 50-100 Holmers Farm Way, High Wycombe HP12 4EG, Bucks, England.",ckerr8@its.jnj.com,"Penton, James/JZE-3681-2024","Penton, James/0000-0002-1747-0450; Kerr, Cicely/0000-0003-3921-0841",Janssen-Cilag Ltd,Janssen-Cilag Ltd,This study was funded by Janssen-Cilag Ltd and conducted by ICON plc.,,31,31,32,0,14,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,DEC,2015,18.0,8.0,,,,,1152,1157,,10.1016/j.jval.2015.08.012,0.0,,,6,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DF3GG,26686802.0,hybrid,,,2024-03-09,WOS:000371231500026,0
J,"Aggarwal, S; Topaloglu, H; Kumar, S",,,,"Aggarwal, S.; Topaloglu, H.; Kumar, S.",,,IMPACT OF ESSENTIAL HEALTH BENEFIT BENCHMARK PLANS ON US MARKET ACCESS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Aggarwal, S.; Topaloglu, H.] NOVEL Hlth Strategies, Chevy Chase, MD USA; [Kumar, S.] GLOBAL ACCESS Monitor, Bethesda, MD USA",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP187,A546,A546,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300227,0
J,"Ajmera, MR; Sambamoorthi, U",,,,"Ajmera, M. R.; Sambamoorthi, U.",,,"RISK OF NEW-ONSET DIABETES ASSOCIATED WITH CONCOMITANT ANTIDEPRESSANT, INHALED CORTICOSTEROIDS, AND STATIN USE AMONG MEDICAID BENEFICIARIES WITH COPD",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ajmera, M. R.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Sambamoorthi, U.] West Virginia Univ, Morgantown, WV USA",Research Triangle Institute; West Virginia University,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB1,A597,A597,,10.1016/j.jval.2015.09.2041,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300513,0
J,"Akram, A; Ul Haq, N; Riaz, S; Ahmed, N; Hamid, R",,,,"Akram, A.; Ul Haq, N.; Riaz, S.; Ahmed, N.; Hamid, R.",,,SATISFACTION WITH LIFE OF GENERAL POPULATION OF PAKISTAN. A NATION WIDE SURVEY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Akram, A.; Ul Haq, N.; Riaz, S.; Ahmed, N.] Univ Balochistan, Quetta, Pakistan; [Hamid, R.] Univ Milan, Milan, Italy",University of Balochistan; University of Milan,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH64,A743,A743,,10.1016/j.jval.2015.09.2862,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400361,0
J,"Anelli, M; Puglisi, R",,,,"Anelli, M.; Puglisi, R.",,,THE ACTUAL COST OF A FORCED SWITCH OF PSYCHIATRIC PATIENTS TO A NEW THERAPY: A MARKOV CHAIN - MONTE CARLO SIMULATION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Anelli, M.; Puglisi, R.] Keypharma Srl, Prod Life Grp, Milan, Italy",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMH17,A409,A409,,10.1016/j.jval.2015.09.970,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400409,0
J,"Babela, R; Ferancova, D",,,,"Babela, R.; Ferancova, D.",,,ANALYSIS OF DIRECT COSTS ASSOCIATED WITH CYSTIC FIBROSIS IN SINGLE CENTER IN SLOVAKIA: 5 YEARS REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Babela, R.; Ferancova, D.] St Elizabeth Univ Hlth & Social Work, Bratislava, Slovakia",,,,"Babela, Robert/ABD-9615-2020",,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY47,A666,A667,,10.1016/j.jval.2015.09.2431,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300897,0
J,"Barsdorf, AI; Carlsson, M; Bushmakin, AG; Quinn, S; Cappelleri, JC; Pleil, A",,,,"Barsdorf, A., I; Carlsson, M.; Bushmakin, A. G.; Quinn, S.; Cappelleri, J. C.; Pleil, A.",,,VALIDATION OF THE OVERACTIVE BLADDER QUESTIONNAIRE (OAB-Q; 1-WEEK RECALL) IN MEDICALLY COMPLEX ELDERLY ADULTS WITH OVERACTIVE BLADDER,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Barsdorf, A., I; Carlsson, M.; Quinn, S.] Pfizer Inc, New York, NY USA; [Bushmakin, A. G.; Cappelleri, J. C.] Pfizer Inc, Groton, CT 06340 USA; [Pleil, A.] Pfizer Inc, San Diego, CA USA",Pfizer; Pfizer; Pfizer,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PUK23,A512,A512,,10.1016/j.jval.2015.09.1478,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300030,0
J,"Bereza, BG; Pechlivanoglou, P; Coyle, D; Wells, G; So, D; Grootendorst, P; Papadimitropoulos, M",,,,"Bereza, B. G.; Pechlivanoglou, P.; Coyle, D.; Wells, G.; So, D.; Grootendorst, P.; Papadimitropoulos, M.",,,A DISCRETE CHOICE EXPERIMENT (DCE) TO ELICIT PREFERENCES FOR ATTRIBUTES OF A BEDSIDE PHARMACOGENETIC TEST - PRELIMINARY RESULTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bereza, B. G.; Grootendorst, P.; Papadimitropoulos, M.] Univ Toronto, Toronto, ON, Canada; [Pechlivanoglou, P.] THETA Toronto Hlth Econ & Technol Assessment Coll, Toronto, ON, Canada; [Coyle, D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Wells, G.; So, D.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada",University of Toronto; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute,,,,"Coyle, Doug/0000-0003-3492-2268",,,,,0,1,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV146,A399,A399,,10.1016/j.jval.2015.09.916,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400356,0
J,"Boncz, I; Endrei, D; Agoston, I; Csákvári, T; Danku, N; Brodszky, V",,,,"Boncz, I; Endrei, D.; Agoston, I; Csakvari, T.; Danku, N.; Brodszky, V",,,PREDICTION OF FUTURE HEALTH INSURANCE EXPENDITURES IN HUNGARY ACCORDING TO POPULATION FORECAST SCENARIOS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Boncz, I; Endrei, D.; Agoston, I; Danku, N.] Univ Pecs, Pecs, Hungary; [Csakvari, T.] Univ Pecs, Zalaegerszeg, Hungary; [Brodszky, V] Corvinus Univ Budapest, Budapest, Hungary",University of Pecs; University of Pecs; Corvinus University Budapest,,,"Ágoston, István/AAS-1564-2020; Brodszky, Valentin/AFN-4112-2022; Csakvari, Timea/AAE-2141-2019; Boncz, Imre/A-8940-2013","Brodszky, Valentin/0000-0002-6095-2295; Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,9,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP129,A536,A536,,10.1016/j.jval.2015.09.1682,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300169,0
J,"Borowiack, E; Garbacka, M; Borowiack, M; Zapalska, A; Wepsiec, K; Tronczynska, D; Ksiazek, A; Van Bellinghen, L; Van Vlaenderen, I; Schecroun, N",,,,"Borowiack, E.; Garbacka, M.; Borowiack, M.; Zapalska, A.; Wepsiec, K.; Tronczynska, D.; Ksiazek, A.; Van Bellinghen, L.; Van Vlaenderen, I; Schecroun, N.",,,THE DEVIL IS NOT SO BLACK AS HE IS PAINTED - THE FUTURE OF IMMUNIZATION IN POLAND,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Borowiack, E.; Garbacka, M.; Borowiack, M.; Zapalska, A.] NUEVO IITA CLP, Krakow, Poland; [Wepsiec, K.; Tronczynska, D.; Ksiazek, A.] GSK Serv Sp Zoo, Warsaw, Poland; [Van Bellinghen, L.; Van Vlaenderen, I] CHESS Hlth, Ternat, Belgium; [Schecroun, N.] Keyrus Biopharma GSK Vaccines, Wavre, Belgium",GlaxoSmithKline; GlaxoSmithKline,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN43,A583,A583,,10.1016/j.jval.2015.09.1953,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300436,0
J,"Brantmüller, É; Horváth, O; Karacsony, I; Gyuró, M; Oláh, A; Boncz, I; Gelencsér, E; Pakai, A",,,,"Brantmuller, E.; Horvath, O.; Karacsony, I; Gyuro, M.; Olah, A.; Boncz, I; Gelencser, E.; Pakai, A.",,,CONNECTION BETWEEN THE WAY OF PARENTING AND THE BEHAVIOR OF ADOLESCENTS IN THE LIGHT OF A SURVEY IN HUNGARY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Brantmuller, E.; Horvath, O.; Gelencser, E.] Univ Pecs, Kaposvar, Hungary; [Karacsony, I] Univ Pecs, Szombathely, Hungary; [Gyuro, M.; Olah, A.; Boncz, I] Univ Pecs, Pecs, Hungary; [Pakai, A.] Univ Pecs, Zalaegerszeg, Hungary",University of Pecs; University of Pecs; University of Pecs; University of Pecs,,,"Pakai, Annamaria/AAS-2610-2020; Boncz, Imre/A-8940-2013","Pakai, Annamaria/0000-0002-2849-1310; Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH48,A740,A741,,10.1016/j.jval.2015.09.2846,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400345,0
J,"Byambasuren, T; Amgalanbaatar, A; Sundui, E; Dorjkhuu, A",,,,"Byambasuren, T.; Amgalanbaatar, A.; Sundui, E.; Dorjkhuu, A.",,,THE STRUCTURE OF THE CHOROID PLEXUS OF ADULT AND CHILDREN BRAIN VENTRICLES,VALUE IN HEALTH,,,English,Meeting Abstract,18th Annual European Congress of the International-Society-for-Pharmacoeconomics-and-Outcomes-Research (ISPOR),"NOV 07-11, 2015","Milan, ITALY",Int Soc Pharmacoecon & Outcomes Res,,,,,"[Byambasuren, T.; Amgalanbaatar, A.; Sundui, E.; Dorjkhuu, A.] Mongolian Natl Univ Med Sci, Ulaanbaatar, Mongolia",Mongolian National University of Medical Sciences,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD1,A857,A857,,10.1016/j.jval.2015.09.471,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400783,0
J,"Capel, M; Cordero, L",,,,"Capel, M.; Cordero, L.",,,ECONOMICS ANALYSIS OF DAPAGLIFLOZIN COMPARE TO SULFONYLUREA IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN SPAIN: COST OF ACHIEVING COMPOSITE ENDPOINTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Capel, M.; Cordero, L.] Astrazeneca, Madrid, Spain",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB71,A609,A610,,10.1016/j.jval.2015.09.2110,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300582,0
J,"Charonis, A; Spanakis, M; Kyriopoulos, I; Zavras, D; Athanasakis, K; Pavi, E; Kyriopoulos, J",,,,"Charonis, A.; Spanakis, M.; Kyriopoulos, I; Zavras, D.; Athanasakis, K.; Pavi, E.; Kyriopoulos, J.",,,THE RELATIONSHIP BETWEEN SOCIOECONOMIC CHARACTERISTICS AND SELF-RATED HEALTH IN GREECE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Charonis, A.; Spanakis, M.; Kyriopoulos, I; Zavras, D.; Athanasakis, K.; Pavi, E.; Kyriopoulos, J.] Natl Sch Publ Hlth, Athens, Greece",National & Kapodistrian University of Athens,,,"Zavras, Dimitris/AAP-8288-2021; Athanasakis, Kostas/AAZ-2148-2020; Zavras, Dimitris/K-9280-2018","Zavras, Dimitris/0000-0001-6165-3409;",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP76,A527,A527,,10.1016/j.jval.2015.09.1631,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300118,0
J,"Chen, Y; Ma, Q; Hines, DM; Zhao, Z; Munakata, J; Barber, BL",,,,"Chen, Y.; Ma, Q.; Hines, D. M.; Zhao, Z.; Munakata, J.; Barber, B. L.",,,CURRENT TREATMENT PATTERNS IN PATIENTS WITH METASTATIC MELANOMA: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS IN THE UNITED STATES (US),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Chen, Y.; Hines, D. M.] IMS Hlth, Fairfax, VA USA; [Ma, Q.; Zhao, Z.; Barber, B. L.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Munakata, J.] IMS Hlth, San Francisco, CA USA",Amgen,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN353,A492,A492,,10.1016/j.jval.2015.09.1370,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400866,0
J,"Corbacho, B; Drummond, M; Jones, E; Espin, J; Hernandez, JE; Borras, JM",,,,"Corbacho, B.; Drummond, M.; Jones, E.; Espin, J.; Exposito Hernandez, J.; Borras, J. M.",,,REGIONAL VERSUS CENTRALIZED HTA: IMPLICATIONS FOR THE ASSESSMENT OF CANCER DRUGS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Corbacho, B.] Univ York, York, N Yorkshire, England; [Drummond, M.; Jones, E.] MAPI, Uxbridge, Middx, England; [Espin, J.] Andalusian Sch Publ Hlth, Granada, Spain; [Exposito Hernandez, J.] Inst Invest Biosanitaria Ibs, Granada, Spain; [Borras, J. M.] Univ Barcelona, Lhospitalet De Llobregat, Spain",University of York - UK; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Barcelona,,,"Espin, Jaime/AAF-3732-2020","Espin, Jaime/0000-0001-7299-6554",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,HT4,A342,A342,,10.1016/j.jval.2015.09.151,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400039,0
J,"Coste, F; Neumann, PJ; Xie, L; Sanon, M; Bent-Ennakhil, N; Wang, Y; Kariburyo, MF; Fillit, H",,,,"Coste, F.; Neumann, P. J.; Xie, L.; Sanon, M.; Bent-Ennakhil, N.; Wang, Y.; Kariburyo, M. F.; Fillit, H.",,,AN UPDATE ON HEALTHCARE RESOURCE USE AND ECONOMIC BURDEN IN ALZHEIMER'S DISEASE IN THE UNITED STATES (US) FROM A MEDICARE SAMPLE ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Coste, F.; Bent-Ennakhil, N.] Lundbeck, Issy Les Muuiineaux, France; [Neumann, P. J.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA USA; [Xie, L.; Wang, Y.; Kariburyo, M. F.] STATinMED Res, Ann Arbor, MI USA; [Sanon, M.] Otsuka Amer Pharmaceut, Princeton, NJ USA; [Fillit, H.] Alzheimers Drug Discovery Fdn, New York, NY USA","Lundbeck Corporation; Lundbeck Corporation - France; Tufts Medical Center; Otsuka Pharmaceutical; Otsuka America Pharmaceutical, Inc.",,,"Xie, Lin/AAX-2889-2020",,,,,,0,0,0,0,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND33,A754,A754,,10.1016/j.jval.2015.09.2924,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400421,0
J,"Dearden, L; Musingarimi, P; Shalet, N; Demuth, D; Alvarez, LG; Muthutantri, A; Venerus, A; Lasry, R; Hankins, M; Maher, T",,,,"Dearden, L.; Musingarimi, P.; Shalet, N.; Demuth, D.; Alvarez, Garcia L.; Muthutantri, A.; Venerus, A.; Lasry, R.; Hankins, M.; Maher, T.",,,A DESCRIPTION OF REAL-WORLD TREATMENT WITH ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN THE POST-CHEMOTHERAPY SETTING IN FRANCE AND THE NETHERLANDS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dearden, L.] Janssen EMEA HEMAR, High Wycombe, Bucks, England; [Musingarimi, P.] Janssen Cilag Ltd, High Wycombe, Bucks, England; [Shalet, N.; Maher, T.] Janssen, High Wycombe, Bucks, England; [Demuth, D.; Alvarez, Garcia L.; Muthutantri, A.; Venerus, A.; Lasry, R.; Hankins, M.] IMS Hlth, London, England",Johnson & Johnson; Johnson & Johnson,,,,"shalet, natalie/0000-0002-7075-492X",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN34,A435,A435,,10.1016/j.jval.2015.09.1049,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400551,0
J,"Dionisi, M; Santomauro, M; Santagada, V; Santomauro, MA; Garofalo, G; Vosa, C; Paolini, D",,,,"Dionisi, M.; Santomauro, M.; Santagada, V; Santomauro, M. A.; Garofalo, G.; Vosa, C.; Paolini, D.",,,INTRODUCTION OF AN ORGANIZATIONAL MODEL OF TELEMEDICINE IN MANAGEMENT OF ORAL ANTICOAGULANT THERAPY: A BUDGET IMPACT ANALYSIS FROM ITALIAN PAYER PERSPECTIVE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Dionisi, M.; Paolini, D.] Roche Diagnost SpA, Monza, Italy; [Santomauro, M.; Santagada, V; Santomauro, M. A.; Garofalo, G.; Vosa, C.] Univ Naples Federico II, Naples, Italy",Roche Holding; University of Naples Federico II,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD29,A349,A349,,10.1016/j.jval.2015.09.630,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400078,0
J,"Enstone, A; Panter, C; Daumont, MM; Miles, R",,,,"Enstone, A.; Panter, C.; Daumont, Manley M.; Miles, R.",,,SOCIETAL BURDEN AND IMPACT ON HEALTH RELATED QUALITY OF LIFE (HRQOL) OF NON-SMALL CELL LUNG CANCER (NSCLC) IN EUROPE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Enstone, A.; Panter, C.; Miles, R.] Adelphi Values Ltd, Bollington, England; [Daumont, Manley M.] Bristol Myers Squibb, Paris, France",Adelphi Group Ltd; Bristol-Myers Squibb,,,,,,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM47,A690,A690,,10.1016/j.jval.2015.09.2563,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400067,0
J,"Eremenco, S; Shaffer, S; Schüler, R",,,,"Eremenco, S.; Shaffer, S.; Schuler, R.",,,MIGRATION OF THE FATIGUE SYMPTOMS AND IMPACTS QUESTIONNAIRE RELAPSING MULTIPLE SCLEROSIS (FSIQ-RMSTm) FROM PAPER TO AN ELECTRONIC DIARY FORMAT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Eremenco, S.; Shaffer, S.] Evidera Inc, Bethesda, MD USA; [Schuler, R.] Actelion Pharmaceut Ltd, Alischwil, Switzerland",Evidera,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM195,A717,A717,,10.1016/j.jval.2015.09.2709,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400211,0
J,"Feinberg, BA; Drenning, J; Garofalo, DF; Lal, L",,,,"Feinberg, B. A.; Drenning, J.; Garofalo, D. F.; Lal, L.",,,INSURANCE PLAN SWITCH PATTERNS AMONG BREAST CANCER PATIENTS COMPARED TO NON-CANCER PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Feinberg, B. A.; Garofalo, D. F.] Cardinal Hlth, Dublin, OH USA; [Drenning, J.] Cardinal Hlth, Dallas, TX USA; [Lal, L.] Cardinal Hlth, Missouri City, TX USA",Cardinal Health Inc; Cardinal Health Inc; Cardinal Health Inc,,,"Feinberg, Bruce/AAX-9378-2021","Feinberg, Bruce/0000-0001-9267-9994",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,Pcn257,A476,A476,,10.1016/j.jval.2015.09.1276,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400774,0
J,"Ferreira, CN; Santana, CF; Rufino, C",,,,"Ferreira, C. N.; Santana, C. F.; Rufino, C.",,,PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN PUBLIC AND PRIVATE SYSTEM VERSUS PPSV23 AND NO VACCINATION IN OLDER ADULTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ferreira, C. N.; Rufino, C.] Pfizer Brasil, Sao Paulo, Brazil; [Santana, C. F.] Pfizer, Sao Paulo, Brazil",Pfizer; Pfizer,,,,,,,,,0,1,2,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS4,A839,A839,,10.1016/j.jval.2015.09.366,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400681,0
J,"Fox, RJ; Cutter, G; Chan, A; Xiao, J; Okwuokenye, M; Levison, D; Lewin, J; Edwards, MR; Marantz, JL",,,,"Fox, R. J.; Cutter, G.; Chan, A.; Xiao, J.; Okwuokenye, M.; Levison, D.; Lewin, J.; Edwards, M. R.; Marantz, J. L.",,,COMPARATIVE EFFECTIVENESS USING A MATCHING-ADJUSTED INDIRECT COMPARISON BETWEEN DELAYED-RELEASE DIMETHYL FUMARATE AND FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fox, R. J.] Cleveland Clin, Cleveland, OH 44106 USA; [Cutter, G.] Univ Alabama Birmingham, Birmingham, AL USA; [Chan, A.] Ruhr Univ Bochum, Bochum, Germany; [Xiao, J.; Okwuokenye, M.; Levison, D.; Lewin, J.; Edwards, M. R.; Marantz, J. L.] Biogen, Cambridge, MA USA",Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Ruhr University Bochum; Biogen,,,"Cutter, Gary/AAY-5392-2021","Cutter, Gary/0000-0002-8455-980X",,,,,0,3,3,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PND10,A750,A750,,10.1016/j.jval.2015.09.2902,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400399,0
J,"Furneri, G; Iannazzo, S; Berti, V; Medici, MF; Parisi, S; Fusaro, E",,,,"Furneri, G.; Iannazzo, S.; Berti, V; Fregonara Medici, M.; Parisi, S.; Fusaro, E.",,,THE COST OF REHUMATOID DISEASES IN ITALY: ANALYSIS FROM AN ITALIAN ADMINISTRATIVE DATABASE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Furneri, G.] EBMA Consulting, Melegnano, Italy; [Iannazzo, S.] SIHS Hlth Econ Consulting, Turin, Italy; [Berti, V] CSI Piemonte, Turin, Italy; [Fregonara Medici, M.] Reg Piemonte, Turin, Italy; [Parisi, S.; Fusaro, E.] Azienda Osped Univ Citta Salute & Sci Torino, Turin, Italy",A.O.U. Citta della Salute e della Scienza di Torino,,,"Fusaro, Enrico/ABG-5071-2021","Fusaro, Enrico/0000-0001-9888-2563",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS47,A642,A642,,10.1016/j.jval.2015.09.2292,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300761,0
J,"Gad, M; Kriza, C; Kolominsky-Rabas, P",,,,"Gad, M.; Kriza, C.; Kolominsky-Rabas, P.",,,ACCESSING THE MEDICAL DEVICES MARKET IN EGYPT AND SAUDI ARABIA: A SYSTEMATIC REVIEW OF POLICIES AND REGULATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gad, M.; Kriza, C.; Kolominsky-Rabas, P.] Friedrich Alexander Univ Erlangen Nurnberg, Ctr Hlth Technol Assessment HTA & Publ Hlth IZPH, Erlangen, Germany; [Kriza, C.; Kolominsky-Rabas, P.] Natl Leading Edge Cluster Med Technol Med Valley, Erlangen, Germany",University of Erlangen Nuremberg,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD132,A367,A367,,10.1016/j.jval.2015.09.734,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,"Green Accepted, Green Submitted, Bronze",,,2024-03-09,WOS:000384252400180,0
J,"Gelhorn, HL; Poon, JL; Davies, EW; Paczkowski, R; Curits, SE; Boye, KS",,,,"Gelhorn, H. L.; Poon, J. L.; Davies, E. W.; Paczkowski, R.; Curits, S. E.; Boye, K. S.",,,EVALUATING DIABETES PATIENTS' PREFERENCES FOR PROFILES OF GLP-1 TREATMENTS IN THE UNITED KINGDOM: A DISCRETE CHOICE EXPERIMENT,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gelhorn, H. L.; Poon, J. L.] Evidera, Bethesda, MD USA; [Davies, E. W.] Evidera, London, England; [Paczkowski, R.; Curits, S. E.; Boye, K. S.] Eli Lilly & Co, Indianapolis, IN 46285 USA",Evidera; Evidera; Eli Lilly,,,"Davies, Evan/GWU-9310-2022",,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB93,A614,A614,,10.1016/j.jval.2015.09.2133,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300604,0
J,"Genovese, S; Torre, E; Baccetti, F",,,,"Genovese, S.; Torre, E.; Baccetti, F.",,,ECONOMIC BURDEN OF TYPE 2 DIABETES MELLITUS TREATMENT STRATEGIES: A COST CONSEQUENCE ANALYSIS OF SITAGLIPTIN VS SULFONYLUREAS IN LOMBARDY REGION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Genovese, S.] IRCCS Multimedia, Milan, Italy; [Torre, E.] Endocrinol Diabetol & Malattie Metab ASL3 Genoves, Genoa, Italy; [Baccetti, F.] SD Diabetol & Malattie Metab ASL1 Massa Carrara, Massa, Italy",IRCCS Multimedica,,,"Genovese, Stefano/F-9706-2017","Genovese, Stefano/0000-0002-6085-437X",,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB49,A606,A606,,10.1016/j.jval.2015.09.2089,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300561,0
J,"Gor, D; Kim, K; Chumnumwat, S; Galanter, WL; You, J; Walton, SM; Garofalo, J; Duarte, J; Krishnan, JA; Bauman, JL; Nutescu, EA",,,,"Gor, D.; Kim, K.; Chumnumwat, S.; Galanter, W. L.; You, J.; Walton, S. M.; Garofalo, J.; Duarte, J.; Krishnan, J. A.; Bauman, J. L.; Nutescu, E. A.",,,COST-EFFECTIVENESS OF A NOVEL PHARMACIST GUIDED WARFARIN PHARMACOGENETIC SERVICE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gor, D.; Kim, K.; Chumnumwat, S.; Galanter, W. L.; Walton, S. M.; Garofalo, J.; Duarte, J.; Krishnan, J. A.; Bauman, J. L.; Nutescu, E. A.] Univ Illinois, Chicago, IL USA; [You, J.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China",University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese University of Hong Kong,,,"Gor, Deval/AAM-6852-2020; You, Joyce H. S./C-2984-2008","You, Joyce H. S./0000-0002-5763-7403; KIM, KIBUM/0000-0002-8676-7434",,,,,0,0,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV97,A390,A390,,10.1016/j.jval.2015.09.866,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400307,0
J,"Gracia, A; Balañá, C; Kaskens, L; Chiavenna, S; Matias-Guiu, X; Rubio-Rodríguez, D; Rubio-Terrés, C; Iglesias, L; Esteller, M",,,,"Gracia, A.; Balana, C.; Kaskens, L.; Chiavenna, S.; Matias-Guiu, X.; Rubio-Rodriguez, D.; Rubio-Terres, C.; Iglesias, L.; Esteller, M.",,,"ECONOMIC ANALYSIS OF EPICUP, AN EPIGENETIC TEST TO PREDICT THE TISSUE OF ORIGIN IN CANCER OF UNKNOWN PRIMARY SITE, FROM THE SPANISH NHS PERSPECTIVE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gracia, A.; Kaskens, L.] HEOR & MA Dept Ferrer, Barcelona, Spain; [Balana, C.] ICO, Med Oncol Dept, Badalona, Spain; [Chiavenna, S.] Ferrer Adv Biotherapeut, Barcelona, Spain; [Matias-Guiu, X.] IRB, Lleida, Spain; [Rubio-Rodriguez, D.; Rubio-Terres, C.] Hlth Value, Madrid, Spain; [Iglesias, L.] Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain; [Esteller, M.] IDIBELL, Barcelona, Spain",Institut de Recerca Biomedica - IRB Lleida; Hospital Universitario 12 de Octubre; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL),,,"matias-guiu, xavier/C-3039-2009; BALANA, CARMEN/A-6828-2012; Esteller, Manel/L-5956-2014","BALANA, CARMEN/0000-0003-0771-0390; Esteller, Manel/0000-0003-4490-6093",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD71,A356,A357,,,,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400120,0
J,"Grau, S; Pozo, J; Romá, E; Salavert, M; Barrueta, J; Peral, C; Rodriguez, I; Rubio-Rodriguez, D; Rubio-Terrés, C",,,,"Grau, S.; Pozo, J.; Roma, E.; Salavert, M.; Barrueta, J.; Peral, C.; Rodriguez, I; Rubio-Rodriguez, D.; Rubio-Terres, C.",,,"PHARMACOECONOMIC ANALYSIS OF ANIDULAFUNGIN, MICAFUNGIN, CASPOFUNGIN AND FLUCONAZOLE IN THE TREATMENT OF CANDIDEMIA AND/OR INVASIVE CANDIDIASIS IN NON-NEUTROPENIC ADULT PATIENTS IN SPAIN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Grau, S.] Hosp del Mar IMIM, Barcelona, Spain; [Pozo, J.; Roma, E.] Hosp Univ Reina Sofia, Cordoba, Spain; [Salavert, M.] Hosp Univ Politecn La Fe, Valencia, Spain; [Barrueta, J.; Peral, C.] Pfizer SLU, Alcobendas, Madris, Spain; [Rodriguez, I] Trial Support Form, Madrid, Spain; [Rubio-Rodriguez, D.; Rubio-Terres, C.] Hlth Value, Madrid, Spain",Hospital del Mar Research Institute; Hospital del Mar; Hospital Universitario Reina Sofia - Cordoba; Hospital Universitari i Politecnic La Fe; Pfizer,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN51,A584,A585,,10.1016/j.jval.2015.09.1961,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300444,0
J,"Guelfucci, F; Bessou, A; Aballea, S",,,,"Guelfucci, F.; Bessou, A.; Aballea, S.",,,REVIEW OF COMORBIDITY MEASURES TO PREDICT ECONOMIC OUTCOMES IN REAL-LIFE DATABASE STUDIES,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Guelfucci, F.; Aballea, S.] Creat Ceut, Paris, France; [Bessou, A.] Natl Sch Stat & Informat Anal ENSAI, Bruz, France",Ecole Nationale de la Statistique et de l'Analyse de l'Information (ENSAI),,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM59,A692,A693,,10.1016/j.jval.2015.09.2575,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400079,0
J,"Hanna, E; Rémuzat, C; Auquier, P; Toumi, M",,,,"Hanna, E.; Remuzat, C.; Auquier, P.; Toumi, M.",,,ADVANCED THERAPY MEDICINAL PRODUCTS MAY DRAMATICALLY IMPACT PAYERS' BUDGET,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hanna, E.; Remuzat, C.] Creativ Ceut, Paris, France; [Auquier, P.] Univ Aix Marseille 2, Marseille, France; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite; Aix-Marseille Universite,,,"Hanna, Ehab Y/B-1593-2017","Hanna, Ehab Y/0000-0003-3241-2440",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP20,A517,A518,,10.1016/j.jval.2015.09.1574,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300062,0
J,"Hargreaves, JA",,,,"Hargreaves, J. A.",,,METHODS FOR DETERMINING PATIENT PATHWAY AND RESOURCE USE IN COMPLEX ABDOMINAL WALL RECONSTRUCTION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Hargreaves, J. A.] Covidien Medtron, Whiteley, Fareham, England",,,,,,,,,,0,1,1,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM135,A706,A706,,10.1016/j.jval.2015.09.2651,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400154,0
J,"Ikeda, S; Murata, T; Kobayashi, M",,,,"Ikeda, S.; Murata, T.; Kobayashi, M.",,,ROLE OF PHARMACOECONOMIC ANALYSIS IN PRICING DECISION IN JAPAN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ikeda, S.] Int Univ Hlth & Welf, Ohtawara City, Japan; [Murata, T.; Kobayashi, M.] CRECON Med Assessment Inc, Tokyo, Japan",International University of Health & Welfare,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP112,A533,A534,,10.1016/j.jval.2015.09.1667,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300154,0
J,"Ito, C; Nishikino, R; Onishi, Y",,,,"Ito, C.; Nishikino, R.; Onishi, Y.",,,DIAGNOSIS OF LIVER DISEASES AMONG INDIVIDUAL WITH HEPATIC DYSFUNCTION DETECTED BY ANNUAL HEALTH CHECKUP BASED ON CLAIMS DATA IN JAPAN,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Ito, C.; Nishikino, R.] Japan Med Data Ctr Co Ltd, Tokyo, Japan; [Onishi, Y.] Creativ Ceutical KK, Tokyo, Japan",,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY123,A680,A680,,10.1016/j.jval.2015.09.2023,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400010,0
J,"Jensen, AV; Fraenkel, CJ; Åkesson, P; Noren, T; Nygren, PR; Lennebratt, D; Hagberg, L",,,,"Jensen, A., V; Fraenkel, C. J.; Akesson, P.; Noren, T.; Rundlof Nygren, P.; Lennebratt, D.; Hagberg, L.",,,THE COST OF TREATING RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS ATTENDING INFECTIOUS DISEASE CLINICS AT FOUR HOSPITALS IN SWEDEN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jensen, A., V] MSD, Stockholm, Sweden; [Fraenkel, C. J.; Akesson, P.] Skane Univ Hosp, Lund, Sweden; [Noren, T.] Orebro Univ Hosp, Orebro, Sweden; [Rundlof Nygren, P.; Lennebratt, D.] Uppsala Univ Hosp, Uppsala, Sweden; [Hagberg, L.] Sahigrenska Univ Hosp, Gothenburg, Sweden",Lund University; Skane University Hospital; Orebro University; Uppsala University; Uppsala University Hospital,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN42,A583,A583,,10.1016/j.jval.2015.09.1952,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300435,0
J,"Kanters, TA; Gertsen, K; Hakkaart, L",,,,"Kanters, T. A.; Gertsen, K.; Hakkaart, L.",,,COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA IN THE NETHERLANDS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kanters, T. A.; Hakkaart, L.] Erasmus Univ, Rotterdam, Netherlands; [Gertsen, K.] Novartis Pharmaceut, Arnhem, Netherlands",Erasmus University Rotterdam - Excl Erasmus MC; Erasmus University Rotterdam; Novartis,,,,"Hakkaart-van Roijen, Leona/0000-0003-0635-7388",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS48,A423,A423,,10.1016/j.jval.2015.09.572,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400489,0
J,"Khurana, L; Durand, E; Gary, S; Otero, T; Hall, C; Dallabrida, S",,,,"Khurana, L.; Durand, E.; Gary, S.; Otero, T.; Hall, C.; Dallabrida, S.",,,"PATIENT USE OF ECLINICAL TECHNOLOGY TO RESEARCH, TRACK, AND SELF-MANAGE CHRONIC DISEASE",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Khurana, L.; Durand, E.; Gary, S.; Otero, T.; Hall, C.] ERT, Boston, MA USA; [Dallabrida, S.] PHT Corp, Boston, MA USA",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH45,A740,A740,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400342,0
J,"Kish, JK; O'Day, K; Manley-Daumont, M; Campbell, DJ; Penrod, J",,,,"Kish, J. K.; O'Day, K.; Manley-Daumont, M.; Campbell, D. J.; Penrod, J.",,,"PATIENT COUNT FORECASTS OF ADVANCED NON-SMALL CELL LUNG CANCER: RESULTS FROM THE UK, GERMANY, FRANCE, ITALY AND SPAIN (EU-5)",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Kish, J. K.; O'Day, K.; Campbell, D. J.] Xcenda, Palm Harbor, FL USA; [Manley-Daumont, M.] Bristol Myers Squibb, Paris, FL USA; [Penrod, J.] Bristol Myers Squibb, New Brunswick, NJ USA","AmerisourceBergen Corporation; Xcenda, LLC; Bristol-Myers Squibb; Bristol-Myers Squibb",,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN305,A484,A484,,10.1016/j.jval.2015.09.1324,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400821,0
J,"Lachaine, J; Bibeau, J; Castonguay, A; Barakat, S",,,,"Lachaine, J.; Bibeau, J.; Castonguay, A.; Barakat, S.",,,COST AND RESOURCE UTILIZATION OF UNCONTROLLED AND PERSISTENT ASTHMA IN CANADA: A SYSTEMATIC LITERATURE REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lachaine, J.; Bibeau, J.; Castonguay, A.] Univ Montreal, Montreal, PQ, Canada; [Barakat, S.] Teva Canada Innovat, Montreal, PQ, Canada",Universite de Montreal,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS73,A506,A506,,10.1016/j.jval.2015.09.1447,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400942,0
J,"Lara, A; Godinez, D; Fonseca, A; Lemus, F",,,,"Lara, A.; Godinez, D.; Fonseca, A.; Lemus, F.",,,ECONOMIC EVALUATION OF LEUPRORELINE 45 MG IN THE ADVANCED PROSTATE CANCER TREATMENT,VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Lara, A.; Godinez, D.; Fonseca, A.] Asofarma Mexico, Mexico City, DF, Mexico; [Lemus, F.] Natl Inst Publ Hlth, Hidalgo, Estado De Mexic, Mexico",Instituto Nacional de Salud Publica,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN44,A823,A823,,10.1016/j.jval.2015.09.272,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400588,0
J,"Lee, D; Hanna, E; El Hammi, E; Remuzat, C; Toumi, M",,,,"Lee, D.; Hanna, E.; El Hammi, E.; Remuzat, C.; Toumi, M.",,,SOFOSBUVIR: THE FAILURE OF PRICING POLICIES IN THE EUROPEAN UNION,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lee, D.; Hanna, E.; Remuzat, C.] Creativ Ceut, Paris, France; [El Hammi, E.] Evidenz, Tunis, Tunisia; [Toumi, M.] Aix Marseille Univ, Marseille, France",Aix-Marseille Universite,,,"Hanna, Ehab Y/B-1593-2017","Hanna, Ehab Y/0000-0003-3241-2440",,,,,0,0,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP339,A572,A573,,10.1016/j.jval.2015.09.1893,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300377,0
J,"Leibfried, MJ; Jun, K; Neuner, C; Arsiwalla, MY; Richardson, SK",,,,"Leibfried, M. J.; Jun, K.; Neuner, C.; Arsiwalla, M. Y.; Richardson, S. K.",,,COMPREHENSIVE REVIEW OF ORPHAN DRUGS POST-AMNOG IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Leibfried, M. J.; Jun, K.; Neuner, C.; Arsiwalla, M. Y.; Richardson, S. K.] GfK Market Access, New York, NY USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY130,A681,A681,,10.1016/j.jval.2015.09.2030,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400017,0
J,"Lemos, LL; Silva, MR; Santos, JB; Costa, JD; Gomes, RM; Nascimento, RC; Almeida, AM; Guerra, AA",,,,"Lemos, L. L.; Silva, M. R.; Santos, J. B.; Costa, J. D.; Gomes, R. M.; Nascimento, R. C.; Almeida, A. M.; Guerra Junior, A. A.",,,POTENTIAL PUBLIC RESOURCE SAVINGS IN BRAZIL: THE SOMATROPIN CASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lemos, L. L.; Silva, M. R.; Costa, J. D.; Gomes, R. M.] Univ Fed Minas Gerais, CCATES, Belo Horizonte, MG, Brazil; [Santos, J. B.; Nascimento, R. C.; Guerra Junior, A. A.] Univ Fed Minas Gerais, Coll Pharm, Belo Horizonte, MG, Brazil; [Almeida, A. M.] Coll Med Sci Mines Gerais, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais,,,"Guerra, Augusto Afonso/AAS-6584-2020; de Oliveira Costa, Juliana/P-8550-2019","Guerra, Augusto Afonso/0000-0001-5256-0577; de Oliveira Costa, Juliana/0000-0002-8355-023X",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PR3,A808,A808,,10.1016/j.jval.2015.09.090,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400505,0
J,"Lesniowska, J",,,,"Lesniowska, J.",,,COSTS OF MENTAL DISORDERS IN POLAND AND THEIR COMPLICATIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lesniowska, J.] Kozminski Univ, Warsaw, Poland",Kozminski University,,,"Leśniowska, Joanna/AAC-2003-2020","Leśniowska, Joanna/0000-0003-2764-9910",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMH20,A409,A409,,10.1016/j.jval.2015.09.973,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400412,0
J,"Lindh, A; Persson, F; Sobocki, P; Bodegard, J; Lindarck, N",,,,"Lindh, A.; Persson, F.; Sobocki, P.; Bodegard, J.; Lindarck, N.",,,NORDIC LONGITUDINAL DATA FROM ELECTRONIC MEDICAL RECORDS AND FULL POPULATION NATIONAL REGISTERS: UNIQUE OPPORTUNITIES FOR NEW INSIGHTS IN BENEFIT OF DIABETES PATIENTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lindh, A.] Osteraker Primary Care Ctr, Akersberga, Sweden; [Persson, F.] Herlve Univ Hosp, Herlev, Denmark; [Sobocki, P.] Pygargus IMS Hlth, Stockholm, Sweden; [Bodegard, J.; Lindarck, N.] AstraZeneca Nord, Sodertalje, Sweden",AstraZeneca,,,"Persson, Frederik/AAE-6572-2020; Bodegard, Johan/B-8398-2017","Persson, Frederik/0000-0001-6242-6638; Bodegard, Johan/0000-0001-5423-3967",,,,,0,5,5,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM246,A726,A726,,10.1016/j.jval.2015.09.2760,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400261,0
J,"Lorenzoni, V; Caselli, C; Rovai, D; Neglia, D; Turchetti, G",,,,"Lorenzoni, V; Caselli, C.; Rovai, D.; Neglia, D.; Turchetti, G.",,,INCREASED COST-EFFECTIVENESS OF DIAGNOSTIC IMAGING IN PATIENTS WITH SUSPECTED CAD BY USING A NEW CLINICAL-BIOHUMORAL PREDICTIVE MODEL OF DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lorenzoni, V; Turchetti, G.] Scuola Super Sant Anna, Pisa, Italy; [Caselli, C.; Rovai, D.; Neglia, D.] CNR, Pisa, Italy",Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR),,,"Lorenzoni, Valentina/K-5306-2018; Turchetti, Giuseppe/K-5393-2018; Neglia, Danilo/AAR-6384-2020; Caselli, Chiara/I-7922-2014","Caselli, Chiara/0000-0001-6705-2460; Neglia, Danilo/0000-0003-0016-9538",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD65,A355,A355,,10.1016/j.jval.2015.09.666,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400114,0
J,"Lu, YJ; Xu, GX; Lu, WQ; Liu, Z; Song, RL; Xuan, J",,,,"Lu, Y. J.; Xu, G. X.; Lu, W. Q.; Liu, Z.; Song, R. L.; Xuan, J.",,,MODELING THE COST-EFFECTIVENESS OF ILAPRAZOLE VS. OMEPRAZOLE FOR THE TREATMENT OF NEWLY DIAGNOSED DUODENAL ULCER PATIENTS IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Lu, Y. J.] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China; [Xu, G. X.; Lu, W. Q.; Liu, Z.] Livzon Pharmaceut Grp Inc, Shenzhen, Peoples R China; [Song, R. L.] China Pharmaceut Innovat & Res Dev Assoc, Beijing, Peoples R China; [Xuan, J.] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China",Sun Yat Sen University,,,,,,,,,0,0,0,0,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI19,A625,A625,,10.1016/j.jval.2015.09.2200,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300670,0
J,"Mansfield, CA; Sikirica, M; Pugh, A; Poulos, C; Martin, AA; Moran, LR; Larragueta, RM",,,,"Mansfield, C. A.; Sikirica, M.; Pugh, A.; Poulos, C.; Martin, A. A.; Ruiz Moran, L.; Morano Larragueta, R.",,,PATIENT PREFERENCES FOR ATTRIBUTES OF TYPE 2 DIABETES MELLITUS (T2DM) TREATMENTS IN SPAIN,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mansfield, C. A.; Pugh, A.; Poulos, C.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Sikirica, M.] GlaxoSmithKline, King Of Prussia, PA USA; [Martin, A. A.] GlaxoSmithKline, Uxbridge, Middx, England; [Ruiz Moran, L.; Morano Larragueta, R.] GlaxoSmithKline, Madrid, Spain",Research Triangle Institute; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline,,,,"Poulos, Christine/0000-0001-7810-3411",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB94,A614,A614,,10.1016/j.jval.2015.09.2134,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300605,0
J,"Martin, A; Martin, C",,,,"Martin, A.; Martin, C.",,,WHEN ALIVE AFTER 5 YEARS DOES NOT MEAN CURED: INTERNATIONAL PATTERNS IN CANCER 10-TO 20-YEAR RELATIVE SURVIVAL RATES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Martin, A.; Martin, C.] Crystallise Ltd, London, England",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN63,A440,A440,,10.1016/j.jval.2015.09.1078,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,Bronze,,,2024-03-09,WOS:000384252400580,0
J,"Mazumder, D; Kapoor, A; Gwatkin, N; Medeiros, C",,,,"Mazumder, D.; Kapoor, A.; Gwatkin, N.; Medeiros, C.",,,HEALTH TECHNOLOGY ASSESSMENT IN CHRONIC HEPATITIS C: ASSESSMENT OF DECISION LANDSCAPE AND MANUFACTURER INPUTS IN SIX AGENCIES,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Mazumder, D.; Kapoor, A.] Optum Global Solut, Noida, India; [Gwatkin, N.] Geni Biopharma, Fareham, Hants, England; [Medeiros, C.] Optum Life Sci, Minneapolis, MN USA",Optum; Optum,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI58,A632,A633,,10.1016/j.jval.2015.09.2239,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300709,0
J,"Mittmann, N; Seung, SJ; Cheng, SY; Liu, N; Camacho, X; Maclagan, L; DeAngelis, C; Earle, C",,,,"Mittmann, N.; Seung, S. J.; Cheng, S. Y.; Liu, N.; Camacho, X.; Maclagan, L.; DeAngelis, C.; Earle, C.",,,GENERATING COSTING ALGORITHMS FOR ONCOLOGY DRUGS USING ADMINISTRATIVE DATABASES,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Mittmann, N.; Seung, S. J.] Sunnybrook Res Inst, Toronto, ON, Canada; [Cheng, S. Y.; Liu, N.; Camacho, X.; Maclagan, L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [DeAngelis, C.] Odette Canc Ctr, Toronto, ON, Canada; [Earle, C.] Ontario Inst Canc Res, Toronto, ON, Canada",University of Toronto; Sunnybrook Health Science Center; Sunnybrook Research Institute; University of Toronto; University of Toronto; University of Toronto; Ontario Institute for Cancer Research,,,,"Liu, Ning/0000-0001-9215-475X",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM52,A691,A691,,10.1016/j.jval.2015.09.2568,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400072,0
J,"Mo, J",,,,"Mo, J.",,,SELECTIVE RETINA THERAPY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mo, J.] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea",National Evidence-based Healthcare Collaborating Agency (NECA),,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSS76,A429,A429,,10.1016/j.jval.2015.09.599,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400516,0
J,"Mokiou, S; De, CE; Standaert, B",,,,"Mokiou, S.; de, Cock E.; Standaert, B.",,,COST OF PAEDIATRIC VACCINE ADMINISTRATION IN THE UNITED KINGDOM (UK): A TIME AND MOTION (T&M) STUDY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Mokiou, S.] UBC, London, England; [de, Cock E.] United BioSource Corp, Barcelona, Spain; [Standaert, B.] GSK Vaccines, Wavre, Belgium",United Biosource Corporation; United Biosource Corporation; GlaxoSmithKline,,,,,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,VA4,A339,A339,,10.1016/j.jval.2015.09.135,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400025,0
J,"Nadendla, R",,,,"Nadendla, R.",,,COST OF MEDICATION NONADHERENCE IN PATIENTS WITH DIABETES MELLITUS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nadendla, R.] Chalapathi Inst Pharmaceut Sci, Guntur, India",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB45,A605,A605,,10.1016/j.jval.2015.09.2085,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300557,0
J,"Nayroles, G; Gabriel, S; Tolley, K; Espin, J; Toumi, M; Kornfeld, A; Frybourg, S",,,,"Nayroles, G.; Gabriel, S.; Tolley, K.; Espin, J.; Toumi, M.; Kornfeld, A.; Frybourg, S.",,,EXTENSION OF INDICATION WITH MATURE PRODUCTS: TOWARD MORE INCENTIVES REWARDING INNOVATION?,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nayroles, G.; Gabriel, S.] IPSEN Pharma, Boulogne, France; [Tolley, K.] Tolley Hlth Econ Ltd, Buxton, Derby, England; [Espin, J.] Andalusian Sch Publ Hlth, Granada, Spain; [Toumi, M.] Aix Marseille Univ, Marseille, France; [Kornfeld, A.; Frybourg, S.] Creativ Ceut, Paris, France",Ipsen; Escuela Andaluza de Salud Publica; Aix-Marseille Universite,,,"Espin, Jaime/AAF-3732-2020","Espin, Jaime/0000-0001-7299-6554",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP323,A570,A570,,10.1016/j.jval.2015.09.1877,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300361,0
J,"Nemeth, B; Csordas, A; Papp, E",,,,"Nemeth, B.; Csordas, A.; Papp, E.",,,THE CUMULATIVE ANALYSIS OF CHECKLIST QUESTIONNAIRES FILLED OUT BY THE HUNGARIAN HTA OFFICE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Nemeth, B.; Csordas, A.; Papp, E.] Natl Inst Pharm & Nutr, Budapest, Hungary",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP276,A562,A562,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300316,0
J,"O'Day, K; Campbell, DJ",,,,"O'Day, K.; Campbell, D. J.",,,COST-UTILITY ANALYSIS OF CHOCOLATE CONSUMPTION FOR PREVENTION OF CARDIOMETABOLIC DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[O'Day, K.; Campbell, D. J.] Xcenda, Palm Harbor, FL USA","AmerisourceBergen Corporation; Xcenda, LLC",,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV121,A395,A395,,10.1016/j.jval.2015.09.890,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400333,0
J,"Odenigbo, AO",,,,"Odenigbo, A. O.",,,HEALTH PROFFESSIONALS INVOLVEMENT IN POLITICS A MEANS TO IMPROVING HEALTHCARE DELIVERY AND HEALTHCARE LEGISLATIONS FOR HEALTHCARE SEEKERS IN AFRICA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Odenigbo, A. O.] Univ Nigeria, Nsukka, Nigeria",University of Nigeria,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP344,A573,A573,,10.1016/j.jval.2015.09.1898,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300382,0
J,"Odnoletkova, I; Annemans, L; Aertgeerts, B; Ramaekers, D",,,,"Odnoletkova, I; Annemans, L.; Aertgeerts, B.; Ramaekers, D.",,,IMPACT OF NURSE-LED TELECOACHING ON THE ANNUAL HEALTHCARE UTILIZATION AND COSTS IN PEOPLE WITH TYPE 2 DIABETES IN BELGIUM. WITHIN-TRIAL ANALYSIS OF HEALTH INSURANCE DATA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Odnoletkova, I; Aertgeerts, B.; Ramaekers, D.] Univ Leuven, Leuven, Belgium; [Annemans, L.] Univ Ghent, Ghent, Belgium",KU Leuven; Ghent University,,,"L, A/HZI-4043-2023; L, A/GYV-6221-2022; Odnoletkova, Irina/A-3269-2015","Aertgeerts, Bert/0000-0003-1142-5402; Odnoletkova, Irina/0000-0001-5224-1250",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB27,A602,A602,,10.1016/j.jval.2015.09.2067,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,"Green Accepted, hybrid",,,2024-03-09,WOS:000209861300539,0
J,"Ondrusova, M; Psenkova, M; Suchansky, M; Chudej, J",,,,"Ondrusova, M.; Psenkova, M.; Suchansky, M.; Chudej, J.",,,DESCRIPTIVE EPIDEMIOLOGY AND TREATMENT STRATEGIES USED IN MULTIPLY MYELOMA IN THE SLOVAK REPUBLIC. RESULTS FROM THE CROSS-SECTIONAL SURVEY IN THE HAEMATOLOGY-ONCOLOGICAL CENTERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ondrusova, M.; Psenkova, M.; Suchansky, M.] Pharm In Ltd, Bratislava, Slovakia; [Chudej, J.] Univ Hosp Martin, Martin, Slovakia",,,,,"Suchansky, Martin/0009-0005-7568-6793",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN204,A466,A466,,10.1016/j.jval.2015.09.1221,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400721,0
J,"Peñaherrera, E; Tettamanti, D; Aguirre, F; Puyol, LF; Cárdenas, E; Torres, G; Herran, S",,,,"Penaherrera, E.; Tettamanti, D.; Aguirre, F.; Puyol, L. F.; Cardenas, E.; Torres, G.; Herran, S.",,,ANALYSIS OF COST-EFFECTIVENESS OF WARFARIN VS. DABIGATRAN ETEXILATE IN ATRIAL FIBRILLATION IN ECUADOR,VALUE IN HEALTH,,,Spanish,Meeting Abstract,,,,,,,,,"[Penaherrera, E.; Tettamanti, D.] Hosp Vernaza, Guayaquil, Ecuador; [Aguirre, F.] Clin Kennedy, Guayaquil, Ecuador; [Puyol, L. F.] Boehringer Ingelheim GmbH & Co KG, Quito, Ecuador; [Torres, G.] Makros, Quito, Ecuador; [Herran, S.] Boehringer Ingelheim GmbH & Co KG, Mexico City, DF, Mexico",Boehringer Ingelheim; Boehringer Ingelheim,,,,,,,,,0,0,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV16,A830,A830,,10.1016/j.jval.2015.09.311,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400627,0
J,"Petryszyn, P; Zachariasz, A; Ekk-Cierniakowski, P; Well, M",,,,"Petryszyn, P.; Zachariasz, A.; Ekk-Cierniakowski, P.; Well, M.",,,HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN POLAND (APPLICATION OF THE EQ-5D AND SELF-ASSESSMENT OF HEALTH STATE),VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Petryszyn, P.; Zachariasz, A.] Wroclaw Med Univ, Wroclaw, Poland; [Ekk-Cierniakowski, P.] Warsaw Sch Econ, Warsaw, Poland; [Well, M.] Wroclaw Univ Econ, Wroclaw, Poland",Wroclaw Medical University; Warsaw School of Economics; Wroclaw University of Economics & Business,,,,"Petryszyn, Pawel/0000-0003-2397-7028",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCI41,A629,A629,,10.1016/j.jval.2015.09.2222,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300692,0
J,"Piha, T; Barbosa, D; Fahham, L",,,,"Piha, T.; Barbosa, D.; Fahham, L.",,,A COST-EFFECTIVENESS ANALYSIS OF GEFITINIB AS THE FIRST LINE TREATMENT IN PATIENTS WITH POSITIVE EGFR MUTATION IN METASTATIC OR LOCALLY ADVANCED NON-SMALL CELL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Piha, T.; Barbosa, D.] AstraZeneca, Cotia, Brazil; [Fahham, L.] Sense Co, Sao Paulo, Brazil",AstraZeneca,,,"Barbosa, Dulce Aparecida/G-7295-2011; Barbosa, Dulce/P-7672-2019",,,,,,0,1,1,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN94,A446,A446,,10.1016/j.jval.2015.09.1110,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400611,0
J,"Poster, E; Guillen, A; Lara, K; Oh, P; Popielnicki, A; Walker, G; Yorke, J",,,,"Poster, E.; Guillen, A.; Lara, K.; Oh, P.; Popielnicki, A.; Walker, G.; Yorke, J.",,,LINGUISTIC VALIDATION OF THE EMPHASIS-10 QUESTIONNAIRE: A PATIENT-REPORTED OUTCOME INSTRUMENT FOR ASSESSING QOL IN PULMONARY HYPERTENSION (PH),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Poster, E.] TransPerfect, Atlanta, GA USA; [Guillen, A.; Lara, K.; Oh, P.; Walker, G.] Gilead Sci Inc, Foster City, CA 94404 USA; [Popielnicki, A.] TransPerfect, Boston, MA USA; [Yorke, J.] Christie NHS Fdn Trust, Manchester, Lancs, England",Gilead Sciences; Christie NHS Foundation Trust,,,"Yorke, Janelle/A-5393-2015",,,,,,0,6,6,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIH69,A744,A744,,10.1016/j.jval.2015.09.2869,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400366,0
J,"Qian, Y; Bhowmik, D; Tc, B; Wang, X; Colman, S",,,,"Qian, Y.; Bhowmik, D.; Tc, Bond; Wang, X.; Colman, S.",,,ASSESSMENT OF RENAL FUNCTION AMONG PATIENTS WITH BONE METASTASES FROM SOLID TUMORS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Qian, Y.; Bhowmik, D.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Tc, Bond; Wang, X.] Covance Market Access, Gaithersburg, MD USA; [Colman, S.] Covance Pty Ltd, N Ryde, Australia",Amgen; Covance,,,"qian, yi/HZH-4175-2023",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN54,A439,A439,,10.1016/j.jval.2015.09.1069,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400571,0
J,"Ramos, M; Caekelbergh, K; Lamotte, M",,,,"Ramos, M.; Caekelbergh, K.; Lamotte, M.",,,THE ECONOMIC BURDEN OF POOR ADHERENCE TO STATINS IN BELGIUM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ramos, M.; Caekelbergh, K.; Lamotte, M.] IMS Hlth, Vilvoorde, Belgium",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV169,A403,A403,,10.1016/j.jval.2015.09.939,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400379,0
J,"Reis, FC; Xavier, LC; Schneiders, RE; Bastos, EA; Domingues, PH; Alexandre, RF; Nascimento, EM",,,,"Reis, F. C.; Xavier, L. C.; Schneiders, R. E.; Bastos, E. A.; Domingues, P. H.; Alexandre, R. F.; Nascimento Junior, E. M.",,,BUDGET IMPACT OF EVEROLIMUS AND SIROLIMUS FOR IMMUNOSUPPRESSANTS IN HEPATIC TRANSPLANTATION IN PUBLIC HEALTH SYSTEM OF BRAZIL,VALUE IN HEALTH,,,Portuguese,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Reis, F. C.; Xavier, L. C.; Schneiders, R. E.; Bastos, E. A.; Domingues, P. H.; Alexandre, R. F.; Nascimento Junior, E. M.] Brazilian Minist Hlth, Brasilia, DF, Brazil",,,,"Domingues, Paulo Henrique Faria/I-6134-2015","Domingues, Paulo Henrique Faria/0000-0001-5489-3551",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP18,A850,A850,,10.1016/j.jval.2015.09.427,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400740,0
J,"Relakis, I; Patrikos, D; Kourlaba, G; Christou, P; Manladakis, N",,,,"Relakis, I; Patrikos, D.; Kourlaba, G.; Christou, P.; Manladakis, N.",,,COST-UTILITY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN GREECE,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Relakis, I; Manladakis, N.] Natl Sch Publ Hlth, Athens, Greece; [Patrikos, D.] Metropolitan Hosp, Athens, Greece; [Kourlaba, G.] Collaborat Ctr Clin Epidemiol & Outcomes Res CLEO, Athens, Greece; [Christou, P.] UCB Pharma, Athens, Greece",National & Kapodistrian University of Athens,,,"Panagiotakos, Demosthenes/C-9776-2013","Panagiotakos, Demosthenes/0000-0001-8583-153X",,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS60,A644,A644,,10.1016/j.jval.2015.09.2304,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300773,0
J,"Lopez, AR",,,,"Reyes Lopez, A.",,,"ECONOMIC EVALUATION OF ERTAPENEM IN THE TREATMENT OF INTRA-ABDOMINAL INFECTIONS, FROM THE PERSPECTIVE OF IMSS",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Reyes Lopez, A.] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico",Hospital Infantil de Mexico Federico Gomez,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PIN22,A871,A871,,10.1016/j.jval.2015.09.016,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400862,0
J,"Lopez, AR; Villafuerte, FL; Rivera, CH; Alvarez, IP; Lemus-Carmona, EA",,,,"Reyes Lopez, A.; Lemus Villafuerte, F.; Hernandez Rivera, C.; Pacheco Alvarez, I; Lemus-Carmona, E. A.",,,DIRECT COST OF MYELODYSPLASTIC SYNDROMES ASSOCIATED WITH A DELETION 5Q CYTOCENETIC ABNORMALITY (DEL5Q MDS) IN PATIENTS WHO ARE RED BLOOD CELL TRANSFUSION DEPENDENT IN MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Reyes Lopez, A.; Lemus-Carmona, E. A.] Mexicos Children Hosp Federico Gomez, Mexico City, DF, Mexico; [Lemus Villafuerte, F.] RCEI Consulting, Mexico City, DF, Mexico; [Hernandez Rivera, C.; Pacheco Alvarez, I] Celgene Mexico, Mexico City, DF, Mexico; [Lemus-Carmona, E. A.] Celgene S de RL de CV, Mexico City, DF, Mexico",Hospital Infantil de Mexico Federico Gomez,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY41,A665,A665,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,,,,2024-03-09,WOS:000209861300891,0
J,"Serrano, JR; de Abreu, MM; Tundia, N; Skup, M; Sorg, R; Macaulay, D; Bao, Y; Chaves, L; Chao, J",,,,"Rojas Serrano, J.; de Abreu, M. M.; Tundia, N.; Skup, M.; Sorg, R.; Macaulay, D.; Bao, Y.; Chaves, L.; Chao, J.",,,"PROJECTED ECONOMIC IMPACT OF INCREASED USE OF BIOLOGIC TREATMENTS FOR RHEUMATOID ARTHRITIS IN ARGENTINA, COLOMBIA, AND MEXICO OVER 10 YEARS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Rojas Serrano, J.] Univ Nacl Autonoma Mexico, Mexico City, DF, Mexico; [de Abreu, M. M.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Tundia, N.; Skup, M.; Bao, Y.; Chaves, L.; Chao, J.] AbbVie Inc, N Chicago, IL USA; [Sorg, R.; Macaulay, D.] Anal Grp Inc, New York, NY USA",Universidad Nacional Autonoma de Mexico; Universidade Federal do Rio de Janeiro; AbbVie; Analysis Group Inc.,,,"Serrano, Jorge/GVT-0742-2022",,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,CE3,A806,A806,,10.1016/j.jval.2015.09.079,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,Bronze,,,2024-03-09,WOS:000209861400494,0
J,"Romero, M; Huerfano, LM; Acero, G",,,,"Romero, M.; Huerfano, L. M.; Acero, G.",,,"ANALYSIS OF COST EFFECTIVENESS AND COST UTILITY OF RITUXIMAB AS A TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS, BEFORE THE FAILURE OR INTOLERANCE IN THE FIRST LINE OF AN ANTI-TNF, IN THE VENEZUELAN CONTEXT",VALUE IN HEALTH,,,Spanish,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Romero, M.; Acero, G.] Salutia Fdn, Bogota, Colombia; [Huerfano, L. M.] Salutia Fdn, Res Ctr Econ Management & Hlth Technol, Bogota, Colombia",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS8,A875,A875,,10.1016/j.jval.2015.09.038,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400884,0
J,"Romero, M; Acero, G",,,,"Romero, M.; Acero, G.",,,ANALYSIS OF BUDGETARY IMPACT OF DETEMIR IN DIABETIC PATIENTS TREATED WITH ANALOGUE INSULINS,VALUE IN HEALTH,,,Spanish,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Romero, M.; Acero, G.] Salutia Fdn, Bogota, Colombia",,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PDB7,A863,A863,,10.1016/j.jval.2015.09.503,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400815,0
J,"Ronco, GL; Mirosa, D; Silvia, V; Carlo, C",,,,"Ronco, G. L.; Mirosa, D.; Silvia, V; Carlo, C.",,,"PREVENTION OF FRAGILITY FRACTURES IN OSTEOPOROTIC PATIENTS: CAN THE SECONDARY THERAPY HELP CONTAIN COSTS FOR ADMISSIONS? A RETROSPECTIVE, OBSERVATIONAL CASE CONTROL STUDY BASED ON ASL PAVIA'S ADMINISTRATIVE DATABASES",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Ronco, G. L.] Emmonos SA, Fenegro, Italy; [Mirosa, D.; Silvia, V; Carlo, C.] ASL Pavia, Pavia, Italy",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMS128,A656,A657,,10.1016/j.jval.2015.09.2373,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,Bronze,,,2024-03-09,WOS:000209861300841,0
J,"Roze, S; Duteil, E; De Brouwer, BF; de Portu, S",,,,"Roze, S.; Duteil, E.; De Brouwer, B. F.; de Portu, S.",,,"HEALTH-ECONOMIC ANALYSIS OF THE USE OF SENSOR-AU GMENTED PUMP (SAP) THERAPY IN THE NETHERLANDS COMPARED TO INSULIN PUMP THERAPY ALONE (CSII), IN TYPE 1 DIABETIC PATIENTS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Roze, S.] HEVA HEOR Sarl, Lyon, France; [Duteil, E.] HEVA HEOR, Lyon, France; [De Brouwer, B. F.] Medtron Trading NL BV, Heerlen, Netherlands; [de Portu, S.] Medtron Int Sarl, Tolochenaz, Switzerland",Medtronic,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PMD93,A360,A360,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,,,,2024-03-09,WOS:000384252400142,0
J,"Sallum, R; Zhang, Y; Xu, Y",,,,"Sallum, R.; Zhang, Y.; Xu, Y.",,,MOVING BEYOND THE PICOS: APPROPRIATE COMPARATIVE OBSERVATIONAL DATA SELECTION CAN FACILITATE META-ANALYSIS OF RELATIVE TREATMENT EFFECTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Sallum, R.; Xu, Y.] Evidera, Lexington, MA USA; [Zhang, Y.] Evidera, London, England",Evidera; Evidera,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM277,A731,A731,,10.1016/j.jval.2015.09.2793,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400292,0
J,"Saturnino, ET; Salgado, JB; Penha, MF",,,,"Saturnino, E. T.; Salgado, J. B.; Penha, M. F.",,,FLUTICASONE PROPIONATE VERSUS BUDESONIDE OR BECLOMETHASONE AS MONOTHERAPY TREATMENT FOR ASTHMA PATIENTS - A SYSTEMATIC REVIEW,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Saturnino, E. T.; Salgado, J. B.; Penha, M. F.] GlaxoSmithkline, Rio De Janeiro, Brazil",GlaxoSmithKline,,,,,GlaxoSmithKline [HO-14-15763],GlaxoSmithKline(GlaxoSmithKline),"Funding for this study was provided by GlaxoSmithKline, study HO-14-15763.",,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS2,A839,A839,,10.1016/j.jval.2015.09.364,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400679,0
J,"Shah, A; Jan, SU",,,,"Shah, A.; Jan, S. U.",,,IRRATIONAL DRUG USE PATTERN IN HOSPITALS. A WARNING FOR HEALTH CARE SYSTEM,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Shah, A.; Jan, S. U.] Univ Balochistan, Quetta, Pakistan",University of Balochistan,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP302,A566,A566,,10.1016/j.jval.2015.09.1858,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300342,0
J,"Stevanovic, J; Kappelhoff, B; Voorhaar, M; Postma, MJ",,,,"Stevanovic, J.; Kappelhoff, B.; Voorhaar, M.; Postma, M. J.",,,Dabigatran For The Treatment And Secondary Prevention Of Venous Thromboembolism,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stevanovic, J.; Postma, M. J.] Univ Groningen, Groningen, Netherlands; [Kappelhoff, B.] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany; [Voorhaar, M.] Boehringer Ingelheim GmbH & Co KG, Alkmaar, Netherlands",University of Groningen; Boehringer Ingelheim; Boehringer Ingelheim,,,,"Postma, Maarten/0000-0002-6306-3653",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCV113,A393,A393,,10.1016/j.jval.2015.09.882,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400323,0
J,"Stuwe, LT; Bellanger, MM; Panopoulou, G; Orci, S; Picon, PD; Gadelha, MI",,,,"Stuwe, L. T.; Bellanger, M. M.; Panopoulou, G.; Orci, S.; Picon, P. D.; Gadelha, M., I",,,A PERSPECTIVE ON THE USE OF HEALTH TECHNOLOGY ASSESSMENT IN BRAZIL AND MEXICO,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Stuwe, L. T.] Pierre & Marie Curie Univ, Paris, France; [Bellanger, M. M.] EHESP French Sch Publ Hlth, Rennes, France; [Panopoulou, G.; Orci, S.] Minist Hlth, Mexico City, DF, Mexico; [Picon, P. D.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Gadelha, M., I] Minist Hlth, Brasilia, DF, Brazil",Sorbonne Universite; Universidade Federal do Rio Grande do Sul,,,"Picon, Paulo D/J-2448-2015",,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP10,A848,A848,,10.1016/j.jval.2015.09.419,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400732,0
J,"Tomita, N; Lee, H; Korchagina, D; Toumi, M; Rémuzat, C; Falissard, B",,,,"Tomita, N.; Lee, H.; Korchagina, D.; Toumi, M.; Remuzat, C.; Falissard, B.",,,"ORPHAN DRUG REGULATION IN THE USA, EUROPEAN UNION, JAPAN AND SOUTH KOREA: A COMPARATIVE ANALYSIS",VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Tomita, N.] Natl Inst Publ Hlth, Saitama, Japan; [Lee, H.] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Korchagina, D.] Univ Paris Sud, Paris, France; [Toumi, M.] Aix Marseille Univ, Marseille, France; [Remuzat, C.] Creativ Ceut, Paris, France; [Falissard, B.] Maison Solenn, Paris, France",National Institute of Public Health - Japan; Seoul National University (SNU); Universite Paris Saclay; Aix-Marseille Universite; Universite Paris Cite,,,,,,,,,0,1,1,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PSY111,A678,A678,,10.1016/j.jval.2015.09.2011,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300961,0
J,"Traina, SB; McQuarrie, K; Barrett, A; DiBenedetti, D; McLeod, L",,,,"Traina, S. B.; McQuarrie, K.; Barrett, A.; DiBenedetti, D.; McLeod, L.",,,CONTENT VALIDITY OF THE CURRENT HEALTH SATISFACTION QUESTIONNAIRE (CHES-Q) AMONG PEOPLE LIVING WITH TYPE 2 DIABETES MELLITUS (T2DM) AND COMORBID CHRONIC KIDNEY DISEASE (CKD),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Traina, S. B.; McQuarrie, K.] Janssen Global Serv, Raritan, NJ USA; [Barrett, A.; DiBenedetti, D.; McLeod, L.] RTI Hlth Solut, Res Triangle Pk, NC USA",Research Triangle Institute,,,,"DiBenedetti, Dana/0000-0003-2294-9519; Barrett, Amy/0000-0001-8671-8803",,,,,0,2,2,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM160,A710,A710,,10.1016/j.jval.2015.09.2675,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400177,0
J,"Tsiantou, V; Maina, A; Karampli, E; Mylona, K; Tzintziropoulou, E; Skroumpelos, A; Pavi, E; Kyriopoulos, J",,,,"Tsiantou, V; Maina, A.; Karampli, E.; Mylona, K.; Tzintziropoulou, E.; Skroumpelos, A.; Pavi, E.; Kyriopoulos, J.",,,FROM DIAGNOSIS TO TREATMENT AND SURVIVAL: THE EMOTIONAL JOURNEY OF PATIENTS WITH BREAST CANCER,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Tsiantou, V; Maina, A.; Karampli, E.; Mylona, K.; Pavi, E.; Kyriopoulos, J.] Natl Sch Publ Hlth, Athens, Greece; [Tzintziropoulou, E.] Panhellen Assoc Women Breast Canc ALMA ZOIS, Athens, Greece; [Skroumpelos, A.] Roche Hellas SA, Athens, Greece",National & Kapodistrian University of Athens; Roche Holding,,,"Karampli, Eleftheria/AAP-5186-2021","Karampli, Eleftheria/0000-0001-7678-2510",,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN330,A488,A489,,10.1016/j.jval.2015.09.1349,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400845,0
J,"Vollmer, L; Dröschel, D; Fröhlich, N; de Paz, B; Walzer, S",,,,"Vollmer, L.; Droeschel, D.; Froehlich, N.; de Paz, B.; Walzer, S.",,,A SYSTEMATIC COMPARISION OF IQWIG RECOMMENDATIONS AND G-BA DECISIONS IN THE AMNOG PROCESS IN GERMANY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Vollmer, L.; Droeschel, D.; Walzer, S.] MArS Market Access & Pricing Strategy GmbH, Weil Am Rhein, Germany; [Froehlich, N.] NF, Bremen, Germany; [de Paz, B.] PRIORITIS Market Access, Paris, France",,,,,,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP193,A547,A547,,10.1016/j.jval.2015.09.1747,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300233,0
J,"Wang, H; Aas, E; Roman, E; Smith, A",,,,"Wang, H.; Aas, E.; Roman, E.; Smith, A.",,,COMPARISON OF DIFFERENT COSTING METHODS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Wang, H.; Roman, E.; Smith, A.] Univ York, York, N Yorkshire, England; [Aas, E.] Univ Oslo, Oslo, Norway",University of York - UK; University of Oslo,,,,,,,,,0,0,0,0,5,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRM28,A687,A687,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CD,,,,,2024-03-09,WOS:000209861400048,0
J,"Whitehouse, JT; Berni, E; Conway, P; Radwan, A; Henrar, R; Currie, CJ",,,,"Whitehouse, J. T.; Berni, E.; Conway, P.; Radwan, A.; Henrar, R.; Currie, C. J.",,,EVALUATION OF THE COST EFFECTIVENESS AND SOCIETAL IMPACT OF RIFAXIMIN-A 550MG IN THE REDUCTION OF RECURRENCE OF OVERT HEPATIC ENCEPHALOPATHY IN THE NETHERLANDS,VALUE IN HEALTH,,,English,Meeting Abstract,18th ISPOR Annual European Congress,"NOV 07-11, 2015","Milan, ITALY",,,,,,"[Whitehouse, J. T.; Radwan, A.] Norgine Ltd, Uxbridge, Middx, England; [Berni, E.] Pharmatelligence, Cardiff, S Glam, Wales; [Conway, P.] Norgine Ltd, Harefield, Middx, England; [Henrar, R.] Norgine BV, Amsterdam, Netherlands; [Currie, C. J.] Cardiff Univ, Cardiff, S Glam, Wales",Cardiff University,,,,,,,,,0,5,5,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI38,A629,A629,,10.1016/j.jval.2015.09.2219,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science & Humanities (CPCI-SSH),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300689,0
J,"Witte, J; Greiner, W",,,,"Witte, J.; Greiner, W.",,,EARLY BENEFIT ASSESSMENT AND UPTAKE OF PHARMACEUTICAL INNOVATIONS - EXPERIENCES FROM GERMANY 2011 TO 2014,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Witte, J.; Greiner, W.] Univ Bielefeld, Sch Publ Hlth, Bielefeld, Germany",University of Bielefeld,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PHP144,A539,A539,,10.1016/j.jval.2015.09.1698,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300184,0
J,"Wójcik, P; Chudziak, D; Macioch, T; Niewada, M",,,,"Wojcik, P.; Chudziak, D.; Macioch, T.; Niewada, M.",,,COST-EFFECTIVENESS OF ESOMEPRAZOLE COMPARED WITH OTHER PPIS CURRENTLY REIMBURSED IN POLAND IN THE TREATMENT OF GERD,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Wojcik, P.; Chudziak, D.; Macioch, T.] HealthQuest, Warsaw, Poland; [Niewada, M.] Med Univ Warsaw, Warsaw, Poland",Medical University of Warsaw,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PGI20,A625,A626,,10.1016/j.jval.2015.09.2201,0.0,,,2,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CC,,hybrid,,,2024-03-09,WOS:000209861300671,0
J,"Xue, M; Gao, X; Ferreira, CN; Stephens, JM; Haider, S; Valente, MLF; Charbonneau, C",,,,"Xue, M.; Gao, X.; Ferreira, C. N.; Stephens, J. M.; Haider, S.; Figueiredo Valente, M. L.; Charbonneau, C.",,,COST ANALYSIS OF VORICONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN B FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS AMONG HIGH-RISK HEMATOLOGIC CANCER PATIENTS IN BRAZIL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Xue, M.; Gao, X.; Stephens, J. M.] Pharmerit Int, Bethesda, MD USA; [Ferreira, C. N.; Figueiredo Valente, M. L.] Pfizer Brasil, Sao Paulo, Brazil; [Haider, S.] Pfizer Inc, Groton, CT 06340 USA; [Charbonneau, C.] Pfizer Inc, Paris, France",Pharmerit North America LLC; Pfizer; Pfizer; Pfizer,,,"Gao, Xin/D-5487-2013",,,,,,0,1,1,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PCN29,A820,A820,,10.1016/j.jval.2015.09.257,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,V46CD,,hybrid,,,2024-03-09,WOS:000209861400573,0
J,"Yarlas, A; O'Callaghan, L; Lopes, V; Suthoff, E; Wagener, J",,,,"Yarlas, A.; O'Callaghan, L.; Lopes, V; Suthoff, E.; Wagener, J.",,,MEASURING GENERIC HEALTH-RELATED QUALITY OF LIFE AND IMPACT OF HEALTH RESOURCE UTILIZATION IN ADULTS WITH CYSTIC FIBROSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Yarlas, A.; Lopes, V] Optum Inc, Lincoln, RI USA; [O'Callaghan, L.; Suthoff, E.] Vertex Pharmaceut Inc, Boston, MA USA; [Wagener, J.] Univ Colorado, Aurora, CO USA",Optum; Vertex Pharmaceuticals; University of Colorado System; University of Colorado Anschutz Medical Campus,,,"Yarlas, Aaron S/B-9788-2009","Yarlas, Aaron S/0000-0003-4600-259X",,,,,0,1,2,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,NOV,2015,18.0,7.0,,,,PRS55,A503,A503,,10.1016/j.jval.2015.09.1429,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,DX3DD,,hybrid,,,2024-03-09,WOS:000384252400924,0
J,"Schokkaert, E",,,,"Schokkaert, Erik",,,"EQUALITY OF OPPORTUNITY, A FLEXIBLE FRAMEWORK",HEALTH ECONOMICS,,,English,Editorial Material,,,,,,,HEALTH-CARE,,"[Schokkaert, Erik] Univ Leuven, Dept Econ, Leuven, Belgium; [Schokkaert, Erik] Catholic Univ Louvain, CORE, Leuven, Belgium",KU Leuven,"Schokkaert, E (通讯作者)，Univ Leuven, Dept Econ, Leuven, Belgium.",erik.schokkaert@econ.kuleuven.ac.be,,"Schokkaert, Erik/0000-0003-0981-3449",,,,,6,1,1,1,9,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,OCT,2015,24.0,10.0,,,,,1250,U4,,10.1002/hec.3202,0.0,,,3,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CQ7NL,26122988.0,,,,2024-03-09,WOS:000360790800003,0
J,"Biró, P; Kóczy, LA; Sziklai, B",,,,"Biro, Peter; Koczy, Laszlo A.; Sziklai, Balazs",,,Fair apportionment in the view of the Venice Commission's recommendation,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,REPRESENTATIVES; HOUSE,"The Venice Commission in its Code of Good Practice in Electoral Matters specifies that (single-seat) constituencies should be drawn so that the size difference of a constituency's size from the average should not exceed a fixed limit while its borders must not cross the borders of administrative regions, such as states or counties. Assuming that constituencies are of equal size within each of the administrative regions, the problem is equivalent to the apportionment problem, that is, the proportional allocation of voting districts among the administrative regions. We show that the principle of maximum admissible departure is incompatible with common apportionment properties, such as monotonicity and Hare-quota. When multiple apportionments satisfy the smallest maximum admissible departure property we find a unique apportionment by the repeated application of the property. The allotment such that the differences from the average district size are lexicographically minimized can be found using an efficient algorithm. This apportionment rule is a well-defined allocation mechanism compatible with and derived from the recommendation of the Venice Commission. Finally, we compare this apportionment rule with mainstream mechanisms using data from Hungary, Germany and the United States. (C) 2015 Elsevier B.V. All rights reserved.","[Biro, Peter; Koczy, Laszlo A.; Sziklai, Balazs] Hungarian Acad Sci, Ctr Econ & Reg Studies, Momentum Game Theory Res Grp, H-1112 Budapest, Hungary; [Biro, Peter] Corvinus Univ Budapest, Dept Operat Res & Actuarial Sci, Budapest, Hungary; [Koczy, Laszlo A.] Obuda Univ, Keleti Fac Business & Management, Budapest, Hungary",Hungarian Academy of Sciences; Hungarian Research Network; HUN-REN Centre for Economic & Regional Studies; Corvinus University Budapest; Obuda University,"Kóczy, LA (通讯作者)，Hungarian Acad Sci, Ctr Econ & Reg Studies, Momentum Game Theory Res Grp, Budaorsi 45, H-1112 Budapest, Hungary.",biro.peter@krtk.mta.hu; koczy@krtk.mta.hu; sziklai.balazs@krtk.mta.hu,"Kóczy, László Á./B-3519-2011; Sziklai, Balazs/F-6859-2015","Kóczy, László Á./0000-0002-8588-6140; Biro, Peter/0000-0001-7011-3463; Sziklai, Balazs/0000-0002-0068-8920","'Momentum' Programme [LP-004/2010]; OTKA [K108383, K109354]",'Momentum' Programme; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)),The authors thank the comments of an anonymous referee and Friedrich Pukelsheim from the University of Augsburg and Attila Tasnadi from the Corvinus University and all the participants of the Mathematics of Electoral Systems at Corvinus University for the helpful suggestions. The authors acknowledge the support of the 'Momentum' Programme (LP-004/2010) and the OTKA grants K108383 and K109354.,,37,5,5,0,8,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,SEP,2015,77.0,,,,,,32,41,,10.1016/j.mathsocsci.2015.06.001,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CR3RN,,"Green Submitted, Green Accepted",,,2024-03-09,WOS:000361250900004,0
J,"Dong, CH; Gao, JT; Peng, B",,,,"Dong, Chaohua; Gao, Jiti; Peng, Bin",,,Semiparametric single-index panel data models with cross-sectional dependence,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Asymptotic theory; Closed-form estimation; Nonlinear panel data model; Orthogonal series expansion method,REGRESSION,"In this paper, we consider a semiparametric single-index panel data model with cross-sectional dependence and stationarity. Meanwhile, we allow fixed effects to be correlated with the regressors to capture unobservable heterogeneity. Under a general spatial error dependence structure, we then establish some consistent closed-form estimates for both the unknown parameters and the link function for the case where both cross-sectional dimension (N) and temporal dimension (T) go to infinity. Rates of convergence and asymptotic normality are established for the proposed estimates. Our experience suggests that the proposed estimation method is simple and thus attractive for finite-sample studies and empirical implementations. Moreover, both the finite-sample performance and the empirical applications show that the proposed estimation method works well when the cross-sectional dependence exists in the data set. (C) 2015 Elsevier B.V. All rights reserved.","[Dong, Chaohua; Gao, Jiti] Monash Univ, Clayton, Vic 3800, Australia; [Peng, Bin] Univ Technol Sydney, Econ Discipline Grp, Sydney, NSW 2007, Australia; [Dong, Chaohua] Southwestern Univ Finance & Econ, Chengdu, Peoples R China",Monash University; University of Technology Sydney; Southwestern University of Finance & Economics - China,"Peng, B (通讯作者)，Univ Technol Sydney, Econ Discipline Grp, Sydney, NSW 2007, Australia.",Bin.Peng@uts.edu.au,,"Gao, Jiti/0000-0002-4261-0021; Peng, Bin/0000-0003-4231-4713","Australian Research Council [DP1096374, DP130104229]; Australian Research Council [DP1096374] Funding Source: Australian Research Council",Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council),"The authors would like to thank the Co-Editor, Professor Jianging Fan, the Associate Editor and the referees for their constructive suggestions and comments on an earlier version of this paper. The authors also acknowledge the Australian Research Council Discovery Grants Program support under Grant numbers DP1096374 and DP130104229.",,27,24,25,0,21,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,SEP,2015,188.0,1.0,,,,,301,312,,10.1016/j.jeconom.2015.06.001,0.0,,,12,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CO3AI,,Green Submitted,,,2024-03-09,WOS:000359028200017,0
J,"Hackl, F; Hummer, M; Pruckner, GJ",,,,"Hackl, Franz; Hummer, Michael; Pruckner, Gerald J.",,,Old boys' network in general practitioners' referral behavior?,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Referral behavior; General practitioner; Information asymmetry; Personal networks; Affinity-based networks,RATES; DEMAND; CARE,"We analyzed the impact of social networks on general practitioners' (GPs) referral behavior based on administrative panel data from 2,684,273 referrals to specialists made between 1998 and 2007. For the definition of social networks, we used information on the doctors' place and time of study and their hospital work history. We found that GPs referred more patients to specialists within their personal networks and that patients referred within a social network had fewer follow-up consultations and less inpatient days thereafter. The effects on patient outcomes (e.g. waiting periods, days in hospital) of referrals within personal networks and affinity-based networks differed. Specifically, whereas empirical evidence showed a concentration on high-quality specialists for referrals within the personal network, suggesting that referrals within personal networks overcome information asymmetry with respect to specialists' abilities, the empirical evidence for affinity-based networks was different and less clear. Same-gender networks tended to refer patients to low-quality specialists. (C) 2015 Elsevier B.V. All rights reserved.","[Hackl, Franz; Hummer, Michael; Pruckner, Gerald J.] Johannes Kepler Univ Linz, Austrian Ctr Labor Econ & Anal Welf State, A-4040 Linz, Austria",Johannes Kepler University Linz,"Hackl, F (通讯作者)，Johannes Kepler Univ Linz, Dept Econ, Altenberger Str 69, A-4040 Linz, Austria.",franz.hackl@jku.at,,,Austrian Science Fund (FWF) under the National Research Network The Austrian Center for Labor Economics and the Analysis of the Welfare State [S10306-G16],Austrian Science Fund (FWF) under the National Research Network The Austrian Center for Labor Economics and the Analysis of the Welfare State,"We would like to thank Alexander Ahammer, Rene Boheim, Josef Falkinger, Martin Halla, Rupert Sausgruber, Josef Zweimuller, the participants of the Spring Meeting of Young Economists in Aarhus, the Cesifo/JKU Workshop Applied Labor Economics in Bischofswiesen, and the participants of the research seminars at the Universities of Linz and Innsbruck for their helpful discussions and comments. We would also like to thank two anonymous referees for their helpful suggestions as well as the Upper Austrian Sickness Fund and the Upper Austrian Chamber of Medicine for providing data. Financial support from the Austrian Science Fund (FWF) under the National Research Network The Austrian Center for Labor Economics and the Analysis of the Welfare State, project no. S10306-G16, is gratefully acknowledged.",,36,11,14,0,20,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,SEP,2015,43.0,,,,,,56,73,,10.1016/j.jhealeco.2015.06.005,0.0,,,18,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CT8PN,26184383.0,Green Submitted,,,2024-03-09,WOS:000363078600005,0
J,"Balasko, Y",,,,"Balasko, Yves",,,Wealth concerns and equilibrium,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Externalities; Herding behavior; Other-regarding preferences; Wealth concerns,SET; EXTERNALITIES; ECONOMIES,"Most properties of the classical general equilibrium model without externalities fail to extend to the wildest forms of consumption externalities. The recent interest for wealth concerns, a kind of externality associated with herding behavior and other-regarding preferences, motivates a study of the general equilibrium exchange model with those externalities. The diffeomorphism of the equilibrium manifold with a Euclidean space, the smoothness and properness of the natural projection and its non-zero degrees are shown to hold true for endowment spaces with variable total resources. Other properties of the classical exchange model without externalities are fragile in the sense that they do not resist the introduction of wealth concerns even in models where consumers preferences are represented by the simplest forms of utility functions like the log-linear (or Cobb-Douglas) functions. The most notable fragile properties are the uniqueness and regularity of equilibrium at equilibrium allocations and the stability of no-trade equilibria. (C) 2015 Elsevier B.V. All rights reserved.","Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England",University of York - UK,"Balasko, Y (通讯作者)，Univ York, Dept Econ & Related Studies, York YO10 5DD, N Yorkshire, England.",yves.balasko@york.ac.uk,,"balasko, yves/0000-0001-7693-8124",,,,,28,6,6,0,9,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2015,59.0,,,,,,92,101,,10.1016/j.jmateco.2015.04.001,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CN5GJ,,,,,2024-03-09,WOS:000358457500010,0
J,"Duong, D; Swanson, NR",,,,"Duong, Diep; Swanson, Norman R.",,,"Empirical evidence on the importance of aggregation, asymmetry, and jumps for volatility prediction",JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Realized volatility; Jump power variations; Downside risk; Semivariances; Market microstructure; Volatility forecasts; Jump test,HIGH-FREQUENCY DATA; MARKET MICROSTRUCTURE NOISE; REALIZED VOLATILITY; SPOT VOLATILITY; ASSET RETURNS; STOCK RETURNS; COMPONENTS; INFERENCE; VARIANCE; DISCRETE,"Many recent modeling advances in finance topics ranging from the pricing of volatility-based derivative products to asset management are predicated on the importance of jumps, or discontinuous movements in asset returns. In light of this, a number of recent papers have addressed volatility predictability, some from the perspective of the usefulness of jumps in forecasting volatility. Key papers in this area include Andersen et al. (2003), Corsi (2004), Andersen et al. (2007), Corsi et al. (2008), Barndorff et al. (2010), Patton and Shephard (2011), and the references cited therein. In this paper, we review the extant literature and then present new empirical evidence on the predictive content of realized measures of jump power variations (including upside and downside risk, jump asymmetry, and truncated jump variables), constructed using instantaneous returns, i.e.,vertical bar r(t)vertical bar(q), 0 <= q <= 6 in the spirit of Ding et al. (1993) and Ding and Granger (1996). We also present new empirical evidence on the predictive content of realized measures of truncated large jump variations, constructed using truncated squared instantaneous return, i.e., r(t)(2) x I-vertical bar rt vertical bar>gamma, where gamma is the threshold jump size. Our prediction experiments use high frequency price returns constructed using S&P500 futures data as well as stocks in the Dow 30, and our empirical implementation involves estimating linear and nonlinear heterogeneous autoregressive realized volatility (HAR-RV) type models. We find that past large jump power variations help less in the prediction of future realized volatility, than past small jump power variations. Additionally, we find evidence that past realized signed jump power variations, which have not previously been examined in this literature, are strongly correlated with future volatility, and that past downside jump variations matter in prediction. Finally, incorporation of downside and upside jump power variations does improve predictability, albeit to a limited extent. (C) 2015 Elsevier B.V. All rights reserved.","[Duong, Diep] Utica Coll, Utica, NY 13502 USA; [Swanson, Norman R.] Rutgers State Univ, Dept Econ, New Brunswick, NJ 08901 USA",Rutgers University System; Rutgers University New Brunswick,"Swanson, NR (通讯作者)，Rutgers State Univ, Dept Econ, 75 Hamilton St, New Brunswick, NJ 08901 USA.",dnduong@utica.edu; nswanson@econ.rutgers.edu,,,,,,,46,56,64,1,41,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,AUG,2015,187.0,2.0,,,,,606,621,,10.1016/j.jeconom.2015.02.042,0.0,,,16,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CM0DJ,,Green Submitted,,,2024-03-09,WOS:000357348300017,0
J,"Streufert, PA",,,,"Streufert, Peter A.",,,An elementary proof that additive i-likelihood characterizes the supports of consistent assessments,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Infinite relative likelihood; I-likelihood; Additive representation; Consistency,INEQUALITIES; PROBABILITY; GAMES,"I prove a convenient reformulation of Kreps and Wilson (1982, Lemma Al), whose proof has a nontrivial gap. Essentially, the support of a consistent assessment is characterized by the additive representability of the infinite-relative-likelihood relation that the support implies. My proof is unexpectedly elementary, for it relies solely on a classic result about additive representation, which in turn relies solely on Farkas' Lemma. (C) 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).","Univ Western Ontario, Dept Econ, London, ON N6A 3K7, Canada",Western University (University of Western Ontario),"Streufert, PA (通讯作者)，Univ Western Ontario, Dept Econ, London, ON N6A 3K7, Canada.",pstreuf@uwo.ca,,"Streufert, Peter/0000-0003-4197-7697",,,,,26,2,2,0,3,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,AUG,2015,59.0,,,,,,37,46,,10.1016/j.jmateco.2015.03.003,0.0,,,10,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CN5GJ,,hybrid,,,2024-03-09,WOS:000358457500004,0
J,"Granero, LM; Ordóñez-de-Haro, JM",,,,"Granero, Lluis M.; Ordonez-de-Haro, Jose M.",,,Entry under uncertainty: Limit and most-favored-customer pricing,MATHEMATICAL SOCIAL SCIENCES,,,English,Article,,,,,,,INCOMPLETE INFORMATION; DETERRENCE; GUARANTEES; REPUTATION; COLLUSION; DUOPOLY; MODEL; GAME,"In the absence of uncertainty, an incumbent that attempts to prevent entry of rival firms can have no incentive to offer a most-favored-customer (MFC) clause because it could lead to higher post-entry prices. Our analysis suggests that this is not necessarily the case under uncertainty. In the presence of uncertainty, the incumbent can set a limit price that affects the entry decision. Limit pricing involves a pre-entry price different from the static monopoly price, which leads to a signaling cost. We show that part of this cost can be distributed over several periods by means of consumer refunds from the MFC clause. If the discount factor is not very high, the incumbent adopts this pricing and prevents entry to a larger extent. (C) 2015 Elsevier B.V. All rights reserved.","[Granero, Lluis M.] Univ Valencia, Valencia 46022, Spain; [Ordonez-de-Haro, Jose M.] Univ Malaga, E-29071 Malaga, Spain",University of Valencia; Universidad de Malaga,"Granero, LM (通讯作者)，Univ Valencia, Dept Anal Econ, Avda Tarongers S-N, Valencia 46022, Spain.",Imgraner@uv.es,"ORDÓÑEZ-DE-HARO, JOSE MANUEL/GWU-8843-2022; Granero, Luis/K-7692-2014","Granero, Luis/0000-0001-7575-1261",Spanish Ministry of Economy and Competitiveness [ECO2014-53419-R],Spanish Ministry of Economy and Competitiveness(Spanish Government),"Some results in this paper were formerly circulated in a draft entitled Entry under Uncertainty: Limit Pricing and Customer Clauses selected as a winner of the EARIE's Young Economists' Essay Competition Award. We would like to thank Kyle Bagwell, Lluis Bru, Ramon Caminal, Maria-Paz Espinosa, Joe Harrington, Ines Macho-Stadler, Xavier Martinez-Giralt, Carmen Matutes, Massimo Motta, Jorge Padilla and two referees for helpful suggestions. Partial financial support from the Spanish Ministry of Economy and Competitiveness (grant ECO2014-53419-R) is gratefully acknowledged. The usual disclaimer applies.",,28,1,1,0,9,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0165-4896,1879-3118,,MATH SOC SCI,Math. Soc. Sci.,JUL,2015,76.0,,,,,,1,11,,10.1016/j.mathsocsci.2015.02.008,0.0,,,11,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CN2RB,,,,,2024-03-09,WOS:000358268500001,0
J,"Pieterse, D",,,,"Pieterse, Duncan",,,Childhood Maltreatment and Educational Outcomes: Evidence from South Africa,HEALTH ECONOMICS,,,English,Article,,,,,,childhood maltreatment; education,LABOR-MARKET OUTCOMES; NATURAL EXPERIMENT; DOMESTIC VIOLENCE; SKILL FORMATION; BIRTH-WEIGHT; CHILDREN; RISK; PERFORMANCE; BEHAVIOR; EXPOSURE,"Many South African children experience maltreatment, but we know little about the effects on long-term child development. Using the only representative dataset that includes a module on childhood maltreatment for a metropolitan city in South Africa, we explore the association between different measures of childhood maltreatment and two educational outcomes (numeracy test scores and dropout). Our study provides an estimate of the association between childhood maltreatment and educational outcomes in a developing country where maltreatment is high. We control for potential confounders using a range of statistical techniques and add several robustness checks to evaluate the strength of our findings. Our results indicate that children who are maltreated suffer large adverse consequences in terms of their numeracy test scores and probability of dropout and that the estimated effects of maltreatment are larger and more consistent for the most severe type of maltreatment. Copyright (c) 2014 John Wiley & Sons, Ltd.","Natl Treasury, Pretoria, South Africa",,"Pieterse, D (通讯作者)，Natl Treasury, 240 Madiba St, Pretoria, South Africa.",duncanpieterse@gmail.com,,,African Economic Research Consortium; National Research Foundation (South Africa); Centre for Social Science Research (University of Cape Town),African Economic Research Consortium; National Research Foundation (South Africa)(National Research Foundation - South Africa); Centre for Social Science Research (University of Cape Town),"The author would like to thank Prof. Nicoli Nattrass and Prof. Martin Wittenberg at the University of Cape Town for comments and suggestions that substantially improved the quality of the paper. Financial assistance was received from the African Economic Research Consortium, National Research Foundation (South Africa) and the Centre for Social Science Research (University of Cape Town). A substantial part of this paper was completed while the author was a Graduate Program for Development fellow at the Watson Institute, Brown University.",,82,16,18,0,20,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1057-9230,1099-1050,,HEALTH ECON,Health Econ.,JUL,2015,24.0,7.0,,,,,876,894,,10.1002/hec.3065,0.0,,,19,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CJ7SO,24890398.0,,,,2024-03-09,WOS:000355699900007,0
J,"Kelly, B; Pruitt, S",,,,"Kelly, Bryan; Pruitt, Seth",,,The three-pass regression filter: A new approach to forecasting using many predictors,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Forecast; Factor model; Principal components; Constrained least squares; Partial least squares,DYNAMIC-FACTOR MODEL; PRINCIPAL COMPONENTS; DIVIDEND YIELDS; STOCK RETURNS; LARGE NUMBER; INFERENCE; ASYMPTOTICS; INFLATION; SHRINKAGE; VARIANCE,"We forecast a single time series using many predictor variables with a new estimator called the three-pass regression filter (3PRF). It is calculated in closed form and conveniently represented as a set of ordinary least squares regressions. 3PRF forecasts are consistent for the infeasible best forecast when both the time dimension and cross section dimension become large. This requires specifying only the number of relevant factors driving the forecast target, regardless of the total number of common factors driving the cross section of predictors. The 3PRF is a constrained least squares estimator and reduces to partial least squares as a special case. Simulation evidence confirms the 3PRF's forecasting performance relative to alternatives. We explore two empirical applications: Forecasting macroeconomic aggregates with a large panel of economic indices, and forecasting stock market returns with price-dividend ratios of stock portfolios. (C) 2015 Elsevier B.V. All rights reserved.","[Kelly, Bryan] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Pruitt, Seth] Board Governors Fed Reserve Syst, Washington, DC USA; [Pruitt, Seth] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA",University of Chicago; Federal Reserve System - USA; Federal Reserve System Board of Governors; Arizona State University; Arizona State University-Tempe,"Kelly, B (通讯作者)，Univ Chicago, Booth Sch Business, 5807 S Woodlawn Ave, Chicago, IL 60637 USA.",bryan.kelly@chicagobooth.edu; seth.pruitt@asu.edu,,,,,,,43,148,178,2,39,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,JUN,2015,186.0,2.0,,,,,294,316,,10.1016/j.jeconom.2015.02.011,0.0,,,23,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CJ3AT,,,,,2024-03-09,WOS:000355356500003,0
J,"Ritrouato, M; Faggiano, FC; Tedesco, G; Derrico, P",,,,"Ritrouato, Matteo; Faggiano, Francesco C.; Tedesco, Giorgia; Derrico, Pietro",,,Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals,VALUE IN HEALTH,,,English,Article,,,,,,analytic hierarchy process; decision tree; Decision-Oriented Health Technology Assessment; doHTA; health technology assessment; hospital-based HTA; multicriteria decision analysis system,HTA CORE MODEL; EUROPEAN NETWORK; IMPLEMENTATION,"Objectives: This article outlines the Decision-Oriented Health Technology Assessment a new implementation of the European network for Health Technology Assessment Core Model, integrating the multicriteria decision-making analysis by using the analytic hierarchy process to introduce a standardized methodological approach as a valued and shared tool to support health care decision making within a hospital. Methods: Following the Core Model as guidance (European network for Health Technology Assessment. HTA core model for medical and surgical interventions. Available from: http://www.ennethta.eu/outputs/hta-core-model-medical-and-surical-interventions-10r. [Accessed May 27, 2014]), it is possible to apply the analytic hierarchy process to break down a problem into its constituent parts and identify priorities (i.e., assigning a weight to each part) in a hierarchical structure. Thus, it quantitatively compares the importance of multiple criteria in assessing health technologies and how the alternative technologies perform in satisfying these criteria. The verbal ratings are translated into a quantitative form by using the Saaty scale (Saaty TL. Decision making with the analytic hierarchy process. Int J Serv Sci 2008;1:83-98). An eigenvectors analysis is used for deriving the weights' systems (i.e., local and global weights' system) that reflect the importance assigned to the criteria and the priorities related to the performance of the alternative technologies. Results: Compared with the Core Model, this methodological approach supplies a more timely as well as contextualized evidence for a specific technology, making it possible to obtain data that are more relevant and easier to interpret, and therefore more useful for decision makers to make investment choices with greater awareness. Conclusions: We reached the conclusion that although there may be scope for improvement, this implementation is a step forward toward the goal of building a solid bridge between the scientific evidence and the final decision maker's choice.","[Ritrouato, Matteo; Faggiano, Francesco C.; Tedesco, Giorgia] Bambino Gesu Pediat Hosp, Hlth Technol Assessment & Safety Res Unit, Rome, Italy; [Derrico, Pietro] Bambino Gesu Pediat Hosp, Clin Technol lnnovat Res Area, Rome, Italy",IRCCS Bambino Gesu; IRCCS Bambino Gesu,"Ritrouato, M (通讯作者)，Viale Ferdinando Baldelli n 41, I-00146 Rome, Italy.",matteo.ritrovato@opbg.net,"Faggiano, Francesco Cosimo/AAT-6104-2020; DERRICO, Pietro/AAA-6382-2020","Faggiano, Francesco Cosimo/0000-0001-5218-0515; Ritrovato, Matteo/0000-0003-3686-6108; DERRICO, PIETRO/0000-0002-8733-1042",,,,,18,23,30,2,30,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,JUN,2015,18.0,4.0,,,,,505,511,,10.1016/j.jval.2015.02.002,0.0,,,7,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CK6SQ,26091605.0,hybrid,,,2024-03-09,WOS:000356358600018,0
J,"Allaert, F; Courau, S; Forestier, A",,,,"Allaert, F.; Courau, S.; Forestier, A.",,,VALIDATION OF A VITALITY QUOTIENT TO MEASURE THE EFFECT OF FOOD SUPPLEMENTS ON FATIGUE IN HEALTHY SUBJECTS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Allaert, F.] Med Evaluat Chair ESC Dijon, Dijon, France; [Courau, S.; Forestier, A.] Merck CH, Dijon, France",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM112,A29,A29,,10.1016/j.jval.2015.03.178,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500152,0
J,"Almanie, SA; Holdford, DA",,,,"Almanie, S. A.; Holdford, D. A.",,,"ECONOMIC IMPACT OF WASTE IN PRESCRIBING, DISPENSING, AND MEDICATION CONSUMPTION IN THE UNITED STATES",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Almanie, S. A.; Holdford, D. A.] Virginia Commonwealth Univ, Richmond, VA USA",Virginia Commonwealth University,,,,,,,,,0,2,3,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP66,A81,A82,,10.1016/j.jval.2015.03.476,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,"Green Published, hybrid",,,2024-03-09,WOS:000354498501149,0
J,"Anifowoshe, R",,,,"Anifowoshe, R.",,,A REVIEW OF THE EFFECTIVENESS OF VISUAL MEDICATION TOOLS IN BOOSTING PATIENT ADHERENCE AND REDUCING HOSPITAL ADMISSIONS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Anifowoshe, R.] Mercer, Norcross, GA USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIH28,A108,A108,,10.1016/j.jval.2015.03.634,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498501297,0
J,"Arabyat, R; Raisch, DW",,,,"Arabyat, R.; Raisch, D. W.",,,"THE IMPACT OF EMOTIONAL AND SOCIAL SUPPORT ON THE QUALITY OF LIFE, DEPRESSION, AND DISABILITY AMONG US ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD): A PROPENSITY SCORE ANALYSIS",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Arabyat, R.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; [Raisch, D. W.] Univ New Mexico, Albuquerque, NM 87131 USA",University of New Mexico; University of New Mexico,,,,,,,,,0,1,1,0,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS38,A176,A176,,10.1016/j.jval.2015.03.1016,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498503045,0
J,"Araujo, L; Camargo, B",,,,"Araujo, Luis; Camargo, Braz",,,Limited monitoring and the essentiality of money,JOURNAL OF MATHEMATICAL ECONOMICS,,,English,Article,,,,,,Limited monitoring; Essentiality; Community enforcement,MONETARY-POLICY; SOCIAL NORMS; MODEL; SEARCH; EQUILIBRIA,"Monetary theory emphasizes that imperfect monitoring is necessary for money to be essential, that is, for money to achieve socially desirable allocations. Little is known about how limited monitoring must be if money is to be essential, though. Understanding sufficient conditions for the essentiality of money is important since monitoring is a natural way in which credit is introduced in monetary models. In this paper, we show that money can fail to be essential even if monitoring is quite limited. This indicates that one must be careful when introducing monitoring in monetary models to allow for the coexistence of money and credit. (C) 2015 Elsevier B.V. All rights reserved.","[Araujo, Luis; Camargo, Braz] Sao Paulo Sch Econ FGV, Sao Paulo, Brazil; [Araujo, Luis] Michigan State Univ, Dept Econ, E Lansing, MI 48824 USA",Getulio Vargas Foundation; Michigan State University,"Camargo, B (通讯作者)，Sao Paulo Sch Econ FGV, Sao Paulo, Brazil.",braz.camargo@fgv.br,"Araujo, Luis/HLW-6959-2023",,CNPq,CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)),"We thank Satoru Takahashi for comments on an early draft of this paper and three anonymous referees for their comments and suggestions. We also thank seminar participants at Illinois, Paris X, and PUC-Rio, and audience members at the SAET meetings in Italy and the Workshop on Money, Banking, and Payments at the Federal Reserve Bank of Chicago for their feedback. The authors gratefully acknowledge financial support from CNPq.",,28,8,9,0,5,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4068,,,J MATH ECON,J. Math. Econ.,MAY,2015,58.0,,,,,,32,37,,10.1016/j.jmateco.2015.03.004,0.0,,,6,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CJ2XP,,,,,2024-03-09,WOS:000355348300005,0
J,"Arnold, MR; Ito, D; Magee, G; Xiong, Y; Testa, D; Rubinstein, M; Tackett, S",,,,"Arnold, M. R.; Ito, D.; Magee, G.; Xiong, Y.; Testa, D.; Rubinstein, M.; Tackett, S.",,,COMPARATIVE EFFECTIVENESS OF FIBRIN SEALANTS IN CARDIAC SURGERY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Arnold, M. R.; Ito, D.; Xiong, Y.; Rubinstein, M.; Tackett, S.] Baxter Healthcare Corp, Westlake Village, CA USA; [Magee, G.] Premier Inc, Charlotte, NC USA; [Testa, D.] Seven Nine Syst, Studio City, CA USA","Baxter International Inc; Premier, Inc.",,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD5,A38,A38,,10.1016/j.jval.2015.03.229,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500201,0
J,"Azhar, SA; Hassali, AA; Sana, SS; Faiza, FI; Zainab, ZB; Sundas, SA; Mahrukh, MA; Noman, NH; Fahad, FS; Izhar, IH",,,,"Azhar, S. A.; Hassali, A. A.; Sana, S. S.; Faiza, F., I; Zainab, Z. B.; Sundas, S. A.; Mahrukh, M. A.; Noman, N. H.; Fahad, F. S.; Izhar, I. H.",,,"ASESSMENT OF AWARENESS REGARDING HEPATITIS B AMONG WOMEN IN ABBOTTABAD, KPK PAKISTAN",VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Azhar, S. A.; Sana, S. S.; Faiza, F., I; Zainab, Z. B.; Sundas, S. A.; Mahrukh, M. A.; Izhar, I. H.] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [Hassali, A. A.; Fahad, F. S.] Univ Sains Malaysia, George Town, Malaysia; [Noman, N. H.] Univ Balochistan, Quetta, Pakistan",COMSATS University Islamabad (CUI); Universiti Sains Malaysia; University of Balochistan,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHS15,A250,A250,,10.1016/j.jval.2015.03.1454,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504139,0
J,"Berger, A; Kauf, T; Oster, G",,,,"Berger, A.; Kauf, T.; Oster, G.",,,PROJECTING CHANGES IN TOTAL DAYS OF THERAPY (DOT) IN PATIENTS HOSPITALIZED FOR ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Berger, A.] Evidera, Lexington, MA USA; [Kauf, T.] Cubist Pharmaceut, Lexington, MA USA; [Oster, G.] PAI, Brookline, MA USA; [Oster, G.] MINERVA Hlth Econ Network, Brookline, MA USA",Evidera; Cubist Pharmaceuticals; Policy Analysis Inc,,,,,,,,,0,0,0,1,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN94,A244,A244,,10.1016/j.jval.2015.03.1418,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504105,0
J,"Bhounsule, P; Peterson, AM",,,,"Bhounsule, P.; Peterson, A. M.",,,COMPARISON OF DIFFERENT METABOLIC SYNDROME CRITERIA AND INDIVIDUAL RISK FACTORS IN THE RISK PREDICTION OF CARDIOVASCULAR AND CHRONIC DISEASES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Bhounsule, P.; Peterson, A. M.] Univ Sci Philadelphia, Philadelphia, PA USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV32,A135,A135,,10.1016/j.jval.2015.03.785,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502126,0
J,"Leandro, LB; Ruben, RR; Francisca, FF; Marcela, MP",,,,"Biagini Leandro, L.; Rojas Ruben, R.; Fuentealba Francisca, F.; Pezzani Marcela, M.",,,COST/UTILITY ANALYSIS OF PNEUMOCOCCAL VACCINES PCV13 VERSUS PPSV23 IN ADULTS OVER 18 YEARS OLD IN CHILE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Biagini Leandro, L.; Rojas Ruben, R.; Fuentealba Francisca, F.] Univ Mayor, Santiago, Chile; [Pezzani Marcela, M.] Univ San SebastiAm, Santiago, Chile",Universidad Mayor,,,,,,,,,0,1,1,1,7,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PIN76,A240,A241,,,,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498504089,0
J,"Casciano, J; Krishnan, J; Buatti-Small, M; Li, C; Dotiwala, Z",,,,"Casciano, J.; Krishnan, J.; Buatti-Small, M.; Li, C.; Dotiwala, Z.",,,COST-CONSEQUENCE OF EOSINOPHILIC ASTHMA AMONG PATIENTS TREATED ACCORDING TO ERS/ATS GUIDELINES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Casciano, J.; Dotiwala, Z.] eMAX Hlth Syst LLC, White Plains, NY USA; [Krishnan, J.] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA; [Buatti-Small, M.] Teva, Frazer, PA USA; [Li, C.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA",University of Arkansas System; University of Arkansas Medical Sciences,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS32,A175,A175,,10.1016/j.jval.2015.03.1010,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498503040,0
J,"Crispo, J; Willis, AW; Fortin, Y; Emons, MF; Bjerre, LM; Kohen, DE; Lloret, SP; Mattison, DR; Krewski, D",,,,"Crispo, J.; Willis, A. W.; Fortin, Y.; Emons, M. F.; Bjerre, L. M.; Kohen, D. E.; Lloret, Perez S.; Mattison, D. R.; Krewski, D.",,,RISK OF CARDIOVASCULAR EVENTS ASOCIATED WITH NECESSARY INTERVENTIONS FOR PARKINSON DISEASE,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Crispo, J.; Fortin, Y.; Bjerre, L. M.; Kohen, D. E.; Krewski, D.] Univ Ottawa, Ottawa, ON, Canada; [Willis, A. W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emons, M. F.] Cerner Corp, Culver City, CA USA; [Lloret, Perez S.] Catholic Univ, Buenos Aires, DF, Argentina; [Mattison, D. R.] Risk Sci Int, Ottawa, ON, Canada",University of Ottawa; University of Pennsylvania; Oracle; Cerner Corporation; Pontificia Universidad Catolica Argentina,,,"Willis, Allison/ABC-9010-2020; Mattison, Donald R/C-2015-2009; Perez-Lloret, Santiago/J-2134-2019","Willis, Allison/0000-0001-5724-7192; Perez-Lloret, Santiago/0000-0001-9069-6512",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PND4,A278,A278,,10.1016/j.jval.2015.03.1624,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498504294,0
J,"Diamand, F; Painchault, C; Brignone, M",,,,"Diamand, F.; Painchault, C.; Brignone, M.",,,RELATIVE EFFICACY AND TOLERABILITY OF VORTIOXETINE COMPARED WITH SELECTED ANTIDEPRESSANTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PRIOR THERAPY,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Diamand, F.; Brignone, M.] Lundbeck SAS, Paris, France; [Painchault, C.] Keyrus Biopharma, Levallois Perret, France",Lundbeck Corporation; Lundbeck Corporation - France,,,,,,,,,0,0,0,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH8,A116,A116,,10.1016/j.jval.2015.03.680,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502023,0
J,"Fehnel, SE; Brown, TM; Nelson, L; Chen, A; Kim, DD; Roof, E; Dykens, EM",,,,"Fehnel, S. E.; Brown, T. M.; Nelson, L.; Chen, A.; Kim, D. D.; Roof, E.; Dykens, E. M.",,,DEVELOPMENT OF THE HYPERPHAGIA QUESTIONNAIRE FOR USE IN PRADER-WILLI SYNDROME CLINICAL TRIALS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Fehnel, S. E.; Brown, T. M.; Nelson, L.] RTI Hlth Solut, Res Triangle Pk, NC USA; [Chen, A.; Kim, D. D.] Zafgen Inc, Boston, MA USA; [Roof, E.; Dykens, E. M.] Vanderbilt Univ, Nashville, TN 37235 USA",Research Triangle Institute; Vanderbilt University,,,,"Fehnel, Sheri/0000-0001-8568-0102; Moore, Lauren/0000-0001-7117-6757",,,,,0,17,16,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM88,A25,A25,,10.1016/j.jval.2015.03.154,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500128,0
J,"Foster, AD; Lee, YS",,,,"Foster, Andrew D.; Lee, Yong Suk",,,Staffing subsidies and the quality of care in nursing homes,JOURNAL OF HEALTH ECONOMICS,,,English,Article,,,,,,Medicaid; Wage pass-through; Nursing home; Quality of care; FGLS,MEDICAID REIMBURSEMENT; MARKET,"Concerns about the quality of state-financed nursing home care has led to the wide-scale adoption by states of pass-through subsidies, in which Medicaid reimbursement rates are directly tied to staffing expenditure. We examine the effects of Medicaid pass-through on nursing home staffing and quality of care by adapting a two-step FGLS method that addresses clustering and state-level temporal autocorrelation. We find that pass-through subsidies increases staffing by about 1% on average and 2.7% in nursing homes with a low share of Medicaid patients. Furthermore, pass-through subsidies reduce the incidences of pressure ulcer worsening by about 0.9%. (C) 2015 Elsevier B.V. All rights reserved.","[Foster, Andrew D.] Brown Univ, Dept Econ, Providence, RI 02912 USA; [Lee, Yong Suk] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA",Brown University; Stanford University,"Lee, YS (通讯作者)，Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA.",afoster@brown.edu; yongslee@stanford.edu,"Foster, Andrew/HNC-3246-2023",,"NIH [AG26465, P01AG027296]",NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),The article is funded by NIH under Grant numbers: AG26465 and P01AG027296.,,21,11,15,2,18,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0167-6296,1879-1646,,J HEALTH ECON,J. Health Econ.,MAY,2015,41.0,,,,,,133,147,,10.1016/j.jhealeco.2015.02.002,0.0,,,15,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI2NU,25814437.0,"Green Submitted, Green Accepted",,,2024-03-09,WOS:000354585100010,0
J,"Gabriel, S; Herrera, V; Hoskin, B; Anderson, P; Karagiannis, T",,,,"Gabriel, S.; Herrera, V; Hoskin, B.; Anderson, P.; Karagiannis, T.",,,EXPLORING THE REAL WORLD SETTING OF CHRONIC IDIOPATHIC URTICARIA AND PHYSICIAN ATTITUDES TOWARDS IT IN THE US,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gabriel, S.; Herrera, V] Novartis Pharmaceut, E Hanover, NJ USA; [Hoskin, B.; Anderson, P.] Adelphi Real World, Macclesfield, MA USA; [Karagiannis, T.] Jefferson Sch Populat Hlth Novartis Pharmaceut, E Hanover, NJ USA",Novartis,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM133,A33,A33,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,,,,2024-03-09,WOS:000354498500173,0
J,"Gao, X; Xue, M; Stephens, J; Chen, Y; Haider, S; Charbonneau, C",,,,"Gao, X.; Xue, M.; Stephens, J.; Chen, Y.; Haider, S.; Charbonneau, C.",,,COST ANALYSIS OF VORICONAZOLE VERSUS CASPOFUNGIN FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS AMONG HIGH-RISK HEMATOLOGIC CANCER PATIENTS IN CHINA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gao, X.; Xue, M.; Stephens, J.] Pharmerit Int, Bethesda, MD USA; [Chen, Y.] Pfizer Investment Co Ltd, Beijing, Peoples R China; [Haider, S.] Pfizer Inc, Groton, CT 06340 USA; [Charbonneau, C.] Pfizer Inc, Paris, France",Pharmerit North America LLC; Pfizer; Pfizer; Pfizer,,,"Gao, Xin/D-5487-2013",,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PSY22,A295,A295,,10.1016/j.jval.2015.03.1720,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498505074,0
J,"Gilardino, R; Koffsmon, AL; Cabra, HA",,,,"Gilardino, R.; Koffsmon, A. L.; Cabra, H. A.",,,ACCESS TO IMPORTED MEDICAL DEVICES DUE TO INFLATION AND UNDER FUNDING OF ARGENTINIAN HEALTH SECTOR IN 2013,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Gilardino, R.; Koffsmon, A. L.] Johnson & Johnson Med Argentina, Buenos Aires, DF, Argentina; [Cabra, H. A.] Johnson&Johnson Med, Mexico City, DF, Mexico",Johnson & Johnson,,,"Gilardino, Ramiro E./AGX-6637-2022; Gilardino, Ramiro/ABC-5333-2021","Gilardino, Ramiro E./0000-0002-9238-7729;",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMD69,A50,A50,,10.1016/j.jval.2015.03.293,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500264,0
J,"Gomez-Biscarri, J; Hualde, J",,,,"Gomez-Biscarri, Javier; Hualde, Javier",,,Regression-based analysis of cointegration systems,JOURNAL OF ECONOMETRICS,,,English,Article,,,,,,Cointegrating space; Phillips' triangular form; Johansen's methodology; Regression-based cointegration testing,VECTOR AUTOREGRESSIVE MODEL; TIME-SERIES; UNIT-ROOT; TESTS; HYPOTHESIS; SUBMATRIX; INFERENCE; TRENDS; YIELDS; RANK,"Two estimation procedures dominate the cointegration literature: Johansen's maximum likelihood inference on vector autoregressive error correction models and estimation of Phillips' triangular forms. This latter methodology is essentially semiparametric, focusing on estimating long run parameters by means of cointegrating regressions. However, it is less used in practice than Johansen's approach, since its implementation requires prior knowledge of features such as the cointegrating rank and an appropriate set of non-cointegrated regressors. In this paper we develop a simple and automatic procedure (based on unit root and regression-based cointegration testing) which, without imposing a parametric specification for the short run components of the model, provides an estimator of the cointegrating rank and data-based just-identifying conditions for the cointegrating parameters which lead to a Phillips' triangular form. A Monte Carlo analysis of the properties of the estimator and an empirical application are also provided. (C) 2015 Elsevier B.V. All rights reserved.","[Gomez-Biscarri, Javier] Univ Pompeu Fabra, Barcelona, Spain; [Gomez-Biscarri, Javier] Barcelona GSE, Barcelona, Spain; [Hualde, Javier] Univ Publ Navarra, Pamplona 31006, Spain",Pompeu Fabra University; Barcelona School of Economics; Universidad Publica de Navarra,"Hualde, J (通讯作者)，Univ Publ Navarra, Dept Econ, Campus Arrosadia,Edificio Los Madronos, Pamplona 31006, Spain.",javier.hualde@unavarra.es,"Gomez Biscarri, Javier/A-8817-2013; Hualde, Javier/F-9993-2015","Gomez Biscarri, Javier/0000-0001-7347-3448; Hualde, Javier/0000-0001-5516-6508","Barcelona GSE; Spanish Ministerio de Ciencia e Innovacion through the Severo Ochoa Program for Centers of Excellence in RD [SEV-2011-0075]; Spanish Ministerio de Ciencia e Innovacion [ECO2011-25607, ECO2011-24304]",Barcelona GSE; Spanish Ministerio de Ciencia e Innovacion through the Severo Ochoa Program for Centers of Excellence in RD; Spanish Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIISpanish Government),"We are grateful to three referees, James Davidson, Jose Garcia-Montalvo, Jesus Gonzalo, Adrian Pagan, Carlos Velasco and seminar participants at University of Sassari, Universidad Carlos III, Universitat Pompeu Fabra and Universidad Publica de Navarra for useful comments. Javier Gomez-Biscarri acknowledges financial support from the Barcelona GSE and from the Spanish Ministerio de Ciencia e Innovacion through the Severo Ochoa Program for Centers of Excellence in R&D (SEV-2011-0075) and from the Spanish Ministerio de Ciencia e Innovacion through project ECO2011-25607. Javier Hualde's research is supported by the Spanish Ministerio de Ciencia e Innovacion through project ECO2011-24304.",,35,2,2,0,15,ELSEVIER SCIENCE SA,LAUSANNE,"PO BOX 564, 1001 LAUSANNE, SWITZERLAND",0304-4076,1872-6895,,J ECONOMETRICS,J. Econom.,MAY,2015,186.0,1.0,,,,,32,50,,10.1016/j.jeconom.2014.12.007,0.0,,,19,"Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Mathematics; Mathematical Methods In Social Sciences,CF6IY,,,,,2024-03-09,WOS:000352661600003,0
J,"Grozdanova, A; Olasupo, O; Vazquez, ES",,,,"Grozdanova, A.; Olasupo, O.; Vazquez, Seoane E.",,,AN ASSESSMENT OF THE THERAPEUTIC BIOLOGIC PRODUCTS LICENSED BY THE FDA AND THE EMA,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Grozdanova, A.] Fac Pharm UKIM, Skopje, Macedonia; [Olasupo, O.] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA; [Vazquez, Seoane E.] MCPHS Univ, Boston, MA USA",,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PHP15,A73,A73,,10.1016/j.jval.2015.03.425,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498501100,0
J,"Huicochea-Bartelt, JL; Camacho-Cordero, LM; Herran, S",,,,"Huicochea-Bartelt, J. L.; Camacho-Cordero, L. M.; Herran, S.",,,INPATIENT VERSUS OUTPATIENT TREATMENT RELATED TO EXACERBATION EPISODES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM A PUBLIC MEXICAN INSTITUTIONAL PERSPECTIVE),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Huicochea-Bartelt, J. L.; Herran, S.] Boehringer Ingelheim GmbH & Co KG, Xochimilco, DF, Mexico",Boehringer Ingelheim,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRS18,A172,A172,,10.1016/j.jval.2015.03.996,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498503026,0
J,"Ishak, KJ; Kansal, A; Krotneva, M; Tarko, L; Tafazzoli, A",,,,"Ishak, K. J.; Kansal, A.; Krotneva, M.; Tarko, L.; Tafazzoli, A.",,,IMPORTANT STATISTICAL CONSIDERATIONS FOR DEVELOPING EQUATIONS FOR DISEASE SIMULATORS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Ishak, K. J.; Krotneva, M.] Evidera, St Laurent, PQ, Canada; [Kansal, A.; Tafazzoli, A.] Evidera, Bethesda, MD USA; [Tarko, L.] Evidera, Lexington, MA USA",Evidera; Evidera,,,,,,,,,0,0,0,0,3,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM143,A35,A35,,10.1016/j.jval.2015.03.208,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498500183,0
J,"Jacobs, DM; Hempel, C; Feuerstein, S",,,,"Jacobs, D. M.; Hempel, C.; Feuerstein, S.",,,EVALUATION OF BLEEDING OUTCOMES LINKED TO NEW ORAL ANTICOAGULANTS: REVIEW OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS),VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jacobs, D. M.; Hempel, C.; Feuerstein, S.] SUNY Buffalo, Buffalo, NY 14260 USA",State University of New York (SUNY) System; State University of New York (SUNY) Buffalo,,,,,,,,,0,0,0,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PCV25,A133,A134,,10.1016/j.jval.2015.03.778,0.0,,,4,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502119,0
J,"Jiang, M; You, J",,,,"Jiang, M.; You, J.",,,UNIVERSAL CLOPIDOGREL VERSUS CYP2C19-GUIDED ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME - A COST-EFFECTIVENESS ANALYSIS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jiang, M.; You, J.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China",Chinese University of Hong Kong,,,"You, Joyce H. S./C-2984-2008","You, Joyce H. S./0000-0002-5763-7403",,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PRM54,A19,A19,,10.1016/j.jval.2015.03.120,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498500097,0
J,"Jiang, Y; Park, S; McCombs, J",,,,"Jiang, Y.; Park, S.; McCombs, J.",,,THE IMPACT OF ALTERNATIVE ANTIPSYCONTIC MEDICATIONS ON THE RISK OF ADVERSE EVENTS IN PATIENTS TREATED FOR BIPOLAR DISORDERS,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Jiang, Y.; Park, S.; McCombs, J.] Univ So Calif, Los Angeles, CA USA",University of Southern California,,,,,,,,,0,0,0,0,1,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH4,A115,A115,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,Bronze,,,2024-03-09,WOS:000354498502019,0
J,"Joshi, K; Lin, J; Lingohr-Smith, M; Fu, DJ",,,,"Joshi, K.; Lin, J.; Lingohr-Smith, M.; Fu, D. J.",,,MEDICAL COST-OFFSET OF ONCE-MONTHLY PALIPERIDONE PALMITATE MONOTHERAPY AND ADJUNCTIVE THERAPY IN 15-MONTH TRIAL,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Joshi, K.; Fu, D. J.] Janssen Sci Affairs, Titusville, NJ USA; [Lin, J.; Lingohr-Smith, M.] Novosys Hlth, Green Brook, NJ USA",Johnson & Johnson; Janssen Pharmaceuticals,,,,,,,,,0,0,0,0,2,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMH37,A121,A121,,10.1016/j.jval.2015.03.709,0.0,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502052,0
J,"Juhász, K; Gajdácsi, J; Boncz, I; Molics, B; Sebestyén, A",,,,"Juhasz, K.; Gajdacsi, J.; Boncz, I; Molics, B.; Sebestyen, A.",,,MULTINOMINAL LOGISTIC REGRESSION ANALYSIS OF RISK FACTORS INFLUENCING THE TIME UNTIL SECONDARY HIP FRACTURES,VALUE IN HEALTH,,,English,Meeting Abstract,,,,,,,,,"[Juhasz, K.] Natl Hlth Insurance Fund Adm, Pecs, Hungary; [Gajdacsi, J.] Natl Hlth Insurance Fund Adm, Budapest, Hungary; [Boncz, I; Molics, B.; Sebestyen, A.] Univ Pecs, Pecs, Hungary",University of Pecs,,,"Boncz, Imre/A-8940-2013","Boncz, Imre/0000-0003-3699-6236",,,,,0,0,0,3,19,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1098-3015,1524-4733,,VALUE HEALTH,Value Health,MAY,2015,18.0,3.0,,,,PMS23,A156,A156,,,,,,1,Economics; Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services,CI1IZ,,hybrid,,,2024-03-09,WOS:000354498502244,0
